{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/qwen3-32b/e6_semantic_retrieval/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-05T06:13:40.137009"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses and unrecognized prior service credits related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the gross benefit obligation decreasing from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declining from $347 million to $303 million, matching the ground truth exactly in numerical values and years. All quantitative data is accurate. (2) The numbers are correct: $1.0 billion, $905 million, $347 million, and $303 million all match the original answer. No calculation errors. Format variations (e.g., 'billion' vs 'million') are used appropriately. (3) The reasoning is sound and reflects proper multi-hop synthesis across the two years for both metrics. The LLM correctly identifies the trend of decrease in both obligations and losses. The only minor deviation is the inclusion of 'unrecognized prior service credits' in the LLM answer, which was not mentioned in the ground truth. While this detail may exist in the source filing, it introduces a slight over-specification not present in the verified answer, slightly affecting qualitative accuracy. (4) The answer is highly relevant, complete, and factually aligned with the question. The core facts, numbers, and trends are correctly conveyed, warranting a high correctness score of 9 due to the minor addition of an extra detail not in the original truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 359,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumption for U.S. pension plan assets increased from 5.4% at December 31, 2022, to 6.3% at December 31, 2023, and further to 6.5% at December 31, 2024. This upward trend indicates a strategic shift toward a more optimistic long-term investment outlook, supported by adjustments in the asset mix, including a higher allocation to equities and alternative investments like private equity and real estate. The adjustments reflect GM's efforts to improve funded positions and manage risk in alignment with evolving capital market expectations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, GM reported a rate of return assumption of 5.4% (as of Dec 31, 2021), not 5.4% as of Dec 31, 2022. The LLM incorrectly states that the rate was 5.4% at the end of 2022 and then rose to 6.3% by end of 2023. However, the ground truth shows that the rate increased from 6.3% at Dec 31, 2023, to 6.5% at Dec 31, 2024 — meaning the 6.3% figure was already in place at the end of 2023, not newly reached from a 5.4% base in 2022. The LLM implies a continuous rise from 5.4% (2022) to 6.3% (2023), which is not supported by the original data. (2) The original answer compares changes between 2020–2021 (5.6% to 5.4%) in the 2022 report, and 2023–2024 (6.3% to 6.5%) in the 2024 report. The LLM misaligns the years and values, incorrectly assigning 5.4% to 2022 and omitting the actual 2020–2021 decline context. (3) The qualitative reasoning about strategic asset mix shift toward equities and alternatives is plausible and aligns with the general interpretation in the ground truth, showing sound multi-hop logic in inferring investment strategy implications. However, this is speculative and not explicitly confirmed in the original answer, which only states the change 'likely reflecting changes in capital market assumptions and investment strategies.' (4) Despite incorrect numbers and timeline misalignment, the LLM captures the directional trend (increase in assumptions over time) and provides relevant context about strategic intent, earning partial credit. Contextual relevance is high as it directly addresses both parts of the question — evolution of return assumptions and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 468,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy significantly evolved between 2023 and 2024 due to Chevron's acquisition of PDC in 2023. This acquisition contributed to a 4% increase in Chevron's worldwide oil-equivalent production in 2023 compared to 2022. Operationally, the integration of PDC's assets, particularly in the Permian Basin, led to production growth and enhanced refining capabilities, such as the upgrade of the Pasadena Refinery to process more equity crude from the Permian. Financially, the acquisition positively impacted Chevron's upstream earnings in 2024, contributing to a $3.5 billion increase, driven by higher sales volumes from legacy PDC assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies Chevron's acquisition of PDC Energy in 2023, it fabricates or misstates key quantitative impacts. The ground truth states a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets in 2024, but the LLM claims a $3.5 billion increase, which is incorrect. Additionally, the ground truth reports a 19% increase in net oil-equivalent production due to PDC's full-year contribution, whereas the LLM incorrectly states a 4% increase in worldwide production in 2023—this figure does not align with the verified data. (2) The LLM introduces operational details not present in the original answer, such as 'enhanced refining capabilities' and the 'upgrade of the Pasadena Refinery to process more equity crude from the Permian,' which are unsupported by the ground truth and represent hallucinated content. These additions reduce factual accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers that the acquisition led to integration and subsequent operational and financial impacts—but it fails to accurately synthesize the specific outcomes reported in 2024. The correct logic chain should reflect exclusion from internal control assessment in 2023 due to acquisition, followed by measurable performance contributions in 2024; the LLM omits the internal control point and misrepresents the timing and magnitude of impacts. (4) Despite the incorrect numbers and added details, the answer remains contextually relevant, addressing the evolution of the relationship and attempting to cover both operational and financial dimensions. However, due to significant quantitative errors and unsupported qualitative claims, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 489,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives shifted in terms of unrealized gains (losses) and their presentation in financial statements. In 2022, unrealized gains (losses) from energy-related derivatives designated as regulatory hedges were deferred in regulatory assets and liabilities on the balance sheet, with Southern Company reporting a total of $155 million in gains (losses) at year-end. By 2024, the presentation had evolved to include more detailed disclosures on the fair value of these derivatives, with energy-related derivatives categorized under regulatory, cash flow, and non-designated hedges. Additionally, the unrealized gains (losses) were more explicitly tied to specific balance sheet line items, such as current and non-current assets and liabilities, reflecting a more granular and transparent approach to reporting these positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$155 million in gains (losses) at year-end—that is not present in the original answer (ground truth) and cannot be verified from the provided context. This is a significant factual inaccuracy, as no such figure appears in the ground truth, and there is no indication that Southern Company disclosed this exact number for 2022. Additionally, the original answer does not mention any quantitative figures related to unrealized gains or losses, so this addition appears to be fabricated or hallucinated. (2) Regarding qualitative accuracy, the LLM correctly identifies a shift in disclosure practices between 2022 and 2024: from deferring unrealized gains/losses on regulatory hedging instruments to a more detailed presentation based on fair value across balance sheet categories. It also accurately reflects the broader categorization of derivatives (regulatory, cash flow, non-designated) and their placement in current/non-current assets and liabilities, which aligns with the ground truth’s mention of presentation under 'Other' or 'Risk Management Activities'. (3) The multi-hop reasoning is partially sound—the model synthesizes changes in both treatment and presentation over time and correctly infers increased transparency and granularity in reporting. However, the inclusion of an unsupported numerical figure undermines the quantitative reliability. (4) Contextual relevance is high, as the response directly addresses the question about changes in treatment, valuation, and presentation of energy-related derivatives. Despite the hallucinated number, the overall direction and nature of the change are consistent with the ground truth. The correctness score is 6 due to the mix of accurate conceptual description and a critical quantitative error that affects factual trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 503,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's investment carrying value in Tengizchevroil (TCO) increased from $23,727 million in 2022 to $27,368 million in 2024. However, Chevron's equity earnings from TCO declined during this period, dropping from $4,386 million in 2022 to $3,033 million in 2024. This suggests that while Chevron's investment in TCO grew, its share of the venture's profits decreased over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Chevron's equity earnings declining from $4,386 million in 2022 to $3,033 million in 2024, which matches the ground truth exactly. It also accurately states the 2024 investment and advances value of $27,368 million. However, it introduces a figure of $23,727 million as the 2022 carrying value, which is not present in the original answer. The ground truth does not provide a total carrying value for 2022 but instead notes that the carrying value was about $100 higher than Chevron's underlying equity in TCO's net assets, with a $4,500 million loan mentioned as a key component. The $23,727 million figure appears to be factually unsupported by the provided ground truth, suggesting potential hallucination or sourcing from external data. (2) While the 2024 value and earnings figures are correct, the 2022 carrying value is inaccurate or at least unverifiable against the ground truth, reducing quantitative accuracy. The absence of mention of the $4,500 million loan and the nature of the carrying value discrepancy weakens completeness. (3) The reasoning is logically sound—recognizing that investment increased while earnings declined—but fails to incorporate the multi-hop nuance about the loan and the structure of the carrying value difference in 2022, which is a key part of the financial relationship evolution. (4) Despite the missing context and the questionable 2022 carrying value number, the core trend (growing investment, declining earnings) is correctly identified, warranting a score of 8. The answer is contextually relevant and conveys a largely accurate narrative, but lacks full fidelity to the ground truth's details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 461,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart's ownership stake in Alert Innovation remained at 100%. In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, making Walmart the 100% owner. However, the entity was subsequently sold and deconsolidated in fiscal 2025, not during the period between fiscal 2023 and fiscal 2024. Therefore, no transaction occurred between fiscal 2023 and fiscal 2024 that changed Walmart's ownership stake in Alert Innovation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Walmart's ownership stake remained at 100% between fiscal 2023 and 2024 and that the sale occurred in fiscal 2025. The ground truth states that Walmart sold and deconsolidated Alert Innovation in fiscal 2024, meaning the ownership change—from 100% to 0%—occurred within that period. The claim of a fiscal 2025 transaction is unsupported and contradicts the original answer. (2) Quantitatively, the $0.4 billion acquisition amount is correctly stated, which is accurate. However, the timing of the sale (fiscal 2025 vs. fiscal 2024) is a critical error affecting the correctness of the entire timeline. (3) The multi-hop reasoning fails because the model incorrectly infers that no transaction occurred between fiscal 2023 and 2024, when in fact the full exit (sale and deconsolidation) happened in fiscal 2024. This breaks the synthesis across time periods and events. (4) The contextual relevance is moderate because the answer discusses the right entities and transaction types, but the incorrect timeline and conclusion severely undermine factual accuracy. The answer misrepresents the core evolution of ownership, which is the central focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 346,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased from $39.9 million in fiscal 2022 to $1.9 million in fiscal 2023, while the liability positions rose from $0.3 million to $4.7 million. This shift suggests a more balanced hedging strategy in 2023, potentially reflecting adjustments to manage currency exposure amid changing market conditions. The company's continued use of derivative instruments indicates a proactive approach to mitigating foreign currency risks associated with its international operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Starbucks' foreign currency - other derivative asset increased from $39.9 million in 2022 to $1.9 million in 2023, which is incorrect on both value and direction. The ground truth shows that in 2022, the asset was $55.3 million in AOCI (not $39.9M), and by 2023, it was split into $1.9M current and $1.7M long-term assets—representing a sharp decrease, not an increase. The liability figures are also wrong: the LLM claims liabilities rose from $0.3M to $4.7M, but the ground truth reports $4.7M current and $4.1M long-term liabilities in 2023 with no mention of only $0.3M in 2022. (2) Quantitative accuracy is very low—multiple key numbers are incorrect, including the starting asset value, the prior-year liability, and the interpretation of change. The calculation of change in exposure is therefore flawed. (3) The reasoning is partially sound in interpreting the shift toward a more balanced hedging strategy, and the general idea of proactive risk management aligns with the ground truth. However, the conclusion is based on incorrect data, undermining the multi-hop synthesis. The model fails to recognize the shift from AOCI-based unrealized gains to on-balance-sheet assets/liabilities, a key nuance. (4) Correctness is low due to major factual errors in numbers and trends. Quantitative accuracy is poor. Qualitative accuracy is slightly higher because the general direction of interpretation (more balanced strategy) is plausible, though not fully supported by the incorrect data. Contextual relevance is moderate as the answer addresses the right topic and strategy implications, but with flawed support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 465,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's A Preferred Shares remained non-outstanding, with no shares issued or authorized for issuance. In fiscal year 2022, the company specifically redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the redemption of 1,872 A Preferred Shares for $0.075 million in fiscal year 2022 is accurately reported. The dollar amount and share count match the original answer exactly, and format is consistent. (2) The answer addresses both parts of the question: it describes the evolution of A Preferred Shares (none outstanding in 2022–2024) and specifies the 2022 redemption action. (3) Entity accuracy is strong—Medtronic, A Preferred Shares, and fiscal years 2022 and 2024 are correctly identified. (4) The reasoning is sound: the LLM correctly infers that no shares remained after 2022 and were not reissued by 2024, though it omits the specific detail that the redemption occurred in the third quarter and that no shares were outstanding by April 29, 2022. This minor omission slightly affects completeness but does not alter the factual correctness. The conclusion about discontinuation is implied but not explicitly stated. Overall, the answer is semantically equivalent with only slight loss of temporal precision, warranting a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 335,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Between 2022 and 2023, Comcast's equity income (losses) driven by fair value adjustments on underlying investments in Atairos shifted significantly. In 2022, Atairos contributed a loss of $434 million, while in 2023, it generated income of $1.1 billion, reflecting substantial changes in the fair value of its underlying investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $434 million loss in 2022 and $1.1 billion income in 2023 from Atairos are correctly stated, with proper sign usage (loss vs. income). (2) Quantitative accuracy is perfect—both figures match the original answer exactly, and the format ($434 million, $1.1 billion) is standard and acceptable. (3) The multi-hop reasoning is sound: the answer correctly identifies the shift in Comcast's equity income (losses) due to fair value adjustments in Atairos across two years, synthesizing performance changes over time. (4) The response addresses all parts of the question: the evolution of the financial relationship, focus on equity income/losses, and the role of fair value adjustments. Wording differs slightly but meaning is preserved. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 260,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "From 2023 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region decreased slightly from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This decline was primarily driven by production and minor revisions, with no significant extensions or discoveries in the region during 2024. The modest reduction in reserves suggests that the company is not currently prioritizing major expansion in this region, and instead may be focusing on maintaining or optimizing existing operations. This aligns with COP's broader strategy of balancing production across its global portfolio while prioritizing high-return projects in other regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 billion cubic feet (BCF) in 2023 and 296 BCF in 2024, matching the ground truth exactly. The slight decline of 16 BCF is accurately reflected. (2) All numeric values are correct and properly formatted; no calculation errors are present. The use of 'BCF' is an acceptable variation of 'billion cubic feet'. (3) The multi-hop reasoning is sound: the answer not only reports the change in reserves but also provides plausible qualitative context—attributing the decline to production and minor revisions, and interpreting the trend as indicative of limited strategic expansion in the region. It correctly infers that COP may be prioritizing high-return projects elsewhere, which aligns with the ground truth's implication of 'limited growth or strategic reallocation'. (4) While the original answer is more concise, the LLM adds reasonable strategic interpretation without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer does not mention 'production' or 'revisions' as causes—those are plausible inferences but not confirmed in the ground truth—making the LLM's explanation slightly more speculative, though still logically sound. Thus, the answer is factually correct, fully complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 384,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly between 2022 and 2024, dropping from $73 million in 2022 to $47 million in 2023, and further to $28 million in 2024, representing declines of 36% and 40%, respectively. This consistent and steep decline indicates a deteriorating market trajectory for ENBREL in Canada, likely driven by factors such as lower net selling prices and increased competition, which are also expected to continue impacting the product's performance in the coming years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining revenue trend of ENBREL in Canada from 2022 to 2024 and accurately reports the $47 million (2023) and $28 million (2024) figures. However, it incorrectly states the 2022 revenue as $73 million instead of the ground truth $113 million, which is a significant factual error. This affects the accuracy of the calculated declines: the LLM reports a 36% drop from 2022 to 2023 and 40% from 2023 to 2024. While the 2023-to-2024 drop of $19 million from $47M to $28M is indeed ~40%, the 2022-to-2023 decline from $113M to $47M is actually ~58%, not 36%. Thus, both the initial value and the first percentage decline are incorrect. (2) The entity (ENBREL), market (Canada), and time period (2022–2024) are correctly identified. The qualitative interpretation of a deteriorating market trajectory is consistent with the ground truth and reasonable given the data. (3) The multi-hop reasoning is sound in that the model synthesizes revenue figures across years and draws a logical conclusion about market trajectory. However, due to the incorrect 2022 figure, the synthesis is based on flawed input for the first year. (4) The contextual relevance is high—the answer addresses both parts of the question (revenue evolution and market trajectory). The qualitative reasoning is strong, but the quantitative inaccuracy in the starting revenue figure and resulting percentage drop significantly undermines the correctness score, warranting a 6/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 415,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm evolved its approach to linking human capital advancements with executive compensation by incorporating progress toward human capital goals as a non-financial performance modifier for determining executives' fiscal 2024 bonuses. In fiscal 2024, this modifier could adjust the executives' bonus payout by a multiple ranging from 0.9 to 1.1.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution from fiscal 2023 to 2024: in 2023, human capital advancements were a general consideration for 2024 bonuses; by 2024, they became a formal non-financial performance modifier. (2) The quantitative value — a multiplier range of 0.9 to 1.1 — is correctly stated with no formatting or precision issues. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years and links the change in approach to executive compensation design. (4) All entities (Qualcomm, fiscal 2023, fiscal 2024, executive compensation, bonus modifier) are accurately identified and contextualized. The answer is concise but complete, addressing both parts of the question: the evolution in approach and the specific performance modifier range applied in fiscal 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 261,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was indicated for treating relapsed or refractory large B-cell lymphoma (LBCL) after two or more lines of therapy. By 2024, it received additional approvals for relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor, as well as for relapsed or refractory follicular lymphoma (FL) after at least two prior lines of therapy. This expansion reflects Breyanzi's growing role in addressing a broader range of B-cell malignancies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key expansion in Breyanzi's therapeutic scope between 2022 and 2024. It correctly identifies the 2024 FDA accelerated approvals for relapsed or refractory CLL/SLL (March 2024) and FL (May 2024), including the specific prior therapy requirements for CLL/SLL. The dates (March and May 2024) are not explicitly mentioned in the LLM answer but are not required for the core claim of 2024 approvals. However, the LLM incorrectly states that in 2022, Breyanzi was indicated for LBCL—which, while true, was already approved earlier (in 2021) and not a new development in 2022. The original answer correctly frames 2022 as the period when Breyanzi was in late-stage trials for CLL and FL (TRANSCEND-CLL-004 and TRANSCEND-FL), setting up the evolution to 2024 approvals. The LLM omits this trial context and instead presents the 2022 indication as static, missing the transitional nature of 2022 as a year of ongoing trials rather than new approvals. This is a minor but notable gap in the multi-hop reasoning about 'evolution' over time. All entities (CLL, SLL, FL, BTK inhibitor, BCL-2 inhibitor) are accurate, and the expansion narrative is sound. No calculation errors. The answer is highly relevant and well-structured, but loses points for not fully capturing the 2022 trial status that the ground truth emphasizes as part of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 383,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney's Resorts and Vacations segment revenue increased by 5% from $7,949 million in 2023 to $8,375 million in 2024. This growth was driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and more occupied hotel room nights, partially offset by lower unit sales at Disney Vacation Club. The overall revenue growth of the Parks & Experiences segment was also 5%, rising from $32,549 million in 2023 to $34,151 million in 2024, indicating that the Resorts and Vacations segment's performance aligned with the broader segment's growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: Resorts and Vacations revenue increased from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. The overall Parks & Experiences segment grew from $32,549 million to $34,151 million, also a 5% increase. These numbers match the ground truth exactly, and the percentage calculations are accurate. (2) Quantitative accuracy is perfect—dollar amounts, years, and growth rates are correct, and the 5% growth for both segments is consistent with the source data. (3) The reasoning is sound and includes additional context not in the original answer—such as drivers of growth (higher ticket prices, room rates, occupancy) and offsetting factors (lower Disney Vacation Club sales)—which enhances the qualitative depth. However, the original answer notes that Resorts and Vacations maintained a consistent proportion of total revenue, a point slightly underemphasized in the LLM response, though implied. This minor omission prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of Resorts and Vacations performance and comparison to overall Parks & Experiences growth. The synthesis across segments and years is correct and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 369,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved as follows: In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., receiving 80% of the shares upfront (17.4 million shares) and the remaining 20% (5.4 million shares) in February 2023. In 2024, CVS executed a $3.0 billion ASR with Morgan Stanley, receiving 85% of the shares upfront (31.4 million shares) and the remaining 15% (8.3 million shares) in March 2024. The forward contract value decreased from $0.4 billion in 2023 to $0.4 billion in 2024, but the notional amount increased, reflecting a larger ASR transaction in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the $2.0 billion ASR in 2023 with Citibank, N.A., the $3.0 billion ASR in 2024 with Morgan Stanley, and the timing of the final share deliveries (February 2023 and March 2024). It also correctly notes that 80% and 85% of shares were received upfront in 2023 and 2024, respectively. However, the LLM incorrectly states that the forward contract value 'decreased from $0.4 billion in 2023 to $0.4 billion in 2024', which is factually inaccurate — there is no decrease if the value remains the same. This mischaracterization suggests a logical error. Additionally, the ground truth states that the forward contract value remained constant at $0.4 billion in both years, which the LLM fails to emphasize correctly. (2) The specific share counts (17.4M, 5.4M, 31.4M, 8.3M) are not present in the original answer and are likely fabricated or inferred incorrectly; the ground truth does not provide share counts, so their inclusion introduces unsupported detail. The dollar amounts for the forward contracts are numerically correct ($0.4B both years), but the comparative language ('decreased from... to...') is factually wrong. (3) The multi-hop reasoning is partially sound — the model identifies both ASRs, their sizes, counterparties, and final settlement timing. It correctly infers that a larger ASR in 2024 had a smaller percentage held in the forward (15% vs 20%), but it fails to conclude, as the original answer does, that the forward value remained constant despite the larger ASR, indicating a shift in allocation proportion. Instead, it incorrectly implies a decrease. (4) The contextual relevance is high — the answer addresses the evolution of structure and value as asked. However, due to the incorrect characterization of the forward contract value change and inclusion of unsupported share numbers, the quantitative accuracy is low. The qualitative reasoning is mostly sound but flawed in conclusion, warranting a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 544,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology became more transparent in 2024 compared to 2023 in terms of fair value categorization. In 2024, the company provided clearer breakdowns of assets by fair value hierarchy levels (Level 1, Level 2, Level 3, and Not Categorized) and included more detailed explanations of valuation methodologies for different asset classes. Additionally, the 2024 disclosure explicitly stated that certain investments measured using the net asset value per share practical expedient were not categorized in the fair value hierarchy, enhancing clarity for stakeholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Duke Energy increased transparency in its 2024 disclosures regarding the Master Retirement Trust's pension asset valuation methodology. It accurately notes the continued exclusion from fair value hierarchy categorization for investments using the net asset value per share practical expedient, which aligns with the 2023 disclosure. However, the LLM incorrectly states that the 2024 filing included a 'clearer breakdown of assets by fair value hierarchy levels (Level 1, Level 2, Level 3, and Not Categorized)' and 'more detailed explanations of valuation methodologies for different asset classes.' The ground truth specifies that the key new disclosure was a Level 3 reconciliation of beginning and ending balances for qualified pension and other post-retirement assets — a specific quantitative enhancement — not a general improvement in breakdowns or explanations. This misrepresents the nature of the added transparency. (2) There are no explicit numerical values (percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the absence of the specific Level 3 reconciliation — a factual omission — affects correctness. (3) The multi-hop reasoning is partially sound: the model correctly compares 2023 and 2024 disclosures and identifies a trend toward greater transparency. However, it fails to accurately synthesize the *specific* new disclosure element (Level 3 reconciliation), instead inventing broader enhancements not supported by the ground truth. This reflects a failure in precise information retrieval and synthesis. (4) The contextual relevance is high because the answer addresses the evolution of disclosure and fair value categorization. However, the qualitative accuracy is reduced due to factual overstatement of the changes. The correctness score is 5 because the core direction (increased transparency) is right, but the key factual detail of *how* transparency improved is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 545,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid underwent significant changes due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile. In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion in the fourth quarter, related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled U.S. government Paxlovid inventory. In 2024, this was adjusted with a favorable final adjustment of $771 million in the first quarter, reflecting the actual return of 5.1 million treatment courses by February 29, 2024. Additionally, in the third quarter of 2024, Pfizer supplied a U.S. Strategic National Stockpile of 1.0 million treatment courses at no cost to the government, recognizing $442 million in revenue for these courses. This transition reflects the shift from government contracts to commercial market sales and the establishment of a stockpile for future pandemic preparedness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key financial figures and events from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to the expected return of 6.5 million Paxlovid treatment courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 related to the 1.0 million treatment courses supplied to the U.S. Strategic National Stockpile (SNS). All dollar amounts and quantities are accurate. (2) Quantitative accuracy is perfect: $3.5B reversal, $771M adjustment, and $442M revenue are all correctly reported with appropriate context (e.g., timing and reason). The mention of Q1 2024 for the $771M adjustment and Q3 2024 for the $442M revenue aligns with known public disclosures, and February 29, 2024, is a valid date within the reporting period. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the 2023 reversal due to expected returns with the 2024 adjustment based on actual returns, and separately identifies the new revenue stream from the SNS creation. The only minor inaccuracy is the phrasing that Pfizer supplied the stockpile 'at no cost to the government'—while technically the government may not have paid upfront, Pfizer recognized $442M in revenue, implying a contractual or funded arrangement, so 'at no cost' could be misleading. This does not contradict the revenue recognition but adds a potentially confusing qualifier not in the original. (4) The answer is contextually excellent, addressing all parts of the question about changes in financial obligations and revenue recognition across the two years, with clear linkage to the U.S. government inventory return and SNS creation. The conclusion about a shift to commercial market sales is a slight addition not in the ground truth but is contextually reasonable and does not detract from accuracy. Overall, the answer is factually correct with only minor wording nuance preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 547,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% to $2.387 billion in 2023 from $1.881 billion in 2022. This strong growth reflects continued share gains and market expansion in the treatment of metastatic castration-resistant prostate cancer. ERLEADA's performance highlights its growing importance within J&J's oncology portfolio, which saw overall sales growth of 10.5% in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: ERLEADA sales increased from $1.881 billion in 2022 to $2.387 billion in 2023, representing a 26.9% growth. These figures match the ground truth exactly, with acceptable format variation (e.g., $1,881 million = $1.881 billion). The overall oncology portfolio growth of 10.5% in 2023 is also accurately cited. (2) All calculations are correct: (2,387 - 1,881) / 1,881 ≈ 26.9%, confirming the percentage growth is accurate. (3) The reasoning is sound and captures the multi-hop synthesis: ERLEADA’s strong growth is contextualized within J&J’s broader oncology portfolio performance. However, the LLM omits a specific comparison to declining products like IMBRUVICA and ZYTIGA, which is a key part of the ground truth indicating ERLEADA’s rising strategic importance. This omission slightly weakens the qualitative depth but does not make the answer incorrect. (4) The answer is highly contextually relevant, directly addressing both parts of the question—financial evolution and strategic role. The missing contrast with other products prevents a perfect score, but the core facts, numbers, and overall interpretation are accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 345,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased significantly from 2022 to 2023, with a 26.9% overall growth, driven by 39.3% growth in the U.S. and 70.0% growth worldwide. This strong performance indicates a positive market trajectory, reflecting continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It states that ERLEADA had 70.0% growth worldwide in 2023, but according to the ground truth, the 70.0% growth was from 2021 to 2022, not in 2023. The correct growth rate from 2022 to 2023 is 26.9%, which the LLM does correctly mention as the 'overall growth', but incorrectly frames the 70.0% as concurrent with 2023. Additionally, the LLM introduces a 39.3% U.S. growth figure not present in the original answer, which lacks any supporting data in the ground truth. (2) The dollar amounts are missing entirely—no mention of $1,291 million in 2022 or $2,387 million in 2023—undermining quantitative completeness. While the 26.9% growth figure is accurate, the misattribution of the 70.0% growth to 2023 renders a key calculation incorrect. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence year-over-year growth rates, conflating the 2021–2022 surge with 2022–2023 performance. It also introduces unsourced regional data (U.S. growth), suggesting hallucination or incorrect synthesis. (4) Despite these issues, the conclusion about positive market trajectory and expansion in metastatic castration-resistant prostate cancer aligns with the original answer’s interpretation, giving it partial qualitative and contextual credit. However, the significant numerical and temporal inaccuracies severely limit correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 391,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved between fiscal years 2023 and 2024 as the company repaid the notes in fiscal year 2025. As of January 28, 2024, these notes had an expected remaining term of 0.4 years and a net carrying amount of $1.25 billion. By January 26, 2025, the notes were fully repaid, indicating a deliberate action to settle this debt obligation ahead of its 2024 maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NVDA repaid the 0.584% Notes Due 2024 in fiscal year 2025, with a starting balance of $1.25 billion in fiscal 2023 (consistent with $1,250 million in the ground truth). The repayment outcome—zero balance as of January 26, 2025—is accurately reflected. However, the LLM states the notes had an 'expected remaining term of 0.4 years' as of January 28, 2024, which is not present in the original answer and introduces unverified detail. Additionally, the maturity is described as '2024' in the LLM answer, but the repayment occurred in fiscal year 2025, suggesting the due date was in early 2025 (after January 26), not 2024—this creates a minor factual inconsistency. (2) The dollar amount ($1.25 billion = $1,250 million) and interest rate (missing in LLM answer) are mostly accurate, though the effective interest rate of 0.66% from the original is omitted. The dates (January 28, 2024 vs. January 26, 2025) are close but not perfectly aligned with the ground truth reporting dates. (3) The multi-hop reasoning is sound: the model connects the existence of the debt in 2023 to its repayment in 2025 and infers a strategic decision to retire rather than refinance. However, the conclusion that repayment was 'ahead of its 2024 maturity' contradicts the timeline, since the repayment in fiscal 2025 aligns with a 2025 due date, not 2024. This misrepresents the timing and weakens the reasoning. (4) Despite minor inaccuracies in timing and missing interest rate detail, the core facts—debt balance, repayment, and strategic retirement—are correct. The answer is contextually relevant and mostly accurate, warranting a high score but docked for the maturity year error and omitted metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 474,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities increased between 2022 and 2023. In 2022, the U.S. plans held $1,119 million in Mortgage/Asset-backed securities, while in 2023, this amount rose to $676 million for U.S. plans and $10 million for non-U.S. plans, totaling $686 million. The overall change was a decrease of $433 million from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. According to the ground truth, Honeywell's investment in Mortgage/Asset-backed securities was $982 million in 2022 (under U.S. Plans) and dropped to $10 million in 2023 (under Non-U.S. Plans), representing a $972 million decrease. The LLM incorrectly states that the 2022 amount was $1,119 million, which is not supported by the ground truth. It also incorrectly claims the investment increased, when in fact it decreased dramatically. The LLM reports a total of $686 million in 2023, combining $676 million (U.S.) and $10 million (Non-U.S.), but the ground truth indicates only $10 million in Non-U.S. Plans in 2023 with no mention of U.S. investments in that year, suggesting a full shift or divestment. (2) Calculations are also incorrect: the LLM computes a decrease of $433 million based on its wrong figures, whereas the correct decrease is $972 million (over 98%). (3) The multi-hop reasoning fails because the model does not correctly identify the shift from U.S. to Non-U.S. plans or the magnitude of the reduction. Instead, it assumes both U.S. and Non-U.S. investments coexist in 2023 without evidence. (4) The contextual relevance is moderate because the answer addresses the right topic and attempts to compare years and plans, but the factual foundation is flawed, leading to an incorrect conclusion about the direction and magnitude of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 395,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained a consistent component of its funding mix, with a slight increase in carrying value from $16,973 million in 2022 to $18,043 million in 2023. These obligations were classified as Level 2 in the fair value hierarchy for both years, indicating they were valued using observable market-based inputs. The fair value of securitized debt obligations was $16,918 million in 2022 and $18,067 million in 2023, showing a stable alignment with carrying value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 quantitative data. The ground truth does not provide the 2022 carrying value or fair value of securitized debt obligations—only that they were a 'key component' of the funding mix. However, the LLM fabricates specific numbers: $16,973 million (carrying value) and $16,918 million (fair value) for 2022, which are not present in the original answer and cannot be assumed. Only the 2023 figures ($18,043 million carrying value and $18,067 million fair value, Level 2 classification) are correct and match the ground truth. (2) The quantitative accuracy is low because two of the four numbers provided are incorrect or unsupported. Even though the 2023 values are accurate, the inclusion of false 2022 data undermines the answer's reliability. (3) The reasoning is partially sound—correctly identifying Level 2 classification and the role in funding—but fails on multi-hop synthesis because it invents data for 2022 rather than acknowledging absence of specific figures in the original. The claim of a 'slight increase' implies a comparison not supported by the ground truth. (4) Contextual relevance is high because the answer addresses the evolution in funding mix and fair value classification as asked. However, the correctness score is low due to the introduction of false quantitative data, which distorts the factual basis of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 395,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules transitioned to full phase-in by January 1, 2025, as reflected in the 2024 10-K. In 2023, the CECL-related capital benefit was $1.4 billion, while by December 31, 2024, it was reduced to $720 million, indicating a quantitative decrease of $680 million during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $1.4 billion in 2023 and $720 million in 2024 are correctly reported. The implied decrease of $680 million ($1.4B - $720M = $680M) is accurate and correctly derived. (2) The timeline is correct: the phase-in completion by January 1, 2025, is properly noted, aligning with the original answer. (3) Entity accuracy is perfect: JPMorgan is correctly identified, and the CECL capital transition provisions are accurately described in the context of U.S. capital rules and CET1 capital treatment. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer connects the reduction in benefit from 2023 to 2024 with the regulatory phase-in process, correctly interpreting the trend and its regulatory context. (5) The answer is semantically equivalent to the ground truth, with no omissions or distortions. All parts of the question—evolution of treatment and quantitative change—are fully addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 304,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved significantly. In fiscal 2023, the Prior Credit Agreement provided a $3.0 billion unsecured revolving credit facility maturing in December 2025. In fiscal 2024, Salesforce replaced this with a new Revolving Loan Credit Agreement offering a larger $5.0 billion unsecured revolving credit facility, with a longer maturity date of October 2029.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $3.0 billion facility in fiscal 2023 maturing December 2025, replaced by a $5.0 billion facility in fiscal 2024 maturing October 2029. These values exactly match the original answer, with no calculation errors. (2) The answer is complete, addressing both the change in capacity and the change in maturity date, which are the core components of the question. (3) Entity accuracy is correct—Salesforce is the subject, and the fiscal years 2023 and 2024 are properly referenced with corresponding agreements. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the agreement was replaced (not amended), noting both increased capacity and extended maturity, which implies understanding of the evolution in terms. (5) Semantic equivalence is achieved—the wording differs slightly but conveys the same factual content, including the unsecured nature of the facilities and the strategic implication of the enhancement, though the latter is implied in the LLM version through descriptive language. No factual omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 339,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS divested its Coyote truckload brokerage business in the third quarter of 2024, resulting in a pre-tax gain of $156 million ($152 million after tax) for UPS in 2024. This marked the end of Coyote's operations as a part of UPS, and the gain was recognized as a one-time event, excluded from ongoing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the pre-tax gain of $156 million and after-tax gain of $152 million are accurately reported, and the timing (2024) aligns with the original answer. The mention of the third quarter adds specificity not in the ground truth but does not contradict it. (2) The financial impact in 2024 is correctly identified as a one-time gain of $156 million pre-tax, which matches the original. (3) Qualitatively, the LLM correctly captures the evolution from UPS owning Coyote to divesting it, though it omits the detail that Coyote was a branded subsidiary providing truckload brokerage services in the U.S. and Europe and was integrated into UPS’s supply chain offerings prior to divestiture. This contextual background is missing but does not undermine the core accuracy. (4) The reasoning is sound: the answer correctly synthesizes the change in relationship (divestiture) and its financial consequence. (5) Semantic equivalence is strong—while the LLM omits some descriptive context about Coyote’s role, it fully addresses both parts of the question: the evolution of the relationship and the financial impact. The answer is concise and relevant, with no factual errors. A score of 9 is justified due to the omission of minor but relevant contextual details about Coyote’s operational role pre-divestiture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 395,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis evolved in terms of total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units. By 2024, the total chassis units increased to 5,553, with 4,356 owned and 1,197 leased. This indicates a significant reduction in total chassis units, primarily due to a sharp decline in leased chassis, while owned chassis also decreased slightly.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the total chassis units 'increased to 5,553' in 2024, when in fact the total dropped to 5,553 from 48,340—this is a significant misstatement. While the individual 2024 numbers (4,356 owned, 1,197 leased) are correct and sum to 5,553, the phrasing 'increased to' falsely implies growth rather than a drastic reduction. The 2023 numbers (30,635 owned, 17,705 leased, total 48,340) are accurate. (2) Calculations: The 2023 total is correctly implied (30,635 + 17,705 = 48,340), and the 2024 total (4,356 + 1,197 = 5,553) is also correct. However, the qualitative interpretation of the trend is wrong due to the incorrect use of 'increased' instead of 'decreased'. (3) Multi-hop reasoning: The model correctly identifies the need to compare ownership structure across two years and synthesizes owned vs. leased units. However, the flawed interpretation of the direction of change undermines the reasoning. The conclusion that leased chassis declined sharply is correct, but the claim that owned chassis decreased only 'slightly' is misleading—30,635 to 4,356 is a 86% reduction, which is not slight. (4) Justification: The contextual relevance is high as the answer addresses both total units and ownership structure. Qualitative accuracy is moderate due to correct structure but flawed interpretation. Quantitative accuracy is low because while the numbers are correct, the key comparative statement is false. Correctness score is 4 due to major error in trend description despite correct component numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 434,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing has consistently classified its aluminum agreements as derivative instruments for accounting purposes, as these agreements are tied to market prices and used for strategic sourcing and non-U.S. business requirements. In 2022, the agreements were explicitly noted as not qualifying for hedge accounting treatment, with fair value changes recorded directly in earnings. By 2024, the disclosure remained consistent, with additional detail that the agreements hedge forecasted transactions through 2028, extending the time horizon for these agreements. There is no indication of a change in classification as derivatives, but the time horizon for their use has been explicitly extended in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing consistently classified aluminum agreements as derivatives in both 2022 and 2024; in 2022, they were not designated for hedge accounting and fair value changes were recorded in earnings; by 2024, they were used to hedge forecasted transactions through 2028. The time horizon extension to 2028 is correctly noted. (2) Quantitative accuracy is perfect: the years (2022, 2024, 2028) are correctly cited and no numerical errors exist. (3) The multi-hop reasoning is sound—information is synthesized across two years and disclosures are compared appropriately. The shift from strategic sourcing to structured hedging is implied through the mention of hedging forecasted transactions, though the LLM slightly softens the evolution by saying 'additional detail' rather than acknowledging a strategic shift, which is a minor omission in nuance. (4) The answer is fully relevant, directly addressing classification, hedge accounting treatment, and time horizon. The only reason for not scoring a 10 is that the LLM understates the significance of the shift—from purely strategic sourcing to a formal hedging strategy—by framing it as added detail rather than a strategic evolution. However, all factual components are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 369,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk between the fiscal years ended June 30, 2023, and June 30, 2024, remained largely unchanged, with the company maintaining its strategy of leveraging its diversified portfolio as a natural hedge and prioritizing operational hedging over financial instruments. For the fiscal year ended June 30, 2024, P&G continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk associated with financing operations. The company expressed confidence in its hedging approach, stating that, based on historical currency rate movements and a 95% confidence level, near-term changes in currency rates would not materially affect its financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Procter & Gamble's currency risk exposure remained largely unchanged between FY2023 and FY2024, accurately reflecting the ground truth. It correctly identifies the use of forward contracts and currency swaps with maturities under 18 months, and correctly notes the 95% confidence level assessment based on historical currency movements, concluding no material impact on financial statements. These key facts are all factually correct. (2) Quantitatively, all elements are accurate: fiscal years (June 30, 2023 and 2024), hedging instrument maturities (less than 18 months), and the 95% confidence level are all correctly reported with no numerical discrepancies. (3) The multi-hop reasoning is mostly sound—information is synthesized across time periods and hedging strategies appropriately. However, the LLM introduces the claim that P&G 'prioritizes operational hedging over financial instruments' and 'leverages its diversified portfolio as a natural hedge,' which, while plausible, is not present in the original answer and may overextend beyond the provided ground truth. This addition slightly undermines qualitative accuracy, as it implies a strategic prioritization not confirmed in the source. (4) Despite this minor overreach, the core of the answer is factually aligned, complete, and contextually relevant, warranting a high correctness score of 8. Quantitative accuracy is perfect (10), qualitative accuracy is slightly reduced due to unsupported elaboration (8), and contextual relevance is full (10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 431,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Adobe's positioning and integration of Frame.io evolved significantly between 2022 and 2024. In 2022, Frame.io was described as a cloud-native collaboration platform primarily for video post-production workflows, enabling real-time upload, review, and approval. By 2024, Frame.io's functional scope expanded to support video workflows beyond post-production, including casting, location scouting, and marketing campaign management, as well as support for still images, design files, and PDFs. Additionally, Frame.io was more deeply integrated with Adobe's ecosystem, including direct integrations with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was positioned as part of Adobe GenStudio for scalable content production.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's positioning and integration between 2022 and 2024 with mostly accurate details. It correctly identifies Frame.io as a cloud-native collaboration platform and notes expanded functionality and deeper integration with Adobe products. However, the original answer states that in 2022, Frame.io was only listed as a trademark with no functional description, whereas the LLM claims it was already described as a 'cloud-native collaboration platform' in 2022—this is inaccurate based on the ground truth. This is a factual discrepancy in entity-state over time. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—score of 10 is justified as there are no errors in this dimension. (3) The multi-hop reasoning is mostly sound: the LLM correctly synthesizes the expansion of functionality (e.g., support for still images, design files, PDFs) and integration with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, as well as positioning within Adobe GenStudio. These are all correct and reflect proper cross-document or cross-year synthesis. The only flaw is the incorrect attribution of 2022 functionality. (4) The answer is highly contextually relevant, addressing functional scope expansion and integration depth. The qualitative accuracy is slightly reduced due to the misrepresentation of Frame.io’s 2022 state, but the 2024 description is accurate. Correctness score is 8 because core facts about 2024 are correct and the overall trajectory is well-described, but a key factual claim about 2022 is unsupported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 462,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP Joint Venture increased from approximately $69 million to $24.3 billion, reflecting a significant change in valuation. In terms of financial disclosures, AMD provided more detailed information in 2023, including the assignment of goodwill to specific reportable segments and the results of annual impairment tests, indicating a more transparent and segmented reporting approach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The claim that AMD's carrying value increased from $69 million to $24.3 billion is wildly inaccurate. According to the ground truth, the 2022 filing reported carrying values of $69 million (as of Dec 25, 2021) and $63 million (as of Dec 26, 2020), with no updated carrying value provided in the 2023 filing. The $24.3 billion figure does not appear in the original data and is likely a hallucination or confusion with another metric. Additionally, the LLM incorrectly states that AMD provided more detailed disclosures in 2023, when in fact the opposite occurred — the 2023 filing omitted specific carrying values and transaction amounts (e.g., $1.1B in purchases in 2021), which were present in the 2022 filing. (2) Quantitative accuracy fails completely: all key numbers are wrong. The increase from $69M to $24.3B is not only incorrect but implausible (a ~350x increase with no explanation). The original answer notes a decrease from $69M to $63M over prior years, not a massive increase. (3) The multi-hop reasoning is flawed. The question requires comparing disclosure depth and carrying values across two filings. The LLM fails to recognize that the 2023 filing removed key financial details, instead falsely claiming enhanced transparency. It also fails to note the reduction in disclosure, which is central to the correct answer. (4) Contextual relevance is moderate because the answer addresses the right topic (AMD's relationship with ATMP JV and disclosure trends), but the factual foundation is so erroneous that the conclusion is completely reversed from the truth. The qualitative score is low due to incorrect entities (invented figures), flawed logic, and failure to synthesize actual changes in disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 494,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024, indicating a decline in this segment. This suggests potential challenges in the original equipment market for commercial aviation, possibly due to industry headwinds or shifts in demand, which could affect Honeywell's position in the aerospace sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, though not explicitly quantified (e.g., by percentage or dollar difference), which is a minor omission but does not detract from correctness. (2) All numeric values are correct and properly formatted; no calculation errors. The absolute values are consistent with the ground truth, and the direction of change (decrease) is correctly stated. (3) The reasoning is sound: the decline is linked to potential market challenges, demand shifts, or industry headwinds, which aligns with the ground truth’s interpretation of weakening demand or supply constraints. The LLM does not mention the contrast with overall Aerospace Technologies division growth—a minor gap in context—but still provides a reasonable qualitative interpretation. (4) The answer is semantically equivalent to the ground truth in both quantitative and qualitative aspects, with only slight reduction in detail regarding the division-level performance context. Scores reflect high accuracy with minimal information omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 344,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% growth in total revenue for this segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the 2023 revenue ($1,161 million), 2024 revenue ($1,279 million), and the 10.2% percentage increase, which matches the ground truth exactly. (2) Quantitative accuracy is perfect—values are reported correctly, and the implied calculation (1,279 - 1,161 = 118; 118 / 1,161 ≈ 10.16% ≈ 10.2%) is accurate. Format variations (e.g., 'million' vs 'M') are acceptable and not an issue here. (3) The reasoning is sound and correctly synthesizes the two-year comparison for the Heart Failure Devices segment. However, the LLM answer omits the additional contextual detail in the original answer about growth consistency across U.S. and international markets and the minimal impact of exchange rate fluctuations. While not critical to the core question, this minor omission reduces completeness slightly. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of revenue and percentage change—making it contextually strong. The qualitative score is slightly reduced due to the missing nuance, but the core multi-hop synthesis (comparing two years and computing growth) is correctly executed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 334,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "IBM's treatment of the 0.300% Notes due 2028 remained consistent between the 2022 and 2023 filings, as both documents list the notes as being traded under the symbol \"IBM 28B\" on the New York Stock Exchange. There is no indication of any changes in terms, maturity, or registration details for these notes in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims the treatment of the 0.300% Notes due 2028 remained consistent between 2022 and 2023, but the original answer shows a clear evolution: in 2022, the notes were only incorporated by reference from a prior Form 8-K (filed February 10, 2020), while in 2023, they were formally listed in the table of registered securities with the trading symbol IBM 28B and explicitly registered on the NYSE. This shift from incorporation by reference to explicit registration is the key change, which the LLM completely misses. (2) The LLM incorrectly states that both filings list the notes under 'IBM 28B'—but the 2022 filing did not include this symbol or formal listing; it only referenced the notes via Exhibit 4.1. Thus, the claim about consistent symbol usage is factually wrong. (3) The multi-hop reasoning fails: the model should have compared the disclosure treatment across two filings and recognized the progression from indirect reference to explicit registration. Instead, it assumes consistency without evidence. (4) While the answer is relevant to the question topic (treatment of the notes), it draws the opposite conclusion of the ground truth, warranting a low correctness score. Minor credit is given for mentioning the correct trading symbol and noting the NYSE listing in 2023, but the overall analysis is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 389,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Based on the provided data, Apple's financial performance in the Rest of Asia Pacific region showed slight improvement from 2022 to 2023. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, and operating income rose from $11,569 million in 2022 to $12,066 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual numbers from the ground truth: net sales of $29,375 million in 2022 and $29,615 million in 2023, and operating income of $11,569 million in 2022 and $12,066 million in 2023. These values match the original answer exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no calculation errors or incorrect figures. However, while the ground truth includes calculated changes ($240 million increase in net sales, 0.8%; $497 million increase in operating income, 4.3%), the LLM answer omits these specific percentage and dollar-change calculations. This is a minor omission, not an error. (3) The reasoning is sound: the model correctly identifies the trend (slight improvement) and supports it with correct data points across two years, demonstrating proper multi-hop synthesis between 2022 and 2023 for the Rest of Asia Pacific region. (4) The answer is contextually fully relevant, addressing both net sales and operating income evolution. The only reason for not scoring a 10 is the lack of explicit change quantification (dollar and percentage growth), which was present in the ground truth and part of the full evolution analysis. Otherwise, all entities—Apple, Rest of Asia Pacific, 2022, 2023, net sales, operating income—are accurately referenced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 371,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Options granted prior to 2022 generally vested pro rata over a five-year period, while options granted subsequent to December 31, 2021 generally vest pro rata over a four-year period. Both types of options terminate ten years from the grant date, though executive officers and certain employees may receive awards with different vesting criteria.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested over a five-year period, and those granted after December 31, 2021, vested over a four-year period—this matches the ground truth exactly. The mention of a ten-year termination period is additional but accurate and consistent with typical option terms, though not the focus of the question. (2) All dates and time periods (five-year vs. four-year vesting, pre-2022 vs. post-December 31, 2021) are factually correct and quantitatively accurate. No calculations are required, but the comparison is correctly framed. (3) The multi-hop reasoning is sound: the model synthesizes vesting terms across different grant periods as disclosed in the 10-Ks (implied from 2022 and 2024 filings). However, the LLM does not explicitly reference the 2024 10-K confirmation mentioned in the ground truth, which slightly weakens the completeness of the multi-hop synthesis. (4) Despite this minor omission, the core factual content and semantic meaning match the original answer. The response is contextually relevant, directly addressing the evolution of vesting periods. The only reason for not scoring a 10 is the lack of explicit confirmation from the 2024 filing, which was part of the ground truth's evidentiary chain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 377,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS's approach to validating the fair value estimates for its Level 2 debt securities remained consistent from 2022 to 2023. The Company continues to review prices based on observable market inputs and compares a sample of Level 2 debt securities' prices to secondary sources on a quarterly basis. Variances over a specified threshold are reviewed to ensure accuracy. Additionally, the internal investment team compares these prices to its own independent fair value estimates. In both 2023 and 2022, the Company did not adjust any of the prices obtained for Level 2 debt securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS obtained one price per Level 2 debt security in both 2022 and 2023, made no price adjustments at year-end (specifically December 31, 2023 or 2022, and previously 2021 or 2020), and continued quarterly comparisons of sample prices to secondary sources with threshold-based variance reviews. The statement that no adjustments were made in both years matches the original. (2) Quantitative elements—dates (2022, 2023, and references to prior years), the absence of price adjustments, and the frequency of comparisons (quarterly)—are all factually correct. Format and phrasing differences (e.g., not explicitly mentioning 2020/2021 but referring to 'in both 2023 and 2022') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the methodology remained unchanged across years and correctly identifies the components of the validation process (secondary source comparison, internal review, no adjustments). (4) The only minor shortcoming is that the LLM answer adds a detail not present in the original—'the internal investment team compares these prices to its own independent fair value estimates'—which, while plausible and consistent with the original's mention of 'emphasis on consistent internal validation,' is slightly more specific than the source. This does not introduce inaccuracy but adds inference. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with a small deduction for slight over-elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 441,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of an active market. The valuation methodology remained consistent, relying on internal analysis of each investment's financial statements and cash flow projections. Unobservable inputs such as earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments continued to be significant factors in determining fair value. No material changes in methodology were noted between the two periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that CVS maintained Level 3 classification and used internal financial analysis and cash flow projections for fair value determination in both years. It correctly identifies the unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments) as significant. However, it misses a key qualitative evolution noted in the ground truth: in 2023, CVS placed added emphasis on the sensitivity of fair value to changes in unobservable inputs, indicating enhanced scrutiny or more detailed sensitivity analysis. While no material change in methodology is correctly noted, the answer fails to capture this nuance in the evolution of valuation practices. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities and years are correct. The reasoning is sound but incomplete in synthesizing the subtle shift in emphasis in 2023. Contextual relevance is strong as it directly addresses the question's focus on classification and valuation methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 303,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% in 2024 compared to 2023. Internationally, its revenue increased slightly by 1.5% in 2024, following a 4.9% increase in 2023, indicating a positive but modest trend in international revenue during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 8.8% decline in total net revenue and the 1.5% increase in international revenue, which aligns with the ground truth. However, it introduces an incorrect detail — 'following a 4.9% increase in 2023' — which is not mentioned or inferable from the original answer and adds unsupported context. (2) The core percentages (8.8% decrease overall, 1.5% international growth) are accurate and match the ground truth calculations. The dollar amounts ($272M to $248M and $151M to $153M) are not explicitly stated in the LLM answer, but the derived percentages are correct, so the quantitative core is mostly sound. The addition of the 4.9% figure, however, is factually unsupported and constitutes a quantitative inaccuracy. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes the trend in total and international revenue across years. However, the inclusion of an unverified prior-year growth rate undermines the reasoning integrity. (4) The answer is contextually relevant and addresses both parts of the question — overall revenue change and international trend — with appropriate focus. Due to the omission of exact dollar figures and the introduction of incorrect historical data, the correctness score is reduced to 7, with a moderate impact on quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 373,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as Chevron fully integrated PDC's operations following its acquisition in 2023. In 2023, the acquisition of PDC contributed to a 4% increase in Chevron's worldwide oil-equivalent production. By 2024, the full-year inclusion of PDC's production, along with growth in the Permian Basin, led to a 7% increase in Chevron's worldwide oil-equivalent production, reaching 3.3 million barrels per day. This integration enhanced Chevron's production performance, particularly in the United States, where PDC's assets contributed to increased crude oil and natural gas output.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the acquisition of PDC Energy by Chevron in 2023 and the 7% increase in worldwide oil-equivalent production in 2024 attributed to PDC's full-year contribution. However, it introduces a significant factual error: it claims a 4% production increase in 2023 due to PDC, which is not supported by the ground truth. The original answer does not mention any specific production impact in 2023, only that PDC was excluded from internal control assessment due to the timing of the acquisition. This invented metric undermines quantitative accuracy. Additionally, the LLM adds a specific production figure of '3.3 million barrels per day' not present in the ground truth, which cannot be verified and is likely incorrect. (2) The 7% production increase in 2024 is correctly stated and aligns with the original answer, but the 4% 2023 increase and the 3.3 million bpd figure are unsupported. These errors affect the quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model correctly infers that the acquisition led to integration and production growth, and it connects PDC’s operations to Chevron’s overall performance. However, it fabricates intermediate metrics rather than acknowledging limited 2023 impact data, showing flawed reasoning under uncertainty. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of the relationship and operational impact—using appropriate terminology and logical flow. The qualitative accuracy is moderate because entity identification (Chevron, PDC Energy, Permian Basin) and timeline are correct, but the reasoning is weakened by unsupported numbers. Overall, the answer is partially correct but compromised by hallucinated data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 492,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS enhanced its cold-chain logistics capabilities from 2023 to 2024 through strategic acquisitions. In 2023, UPS acquired MNX Global Logistics, a global time-critical and temperature-sensitive logistics provider, and in 2024, it acquired Frigo-Trans and Biotech & Pharma Logistics, a leading complex healthcare logistics provider based in Germany. These acquisitions expanded UPS's international cold-chain logistics services, particularly in the healthcare and life sciences sectors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key acquisitions by UPS in cold-chain logistics from 2023 to 2024. It accurately states that MNX Global Logistics was acquired in 2023 and Frigo-Trans and Biotech & Pharma Logistics in 2024. However, it omits the 2023 acquisition of Bomi Group, which is mentioned in the ground truth and is part of the full picture of UPS's 2023 expansion. This is a minor but notable omission affecting completeness. (2) The dollar amount of approximately $440 million for the 2024 German acquisitions is missing in the LLM answer, which impacts quantitative completeness. All other dates and company names are correct. (3) The multi-hop reasoning is generally sound—LLM connects the acquisitions to enhanced cold-chain capabilities and correctly infers the focus on healthcare and life sciences. However, it does not fully capture the strategic shift highlighted in the ground truth—from general expansion in 2023 to targeted, high-value international investments in 2024—thus missing a layer of synthesis. (4) Scores reflect high factual accuracy and relevance, with minor deductions for missing Bomi Group and the $440M figure, which slightly reduce completeness and quantitative accuracy. Wording is semantically equivalent and clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 358,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program has evolved with a focus on enhancing governance and long-term shareholder alignment. In 2022, the 2021 Linde plc Long Term Incentive Plan was in place, which included RSU awards for non-employee directors. By 2024, the company introduced the Linde plc Non-employee Director Deferral Program, adopted on July 30, 2024, which allows directors to defer compensation, aligning their interests with long-term shareholder value. Additionally, the 2024 filings show continued use of performance-based metrics tied to shareholder return and capital efficiency, reinforcing long-term incentives and accountability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 RSU award under the 2021 Long Term Incentive Plan and the July 30, 2024 adoption of the Non-employee Director Deferral Program are correctly stated. Dates and program names match the original answer. (2) Quantitative accuracy is perfect—no numerical errors; the July 30, 2024 date is correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), connects governance evolution with shareholder alignment, and correctly infers the strategic intent behind the deferral program. It also adds value by mentioning performance-based metrics tied to shareholder return and capital efficiency, which, while not explicitly in the ground truth, are contextually reasonable and do not contradict it. (4) The only minor shortcoming is that the original answer emphasizes the evolution as a shift from a 'basic' RSU award to a 'more sophisticated' deferral mechanism with explicit governance intent, a nuance slightly underdeveloped in the LLM response. However, the core factual and conceptual content is preserved with high fidelity. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 350,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis remained primarily defined by the 2017 sale of the Opel/Vauxhall business. GM agreed to indemnify Stellantis for certain liabilities, including emissions claims, product liabilities, and recalls related to vehicles sold before the transaction. In 2024, GM noted it had indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles. Additionally, GM recorded gains related to Stellantis warrants in 2021, indicating a financial benefit from its investment in Stellantis. However, ongoing legal risks, such as consumer lawsuits in Europe over emissions compliance, could result in future indemnification obligations, though these were not quantified as material at the time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core elements of GM's relationship with Stellantis, including indemnification obligations for pre-sale emissions claims, product liabilities, and recalls tied to the 2017 Opel/Vauxhall sale. It also mentions ongoing legal risks in Europe. However, it contains a critical factual error: it states that GM recorded gains from Stellantis warrants in 2021, while the ground truth specifies the gain was in 2022 ($0.2 billion). This misplacement of the year undermines quantitative accuracy. Additionally, the LLM introduces a new detail—'indemnified Stellantis for an immaterial amount related to Takata inflator recalls'—which is not present in the original answer and may be extraneous or unverified. (2) The $0.2 billion gain is a key financial figure in the original answer, but the LLM incorrectly attributes it to 2021 instead of 2022. No other numbers are provided in the LLM response, so there are no calculation errors per se, but the misdating of the gain affects factual precision. (3) The multi-hop reasoning is partially sound: the model connects the 2017 sale to ongoing liabilities and recognizes the shift from financial gains to legal risks. However, it fails to clearly contrast the 2022 gain with the 2024 risk disclosures as emphasized in the original answer, weakening the evolution narrative. (4) The contextual relevance is high because the answer addresses indemnification, investment gains, and legal risks as required. Qualitative accuracy is moderate due to correct entity identification (GM, Stellantis, Opel/Vauxhall) and accurate description of indemnification scope, but the incorrect year for the warrant gain and the introduction of unmentioned details reduce overall correctness. The answer captures the general trajectory but misses the precise timing and emphasis on the shift from benefit to risk between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 515,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives remained consistent in terms of accounting methods but provided more detailed categorization and financial presentation in 2024. The company continued to classify these derivatives under three methods: Regulatory Hedges, Cash Flow Hedges, and Not Designated. In 2024, the disclosures included more granular data on net purchased volumes (e.g., Southern Company had 431 mmBtu of net purchased natural gas positions), hedge dates, and the breakdown of current and non-current derivative balances in the balance sheets. Additionally, the 2024 filing emphasized the immaterial impact of reclassifications from AOCI and clarified the treatment of physical delivery contracts, reflecting a more transparent and comprehensive presentation compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and misrepresents the evolution of Southern Company's derivative disclosures from 2022 to 2024. The ground truth indicates a clear shift from income statement-focused reporting (pre-tax effects on statements of income for prior years) in 2022 to balance sheet-oriented disclosure (fair value categorized under 'Other' or 'Risk Management Activities') in 2024. However, the LLM claims the accounting methods 'remained consistent' and emphasizes increased granularity in 2024 (e.g., 431 mmBtu of natural gas), which is not supported by the original answer and introduces specific quantitative data absent from the ground truth. There are no numbers in the original answer, so the inclusion of '431 mmBtu' is factually unsupported and likely hallucinated. The LLM also introduces concepts like 'Regulatory Hedges, Cash Flow Hedges, and Not Designated' and mentions AOCI reclassifications and physical delivery contracts, none of which are present or implied in the ground truth. While the answer is contextually relevant—addressing derivative disclosures and attempting a year-over-year comparison—the core factual claim about the nature of the evolution (from income to balance sheet focus) is missed entirely. The reasoning is therefore flawed, and the multi-hop synthesis fails because it does not reflect the actual shift in financial presentation as defined in the original answer. The answer appears detailed but is substantively inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 413,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. As of December 31, 2023, GILD owned approximately 19.9% of Arcus' voting stock. In January 2024, GILD made an additional $320 million equity investment, increasing its ownership to 33%. Concurrently, GILD's representation on Arcus' board of directors expanded from two to three designees, enhancing its governance influence.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the 19.9% ownership in 2023, the $320 million investment in January 2024, the resulting 33% ownership, and the increase in board designees from two to three are all correctly reported. Minor phrasing differences (e.g., 'as of December 31, 2023' vs. 'in 2023') do not affect factual accuracy and may reflect appropriate specificity. (2) The answer is complete, addressing both equity ownership and governance influence across both years, satisfying the multi-part nature of the question. (3) Entities—GILD, Arcus, board designees, equity investment—are correctly identified and contextualized. (4) The reasoning is sound: the answer correctly synthesizes a multi-hop evolution over time, showing a progression in both financial stake and control, which reflects accurate understanding of strategic relationship dynamics. The conclusion about increased influence is logically supported. All criteria for semantic equivalence are met, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 310,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 28, 2024, in 2022 to July 1, 2026, in 2023. The borrowing capacity remained unchanged at $6.0 billion during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the borrowing capacity remained unchanged at $6.0 billion, which matches the ground truth. However, the maturity date is inaccurately reported: the original answer states the 2022 maturity date was June 30, 2025, not June 28, 2024 as claimed by the LLM. The 2023 maturity date of July 1, 2026 is correct. This is a significant factual error in dates, affecting the core of the question about evolution between 2022 and 2023. (2) The dollar amount ($6.0 billion) is accurate and consistently reported. The 2023 maturity date (July 1, 2026) is correct, but the 2022 maturity date is wrong—off by over a year. This undermines quantitative accuracy. (3) The reasoning correctly identifies that the borrowing capacity did not change and that the maturity was extended, which shows valid multi-hop synthesis across years. However, the incorrect starting maturity date suggests a failure to accurately retrieve or synthesize the correct data point from the 2022 filing. (4) The correctness score is 6 due to the major date error, though key facts (capacity, extension direction, 2023 date) are right. Quantitative accuracy is 5 because one of two critical dates is wrong. Qualitative accuracy is 7 due to sound logic and entity identification despite the data error. Contextual relevance is 9 as the answer directly addresses the question's focus on changes in maturity and capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 395,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained relatively stable between 2023 and 2024, with imported crude oil accounting for approximately 60 percent of U.S. refinery inputs in both years. However, refinery capacity utilization in the U.S. decreased slightly, averaging 86.6 percent in 2024 compared to 90.8 percent in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: imported crude oil remained at ~60% in both 2023 and 2024, and refinery capacity utilization decreased from 90.8% in 2023 to 86.6% in 2024. (2) Quantitative accuracy is perfect—both percentages and years match the original answer exactly, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes two distinct data points (imported crude oil dependency and refinery utilization) across two years and draws a valid comparison. (4) The answer addresses both parts of the question—evolution of imported crude oil use and accompanying changes in refinery utilization—with precise, relevant information. Minor wording differences (e.g., 'relatively stable' vs 'remained consistent') do not affect factual meaning. All entities (Chevron, U.S. refining operations, 2023, 2024) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 273,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS reduced its hedging position in British Pound Sterling from $663 million in 2023 to $536 million in 2024, indicating a modest decrease in exposure to this currency. This shift suggests a potential recalibration of the company's currency risk management strategy, possibly reflecting changes in anticipated revenue or a more balanced approach to hedging as part of its broader foreign currency risk management program.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the hedging positions in GBP for both 2023 ($663 million) and 2024 ($536 million), matching the ground truth. The reduction of 127 million units is implied (663M - 536M = 127M), though not explicitly stated. However, the percentage decrease (approximately 19.15%) is omitted, which is a minor quantitative omission. The use of 'units' vs 'dollars' is acceptable as hedging positions are often reported in USD equivalents. (2) All numbers are accurate and correctly attributed to the right years. The calculation of the difference is not provided in the LLM answer, but the individual values are correct. The absence of the percentage change slightly reduces completeness. (3) The reasoning is sound: the reduction in hedge position is correctly interpreted as a decrease in GBP exposure, and the conclusion about a recalibrated risk management strategy aligns with the ground truth's interpretation of a more conservative approach. The LLM does not mention 'reassessed risk' or 'lower anticipated risk' explicitly but captures the essence with 'recalibration' and 'changes in anticipated revenue'. (4) The answer is fully relevant to the question, addressing both the evolution of the hedging position and its strategic implication. The omission of the exact percentage reduction prevents a perfect score, but core facts and interpretation remain correct and meaningful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 394,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion in 2023 to $1.3 billion in 2024. This slight increase suggests that the company maintained a stable short-term investment strategy, likely prioritizing liquidity and low-risk instruments amid market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value of money market investments increasing from $1.2 billion in 2023 to $1.3 billion in 2024, matching the ground truth in both values and time periods. There are no calculation errors or numeric inaccuracies. (2) Quantitative accuracy is perfect—both dollar amounts and years are correct, with acceptable simplification of 'December 31, 2023/2024' to '2023/2024', which does not affect factual correctness. (3) The reasoning is sound: the model correctly infers a slight increase and links it to short-term investment strategy. While the original answer interprets this as a 'modest growth' indicating 'slight expansion', the LLM describes it as a 'stable' strategy prioritizing liquidity—this is a minor interpretive difference but still logically consistent with the data. It does not contradict the ground truth but offers a slightly more conservative characterization. (4) All parts of the question are addressed: the evolution of fair value and its implication for short-term strategy. Entity accuracy (Bank of America, money market investments, years) is correct. The answer is fully contextually relevant. The only reason for not scoring a 10 is the slightly less precise characterization of strategic intent—'stable' vs. 'slight expansion'—but this does not constitute a factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 377,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options for Southern Company decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024. For the subsidiaries, the volumes also decreased: Alabama Power from 6 million to 4 million mmBtu, Georgia Power from 8 million to 6 million mmBtu, Mississippi Power from 4 million to 2 million mmBtu, and Southern Power from 8 million to 3 million mmBtu.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values for both 2022 and 2024 are accurate: company-wide totals (26 million mmBtu in 2022, 15 million mmBtu in 2024) and subsidiary-specific volumes (Alabama Power: 6M to 4M, Georgia Power: 8M to 6M, Mississippi Power: 4M to 2M, Southern Power: 8M to 3M) are correctly reported. (2) The quantitative accuracy is perfect—no calculation errors, and all figures align with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesized data across Southern Company and its four subsidiaries over two years, capturing the consistent reduction trend. (4) The answer is semantically equivalent to the ground truth, conveying the same information concisely without omissions or distortions. All entities, metrics, and time periods are correctly identified. The response fully addresses the question about changes in natural gas volume across subsidiaries between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 284,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Adobe's Firefly Vector Model has seen significant integration and application expansion across its product suite between 2023 and 2024. In 2023, Firefly's Vector Model was introduced as part of Adobe Firefly, enabling users to generate fully editable vector graphics from text prompts. By 2024, this model was more deeply embedded in key creative tools like Adobe Illustrator, where it powers features such as Generative Recolor, allowing users to generate color palettes using text prompts. Additionally, Firefly Vector Model capabilities were extended to Adobe Express and Adobe Acrobat, enhancing content creation and customization workflows. The evolution reflects Adobe's broader strategy to leverage generative AI across its Digital Media offerings, improving efficiency and creative possibilities for users.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of the Firefly Vector Model from 2023 to 2024, noting its initial integration and expansion into Adobe Illustrator with features like Generative Recolor. The core facts—text-to-vector generation, use of text prompts, and application in creative tools—are accurate. However, the LLM incorrectly states that the Firefly Vector Model was introduced 'as part of Adobe Firefly' in 2023, whereas the ground truth specifies it was integrated into Adobe Express. Additionally, the LLM claims integration into Adobe Acrobat by 2024, which is not supported by the original answer and represents an overextension. (2) There are no numeric values, dates, or calculations in the response beyond '2023' and '2024', both of which are used correctly. Thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is mostly sound—connecting the model’s introduction to its broader application across products—but introduces unsupported claims (Acrobat) and misattributes the initial product (Firefly vs. Adobe Express), slightly weakening the synthesis. (4) Despite minor inaccuracies in entity mapping and added content not in the ground truth, the answer captures the essential evolution and strategic direction, making it contextually relevant and largely factually correct. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 407,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, the commercial significance of Biktarvy for Gilead has grown, with U.S. sales increasing from $9,692 million in 2023 to $10,240 million in 2024 (based on the total HIV product sales of $14,848 million in 2023 and $15,000 million in 2024, with Biktarvy maintaining a dominant share). This growth reinforces Biktarvy's position as Gilead's flagship HIV treatment and supports the company's strategy to maintain leadership in the HIV market despite competitive pressures. The continued strong performance of Biktarvy underscores Gilead's focus on innovation and market retention in its HIV portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Biktarvy generated $11,850 million in global sales in 2023, but the LLM incorrectly reports U.S. sales of $9,692 million in 2023 and $10,240 million in 2024, which are not supported by the original data. There is no mention of 2024 global sales in the ground truth, but the LLM fabricates a 2024 figure and implies growth, whereas the original answer highlights increasing risks and pressures, not continued growth. The LLM also misrepresents total HIV product sales as $14,848 million in 2023 and $15,000 million in 2024, which are not present in the ground truth and appear to be invented. (2) The quantitative inaccuracies are severe: the only correct number in the original answer is Biktarvy’s 2023 global sales of $11,850 million, which the LLM does not mention at all. Instead, it introduces incorrect U.S.-only figures and false 2024 data. Calculations or inferences based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed. The original answer emphasizes a strategic concern—growing reliance on TAF-based products like Biktarvy amid generic competition and shifting treatment paradigms. The LLM, however, portrays Biktarvy as growing and reinforcing GILD’s leadership, missing the critical nuance of increasing risk and the need for pipeline diversification. This reflects a failure to synthesize the correct implications for GILD’s HIV business strategy. (4) While the LLM addresses the general topic of Biktarvy’s commercial role and GILD’s HIV strategy, its factual foundation is incorrect, leading to a misleading conclusion. Contextual relevance is moderate because it discusses the right themes (commercial significance, strategy), but correctness and reasoning are severely compromised by fabricated data and misinterpretation of trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 509,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "Between 2022 and 2023, the outstanding principal of the Series 2018-1A Securities remained unchanged at $496.8 million. The interest rate for the Series 2018-1A Securities was 3.652%, and the anticipated repayment date is March 15, 2028, with a final legal maturity of March 15, 2048. No payments of principal were required prior to March 2028, as outlined in the terms of the 2018 Securitization.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the outstanding principal remained unchanged at $496.8 million between 2022 and 2023, but the ground truth states that in 2022 the principal was $500.0 million and decreased to $496.8 million in 2023. This misrepresents a key quantitative change. The interest rate of 3.652% is correctly reported. However, the LLM introduces information not requested (anticipated repayment date and final legal maturity) which, while possibly accurate, does not address the core question about evolution between 2022 and 2023. (2) Quantitative accuracy is low because the principal amounts are incorrectly stated: $500.0 million in 2022 is omitted, and the $496.8 million is wrongly presented as constant across both years. The calculation of a $3.2 million reduction is missing. (3) The reasoning is flawed: the model fails to recognize that principal decreased over the period, contradicting its own statement that no principal payments were due before 2028—this creates internal inconsistency. It also fails to synthesize the correct multi-hop fact that principal declined slightly despite no required payments, possibly due to optional or partial repayments. (4) Contextual relevance is moderate because the answer discusses the correct security and relevant attributes (principal, interest rate), but omits the year-on-year comparison and introduces extraneous details. The core evolution—reduction in principal with stable rate—is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 416,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved significantly from 2023 to 2024, both financially and strategically. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenue and challenging market conditions in the truckload brokerage business. By 2024, UPS completed the divestiture of Coyote in September, resulting in a $156 million gain on the divestiture. Strategically, this marked a shift as UPS exited the truckload brokerage segment, focusing instead on higher-growth areas within its Supply Chain Solutions division, such as freight forwarding and logistics. Financially, the divestiture reduced operating expenses and improved operating margins in the Forwarding business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly in quantitative details. While it correctly states the $111 million impairment charge in 2023, it introduces a $156 million gain on divestiture in 2024, which is not present in the ground truth and contradicts it. The original answer mentions no such gain, only that the divestiture contributed to a revenue decrease. This is a major factual error. Additionally, the claim that the divestiture improved operating margins in the Forwarding business is unsupported by the ground truth, which only notes a revenue decline due to Coyote's exit. (2) The date of divestiture (September 2024) is correctly identified and aligns with the original answer. The $111 million impairment charge is accurately reported. However, the $156 million gain is unverified and incorrect per the ground truth, making the quantitative accuracy low. (3) The qualitative reasoning is partially sound: the model correctly infers a strategic shift from impairment to divestiture and identifies a move away from truckload brokerage. It plausibly connects this to a focus on higher-growth areas like freight forwarding, which is consistent with strategic logic, though this specific reorientation is not detailed in the ground truth. The synthesis across 2023 and 2024 is appropriate for a multi-hop question, but the addition of unsupported financial outcomes weakens the reasoning. (4) Contextual relevance is high, as the answer directly addresses the evolution of the UPS-Coyote relationship in both financial and strategic terms. However, the inclusion of fabricated financial data (the $156M gain and margin improvements) significantly undermines factual correctness, warranting a moderate overall score of 6 due to partial accuracy on core facts but major errors in financial impact reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 499,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards for grants beginning in 2019 utilized two distinct performance metrics: Return on Capital and Total Shareholder Return. These were outlined in the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, as detailed in the 2018 Annual Report. There is no indication of a change in these metrics by 2024, suggesting the structure remained consistent between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the two performance metrics used in Linde plc's Performance Share Unit Awards for grants beginning in 2019—Return on Capital and Total Shareholder Return—and notes their origin in the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan. It accurately states that there was no change in these metrics by 2024, aligning with the ground truth that the dual structure remained in place. However, the LLM references the '2018 Annual Report' as the source, which is not mentioned in the original answer and may be incorrect or at least unsupported by the provided truth; the ground truth cites specific exhibits from 2022 and 2024 filings (Exhibits 10.11k/l and 10.10l/m) as evidence, which the LLM omits. This affects completeness and precision in sourcing, though the core factual claim about structural consistency is correct. The answer is semantically close and contextually relevant, with accurate entity names and timeframes, but lacks the detailed exhibit-level verification that supports the multi-hop reasoning between 2022 and 2024. No numerical errors are present, and all dates and metrics are correctly referenced, earning high marks for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 344,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's regulatory status advanced significantly, with the FDA granting it Breakthrough Therapy designation in 2024 for the treatment of extensive-stage small cell lung cancer. In 2023, Trodelvy received approvals for new indications in HR+/HER2- breast cancer and was approved by the EC for similar use. These developments indicate a positive trajectory in Trodelvy's clinical and commercial potential, with expanded therapeutic applications and regulatory recognition supporting its growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer, which aligns with the ground truth and is a key development. It also correctly references 2023 approvals, though it specifies 'HR+/HER2- breast cancer' and EC approval, which are partially accurate but omit the full scope of 2023 indications (triple-negative breast cancer, urothelial cancer). The answer adds information not in the ground truth—specifically EC approval—without confirmation from the source. (2) Dates (2023, 2024) are accurate and correctly attributed. No numerical values require verification, but the temporal facts are correct. (3) The multi-hop reasoning is partially sound: the model connects regulatory developments across years and infers a positive development trajectory, which matches the ground truth's conclusion. However, it fails to fully represent the breadth of 2023 indications and introduces an unverified detail (EC approval), weakening the synthesis. (4) The answer is contextually relevant and captures the essence of regulatory progression and strategic expansion. While the core facts about the Breakthrough Therapy designation and trajectory are correct, omissions and slight overreach in details reduce completeness and qualitative accuracy. Hence, correctness is scored 7—accurate on key points but lacking full completeness and introducing minor unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 398,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud evolved significantly in terms of capabilities and integration with generative AI models. In 2023, Vertex AI was highlighted as a tool for developers to train, tune, and deploy applications using generative AI models. By 2024, the platform had expanded to include Gemini, Google's most capable and general model, and was further integrated with AI-powered agents such as Gemini for Google Cloud and Google Workspace. This evolution enabled developers to leverage advanced, multimodal generative AI models for a broader range of applications, including Search, Customer Engagement, and Workspace tools like Gmail, Docs, and Sheets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Vertex AI from 2023 to 2024 with accurate core facts: in 2023, it supported training, tuning, and deploying generative AI applications; by 2024, it integrated Gemini and expanded capabilities. The mention of Gemini as Google's most capable model and integration with Google Workspace and Cloud tools aligns with the direction of enhanced generative AI integration. However, the LLM omits specific 2024 capabilities highlighted in the ground truth—namely vector search, grounding, and distillation—which are key technical enhancements for improving model cost and quality. Also, while the LLM mentions 'AI-powered agents' and specific Workspace tools, these details, though plausible, are not present in the original answer and slightly extend beyond the provided ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time (2023 vs 2024) and identifies the correct platform (Vertex AI) and company (Google Cloud), correctly noting the integration of Gemini. The logic connecting expanded capabilities to broader applications is reasonable, though slightly less technically precise than the original. (4) The answer is contextually relevant and conveys most of the same information, with minor omissions and slight over-extension on use cases. The core evolution is accurately described, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 443,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, SO's treatment and valuation of weather derivatives remained consistent in terms of immateriality, with both periods excluding immaterial premium and intrinsic value associated with weather derivatives from derivative valuations. In 2022, the 10-K noted that these immaterial amounts were excluded for all periods presented in the fair value tables. Similarly, in 2024, the 10-K stated that net derivative amounts exclude immaterial premium and intrinsic value related to weather derivatives for all periods presented. No significant changes in the treatment or materiality thresholds for weather derivatives were disclosed during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent treatment of weather derivatives as immaterial from 2022 to 2024 and accurately states that SO excluded the premium and intrinsic value in both years. It correctly reflects that no materiality threshold changes were disclosed. However, it omits a key quantitative and qualitative development in the 2024 disclosures: the specific mention of cash collateral held in broker margin accounts ($17 million at end of 2024 and $62 million at end of 2023), which adds context to SO's derivative disclosures and indicates a more structured reporting approach. While the LLM captures the continuity in treatment, it fails to note this incremental transparency, which is central to the evolution in disclosure practices. This omission reduces completeness and weakens the multi-hop synthesis required to compare disclosure depth across years. The entities (SO, weather derivatives, 2022–2024), years, and financial concepts are correctly identified, and there are no factual inaccuracies in what is stated. The reasoning is sound but incomplete, missing the significance of the new collateral data in 2024. Quantitative accuracy is high because no incorrect numbers are presented (though the $17M and $62M are missing), and contextual relevance is strong as the response directly addresses the question’s focus on changes in treatment and valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 383,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved with the FDA approving an expanded indication to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated to include data supporting its safety and efficacy in treating pregnant individuals with HIV-1 who have suppressed viral loads. These updates enhance Biktarvy's market relevance by addressing specific patient populations and resistance challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key regulatory developments for Biktarvy in 2024: the FDA's expanded indication for patients with suppressed viral loads and known or suspected M184V/I resistance, and the updated label supporting use in pregnant individuals with HIV-1. These points align fully with the ground truth. The answer accurately reflects GILD's disclosures and captures the shift in market positioning toward broader therapeutic application. However, it omits the 2023 patent expiration detail (2033 U.S. patent expiry), which is part of the original answer and relevant to market positioning through intellectual property protection. This omission slightly reduces completeness and qualitative accuracy, though the core regulatory advancements are correctly and precisely reported. All entities (Biktarvy, FDA, HIV patient populations) and years (2023–2024 evolution) are accurate. There are no numerical inaccuracies—no calculations or figures were misstated. The reasoning is sound, focusing on expanded eligibility and clinical relevance, which correctly infers enhanced market positioning. The answer is highly contextually relevant and semantically aligned with the ground truth, just missing one key element from 2023. Hence, a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 356,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility decreased between 2022 and 2023, as the company borrowed $3.0 billion and repaid $6.1 billion during 2023, resulting in a net reduction in borrowings. Additionally, the facility was amended in June 2023 to extend its maturity date to July 1, 2026, and to replace the LIBOR pricing benchmark with an Adjusted Term SOFR pricing benchmark.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion borrowed and $6.1 billion repaid in 2023, the June 2023 amendment, the extension of maturity to July 1, 2026, and the replacement of LIBOR with SOFR (specifically Adjusted Term SOFR, which aligns with ground truth). It also accurately implies a net reduction in borrowings in 2023. However, it omits the 2022 borrowing activity—specifically the $850.0 million in additional net borrowings—which is a key part of the multi-hop comparison between 2022 and 2023. This omission reduces completeness. (2) All provided numbers and dates are accurate: $3.0 billion borrowed, $6.1 billion repaid, EUR 842.6 million equivalent to $919.1 million is correctly contextualized in the ground truth but not required to be repeated if net repayment is implied. The amendment date is not specified in the LLM answer (June 2023 vs. ground truth's implied timing), but '2023' is acceptable. (3) The reasoning correctly infers a decrease in utilization due to higher repayments than borrowings in 2023, which is sound. However, the failure to mention 2022's $850M borrowing weakens the comparative analysis across years, which is central to the question. The synthesis is partially correct but incomplete. (4) The answer is highly relevant and conveys most of the key developments in 2023, but the absence of 2022 borrowing data limits full multi-hop reasoning. Quantitative accuracy is high; qualitative accuracy is slightly reduced due to omission. Contextual relevance is strong as all included information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 436,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager's role in Alphabet's advertising revenue recognition strategy remained consistent in its function as a primary platform for customers to purchase advertising inventory. However, the 2024 filings emphasize a continued focus on integrating Google Ad Manager with broader revenue reporting models, particularly in ensuring transparency and alignment with GAAP standards for revenue recognition. This includes maintaining gross revenue reporting for ads placed on Google Network properties, where Alphabet is deemed the principal, and refining processes to evaluate and report performance and brand advertising revenues accurately. No significant structural or strategic changes to Google Ad Manager's integration with revenue reporting models were explicitly noted in the 2024 filings compared to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key strategic evolution described in the ground truth. (1) What was correct: The answer correctly identifies that Google Ad Manager is used for advertising on Google Network properties and that Alphabet reports revenue on a gross basis where it acts as principal. It also correctly notes alignment with GAAP and revenue recognition standards. There are no numeric values to verify, so quantitative accuracy is not applicable but assumed correct by default. (2) What was incorrect: The LLM claims 'no significant structural or strategic changes' were noted in 2024, which directly contradicts the ground truth. The original answer highlights a clear shift in language and strategy—from a transactional gross reporting model in 2023 to a more control-based justification in 2024 emphasizing Alphabet's role as principal through control of inventory, pricing discretion, and primary responsibility. This evolution reflects a strategic refinement in revenue recognition rationale, which the LLM fails to capture. (3) Multi-hop reasoning assessment: The question requires synthesizing changes in narrative and accounting logic across two years. The LLM does not demonstrate this synthesis—it downplays change rather than identifying the shift in emphasis from operational function to control-based justification. (4) Justification for scores: Correctness is scored 5 due to major omission of the strategic shift despite accurate background facts. Quantitative accuracy is 10 because no numbers are involved. Qualitative accuracy is 5 due to flawed reasoning and failure to identify the conceptual evolution. Contextual relevance is 8 because the response stays on topic and discusses relevant aspects of revenue reporting, even if it mischaracterizes the change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 490,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial stress, while in 2024, no goodwill impairments were recorded for Roadie, suggesting improved performance or revised forecasts. However, as of 2024, Roadie remained one of three reporting units with limited excess fair value, exposing it to a higher risk of future impairment if business conditions or cost of capital assumptions change. This reflects ongoing strategic monitoring and risk assessment of Roadie's positioning within UPS's broader operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $56 million goodwill impairment charge in 2023 and the absence of further impairments in 2024, which matches the ground truth. It accurately notes that Roadie remained a reporting unit with limited excess fair value over carrying value in 2024, signaling ongoing risk. The only minor omission is not explicitly stating that Roadie was 'among the reporting units' (plural), though it does say 'one of three,' which is consistent and possibly more specific. (2) All numeric values—$56 million, 2023, 2024—are correct and properly contextualized. No calculations are required, but the temporal comparison is accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, connects impairment to risk assessment, and infers strategic positioning (cautious monitoring). It correctly interprets the significance of limited excess fair value as exposure to future impairment under changing conditions, aligning with the ground truth's emphasis on sensitivity to cost of capital and forecasts. (4) The answer is contextually fully relevant, addressing both financial exposure (impairment, risk of future impairment) and strategic positioning (ongoing monitoring). The wording differs slightly but maintains semantic equivalence. The qualitative score is 9 due to slightly less precise phrasing around 'one of three' versus 'among the reporting units,' but this does not detract from factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 410,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's relationship with helium from 2022 to 2024 shifted from a negative impact to a neutral one. In 2024, the company reported a 2% decrease in underlying sales for the \"Other\" segment due to lower volumes in global helium, but this was partially offset by insurance recovery for LAMT. Operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery, despite higher helium-related costs. In contrast, in 2022, helium was not explicitly mentioned as a factor in sales or operating profit. Thus, the impact of helium on Linde's financials became more pronounced in 2024, primarily through cost increases and volume declines.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Linde's relationship with helium shifted from 'negative' in 2022 to 'neutral' in 2024, while the ground truth indicates helium was a supply component (positive/neutral) in 2022 and became a source of cost pressure (negative) in 2024—this reverses the actual evolution. (2) Quantitatively, the 2% underlying sales decrease in the 'Other' segment due to lower helium volumes is correctly cited. However, the claim that operating profit increased by 44% due to insurance recovery is not supported by the ground truth, which mentions increased costs partially offset by insurance recovery but does not state any percentage increase in operating profit. This 44% figure is a critical error. (3) The multi-hop reasoning is partially sound in linking helium volumes to sales impact and mentioning LAMT and insurance recovery, but the synthesis is flawed because it misrepresents the direction of change over time and invents a specific operating profit increase not present in the source. (4) Contextual relevance is high as the answer addresses the right segments, time frame, and financial metrics, but correctness is undermined by key factual and quantitative errors, especially the reversal of helium’s role and the unsupported 44% profit increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 375,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased slightly from $9.5 billion in 2022 to $8.7 billion in 2023 and further to $8.0 billion in 2024. This decline suggests a reduction in the Corporation's credit risk exposure on residential mortgage loans, as these agreements provide full credit protection on severely delinquent loans, and all covered loans are individually insured.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.7 billion in 2023 and $8.0 billion in 2024, matching the ground truth for those years. However, it introduces a figure of $9.5 billion in 2022, which is not mentioned in the original answer and is extraneous to the question. While this addition does not contradict the ground truth, it introduces data not requested and potentially misleading if inaccurate. (2) The key quantitative evolution from 2023 to 2024 is accurate: a decrease from $8.7B to $8.0B. Calculations and comparisons between these years are correct. The 2022 number fails the quantitative accuracy check as it is unsupported by the ground truth. (3) The multi-hop reasoning is sound: the model correctly links the decline in covered loans to reduced credit risk exposure, noting that these agreements provide full credit protection and that no allowance for credit losses is recorded. This aligns with the original answer's interpretation. (4) The answer is contextually relevant and addresses both parts of the question: the evolution of loan values and the implication for credit risk. The reasoning is strong and semantically equivalent to the ground truth, despite the extra 2022 data. The correctness score is 8 due to the accurate core facts but minor overreach with unrequested and unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 371,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe Firefly's strategic positioning evolved by emphasizing its integration with Adobe's Creative Cloud and Document Cloud products, offering generative AI capabilities that are safe for commercial use and accessible to a wide audience. This focus on natively integrated, AI-driven tools aimed to enhance competitive differentiation. However, associated regulatory risks increased due to the evolving global AI regulatory landscape, such as the EU AI Act, which could impose compliance costs, affect monetization strategies, and introduce potential legal liabilities. Adobe has taken a responsible approach to AI development, but the regulatory environment remains a growing concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe emphasized Firefly's integration into its product suite (Creative Cloud and Document Cloud), its commercial safety, and competitive differentiation in both 2023 and 2024. The mention of increased regulatory risks due to the EU AI Act in 2024 is correctly identified, including potential compliance costs and legal implications. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023–2024) and references to the EU AI Act are accurate. (3) The multi-hop reasoning is sound: the model synthesizes Firefly’s strategic evolution across time, connects competitive positioning with emerging risks, and correctly infers a shift in emphasis from differentiation to risk awareness. (4) The only minor shortcoming is that the original answer explicitly notes a 'shift from purely competitive emphasis to a more risk-aware strategic positioning,' which the LLM implies but does not state as clearly. However, the core meaning—evolving focus with growing regulatory concern—is preserved. Wording differences are acceptable under semantic equivalence. All parts of the question (competitive differentiation, regulatory risks, evolution between years) are addressed thoroughly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 379,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Trodelvy's financial performance improved significantly between 2023 and 2024, with product sales increasing by 24% to $1.3 billion in 2024 from $1.06 billion in 2023, driven by higher demand across all regions. Additionally, in 2024, Trodelvy received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer, marking a key regulatory milestone that could expedite its development and approval for this new indication.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Trodelvy generated $1,063 million in product sales in 2023 with a 56% year-over-year increase. The LLM incorrectly states that 2023 sales were $1.06 billion (approximately correct, minor rounding) but claims 2024 sales reached $1.3 billion with a 24% increase, which is unsupported by the original answer—no 2024 sales figure or growth rate was provided in the ground truth. Thus, the 24% growth and $1.3 billion figures are fabricated or extrapolated without basis. (2) The regulatory milestone is accurately described: the FDA granted Breakthrough Therapy designation in 2024 for extensive-stage small cell lung cancer after platinum-based chemotherapy, matching the original answer. This part is factually correct and contextually relevant. (3) The multi-hop reasoning is partially sound—linking financial performance and regulatory developments across years—but fails on the financial side due to incorrect extrapolation. The model invents a 2024 sales figure and growth rate not present in the source, undermining the quantitative foundation of the response. (4) Despite the incorrect numbers, the qualitative direction—strong financial performance and positive regulatory trajectory—is consistent with the ground truth. The entity (Trodelvy), year (2024), regulatory body (FDA), and indication are all correct. Contextual relevance is high as it directly addresses both financial and regulatory aspects of the question. However, the made-up sales data severely impacts factual correctness, warranting a mid-range score of 5 for overall correctness and low quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 462,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, as disclosed in its equity investments and affiliate transactions. In 2022, Chevron reported equity in earnings from Angola LNG Limited at $336 million, with a carrying value of its investment at $2,180 million. By 2024, Chevron's equity in earnings from Angola LNG Limited had decreased to a negative $166 million, while the carrying value of its investment was $2,180 million in 2022 and remained significant in 2024. Additionally, Chevron has a 36.4 percent interest in Angola LNG Limited, which processes and liquefies natural gas produced in Angola for delivery to international markets, indicating continued strategic importance despite fluctuating earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, Chevron reported improved income from equity affiliates including Angola LNG, with total income from equity affiliates at $5,657 million, but it does not specify Angola LNG's individual contribution as $336 million—this figure is not present in the original answer and appears fabricated. Similarly, the LLM claims a 2024 equity loss of -$166 million and a carrying value of $2,180 million in 2022 'remaining significant' in 2024, but the original answer does not provide these specific carrying values or losses, making these details unsupported. The only correct quantitative detail is Chevron’s 36.4% ownership stake in Angola LNG Limited in 2024, which matches the ground truth. (2) Calculations or financial metrics such as earnings and carrying values are entirely inconsistent with the original answer and introduce false precision. The original answer does not break down Angola LNG earnings individually, nor does it report a negative earning in 2024. (3) The multi-hop reasoning is partially sound in that the LLM attempts to compare 2022 and 2024 disclosures and infers strategic continuity based on ownership and operations, which aligns with the original’s conclusion about strategic emphasis on LNG. However, the reasoning is undermined by reliance on incorrect data. (4) The contextual relevance is high because the LLM addresses the evolution of Chevron’s involvement, equity investments, and affiliate transactions, and correctly identifies Angola LNG Limited’s role in gas processing. However, due to major quantitative errors and unsupported specifics, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the structure and intent of the response are reasonable, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 519,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased significantly from $18.50 billion to $29.0 billion. This increase was driven by the issuance of $10.50 billion in new Notes during August 2024. The 2023 value included $10.0 billion from August 2022 Notes and $8.50 billion from May 2023 Notes, while the 2024 value added the August 2024 Notes to the existing amounts.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in total value of META's Fixed-Rate Senior Unsecured Notes from $18.50 billion (end of 2023) to $29.0 billion (end of 2024), and correctly attributes $10.50 billion in new issuances in August 2024. However, it incorrectly states that the 2023 total included $10.0 billion from August 2022 Notes and $8.50 billion from May 2023 Notes. The ground truth specifies $8.46 billion in net proceeds from May 2023 issuance (not $8.50 billion), and does not mention the August 2022 Notes as part of the 2023 total composition. This introduces a minor factual inaccuracy in the breakdown of the 2023 total. (2) The key numbers—$18.50 billion (2023 total), $29.0 billion (2024 total), and $10.50 billion (August 2024 issuance)—are correct and calculations (e.g., $29.0B - $18.50B = $10.50B) are accurate. However, the $8.50 billion figure for May 2023 is a rounding error or misstatement; the correct net proceeds were $8.46 billion. The mention of August 2022 Notes is unsupported in the ground truth and potentially misleading. (3) The multi-hop reasoning is mostly sound: the model correctly infers that the increase in total value is due to new issuance in 2024 and connects issuance activity across years. However, it introduces an unsupported detail (August 2022 Notes) that was not in the original answer, suggesting flawed synthesis or hallucination. (4) The answer is contextually relevant and captures the evolution of value and issuance activity well, but loses points on quantitative and qualitative accuracy due to the incorrect breakdown of 2023 composition and minor number inaccuracies. Hence, correctness score is 8—core facts are correct, but with minor but notable errors in detail and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 480,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium shifted from being categorized as a \"supply\" in 2023 to a \"dependency\" in 2024, indicating a heightened reliance on helium as a critical raw material. In 2023, helium costs were included in raw materials and supplies inventory at $614 million, while in 2024, this value decreased to $529 million. This reduction, combined with the reclassification to \"dependency,\" suggests increased sourcing challenges or cost volatility in 2024, as helium became more central to LIN's operations and subject to potential supply constraints or price fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, helium costs were 4.2% of total raw material expenses in 2023 and increased to 6.8% in 2024, reflecting rising exposure. However, the LLM claims absolute dollar amounts of $614M in 2023 and $529M in 2024, which contradicts the ground truth—both in magnitude and trend (the LLM reports a decrease, while the truth shows an increase in cost exposure as a percentage). These dollar figures are not present in the original answer and appear to be fabricated or misattributed. (2) The quantitative accuracy is very low because the core financial data is incorrect. The ground truth uses percentages of raw material expenses, not absolute inventory values, and the LLM introduces unsupported dollar figures. There is no indication in the original answer that helium costs decreased; on the contrary, the increase from 4.2% to 6.8% indicates growing cost exposure. (3) The qualitative reasoning partially captures the conceptual shift from 'supply' to 'dependency' and links it to increased strategic importance and potential sourcing challenges. This reflects some correct multi-hop understanding of categorization changes implying operational significance. However, the reasoning is undermined by incorrect data, leading to a flawed conclusion about cost trends. (4) Contextual relevance is moderate—the answer addresses the right topic, time frame, and conceptual shift, and attempts to explain the implications of reclassification. But due to major factual and numerical errors, the overall correctness score is low. The answer misrepresents the financial exposure trend, which is the central point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 467,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal's utilization of European customer balances for credit activities decreased. The total amount approved for such activities was $3.8 billion as of December 31, 2022, and reduced to $3.0 billion by December 31, 2023. This represents a percentage change of approximately -21% in the approved amount for credit activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the approved amounts for credit activities in both years ($3.8 billion in 2022 and $3.0 billion in 2023), matching the ground truth exactly. The percentage change is accurately calculated as approximately -21% ((3.0 - 3.8) / 3.8 ≈ -0.2105), which is correctly rounded. (2) All numeric values, dates (implied by year-end), and calculations are factually correct. The dollar amounts and their change are precise. (3) The multi-hop reasoning is sound: the model correctly compares two time points and computes the percentage change. While the LLM does not mention the percentage of European customer balances (37% in 2022, 39% in 2023), it still captures the core trend — a decrease in absolute approved amount — which directly addresses the question about evolution and quantitative change. The omission of the relative percentage (of balances) slightly reduces qualitative completeness but does not invalidate the main conclusion. (4) The answer is highly relevant, directly addressing how utilization evolved and providing the correct percentage change. The missing nuance about the slight increase in proportional usage (from 37% to 39%) means a perfect qualitative score is not warranted, but the primary facts and calculation are correct, justifying a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 373,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Between 2023 and 2024, Starbucks' exposure to foreign currency - other instruments showed a significant shift in fair value and expected reclassification impact on earnings. In 2024, the fair value of foreign currency - other instruments was $920 million, compared to $1,164 million in 2023, indicating a decrease of $244 million. Additionally, the expected reclassification impact on earnings for foreign currency - other instruments in 2024 was $9.5 million, compared to $39.6 million in 2023, showing a notable decline in the anticipated impact on earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of foreign currency - other instruments in both 2023 ($1,164 million) and 2024 ($920 million), as well as the decrease of $244 million, which is accurate. It also correctly reports the expected reclassification impact on earnings in 2024 as $9.5 million. However, it incorrectly states that the 2023 reclassification amount was $39.6 million, when in fact $39.6 million was the net gain included in AOCI (not the reclassification amount). The correct 2023 reclassification amount is $55.3 million, which the LLM omits and replaces with the AOCI gain figure, leading to a factual error. (2) The fair value numbers and their difference are correct. The reclassification figures are partially wrong: $9.5 million in 2024 is correct, but $39.6 million for 2023 is incorrect (should be $55.3 million). This misrepresents a key metric and affects the accuracy of the comparison. (3) The multi-hop reasoning is mostly sound—comparing fair values and reclassification impacts across years—but the model conflates two distinct financial metrics (AOCI net gain vs. expected reclassification), indicating a failure to correctly disentangle related but different disclosures. (4) The answer is contextually relevant and well-structured, addressing both fair value and earnings impact. Due to the significant but not central error in the reclassification figure, the correctness score is reduced to 8 rather than 9 or 10. Quantitative and qualitative accuracy are also scored 8 due to this key numerical mix-up, though other elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 439,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $15 million to $7 million, while Georgia Power's fair value decreased from $13 million to $15 million. For Alabama Power, the directional change shifted from a net asset position in 2022 to a smaller asset position in 2023, while Georgia Power maintained a net asset position, with a slight increase in value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Alabama Power had $55M in assets and $11M in liabilities, and Georgia Power had $75M in assets and $8M in liabilities. In 2023, Alabama Power had $15M in assets and $110M in liabilities, while Georgia Power had $13M in assets and $124M in liabilities. The LLM incorrectly reports Alabama Power's 2022 derivatives as $15M (vs. correct $55M) and 2023 as $7M (vs. $15M), and Georgia Power's 2022 as $13M (vs. $75M) and 2023 as $15M (vs. $13M). These numbers are entirely wrong and misrepresent the scale and direction of change. (2) The LLM fails to report liabilities at all and incorrectly frames both companies as having net asset positions in 2023, when in fact both shifted to substantial net liability positions—Alabama Power from $44M net asset to $95M net liability, and Georgia Power from $67M net asset to $111M net liability. The directional change is completely misrepresented. (3) The multi-hop reasoning is flawed: the model fails to synthesize asset and liability data across years and companies, and instead appears to invent numbers. It does not recognize the shift from net asset to net liability, which is the key insight in the original answer. (4) The contextual relevance is moderate because it addresses the right companies and time frame and attempts to discuss directional changes, but the qualitative and quantitative inaccuracies severely undermine the answer's validity. Correctness and quantitative accuracy are very low due to pervasive number errors and missing liability data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 443,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan remained consistent between 2022 and 2023, with fixed income securities and cash equivalents maintaining a target range of 75% to 85% and equity securities within 15% to 25%. As of December 31, 2023, the actual allocation was 80% for fixed income and 20% for equity, aligning with the 2022 allocation of 65% fixed income and 35% equity. Thus, no significant evolution in the percentage distribution occurred during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2023 allocation (80% fixed income, 20% equity), it incorrectly claims the 2022 allocation was within the same range and that there was no significant evolution. The ground truth shows a clear shift from 65% fixed income and 35% equity in 2022 to 80% and 20% in 2023, indicating a meaningful strategic change. The LLM falsely asserts consistency, contradicting the documented evolution. (2) Quantitatively, the 2023 numbers are correct (80%/20%), but the characterization of 2022 allocation is wrong — it misrepresents 65%/35% as being within a 75%-85% fixed income target range, which it is not. This leads to an incorrect conclusion. (3) The multi-hop reasoning fails: the model should have compared the two years’ allocations and recognized the 15-percentage-point shift toward fixed income as a strategic evolution. Instead, it denies any change, showing flawed synthesis. (4) Contextual relevance is moderate — it discusses the right plan and asset classes and provides actual 2023 figures, but the core conclusion is factually wrong, severely undermining correctness. Minor point: citing a 'target range' not present in the original answer introduces unsupported information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 359,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received regulatory approvals for new indications. In 2023, the U.S. Food and Drug Administration (FDA) approved Trodelvy for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission (EC) granted approval for Trodelvy as monotherapy for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Trodelvy's regulatory approval status between 2022 and 2023. It correctly identifies the 2023 FDA and European Commission (EC) approvals for the treatment of unresectable or metastatic HR+/HER2- breast cancer in patients who have received endocrine-based therapy and at least two additional systemic therapies. The indications are accurately described, with correct terminology and regulatory bodies. The only minor omission is that the original answer includes a summary of the 2022 indications (for TNBC and urothelial cancer), which provides context for the expansion. While the LLM mentions the timeline ('between 2022 and 2023'), it does not explicitly restate the 2022 indications, slightly reducing completeness. However, the core of the question—regarding the evolution and new 2023 indications—is fully addressed with factual precision. All entities (FDA, EC, HR+/HER2- breast cancer, endocrine-based therapy) are correct, and the reasoning correctly synthesizes the regulatory progression. There are no numerical inaccuracies (dates are correct), and the semantic meaning matches the ground truth. Thus, the answer is excellent but loses one point for partial omission of the baseline 2022 status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 356,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta expanded its disclosure on user perception as a risk factor by emphasizing the impact of competitive pressures, regulatory changes, and evolving user expectations on engagement and platform trust. In 2023, the focus was primarily on user retention, engagement fluctuations, and the threat of competitors like TikTok. By 2024, the discussion broadened to include risks related to AI-driven product changes, regulatory compliance (e.g., GDPR, DMA), and the potential for user dissatisfaction due to platform modifications aimed at safety and privacy. This evolution reflects a heightened awareness of how external factors and internal decisions could shape user behavior and, consequently, Meta’s business performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of Meta's risk disclosures. The ground truth states that Meta *reduced* its emphasis on user perception as a risk factor in 2024, shifting focus to operational and financial risks like acquisition integration and tax liabilities. In contrast, the LLM claims Meta *expanded* its disclosure on user perception, which directly contradicts the original answer. While the LLM correctly identifies some relevant themes (e.g., regulatory changes, privacy, competition), it misrepresents the directional shift in Meta's risk communication. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is low due to the incorrect synthesis of the multi-hop information—specifically, the failure to recognize the strategic *downgrading* of user perception as a highlighted risk. Contextual relevance is moderate because the answer discusses related topics (regulation, competition, user behavior), but it fails to capture the actual trend in disclosure strategy between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 315,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased significantly from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate swaps as part of its interest rate risk management strategy, likely to hedge against potential fluctuations in interest rates and manage the mix between fixed and variable rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. These figures are critical quantitative data points and are accurately reported with correct formatting and time periods. (2) All numbers and dates are factually correct—no calculation errors or misstatements. The increase from $500M to $1.3B is accurately portrayed as a significant rise, which aligns with the ground truth. (3) The reasoning is sound and captures the essence of the strategy: increased use of variable interest rate swaps as part of risk management. While the LLM does not explicitly state that the company is converting fixed-rate debt to variable-rate debt (a key nuance in the original answer), it correctly infers that the expansion relates to managing interest rate risk and adjusting the fixed-versus-variable debt mix. This constitutes a minor omission in qualitative depth but does not misrepresent the strategy. (4) The answer is fully contextually relevant, directly addressing both parts of the question—evolution over time and strategic implication. The slight lack of specificity on the directional shift (fixed-to-variable conversion) prevents a perfect 10, but overall, the response is factually accurate, well-reasoned, and complete for practical purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 376,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal's approach to its Seller Protection Programs between 2022 and 2023 remained consistent in terms of financial provisions for transaction losses, as the allowance for transaction losses slightly decreased from $66 million at the end of 2022 to $64 million at the end of 2023. The provision for transaction losses increased slightly to $1,192 million in 2023 compared to $1,170 million in 2022, while realized losses also increased to $1,313 million from $1,417 million in the prior year. These figures indicate a stable and measured approach to provisioning for transaction losses associated with the Seller Protection Programs during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that the allowance for transaction losses decreased from $66 million in 2022 to $64 million in 2023, it introduces incorrect figures for 'provision for transaction losses' ($1,192M in 2023 vs $1,170M in 2022) and 'realized losses' ($1,313M vs $1,417M), which are not present in the original answer and contradict the ground truth. These numbers appear fabricated or misattributed, as the ground truth does not mention provisions or realized losses at this scale. (2) The quantitative accuracy is severely compromised: the original answer discusses only the allowance for transaction losses and historical loss rates as a percentage of TPV (0.09%–0.15%), but the LLM invents large-magnitude financial figures without basis. There is no mention in the ground truth of a $1.17B or $1.19B provision, nor any realized loss figures. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift from qualitative risk disclosure in 2022 to more structured, quantified disclosures in 2023. The LLM fails to capture this evolution in approach, instead framing it as a 'consistent' approach, which contradicts the ground truth's emphasis on increased specificity and quantification in 2023. (4) Contextual relevance is moderate because the answer addresses PayPal, Seller Protection Programs, and financial provisions across 2022–2023, but the incorrect data and mischaracterization of the evolution undermine the response. The core takeaway — a shift toward more defined financial disclosures — is missed entirely due to reliance on false metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 452,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative asset position for foreign currency - other decreased from $1,164 million as of October 1, 2023, to $920 million as of September 29, 2024, representing a decrease of $244 million. This change reflects a reduction in the balance sheet impact of foreign currency derivatives used to hedge currency exposure in fiscal year 2024 compared to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Starbucks' derivative asset for 'Foreign currency - other' decreased from $1,164 million in fiscal year 2023 to only $1.9 million in 2024, not $920 million as stated by the LLM. The LLM incorrectly reports a decrease of $244 million, whereas the actual decrease was approximately $1,162.1 million. Additionally, the LLM completely omits the change in derivative liabilities, which increased from $2.0 million in 2023 to $4.7 million in 2024—a key part of the original answer. (2) The numbers are fundamentally wrong: the $920 million asset value in 2024 and the $244 million decrease are not supported by the ground truth. The correct magnitude of change in assets is over $1.16 billion, not $244 million. Dates (October 1, 2023, and September 29, 2024) may align with Starbucks' fiscal calendar, but the values assigned to those dates are incorrect. (3) The reasoning is partially sound in that the LLM recognizes a decrease in derivative assets and attempts to explain the balance sheet impact, but it fails at multi-hop synthesis—specifically, it does not incorporate liability changes and uses incorrect asset figures. The conclusion about reduced balance sheet impact is directionally plausible but based on false data. (4) The contextual relevance is moderate because the answer addresses the right topic (derivative positions in foreign currency) and the general direction of change (decrease in assets), but due to severe quantitative inaccuracies and omission of liability data, the overall correctness score is very low. The answer does not reflect the true magnitude or full nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 465,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions showed notable changes. In 2023, energy-related derivatives not designated as hedging instruments resulted in a $59 million gain on the cost of natural gas and a $11 million loss on natural gas revenues, leading to a total net gain of $48 million. In contrast, in 2022, these derivatives led to a $65 million loss on the cost of natural gas and an $117 million loss on natural gas revenues, resulting in a total net loss of $182 million. This indicates a significant improvement in the financial impact from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, energy-related derivatives had a $117 million negative impact on natural gas revenues and a $27 million negative impact on cost. However, the LLM incorrectly states a $117 million loss on revenues (partially correct) but a $65 million loss on cost (should be $27 million). In 2023, the ground truth states a $59 million gain on cost (correct in LLM) but a $0 impact on revenue (LLM incorrectly states an $11 million loss). Thus, key numbers are wrong. (2) Calculations are also incorrect: LLM reports a net loss of $182 million in 2022 (should be $144 million: $117M + $27M), and a net gain of $48 million in 2023 (should be $59 million gain, as revenue impact was neutral). The $59 million gain on cost in 2023 is the only correct figure. (3) Multi-hop reasoning is partially sound—the model attempts to compare 2022 and 2023 impacts and draws a conclusion about improvement, which aligns with the direction of change. However, due to incorrect inputs, the synthesis is flawed. The mention of 'not designated as hedging instruments' adds detail not present in the original and may misrepresent the scope. (4) Correctness score is low (3/10) due to major quantitative errors in both years across both revenue and cost impacts. Quantitative accuracy is 2/10 due to only one correct number out of four key figures. Qualitative accuracy is 3/10 because while the model recognizes a shift in impact, the reasoning is based on incorrect data. Contextual relevance is 7/10 as the structure and intent match the question, discussing evolution over time and hedging impacts, but with wrong specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 465,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as noted in the 2024 10-K filing. In the 2023 10-K, the plan was not specifically mentioned as being amended during that year, indicating that the most significant change occurred in 2023 with the effective date of the amendment being in November 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the effective date of the amendment as November 8, 2023, which matches the ground truth. However, it incorrectly states that the plan was 'not specifically mentioned as being amended' in the 2023 10-K, when in fact the 2023 10-K explicitly introduced the plan as 'amended and restated effective November 8, 2023'—this is a key factual error. (2) Quantitatively, the date (November 8, 2023) is accurate and correctly reported, earning high marks for numerical/date accuracy. (3) The multi-hop reasoning is flawed: the question asks for a comparison between the 2023 and 2024 10-K treatments, particularly regarding documentation status and evolution. The LLM fails to mention that in the 2024 10-K, the plan was no longer labeled as newly introduced and was instead 'incorporated by reference,' indicating institutionalization. This shift in documentation status is a central point in the ground truth and is entirely missing from the LLM answer. (4) The answer is partially relevant and contains correct elements (effective date), but misses the core evolution in how the plan was documented—transitioning from newly introduced to established—which is the essence of the question. Thus, while some facts are correct, the synthesis and completeness are significantly lacking, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 378,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of LTIP Units remained largely consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. Additionally, the accrual policy for dividends and distributions remained unchanged, with the company continuing to accrue dividends and distributions when they are declared. There is no indication of a material change in the treatment or impact of LTIP Units during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the dilutive effect of LTIP Units remained immaterial in both 2023 and 2024, and no adjustment was made to net income or share counts due to lack of dilutive impact. The accrual policy—distributions accrued when declared—is correctly stated and consistent across years. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the temporal scope (2023 and 2024, with reference to prior years) is accurately reflected. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across two years, identifying consistency in both dilutive effect and accrual treatment. (4) The only minor shortcoming is that the LLM omits the detail about the 2024 disclosure being 'simplified' compared to 2023, which is present in the original answer. While not critical to the core conclusion, this nuance reflects a slight reduction in completeness. However, the semantic meaning and key takeaway—that there was no significant change in treatment or impact—remain fully preserved. Thus, the answer is factually correct, contextually relevant, and logically sound, warranting a high score with only a small deduction for missing a minor descriptive detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 364,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024 by implementing steps to align with the new adequacy decision adopted by the European Commission on July 10, 2023, which replaced the invalidated Privacy Shield framework. In response to regulatory actions, such as the Irish Data Protection Commission's (IDPC) Final Decision in May 2023, Meta began taking corrective measures to comply with GDPR requirements, including suspending certain data transfers and modifying data processing operations. Additionally, Meta continued to engage with regulators on compliance with the GDPR, Digital Markets Act (DMA), and EU consumer laws, particularly as the European Commission initiated formal proceedings in March 2024 to assess the compliance of Meta's \"subscription for no ads\" model under the DMA.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Meta's compliance approach to the EU-U.S. DPF between 2023 and 2024. It accurately notes the July 10, 2023, adequacy decision by the European Commission, which is factually correct and aligns with the ground truth. It correctly references the Irish Data Protection Commission's (IDPC) Final Decision in May 2023 and Meta's corrective actions, including suspending certain data transfers—consistent with the €1.2 billion fine and directive to halt unlawful transfers under SCCs. The mention of Meta's engagement with regulators on GDPR, DMA, and consumer laws is accurate. It also correctly identifies the 'subscription for no ads' model and the European Commission's formal proceedings under the DMA in 2024. However, the LLM states the proceedings began in March 2024, while the ground truth specifies proceedings opened in 2024 with preliminary findings in July 2024—this slight misstatement of timing reduces quantitative accuracy slightly. Additionally, the LLM omits explicit mention that the €1.2 billion fine was issued in 2023 and does not reference the November 2023 launch of the subscription model, which is a minor completeness gap. The answer synthesizes multi-hop information well—linking regulatory actions, Meta’s compliance steps, and evolving business models—but could better emphasize the shift from foundational DPF compliance to scrutiny under new frameworks like the DMA. Wording differs but meaning is semantically equivalent in most places. No calculation errors. Overall, factually strong with minor omissions and a small date discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 444,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on renewable energy sources for hydrogen production, particularly green hydrogen. In 2023, the company described green hydrogen as being produced by electrolysis using renewable energy or from steam methane reforming of biomethane. By 2024, Linde explicitly defined green hydrogen as being produced by electrolysis using renewable energy and water as feedstock, with a stronger focus on non-fossil feedstocks and clean energy solutions. This indicates a more deliberate shift toward renewable energy integration in its hydrogen production methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Linde's 2023 definition of green hydrogen as involving electrolysis using renewable energy or steam methane reforming of biomethane. It also accurately reflects the 2024 shift to defining green hydrogen via electrolysis using renewable energy and water, emphasizing non-fossil feedstocks. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in Linde’s terminology and strategic emphasis across two years, correctly identifying a shift toward clearer differentiation and renewable focus. (4) The only minor omission is that the LLM answer does not explicitly mention the increased emphasis on 'carbon intensity' as a metric to differentiate green from blue hydrogen in 2024, which was present in the original answer. This is a small but notable detail affecting completeness. Otherwise, the semantic meaning and factual content are equivalent. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to correct use of time periods and no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 365,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company's relationship with Sequent ended in 2021 when Southern Company Gas sold Sequent to Williams Field Services Group on July 1, 2021, for $159 million. This sale resulted in a pre-tax gain of $121 million ($92 million after tax) for Southern Company Gas. Financial implications included $85 million in additional tax expenses due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company Gas' operations, as it was excluded from reportable segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has a critical factual error in the timeline. The original answer states the sale occurred in 2022, but the LLM claims it happened on July 1, 2021—this incorrect date undermines the core of the multi-hop reasoning about the evolution between 2022 and 2023. All financial figures are accurate: $159 million sale price, $121 million pre-tax gain, $85 million additional tax expense—all match the ground truth. However, the after-tax gain of $92 million is mentioned in the LLM answer but not in the original; while plausible, it's an unverified addition not supported by the ground truth. (2) Quantitative accuracy is partially compromised due to the incorrect year—though dollar amounts are correct, the temporal placement of the transaction is wrong, which affects financial period attribution. Calculations are not shown, but the numbers themselves are consistent with the source. (3) The reasoning correctly identifies the divestiture and its financial implications, and acknowledges Sequent’s absence from operations by 2023, satisfying part of the multi-hop requirement. However, the evolution 'between 2022 and 2023' cannot be accurately described if the sale occurred in 2021—this breaks the logical chain. The entity names (Southern Company Gas, Sequent, Williams Field Services Group) are correct. (4) Contextual relevance is high—the answer addresses the relationship change and financial impact directly. Due to the date error, the correctness score is reduced to 5 (partially correct), quantitative accuracy to 5 (key numbers right but misdated), qualitative accuracy to 6 (sound logic but flawed premise), and contextual relevance remains high at 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 471,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's Allswell brand is consistently listed among its private brand portfolio in both the 2023 and 2024 10-K filings, indicating that it remains a strategic private label brand within the Walmart U.S. segment. The continued inclusion of Allswell in the list of private brands highlights Walmart's ongoing commitment to leveraging private labels to offer value to customers while maintaining control over pricing and product quality. This consistency suggests that Allswell has a stable position in Walmart's portfolio, supporting its strategy of price leadership and customer convenience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2023 and 2024) and correctly identifies Allswell as part of Walmart's private brand portfolio in both years, which aligns with the original answer. There are no numeric inaccuracies, so quantitative accuracy is perfect. Contextually, the response is highly relevant, addressing Walmart's strategic positioning of Allswell within its private brand strategy. However, the LLM misses a key nuance in the evolution: the original answer emphasizes that Allswell was *introduced* in 2023 and then *retained and grouped with mature brands* like 'bettergoods' and 'Great Value' in 2024, signaling progression from new to established. The LLM correctly notes continuity but does not capture this developmental trajectory—transitioning from a new to a mature brand—which is central to the question about evolution and strategic positioning. This omission reduces qualitative accuracy, as the multi-hop reasoning (from introduction to maturation) is underdeveloped. While the LLM infers stability and strategic importance, it does not fully synthesize the implication that Allswell has gained traction and is now considered a core brand, which weakens the depth of the reasoning compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 355,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products increased from 2022 to 2023, as evidenced by a rise in revenue and strategic emphasis. In 2023, Embedded Processing revenue grew to $3.05 billion from $2.57 billion in 2022, while Analog revenue declined. Additionally, the 2023 10-K highlights a strategic focus on analog and embedded processing, with embedded processing partially offsetting the decline in analog revenue, indicating a shift in emphasis toward this segment for growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, but the LLM claims $2.57 billion in 2022 and $3.05 billion in 2023—these numbers are not supported by the original answer and are therefore incorrect. There is no mention in the ground truth of exact Embedded Processing revenues, so providing precise figures undermines factual accuracy. (2) The calculation of growth from $2.57B to $3.05B is irrelevant because these numbers do not appear in the original answer; thus, the quantitative foundation of the LLM response is flawed. The only accurate number mentioned in passing is the $17.52 billion total revenue in 2023, which aligns with the ground truth. (3) The reasoning partially captures the multi-hop insight: it correctly identifies that Embedded Processing partially offset the decline in Analog revenue and remained strategically important. However, it incorrectly frames this as a 'rise in revenue' and a 'shift in emphasis' due to fabricated numbers, leading to an erroneous conclusion about increasing strategic importance. The original answer emphasizes continuity in strategic importance with an added compensatory role—not an increase in strategic importance. (4) While the LLM addresses the right context (strategic role, revenue composition, offsetting decline), the use of incorrect data severely undermines correctness. The qualitative reasoning is partially sound but built on false premises. Contextual relevance is high because it engages with the right concepts and documents. Final scores reflect major quantitative errors dragging down overall correctness despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 482,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has remained consistent, with the company maintaining a 36.4% interest in Angola LNG Limited, as noted in both the 2022 and 2024 filings. In 2024, Angola LNG contributed to transfers to proved developed reserves, indicating ongoing operational development and production. This continuity suggests Chevron is strategically positioning itself to maintain a strong presence in the LNG market, leveraging long-term projects in key regions like Africa to support its global energy supply and meet growing LNG demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Chevron maintained a 36.4% interest in Angola LNG Limited in both 2022 and 2024. According to the ground truth, the 36.4% stake was only explicitly stated in 2024; in 2022, Chevron's involvement was referenced in terms of production volumes, not ownership percentage. This misrepresents the evolution of Chevron's involvement. (2) The quantitative accuracy is partially correct—the 36.4% figure is accurate for 2024, but its attribution to 2022 is unsupported by the ground truth. No calculations were required, but the incorrect temporal assignment of the percentage undermines factual precision. (3) The multi-hop reasoning is flawed: the question asks how Chevron's involvement evolved, implying a change or progression. The LLM asserts continuity, contradicting the ground truth, which indicates a shift from operational participation (2022) to a formally defined equity stake (2024). This fails to capture the strategic evolution. (4) Contextual relevance is high—the answer addresses Chevron, Angola LNG, and strategic positioning in the LNG market, using appropriate terminology and logical framing. However, due to the core factual error about the timeline of stake ownership, the overall correctness is significantly reduced. The conclusion about strategic positioning is plausible but based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 383,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has shown consistent production growth and financial contribution within Lockheed Martin's RMS division between 2021 and 2024. In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales due to higher production volume. By 2024, it continued to drive growth, with higher production volume contributing to a $1.1 billion increase in RMS product sales. This indicates that the CH-53K remains a strategically important and expanding program for RMS, reflecting its significance in meeting defense needs and contributing to the division's revenue and operating performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $540 million increase in RMS net sales in 2021 and the $1.1 billion contribution to product sales in 2024, both of which match the ground truth. However, it omits the $140 million increase in operating profit in 2021, which is a significant financial metric mentioned in the original answer and directly relevant to the program's financial contribution. This omission reduces completeness. (2) Quantitatively, all provided numbers are accurate—$540 million in 2021 and $1.1 billion in 2024—and correctly attributed to production volume. The dollar amounts are consistent with the ground truth, and no calculation errors are present. (3) The reasoning is sound in identifying the program's growing role and production ramp-up, and the conclusion that CH-53K is a key growth driver is supported. However, the LLM does not explicitly mention the transition from 'risk retirement' in 2021 to 'production ramp-up' in 2024, missing a key qualitative shift in the program’s maturity. This weakens the multi-hop synthesis of how the nature of the program evolved beyond just volume increases. (4) Despite these omissions, the answer remains contextually relevant, addresses the core evolution of financial and production status, and draws a reasonable conclusion about the program’s strategic importance. The scores reflect high accuracy with minor but notable gaps in completeness and depth of reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 402,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "PayPal updated its use of macroeconomic factors in loss curves for revolving consumer credit products between 2022 and 2023. In 2022, macroeconomic forecasts were applied using a reasonable and supportable forecast period of 2 years. By 2023, this period was extended to approximately 5 years and 7 months for revolving products. Additionally, in the second quarter of 2023, PayPal updated its expected credit loss models for revolving consumer receivables, though these changes did not have a material impact on the provision recorded for the year ended December 31, 2023. The macroeconomic factors considered included forecasted trends in household disposable income and retail e-commerce sales, with unemployment rates included through the first quarter of 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omits key details from the ground truth. (1) Correctly notes the shift in macroeconomic factors in 2023 to include household disposable income and retail e-commerce sales, and correctly states that unemployment rates were used through Q1 2023. However, it introduces a specific forecast period of '2 years' in 2022 and '5 years and 7 months' in 2023, which are not mentioned in the original answer and appear to be fabricated or misattributed details. These quantitative claims cannot be verified and contradict the ground truth, which does not specify forecast horizon lengths. (2) The LLM incorrectly frames the model update as having 'no material impact' on the provision for 2023, which, while possibly true, is not part of the original answer’s focus on the evolution of macroeconomic factor usage. (3) The qualitative reasoning is partially sound—there is recognition of a model update and a shift in indicators—but fails to clearly state that unemployment and benchmark credit card charge-off rates were used in 2022, and that unemployment was *replaced* (not just phased out) after Q1 2023. The answer also omits the mention of benchmark credit card charge-off rates entirely, a key component of the 2022 approach. (4) Contextual relevance is high because the response stays on topic and discusses the correct company, product type, and general evolution of models. However, the inclusion of unverified quantitative details and omission of key macroeconomic variables reduce factual accuracy. Overall, the answer is partially correct but contains critical omissions and unsupported numerical claims, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 467,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI decreased from a net gain of $140.2 million in 2023 to $135.2 million in 2024. This slight decrease suggests that the company's exposure to foreign currency fluctuations remained relatively stable, though it indicates a marginal reduction in the positive impact of foreign currency movements on its debt-related hedging activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Starbucks had a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024, representing a shift from loss to large gain. The LLM incorrectly claims a gain of $140.2 million in 2023, which is not supported by the data. This misrepresents the financial outcome and trend. (2) The quantitative inaccuracies are severe: the 2023 figure is wrong ($140.2M vs. actual $6.3M loss), and the characterization of both years as gains ignores the actual loss in 2023. The 2024 figure ($135.2M gain) is correct, but the comparison is invalid due to the incorrect 2023 value. (3) The multi-hop reasoning fails because the model does not recognize the reversal from loss to gain, leading to an incorrect conclusion about stable exposure. In reality, the shift from a loss to a large gain indicates a significant change in foreign currency exposure or hedging effectiveness, not stability. (4) The contextual relevance is moderate because the answer addresses the right topic (AOCI, foreign currency debt gains/losses, exposure implications), but the incorrect data and flawed reasoning undermine the conclusion. Correctness and quantitative accuracy are low due to fundamental factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 363,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "The fair value of energy-related derivatives for Alabama Power decreased from $19 (Level 2) in 2022 to $15 (Level 2) in 2023, while Georgia Power's fair value decreased from $18 (Level 2) in 2022 to $13 (Level 2) in 2023. The combined liabilities related to these derivatives also showed a downward trend, decreasing from $210 million in 2022 to $234 million in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It reports Alabama Power's fair value of energy-related derivatives as $19 million in 2022 and $15 million in 2023, and Georgia Power's as $18 million in 2022 and $13 million in 2023. However, the ground truth states that in 2022, Alabama Power had a net liability of $144 million (no asset figure provided separately), and in 2023, Alabama Power had $15 million in assets and $110 million in liabilities (net $95 million), while Georgia Power had $13 million in assets and $124 million in liabilities (net $111 million). The LLM incorrectly treats asset values as total fair values and fabricates 2022 figures for Georgia Power, which are not present in the original answer. (2) The combined liabilities calculation is incorrect: the LLM claims a decrease from $210 million in 2022 to $234 million in 2023, which is both numerically wrong and directionally opposite to the truth. The correct combined net liability was $255 million in 2022 ($144M from Alabama Power, assuming Georgia Power's 2022 data is missing but implied to be part of the total) and $206 million in 2023 (sum of $95M and $111M), showing a decrease. The LLM incorrectly states an increase from 2022 to 2023 despite claiming a 'downward trend'. (3) Multi-hop reasoning is flawed: the model fails to correctly identify and synthesize net liabilities across two companies and two years. It misrepresents partial asset data as total fair value and invents missing data. (4) Despite incorrect numbers and reasoning, the answer attempts to address the question's structure—discussing both companies, both years, and the trend—hence moderate contextual relevance. However, due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 487,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, gaining approximately 100% ownership. The company later disposed of the entity, as it was deconsolidated in fiscal 2025. No further details about the terms or timing of the disposition are provided in the documents.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart's ~100% ownership, which matches the ground truth. However, it incorrectly states that deconsolidation occurred in fiscal 2025, while the original answer specifies fiscal 2024. This is a critical error in temporal accuracy that affects the core timeline of the financial relationship evolution. (2) The dollar amount ($0.4 billion) is accurate and correctly formatted. The fiscal 2023 acquisition date is correct, but the disposition year is off by one year, which undermines the claim of a one-year evolution from acquisition to divestiture. (3) The reasoning correctly follows the multi-hop structure—acquisition followed by disposition—and recognizes deconsolidation as a signal of exit. However, the incorrect fiscal year breaks the logical synthesis of the full cycle occurring within a single year, which is a key point in the original answer. (4) Contextually, the answer is relevant and addresses both acquisition and disposition. Due to the significant error in the fiscal year of deconsolidation, the correctness and quantitative accuracy scores are reduced, though the qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 351,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received regulatory approvals for new indications, including HR+/HER2- breast cancer in both the U.S. and the European Union. This expansion of Trodelvy's approved uses reflects Gilead's oncology strategy of broadening the therapeutic applications of its key products to increase market reach and revenue potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Trodelvy received regulatory approvals in 2023 for HR+/HER2- breast cancer in both the U.S. (FDA) and European Union (EC), which matches the original answer. There are no numeric values requiring calculation, but the temporal framing (between 2022 and 2023) is correctly interpreted as the approval occurring in 2023, with no major regulatory updates in 2022. (2) The answer correctly identifies the entities: Trodelvy, Gilead, and the regulatory bodies (implied by 'U.S. and European Union'). (3) The reasoning is sound: the expansion into new indications reflects a strategy to broaden therapeutic applications, which is consistent with the original answer’s conclusion about strengthening Gilead's oncology position. (4) While the LLM answer omits the detail that Trodelvy was already part of Gilead’s marketed portfolio in 2022 contributing to oncology growth, this omission does not undermine the core accuracy of the regulatory evolution or strategic implication. The answer captures the key multi-hop insight—regulatory progress indicating strategic focus—making it semantically equivalent in intent and substance. Minor completeness gap prevents a perfect 10, but overall highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 365,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions. In 2023, Simon experienced dilution of its ownership in ABG due to capital transactions, recognizing non-cash gains from deemed disposals of proportional interests. By 2024, Simon sold all of its remaining interest in ABG for $1.2 billion, resulting in a substantial pre-tax gain of $414.8 million. This strategic divestment reflects Simon's shift in focus and capital allocation away from ABG, marking a key step in its broader strategic positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It claims that in 2024, Simon Property Group (SPG) sold all of its remaining interest in ABG for $1.2 billion, resulting in a pre-tax gain of $414.8 million. This is incorrect—according to the ground truth, SPG did not report any active capital transactions with ABG in 2024, including such a sale or gain. Instead, the 2024 filing only referenced historical transactions (e.g., 2021 and 2022 events). The $414.8 million gain and $1.2 billion sale are entirely fabricated and not supported by the data. (2) Quantitatively, the 2023 gains mentioned in the LLM answer are partially correct in concept (gains from dilution) but lack specific numbers. The ground truth specifies a $36.4 million gain in Q2 and $145.8 million in Q3 2023—neither of which are mentioned in the LLM response. The invented $414.8 million gain in 2024 is false. (3) The multi-hop reasoning is flawed. The model incorrectly infers a full divestment in 2024, failing to recognize that the absence of new transactions indicates a stabilization or wind-down of active engagement, not a major sale. It also fails to mention the strategic licensing ventures (Forever 21, Brooks Brothers, Eddie Bauer) that were part of the ongoing relationship. (4) While the answer addresses the evolution of the financial relationship and attempts to discuss strategic positioning, the core factual errors—especially the invented 2024 transaction—severely undermine correctness. The contextual relevance is moderate because it attempts the right narrative arc (shifting focus), but the foundation is factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 448,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) evolved between 2022 and 2024, with CPChem's investment value and financial reporting showing growth. In 2024, Chevron's investment in CPChem was $8.57 billion, an increase from $7.77 billion in 2023 and $7.77 billion in 2022. Additionally, Chevron's equity in earnings from CPChem rose to $903 million in 2024, compared to $608 million in 2023 and $867 million in 2022, indicating improved financial performance and value contribution from CPChem during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature of Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem). The original answer correctly identifies a structural shift in accounting treatment—from consolidated subsidiary in 2022 to equity method investee in 2024—based on specific disclosures in the 10-K (Note 8, page 70 in 2022). The LLM answer completely omits this critical evolution in financial reporting, which is central to the question. Instead, it incorrectly implies consistent equity method reporting by providing investment values for all three years (2022–2024), stating $7.77 billion in both 2022 and 2023. However, the ground truth states that CPChem was a consolidated subsidiary in 2022, meaning it would not have had a standalone 'investment value' reported under equity method accounting. Thus, assigning a $7.77 billion investment value for 2022 is factually incorrect. The 2024 value of $8.57 billion is close to the correct $8,571 million, and $7.77 billion is close to the correct $7,765 million in 2023, so those figures are approximately accurate. (2) The LLM introduces equity earnings data ($903M in 2024, $608M in 2023, $867M in 2022) that are not present in the original answer or ground truth, making them unverified and potentially hallucinated. These figures undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about the evolution in relationship, particularly in financial reporting and investment value. The key insight is the change in accounting method, which reflects a change in control or ownership structure. The LLM fails to recognize or report this shift, instead focusing only on investment value and earnings trends, missing the core qualitative transformation. (4) While the answer is contextually relevant—discussing CPChem, investment values, and earnings—it scores low on correctness and qualitative accuracy due to the omission of the consolidation-to-equity shift and the introduction of unsupported earnings data. The approximate correctness of the 2023 and 2024 investment values prevents a lower score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 578,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta completed its 2022 Facilities Consolidation Strategy, which involved subleasing, early termination, or abandonment of office buildings under operating leases. In 2024, the restructuring charges related to this strategy were $389 million, all attributed to facilities consolidation, compared to $2,255 million in 2023. This decline reflects the winding down of the initiative, with Meta reporting that the 2022 restructuring initiatives were fully completed by December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states that Meta completed the 2022 restructuring initiatives by the end of 2024, it introduces specific restructuring charge figures—$389 million in 2024 and $2,255 million in 2023—that are not present in the ground truth. The original answer does not provide annual breakdowns of facilities consolidation charges for 2023 or 2024, nor does it state that $389 million in 2024 was 'all attributed' to facilities. These numbers appear fabricated or misattributed, severely undermining factual correctness. (2) The ground truth mentions a retrospective summary of pre-tax charges across 2022–2024 but does not specify the amounts for 2023 or 2024 individually. Therefore, the LLM’s precise figures and year-over-year comparison are unsupported and incorrect. There is no verification possible for the $389M or $2,255M claims, making the quantitative accuracy very low. (3) The qualitative reasoning is partially sound: the LLM correctly infers progression from 'substantially completed' in 2023 to 'completed' in 2024, and links completion to declining charges. However, it fails to mention the key qualitative shift in disclosure—retrospective quantification of total financial impact in 2024, which was absent in 2023. This is a critical omission in the multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the evolution of the facilities strategy and attempts to explain financial impact. However, due to major quantitative errors and missing key qualitative disclosures, the overall correctness score is low. The answer creates a plausible narrative but with incorrect data, leading to a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 487,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin's involvement in hypersonics programs has remained a strategic focus, with continued emphasis on design, development, and production of hypersonic strike weapons. In 2022, the company highlighted its hypersonics programs in collaboration with the U.S. Army and Navy, while by 2024, these programs were still a key part of its portfolio, indicating sustained investment and progress in this high-priority defense technology area.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's continued strategic focus on hypersonics from 2022 to 2024 and mentions collaboration with U.S. military branches, which aligns with the ground truth. However, it fails to capture the key evolution in program status—specifically, the shift from a funding-dependent development phase in 2022 to active production under the Air Force and Army by 2024. This critical transformation is omitted, significantly weakening the qualitative accuracy. The LLM also incorrectly states collaboration with the Navy in 2022, which is not mentioned in the original answer (the ground truth specifies Army and Air Force, not Navy). (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model recognizes hypersonics as a sustained strategic focus, but it does not synthesize the progression from developmental dependency to active production, which is the core of the evolution. This represents a failure in deeper reasoning and synthesis across time points. (4) Contextual relevance is high because the answer addresses the right topic and timeframe, but the missing evolution and incorrect military branch reduce completeness and factual precision. Correctness score is 6 due to partially correct information with significant omissions and one entity error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 395,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed notable changes in both designation and financial impact. In 2023, the assets from risk management activities for energy-related derivatives designated as hedging instruments for regulatory purposes dropped significantly from $123 million in 2022 to $12 million, while liabilities increased from $121 million to $198 million. Additionally, the total derivatives designated as hedging instruments in cash flow and fair value hedges saw a decrease in assets from $21 million to $3 million, with liabilities rising from $549 million to $419 million. This suggests a shift in the balance and classification of these derivatives, likely reflecting changes in hedging strategies or regulatory requirements. The financial impact also shows a net increase in liabilities, indicating a more pronounced exposure or obligation related to these derivatives in 2023 compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical values (e.g., $123 million, $12 million, $549 million) that are not present in the original ground truth answer and cannot be verified from the provided context. The original answer does not mention any balance sheet amounts for assets or liabilities related to derivatives, nor does it provide figures on changes in hedging instrument designations. Instead, the ground truth emphasizes a qualitative shift in disclosure practices: in 2022, Southern Company reported only the pre-tax effects of unrealized gains/losses from energy-related derivatives designated as regulatory hedging instruments; in 2023, it expanded disclosure to include derivatives not designated as hedging instruments, with retrospective presentation for 2023, 2022, and 2021. The LLM answer completely misses this key evolution in disclosure policy and instead fabricates quantitative details about asset and liability movements, which are not supported by the original answer. While the LLM attempts to address the question's focus on changes in treatment and financial impact, it fails on factual accuracy and multi-hop reasoning. The mention of 'cash flow and fair value hedges' introduces concepts absent from the ground truth, further indicating a lack of alignment. The contextual relevance is moderate because the response stays within the topic of derivative treatment, but the core factual content is incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 410,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved with a key development in 2022 when the company settled patent litigation with five generic manufacturers (Lupin Ltd., Apotex Inc., Macleods Pharma Ltd., Hetero Labs Ltd., and Cipla Ltd.) concerning the patents protecting TAF in Descovy, Vemlidy, and Odefsey. This settlement, disclosed in the 2023 10-K filing, allowed for the resolution of legal uncertainties and provided clarity on the timeline for generic competition. In 2023, Gilead continued to emphasize its broader IP strategy, including patent term extensions and supplementary protection certificates, to maintain exclusivity for key products. However, no new major patent litigation settlements or extensions specific to Truvada were disclosed in 2023, indicating a period of stabilization following the 2022 resolution.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the specific evolution of Gilead's intellectual property strategy regarding Truvada between 2022 and 2023. The ground truth states that in 2022, Gilead acknowledged the October 2020 loss of exclusivity of Truvada in the U.S. as a past event affecting revenue, and in 2023 shifted to proactively disclosing structured timelines for patent expirations of key products including Truvada. However, the LLM answer incorrectly focuses on a 2022 patent litigation settlement involving TAF-containing products (Descovy, Vemlidy, Odefsey), not Truvada, and attributes this disclosure to the 2023 10-K. This misrepresents the core subject of the question—Truvada’s IP strategy—with information about other products. (2) The dates mentioned (e.g., '2022 settlement') are not contradicted by the ground truth, but no specific dates for settlements are provided in the original answer, so their accuracy cannot be confirmed. More critically, the October 2020 loss of exclusivity—a key date in the ground truth—is omitted entirely. (3) The multi-hop reasoning is flawed: the LLM fails to connect the shift from reactive acknowledgment of Truvada’s patent expiry in 2022 to proactive disclosure of expiration timelines in 2023. Instead, it introduces an unrelated legal settlement concerning different drugs, breaking the logical chain required by the question. (4) While the general theme of IP strategy evolution is addressed, the specific factual content is inaccurate. The answer discusses stabilization and broader IP strategies but misses the central point: the change in disclosure approach around Truvada’s patent status. Thus, despite some plausible-sounding details, the answer does not align with the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 491,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved with specific borrowing and repayment activities. In 2022, SPG repaid $1.05 billion under the Supplemental Facility using proceeds from the issuance of senior unsecured notes. By 2024, the Supplemental Facility had a borrowing capacity of $3.5 to $4.5 billion, and SPG used it to issue €750 million in senior unsecured bonds in November 2023, which were subsequently used to repay €750 million ($815.4 million) outstanding under the Supplemental Facility. Additionally, as of December 31, 2024, SPG had $323.7 million outstanding under the Credit Facility, but no specific large borrowings or repayments under the Supplemental Facility were noted for 2024, indicating a reduction in active use compared to previous years.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that in 2022, SPG 'repaid $1.05 billion using proceeds from senior unsecured notes' — the ground truth indicates SPG *borrowed* $1.05 billion under the Supplemental Facility in January 2022 to repay $1.16 billion in mortgages, and this borrowing was repaid shortly after. The LLM reverses the direction of the transaction and misattributes the source of repayment. Second, the LLM claims that SPG 'used the Supplemental Facility to issue €750 million in senior unsecured bonds' — this is incorrect. The ground truth states SPG *borrowed* €750 million (equivalent to $815.4 million) under the Supplemental Facility in November 2023, which was repaid on November 17, 2023. The LLM confuses borrowing under the facility with issuing bonds, which are distinct financial actions. Additionally, the LLM introduces a 'borrowing capacity of $3.5 to $4.5 billion' and an outstanding balance of $323.7 million under the 'Credit Facility' as of December 31, 2024 — none of which is mentioned in the ground truth and appears extraneous or fabricated. (2) Quantitatively, the €750 million and $815.4 million figures are correct in amount and equivalence, and the November 2023 timing aligns. However, the $1.05 billion is mischaracterized in context (repayment vs. borrowing), undermining its accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the sequence of borrowing and repayment in 2022 and misrepresents the nature of the 2023 activity. It also introduces a supposed 'reduction in active use' in 2024, which contradicts the ground truth's indication of continued short-term reliance. The shift in financing strategy noted in the original answer (issuing new notes to redeem others) is omitted. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of SPG's use of the facility and attempting to compare years. However, due to major factual and directional errors in financial activities, the correctness score is low. Quantitative accuracy is partially preserved, but qualitative reasoning is significantly flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 582,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife has increasingly emphasized maintaining a robust cash buffer to support its capital management strategy, particularly in response to evolving market and regulatory conditions. In 2022, the company highlighted its strong liquidity position and ability to manage capital through a diversified approach, including access to global funding sources and stress testing. By 2024, MetLife explicitly noted that cash buffer needs could limit its ability to return capital to shareholders through dividends or stock repurchases, reflecting a more cautious stance amid heightened regulatory scrutiny and potential economic stress scenarios. This evolution indicates a strategic shift toward prioritizing liquidity and capital preservation to ensure resilience against uncertainties, which in turn affects capital allocation decisions by potentially reducing funds available for shareholder returns or growth initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in MetLife's capital management strategy from 2022 to 2024, noting the shift toward a more cautious tone regarding cash buffers and their impact on capital allocation. However, it omits the specific quantitative figures from 2022—$12.4 billion in short-term liquidity and $223.0 billion in total liquid assets—which are present in the ground truth. These numbers are critical for full factual completeness, especially since the question asks about liquidity levels. (2) While no calculations are required, the absence of exact dollar amounts reduces quantitative accuracy. The LLM refers generally to a 'strong liquidity position' in 2022 but does not cite the actual figures, which were explicitly provided in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the strategic shift over time, connecting increased cash buffer needs to trade-offs in capital allocation (e.g., reduced shareholder returns or innovation funding). It accurately reflects the evolving narrative from confidence in liquidity to concern about opportunity costs. (4) Despite missing specific numbers, the LLM conveys the correct qualitative trend and strategic implications, with accurate entities (MetLife, 2022–2024), correct time periods, and appropriate financial context. The answer remains highly relevant and semantically aligned with the ground truth, just lacking precision in numerical detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 409,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives shifted significantly. In 2022, the asset classification showed $39.9 million in \"Prepaid expenses and other current assets\" and $33.5 million in \"Other long-term assets,\" while the liability side showed $0.3 million in \"Accrued liabilities\" and negligible long-term liabilities. By 2023, the asset classification dropped to $1.9 million in current assets and $1.7 million in long-term assets, indicating a substantial reduction. On the liability side, \"Foreign currency - other\" increased to $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities, reflecting a shift toward greater liability exposure in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had *no asset value* reported for 'Foreign currency - other' derivatives, only a $0.3 million liability. However, the LLM claims there were asset values of $39.9 million in current assets and $33.5 million in long-term assets in 2022, which is entirely incorrect. Similarly, in 2023, the LLM reports $1.7 million in long-term assets and $4.1 million in long-term liabilities, but the ground truth states only a $1.9 million current asset and $4.7 million current liability—no long-term values are mentioned. These numbers are completely fabricated or misattributed. (2) The only correct numbers in the LLM answer are the $0.3 million liability in 2022 and the $4.7 million liability in 2023, as well as the $1.9 million asset in 2023. All other figures (e.g., $39.9M, $33.5M, $1.7M, $4.1M) are unsupported by the ground truth and incorrect. (3) The multi-hop reasoning is flawed because the model fails to correctly retrieve and synthesize the actual data from the knowledge graph. It invents asset and liability classifications (long-term assets/liabilities) that were not present in the original answer, leading to a false narrative of 'reduction in assets' and 'increase in liabilities' across both current and long-term buckets. The actual evolution—from no asset in 2022 to a net asset in 2023 alongside increased liability—is misrepresented. (4) While the LLM attempts to address the question's focus on evolution and classification, the severe quantitative errors undermine the qualitative and contextual accuracy. The contextual relevance is moderate because the structure and intent align with the question, but the factual foundation is unsound. Correctness is low due to major factual and quantitative discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 501,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's relationship with Coca-Cola FEMSA in 2024 shows a continued strategic focus on its bottling and distribution operations in Latin America, with Coca-Cola FEMSA maintaining a significant role in key markets like Mexico, Guatemala, Colombia, and Brazil. Financially, The Coca-Cola Company held a 28% stake in Coca-Cola FEMSA as of December 31, 2024, with a carrying value of $1,786 million, while the fair value of its shares was $4,544 million. This indicates a substantial undervaluation of the investment on the balance sheet, reflecting the ongoing strategic engagement and potential for future value realization.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies The Coca-Cola Company's 28% ownership stake in Coca-Cola FEMSA as of 2024, which aligns with the ground truth and reflects the shift to an equity method investee. However, the original answer does not mention the carrying value ($1,786 million) or fair value ($4,544 million) of the investment—these figures, while potentially accurate, are not supported by the ground truth provided and introduce unverified quantitative details. Since the question focuses on the evolution from 2023 to 2024, the LLM omits the key 2023 context that Coca-Cola FEMSA was one of the top five independent bottlers accounting for 42% of global unit case volume through the concentrate supplier model. This missing comparative baseline weakens the multi-hop synthesis. (2) The 28% stake is correct and matches the ground truth. However, the specific dollar amounts (carrying value and fair value) cannot be verified against the original answer and appear to be external data not present in the ground truth, reducing quantitative accuracy. (3) The reasoning correctly infers deeper financial engagement due to equity ownership but fails to contrast the 2023 bottler relationship with the 2024 equity investee shift, which is central to the question’s multi-hop requirement. The evolution in strategic engagement is underdeveloped without this before-and-after synthesis. (4) The answer is contextually relevant and focuses on the right companies and time period, with accurate terminology. However, the correctness score is reduced due to the omission of key 2023 facts and introduction of unsupported financial figures, making the response partially correct but incomplete in its comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 471,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has increasingly positioned FPGAs (Field-Programmable Gate Arrays) as a strategic component within its broader product portfolio, particularly in adjacent products and advanced manufacturing initiatives. In 2022, FPGAs were highlighted as part of Intel's \"adjacent products\" under the Programmable Solutions Group (PSG), emphasizing their role in solutions such as AI, 5G, and data center applications. By 2024, the strategic focus on FPGAs expanded, with increased emphasis on their integration into Intel's advanced manufacturing roadmap, including the adoption of EUV lithography for leading-edge process nodes like Intel 4 and Intel 3. Additionally, FPGAs are being leveraged to support Intel's external foundry services and high-performance computing initiatives, reflecting a broader production and market expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in entity identification and strategic positioning details. While it correctly identifies a growing strategic focus on FPGAs between 2022 and 2024, it misattributes the organizational placement of FPGAs in 2022 to the 'Programmable Solutions Group (PSG)'—the ground truth states they were positioned under 'adjacent products' within CCG, DCG, and IOTG, not PSG. This is a significant factual error. Additionally, the LLM introduces details not present in the ground truth, such as EUV lithography, Intel 4/Intel 3 process nodes, external foundry services, and specific technology initiatives, which are unsupported by the original answer and represent overreach or hallucination. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default due to absence of numerical claims. (3) The multi-hop reasoning is partially sound in that the model infers an increased strategic role for FPGAs over time, aligning with the core trend in the ground truth. However, it fails to accurately reflect the structural and categorization shift—from 'adjacent products' to 'direct product definitions'—which is the key evidence for strategic evolution. Instead, it substitutes this with unverified technical and manufacturing details, undermining the reasoning chain. (4) The contextual relevance is high because the answer addresses the evolution of FPGA positioning and broader production focus, staying on topic. However, the correctness score is reduced to 6 due to significant factual inaccuracies in entity placement and the introduction of unsupported technical claims, despite capturing the general directional shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 476,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips significantly increased its asset acquisition activity in the Lower 48 region, primarily driven by the Concho acquisition in 2021, which added 1,169 MMBOE to its reserves. In terms of depreciation, depletion, and amortization (DD&A) expenses, the Lower 48 segment saw a notable increase, rising from $4,854 million in 2022 to $5,729 million in 2023, reflecting higher production and asset utilization following the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for the Lower 48 region as $4,854 million in 2022 and $5,729 million in 2023, matching the ground truth exactly. The increase of $875 million is accurate (5,729 - 4,854 = 875), though not explicitly stated, the rise is correctly implied. (2) All numeric values and years are correct. The mention of the Concho acquisition adding 1,169 MMBOE to reserves is factually accurate based on public filings, though this specific detail was not included in the original ground truth answer. This adds useful context but does not contradict or distort the core answer. (3) The reasoning is sound: the LLM correctly links the Concho acquisition (which occurred in 2021) to increased asset utilization and higher DD&A expenses in 2022–2023, demonstrating proper multi-hop synthesis across time and financial impact. The original answer references the Concho acquisition as a 2022 driver, but since the acquisition closed in early 2022 (January 2022), both characterizations are contextually acceptable. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced detail. The only minor deviation is the emphasis on 2021 for the acquisition, while the original answer frames its impact in 2022, but the financial data and trend interpretation align perfectly. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 393,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased from 55% to 57%, as Emerson proposed to acquire the remaining shares in November 2024. Financially, the Heritage AspenTech acquisition in 2022 positively impacted gross margins by 0.6 percentage points in 2023, contributing to an overall increase in gross margin to 49.0%. However, in 2024, the gross margin increased by 1.8 percentage points to 50.8%, driven by the Test & Measurement acquisition and higher pricing, though partially offset by acquisition-related inventory step-up amortization. Thus, the strategic integration of AspenTech enhanced Emerson's financial performance, particularly in gross margin, over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in ownership structure and financial details. According to the ground truth, Emerson owned 55% of AspenTech by 2024 on a fully diluted basis — the LLM incorrectly states ownership increased from 55% to 57% and claims Emerson proposed acquiring the remaining shares in November 2024, which is not supported by the original answer. The original does not mention any such proposal or ownership increase beyond 55%. (2) Quantitative inaccuracies include the claim that gross margin increased to 49.0% in 2023 — the original answer states a 0.6 percentage point positive impact in 2023 but does not specify the overall gross margin for that year. The LLM fabricates the 49.0% figure. While the 2024 gross margin increase of 1.8 percentage points to 50.8% is correct, the LLM attributes this partly to the 'Test & Measurement acquisition,' which is not mentioned in the ground truth — the correct driver per the original is the AspenTech acquisition itself. The $231 million inventory step-up amortization reducing margins by 1.3 percentage points is omitted in the LLM answer, though it is a key financial impact. (3) The multi-hop reasoning is partially sound — the model correctly links the 2022 acquisition to margin impacts in 2023 and 2024, and recognizes ongoing financial effects. However, it introduces incorrect entities (Test & Measurement acquisition) and misrepresents ownership evolution, undermining the synthesis. (4) Despite these issues, the answer is contextually relevant, addressing both ownership and financial impact on gross margins as asked. The qualitative reasoning about strategic integration enhancing performance is consistent in spirit, though based on flawed data. Scores reflect partial correctness with significant factual and quantitative errors that affect reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 509,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan remained consistent in terms of share recovery and issuance mechanics. Shares recovered due to forfeitures, cash settlements, or other non-issuance events are added back to the available pool for future grants under the plan. Additionally, when awards are settled with shares net of shares tendered (e.g., for tax withholding or exercise price), only the net shares issued are counted against the available share pool. The 2024 disclosures confirm that these mechanics have not changed since 2022, maintaining the same ratios and recovery rules for share availability.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing the general mechanics of share recovery and net share issuance, stating that forfeited or cash-settled shares are added back to the pool and that net shares issued are counted against the pool. However, it fails to provide any of the specific quantitative data from the ground truth, such as the total authorized shares (35,395,894), the 37,608,213 shares recovered, the 42,343,146 shares covered by new awards and reinvested dividends, or the 30,660,961 shares available for future issuance. These numbers are central to understanding the evolution of share availability between 2022 and 2024. (2) The LLM claims the mechanics 'remained consistent' between 2022 and 2024, but the ground truth indicates a net reduction in available shares despite ongoing recovery, implying a shift in the balance between issuances and recoveries — a key evolution that the LLM overlooks. The absence of any numerical data or trend analysis severely undermines quantitative accuracy. (3) While the LLM correctly identifies the general rules of share recovery and net issuance (showing some qualitative understanding), it fails to perform the necessary multi-hop synthesis of data across time (2015–2024) and between issuance, recovery, and net availability. The answer does not reflect the net depletion of shares or the fact that more shares were issued (42.3M) than recovered (37.6M), which is critical to the question. (4) The answer is contextually relevant and addresses the right plan and topic, but lacks the factual depth and numerical precision required for a correct response. The correctness score is low due to missing key data and misrepresenting the evolution as static when the ground truth shows a dynamic, net reduction in availability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 489,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' strategic emphasis with the Global Coffee Alliance shifted in fiscal 2023 to focus on expanding its global ready-to-drink business and enhancing digital customer experience innovations, as highlighted by the leadership changes and role assignments of executives like Brady Brewer. In terms of revenue contribution, the Channel Development segment, which includes the Global Coffee Alliance, saw an increase in revenue by $250 million (16%) in fiscal 2022 compared to fiscal 2021, driven by higher product sales to and royalty revenue from the Global Coffee Alliance. However, the operating margin for this segment decreased by 520 basis points to 44.3% in fiscal 2022, primarily due to challenges in the North American Coffee Partnership joint venture. While specific 2023 figures are not provided, the continued strategic emphasis on innovation and partnerships suggests a sustained, if not increased, focus on the Global Coffee Alliance in fiscal 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $250 million revenue increase in the Channel Development segment in fiscal 2022 (vs. 2021), which aligns with the ground truth. However, the ground truth does not mention operating margin changes or the North American Coffee Partnership, which are factually accurate but not directly tied to the Global Coffee Alliance—this introduces extraneous detail and slightly misattributes performance factors. The LLM incorrectly implies that the $250M increase is part of a 16% growth without confirming that percentage from the ground truth (which omits it), introducing unsupported quantitative detail. (2) The LLM claims leadership changes (e.g., Brady Brewer) and digital experience innovations as drivers in fiscal 2023, but the ground truth does not mention these—this adds speculative content not supported by the source. The absence of specific 2023 revenue figures is acceptable since the original answer also lacks them, but the LLM fails to highlight the key strategic evolution emphasized in the ground truth: the explicit focus on the Nestlé licensing relationship as a core distribution channel. Instead, it generalizes to 'innovation and partnerships,' which is vague and less precise. (3) The multi-hop reasoning is partially sound—linking the Global Coffee Alliance to Channel Development revenue is correct, and recognizing continued strategic importance in 2023 is aligned. However, it misses the core shift in strategic framing: from revenue driver (2022) to strategic enabler of global reach (2023), particularly through the Nestlé licensing structure. This is a significant omission in qualitative synthesis. (4) The contextual relevance is high because the answer addresses both strategic emphasis and revenue contribution across the two fiscal years. Quantitative accuracy is mostly correct but penalized for the unverified 16% figure and margin details not tied to the alliance. Qualitative accuracy suffers from missing the key strategic pivot and introducing unsupported executive-level details. Correctness score reflects partial accuracy with significant gaps in capturing the true evolution of the alliance’s strategic role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 589,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "NEE's financial stake in the Mountain Valley Pipeline (MVP) declined significantly between 2022 and 2023, as evidenced by the impairment charges and reduced investment carrying amounts. In 2022, NEE recorded a $674 million impairment charge related to its investment in MVP, and by 2023, it recorded an additional $38 million impairment, indicating ongoing financial challenges with the project. The investment carrying amount for MVP and other equity method investees dropped from $6,582 million in 2022 to $6,156 million in 2023, with the difference largely attributed to impairment charges, particularly for MVP. This suggests that NEE is actively reassessing and reducing its exposure to underperforming or high-risk investments, aligning with a strategy to focus on more stable and profitable ventures, particularly in renewable energy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The original answer states that NEE's total equity method investments were $6,159 million in 2022 and $6,156 million in 2023—essentially unchanged. However, the LLM claims the carrying amount dropped from $6,582 million to $6,156 million, which is not supported by the ground truth. Furthermore, the LLM introduces impairment charges of $674 million in 2022 and $38 million in 2023 related to MVP, but these figures are not present in the original answer and contradict it—no such impairments are mentioned in the ground truth. (2) Completeness: While the question asks about the evolution of NEE's stake and what it indicates about investment strategy, the LLM fabricates financial data (impairments, carrying amounts) rather than reporting the actual ownership range changes (32%–55% in 2022 to 32.8%–52.6% in 2023) and the shift in financial disclosure (MVP noted in Nonrecurring Fair Value Measurements in 2023). (3) Entity Accuracy: The company (NEE) and project (Mountain Valley Pipeline) are correctly identified, and the years (2022–2023) are accurate. (4) Reasoning: The multi-hop reasoning is flawed because the LLM infers a 'decline in financial stake' based on fabricated impairment charges rather than analyzing the actual change in ownership percentage ranges and disclosure context. The conclusion that NEE is reducing exposure due to underperformance is speculative and not supported by the ground truth, which suggests a refinement in investment posture, not a strategic retreat. (5) Semantic Equivalence: The LLM's narrative contradicts the original answer—it frames the evolution as a negative reassessment due to financial trouble, while the ground truth indicates a stable investment with nuanced ownership adjustments and potential revaluation. Thus, despite addressing the general topic, the answer is factually incorrect in key aspects, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 539,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line expanded its neurostimulator offerings and therapeutic indications. In 2022, the InterStim Micro neurostimulator was highlighted as a recently launched product for Pelvic Health, targeting overactive bladder, urinary retention, and chronic fecal incontinence. By 2024, the product line included the InterStim X and InterStim II recharge-free neurostimulators, as well as the InterStim Micro rechargeable neurostimulator, broadening treatment options for similar conditions. Additionally, advancements in spinal cord stimulation (SCS) therapy for chronic pain and Diabetic Peripheral Neuropathy (DPN) were noted, with the introduction of the Inceptiv closed-loop rechargeable SCS system receiving U.S. FDA approval in April 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but includes significant inaccuracies and irrelevant information. (1) Correct elements: The mention of InterStim II and InterStim X as recharge-free neurostimulators by 2024 aligns with the ground truth. The conditions overactive bladder and urinary retention are correctly identified. (2) Incorrect/misleading elements: The claim that InterStim Micro was targeting 'chronic fecal incontinence' in 2022 is incorrect — the ground truth states that bowel incontinence was included in 2022, but the specific term 'chronic fecal incontinence' was only introduced in 2024 as an expansion. More critically, the LLM incorrectly states that InterStim Micro is a 'rechargeable' neurostimulator in 2024, which contradicts the ground truth that positions InterStim X and II as 'recharge-free' — no mention is made of InterStim Micro being rechargeable in the original. (3) Irrelevant information: The discussion of spinal cord stimulation (SCS), Diabetic Peripheral Neuropathy (DPN), and the Inceptiv system is entirely off-topic — these are not part of the InterStim Therapy product line, which focuses on sacral neuromodulation for pelvic health, not SCS for chronic pain. This reflects a failure in entity accuracy and reasoning. (4) Multi-hop reasoning is flawed: The answer fails to correctly synthesize the evolution — it misrepresents the timeline of indications and introduces unrelated product lines. While it captures some product names and conditions, the core evolution (refinement in labeling and expansion to chronic fecal incontinence) is misrepresented. (5) Quantitative accuracy is moderate: No explicit numbers or dates are wrong (e.g., April 2024 FDA approval is plausible), but the misuse of product attributes (rechargeable vs. recharge-free) affects technical correctness. Overall, the answer is partially correct but contains key factual errors and lacks focus, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 525,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2022, Simon contributed its interests in the licensing ventures of Forever 21 and Brooks Brothers to ABG in exchange for additional interests, increasing its ownership. By 2023, Simon sold portions of its ABG stake, resulting in pre-tax gains, and its ownership was diluted to approximately 9.6%. In 2024, Simon fully exited its remaining interest in ABG, selling it for $1.2 billion and recording a pre-tax gain of $414.8 million, marking the end of its strategic investment in ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Simon held a 1.37% interest in ABG and co-owned SPARC Group (50% with ABG) after merging Forever 21 operations. However, the LLM incorrectly states that Simon increased its ownership in ABG in 2022 via contribution of licensing ventures, which is not supported. The LLM claims Simon's stake was diluted to 9.6% by 2023, but the original answer does not mention this percentage. Most critically, the LLM asserts that in 2024 Simon fully exited its ABG stake with a $1.2 billion sale and $414.8 million pre-tax gain, which directly contradicts the ground truth: Simon actually *acquired additional interests* in ABG for $100 million in 2024, not sold its remaining stake. The only partially correct element is that Simon did sell a portion of its stake and realized a pre-tax gain—however, the ground truth specifies this gain as $18.8 million, not $414.8 million or prior gains. (2) Quantitative accuracy is very low: the $1.2 billion sale, $414.8 million gain, 9.6% ownership, and $100 million purchase (which the LLM reverses as a sale) are all incorrect in direction and magnitude. Only the concept of a partial sale with a gain is correct, but even the amount is wrong. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution—instead of showing an ongoing strategic relationship with ups and downs, it incorrectly concludes with a full exit, missing the reinvestment in 2024. The model appears to confuse the direction of transactions. (4) Contextual relevance is moderate because the answer addresses the evolution of the relationship and mentions key entities and timeframes, but the core financial and strategic narrative is factually inverted. Due to major factual and directional errors in both numbers and strategic interpretation, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 517,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and production levels in the region over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for ConocoPhillips in the Lower 48 region as $4,067 million in 2021, $4,854 million in 2022, and $5,729 million in 2023. These values match the ground truth data, with the 2023 figure explicitly confirmed and the 2022 figure being an accurate intermediate data point not contradicted by the original answer. The upward trend and final 2023 value are correctly emphasized. (2) All numeric values are factually accurate and consistent with the knowledge graph. The increase from $4,067M to $5,729M over the two-year period is correctly implied through the stepwise reporting. No calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that rising DD&A expenses reflect increased investment activity and production, which aligns with the ground truth's interpretation of growing emphasis on the Lower 48. The multi-hop synthesis across years is accurate and well-articulated. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer did not include the 2022 figure, so while the LLM's inclusion of it is accurate and enhances clarity, it slightly exceeds the provided ground truth without external sourcing. However, since the number is correct and improves the explanation, this is a minor point. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth with enhanced detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 409,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds remained consistent from 2023 to 2024, as both years disclose that international bonds were valued using matrix prices with input from independent third-party valuation sources, and were categorized under Level 2 of the fair value hierarchy. No significant changes in methodology or valuation approach were noted in the disclosures between the two periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Verizon's treatment and valuation approach remained consistent between 2023 and 2024. The ground truth shows a clear evolution: in 2023, international bonds were described generally as valued using matrix prices via third-party sources and included within broader fixed income securities, with no specific dollar value or level breakdown provided. In 2024, Verizon specifically itemized international bonds with a total value of $12 million, split into $10 million in Level 1 and $2 million in Level 2 inputs — a significant shift toward greater transparency and segmentation. The LLM incorrectly claims no change occurred. (2) Quantitatively, the LLM omits all numerical data ($12M total, $10M Level 1, $2M Level 2) present in the ground truth, which are critical to the answer. These numbers represent a key evolution in disclosure and are entirely missing from the LLM response. (3) The multi-hop reasoning is flawed: the question requires comparing two years of disclosures to identify changes in valuation approach and transparency. The LLM failed to detect the shift from a general description to a detailed, itemized disclosure with granular fair value hierarchy breakdown, which constitutes a meaningful change in both treatment and transparency. (4) While the LLM stays on topic (hence partial contextual relevance), it fundamentally misrepresents the core fact — that there *was* a change — and thus scores very low on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 428,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly between 2022 and 2024. In 2022, Emerson acquired a controlling stake in Heritage AspenTech, increasing its ownership to 55% of AspenTech's outstanding shares through a transaction that combined Emerson's industrial software businesses with Heritage AspenTech. By 2024, Emerson proposed to acquire the remaining outstanding shares of AspenTech not already owned by Emerson for $240 per share, implying a total enterprise value of $15.1 billion. This proposal reflects a move toward full ownership and deeper operational integration, aligning AspenTech more closely with Emerson's automation and software strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) In 2022, the ground truth states Emerson had a financial stake in AspenTech valued at $8,326 million on its balance sheet due to prior acquisitions and currency adjustments—not that it acquired a 55% stake in that year. The LLM incorrectly claims Emerson increased ownership to 55% in 2022 via a transaction combining its software businesses, which contradicts the timeline and nature of the deal. (2) By 2024, the actual event was not a proposal to acquire the remaining shares at $240 per share for a $15.1B enterprise value, but rather the completion of a strategic restructuring: Emerson contributed the AspenTech Industrial Software Business and $6.0 billion in cash to form 'New AspenTech,' in which it retained a 55% ownership stake. The LLM misrepresents this as a proposed acquisition rather than a completed integration with majority control already established. (3) Quantitatively, the $240/share and $15.1B enterprise value figures do not appear in the ground truth and are therefore unverified or incorrect; the correct financial inputs are the $8,326M stake in 2022 and the $6.0B cash contribution in 2024. (4) The reasoning is flawed: the LLM fails to recognize that the 55% ownership was retained post-restructuring in 2024, not newly acquired in 2022. It also misses the key point of operational integration through the creation of 'New AspenTech' as a combined entity. (5) While the answer addresses the evolution of the relationship and touches on financial and operational aspects, the core facts, timing, and structure are wrong. The contextual relevance is moderate because it discusses the right companies and general theme of increasing integration, but the specifics are largely fabricated or reversed in time. Overall, major factual and chronological errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 513,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps evolved in terms of classification and associated liabilities. In 2022, interest rate swaps were classified as \"Designated Derivative Instruments\" and were recorded under \"Other long-term assets\" with no liabilities recorded. By 2023, interest rate swaps were still designated, but liabilities increased significantly, with $19.2 million recorded under \"Other long-term liabilities\" as of September 29, 2024, compared to $41.4 million as of October 1, 2023. This reflects a shift from asset-heavy positions in 2022 to a more liability-focused position in 2023, likely due to changes in market interest rates and hedging activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Starbucks had a $34.0 million long-term liability from interest rate swaps. However, the LLM incorrectly states that in 2022, swaps were recorded as 'Other long-term assets' with no liabilities, which contradicts the original data. This misrepresents the entire financial position. In 2023, the ground truth shows $0.4 million in current liabilities (accrued liabilities) and $19.2 million in long-term liabilities, totaling $19.6 million. The LLM only mentions the $19.2 million long-term liability but incorrectly frames it as an increase, when in fact it represents a decrease from $34.0 million in 2022. Additionally, the LLM cites liabilities as of October 1, 2023 ($41.4 million) and September 29, 2024 — dates and figures not present in the ground truth and factually incorrect. (2) Quantitative accuracy is very low: the only correct number is $19.2 million (long-term portion in 2023), but it omits $0.4 million current liability and falsely claims a rise in liabilities. The $41.4 million figure and future date (2024) are entirely fabricated. The net change should be a decrease from $34.0M to $19.6M, but the LLM implies an increase, failing basic calculation and comparison. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the shift in classification (from solely long-term liability in 2022 to split current/long-term in 2023) and misinterprets the direction of liability change. It incorrectly infers a shift from asset to liability, when the truth is a reclassification and reduction of existing liability. (4) Contextual relevance is moderate because the answer addresses the general topic (classification and liability evolution), but due to severe factual and numerical errors, the conclusion is misleading. Correctness and accuracy scores are low due to fundamental errors in financial representation, incorrect data, and flawed logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 537,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources (NEER) significantly reduced its involvement in the Mountain Valley Pipeline (MVP) from 2022 to 2023. In 2022, due to legal and regulatory challenges, including the U.S. Court of Appeals for the Fourth Circuit vacating key permits, NEER recorded an impairment charge of approximately $0.8 billion ($0.6 billion after tax), completely writing off its equity method investment of $0.6 billion and recording a $0.2 billion liability for future asset retirement obligations. By 2023, NEER's financial commitment to MVP was limited to an equity contribution in 2024 and a 20-year natural gas transportation agreement (approximately $70 million per year), reflecting a much-reduced role in the project.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.8 billion impairment charge in 2022 and the $70 million annual obligation under the 20-year transportation agreement in 2023, which aligns with the ground truth. However, it incorrectly states that NEER recorded a $0.2 billion liability for future asset retirement obligations as part of the impairment, a detail not present in the original answer and not supported by the knowledge graph. Additionally, the mention of an 'equity contribution in 2024' is not mentioned in the ground truth and introduces a forward-looking commitment not confirmed in the source. (2) The $0.8 billion impairment and $70 million annual obligation are quantitatively accurate. The breakdown into $0.6 billion after tax and $0.2 billion liability appears to be an inference or external detail not in the original answer, reducing quantitative accuracy. (3) The reasoning correctly captures the evolution from a full write-off in 2022 to continued contractual commitment in 2023, showing sound multi-hop synthesis across years and financial instruments. However, the addition of unverified details (liability amount, 2024 contribution) weakens the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution of financial commitment and involvement, though with minor factual overreach. The core facts are correct, but the extra details reduce overall correctness. Thus, a score of 7 is justified for correctness, with slightly lower scores for quantitative and qualitative accuracy due to unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 433,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company, which reinsures group annuity insurance contracts covering obligations of certain European and Canadian pension plans, increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This reflects a $240 million increase in the value of these securities over the one-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,643 million (2023) and $1,883 million (2024) are accurately reported with correct dates (December 31, 2023, and December 31, 2024), and the implied $240 million increase ($1,883M - $1,643M) is accurate. (2) The answer is complete, addressing the evolution of investments between 2023 and 2024, including both years' figures and the direction and magnitude of change. (3) Entity accuracy is correct: The Coca-Cola Company, its captive insurance company, and the context of reinsuring group annuity contracts (linked to European and Canadian pension plans, which adds contextual detail not in the original but does not contradict it) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly interprets that the solvency capital funds consist of equity and debt securities held by the captive insurer and tracks their change over time. (5) Semantic equivalence is maintained — while the LLM adds minor contextual detail (geographic scope of pension plans), it does not introduce errors and enhances clarity without deviating from the truth. All scoring dimensions warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 348,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, Intel 4 was positioned as its first EUV lithography node, with the Intel Core Ultra processor as the first high-volume client product, beginning to ship in 2023. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was expected to represent an increasing portion of processor production in 2025. Intel 4 was strategically positioned as a foundational node for performance-per-watt improvements and was part of Intel's broader roadmap to scale production and support both internal and external foundry customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel 4 from initial ramp-up to high-volume manufacturing and its strategic role in the product roadmap. It accurately states that Intel 4 moved to high-volume manufacturing in Ireland by 2024 and was used for the Intel Core Ultra processor. However, it incorrectly states that the Core Ultra began shipping in 2023, which is not supported by the ground truth (the original answer notes high-volume production in 2024). This is a minor factual inaccuracy regarding timing. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is based on dates. The mention of 2023 as the shipping start is the only deviation; otherwise, 2022 and 2024 are used appropriately. (3) The multi-hop reasoning is sound: the model synthesizes information about production status (ramp-up in 2022, HVM in 2024) and strategic positioning (foundation for performance-per-watt, part of broader roadmap). It correctly infers the strategic importance of Intel 4, even adding context about EUV and foundry ambitions not in the ground truth but plausibly aligned. (4) The answer is highly relevant and mostly accurate, with only a slight error in the product shipment timeline. The core facts—transition from early investment to volume production and strategic centrality—are correct, warranting a high score but not perfect due to the 2023 claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 401,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In May 2022, Emerson completed a transaction to contribute two of its industrial software businesses to AspenTech in exchange for approximately $6.0 billion in cash and ownership of 55% of AspenTech's outstanding shares on a fully diluted basis. By 2024, Emerson's ownership had increased to approximately 57%, and on November 5, 2024, Emerson announced a proposal to acquire the remaining shares of AspenTech for $240 per share in cash, signaling full financial integration and control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, AspenTech was a strategic partner with no ownership stake or financial integration by Emerson. However, the LLM claims that in May 2022, Emerson contributed software businesses to AspenTech in exchange for $6.0 billion and a 55% stake—this transaction did not occur in 2022 as described. The merger forming 'New AspenTech' with 55% ownership by Emerson occurred later, culminating in 2023–2024, not starting in May 2022. Additionally, the LLM states Emerson’s ownership increased to 57% by 2024 and that a full acquisition was announced on November 5, 2024, at $240 per share—none of which is supported by the original answer, which only confirms a 55% stake and integration into financials, with no mention of a full buyout announcement. (2) Quantitative inaccuracies include the $6.0 billion cash figure, the 57% ownership, the $240 per share offer, and the November 5, 2024 announcement date—all of which are fabricated or incorrect. The only correct number is the ~55% ownership, though the timing is misrepresented. (3) The multi-hop reasoning is flawed: the model incorrectly synthesizes a complex transaction timeline that does not align with the ground truth. It invents a full acquisition proposal not present in the original data and misrepresents the evolution from partnership to partial ownership. (4) While the answer addresses ownership and financial integration (hence moderate contextual relevance), the core facts, numbers, and timeline are largely incorrect, leading to low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 455,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024, with a focus on manufacturing readiness and performance improvements. In 2022, Intel 4 was introduced as its first EUV lithography node, delivering approximately 20% performance-per-watt improvement over Intel 7, with the Intel Core Ultra processor as its first high-volume product. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was expected to represent an increasing portion of processor production in 2025, indicating improved readiness and scalability. Additionally, performance improvements were further emphasized with the introduction of Intel 3, which offered up to 18% performance-per-watt improvement over Intel 4, showcasing Intel's continued progress in optimizing its process nodes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies Intel 4 as Intel's first EUV lithography node and notes the ~20% performance-per-watt improvement over Intel 7, which aligns with the ground truth. It also correctly mentions high-volume manufacturing in Ireland by 2024. However, it incorrectly states that the Intel Core Ultra processor was the first high-volume product on Intel 4 in 2022, when in fact the processor began shipping in 2023, not 2022. This misplacement of timing undermines the evolution narrative. (2) The claim that Intel 3 offers up to 18% improvement over Intel 4 is factually unsupported in the provided ground truth and introduces unverified information, potentially confusing the progression. The ground truth does not mention Intel 3 at all. (3) The multi-hop reasoning is partially sound—linking process node advancement with manufacturing readiness and performance—but incorrectly projects future production share in 2025, which is not in the original answer. The original emphasizes the transition from roadmap to production by 2024, which the LLM captures in spirit but distorts with speculative forward-looking statements. (4) The contextual relevance is high as it directly addresses the evolution of Intel 4 across manufacturing and performance. However, due to the incorrect timeline (2022 vs. 2023 for Core Ultra), unsupported comparison to Intel 3, and minor factual overreach, the quantitative accuracy is reduced significantly, pulling the overall correctness score into the mid-range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 435,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the InterStim Micro has maintained a central role within Medtronic's Pelvic Health therapies, specifically in treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In 2022, it was highlighted as part of the Pelvic Health product line under the Specialty Therapies division, alongside other offerings like InterStim X and InterStim II. By 2024, the InterStim Micro continued to be emphasized as a key rechargeable neurostimulator within Pelvic Health therapies, with continued acceptance and growth noted in the context of broader Neuromodulation advancements. This reflects a consistent positioning as a core solution in Medtronic's Pelvic Health portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the role of InterStim Micro within Medtronic's (MDT) Pelvic Health therapies in both 2022 and 2024, accurately stating its use in treating overactive bladder, urinary retention, and fecal incontinence. It correctly notes that InterStim Micro was part of the product lineup alongside InterStim X and InterStim II in 2022. By 2024, it correctly identifies InterStim Micro as the rechargeable neurostimulator option, which aligns with the ground truth. However, the LLM answer does not explicitly contrast InterStim Micro (rechargeable) with InterStim X and II (recharge-free) as clearly as the original answer, missing a key strategic repositioning nuance. (2) There are no numerical values, dates, or calculations in the question or answers that require verification—dates (2022, 2024) are consistent and correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024) and product lines to show evolution in positioning. It correctly infers continued importance and growth, though it could have more precisely articulated the differentiation strategy. (4) The answer is contextually fully relevant and semantically close to the ground truth, with only a minor gap in emphasizing the explicit rechargeable vs. recharge-free distinction that defines the strategic shift. Thus, the correctness and qualitative accuracy scores are high but not perfect due to this omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 405,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units from 2022 to 2024 indicates that no securities, including LTIP Units, had a material dilutive effect in any of the reporting periods (2022, 2023, and 2024). The company consistently stated that potentially dilutive securities, such as LTIP Units, were considered, but none were found to have a material impact on diluted earnings per share or unit during these years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that no securities, including LTIP Units, had a material dilutive effect in the reporting periods from 2022 to 2024, which aligns with the ground truth. However, it fails to capture the evolution in disclosure detail — specifically, the removal of the explicit mention of LTIP units being exchangeable for common stock in the 2024 filing. This change in narrative and level of detail is a key part of the original answer and is entirely omitted in the LLM response. (2) Quantitatively, the years (2022, 2023, 2024) and the conclusion about lack of material dilutive impact are accurate. There are no calculation errors or incorrect dates. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes the consistent conclusion about dilution across years, but it does not address the qualitative shift in disclosure language regarding the exchangeability feature of LTIP units, which is central to the question about 'evolution' of disclosure. This represents a failure in comparative textual analysis across filings. (4) While the answer is factually correct in its core assertion and contextually relevant, the omission of the reduced disclosure detail significantly undermines the qualitative accuracy and overall correctness, as the evolution in transparency — not just the numerical impact — is the focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 386,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has emphasized liquidity considerations and regulatory constraints. In 2022, the company highlighted that cash buffer requirements and regulatory restrictions could limit its ability to repurchase shares, as it maintained a buffer of cash and liquid assets to ensure financial stability. By 2024, MetLife continued to emphasize that cash buffer needs and legal or regulatory restrictions remained key factors influencing its stock repurchase decisions, while also noting that governments or market pressures could impact its ability to return capital to shareholders. The remaining repurchase authorization was not explicitly stated in the provided pages, but the company maintained a focus on balancing liquidity needs with capital return strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the qualitative shift in MetLife's approach from 2022 to 2024, noting increased emphasis on liquidity and regulatory constraints. However, it fails to include key quantitative information present in the ground truth: specifically, the $1.5 billion remaining repurchase authorization under the $3.0 billion program as of the end of 2021 (referenced in the 2022 context). This omission significantly impacts factual completeness and accuracy. (2) The absence of the $1.5 billion and $3.0 billion figures constitutes a major quantitative inaccuracy, even though the model acknowledges that remaining authorization was not explicitly stated in the 'provided pages'—but the ground truth confirms this data should have been available and included. No calculations are required in this question, but reporting the correct figures is essential. (3) The multi-hop reasoning is partially sound: the model correctly infers a continued focus on liquidity buffers and regulatory limits across years, and synthesizes the idea that capital return is balanced against stability. However, it misses the evolution from a more active repurchase posture (with specific capacity remaining) in 2022 to a more cautious stance in 2024, weakening the comparative analysis. (4) Contextual relevance is high—the response stays on topic and addresses cash buffers, repurchases, and liquidity. Qualitative accuracy is moderate due to correct framing but missing key details. Correctness score is 6 due to significant omission of critical numbers that define the starting point of the evolution, making the answer partially correct but incomplete for a multi-hop financial comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 465,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative asset and liability positions changed significantly. In 2022, the foreign currency - other derivative assets were $39.9 million (current) and $33.5 million (long-term), with liabilities of $0.3 million (current) and $- (long-term). By 2023, the derivative assets increased to $32.0 million (current) and $22.9 million (long-term), while liabilities rose to $4.7 million (current) and $4.1 million (long-term). The balance sheet classifications remained similar, with assets primarily in \"prepaid expenses and other current assets\" and \"other long-term assets,\" and liabilities in \"accrued liabilities\" and \"other long-term liabilities.\"",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings — not the $39.9M (current) and $33.5M (long-term) claimed by the LLM. The LLM incorrectly presents balance sheet line-item values for 2022 that do not appear in the ground truth. For 2023, the ground truth states that derivative assets were $1.9 million (current) and $1.7 million (long-term), but the LLM reports $32.0M and $22.9M — over 10x higher. Similarly, the LLM claims liabilities rose to $4.7M (current) and $4.1M (long-term) in 2023, which matches the ground truth for liabilities, so this part is correct. However, the asset figures are completely wrong. (2) The quantitative accuracy is very low: asset numbers for both years are incorrect, and the LLM fabricates 2022 balance sheet classifications that are not in the original answer. The only correct numbers are the 2023 liability amounts. There is no mention in the ground truth of 2022 liabilities being $0.3M or long-term liabilities being '-' — this is fabricated. (3) The multi-hop reasoning is flawed. The question asks about evolution and classification changes, but the LLM incorrectly infers that asset positions increased from 2022 to 2023 when in fact they decreased dramatically (from $103.9M in OCI to just $3.6M total on balance sheet in 2023). The LLM also misses the key point about reclassifications from AOCI to earnings in 2022 and fails to note the significant reduction and shift in classification. Instead, it falsely claims classifications 'remained similar,' contradicting the ground truth's emphasis on a 'shift in balance sheet classification' and a 'significant reduction.' (4) Correctness is scored 2/10 due to major factual errors in numbers and reasoning, with only partial accuracy on 2023 liabilities. Quantitative accuracy is 2/10 due to almost all numbers being incorrect. Qualitative accuracy is 3/10 because the model identifies the correct balance sheet categories (e.g., prepaid expenses, accrued liabilities) but misapplies them. Contextual relevance is 6/10 because the structure and intent of the response match the question, but the content is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 631,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy has evolved in response to its restructuring activities and financial performance between fiscal 2022 and 2024. In fiscal 2024, the company incurred $659 million in restructuring costs, including a significant non-cash foreign currency translation loss of $216 million from the liquidation of operations in certain Enterprise Markets. These restructuring efforts were part of a broader initiative to optimize manufacturing and workforce operations, with approximately 64% of the charges settled in cash. Meanwhile, the company's cash flow and liquidity remained strong, with a global strategy focused on liquidity management, economic factors, and tax considerations. Excess operating cash was prioritized for shareholder dividends, with discretionary uses including share repurchases and acquisitions. This reflects a continued emphasis on balancing cost savings from restructuring with maintaining financial flexibility to support shareholder returns and strategic growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements but contains significant factual inaccuracies, particularly regarding fiscal 2022 data and the nature of financial impacts. The ORIGINAL ANSWER states that in fiscal 2022, P&G incurred restructuring costs within the $250–$500 million range with $147 million in accruals and that corporate net earnings improved by $872 million to $485 million. The LLM answer omits all fiscal 2022 financial data entirely, failing to address the evolution from 2022 to 2024 as required by the multi-part question. This omission severely undermines completeness and correctness. (2) Quantitative accuracy is partially correct for fiscal 2024: the LLM correctly states $659 million in restructuring costs and $216 million in non-cash foreign currency translation losses. However, it introduces a new figure—'64% of the charges settled in cash'—which is not present in the ground truth and cannot be verified. Additionally, the LLM fails to mention the critical $1.4 billion impairment charge of the Gillette intangible asset, a major driver of the $1.0 billion decline in corporate net earnings, thus missing a key financial event. (3) Reasoning and synthesis are partially sound: the LLM correctly infers that restructuring was linked to optimization in Enterprise Markets and that cash management prioritized liquidity, taxes, and shareholder returns. However, it does not acknowledge the increased financial pressure from restructuring and impairments, instead suggesting strong cash flow and liquidity without addressing the negative earnings trend. This misrepresents the financial performance trajectory. (4) Contextual relevance is high—the response stays on topic and addresses cash management, restructuring, and financial performance. But due to missing 2022 data, incorrect emphasis on financial health, and omission of the Gillette impairment, the overall correctness score is reduced to 6. Quantitative accuracy is 5 due to partial number correctness but inclusion of unverified percentages and missing key figures. Qualitative accuracy is 7 because reasoning is logical but based on incomplete facts. Contextual relevance is 9 as the answer aligns well with the question's scope despite factual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 602,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's Omniverse evolved significantly in terms of enterprise integration and simulation technologies. In 2023, Omniverse was positioned as a fully managed cloud service (NVIDIA Omniverse Cloud) on Microsoft Azure, enabling the development and deployment of industrial metaverse applications. This marked a strategic shift toward cloud-based scalability and enterprise accessibility. Additionally, Omniverse's role expanded in digital twin technologies, allowing industrial enterprises to simulate complex physical assets, processes, and environments—such as virtual factories and autonomous vehicle testing—leveraging NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This evolution reflects a stronger focus on enterprise solutions and industrial digitalization.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of NVIDIA Omniverse between 2022 and 2023. It accurately captures the shift toward enterprise integration, digital twin applications, and tighter coupling with NVIDIA's accelerated computing infrastructure. The mention of cloud deployment via Microsoft Azure and the introduction of NVIDIA Omniverse Cloud is contextually accurate and reflects a real strategic development, though the original answer does not specify Azure integration—this is a minor addition not contradicted by the ground truth. The LLM correctly identifies key use cases such as virtual factories and autonomous vehicle testing, consistent with DRIVE Sim and industrial digitalization themes. However, the original answer emphasizes Omniverse's 2022 positioning as a collaboration platform for 3D workflows with free individual access and subscription enterprise model, which the LLM omits. Additionally, the 2022 use cases like surgical training and architectural walkthroughs are not mentioned, representing a minor completeness gap. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the reasoning is sound, showing appropriate multi-hop synthesis between enterprise adoption, simulation technologies, and infrastructure integration. The answer remains semantically equivalent in key aspects and highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 401,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites evolved from 2023 to 2024 with an increase in anticipated spending and future obligations. In 2023, AMT projected total capital expenditures of $1,545 to $1,655 million, including $70 to $90 million for ground lease purchases. By 2024, the company's total capital expenditures were expected to remain in a similar range, with a breakdown of $790 to $820 million for discretionary capital projects, $70 to $90 million for ground lease purchases, and $455 to $485 million for redevelopment. Additionally, AMT's long-term debt obligations increased from $35,734 million in 2023 to $36,756.3 million in 2024, reflecting higher future debt maturities and obligations. These figures indicate a strategic focus on maintaining and expanding communications infrastructure while managing significant debt commitments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of the specific financial commitments related to communications sites as defined in the ground truth. The original answer highlights a shift from $450 million in anticipated spending on data center assets for 2,500 to 3,500 communications sites in 2023 to a $4.5 billion undiscounted future cash outlay for asset retirement obligations (AROs) on leased sites in 2024. The LLM instead cites total capital expenditure ranges ($1,545–$1,655M in 2023 and similar in 2024) and breaks them into discretionary projects, ground lease purchases, and redevelopment, which are not mentioned in the ground truth and misrepresent the nature of the commitment. The $70–$90M for ground lease purchases appears repeatedly but is unrelated to the $450M or $4.5B figures in the original. (2) The numbers provided in the LLM answer do not match the ground truth: $450M (correct 2023 figure) is absent, and the critical $4.5B ARO in 2024 is entirely missing. Instead, the LLM introduces unrelated capex categories and total debt figures ($35,734M and $36,756.3M), which, while possibly accurate from filings, do not address the specific evolution of financial commitments tied to communications sites as defined in the original answer. (3) The multi-hop reasoning is flawed: the question asks for evolution in commitments specifically related to communications sites, particularly anticipated spending and future obligations. The ground truth shows a qualitative shift from near-term construction capex to long-term AROs, indicating maturation of obligations. The LLM fails to capture this shift and instead discusses general capex and debt trends without linking them to site-related obligations or AROs. (4) The contextual relevance is moderate because the answer discusses AMT’s financials and infrastructure spending, but it misses the core concept of asset retirement obligations and mischaracterizes the nature and scale of the commitments. The qualitative accuracy is low because the entities (metrics like AROs) and reasoning are incorrect. Quantitative accuracy is very low due to complete mismatch in key figures. Correctness score is 2 due to major factual and conceptual errors, with only a vague acknowledgment of increasing obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 611,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures and the proceeds from these transactions has evolved to emphasize their role in optimizing capital and aligning with strategic objectives. In 2023, the proceeds from asset sales were described as part of a disciplined review process to ensure assets contribute to strategic goals, with the cash flow from operations and asset sales being useful for evaluating cash available for investment and shareholder distributions. By 2024, the language became more specific, highlighting that asset divestitures were driven by a long-standing review process to ensure assets align with strategic objectives or are worth more to others, and that proceeds are integrated with operating cash flows to support capital investment and financing activities. This shift reflects a more strategic and value-focused framing of asset sales in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a key mischaracterization in the evolution of language used by ExxonMobil. (1) Correct elements: The answer correctly identifies that in 2023, ExxonMobil emphasized a disciplined review process to align assets with strategic goals and that proceeds were discussed in the context of cash flow for investment and distributions. It also correctly notes that in 2024, the company continued to reference strategic alignment. (2) Quantitative accuracy: There are no numerical figures in the question or ground truth, so this aspect is not applicable; however, the use of years (2023 and 2024) is accurate. (3) Multi-hop reasoning: The model attempts to synthesize across years, but incorrectly frames the 2024 language as 'more specific' and 'more strategic and value-focused.' In contrast, the ground truth indicates that the 2024 description was actually more consolidated and broadened—removing specific references to subsidiaries and equipment—thus representing a streamlining, not a specification. The LLM incorrectly infers increased specificity when the actual change was toward generality. (4) This misrepresentation of the direction of linguistic evolution undermines the qualitative accuracy. While the core idea of strategic alignment is preserved, the characterization of how the language evolved is flawed, leading to an incomplete and somewhat misleading conclusion. Hence, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 409,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort decreased slightly from 2022 to 2023. In 2022, the consolidated assets and liabilities of Universal Beijing Resort were $9.7 billion and $8.1 billion, respectively. By 2023, these amounts were $7.8 billion and $7.2 billion, respectively, indicating a reduction in both asset and liability exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: $9.7 billion in assets and $8.1 billion in liabilities for 2022, and $7.8 billion in assets and $7.2 billion in liabilities for 2023. These values match the original answer exactly, with no discrepancies in numbers or years. (2) All numeric values are accurate and properly attributed to the correct years and financial categories (assets and liabilities). The format is consistent and clear, using billions with correct decimal precision. (3) The reasoning is sound: the LLM correctly infers a reduction in financial exposure based on the decline in both assets and liabilities, which aligns with the multi-hop requirement of comparing consolidated balance sheet items across two years. While the original answer adds interpretive possibilities (e.g., asset depreciation, debt repayment, strategic reduction), the LLM captures the core conclusion—decreased exposure—without introducing any incorrect logic. (4) The answer is fully contextually relevant, directly addressing how Comcast’s financial exposure evolved. The only minor shortcoming is the lack of interpretive depth present in the original answer (e.g., possible reasons for the decline), but this does not affect factual correctness. Hence, full marks for quantitative accuracy and contextual relevance, a 9 for qualitative accuracy due to slightly less explanatory depth, and a 9 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 404,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's exposure to Customer Demand Volatility as a risk factor has intensified due to heightened macroeconomic uncertainties, including global economic weakness, commodity price fluctuations, and supply chain disruptions. In 2024, the risk is more explicitly tied to inflationary pressures, pandemic-related disruptions, and the compounding effects of economic uncertainties on customer behavior, which can lead to abrupt shifts in demand and impact financial performance. Additionally, the volatility has strained supply chain stability, with material shortages and logistics constraints becoming more pronounced, further affecting Caterpillar's ability to meet customer demand and maintain operational efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and contextually relevant, but contains a misalignment in the evolution of risk factors between 2023 and 2024. (1) What was correct: The answer correctly identifies macroeconomic uncertainties, supply chain disruptions, inflationary pressures, and material shortages as key elements affecting Customer Demand Volatility. It appropriately links these to impacts on financial performance and supply chain stability, which aligns with the original answer. There are no numeric values in the question or answers, so (2) quantitative accuracy is not applicable—no numbers to verify, thus scored as 10 by default. (3) Multi-hop reasoning is partially sound: the model correctly synthesizes demand volatility with financial and supply chain impacts across years. However, it inaccurately portrays the evolution—claiming that in 2024 the risk is 'more explicitly tied' to pandemic-related disruptions, whereas the original answer states that by 2024 the focus had shifted *away* from pandemic effects (which were central in 2023) toward broader supply-side issues like commodity and material prices. The original emphasizes a broadening of risk to include systemic supply-side challenges, while the LLM answer incorrectly retains pandemic disruptions as a growing or persistent emphasis in 2024. (4) This reasoning error reduces qualitative accuracy to 7. Despite this, the answer remains contextually relevant and captures the general trend of increasing complexity in risk factors, warranting a correctness score of 7—core facts are present but with a notable misrepresentation of the shift in risk emphasis over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 455,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair value of Net Derivative Assets (Liabilities) increased from $58 million in 2023 to $69 million in 2024. The valuation methodology remained consistent, using discounted cash flows based on swap rates as the significant unobservable input, with a weighted average swap rate of 4% for both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The fair value in 2022 (as of December 31, 2021) was $19 million, not $58 million. The $58 million figure is the fair value as of December 31, 2023 (i.e., for 2024 reporting), which the LLM incorrectly states as increasing to $69 million in 2024—this $69 million figure is not supported by the ground truth. The ground truth reports $58 million as the 2024 value, so both the starting and ending values are wrong in the LLM response. (2) The valuation methodology shift is misrepresented: the ground truth states a move *to* discounted cash flows using *observable inputs* (like swap rates of 3–5%, weighted average 4%), whereas the LLM claims the methodology 'remained consistent' and incorrectly labels swap rates as 'significant unobservable input'—this is a critical error, as the shift to observable inputs is a key qualitative change. (3) Multi-hop reasoning is flawed: the question asks for evolution from 2022 to 2024, requiring synthesis of data across years and methodology changes. The LLM fails to correctly identify the starting value (2022), misstates the ending value (2024), and denies a methodology shift that actually occurred. (4) Contextual relevance is moderate—the answer addresses fair value and methodology, so it stays on topic, but factual and conceptual errors severely undermine correctness. Quantitative accuracy is very low due to wrong dollar amounts and mischaracterized inputs. Qualitative accuracy is low because of incorrect reasoning about methodology consistency. Correctness score is 2 due to almost entirely incorrect numbers and a key misrepresentation of methodological evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 462,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved to become more integrated within the company's broader GPU and cloud platform ecosystem. In 2023, GeForce NOW was positioned not only as a standalone cloud gaming service but also as a complementary component of NVIDIA's full-stack accelerated computing platform. This was evident through its use of NVIDIA Ada Lovelace architecture GPUs and its alignment with AI-powered technologies like DLSS, which are central to NVIDIA's broader gaming and AI strategies. Additionally, GeForce NOW's expansion to support underpowered devices reinforced NVIDIA's vision of delivering high-quality gaming experiences across diverse hardware, leveraging the scalability of its cloud infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of GeForce NOW from 2022 to 2023 within NVIDIA's broader ecosystem. It accurately captures the shift toward deeper integration with NVIDIA's full-stack accelerated computing platform, which matches the 2023 strategic positioning described in the original answer. The mention of Ada Lovelace architecture GPUs and DLSS ties GeForce NOW to NVIDIA's broader AI and gaming technologies, supporting the idea of alignment with GPU-driven cloud services. However, the LLM answer omits explicit mention of the comparison to other cloud platforms like vGPU in 2022 or the linkage to AI training platforms such as NVIDIA DGX Cloud in 2023, which were key elements in the original answer’s depiction of ecosystem integration. While the LLM implies integration through technology alignment, it does not fully convey the narrative shift in corporate positioning as part of a broader suite of cloud services. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The reasoning is sound and contextually relevant, with only minor gaps in completeness regarding the multi-hop synthesis of GeForce NOW’s strategic repositioning relative to other cloud offerings. Thus, the answer is factually accurate and relevant but slightly less comprehensive in qualitative depth compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 399,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta's revenue increased by 3% in 2023 compared to 2022, driven by continued growth in emerging markets and adoption of combinations of immune checkpoint inhibitors with Inlyta for the first-line treatment of advanced RCC in the U.S. However, this growth was partially offset by lower volumes and lower net price in certain European markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% revenue growth in 2023 compared to 2022, which aligns with the ground truth (from $1,003 million to $1,036 million). The percentage calculation is accurate: (1,036 - 1,003) / 1,003 ≈ 3.3%, which rounds to 3% as stated. All numeric values and growth rate are correct, satisfying quantitative accuracy. (2) The key drivers of growth—continued adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC in the U.S. and growth in emerging markets—are accurately reported. The offsetting factor of lower volumes and net prices in certain European markets is also correctly included. (3) The multi-hop reasoning is sound: the model synthesizes revenue figures across two years and correctly infers the growth trend, then links it to clinical adoption and regional market dynamics. (4) The only minor omission is that the LLM does not explicitly state the absolute revenue figures for 2022 and 2023 ($1,003M and $1,036M), which were present in the original answer. While not critical to the percentage change, their absence slightly reduces completeness. However, since the question focuses on the evolution and factors—and the percentage change is correct—the impact is minimal. Wording is semantically equivalent and contextually appropriate. Thus, high scores across all dimensions with a 9 in correctness and qualitative accuracy due to this small omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 401,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the treatment and valuation of network location intangibles evolved with a key change in amortization assumptions. In 2024, the company extended the estimated useful life of its tower assets from 20 to 30 years, which directly impacted the amortization of related intangible assets, as these are amortized similarly to towers. This change reduced amortization expense by an estimated $730 million pre-tax for 2024. Additionally, impairment reviews for network location intangibles continued to be conducted on an individual tower basis, with impairments typically arising from sites lacking tenant leases or having expenses exceeding revenues. The impairment review process remained consistent, focusing on projected undiscounted future cash flows to assess recoverability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, network location intangibles were amortized over a weighted average period of 15 years, but the LLM incorrectly claims that tower assets had a useful life of 20 years extended to 30 years in 2024—this specific change and the associated $730 million pre-tax reduction in amortization expense are not supported by the original answer and are factually incorrect. The original answer mentions a $470 million increase in asset retirement obligations, not $730 million, and this relates to liabilities, not amortization savings. (2) The quantitative inaccuracies are severe: the $730 million figure is fabricated, the 20-to-30-year extension is not mentioned in the ground truth, and the $470 million liability increase is misrepresented. The original answer does not state any change in amortization periods for intangibles or towers, only that the weighted average amortization period was 15 years in 2023. (3) The reasoning is flawed: the LLM incorrectly infers a change in useful life and links it to amortization of intangibles, while the ground truth emphasizes enhanced impairment disclosures and indirect impacts from liability revisions. The impairment review process is correctly noted as being on an individual tower basis and triggered by lack of leases or negative cash flow, which is consistent with the original answer. However, the claim that the process 'remained consistent' contradicts the ground truth, which states that the company *expanded* its disclosures and introduced more detailed impairment reviews in 2024. (4) The contextual relevance is moderate because the answer addresses amortization and impairment of network location intangibles, but the core factual claims about changes in assumptions and financial impacts are incorrect, leading to a low correctness score. The answer fails to mention the indirect impact of the $470 million liability increase on valuation and useful life assumptions, which is a key point in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 558,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2023 and 2024, as Guyana has become a core component of its upstream growth portfolio. In 2023, the company achieved exploration success with four new discoveries on the Stabroek Block and brought the third FPSO vessel, Prosperity, online, which reached nameplate capacity ahead of schedule. By 2024, production from Guyana had expanded, with combined gross output from three FPSO vessels exceeding 390 thousand barrels of oil per day (kbd) in 2023 and nearly 440 kbd in Q4 2023. The company anticipates having six FPSO vessels operational on the Stabroek Block by late 2027, with the sixth project at Whiptail in regulatory review. This reflects a continued prioritization of Guyana as a key growth driver for ExxonMobil’s production capacity and resource portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key developments in ExxonMobil's Guyana strategy between 2023 and 2024, including four discoveries on the Stabroek Block and the startup of the Prosperity FPSO. However, there is a significant quantitative discrepancy: the LLM states that combined gross output from three FPSOs was 'exceeding 390 kbd in 2023 and nearly 440 kbd in Q4 2023', which conflates annual and quarterly figures. The ground truth specifies that production reached nearly 440 kbd in Q4 2023, not that it exceeded 390 kbd across the full year. This misrepresentation of production levels over time reduces quantitative accuracy. (2) The LLM incorrectly implies that the 390 kbd figure was achieved across 2023, while the ground truth only supports the Q4 2023 figure of nearly 440 kbd. Additionally, the mention of 'three FPSO vessels' being operational by end-2023 is plausible but not explicitly confirmed in the ground truth. (3) The qualitative reasoning is strong: the LLM captures the strategic elevation of Guyana, though it omits the critical 2024 update that Guyana was formally categorized under 'Advantaged Assets' alongside Permian and LNG projects—a key indicator of strategic repositioning. This omission limits completeness and conceptual precision. (4) Contextual relevance is excellent: the response directly addresses the evolution of strategic emphasis, upstream growth, and production capacity. Despite missing the 'Advantaged Assets' reclassification, it correctly frames Guyana as a core growth driver. Overall, the answer is factually mostly correct with solid reasoning but contains notable quantitative inaccuracies and a missing key strategic detail, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 471,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services evolved by enhancing its unified viewing experience, incorporating more DTC streaming services, and improving accessibility through features like integrated search and voice-activated remote control. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a comprehensive, user-friendly platform that combines linear TV with popular streaming services, thereby increasing customer retention and ARPU by encouraging bundled service adoption and enhancing the value proposition of their video offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks specific factual details present in the ground truth, particularly regarding the actual third-party services integrated in 2022 and 2023. It correctly identifies the general trend of enhanced integration of DTC streaming services and improved user experience features like search and voice control, which aligns with Comcast's strategy to reduce cord-cutting and increase ARPU. However, it omits key entities explicitly mentioned in the ground truth: Disney+, Netflix, and Peacock in 2022; and Xumo Play, NBC, Sky, and NOW TV in 2023. Additionally, it fails to mention that Comcast earns commission revenue from selling third-party services—a critical component of the ARPU growth strategy. While the reasoning about bundling and customer retention is sound and contextually relevant, the answer does not fully reflect the multi-hop synthesis of specific platform changes year-over-year. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative accuracy suffers due to missing specific entities and strategic details. The answer is well-framed and relevant to the question, earning high marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 336,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's distribution network coverage for FG Wilson branded electric power generation systems slightly decreased. In 2023, FG Wilson had a network of 110 distributors covering 109 countries, while in 2024, it had 108 distributors covering 158 countries. This suggests a reduction in the number of distributors, but an increase in the number of countries covered, indicating a potential shift in the geographic distribution strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: in 2023, FG Wilson had 110 distributors covering 109 countries; in 2024, this changed to 108 distributors covering 158 countries. These numbers exactly match the ground truth. The conclusion about reduced distributor count but expanded geographic reach is accurate and consistent with the original answer. (2) Quantitative accuracy is perfect—no calculation errors, and all numbers (110, 109, 108, 158) are correctly cited. Format is consistent and clear. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change over time and infers a strategic shift in distribution strategy. The only minor shortcoming is that it does not explicitly mention Caterpillar’s relationship with FG Wilson beyond distribution (e.g., ownership or branding), but since the question focuses on distribution network coverage, this does not detract significantly. Also, the original answer notes a 'strategic shift toward optimizing distributor efficiency,' which the LLM implies but does not explicitly state. (4) Scores reflect near-perfect factual accuracy, with only a slight deduction in qualitative accuracy due to less complete articulation of strategic implications. Contextual relevance is full—answer directly addresses the evolution of the distribution network between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 378,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations increased between 2022 and 2024. As of December 31, 2024, the carrying value of securitized debt obligations was $18,043 million, compared to $15,203 million as of December 31, 2022. The fair value of these obligations also increased to $18,067 million in 2024 from $15,203 million in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 carrying and fair values ($18,043 million and $18,067 million) as per the ground truth, which is accurate. However, it introduces a specific 2022 carrying and fair value of $15,203 million, which is not present in the original answer or supported by the provided ground truth. The original answer does not provide exact 2022 figures but only describes the composition and reporting of securitized debt obligations in that year. Thus, the inclusion of precise 2022 numbers is an unsupported addition. (2) The calculation of an increase from $15,203M to $18,043M is numerically consistent but based on fabricated data, making the quantitative comparison invalid. The ground truth does not confirm any specific dollar amounts for 2022, so asserting a change with exact figures reduces quantitative accuracy. (3) The reasoning partially reflects multi-hop understanding by comparing two years and discussing exposure trends, but it fails to acknowledge that the 2022 data is descriptive rather than numerical in the source. The conclusion about increased exposure may be plausible but is not verifiable from the given ground truth. (4) Despite the incorrect numbers, the LLM captures the correct direction of change, maintains focus on carrying and fair values, and correctly reports 2024 data, earning moderate scores in qualitative accuracy and high relevance. The correctness score is limited by the invention of unsupported 2022 figures, which undermines factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 422,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's line of credit agreements remained stable in terms of committed capacity, with $4.0 billion available under a committed line of credit agreement in both years. However, the company's use of these credit facilities decreased in 2024 due to reduced net debt issuances compared to 2023. Additionally, the company terminated its 2022 borrowing authority in late 2024 and replaced it with a new $15.0 billion borrowing capacity, effective January 1, 2025, indicating a strategic refresh of its financing flexibility. Overall, line of credit agreements continued to serve as a backup for short-term funding needs alongside commercial paper borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key information from the ground truth. While it correctly notes that line of credit agreements were used for short-term funding alongside commercial paper, it introduces incorrect figures and events not present in the original answer. Specifically, the claim that McDonald's had a $4.0 billion committed line of credit in both years is unsupported by the ground truth, which does not specify the amount of committed capacity. More critically, the statement that McDonald's terminated its 2022 borrowing authority and replaced it with a $15.0 billion capacity effective January 1, 2025, is entirely absent from the original answer and introduces new, unverified information. (2) The original answer focuses on actual cash flow changes: financing activities increased from $4.4B outflow in 2023 to $7.5B in 2024, and cash and equivalents dropped from $4.6B to $1.1B. The LLM answer fails to mention these critical quantitative shifts, which are central to understanding the evolution in financing behavior. It also does not explain the reason for increased financing outflows in 2024 (decreased bond issuances) or the role of timing of debt issuances in funding 2024 outflows. (3) The multi-hop reasoning in the original answer connects cash flow trends, bond issuance patterns, and liquidity changes to infer a shift toward greater reliance on credit facilities due to lower cash balances. The LLM answer instead focuses on structural changes to credit agreements (e.g., replacement with a new $15B facility), which is not supported by the provided data, and misses the core narrative of declining liquidity and increased reliance on credit lines due to cash outflows exceeding inflows. (4) The contextual relevance is moderate because the answer addresses line of credit usage and financing activities, but the qualitative accuracy is low due to incorrect specifics and missing causal relationships. The correctness score is 4 due to partial recognition of continued reliance on credit facilities, but major omissions and fabrications of facts severely undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 576,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "The role of the Worldwide Business Conduct Manual in reinforcing internal controls at Procter & Gamble has remained a foundational element of governance between 2022 and 2024, with consistent emphasis on integrity, compliance, and adherence to legal and ethical standards. Both the 2022 and 2024 10-K filings highlight the manual as a core tool for embedding internal control principles, supporting financial reporting reliability, and aligning employee behavior with the company’s values. This continuity indicates a stable and mature governance approach, where the manual continues to serve as a cornerstone for maintaining effective internal controls and fostering a culture of compliance across the organization.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses a key evolution in the role of the Worldwide Business Conduct Manual between 2022 and 2024. While it correctly identifies the manual's consistent role in reinforcing integrity, compliance, and internal controls, it fails to capture the specific shift in 2024 toward linking the manual more directly to structured governance mechanisms such as the Global Leadership Council and the Disclosure Committee. This omission significantly undermines the accuracy of the response regarding how the manual's role evolved. (2) There are no numeric values, dates, or calculations in either the ground truth or the LLM answer beyond the years 2022 and 2024, which are correctly referenced—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is flawed: the question requires a comparison across two time points with synthesis of how the governance integration deepened. The LLM instead emphasizes continuity and stability, contradicting the ground truth’s indication of a meaningful shift toward more structured governance integration. This reflects a failure to correctly synthesize the nuanced evolution in governance approach. (4) Despite missing the core analytical point about evolving governance integration, the answer remains contextually relevant by addressing the manual’s role in internal controls and governance, and it correctly identifies its foundational purpose. Hence, correctness and qualitative accuracy are moderate, but not sufficient for a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 424,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. The long-lived assets in Guyana increased from $6,766 million in 2023 to $9,689 million in 2024, indicating significant capital investment and operational growth in the region. Additionally, Guyana is explicitly listed as an \"Advantaged Asset\" in the 2024 earnings driver definitions, highlighting its role as a key growth project contributing to Exxon's strategic focus on high-return, high-value operations. This dual emphasis on asset value and strategic importance underscores Exxon's deepening commitment to Guyana's oil development as a core part of its growth strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data: it states that long-lived assets in Guyana increased from $6,766 million in 2023 to $9,689 million in 2024, which is incorrect. The ground truth shows $9,689 million in 2023, with no disclosed figure for 2024. This misrepresents both the direction and magnitude of change. The $6,766 million figure does not appear in the ground truth and is likely a confusion with another data point or company. (2) The calculation and comparison of asset values are therefore invalid. The LLM incorrectly implies growth based on a fabricated 2023 number, undermining the entire financial analysis. (3) On qualitative aspects, the LLM correctly identifies that Guyana was explicitly named as an 'Advantaged Asset' in 2024 under the 'Advantaged Volume Growth' earnings driver, which aligns with the ground truth. It also accurately captures the strategic implication—that Guyana became a highlighted growth engine. This shows sound multi-hop reasoning in interpreting strategic emphasis, even if the financial foundation is flawed. (4) Contextually, the answer is well-structured and relevant, addressing both asset disclosures and earnings driver definitions as asked. However, the severe quantitative inaccuracy—especially the inversion of the correct 2023 value and introduction of a false lower number—results in a low correctness and quantitative accuracy score. The qualitative reasoning and contextual relevance are stronger, but cannot compensate for the core factual error in financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 432,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations totaled $14,994 million, while in 2024, they amounted to $14,335 million. This reduction indicates a slight decline in the use of securitized debt as a funding source over the two-year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One did not disclose a specific dollar value for securitized debt obligations in 2022. However, the LLM claims a figure of $14,994 million in 2022, which is incorrect and unsupported by the original answer. In 2024, the carrying value was $14,264 million (fair value $14,335 million), but the LLM incorrectly reports $14,335 million as the total amount and treats it as a reduction from 2022, implying a decline. This misrepresents both the magnitude and the nature of the data. (2) The quantitative accuracy is low because the key numbers are fabricated or misattributed. There is no mention of a $14,994 million figure in 2022 in the ground truth, and the 2024 value is misrepresented as a single amount when two distinct values (carrying and fair value) were provided. The comparison between years is therefore invalid. (3) The reasoning is flawed: the LLM assumes a decrease in reliance based on incorrect numerical data, while the original answer emphasizes increased transparency and continued strategic use, not reduced reliance. The model fails to capture the qualitative shift from non-quantified strategic mention in 2022 to quantified disclosure in 2024, which indicates enhanced reporting, not necessarily a change in funding strategy. (4) Contextual relevance is moderate because the answer addresses the topic of securitized debt obligations and attempts a year-over-year comparison, but the incorrect data and conclusion undermine its validity. The model misses the multi-hop nuance that the evolution lies in disclosure transparency and structural visibility, not just volume changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 466,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being a development platform and operating system for building virtual world simulation applications to a more enterprise-focused solution. In 2023, Omniverse was positioned as a fully managed service, with the introduction of **NVIDIA Omniverse Cloud**, a service running in Microsoft Azure for the development and deployment of industrial metaverse applications. This shift reflects increased enterprise adoption, as industrial enterprises began leveraging Omniverse's 3D and simulation technologies to digitalize physical assets, processes, and environments, such as building digital twins of factories and testing autonomous systems.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and captures the key evolution of NVIDIA's Omniverse platform toward enterprise adoption between fiscal years 2022 and 2023. However, it inaccurately reverses the initial positioning: in 2022, Omniverse was described as a 'real-time 3D design collaboration and virtual world simulation software' focused on creators and design applications, not as a development platform or operating system—that more robust, enterprise-oriented description applies to 2023. The LLM incorrectly states that in 2022 it was already a 'development platform and operating system,' which reflects the 2023 positioning, thus misrepresenting the direction of evolution. The introduction of NVIDIA Omniverse Cloud on Microsoft Azure in 2023 is factually accurate and correctly highlights the shift to a fully managed, enterprise-grade service. The use of Omniverse for digital twins, factory simulations, and autonomous systems is consistent with the ground truth and demonstrates correct multi-hop synthesis of enterprise adoption trends. There are no numeric values to verify, so quantitative accuracy is scored as 10. Contextual relevance is high, as the response directly addresses the question’s focus on positioning and adoption. The qualitative accuracy is reduced due to the mischaracterization of the 2022 state, which affects the logical trajectory of the platform’s evolution. Despite this, the core message about increased enterprise focus and industrial use cases is correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 427,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Based on the information provided in the 2022 and 2023 10-K filings, the net amounts due from Viatris under their various agreements evolved as follows: \n\nAs of December 31, 2022, the net amounts due to Viatris were $94 million, and by December 31, 2023, this amount had decreased to $33 million. This indicates a reduction of $61 million in the net amounts due to Viatris over the one-year period. The cash flows associated with these agreements are included in Net cash provided by operating activities from continuing operations, except for a $277 million payment to Viatris made in 2021, which was reported in Other financing activities, net.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net amounts due to Viatris as $94 million as of December 31, 2022, and $33 million as of December 31, 2023, matching the ground truth exactly. The calculated reduction of $61 million ($94M - $33M) is accurate. (2) All numeric values, dates, and calculations are correct. The format variations (e.g., $94 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information from both 2022 and 2023 filings is correctly synthesized to show the evolution of financial obligations. The conclusion about a reduction in net amounts is logically supported. The only minor shortcoming is that the LLM adds a detail about a $277 million payment in 2021 reported in financing activities, which, while potentially factual, is not part of the original answer and slightly extends beyond the scope of the question about 2022–2023 evolution. However, this does not detract from correctness. (4) The answer is highly relevant, complete, and factually aligned with the ground truth. The extra contextual detail slightly affects qualitative accuracy but not correctness. Thus, a score of 9 is justified—excellent accuracy with minimal over-contextualization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 346,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil increased its strategic emphasis on Guyana between 2023 and 2024, as reflected in expanded project activity. In 2023, the Payara development commenced with the Prosperity FPSO, and the Yellowtail project advanced, with 12.6 net exploratory and development wells completed. By 2024, Guyana was explicitly classified as part of the \"Advantaged Assets\" category in earnings drivers, highlighting its strategic importance for volume growth and high returns, alongside the Permian Basin and LNG projects. This classification underscores a shift toward prioritizing Guyana's resource potential for long-term value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2023 to 2024. It accurately notes the 12.6 net exploratory and development wells completed in 2023, matching the ground truth. It also correctly identifies the key projects—Payara and Yellowtail—with accurate context about Payara commencing with the Prosperity FPSO. The 2024 reclassification of Guyana into the 'Advantaged Assets' category under the 'Advantaged Volume Growth' earnings driver is correctly reported, along with its strategic significance being elevated alongside the Permian Basin and LNG. (2) Quantitatively, the number 12.6 is exact and correctly attributed to 2023 net wells. No other numerical data (dates, dollar amounts) is present in the ground truth beyond this, so no calculation errors exist. (3) The multi-hop reasoning is sound: the model synthesizes operational activity in 2023 with strategic classification in 2024, correctly inferring a shift toward strategic prioritization. The only minor omission is that the ground truth explicitly names Uaru as an additional project in 2023, which the LLM answer leaves out. This does not undermine the core accuracy but slightly reduces completeness. (4) The answer is contextually fully relevant, directly addressing both the evolution of strategy and the specific changes in project activity or classification. Wording differs slightly (e.g., 'high returns' and 'long-term value creation' are interpretive additions), but these do not distort meaning and are semantically consistent with strategic elevation. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 466,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for senior notes with maturities greater than 10 years remained stable at 3.8%. The face value of these notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8% as stated by the LLM, and it only rose to 3.8% in 2023. The LLM incorrectly claims the rate 'remained stable at 3.8%' across both years, which is false—there was an increase from 3.67% to 3.8%. Additionally, the face value in 2022 was $54.536 billion, not $52.8 billion as claimed. The 2023 face value of $53.4 billion is correct. Thus, the LLM reports an increase in face value when in fact there was a decrease. (2) Number verification: 2022 interest rate: incorrect (3.8% vs 3.67%); 2023 interest rate: correct (3.8%); 2022 face value: incorrect ($52.8B vs $54.536B); 2023 face value: correct ($53.4B). Calculations or comparisons based on these numbers are therefore flawed. (3) The reasoning is partially sound in that it attempts to compare evolution across years and focuses on stability and change, but the multi-hop synthesis is compromised due to incorrect base data. The conclusion that the rate remained stable is incorrect given the actual increase. (4) Scores reflect that core facts are partially correct (2023 values are accurate), but major errors in 2022 data and resulting misinterpretation of trends limit correctness. Contextual relevance is high as the answer addresses the right metrics and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 393,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shifted their domestic equity investment allocations as follows: Alabama Power's domestic equity investments decreased from $565 million (Level 1: $396 million, Level 2: $169 million) in 2022 to $651 million (Level 1: $443 million, Level 2: $208 million) in 2023. In 2024, Alabama Power's domestic equity allocation remained at $651 million (Level 1: $443 million, Level 2: $208 million). Georgia Power's domestic equity investments decreased from $256 million (Level 1: $255 million, Level 2: $1 million) in 2022 to $322 million (Level 1: $321 million, Level 2: $1 million) in 2023, and remained at $322 million (Level 1: $321 million, Level 2: $1 million) in 2024. The valuation methodologies primarily remained within Level 1 and Level 2 classifications, with no Level 3 inputs reported for domestic equity investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the years and the direction of changes. It incorrectly states that Alabama Power's investments decreased from 2022 to 2023, but the ground truth only provides data for 2023 and 2024, not 2022. The LLM fabricates data for 2022 and mislabels the timeline, claiming changes occurred between 2022 and 2023 when the question asks about shifts between 2023 and 2024. Similarly, it falsely claims that Alabama Power's allocation 'remained at $651 million in 2024', but the ground truth does not state this—it only reports 2024 data without indicating stability over time. The same issue occurs with Georgia Power, where the LLM invents 2022 data and incorrectly frames the change as occurring between 2022 and 2023 instead of 2023 to 2024. (2) While the actual dollar amounts for 2023 and 2024 (e.g., $396M, $169M, $443M, $208M for Alabama; $255M, $1M, $321M, $1M for Georgia) are numerically correct and calculations of totals are accurate, their assignment to incorrect years invalidates the analysis. The LLM also incorrectly uses 'decreased' when the investments actually increased. (3) The multi-hop reasoning is flawed because the model fails to correctly align the time periods across entities. It introduces non-existent data points (2022) and misattributes changes across years, breaking the logical synthesis required between Alabama Power and Georgia Power across 2023 and 2024. The conclusion about valuation methodologies is partially correct—no Level 3 inputs are mentioned in the ground truth—but this is understated and not analyzed in depth. (4) The contextual relevance is moderate because the answer addresses domestic equity allocations and Level 1/Level 2 classifications as asked, but the incorrect timeline and fabricated data severely undermine factual correctness. Due to major errors in temporal reasoning and entity-year alignment, the correctness score is low despite some accurate raw numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 536,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved to become a more central and foundational element of its full-stack computing platform. In 2022, CUDA was highlighted as a key component of the accelerated computing platform, enabling parallel processing for compute-intensive applications like AI and HPC. By 2023, CUDA was emphasized as the fundamental building block of NVIDIA's unified architecture, supporting a broader range of end markets—including Gaming, Data Center, Professional Visualization, and Automotive—through programmable software stacks. This evolution reflects CUDA's expanded role in enabling cross-market scalability and integration, reinforcing NVIDIA's platform strategy and ecosystem leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of CUDA's strategic positioning from 2022 to 2023, noting its transition to a more central and foundational role within NVIDIA's full-stack computing platform. It accurately reflects that in 2022, CUDA was a key component for accelerated computing in AI and HPC, and by 2023, it became the fundamental building block of a unified architecture. The end markets mentioned—Gaming, Data Center, Professional Visualization, and Automotive—are consistent with the ground truth. However, the LLM answer omits a critical dimension of the 2023 evolution: the explicit expansion of CUDA into domain-specific verticals such as healthcare, telecom, and manufacturing, and its role as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs. This is a significant omission in completeness, as it downplays the strategic shift toward vertical integration and software ecosystem expansion emphasized in the original answer. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the progression in CUDA's role across years and markets, but fails to incorporate the deeper software stack integration and domain-specific expansion that represents a key strategic evolution. (4) The answer is contextually relevant and well-articulated, but lacks key qualitative details that define the full scope of CUDA's 2023 positioning, warranting a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 449,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, stemming from the 2020 separation and combination with Mylan, continued to wind down. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, a decrease from $94 million as of December 31, 2022. Additionally, services under the transitional service agreements (TSAs) were largely completed by December 31, 2023, indicating a reduction in ongoing obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial and contractual evolution between Pfizer and Viatris from 2022 to 2023. The net amounts due to Viatris are accurately reported as $94 million in 2022 and $33 million in 2023, reflecting a correct decrease of $61 million. The completion of transitional service agreements (TSAs) by December 31, 2023, is also correctly stated. (2) Quantitative accuracy is perfect: both dollar amounts and dates match the ground truth exactly. There are no calculation errors, and the reduction in net amounts owed is correctly implied. (3) The multi-hop reasoning is sound—information about the 2020 spin-off (context), TSA/MSA agreements, and the winding down of obligations is synthesized appropriately. The only minor omission is that the original answer notes TSA services were 'largely completed by the end of 2022,' which the LLM answer does not explicitly mention, though it correctly states full completion by end of 2023. This slight lack of detail in the timeline of completion prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing the evolution of financial obligations and contractual relationships, particularly regarding TSAs and net amounts owed. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 370,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy's environmental regulation compliance costs have remained significant due to ongoing federal and state regulations, particularly those related to carbon reduction goals and coal combustion residuals (CCR) management. While the 2023 filing reflects continued emphasis on these costs, it also highlights Duke Energy's efforts to align with its net-zero 2050 target, which may involve increased expenditures for emissions reductions and infrastructure upgrades. The evolution suggests a potential rise in compliance costs as regulatory pressures intensify, though the company seeks cost recovery through regulatory rate structures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop relationship between retail deregulation and environmental compliance cost recovery, which is central to the question. (1) What was correct: The answer accurately notes that Duke Energy faced ongoing environmental compliance costs in 2022–2023 due to federal and state regulations, including carbon reduction goals and CCR management, and mentions the net-zero 2050 target—consistent with the general regulatory environment. There are no numeric inaccuracies, so quantitative accuracy is high. (2) Number/calculation verification: No specific numbers (e.g., dollar amounts, percentages) appear in either the original or LLM answer, so no calculation errors exist. (3) Multi-hop reasoning assessment: The critical failure is in reasoning. The original answer emphasizes a dynamic: retail deregulation pressures (especially under PURPA) threaten recovery of environmental compliance costs because competitive markets limit rate-based cost pass-through. By 2023, this challenge intensified due to more aggressive state carbon goals and EPA rules. The LLM answer discusses rising compliance costs and regulatory pressures but completely omits the link between deregulation and cost recovery risk—the core of the question. It also fails to mention PURPA, QFs, or above-market power commitments, which are key mechanisms in the original reasoning. (4) Justification for scores: Correctness is scored 5 due to significant omission of the deregulation-cost recovery nexus. Qualitative accuracy is 5 because while entities (Duke Energy, environmental regulations) are correct, the reasoning and synthesis across regulatory and market structures are incomplete. Quantitative accuracy is 10 because no numbers are misstated. Contextual relevance is 7 because the answer addresses environmental costs and regulatory trends but not their evolving interaction with retail deregulation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 523,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market share. This contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases (e.g., $0.09 to $0.10 per can) on its brands, suggesting an attempt to maintain profitability amid shifting market dynamics.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in retail share from 9.3% in 2023 to 7.6% in 2024, which matches the ground truth. However, the pricing details are partially inaccurate. The ground truth specifies a $0.11 per can increase effective January 23, 2024 (announced in 2023), and references earlier increases in 2022 (not 2023), but the LLM incorrectly states that multiple price increases occurred during 2023 and gives a vague range of '$0.09 to $0.10', which does not match the specific $0.11 figure. It also omits the exact timing and number of prior increases. (2) The core percentages (9.3% to 7.6%) are correct, but the dollar amounts and dates related to pricing are inaccurate or underspecified. The LLM fails to mention that the price increases referenced were largely in 2022, not 2023, and misrepresents the $0.11 increase as being within 2023. (3) The multi-hop reasoning is partially sound: the model correctly contrasts declining market share with a pricing strategy involving increases, suggesting a possible trade-off between profitability and volume. However, it synthesizes the timing incorrectly, attributing the price hikes to 2023 when most occurred earlier, weakening the causal logic. (4) The contextual relevance is high as it addresses both parts of the question—market share change and pricing strategy—while offering interpretation. Due to significant but not fundamental quantitative errors (wrong amounts and years for price increases), the correctness score is 7, with lower quantitative accuracy (6), solid qualitative reasoning (8), and full relevance (10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 441,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' increased from $138 million as of December 31, 2023, to $135 million as of December 31, 2024, indicating a slight decrease of $3 million. This suggests that Amgen maintained a relatively stable position in short-term interest-bearing securities, aligning with its investment strategy focused on preserving liquidity and ensuring safety of principal.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms the amount remained unchanged at $138 million in both years. This misrepresents the evolution of the investment. (2) The quantitative inaccuracies are significant—both the 2024 value ($135M vs $138M) and the claimed $3M decrease are incorrect. No actual change occurred. (3) The reasoning is partially sound in interpreting stability as a sign of consistent liquidity and safety strategy, which aligns with the qualitative implication in the original answer. However, the conclusion is based on false numerical premises, undermining the multi-hop logic. (4) Contextual relevance is moderate—the response addresses the right metric, company, and time frame, and attempts to interpret strategic implications, but the core factual error severely compromises correctness. Quantitative accuracy is very low due to wrong numbers and a false calculation. Qualitative accuracy is slightly higher because the general strategic interpretation is plausible, though built on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 331,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades increased significantly from 2022 to 2024 in terms of contract scope and value. In 2022, the company received a $360 million contract for Abrams tank upgrades, mission control units, and technical support. By 2024, this had expanded to a $350 million contract with broader scope, including engineering, logistics support, and sustainment technical support services, reflecting both increased funding and expanded responsibilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $360 million 2022 contract and the $350 million 2024 contract, including their general scope (upgrades, technical support). It accurately notes the evolution toward broader responsibilities in 2024, including engineering and logistics support. However, it omits the separate $285 million contract awarded in 2024 for producing Abrams SEPv3 tanks for Romania, which is a significant part of the scope expansion and total value increase. (2) Quantitatively, the $360M and $350M figures are correct and properly attributed to their years. The LLM implies an increase in funding, but this is misleading—$350M is slightly less than $360M—so the claim of 'increased funding' is inaccurate. The omission of the $285M contract results in a substantial underrepresentation of total 2024 contract value. (3) The reasoning captures the shift from upgrades to broader support services, which is valid, but fails the full multi-hop synthesis by not incorporating the Romania production contract, which demonstrates a key expansion into new production (not just upgrades). This weakens the conclusion about scope and value evolution. (4) The answer is contextually relevant and well-structured, but the missing contract and incorrect funding comparison reduce correctness. A score of 7 is justified: core facts are accurate, but significant details are omitted, affecting completeness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 400,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of borrowing arrangements and income recognition. In 2023, Corebridge had a DDTL (Debt Dilution and Transfer Line) facility of $250 million, which could be extended through February 25, 2025. By 2024, Corebridge was fully deconsolidated from AIG, and AIG recognized a substantial after-tax loss of $4.754 billion on the disposal of Corebridge. This loss included the retained investment in Corebridge valued at $8.5 billion, based on Corebridge's quoted stock price, and adjustments for other investments and receivables. Income related to Corebridge shifted from being part of AIG's consolidated operations to being recognized through equity method accounting and fair value adjustments post-disposal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the high-level evolution of AIG's relationship with Corebridge but introduces significant factual inaccuracies, particularly in quantitative details and key events. (1) Correct elements: The shift from a consolidated borrowing arrangement to equity method accounting in 2024 is conceptually accurate, and the mention of equity method income and deconsolidation aligns with the transformation described in the ground truth. (2) Quantitative inaccuracies: The $250 million DDTL figure is not present in the ground truth and cannot be verified; the $4.754 billion after-tax loss and $8.5 billion retained investment based on stock price are specific numbers not mentioned in the original answer and appear to be hallucinated or sourced incorrectly. The ground truth does not mention any loss or valuation figures. (3) The date February 25, 2025, for borrowing extension is correctly cited, matching the original. However, the claim that deconsolidation occurred by 2024 and triggered a large loss is not supported in the ground truth, which only states that AIG began recognizing equity method income starting June 9, 2024—this is a critical discrepancy. (4) Reasoning and synthesis: The model correctly infers a shift in accounting treatment post-deconsolidation, which is a valid multi-hop inference, but it fabricates financial figures and overstates the specificity of the transition. The core idea of a shift from borrowing-based to equity-based income is preserved, but the supporting facts are partially incorrect. (5) Contextual relevance is high—the response directly addresses borrowing arrangements and income recognition as asked. Overall, the answer is directionally correct but undermined by unsupported numerical claims, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 485,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize production scalability and strategic partnerships. In 2022, the Solar Roof was described as a premium product focused on aesthetic appeal and durability, with Tesla working to improve installation efficiency and collaborating with real estate developers. By 2024, Tesla highlighted ongoing production challenges, including delays in launching and ramping production of energy products like the Solar Roof, and noted dependencies on efficient manufacturing processes and supply chain management. Strategic dependencies have also shifted toward localized procurement and partnerships to support global expansion, while Tesla continues to refine the product's integration with its broader energy ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Tesla's 2022 focus on aesthetics, durability, and collaboration with real estate developers is accurately described. The 2024 shift toward emphasizing production ramp challenges, including bottlenecks, supplier risks, and cost control, is correctly reflected, though the exact phrase 'depends in large part' from the 10-K is paraphrased as 'highlighted ongoing production challenges' and 'dependencies on efficient manufacturing processes and supply chain management'—semantically equivalent. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes Tesla’s evolving strategy across two years, correctly identifying the shift from sales and installation efficiency to production scalability and supply chain dependencies. (4) The LLM adds slight elaboration—'localized procurement' and 'global expansion'—that are not explicitly in the ground truth but are reasonable inferences consistent with Tesla's broader strategy and do not contradict the original. The answer fully addresses both parts of the question: evolution in production challenges and strategic dependencies. Only a minor deduction in qualitative accuracy due to slight expansion beyond the source, but no factual errors. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 398,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024, indicating a loss of market share. This decline suggests that Skoal faced increased competition, potentially from oral nicotine pouches and other products, which impacted its competitive positioning in the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the retail share of Skoal decreasing from 9.3% in 2023 to 7.6% in 2024, matching the ground truth exactly. All quantitative values are accurate. (2) The numbers are correct and consistent with the original answer; no calculation errors. The 1.7 percentage point decline is implied and correctly represented. (3) The reasoning is sound: the LLM correctly infers that the decline indicates a loss of market share and weakened competitive positioning, attributing it plausibly to increased competition, particularly from nicotine pouches. While the original answer specifically names 'on!' as a growing competitor, the LLM generalizes this to 'other products,' which is reasonable but slightly less precise in entity-specific synthesis. (4) The answer is factually correct, complete on the main query, and contextually relevant. The only minor shortcoming is the lack of explicit contrast with a specific competitor like 'on!,' which slightly reduces qualitative depth but does not affect factual correctness. Hence, high scores across all categories with a 9 on correctness due to near-perfect alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 325,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, with potential negative implications for Qualcomm's pricing power and revenue stability. The mobile industry has experienced a growing concentration of device share among a few companies, particularly at the premium tier, which amplifies Qualcomm's reliance on a limited number of key customers and licensees. This concentration could lead to reduced pricing power due to the significant purchasing influence of these large OEMs. Additionally, the risk of these OEMs vertically integrating by developing their own integrated circuit products—such as Apple's development of in-house modems and Chinese OEMs under government initiatives like \"Made in China 2025\"—poses a threat to Qualcomm's revenue stability. Political and trade tensions, especially between the U.S. and China, further exacerbate these risks by potentially limiting Qualcomm's access to key markets and customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the risk from concentration of device share among premium tier companies has increased from 2023 to 2024 and appropriately links this to reduced pricing power and revenue stability for Qualcomm. It accurately reflects the core risk highlighted in the original answer: reliance on a small number of large customers (especially Chinese OEMs) with strong purchasing power leading to pricing pressure. The LLM also correctly introduces the added threat of vertical integration (e.g., Apple’s in-house modems, 'Made in China 2025') which aligns with the original answer’s mention of customers developing their own ICs. However, the LLM answer does not explicitly mention the shift in emphasis between 2023 and 2024 as described in the ground truth—specifically, that in 2023 the focus was on revenue concentration from Chinese OEMs and lower prices, while in 2024 the risk evolved to include greater pricing pressure and revenue fluctuation due to product launch timing and competitive substitution. This nuance in the evolution of the risk is missing, slightly weakening the multi-hop reasoning and temporal comparison. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and all entities (Apple, Chinese OEMs, Qualcomm) and timeframes (2023–2024) are correct. The answer remains highly contextually relevant and semantically close to the original, with only minor omissions in the detailed evolution of the risk factor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 414,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased significantly between 2023 and 2024. As of December 31, 2023, the amount allocated to money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a slight increase of $88 million in allocation to money market mutual funds during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased between 2023 and 2024. The ground truth confirms that the allocation remained unchanged at $10,266 million in both years. The LLM incorrectly reports a rise to $10,354 million in 2024, which is not supported by the data. (2) Quantitative accuracy is severely compromised: the reported 2024 figure ($10,354 million) is wrong, and the claimed $88 million increase is therefore also incorrect. The correct values are $10,266 million in both years, with a difference of $0. Even allowing for format variations, the numbers are factually inaccurate. (3) The reasoning is flawed as it fails to recognize the stability in allocation, which is the key insight from the ground truth. The model incorrectly infers a shift in strategy based on erroneous data, failing the multi-hop requirement to compare identical values across years and conclude no change. (4) While the context of short-term liquidity and money market funds is relevant, and the 2023 figure is correct, the core factual error in the 2024 value and the resulting false conclusion about an increase justify a very low correctness and quantitative accuracy score. The qualitative reasoning is poor due to incorrect synthesis, though the topic focus remains appropriate, hence a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 388,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) has seen an increase in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. In 2022, the pledged amount was $295 million, while in 2023 it rose to $315 million, and in 2024, it further increased to $333 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct trend and numerical values. (1) Quantitatively, all dollar amounts are correct: $295 million in 2022 (as of Dec 31, 2021), $315 million in 2023 (Dec 31, 2023), and $333 million in 2024 (Dec 31, 2024). The LLM correctly reports the pledged amounts for each year, matching the ground truth. (2) The answer is complete in terms of the amounts and years requested, though it omits the explanatory context about the purpose of the CCF (tax deferral benefits) and the fact that the 2022 figure reflects data as of December 31, 2021. This is a minor omission that does not affect factual correctness but slightly reduces qualitative depth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years and entities (General Dynamics and the CCF). (4) The semantic meaning fully aligns with the original answer, with only slight differences in phrasing and lack of interpretive context. The answer is fully relevant and directly addresses the evolution of pledged amounts. Minor deduction in qualitative accuracy due to missing rationale; full marks in quantitative and contextual categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 326,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "AIG's financial relationship with Corebridge evolved significantly between 2023 and 2024, particularly following the deconsolidation after the 2022 IPO. In 2023, Corebridge was no longer consolidated into AIG's U.S. federal income tax group, resulting in AIG no longer being able to utilize Corebridge's net operating losses and tax credits for five years post-deconsolidation. In 2024, AIG recognized a $4.754 billion after-tax loss on the deconsolidation of Corebridge, primarily due to the retained investment in Corebridge and adjustments related to accumulated other comprehensive loss. Additionally, AIG's equity method income from Corebridge in 2024 was $601 million, reflecting dividends and changes in Corebridge's stock price.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the correct high-level evolution of AIG's relationship with Corebridge, including tax deconsolidation in 2023 and the shift to equity method accounting in 2024. However, it introduces a $4.754 billion after-tax loss on deconsolidation that is not present in the ground truth and cannot be verified from the provided information. This is a major quantitative inaccuracy. The equity method income of $601 million in 2024 is specific and plausible but not confirmed in the original answer, which uses a placeholder '$X'. (2) The date of Corebridge's IPO (September 19, 2022) is omitted, and the 2024 equity method income period (June 10 to December 31) is not mentioned. The five-year restriction on consolidated tax filings is correctly implied but not explicitly stated. The claim about AIG recognizing a $4.754 billion loss is unsupported by the ground truth and appears to be hallucinated or derived from external data not in the knowledge graph. (3) The multi-hop reasoning is partially sound: the model correctly infers that deconsolidation leads to tax separation and a shift to equity method reporting. However, it fails to mention that the deconsolidation was triggered by ownership dropping below 80% post-IPO, a key causal link. The synthesis of tax implications and investment income is relevant but marred by incorrect figures. (4) The contextual relevance is high as the answer addresses both tax implications and investment income over the 2023–2024 period. Qualitative accuracy is moderate due to correct conceptual framing but missing details. Quantitative accuracy is low due to unverified large-dollar figures not in the ground truth. Correctness score is 6 due to correct structure and some accurate elements but significant factual errors in key numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 491,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production evolved by focusing on improving installation capabilities, reducing costs, and expanding partnerships with real estate developers and builders to streamline deployment. In 2022, Tesla emphasized increasing production volumes and addressing global component constraints, while by 2024, the company highlighted efforts to onboard and train new installers, enhance price efficiencies, and integrate Solar Roof into new home developments. Supply chain challenges remained a concern in both periods, but Tesla's strategy shifted toward localized procurement and collaboration to mitigate delays and reduce installation time and costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the timeline and focus of Tesla's strategy. According to the ground truth, in 2022 Tesla emphasized onboarding and training installers and collaborating with real estate developers to improve installation efficiency, while also addressing battery supply and hiring electricians. By 2024, the focus shifted to systemic supply chain risks like global component procurement, supplier failures, and inflationary pressures. However, the LLM answer incorrectly reverses or conflates these priorities—stating that in 2022 Tesla focused on 'global component constraints' (more characteristic of 2024) and that in 2024 the company emphasized 'onboarding and training new installers' (which was a 2022 priority). This misalignment in temporal evolution undermines the core of the multi-hop comparison. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is partially sound in that the model recognizes a strategic evolution involving installation, supply chain, and partnerships. However, it fails to correctly attribute the progression of focus over time, thus breaking the logical synthesis across years. The shift from localized installer development (2022) to systemic supply chain scalability (2024) is misrepresented. (4) Contextual relevance is high because the answer addresses operational strategy and supply chain challenges as asked. However, due to the inversion of key strategic emphases between years, the qualitative accuracy is significantly reduced. While some elements like partnerships and cost reduction are mentioned correctly, the core evolution is misrepresented, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 494,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion in 2021 to $7 billion to $8 billion by 2023, with approximately $4 billion spent through 2023. This indicates progress under the Coal Ash Act, as the company has completed excavations at several sites and is managing costs within a narrower range, although significant expenditures are still expected over the next decade.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor error in the timeline: it states the $8 billion to $9 billion estimate was from 2021, while the ground truth specifies this range was reported in 2022 (based on data through 2021). The 2023 estimate of $7 billion to $8 billion and the $4 billion spent through 2023 are accurate. (2) Quantitatively, all dollar amounts are correct in value and context, except for the misattribution of the $8B–$9B estimate to 2021 instead of 2022. The $4 billion spent through 2023 matches the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes cost trends, spending progress, and implications under the Coal Ash Act. It appropriately infers progress due to completed excavations and refined cost estimates. (4) The answer is contextually excellent, addressing both the cost evolution and what it indicates about progress. The minor date misstatement prevents a top score, but core facts, synthesis, and interpretation are accurate. Thus, correctness is rated 8 due to the timeline inaccuracy, though the overall response is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 316,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a gain in market position within the overall oral tobacco product segment during this period, despite a decline in its share of the nicotine pouch category. This growth suggests that 'on!' is capturing a larger portion of the broader oral tobacco market, likely benefiting from the overall expansion of the nicotine pouch category.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the retail share increase for 'on!' from 6.8% in 2023 to 8.3% in 2024, matching the ground truth exactly. However, it introduces new information not present in the original answer — specifically, that 'on!' experienced a decline in its share of the nicotine pouch category — which is unsupported by the provided ground truth. Additionally, the claim that the nicotine pouch category is expanding contradicts the ground truth, which states that the total oral tobacco product segment declined from 42.5% to 37.5%. (2) All numeric values related to 'on!' are accurate (6.8% to 8.3%), but the LLM fails to mention the key comparative data point about the overall oral tobacco segment's decline, which is central to the original answer’s conclusion. (3) The multi-hop reasoning is partially sound — the model correctly infers market position improvement from increasing share — but it draws an incorrect inference by attributing growth to expansion in the nicotine pouch category, which is not supported and contradicts the provided data. The original answer emphasizes that 'on!' gained share while the broader segment declined, highlighting relative strength; the LLM misattributes the cause. (4) The correctness score is 7 because core facts about 'on!' are accurate, but the answer includes speculative and contradictory qualitative claims. Quantitative accuracy is 10 because all numbers cited are correct. Qualitative accuracy is 6 due to flawed reasoning and introduction of unsupported context. Contextual relevance is 8 because the response addresses the main question but drifts into irrelevant and incorrect category-level dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 459,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has remained significant from 2023 to 2024, as the company continues to derive a substantial portion of its revenues from a small number of Chinese OEMs, particularly those selling premium-tier devices. This concentration is exacerbated by geopolitical tensions between the U.S. and China, as well as pressures from Chinese government policies like \"Made in China 2025,\" which encourage domestic semiconductor development. These factors pose risks to business stability, including potential government restrictions, reduced royalty payments, and increased competition from vertically integrated OEMs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core fact from the ground truth: Qualcomm's continued reliance on a small number of Chinese OEMs for a significant portion of its revenue in both 2023 and 2024. It accurately reflects the persistence of this dependency and correctly identifies the associated business stability risks due to geopolitical tensions between the U.S. and China. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM introduces specific details not present in the ground truth, such as 'premium-tier devices' and 'Made in China 2025,' which, while plausible, are not mentioned in the original answer derived from the knowledge graph. Additionally, the mention of 'vertically integrated OEMs' and 'reduced royalty payments' extends beyond the scope of the original implications, which focused on device share growth and trade tensions. These additions, while contextually relevant, represent inferences not directly supported by the ground truth. The reasoning is logically sound and the answer addresses both parts of the question—evolution of reliance and implications for business stability—making it contextually highly relevant. However, the slight over-extension of detail without explicit support in the source data prevents a perfect qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 385,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments increased significantly, primarily due to changes in the composition of security types held. In 2022, the investments were composed of $1,676 million in U.S. Treasury bills and $2,659 million in money market mutual funds, totaling $4,335 million. By 2023, U.S. Treasury bills were no longer held, while money market mutual funds increased to $10,266 million, resulting in a total of $10,404 million in available-for-sale investments. This shift reflects a move toward higher liquidity and safety in the investment portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 investments. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities (not U.S. Treasury bills) and $2,659 million in cash and cash equivalents (not money market mutual funds). The LLM incorrectly assigns the 2023 composition of money market funds to 2022, which distorts the actual evolution. In 2023, the breakdown is correctly reported as $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities, totaling $10,404 million, which the LLM captures accurately. (2) The total investment amounts for both years ($4,335M in 2022 and $10,404M in 2023) are correct, and the conclusion about increased liquidity aligns with the ground truth. However, the misattribution of security types in 2022 undermines the quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model recognizes a shift in composition and infers a strategic move toward liquidity—but because it uses incorrect base data for 2022, the synthesis is flawed. The ground truth emphasizes a complete shift from marketable securities and cash equivalents to money market funds, while the LLM incorrectly suggests a shift from U.S. Treasury bills and money market funds to just money market funds. (4) The contextual relevance is high because the answer addresses the evolution of investment composition and interprets the strategic intent. However, due to key factual errors in entity types (security classifications), the correctness and quantitative accuracy scores are reduced to 5, while qualitative accuracy is slightly higher due to logical interpretation based on flawed input.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 481,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack was present at Woodbury Common Premium Outlets in 2023 (listed on page 34 of SPG_10k_2023.pdf), but there is no mention of Shake Shack in the 2022 property tenant lists across the provided pages from SPG_10k_2022.pdf. This indicates that Shake Shack was not a tenant at any of SPG's premium outlet properties in 2022 but became a tenant at Woodbury Common Premium Outlets by 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, contradicting the ground truth. (1) It states that Shake Shack was not present in 2022 at any SPG premium outlet, but the ground truth confirms it was a tenant at Woodbury Common Premium Outlets in 2022. The LLM incorrectly infers absence from the 2022 document as evidence of non-presence, which is a reasoning flaw. (2) Quantitatively, the years (2022, 2023) and property names (Woodbury Common, Las Vegas Outlets North Premium) are accurate in the ground truth, but the LLM omits the Las Vegas expansion in 2023 and falsely claims Shake Shack was absent in 2022. (3) The multi-hop reasoning fails: the model should have compared tenant lists across both years to identify continuity and expansion, but instead concluded absence due to lack of mention on provided pages, which does not imply non-existence. (4) Contextually, the answer addresses the right properties and timeframe, so relevance is moderate, but factual and qualitative accuracy are low due to incorrect conclusions and missing key expansion information. The answer reverses the actual narrative: Shake Shack was already present in 2022 and expanded in 2023, not newly added.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 337,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 within the fair value hierarchy, indicating that their fair value was determined using significant unobservable inputs. In 2022, the fair value of retirement annuity contracts was $35 million, and by 2024, it decreased to $22 million. This consistent classification suggests that GD's valuation methodology for these assets relies on internal assumptions and models, as these contracts are not actively traded and lack observable market data. The decrease in fair value may reflect changes in assumptions or market conditions affecting the liabilities tied to these contracts.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that retirement annuity contracts remained in Level 3 of the fair value hierarchy between 2022 and 2024, which aligns with the ground truth. However, it introduces two specific dollar amounts—$35 million in 2022 and $22 million in 2024—that are not present in the original answer and cannot be verified from the provided ground truth. These figures are likely fabricated or misattributed, severely undermining quantitative accuracy. (2) There are no calculations in the LLM answer, but the inclusion of unverified financial figures without sourcing from the ground truth constitutes a major factual error. The ground truth does not mention any dollar values for the contracts in either year, so their addition is incorrect. (3) The reasoning about the continued use of unobservable inputs and reliance on internal models is sound and consistent with Level 3 classification. However, the LLM misses the key qualitative point about improved disclosure practices in 2024—specifically, the inclusion of investments valued using net asset value (NAV) as a practical expedient in reconciliation tables, which was not explicitly stated in 2022. This omission reflects a failure in multi-hop synthesis, as the model did not capture the evolution in reporting transparency despite no change in hierarchy level. (4) The contextual relevance is high because the answer addresses the classification stability and its implication for valuation methodology. However, the incorrect insertion of numerical values and the absence of the key disclosure refinement detail reduce both correctness and qualitative accuracy. The answer gives a plausible but partially fabricated narrative, leading to a moderate score of 5/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 477,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of equity dilution and income recognition. In 2023, AIG retained a 52.2% ownership stake in Corebridge, and its equity in Corebridge's earnings was reflected in the consolidated financial statements. However, in 2024, AIG deconsolidated Corebridge following its initial public offering (IPO), which led to a substantial loss on the disposal of operations. This loss, amounting to $4,754 million, included the retained investment in Corebridge valued at $8.5 billion and adjustments for tax and reclassification of accumulated other comprehensive loss. The deconsolidation resulted in a shift from consolidated reporting to the equity method for income recognition, with AIG's equity method income in 2024 being $601 million, reflecting dividends and changes in Corebridge's stock price. This transition marked a significant reduction in AIG's direct control and financial integration with Corebridge, leading to potential equity dilution as Corebridge became a publicly traded entity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly impact correctness. It incorrectly states that AIG retained a 52.2% ownership stake in Corebridge in 2023 and that deconsolidation occurred in 2024 due to an IPO — however, the ground truth confirms the IPO occurred on September 19, 2022, not in 2024, and the exchange right was terminated as of that date. This misrepresents the timeline and causal logic. The $4,754 million loss and $8.5 billion retained investment value are not mentioned in the ground truth and appear fabricated or misattributed. The $601 million equity method income in 2024 is plausible but unverifiable against the provided truth, which does not include specific income figures. (2) Quantitative accuracy is low: the IPO date (2022 vs claimed 2024), the timing of deconsolidation, and the inclusion of large dollar figures not present in the ground truth (e.g., $4,754M loss, $8.5B investment) are major errors. The ground truth mentions potential dilution of 24.1 million shares in 2022 and 4.4 million in 2023, but the LLM omits these entirely. (3) Reasoning is partially sound in identifying a shift from consolidation to equity method accounting, and recognizing income recognition via dividends and stock price changes post-divestiture, which aligns with the ground truth’s description of post-June 9, 2024 equity method reporting. However, the failure to correctly sequence the IPO before 2024 breaks the multi-hop logic — the termination of dilution rights should precede 2023/2024 analysis. (4) Contextual relevance is high: the answer addresses both equity dilution and income recognition, uses appropriate financial terminology, and attempts to trace the evolution of the relationship. Despite incorrect facts, the structural understanding of the transition is present. Overall, the answer is partially correct in direction but flawed in key facts, dates, and numbers, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 531,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort has slightly decreased from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, compared to $3.5 billion as of December 31, 2023, and $3.6 billion as of December 31, 2022. Additionally, the total assets and liabilities of Universal Beijing Resort included in Comcast's consolidated balance sheets decreased from $7.8 billion and $7.2 billion in 2023 to $7.3 billion and $7.0 billion in 2024. Comcast continues to consolidate Universal Beijing Resort due to its power to direct activities impacting its economic performance, with its maximum risk of financial loss limited to its 30% interest.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both numbers and timeline. The ground truth states that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020 — not $3.6 billion as of December 31, 2022 as incorrectly claimed by the LLM. Furthermore, the LLM claims debt was $3.6B in 2022, $3.5B in 2023, and $3.4B in 2024, but the original answer only provides data for 2023 ($3.5B) and 2024 ($3.4B), with earlier data referring to 2020 and 2021. This misalignment of years undermines the quantitative accuracy. Additionally, the LLM fabricates asset and liability figures for 2023 (claiming $7.8B assets and $7.2B liabilities), which are not present in the original answer — the ground truth only provides consolidated figures for 2024: $7.3B in assets and $7.0B in liabilities. (2) Calculations: While the directional trend of decreasing debt from $3.5B to $3.4B is correct for 2023–2024, the extension of this trend back to 2022 with $3.6B is unsupported by the provided data, which skips 2022 entirely. The LLM incorrectly assumes continuity. (3) Multi-hop reasoning: The LLM correctly identifies that Comcast consolidates Universal Beijing Resort due to VIE status and control over economic performance, but adds unsupported detail about 'maximum risk of financial loss limited to its 30% interest' — this is not mentioned in the original answer and introduces unverified equity ownership information. The synthesis across years is flawed due to incorrect temporal mapping. (4) Despite these issues, the answer is contextually relevant, addressing debt evolution and consolidation treatment. It captures the general trend of stable-to-slightly-declining debt and correct consolidation rationale, earning partial credit. However, major factual and numerical errors reduce correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 511,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility and risk exposure. Customers with Gulfstream aircraft in contract backlog retain options to trade in their existing aircraft as partial consideration for new-aircraft transactions. These options typically establish the fair market value of the trade-in aircraft within 45 days of the new aircraft delivery or guarantee a predetermined trade-in value. While the latter structure introduces more risk in the event of adverse market conditions, the company reported that the estimated change in fair market values from the date of the commitments was not material as of December 31, 2023, indicating no significant increase in risk exposure compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding customer eligibility. The original answer states that in 2022, trade-in options were available to 'some customers' broadly, while in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. However, the LLM answer claims the structure 'remained largely consistent' and only mentions Gulfstream customers in both years, missing the key change in scope. This misrepresents the evolution of customer eligibility. (2) Quantitatively, the LLM correctly notes that the estimated change in fair market values was 'not material' as of December 31, 2023, which aligns with the ground truth. The mention of 45-day valuation windows and predetermined values, while adding detail not contradicted by the original, are not present in the ground truth and may be extraneous or assumed. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from general to specific customer eligibility (from some customers to some Gulfstream customers), which is central to the question about structural changes. It also overlooks the strategic emphasis on Gulfstream in 2023 as a sign of potential risk concentration. Instead, it concludes no significant change in risk exposure, which downplays the more targeted framing in 2023. (4) Contextual relevance is fair—the answer addresses trade-in structures, risk exposure, and valuation impacts—but misses the core analytical point about narrowing eligibility and its implications. The qualitative accuracy is low due to incorrect synthesis of the eligibility change, despite correct use of some terminology and risk assessment language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 470,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi evolved from being a planned commercial electric vehicle to entering \"pilot production\" in Nevada by 2024, as noted in the 2024 10-K. While the 2022 10-K mentioned the Semi as a future product in development, the 2024 10-K indicates progress toward production, reflecting its integration into Tesla's broader strategy to expand its product lineup and leverage advancements in battery and manufacturing technologies. The Semi's strategic positioning emphasizes Tesla's focus on commercial and industrial markets, complementing its consumer vehicle offerings and reinforcing its mission in sustainable energy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, the Tesla Semi was in development (as per the 2022 10-K), and by 2024, it had entered 'pilot production' in Nevada (per the 2024 10-K), which matches the original answer's key facts. (2) There are no numeric values requiring calculation, but the years (2022, 2024) and location (Nevada) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings to show progression in production status and infers strategic positioning—such as targeting commercial markets and complementing consumer offerings—consistent with Tesla's broader mission. (4) While the original answer focuses on the shift from concept to pilot production, the LLM adds context about battery and manufacturing technology and strategic expansion, which is reasonable and supported by typical 10-K disclosures, though slightly more interpretive. This justifies a 9/10 for correctness and qualitative accuracy—excellent, but not perfectly minimalistic to the ground truth. Contextual relevance is full, as all parts of the question (production status, strategic positioning, evolution between 2022–2024) are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 351,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $397 million in 2023 and further to $402 million in 2024. This indicates that Altria continued to maintain a full or significant valuation allowance against the associated deferred tax assets, suggesting that the company does not expect these assets to be realizable in the foreseeable future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the valuation allowance amounts for 2022 ($379 million) and 2024 ($402 million), which match the ground truth. It also includes an intermediate value for 2023 ($397 million), which is not contradicted by the original answer and adds granularity without introducing error. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect: the starting and ending figures align with the ground truth, and the incremental increase is logically consistent. There are no calculation errors. (3) The reasoning is sound—increasing valuation allowance indicates ongoing uncertainty about the realizability of deferred tax assets, and the LLM correctly infers that Altria does not expect these assets to be realizable in the foreseeable future, matching the original answer’s interpretation. The only minor omission is not explicitly stating that the increase suggests a 'cautious stance,' though this is implied in maintaining a significant allowance. (4) The answer is fully relevant, directly addressing both parts of the question: the evolution of the allowance and its implication for deferred tax asset realizability. Semantic equivalence is strong, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 353,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen changed the financial treatment of its investment in BeiGene in the first quarter of 2023, switching from the equity method of accounting to recording the investment at fair value, with changes in fair value recognized in earnings. This change resulted in significant gains being recognized in 2023 due to the fair value adjustment. In 2024, the impact of the BeiGene investment was reflected in net unrealized losses on strategic equity investments, contributing to a decrease in Other income (expense), net compared to the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen changed its accounting method for the BeiGene investment in 2023 from the equity method to fair value, resulting in gains recognized in 2023. In 2024, the investment led to net unrealized losses, impacting Other income (expense), net. These points match the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in accounting treatment (2023) and its subsequent financial impact shift from gains to losses (2024), showing evolution over time. (4) The only minor shortcoming is that the LLM does not explicitly state the 'reversal in financial benefit' framing present in the original, which slightly weakens the qualitative synthesis, but the factual progression is fully correct. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses the evolution between 2023 and 2024 as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 327,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved through a consolidation of services in Latin America and a continued focus on regional branding in key markets like India. In June 2024, Disney merged its Latin American services, including Star+, into a unified Disney+ offering, streamlining its product structure. Additionally, the service remains distinctly branded as Disney+ Hotstar in India and Southeast Asia, emphasizing localized content and sports programming to cater to regional preferences. This strategy reflects Disney's effort to optimize its DTC offerings while maintaining tailored regional identities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the June 2024 merger of Star+ and Disney+ in Latin America is accurately stated, and the continued use of the Disney+ Hotstar brand in India and Southeast Asia is correctly noted. (2) Quantitative accuracy is perfect—'June 2024' matches the ground truth's 'by the end of June 2024'; no numerical errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information about regional branding (India/SEA) and structural changes (Latin America consolidation), demonstrating understanding of Disney’s strategic shift. (4) The only minor shortcoming is a slight omission of the explicit mention that Disney+ Hotstar was described as a DTC service in India in 2023, though this is implied. Also, the answer could have more clearly emphasized the strategic shift toward consolidating under the Disney+ umbrella as a global pattern. However, the core information, entities, dates, and strategic implications are all correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—directly addresses regional branding and service structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 340,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal refined its Protection Programs by enhancing risk exposure management and loss recovery mechanisms. In 2023, the programs primarily focused on mitigating fraud and unauthorized transactions, with losses often stemming from disputes and chargebacks. By 2024, PayPal emphasized proactive risk assessment tools and improved transaction monitoring to detect and prevent fraudulent activities more effectively. Additionally, the company expanded its recovery mechanisms, seeking to recover losses from merchants and payment card issuers more systematically, while also adapting to evolving regulatory and chargeback requirements to reduce overall exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. While it correctly identifies that PayPal's Protection Programs involve risk from disputes and chargebacks, it inaccurately portrays PayPal's 2024 approach as involving 'proactive risk assessment tools,' 'improved transaction monitoring,' and 'expanded recovery mechanisms' with systematic recovery from merchants and card issuers. The original answer does not support these specific enhancements; instead, it emphasizes increased disclosure, acknowledgment of substantial losses, challenges in recovering from insolvent merchants, and heightened exposure due to fraud and regulation. The LLM answer implies operational improvements that are not stated in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound—both years are correctly referenced, and the general topic (evolution of protection programs) is addressed. However, the synthesis is flawed: the LLM infers proactive enhancements rather than the actual shift toward greater risk transparency and concern about loss recovery. The original answer reflects a more cautious, disclosure-focused evolution, not an operational upgrade. (4) Correctness is scored at 5 due to partial factual alignment but significant misrepresentation of the nature of PayPal’s evolution. Qualitative accuracy is low because the reasoning and entity-specific details (e.g., nature of loss recovery efforts) are incorrect. Contextual relevance is high as the response stays on topic and addresses risk exposure and recovery mechanisms, albeit inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 483,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities evolved significantly from 2022 to 2024, particularly in terms of ownership structure and financial exposure. In 2022, FPL committed to expanding its SolarTogether™ program by constructing an additional 1,788 MW of solar generation by 2025, aiming for a total capacity of 3,278 MW. This expansion was supported by a Solar Base Rate Adjustment (SoBRA) mechanism, allowing for potential base rate increases tied to new solar additions. By 2024, NextEra Energy Resources (NEER) had consolidated ownership in multiple variable interest entities (VIEs) with solar generation facilities, including entities with 765 MW and 3,485 MW of generating capacity. These entities were primarily financed through third-party debt and had long-term power sales agreements. NEER's financial exposure increased as it consolidated VIEs with significant solar capacity, and it provided guarantees and credit support for these entities, reflecting a growing strategic and financial commitment to solar generation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies the shift toward VIE consolidation by 2024 and mentions the 765 MW of solar capacity (matching the ground truth), it introduces significant inaccuracies. Most notably, it references FPL's SolarTogether™ expansion of 1,788 MW and a target of 3,278 MW by 2025, which is not mentioned in the ground truth and appears unrelated to the ownership structure evolution. This information may pertain to FPL (a subsidiary) but does not address the core of the question about NextEra Energy Resources' ownership and financial exposure changes. Additionally, the LLM claims NEER consolidated VIEs with 3,485 MW of capacity, which is not supported by the ground truth (only 765 MW is mentioned). (2) Quantitative accuracy is partially correct: the 765 MW figure is accurate, but the 3,485 MW and the 1,788 MW/3,278 MW figures are not present in the original answer and appear fabricated or misattributed. The ground truth emphasizes divestitures in 2022 (e.g., 100% sale of a 100 MW facility, 90% sale of a portfolio), which the LLM omits entirely, instead focusing on expansion plans. (3) The multi-hop reasoning is partially sound in recognizing the strategic shift to VIEs and increased financial exposure via guarantees and credit support, which aligns with the ground truth. However, it fails to acknowledge the 2022 divestiture trend, which is a key contrast to the 2024 consolidation strategy. This omission breaks the logical evolution described in the original answer. (4) The contextual relevance is high because the answer addresses ownership structure and financial exposure in solar facilities over time, and correctly identifies VIEs and financial commitments. However, the inclusion of unsupported capacity numbers and the omission of key divestiture events significantly reduce factual correctness. The answer captures the direction of change but misrepresents the starting point and magnitude, leading to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 549,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities for non-U.S. pension plans increased from $189,337 million as of August 31, 2023, to $253,025 million as of August 31, 2024. The valuation methodology remained consistent, with these investments classified entirely under Level 2 of the fair value hierarchy in both years, indicating they were valued using quoted prices for similar instruments or model-derived valuations with observable inputs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it reports an increase in Mutual Fund Debt Securities from $189,337 million to $253,025 million, which is incorrect on multiple levels: the original answer states the investment decreased from $379,989 in 2022 to $253,025 in 2023 (not 2024), and the amounts are in thousands (not millions). The LLM incorrectly adds 'million' to the dollar amounts, inflating them by 1,000x (e.g., $253,025 thousand = ~$253 million, not $253,025 million). Additionally, the LLM references 'non-U.S. pension plans' and dates 'August 31, 2023' and 'August 31, 2024', which are not mentioned in the original answer and contradict the 2022–2023 timeframe. (2) Quantitative accuracy is severely compromised: the correct values are $379,989 (2022) and $253,025 (2023), both in thousands, with a decrease of $126,964. The LLM reports incorrect years, incorrect direction of change (increase vs. actual decrease), and wrong magnitude due to unit error. (3) The reasoning is flawed: the LLM fails to correctly synthesize the evolution from 2022 to 2023 and introduces unrelated details (pension plans, future year 2024). While it correctly notes Level 2 classification in both years, this is the only accurate qualitative point. (4) Scores are low due to major factual, numerical, and temporal inaccuracies. The answer misrepresents the core data and timeline, despite correctly identifying the Level 2 valuation methodology. Contextual relevance is partially maintained as it discusses the same type of investment and fair value hierarchy, but with wrong entities and timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 447,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023. In 2022, Chevron's investment in TCO was $26,534 million, and by 2023, it rose to $26,954 million. Additionally, Chevron's equity in earnings from TCO increased from $4,386 million in 2022 to $3,375 million in 2023. This indicates a modest growth in Chevron's financial involvement and returns from TCO during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million in 2022, not $26,534 million as stated in the LLM answer. The 2023 carrying value is not explicitly given in the ground truth but is described in terms of an $80 million premium over underlying equity, not $26,954 million. Additionally, the equity in earnings is reported as $1,238 million in 2022 in the ground truth, whereas the LLM claims $4,386 million in 2022 and $3,375 million in 2023—both figures are incorrect and inconsistent with the source. (2) The numbers provided by the LLM do not match the ground truth in any verifiable way; differences are too large to be attributed to rounding or formatting. The LLM also presents a decrease in equity earnings from 2022 to 2023, while the ground truth shows an increase (from $1,238M to an implied higher value due to strategic financing), but exact 2023 earnings are not provided. More critically, the LLM omits the key fact that Chevron provided a $4,500 million loan to TCO in 2023 for the FGP/WPMP projects—a major indicator of deepened financial involvement—which is central to the evolution described in the original answer. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct valuation approach shift (carrying value vs. underlying equity) and omits the strategic loan, which is a critical component of Chevron’s increased involvement. Instead, it fabricates specific investment values and earnings figures not supported by the data. (4) The contextual relevance is moderate because the answer addresses Chevron’s stake and involvement in TCO over the two years, but the incorrect numbers and missing key developments (especially the $4.5B loan) severely undermine factual correctness. The conclusion of 'modest growth' contradicts the ground truth's emphasis on a significant deepening of commitment. Thus, the correctness and quantitative accuracy scores are low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 558,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney has strategically integrated ABC Network more deeply into its broader entertainment ecosystem. ABC remains a key component of Disney's Linear Networks, generating revenue through advertising, affiliate fees, and content licensing. In 2024, ABC programming is available on Hulu SVOD one day after linear airing, enhancing cross-platform viewership and monetization. Additionally, ABC's role in ESPN on ABC—sports programming produced by ESPN for the network—highlights its expanding role in Disney's Sports segment. These moves reflect Disney's strategy to leverage ABC's reach across linear, streaming, and sports platforms to drive audience engagement and revenue synergies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that ABC programming is available on Hulu SVOD one day after linear airing in 2024, which matches the original answer. It correctly identifies ABC as part of Disney's Linear Networks and notes its integration into streaming platforms, reflecting the strategic shift. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect figures are presented. (3) The multi-hop reasoning is sound: the model synthesizes ABC’s role in linear networks with its growing integration into Hulu and acknowledges cross-segment synergy with ESPN on ABC. However, the original answer does not mention ESPN on ABC as a new development between 2023 and 2024, nor does it highlight ABC’s expanding role in the Sports segment as a strategic evolution during this period. This addition, while factually plausible, introduces an element not supported by the ground truth and slightly overextends the synthesis. (4) The answer is contextually relevant and addresses both the evolution of ABC’s strategic positioning and its integration within Disney’s broader ecosystem. The core facts about Hulu integration and shift toward streaming are correct, warranting a high score, but the unsupported emphasis on ESPN on ABC prevents a perfect score on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 399,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics has maintained the ASCOD vehicle as part of its Land Systems portfolio, emphasizing its role as a versatile tracked combat vehicle with multiple versions, including the Spanish Pizarro and the Austrian Ulan. The 2023 filing highlights continued global production and support of ASCOD, alongside other platforms like Piranha and Duro/Eagle tactical vehicles. This consistency in positioning suggests a stable investment allocation in tracked combat systems, with no significant shift in production focus toward ASCOD, indicating that it remains a complementary product within the broader Land Systems portfolio rather than a strategic priority.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that in 2022, General Dynamics was 'producing and upgrading' the ASCOD vehicle, but by 2023, the language changed to merely 'offering' it—indicating a reduction in active development. The LLM incorrectly asserts that there was 'continued global production and support' in 2023, which contradicts the source. This misrepresents the evolution of the vehicle's positioning. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations were made, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires comparing disclosures across two years to infer strategic shifts. The LLM failed to detect the change in language ('producing and upgrading' → 'offering') and thus drew the opposite conclusion of the ground truth. It also incorrectly implies ASCOD remains under active production in 2023, while the truth suggests a de-prioritization. The mention of Piranha and Duro/Eagle is contextually relevant but does not compensate for the incorrect interpretation. (4) Correctness is severely compromised due to the inversion of the factual trend. While the answer is relevant to the topic and structured appropriately, it conveys the opposite of the true strategic signal. Hence, correctness and qualitative accuracy are very low. Contextual relevance is moderate because it discusses the right company, product, and portfolio context, but with incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 430,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased between 2023 and 2024, with the designated amount dropping from $3.0 billion in 2023 to $2.0 billion in 2024. This represents a reduction from 39% of available European customer balances in 2023 to 26% in 2024. This shift suggests a more conservative approach to credit funding, potentially reflecting a strategic reallocation of liquidity or regulatory adjustments. It may also indicate a focus on diversifying funding sources for credit activities, as evidenced by the increased reliance on external partnerships, such as the multi-year agreement with a global investment firm to sell eligible consumer installment receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the decrease in approved European customer balances from $3.0 billion in 2023 to $2.0 billion in 2024, and the corresponding percentages (39% to 26%). These match the ground truth exactly, with no calculation or formatting errors. (2) Quantitative accuracy is perfect—dollar amounts, years, and percentages are all correct and consistent with the original answer. (3) The reasoning is sound and captures the strategic shift toward reduced reliance on customer balances. It appropriately infers a move toward diversified funding sources, referencing the multi-year receivables sale agreement. However, while the LLM mentions 'external partnerships' and a 'global investment firm,' it omits the specific evidence from the ground truth that $20.8 billion in loans were sold in 2024 versus $5.5 billion in 2023—a key data point demonstrating the scale of the shift. This omission slightly weakens the qualitative completeness of the multi-hop synthesis. (4) Despite this minor gap, the answer is contextually excellent, directly addressing both parts of the question—evolution of utilization and strategic implication—and conveying semantically equivalent conclusions. The missing loan volume figures prevent a perfect 10, but the core facts and logic are accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 378,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds showed a significant decline in fair value and an increase in unrealized losses. In 2022, the fair value of available-for-sale debt securities in an unrealized loss position was relatively low, with losses of $19 million for NEE and $15 million for FPL. By 2024, these losses had risen to $119 million for NEE and $61 million for FPL, while the total fair value of the funds increased to $2,224 million for NEE and $1,160 million for FPL. This indicates a more volatile investment environment and a potential shift toward riskier or less liquid assets within the funds. The increase in unrealized losses and the write-downs of equity method investments (e.g., XPLR and Mountain Valley Pipeline) also suggest reduced transparency and a more challenging market for these investments, reflecting broader economic or regulatory pressures.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core aspects of the question. (1) It confuses equity securities with debt securities, stating that 'available-for-sale debt securities' were in unrealized loss positions, while the ground truth focuses exclusively on equity securities in Special Use Funds. This is a fundamental misrepresentation of the asset class. (2) The numbers cited are factually wrong: the LLM claims NEE's total fair value was $2,224 million in 2024, but the ground truth reports $2,614 million in Level 1 equity securities alone for NEE. Similarly, FPL's 2024 equity holdings are reported as $1,028 million (Level 1), not $1,160 million total as stated. The unrealized losses cited ($119M for NEE, $61M for FPL) do not appear in the ground truth and are entirely fabricated. (3) The multi-hop reasoning is flawed: the question asks about valuation categorization (Level 1/2/3) evolution and transparency, but the LLM instead discusses unrealized losses and write-downs of specific investments (XPLR, Mountain Valley Pipeline), which are irrelevant to the Special Use Funds' equity securities disclosure. (4) The conclusion about 'reduced transparency' contradicts the ground truth, which shows increased transparency due to granular Level 1/2/3 disclosures in 2024. The LLM also introduces entities and metrics (e.g., equity method investments) not relevant to the question. While the answer attempts to discuss trends over time, it does so with incorrect data, wrong asset classes, and misleading implications, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 433,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture increased its share repurchase activity under the public program while maintaining employee-related transactions. In fiscal 2022, the company repurchased 1,964,612 shares under the public program, with 97,251 shares acquired through employee-related transactions. By fiscal 2023, Accenture repurchased 11,753,807 shares under the public program, a significant increase, while 2,159,586 shares were acquired through employee-related transactions, primarily for payroll tax obligations. This indicates a larger focus on open-market repurchases in fiscal 2023 compared to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, Accenture purchased 1,964,612 shares under the public program in fiscal 2022 for $576 million and 97,251 shares via employee-related transactions. In fiscal 2023, there is no mention of any shares purchased under the public program, indicating reduced or no activity, while employee-related transactions continued. However, the LLM claims that in fiscal 2023, Accenture repurchased 11,753,807 shares under the public program and 2,159,586 through employee-related transactions—numbers that are not supported by the original answer and contradict its key point of reduced public program activity. (2) The quantitative inaccuracies are severe: the LLM invents large repurchase figures for 2023 with no basis in the source. The fiscal 2022 numbers are correct, but the 2023 numbers are entirely fabricated. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning fails: instead of recognizing the absence of public program activity in 2023 as a key shift, the LLM incorrectly infers an increase. The conclusion that there was a 'larger focus on open-market repurchases' is the opposite of the truth. (4) Scores reflect major factual errors: correctness is low due to false data and reversed trend interpretation; quantitative accuracy is poor due to invented figures; qualitative accuracy is slightly higher only because the structure and terminology are appropriate; contextual relevance is moderate as the answer addresses the right topic and entities but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 450,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023 in terms of its consolidation status and investment accounting approach. In both years, Chevron maintained a 50% equity ownership interest in CPChem and accounted for the investment using the equity method. This is evidenced by the inclusion of CPChem's summarized financial data in both the 2022 and 2023 10-K filings, with no indication of a change in Chevron's consolidation status or accounting treatment during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, Chevron consolidated Chevron Phillips Chemical Company LLC (CPChem) in 2022 but switched to the equity method in 2023, marking a significant change in accounting treatment. The LLM incorrectly claims the accounting method remained consistent across both years. (2) The LLM states Chevron had a 50% ownership interest and used the equity method in both years, which contradicts the original answer indicating consolidation in 2022. This misrepresents the core financial reporting change. (3) The multi-hop reasoning failed: the model should have detected the shift from consolidated subsidiary (evidenced by 'Note 8' in 2022) to equity-method accounting (explicitly stated in 2023), but instead assumed consistency. (4) While the answer addresses the right entities (Chevron, CPChem) and time frame (2022–2023), the central claim is factually wrong, leading to a very low correctness score. Minor contextual relevance is retained due to correct entity and document reference, but no accurate synthesis occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 317,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics' Combat Systems segment has evolved with increased production capacity expansion and continued contract involvement. In 2022, the segment received a $175 million contract from the U.S. Army for the production of Hydra-70 rockets. By 2023, OTS (Ordnance Tactical Systems) received awards to significantly expand its production capacity for Hydra-70 rockets, aiming to increase metal parts production from 18,000 to 86,000 rounds per month by 2025, reflecting a strategic focus on meeting the U.S. Army's demand for artillery and munitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million 2022 contract for Hydra-70 rocket production and the expansion of metal parts production capacity from 18,000 to 86,000 rounds per month by 2025. All quantitative figures (dollar amount, production numbers, timeline) are accurate and match the ground truth. (2) Quantitative accuracy is perfect: $175M contract, 18,000 to 86,000 rounds per month, and the 2025 target date are all correctly reported. Format variations (e.g., '86,000 rounds') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—linking the 2022 contract to the 2023 capacity expansion within General Dynamics' Combat Systems segment via OTS. However, there is a minor entity inaccuracy: the LLM refers to 'Ordnance Tactical Systems (OTS)' whereas the ground truth specifies 'Orbital Technologies Corporation' (also OTS). While both names may refer to the same entity in some contexts, the official name in the knowledge graph is Orbital Technologies Corporation, not Ordnance Tactical Systems. This is a known alias issue but constitutes a small factual deviation. (4) The answer is contextually excellent, addressing both contract involvement and production capacity evolution as asked. The strategic rationale (meeting U.S. Army demand) is a reasonable inference. Due to the minor entity misidentification, the correctness score is 9 instead of 10, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 401,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice and Agreement is listed as \"Form of Global Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan\" (page 127 of the 2023 filing). In the 2024 filing, the same document is still referenced but is now dated as filed on April 30, 2024, indicating an amendment or restatement (page 121 of the 2024 filing). This suggests an update to the agreement's documentation status, likely reflecting changes to terms or compliance requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding the documentation status and dates. According to the ground truth, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained unchanged between 2023 and 2024, with both filings referencing the same form incorporated by reference from the May 14, 2015 10-12B/A filing. However, the LLM incorrectly claims that in the 2024 filing, the document is 'now dated as filed on April 30, 2024,' which is false for this specific exhibit. The April 30, 2024 date in the 2024 filing applies only to the updated Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), not the base RSU notice. This is a critical error in quantitative accuracy (date misattribution). The LLM also fails to mention the key distinction between the unchanged base RSU notice and the updated performance-based variant, missing a core part of the multi-hop reasoning. While it correctly identifies the 2015 plan and acknowledges a documentation update, it conflates two different exhibits. The answer is contextually relevant and addresses the general theme of documentation evolution, but the factual and quantitative errors—especially the incorrect date assignment—severely undermine correctness. The qualitative accuracy is partially correct in identifying a change but flawed in reasoning due to misattribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 387,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has expanded significantly, both in terms of revenue performance and new regulatory approvals. In 2022, Opdivo generated $7,523 million in revenue, and by 2024, it continued to be a key revenue driver. During this period, Opdivo received multiple regulatory approvals, including FDA and EC approvals for new indications such as unresectable urothelial carcinoma, NSCLC, and microsatellite instability-high colorectal cancer, as well as the FDA approval of Opdivo Qvantig, a subcutaneous formulation. These developments strengthened Opdivo's position as a core asset in BMS's oncology portfolio and expanded its therapeutic reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Opdivo's 2022 revenue of $7,523 million, which matches the ground truth. However, it inaccurately claims that Opdivo 'continued to be a key revenue driver' in 2024 without providing actual 2024 revenue figures or acknowledging the lack of significant revenue growth, which is a key point in the original answer. (2) The quantitative data for 2022 is accurate, but no 2024 revenue number is provided, and the assertion of continued strong performance is not supported by the ground truth, which explicitly notes no significant revenue increase. (3) The LLM introduces multiple new regulatory approvals (NSCLC, MSI-high colorectal cancer, EC approvals, and Opdivo Qvantig) that are not mentioned in the ground truth. While Opdivo did receive a real FDA approval in March 2024 for urothelial carcinoma, the expansion to other indications and regions (EC) and the subcutaneous formulation approval are not part of the verified knowledge base, indicating overstatement or hallucination. This undermines the multi-hop reasoning, as the answer extrapolates beyond the provided facts. (4) The contextual relevance is high because the answer addresses both revenue and regulatory evolution. However, the qualitative accuracy is reduced due to unsupported claims about approvals and revenue trajectory. The correctness score is 6 because core facts (2022 revenue, 2024 urothelial approval) are correct, but significant additions not in the ground truth reduce overall factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 418,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) increased between 2022 and 2023, as reflected in the investments and advances. In 2023, Chevron's investment in CPChem rose to $7,765 million from $6,843 million in 2022, and the equity earnings contribution increased to $608 million from $867 million in the prior year. Additionally, Chevron provided a loan of $387 million in 2023 to fund a portion of the Golden Triangle Polymers Project, highlighting continued strategic support for CPChem's expansion initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the $387 million loan in 2023 for the Golden Triangle Polymers Project — which aligns with the ground truth — it introduces financial figures ($7,765 million and $6,843 million investments, and equity earnings of $608M vs $867M) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, severely undermining factual accuracy. (2) The original answer does not mention aggregate investment totals or equity earnings changes, so their inclusion here represents a factual overreach. The drop in equity earnings from $867M to $608M is especially problematic as it contradicts the narrative of increased strategic support. (3) Qualitatively, the LLM captures the evolution from general ownership and project announcements in 2022 to direct financial support via a loan in 2023, which reflects correct multi-hop reasoning and understanding of strategic shift. It correctly identifies CPChem, the Golden Triangle Polymers Project, and the nature of the $387M loan. However, the addition of unverified financial aggregates weakens the reasoning integrity. (4) Contextually, the response is highly relevant, addressing both years, project funding, and investment structure. Despite incorrect numbers, the core idea of increased direct financial involvement is consistent with the ground truth. The score is limited primarily by serious quantitative errors that misrepresent Chevron’s financials, even though the directional insight about increased support has merit.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 451,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses and negative customer balances. The allowance for transaction losses rose from $64 million in 2023 to $86 million in 2024, while the allowance for negative customer balances increased from $218 million to $256 million. The disclosures also showed a higher provision for 2024 ($1,114 million) compared to 2023 ($1,192 million), indicating a continued focus on risk management and consumer/merchant protection.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increases in the allowance for transaction losses ($64M to $86M) and negative customer balances ($218M to $256M), which matches the ground truth. However, it incorrectly states that the provision for 2024 was $1,114 million compared to $1,192 million in 2023, implying a decrease. This contradicts the ground truth, which does not mention these total provision figures, and introduces potentially false information. There is no support in the original answer for these aggregate provision amounts, making this a significant quantitative error. (2) The specific allowance figures are accurate and correctly compared year-over-year, but the inclusion of unverified total provisions undermines confidence in the data sourcing. The direction of change (increase in allowances) is correct and relevant. (3) The multi-hop reasoning is mostly sound—linking increased allowances to greater financial commitments and risk exposure—but the erroneous provision numbers suggest flawed synthesis or hallucination of data not present in the source. The model correctly infers increased risk management focus, which is consistent with the original answer's conclusion. (4) Scores reflect mostly correct core facts with one major quantitative inaccuracy. The answer is contextually relevant and well-structured, but the incorrect provision figures reduce the correctness and quantitative accuracy scores significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 401,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has emphasized the continued centrality of franchising as its core business model while placing greater emphasis on collaboration and co-investment with franchisees. In 2024, the Company highlights that co-investments with franchisees are made to accelerate initiatives such as restaurant modernization and operational improvements, reflecting a strategic shift toward shared financial commitment to drive performance and brand value. This contrasts with earlier descriptions in 2022, which focused more on the traditional franchising structure without explicitly emphasizing co-investment as a strategic tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's strategic framing between 2022 and 2024. It correctly identifies that franchising remained central but that there was a shift toward emphasizing collaboration and co-investment by 2024. The answer accurately contrasts the 2022 focus on structural, traditional franchising arrangements with the 2024 emphasis on co-investment as a strategic lever for performance and brand value. While the original answer uses stronger value-laden language (e.g., 'paramount') and specifies that co-investment enables high restaurant performance in areas like food quality and customer experience, the LLM answer conveys a semantically equivalent point by linking co-investment to restaurant modernization and operational improvements. There are no numeric values to verify, so quantitative accuracy is 10. The qualitative accuracy is slightly reduced (9) because the LLM does not fully capture the depth of the 'value-laden' shift described in the original (e.g., franchising as essential to food quality and profitability), but it still reflects a sound multi-hop synthesis across years and strategic themes. Contextual relevance is perfect, as the response directly addresses franchising as a core model and the evolving role of co-investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 363,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "In January 2023, the FDA authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks, indicating regulatory progress for Altria's heated tobacco products. However, this authorization occurred after the FDA's 2021 ITC-related cease-and-desist order, which had removed Marlboro HeatSticks from the market due to a patent dispute. Despite the 2023 authorization, these products are still subject to potential regulatory challenges, such as the FDA's graphic health warning requirements and ongoing product standard proposals. This evolution suggests incremental progress in Altria's efforts to bring heated tobacco products to market, though continued regulatory scrutiny remains a significant hurdle.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the FDA authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, which matches the ground truth. This is a key factual and quantitative point, and the date and event are accurate. However, the LLM introduces information not present in the ground truth—specifically, the 2021 ITC-related cease-and-desist order and the removal of HeatSticks from the market due to a patent dispute. While factually plausible in a broader context, this detail is not part of the provided ground truth and shifts focus away from the 2022–2023 regulatory evolution as defined. Additionally, the ground truth emphasizes that in 2022, the FDA had not authorized HeatSticks and was evaluating them case-by-case for graphic health warnings—a key point the LLM omits. Instead, the LLM focuses on ongoing regulatory challenges, which, while reasonable, downplays the significance of the 2023 authorization as a 'significant regulatory milestone' per the original answer. (2) All dates and numbers mentioned (January 2023, three varieties) are correct and match the ground truth. No calculations are involved. (3) The multi-hop reasoning is partially sound: the LLM connects the 2023 authorization to Altria’s regulatory progress, which aligns with the original. However, it fails to contrast the 2022 status (no authorization, case-by-case review) with the 2023 approval, weakening the comparative evolution. The introduction of the ITC dispute, while contextually relevant externally, is not supported by the knowledge graph and distracts from the core regulatory timeline. (4) The correctness score is 7 because the core factual event (2023 authorization) is accurate and well-contextualized, but the omission of the 2022 status and insertion of unsupported details reduce completeness and fidelity. Quantitative accuracy is high (9) due to correct dates and counts. Qualitative accuracy is 7 due to sound but partially misaligned reasoning. Contextual relevance is 9 as the answer addresses Altria’s regulatory progress, though with some extraneous details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 568,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans increased from $234,339 in 2022 to $253,494 in 2023, indicating a modest improvement in the value of these investments. This shift suggests a slight enhancement in the positioning of the company's investment portfolio in this category, reflecting either improved market conditions or strategic adjustments in asset allocation to align with long-term investment objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that mutual fund equity securities held by ACN decreased from $239,293 million in 2022 to $196,226 million in 2023, a reduction of $43,067 million. However, the LLM claims an increase from $234,339 to $253,494, which is not only numerically inaccurate but also contradicts the actual trend. (2) The numbers cited by the LLM ($234,339 and $253,494) do not match the ground truth values ($239,293 and $196,226), and the implied increase of $19,155 is factually wrong. Additionally, the LLM introduces 'non-U.S. pension plans' which is not mentioned or implied in the original answer, adding unverified context. (3) The multi-hop reasoning failed completely — instead of identifying a decline indicating a strategic reallocation away from mutual fund equities, the model incorrectly infers an enhancement in positioning due to an imagined increase. This reflects a failure to retrieve and synthesize the correct data points across years. (4) The correctness and quantitative accuracy scores are near lowest due to entirely fabricated numbers and reversed trend. Qualitative accuracy is extremely low because of incorrect entities and flawed logic. Contextual relevance is slightly above zero only because the topic (mutual fund equity securities valuation over time) is addressed, albeit with wrong data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 399,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in Angola LNG Limited, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In 2022, the company continued efforts to develop non-associated gas in offshore Angola to supply the Angola LNG plant, and by 2023, there is no indication of a significant shift in operational focus or investment emphasis, suggesting continued commitment to this project.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained a 36.4% interest in Angola LNG Limited from 2022 to 2023, which matches the ground truth. It also accurately notes the operational context—developing non-associated gas to supply the LNG plant in Soyo, Angola. However, the LLM answer misses a key qualitative shift identified in the original answer: in 2023, Chevron’s disclosure emphasis changed from operational development (e.g., processing associated gas, developing non-associated gas) to a broader financial and portfolio-level presentation, where Angola LNG was grouped with other equity affiliates like Tengizchevroil and Chevron Phillips Chemical. This shift in reporting focus is a critical part of the evolution in Chevron’s involvement and is entirely omitted in the LLM response. Instead, the LLM claims there was 'no indication of a significant shift,' which contradicts the ground truth’s conclusion about changed disclosure emphasis. (2) Quantitatively, all numbers (36.4%, years 2022–2023) are accurate and correctly reported. (3) The multi-hop reasoning is partially sound—while the model correctly identifies continuity in ownership and some operational activities, it fails to synthesize the change in disclosure strategy, which requires connecting information across years and reporting contexts. This represents a failure in higher-order reasoning despite correct data retrieval. (4) The correctness score is 6 due to accurate numbers and partial completeness, but significant omission of the shift in disclosure focus. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 6 due to flawed reasoning about the absence of change. Contextual relevance is 8 because the answer addresses the topic well but misses a key dimension of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 493,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, representing a change of $28 million. This indicates a significant rise in the magnitude of such investments over the one-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $21 million instead of the correct $14 million from the ground truth. The 2023 value is correct at $49 million. The calculated change of $28 million is therefore incorrect; the true increase is $35 million (from $14M to $49M), which corresponds to a 250% increase, not the implied ~133% in the LLM response. (2) Quantitative accuracy is compromised due to the wrong baseline value and resulting incorrect delta. While $49 million in 2023 is accurate, the $21 million figure for 2022 contradicts the ground truth and leads to an erroneous $28 million change. (3) The reasoning structure is sound—comparing two years and computing a change—but the multi-hop synthesis fails because the model used an incorrect data point for 2022, undermining the conclusion. (4) Despite the incorrect numbers, the answer addresses both parts of the question (evolution and magnitude) and uses appropriate terminology, earning points for qualitative reasoning and contextual relevance. However, the magnitude of the error in key financial data severely impacts overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 328,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, the percentage of franchised restaurants in McDonald's system increased from 93% to approximately 95%. In 2021, 37,295 out of 40,031 total restaurants were franchised, while in 2024, 41,303 out of 43,477 total restaurants were franchised. This reflects McDonald's continued emphasis on and expansion of its franchising business model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (93% in 2021 and approximately 95% in 2024) are accurate and supported by the provided absolute numbers: in 2021, 37,295 franchised out of 40,031 total restaurants equals ~93.17%, which rounds to 93%; in 2024, 41,303 out of 43,477 equals ~94.99%, which rounds to 95%. These calculations are correct. (2) The answer is complete, addressing both the percentage change and the underlying trend in McDonald's franchise strategy. (3) Entities (McDonald's, franchised restaurants, years 2021 and 2024) are correctly identified. (4) The reasoning is sound: the model correctly infers a strategic emphasis on franchising from the increasing percentage, which aligns with the original answer's conclusion. The additional detail of absolute restaurant counts enhances completeness without introducing error. (5) The semantic meaning is equivalent to the ground truth, with slightly more granular data but no deviation in interpretation. All scores are 10 due to full factual accuracy, correct multi-hop synthesis, and contextual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 322,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was initially established and later amended and restated. In 2021, it was amended and restated effective March 31, 2021, as noted in the 2022 filing (page 117). Subsequently, in 2022, the plan was further amended and restated effective October 26, 2022, as referenced in the 2023 filing (page 110). These amendments likely updated the structure or terms of the plan to align with evolving governance or compensation practices.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 2015 Plan was amended and restated effective March 31, 2021 (as noted in the 2022 filing), and then further amended and restated effective October 26, 2022 (as noted in the 2023 filing). These dates match the ground truth exactly. (2) Quantitative accuracy is perfect—both dates are correctly cited with no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers evolution between 2022 and 2023 by referencing two different filings (2022 and 2023) that report different effective dates, indicating an update occurred during that period. (4) The answer addresses all parts of the question—both the effective date changes and the implication of structural updates—and uses appropriate context (governance or compensation practices) to explain the likely purpose. Minor wording differences (e.g., 'likely updated' vs 'reflecting a structural or procedural update') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 320,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact as follows: In fiscal 2022, Accenture's equity method investment in Duck Creek Technologies had a carrying amount of $138,902 and an estimated fair value of $223,166 for its approximately 16% ownership. In fiscal 2023, the company reported a $253 million investment gain related to its investment in Duck Creek Technologies, indicating a significant increase in the valuation of the investment. This gain positively impacted Accenture's adjusted earnings per share for fiscal 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: the 2022 carrying amount ($138,902), fair value ($223,166), ~16% ownership, equity method accounting, and the $253 million gain in fiscal 2023. All numbers match exactly or are appropriately contextualized (e.g., 'approximately 16%'). (2) Quantitative accuracy is perfect—no calculation errors, and the $253 million gain is correctly stated (note: $253 million = $253,000,000, which aligns with the original answer's magnitude despite formatting difference from 2022's smaller dollar figures). (3) The multi-hop reasoning is sound: the model connects Accenture’s initial investment in 2022 to the financial gain realization in 2023, correctly interpreting the evolution of the relationship. It notes the shift in financial impact (gain affecting adjusted EPS), though it omits mention of the effect on the effective tax rate, which was explicitly noted in the original answer. This is a minor omission but does not undermine the core correctness. (4) Scores reflect near-perfect factual alignment, with only a slight deduction in qualitative accuracy due to missing the tax rate impact. Contextual relevance is full—answer directly addresses investment valuation and financial impact across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 361,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application expanded significantly, particularly in treating various B-cell malignancies. In 2024, new FDA approvals included indications for relapsed or refractory follicular lymphoma (FL) after at least two prior lines of therapy, relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after two or more lines of therapy, and mantle cell lymphoma (MCL) after two or more lines of therapy. Additionally, Breyanzi received approval in Japan for relapsed or refractory FL after one prior line of therapy in high-risk patients. These approvals expanded Breyanzi's market potential by broadening its use across multiple lymphoma subtypes and patient populations.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Breyanzi's indications in 2024 and mentions two of the correct new indications—relapsed or refractory follicular lymphoma (FL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)—with accurate treatment criteria (after at least two prior lines of therapy). However, it incorrectly adds a third indication for mantle cell lymphoma (MCL), which was not approved in 2024 according to the ground truth and is not supported by the knowledge graph. This is a significant factual error. Additionally, the mention of an approval in Japan for FL after one prior line of therapy in high-risk patients is not present in the original answer and cannot be verified from the provided truth, making it extraneous or potentially incorrect. (2) The dates of approvals—March 2024 for CLL/SLL and May 2024 for FL—are missing from the LLM answer, which reduces quantitative precision. While the years (2022 and 2024) are correctly used contextually, the absence of specific months and the inclusion of an unverified MCL approval (with no date) affect quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that new indications expand market potential and synthesizes the pattern of 'relapsed/refractory after two or more lines of therapy' across indications. However, the addition of MCL and Japan approvals suggests either hallucination or incorrect data synthesis, undermining the reasoning integrity. (4) The contextual relevance is high because the answer addresses the evolution of therapeutic use and links new indications to expanded market potential, directly responding to the question. However, due to the inclusion of unverified indications, the correctness and qualitative accuracy scores are reduced to the mid-range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 498,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 remained consistent in its methodology but reflected evolving circumstances in respirator mask/asbestos litigation. The Company continues to estimate insurance receivables based on policy terms, case law, prior experience, and the nature of claims, applying the loss recovery and gain contingency models under ASC 450. However, in 2023, the nature of claims shifted, with a higher proportion of cases involving more serious injuries (e.g., mesothelioma, black lung disease), which are costlier to resolve. This shift, combined with legal developments such as jury verdicts and appellate decisions, likely influenced 3M's reassessment of probable losses and associated insurance recoveries, though no specific changes in estimation methodology were explicitly noted.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. Most critically, it incorrectly states that 3M's methodology for estimating insurance receivables 'remained consistent' between 2022 and 2023, when the original answer clearly indicates a notable evolution: in 2022, 3M did not specify its methodology for estimating insurance receivables, but in 2023, it explicitly adopted the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, including analysis of policy terms, case law, and claim nature. This is a key methodological shift that the LLM fails to recognize. (2) Quantitatively, the LLM omits the specific numeric data provided in the ground truth: the increase in individual claimants from 4,028 in 2022 to 4,042 in 2023. This quantitative trend is central to the original answer’s explanation of growing exposure influencing the change in approach. The LLM instead introduces unverified qualitative claims about a 'higher proportion of cases involving more serious injuries' and references to 'jury verdicts and appellate decisions' that are not present in the ground truth. (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize the evolution in disclosure and methodology across the two years. It incorrectly assumes consistency in methodology when the knowledge graph shows increased specificity and formalization in 2023. The connection between rising claimant numbers and the more detailed accounting approach in 2023 is missed entirely. (4) While the LLM answer is contextually relevant—focusing on insurance receivables, ASC 450, and respirator/asbestos litigation—and uses appropriate financial terminology, its qualitative and quantitative inaccuracies severely undermine its correctness. The answer fabricates reasoning (e.g., shift in injury severity) not supported by the ground truth. Thus, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 530,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's relationship with Naked evolved as it sold its Tropicana, Naked, and other select juice brands to PAI Partners in the first quarter of 2022. As part of this transaction, PepsiCo retained a 39% noncontrolling interest in the newly formed joint venture, Tropicana Brands Group (TBG), which operates across North America and Europe. PepsiCo also became the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers with chilled direct-store-delivery in the U.S. This transition reduced PepsiCo's direct operational involvement while maintaining a financial stake through its equity interest in the joint venture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key transaction in 2022—PepsiCo sold Tropicana, Naked, and other juice brands to PAI Partners and retained a 39% noncontrolling interest in the newly formed joint venture, referred to as Tropicana Brands Group (TBG). This aligns with the ground truth. It also correctly states PepsiCo's initial role as exclusive distributor for TBG’s brands, including Naked, for small-format and foodservice channels via chilled direct-store-delivery. However, the LLM answer fails to mention the critical evolution in 2023: that PepsiCo ceased its distribution role and had no further operational involvement, shifting to a purely financial stake. This omission significantly weakens the response to the question, which specifically asks about the evolution *between 2022 and 2023*. (2) Quantitatively, all numbers are accurate: the 39% stake is correct, and the timing (Q1 2022) is consistent with known disclosures. The entity name 'Tropicana Brands Group (TBG)' is acceptable, though the ground truth refers to 'The Beachbody Company (TBG)'—this appears to be a known point of confusion in public filings, but 'Tropicana Brands Group' is the correct name of the JV formed with PAI, so this is not an error. (3) The reasoning is sound for the 2022 transaction and correctly synthesizes the financial and operational aspects at that point. However, it does not complete the multi-hop requirement by failing to contrast 2022 with 2023 and describe the withdrawal from distribution. (4) The answer is contextually relevant and well-structured, but the lack of 2023 update reduces completeness and correctness. Hence, correctness and qualitative accuracy are scored at 7, quantitative accuracy at 9 (minor date specificity not contradicted), and contextual relevance at 9 due to strong alignment with the core facts, just missing the temporal evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 510,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure around the ExtraBucks Rewards program remained consistent in recognizing revenue as rewards are redeemed and identifying the performance obligation at the time of the initial transaction. However, in 2024, there was an enhancement in disclosures related to segment reporting under ASU 2023-07, which required more detailed segment expense disclosures, including those related to the ExtraBucks Rewards program. This change did not affect the accounting treatment but added transparency to how the program impacts segment operating results.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claims, despite being free of numerical errors (hence full marks for quantitative accuracy). The Original Answer states that the accounting treatment for the ExtraBucks Rewards program remained consistent in revenue recognition timing and contract liability treatment, but the 2024 disclosure refined the language around performance obligations—specifically tying them to customers who accumulate ExtraBucks based on historical spending—and included more structured language on transaction price allocation and standalone selling price evaluation. In contrast, the LLM Answer incorrectly attributes changes in disclosure to ASU 2023-07 and segment reporting, which is entirely absent from the ground truth. This misrepresents the nature of the evolution, shifting focus to segment expense disclosures rather than the refinement of performance obligation criteria and revenue allocation methodology. The LLM fails to mention the key qualitative enhancements in how performance obligations are defined and how standalone selling prices are assessed. While it correctly notes consistency in revenue recognition timing and initial performance obligation identification, the introduction of irrelevant standard updates (ASU 2023-07) and misattribution of disclosure changes severely undermines the reasoning and factual accuracy. The answer is contextually relevant to the question’s topic but addresses the wrong aspect of disclosure evolution, failing the multi-hop synthesis required to compare specific accounting treatments across years. Thus, the correctness score is low due to major qualitative inaccuracies, even though no numbers were involved or misstated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 464,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Between 2023 and 2024, Netflix's reliance on integrated payment partners, as reflected in the cost of revenues section, appears to have remained relatively consistent. In both years, payment processing fees paid to integrated payment partners are included as part of \"other operating costs\" within cost of revenues. The cost of revenues increased by $1,323 million (7%) from $19,715,368 in 2023 to $21,038,464 in 2024, primarily driven by higher content amortization. However, no specific details are provided in the documents to indicate a significant shift in the proportion or reliance on integrated payment partners during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that payment processing fees related to integrated payment partners were included in 'other operating costs' within cost of revenues in both 2023 and 2024, which aligns with the ground truth. It also accurately reports the increase in cost of revenues from $19,715,368 million to $21,038,464 million (a $1,323 million increase, or approximately 7%), which is quantitatively accurate and matches the data. (2) The numbers and calculations are correct: the dollar amounts and percentage change are accurately computed. The format uses exact figures (in thousands, as typically reported in SEC filings), and the 7% increase is a valid approximation (1,323 / 19,715.368 ≈ 6.71%, rounded to 7%). (3) However, the LLM misses a key qualitative point from the ground truth: in 2024, the cost of revenues section was streamlined, and granular details about payment processing fees were reduced or removed, indicating a shift in disclosure strategy. The LLM interprets the lack of change in disclosure as 'no significant shift in proportion or reliance,' but the ground truth emphasizes a deliberate reduction in detail, suggesting a change in transparency, not just data availability. This reflects a gap in multi-hop reasoning—while the factual continuity is noted, the evolution in disclosure strategy is overlooked. (4) The answer is contextually relevant and well-structured, addressing the question about evolution in reliance. However, because it fails to capture the nuanced shift in reporting detail—which is central to the original answer—it loses points on qualitative accuracy and overall correctness. The core facts are right, but the deeper synthesis is incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 468,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to stricter regulatory changes and new health-based standards. In 2023, the Minnesota Department of Health issued more stringent Health-Based Values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the potential impact on its obligations under the 2007 Settlement Agreement and Consent Order (SACO). Additionally, in 2023, 3M faced a Notice of Violation from the Minnesota Pollution Control Agency (MPCA) related to PFAS in stormwater discharge from its Hutchinson facility and received a draft Clean Water Act permit for its Cottage Grove facility with significantly revised PFAS limits. These developments indicate an increased regulatory focus, leading 3M to engage more intensively with state agencies to address compliance and adapt its remediation strategies accordingly.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's approach to PFAS contamination in Minnesota from 2022 to 2023. It correctly identifies the issuance of more stringent Health-Based Values (HBVs) by the Minnesota Department of Health for PFOA and PFOS, though it inaccurately states they were issued in 2023 when the ground truth specifies January 2024. This is a minor date error but affects quantitative accuracy. The mention of the MPCA's Notice of Violation in 2023 for the Hutchinson facility is accurate. The reference to the draft Clean Water Act permit for Cottage Grove with revised PFAS limits is correct, although the ground truth notes the order was issued in December 2022 and the proposed permit in January 2024—again, the LLM slightly misattributes timing. The LLM omits specific details about ongoing operational activities at Oakdale and Woodbury under the 2007 SACO and the Decatur, Alabama facility obligations, which were part of 3M’s broader context in 2022. However, the core multi-hop reasoning—linking updated health standards and regulatory actions to 3M’s evolving compliance strategy—is sound and semantically equivalent. The answer synthesizes regulatory changes and corporate response effectively, demonstrating strong qualitative accuracy and full contextual relevance. Minor date inaccuracies prevent a top score in quantitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 388,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased from a notional value of $3.0 billion in 2022 to $3.8 billion in 2023, indicating a more active approach to managing foreign exchange risk. This increase suggests that PepsiCo is enhancing its hedging strategies to mitigate the impact of currency fluctuations on its international operations, particularly through forward contracts and net investment hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional values of foreign currency derivatives for PepsiCo in 2022 ($3.0 billion) and 2023 ($3.8 billion), matching the ground truth exactly. These figures are critical quantitative data points and are accurately reported with correct formatting. (2) The calculation of the increase (from $3.0B to $3.8B) is implied correctly, and no mathematical errors are present. The answer accurately reflects the upward trend in derivative usage. (3) The reasoning is sound: the increase is linked to a more active foreign exchange risk management strategy, which aligns with the ground truth's interpretation of strategic expansion. The mention of forward contracts and net investment hedges adds specificity not in the original but is consistent with typical hedging instruments and does not contradict known facts. (4) The only minor omission is that the LLM answer does not explicitly state that there was 'no material net impact on earnings in 2023'—a key qualitative point in the original answer that reinforces the effectiveness of the hedging strategy. While the general intent of risk mitigation is conveyed, this absence slightly reduces completeness in multi-hop synthesis. However, the core facts, numbers, and logical inference are correct and relevant. Thus, the answer is highly accurate and contextually appropriate, warranting a high score but not perfect due to the missing earnings impact detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 404,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil has increasingly focused on expanding chemical production capacity in high-growth markets, particularly in China, to capitalize on improving living standards. In 2023, the company started up new production units in Texas, including a performance polymers line and a linear alpha olefins unit, enhancing its product portfolio for advanced applications. Additionally, ExxonMobil made significant progress on its Dayawan Petrochemical Industrial Park project in China, aiming to meet rising domestic demand for high-performance polyethylene and polypropylene. This reflects a strategic shift toward geographic diversification and capacity additions in key emerging markets to align with long-term demand trends driven by population growth and economic development.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from 2022 to 2023 in ExxonMobil's approach, noting the move toward high-performance chemicals and expansion in China, particularly the Dayawan project. It accurately captures the geographic focus shift and product emphasis on polyethylene and polypropylene. However, it omits key quantitative details from the original answer: the 500,000 metric tons per year of advanced recycling capacity planned for Baytown by 2026 and the over 2.5 million metric tons per year of combined capacity in China. These are significant omissions affecting quantitative accuracy. (2) The LLM mentions 'new production units in Texas' in 2023 but does not specify that these were expansions in performance polymers and linear alpha olefins in Baytown, nor does it reference the 2022 Corpus Christi ethane cracker completion, which is a key part of the evolution. The absence of these specifics weakens completeness and precision. (3) The multi-hop reasoning is generally sound—the model connects improving living standards to demand growth and infers strategic responses in chemical capacity and geographic focus. It correctly synthesizes the shift from domestic U.S. projects to foreign investment in China. However, it fails to contrast 2022’s advanced recycling and joint venture cracker with 2023’s focus, missing a direct comparison that the original answer provides. (4) The contextual relevance is high, as the answer addresses the core of the question—evolution in strategy, capacity additions, and geographic focus. Wording is different but semantically aligned in parts. Due to missing key numbers and some 2022 specifics, the correctness score is 7 rather than higher. Quantitative accuracy is penalized more heavily (6) due to omitted metrics, while qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 504,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly from $21 million to $49 million. This shift suggests a strategic move toward short-term, low-risk investments, potentially to preserve liquidity or capitalize on more favorable short-term interest rates. The increase indicates a focus on maintaining financial flexibility and managing cash effectively in the short term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 3M's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, matching the ground truth exactly. The quantitative evolution is accurately represented, with no errors in dollar amounts or years. (2) All numbers are correct and consistent with the original answer; the increase from $21M to $49M is a more than doubling, which the LLM implies by stating a 'significant increase'—though it does not explicitly state 'more than doubling,' this is a minor omission in wording, not fact. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward low-risk, short-term investments, linking the increase to liquidity preservation, favorable interest rates, and financial flexibility—this aligns with and reasonably expands upon the ground truth's interpretation about stability and short-term cash management. (4) The answer is contextually complete and relevant, addressing both the quantitative change and its strategic implication. The only minor gap is the lack of explicit mention that the amount 'more than doubled,' but the magnitude is clearly conveyed. Thus, the answer is factually and semantically equivalent to the ground truth with high accuracy in all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 361,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights evolved from 2022 to 2023 by emphasizing **data responsibility and trust-building** more explicitly. In 2023, the company highlighted its **\"principled and responsible use of secure consumer and merchant data\"** as a foundational element of its value-added services, including proprietary insights. This reflects a stronger commitment to transparency and ethical data practices compared to 2022, where the language focused on using consumer and merchant data without explicitly emphasizing principles or security. The 2023 language aligns with broader industry trends toward data privacy and trust, reinforcing Mastercard's role as a secure and reliable technology partner in the global payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Mastercard's language from 2022 to 2023: in 2022, the focus was on the 'principled use of consumer and merchant data,' and by 2023, it evolved to 'principled and responsible use of secure consumer and merchant data.' The LLM accurately captures the addition of 'responsible' and 'secure' as key enhancements, reflecting a stronger emphasis on data responsibility and trust. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable—however, the years 2022 and 2023 are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes the change in language across two years and correctly infers the strategic shift toward trust-building and data security. The conclusion about alignment with industry trends and Mastercard’s positioning as a reliable partner is a reasonable qualitative extension supported by the context. (4) The only minor shortcoming is that the LLM does not explicitly quote the 2022 phrasing ('principled use...') as directly as it does the 2023 phrase, though it accurately implies the difference. This slight omission in completeness prevents a perfect 10, but the core facts, reasoning, and synthesis are correct. Overall, the answer is factually accurate, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 398,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans evolved due to changes in key assumptions, particularly the discount rates and expected return on plan assets. In 2023, the U.S. pension discount rate increased to 5.4% from 3.1% in 2022, while the international rate rose to 5.4% from 4.2%. Similarly, the expected return on plan assets increased for U.S. pensions to 7.4% from 6.7%. These changes reflect a more favorable external environment, including improved economic conditions and higher interest rates, which reduced the present value of future obligations and improved the funded status of these plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The original answer states that in 2022, the key factor influencing accounting estimates was uncertainty from the ongoing impacts of the COVID-19 pandemic, and in 2023, it shifted to macroeconomic and geopolitical risks (conflicts in Ukraine and the Middle East, high interest rates, and inflation). The LLM answer instead focuses on changes in discount rates and expected returns on plan assets (e.g., U.S. pension discount rate increasing from 3.1% to 5.4%, international rate to 5.4% from 4.2%, expected return rising to 7.4% from 6.7%), which are not mentioned in the ground truth and appear fabricated or misattributed. (2) There are no quantitative figures in the original answer to verify the LLM's specific percentages; thus, the numbers provided lack support and are factually inaccurate in this context. (3) The multi-hop reasoning is flawed: the question asks about the evolution of *factors influencing accounting estimates*, specifically the external environment, but the LLM misinterprets this as a need to report numerical changes in actuarial assumptions rather than the qualitative risk drivers. It fails to identify the shift from health-related disruptions (2022) to geopolitical and macroeconomic risks (2023). (4) While the mention of 'high interest rate environment' in the LLM answer loosely overlaps with the original's reference to such conditions in 2023, it is embedded in an incorrect explanatory framework. The core of the answer—numerical changes in discount rates and expected returns—does not reflect the actual factors cited in the ground truth, indicating a fundamental misunderstanding. Hence, the correctness score is low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 481,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross thousand acres (11,977 net) in 2022 to 24,221 gross thousand acres (11,548 net) in 2023, representing a reduction of approximately 875 gross thousand acres and 429 net thousand acres. This slight decline suggests a measured approach to acreage retention, potentially reflecting the company's focus on optimizing its portfolio and prioritizing high-potential areas for exploration and development in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numeric values: gross undeveloped acreage decreased from 25,096 to 24,221 thousand acres, and net from 11,977 to 11,548 thousand acres between 2022 and 2023, matching the ground truth exactly. The calculated reductions of 875 gross and 429 net thousand acres are accurate (25,096 - 24,221 = 875; 11,977 - 11,548 = 429). 2) Quantitative accuracy is perfect—numbers, years, and units are correct, and the derived differences are precise. 3) The reasoning is sound: the answer correctly infers that the decline suggests a strategic focus on high-potential areas, aligning with the ground truth's interpretation about portfolio optimization and exploration focus. The only minor difference is that the LLM uses 'measured approach to acreage retention' and 'optimizing its portfolio' instead of mentioning possible relinquishment or transition to developed status, but the semantic meaning is closely aligned. 4) The answer fully addresses both parts of the question—quantitative evolution and its implication for exploration potential—and maintains high contextual relevance. The slight deduction in qualitative accuracy is due to less explicit mention of possible relinquishment or development transition, but the core inference remains valid. Overall, the answer is factually complete, numerically accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 380,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the treatment and financial impact of non-functional currency denominated items showed a significant reduction in the use of foreign currency contracts not designated in hedging relationships. In 2022, the gross notional amount of these contracts was $2,816 million, resulting in a pretax loss of $73 million in fair value. By 2023, the notional amount dropped to $1,023 million, with a much smaller pretax loss of only $7 million. This indicates a strategic shift or reduction in reliance on such contracts to offset currency fluctuations, likely due to changes in market conditions or risk management approaches.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, MMM used foreign exchange contracts not designated in hedging relationships with a gross notional amount of $3.7 billion, but the LLM claims $2,816 million (i.e., $2.816 billion), which is factually wrong. For 2023, the LLM states a drop to $1,023 million with a pretax loss of $7 million, but the original answer does not provide any such numbers or suggest a reduction in notional amount or losses—instead, it describes a strategic shift in the use of derivatives not designated as hedging instruments. There is no mention in the ground truth of pretax losses of $73M or $7M, nor any indication of a reduction in contract volume. (2) The numbers cited in the LLM answer ($2,816M, $1,023M, $73M, $7M) are entirely inconsistent with the ground truth ($3.7 billion in 2022, no 2023 notional amount given), and no such losses are referenced. These figures appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: the question asks about the evolution in treatment and financial impact, particularly regarding non-designated hedging contracts. The ground truth emphasizes a shift in strategy—continuing use of non-designated contracts but with a focus on derivatives whose gains/losses directly impact earnings, indicating a move away from designated hedges. The LLM instead invents a narrative of reduced notional volume and smaller losses, missing the actual qualitative shift described. (4) The contextual relevance is moderate because the LLM addresses the general topic (use of non-designated foreign currency contracts) and attempts to compare 2022 to 2023, but the factual inaccuracies and invented data severely undermine correctness. The qualitative reasoning does not align with the source, resulting in a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 509,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition evolved to become a more integral component of its broader payment solutions and services. In 2023, Mastercard highlighted these solutions as part of its value-added services designed to ensure secure, simple, and confident transactions across its global payments network. The 2023 10-K emphasizes that cyber and intelligence solutions are foundational to enabling secure transactions, reflecting a strategic shift toward strengthening security and trust in the digital payments ecosystem. This evolution aligns with Mastercard's focus on leveraging technology to enhance the safety and efficiency of its payment solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no issues here. (2) The LLM correctly identifies the evolution of Cyber and Intelligence Solutions from a supporting role in 2022 to a more prominent, foundational role in 2023. It accurately reflects that in 2022, these services were part of a broader list of value-added offerings, while in 2023 they were emphasized as critical to secure, confident transactions. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers a strategic shift in emphasis. The only minor shortcoming is that the LLM does not explicitly mention the 2022 grouping with consulting fees, loyalty programs, and gateway services, which slightly reduces completeness. However, the core message about increased prominence is preserved. (4) The answer is contextually relevant, directly addressing the evolution in role and emphasis. Wording differs slightly (e.g., 'secure, simple, and confident' vs. 'secure, easy, and confident'), but this is semantically equivalent. Overall, the answer captures the essential strategic shift accurately and clearly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 350,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in the list of critical accounting policies remained consistent between 2022 and 2023, as both years explicitly list \"income tax expense and accruals\" as one of the four critical accounting policies and estimates. In both years, the policies are described as requiring significant judgment, particularly in determining the annual tax rate and evaluating tax positions, with reserves established for potential challenges to tax return positions. No substantive changes in the approach or disclosure framework for income tax policies were noted between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in that it accurately identifies that 'income tax expense and accruals' was listed as a critical accounting policy in both 2022 and 2023, and correctly notes the use of judgment in tax rate determination and reserve establishment. However, it fails to capture the key evolution highlighted in the ground truth: in 2023, the treatment became more structured with the inclusion of specific references to disclosures such as 'Note 5 - Income Taxes,' indicating enhanced transparency and reorganization under the critical accounting policies section. The LLM incorrectly states there were 'no substantive changes,' which contradicts the ground truth's assertion of a shift toward more detailed and organized reporting. While entities (policy name, years) and general context are accurate, the model misses the multi-hop nuance of how the disclosure format and depth evolved, leading to a significant gap in qualitative accuracy. There are no numerical inaccuracies, hence perfect quantitative score, and the response remains contextually relevant to the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 311,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a core component of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability to enable communication between chips in a system. By 2024, the company emphasized UCIe as part of its broader Open System Foundry offering, integrating it with advanced packaging technologies and ecosystem partnerships to optimize systems of chips for high-growth applications like AI. This evolution reflects Intel's focus on driving industry standards and providing end-to-end solutions to support the shift from monolithic chips to modular, high-performance systems of chips.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel introduced and demonstrated UCIe in silicon in 2023 and advanced to production and integration within broader offerings by 2024. The mention of 'Open System Foundry' in 2024 is consistent with Intel's advanced semiconductor assembly and test strategy, even if not explicitly named in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—correctly linking UCIe’s evolution from demonstration to production and embedding it within Intel’s broader systems of chips strategy, including advanced packaging and ecosystem collaboration. (4) The LLM adds contextual detail (e.g., AI applications, Open System Foundry) that enriches the answer without introducing inaccuracies, demonstrating strong qualitative understanding. The only minor gap is that the original emphasizes 'producing based on this standard' more directly, while the LLM focuses on ecosystem integration—slightly different emphasis but semantically aligned. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 338,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment of CVS's Accelerated Share Repurchase (ASR) transactions remained consistent, with the initial delivery of shares treated as a treasury stock transaction and the remaining shares accounted for as a forward contract classified as an equity instrument. However, the completion timelines of the ASR transactions evolved. In 2023, the ASR with Citibank and Barclays were completed within 1–2 months (e.g., shares received in February 2023 for the January 2023 ASR). In 2024, the ASR with Morgan Stanley took slightly longer, with the remaining shares received in March 2024 for the January 2024 ASR, indicating a marginal extension in the settlement period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the accounting treatment remained consistent between 2023 and 2024, with initial shares treated as treasury stock and the forward contract portion classified in equity, which aligns with the ground truth. It also correctly notes the timeline evolution, stating that the 2024 ASR took longer to complete (into March 2024) compared to the 2023 transaction (completed in February 2023). However, there are key quantitative inaccuracies: the LLM incorrectly states that CVS conducted ASRs with 'Citibank and Barclays' in 2023, while the ground truth specifies only Citibank; no mention of Barclays exists in the original. Additionally, the LLM omits all specific numerical details: the $2.0B and $3.0B notional amounts, the 17.4M and 31.4M initial shares (80% and 85%), and the 5.4M and 8.3M final share deliveries. These omissions significantly impact quantitative accuracy. (2) The dates are partially correct—February 2023 and March 2024 for final settlements are accurate—but the LLM incorrectly implies the 2023 ASR was in January 2023 without specifying the start date in the original answer. The dollar amounts and share counts, critical to the question, are entirely missing. (3) The multi-hop reasoning is sound in comparing the two years’ accounting treatment and settlement duration, showing synthesis across filings. However, the failure to retrieve and report key financial figures and counterparties (Barclays not mentioned in ground truth) weakens the factual foundation. (4) Despite missing hard numbers, the answer captures the core qualitative trend—consistent accounting, slightly longer timeline in 2024—and remains relevant to the question’s intent, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 477,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund evolved with updated actuarial estimates and sensitivity analysis. In 2022, UPS recorded a $10.1 billion pre-tax actuarial loss, with $2.3 billion attributed to coordinating benefits from the Central States Pension Fund. By 2023, the sensitivity analysis showed that a 25 basis point change in the discount rate would significantly impact obligations and expenses, with a $1,550 million decrease or $1,636 million increase in projected pension obligations. Additionally, the return on assets sensitivity showed a $108 million impact on ongoing net periodic benefit costs. These updates reflect a more detailed and dynamic approach to assessing and reporting financial exposure related to the fund.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key financial figures. While it correctly identifies the $2.3 billion pre-tax actuarial loss related to coordinating benefits for the Central States Pension Fund in 2022 (matching the ground truth), it incorrectly states that UPS recorded a $10.1 billion total loss, which is not supported by the original answer and introduces false information. This undermines quantitative accuracy. In 2023, the LLM claims a sensitivity analysis based on a 25 basis point change in the discount rate affecting obligations by $1,550M–$1,636M and return on assets impacting costs by $108M. However, the ground truth states that the 2023 sensitivity analysis focused on a 25 basis point change in *expected and actual returns on assets*, not the discount rate, and does not provide specific dollar impacts like $108M or $1.5–1.6B. These numbers are fabricated or misattributed, indicating major quantitative errors. (2) The only correct number is the $2.3 billion for coordinating benefits in 2022. All other figures ($10.1B, $1,550M, $1,636M, $108M) are either incorrect or not mentioned in the ground truth. The shift in focus from specific obligation quantification to sensitivity analysis is conceptually correct, but the details are misrepresented. (3) The multi-hop reasoning is partially sound—the model recognizes a shift in reporting approach from 2022 to 2023 and attempts to contrast actuarial estimates with sensitivity analysis. However, it misidentifies the key assumption in 2023 (discount rate vs. return on assets) and invents numerical impacts not present in the source, failing to accurately synthesize the correct information. (4) Contextual relevance is high because the answer addresses the evolution of financial exposure and reporting, mentions actuarial estimates and sensitivity analysis, and references the correct fund and time frame. However, due to severe quantitative inaccuracies and misrepresentation of the sensitivity analysis, the correctness score is low despite some structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 568,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard emphasized its Cyber and Intelligence Solutions as a critical component of its value proposition, highlighting their role in enabling secure, confident, and data-driven transactions across its global payments ecosystem. In 2022, the focus was on leveraging these solutions to allow parties to transact \"easily and with confidence,\" while in 2023, the emphasis evolved to include more strategic positioning, such as using these capabilities to provide \"proprietary insights\" and support innovations like open banking and digital identity. This evolution reflects a stronger alignment with broader digital transformation goals and a more proactive role in securing and enhancing the payments ecosystem for stakeholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 emphasis on enabling parties to transact 'easily and with confidence' is accurately reflected, and the 2023 evolution—positioning Cyber and Intelligence Solutions as supporting 'proprietary insights' and strategic initiatives like open banking and digital identity—is consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how Mastercard's messaging evolved across two years, identifying both continuity and expansion in the value proposition. (4) The LLM adds slight rewording (e.g., 'data-driven transactions', 'proactive role') that are semantically consistent and enhance clarity without distorting meaning. The only minor gap is that the original answer explicitly mentions 'principled use of consumer and merchant data' in 2022 and 'integration into overall infrastructure narrative' in 2023—nuances not fully captured in the LLM response. However, the core evolution in positioning and strategic integration is correctly conveyed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 360,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 is referenced as Exhibit 4.12, incorporated by reference to PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note is referenced as Exhibit 4.14, incorporated by reference to the same Form 8-K filing date. Thus, the exhibit number changed from 4.12 to 4.14, but the referenced documentation date remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the exhibit number and Form 8-K date from the 2022 filing (Exhibit 4.12, October 14, 2015), which matches the ground truth. However, it incorrectly states that in the 2023 filing the note was referenced as Exhibit 4.14, while the ground truth specifies Exhibit 4.13. Additionally, the LLM claims the 2023 filing references the same October 14, 2015 Form 8-K, but the ground truth shows a different Form 8-K date—February 24, 2016—indicating a change in both exhibit number and source document. These errors affect factual accuracy. (2) The exhibit numbers (4.12 vs 4.14) and Form 8-K dates (October 14, 2015 vs February 24, 2016) are quantitatively incorrect in the 2023 context. The LLM fails to detect the updated documentation date, which is a key part of the evolution in presentation. (3) The multi-hop reasoning is partially sound—the model recognizes that exhibit numbering and referencing are relevant to tracking disclosure changes over time—but it fails to correctly synthesize the actual changes across the two filings. The conclusion that the referenced documentation date remained unchanged is factually wrong, undermining the reasoning. (4) Despite these errors, the answer is contextually relevant, addressing exhibit referencing and documentation dates as asked. The structure and intent align with the question, but significant factual inaccuracies reduce correctness. Hence, scores reflect partial accuracy with major errors in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 416,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel's engagement with Positive Technologies (Pozitiv Teknolodzhiz, AO) has continued between 2023 and 2024 under OFAC licensing following U.S. sanctions. Prior to the designation of Positive Technologies as a sanctioned entity in April 2021, Intel had communication regarding IT security research and vulnerability disclosures. After obtaining a license from OFAC, Intel resumed these communications in compliance with the terms of the license, with no direct revenues or profits associated with these activities. The company plans to continue these communications in accordance with the OFAC license.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Intel had prior communications with Positive Technologies on IT security research and vulnerability disclosures, resumed these under an OFAC license after sanctions (imposed in April 2021, not 2023/2024, which the model correctly references), and continues engagement under that license with no associated revenues or profits. The answer captures the key point that there are no financial gains from the relationship. It also correctly notes Intel's intent to continue communications under the license, reflecting the forward-looking posture mentioned in the 2024 filing. The only minor shortcoming is that it does not explicitly contrast the evolution from 2023 (disclosure of past communication) to 2024 (intent to sustain future engagement), which is a nuanced but important aspect of the relationship's evolution. However, the core facts, entities, timeline, and regulatory context are all correct. No numerical inaccuracies are present—dates and financial assertions match the ground truth. The reasoning is sound and synthesizes the multi-hop elements (sanctions, licensing, resumption of communication, financial impact, forward intent). Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate with only a slight omission in emphasizing the evolution in tone/posture between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 395,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as shown in the borrowings summary on pages 168 (2023) and 161 (2024). This consistency indicates that the notes were not refinanced, redeemed, or significantly altered during the period, reflecting stability in this portion of the company's long-term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million in both 2023 and 2024, which matches the ground truth exactly. The dollar amount, interest rate, maturity date, and years are all accurate. (2) All numeric values are correct—$5,000 million is consistently reported for both years, and no erroneous calculations are present. The LLM accurately reflects stability in this debt instrument. (3) The reasoning is sound: the stability indicates no retirement or issuance, which aligns with the ground truth's interpretation. However, the LLM answer omits the comparative context provided in the original answer—specifically, the contrast with the 2.7% senior notes due August 2040, which decreased significantly. This comparative insight supports a more complete analysis of CVS's selective debt management strategy, and its absence represents a minor but notable gap in completeness. (4) Despite this omission, the LLM answer is factually correct, contextually appropriate, and synthesizes the correct information from the relevant filings (citing specific pages adds credibility). The missing comparison reduces qualitative completeness slightly, but core multi-hop reasoning (tracking a specific debt instrument over time and interpreting stability) is correctly executed. Hence, a score of 9 is justified—excellent accuracy with minor room for deeper contextual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 403,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 have remained consistently listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings for Exxon Mobil Corporation, with the trading symbol XOM32 on the New York Stock Exchange. There is no indication of any material changes in the status of these notes between the two filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that the 0.835% Notes due 2032 remained listed with the trading symbol XOM32 in both the 2022 and 2024 filings, and that there was no material change in their status. All quantitative details (interest rate: 0.835%, maturity year: 2032, symbol: XOM32) are accurate, earning a perfect score for quantitative accuracy. However, the LLM answer is incomplete in scope compared to the original ground truth. While it correctly notes consistency in the status of the 2032 notes, it omits the key contextual evolution: the removal of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, which helps explain the broader shift in Exxon Mobil’s debt composition. This omission limits the depth of the multi-hop reasoning—comparing changes across multiple debt instruments over time—which the original answer synthesizes to provide a more complete picture of how the 2032 notes fit into a changing debt structure. Thus, while the direct answer about the 2032 notes is correct, the lack of comparative context reduces qualitative accuracy. The response remains highly relevant and factually sound, hence a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 328,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express's investment strategy toward U.S. Government treasury obligations between 2022 and 2024 shows a significant reduction in fair value allocation, dropping from $1,704 million in 2022 to $287 million in 2024. In terms of maturity distribution, the 2024 data indicates that the majority of these obligations were due within one year ($189 million), with no amounts due after five years, suggesting a shift toward shorter-term maturities compared to 2022, where no specific maturity breakdown was provided.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, American Express held $477 million in short-term U.S. Treasury obligations in 2022, not $1,704 million as stated in the LLM response. The 2024 fair value is reported as $287 million in the LLM answer, but the correct total is $287 million ($189M short-term + $98M intermediate-term), which matches only if correctly broken down—however, the LLM fails to mention intermediate-term holdings at all. The claim of a drop from $1,704M to $287M is entirely incorrect and unsupported by data. (2) The ground truth explicitly states that in 2022, all holdings were short-term with no long-term exposure, contradicting the LLM’s claim that 'no specific maturity breakdown was provided.' In fact, the maturity distribution is fully specified in the original answer. Additionally, the LLM incorrectly frames the 2024 shift as toward 'shorter-term maturities,' when in reality the shift was toward *longer* maturities (adding 1–5 year intermediate-term instruments), representing a diversification beyond exclusively short-term holdings. (3) The multi-hop reasoning is flawed: the model fails to recognize that the evolution involves an expansion in maturity profile, not a contraction or shortening. It also does not correctly synthesize the change from exclusive short-term in 2022 to a mixed short- and intermediate-term portfolio in 2024. (4) Despite incorrect numbers and reversed interpretation of strategic direction, the answer is contextually relevant—it addresses investment strategy, fair value, and maturity distribution over the correct time frame. However, due to severe quantitative and qualitative errors, especially the fabricated 2022 value and mischaracterization of the strategy shift, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 494,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 on June 3, 2020, as part of its debt offerings (AMZN_10k_2024.pdf, page 75). Between 2022 and 2024, there is no indication of any material changes to the terms or treatment of this note in the provided documents, suggesting it remained a long-term liability on Amazon's balance sheet throughout this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the introduction date of the 2.500% Note due 2050 as June 3, 2020, which matches the ground truth. It also accurately states that there were no material changes between 2022 and 2024, aligning with the original answer's assertion that the note was reintroduced without modification. However, the LLM omits key details about the document evolution—specifically, that the note was listed in Exhibit 4.5 in 2020 and then reintroduced in Exhibit 4.6 in 2024 as an exact replication. This missing detail weakens the completeness and qualitative accuracy, as it fails to capture the multi-hop synthesis of how the note was formally maintained through specific exhibits across filings. (2) Quantitatively, all dates and percentages (2.500%, June 3, 2020) are correct, and no calculations are required. (3) The reasoning is sound in concluding no material changes occurred, but it lacks the deeper document-level synthesis—Exhibit 4.5 to Exhibit 4.6—required for full qualitative accuracy. (4) The answer is contextually relevant and factually consistent, but the omission of exhibit-level documentation reduces completeness, warranting a score of 7 for correctness and qualitative accuracy despite strong quantitative and relevance scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 357,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from 8 amendments (as of 2022) to 12 amendments (as of 2023), based on the exhibits listed in the document pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. (1) It accurately states that the number of amendments increased from 8 in 2022 to 12 in 2023, correctly reflecting the Eighth Amendment in 2022 and the Twelfth Amendment in 2023. (2) The quantitative accuracy is perfect: the count of amendments (8 and 12) and the implied four additional amendments are correct. Dates (March 10, 2022, and October 11, 2023) are not mentioned in the LLM answer, which is a minor omission but does not detract from the core numerical and comparative accuracy. (3) The reasoning is sound—inferring an increase from 8 to 12 amendments demonstrates correct multi-hop synthesis across years and amendment numbers. (4) While the LLM answer is more concise and omits the specific dates and descriptive context about 'continued evolution,' it still captures the key evolution in amendment count. Semantic equivalence is maintained. The answer is fully relevant and directly addresses the question. A score of 9 is given because the answer, while correct, lacks the full contextual detail (specific dates and qualitative interpretation) present in the ground truth, but this does not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 344,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved to integrate more deeply with new computing architectures and software ecosystems. In 2022, CUDA was already central to NVIDIA's accelerated computing platform, supporting AI, HPC, and graphics applications. By 2024, CUDA's role expanded with the launch of the Blackwell architecture, which introduced neural graphics and enhanced AI capabilities, enabling a new era of graphics innovation and performance improvements. Additionally, CUDA's integration with NVIDIA's broader ecosystem, including the RTX platform and Omniverse, has strengthened, supporting advanced AI-driven workflows and virtual simulation environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of CUDA's role in NVIDIA's ecosystem between 2022 and 2024 and correctly identifies its deepening integration with computing architectures and software platforms. It accurately reflects that CUDA remained central in 2022 to accelerated computing across AI, HPC, and graphics. However, it introduces inaccuracies by citing the 'Blackwell architecture' and 'neural graphics' as key developments by 2024, which are not mentioned or supported in the ground truth. The original answer emphasizes CUDA's expansion into a full-stack platform with CUDA-X libraries, APIs, SDKs, and domain-specific frameworks, as well as integration with NVIDIA's new CPU-based data center platform (introduced in fiscal 2024). The LLM answer omits these critical multi-hop elements—especially the strategic shift toward heterogeneous computing with CPUs and DPUs—and instead focuses on RTX and Omniverse, which, while relevant, are not highlighted in the ground truth. There are no numerical values to verify, so quantitative accuracy is scored as 10. Contextual relevance is high because the response addresses the evolution of CUDA in broad terms, but qualitative accuracy is reduced due to incorrect architectural references and failure to capture the full-stack, heterogeneous computing narrative. The core idea of deeper integration is correct, but key factual and strategic details from the ground truth are missing or replaced with unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 406,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid evolved significantly in terms of revenue recognition and contractual obligations. In 2023, Paxlovid generated $1,279 million in revenue, but this was heavily impacted by a $3.5 billion non-cash revenue reversal in the fourth quarter due to the expected return of EUA-labeled U.S. government inventory. By 2024, revenue from Paxlovid increased to $5,716 million, partly due to a $771 million favorable adjustment in Q1 2024 reflecting fewer returned treatment courses than estimated, and $442 million in revenue from supplying a U.S. Strategic National Stockpile (SNS) of 1.0 million treatment courses. Additionally, deferred revenues for Paxlovid and Comirnaty decreased from $5.1 billion in 2023 to $2.2 billion in 2024, as revenue was recognized upon product delivery and contract adjustments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported 2024 revenue figure of $5,716 million, which is not supported by the ground truth. The original answer does not state total 2024 Paxlovid revenue, only adjustments ($771M favorable reversal and $442M from SNS). The LLM incorrectly implies total revenue increased to $5.7B, which is a major quantitative error. Additionally, the ground truth does not mention deferred revenues for Paxlovid and Comirnaty decreasing from $5.1B to $2.2B, nor does it provide total Paxlovid revenue for 2024—this data is fabricated or misattributed. (2) While the $1.279 billion 2023 revenue, $3.5 billion non-cash reversal, $771 million favorable adjustment, and $442 million SNS revenue are correctly cited, the synthesis into a total 2024 revenue figure is unsupported and incorrect. The actual evolution focuses on adjustments and remaining obligations, not a surge in total revenue. (3) The multi-hop reasoning is partially sound—linking the 2023 reversal to the 2024 adjustment and SNS creation shows understanding of revenue recognition dynamics. However, the model fails to report the key metric of $1 billion in remaining performance obligations as of December 31, 2024, which is central to contractual obligations. Instead, it introduces unrelated deferred revenue data, breaking the chain of accurate synthesis. (4) Scores reflect major quantitative inaccuracies (especially the invented $5.7B revenue) and omission of key contractual obligation data, though the answer correctly identifies some financial events and maintains relevance to the question's theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 452,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47 million shares available by the end of 2024. The structure of the program remained consistent, with a maximum of 220 million shares authorized and awards including restricted stock and stock appreciation rights. The reduction in available shares reflects the issuance of awards over this period, including those related to the Pioneer acquisition in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that 65,754,069 shares were available in 2022 and 47 million remained available by the end of 2024, it incorrectly frames this as a 'decrease' due to usage, when in fact the total authorized capacity was expanded from the original level to 220 million shares in 2024. The ground truth indicates a net increase in program size, not a reduction in availability. The LLM also introduces the 'Pioneer acquisition in 2024' as a reason for share issuance, which is not mentioned in the original answer and appears to be fabricated or inferred incorrectly. (2) Quantitatively, the numbers themselves (65,754,069, 47 million, 220 million) are accurate and properly formatted, and the restricted stock unit figures (9,392 thousand in 2022 to 10,393 thousand in 2024) are missing from the LLM answer, representing a significant omission. The LLM fails to mention the increase in total maximum shares from ~65.8M to 220M, which is a core part of the evolution. (3) The multi-hop reasoning is flawed: the model fails to synthesize that the program was expanded significantly in capacity even as available shares declined, indicating both growth in scale and ongoing usage. Instead, it presents a misleading narrative of simple depletion. The structure mention (restricted stock, SARs) is consistent but lacks detail on the actual evolution. (4) Contextual relevance is high—the answer addresses share availability and program structure—but the incorrect causal explanation and missing data on RSU growth reduce its accuracy. The answer gives a partially correct picture but misrepresents the overall trend of expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 465,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense's role within Google's advertising revenue streams has seen a relative decline, as evidenced by the decrease in Google Network revenues in 2024 compared to 2023. Specifically, Google Network revenues, which include AdSense, fell by $953 million from $31.3 billion in 2023 to $30.4 billion in 2024, primarily due to declines in Google Ad Manager and AdMob revenues. This contrasts with the growth in Google Search & other and YouTube ads, which benefited from increased advertiser spending and improvements in ad delivery. Within Google's broader advertising technology portfolio, the focus has shifted toward AI-driven solutions like Performance Max and Demand Gen, which leverage Google's advancements in AI to optimize ad performance. This evolution reflects a strategic emphasis on performance advertising and AI-powered tools, which have driven growth in core advertising segments, while AdSense's contribution has become relatively smaller and more challenged by factors such as changes in foreign currency exchange rates and shifts in advertiser behavior.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies the strategic shift toward AI-powered tools like Performance Max and Demand Gen as central to Google's advertising growth, it introduces quantitative claims not present in the ground truth. Specifically, the ground truth does not mention Google Network revenue decreasing from $31.3B to $30.4B in 2024, nor does it state a $953M decline. These figures are factually unsupported by the provided knowledge graph and represent a significant deviation. Additionally, the ground truth highlights AdSense's role in an $8.6B year-over-year increase in 2022, which the LLM answer omits entirely. (2) The quantitative inaccuracies are critical: the LLM fabricates specific revenue figures and a year-over-year decline without grounding in the source data. While the direction of change (relative decline in emphasis) is conceptually aligned, the specific numbers are incorrect. The ground truth does not provide absolute revenue values for 2023 or 2024, nor does it confirm a decline—only that AdSense was no longer highlighted as a growth lever. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from AdSense to AI-driven products based on changing emphasis in reporting, which aligns with the ground truth’s narrative of AdSense becoming a more mature, foundational offering. However, it incorrectly attributes revenue declines to AdSense and related products without evidence, and fails to mention AdSense’s positive contribution in 2022. (4) The contextual relevance is high—the answer addresses the evolution of AdSense’s role and ties it to broader portfolio trends. The qualitative reasoning about AI-driven tools gaining prominence is accurate and well-articulated. However, the inclusion of unsupported numerical data significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is penalized more heavily (5/10) due to the invention of precise but unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 560,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan ceased accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. This change marked a shift from the previous structure, where such participants could accrue benefits based on average compensation earned prior to retirement. Moving forward, non-union participants no longer earn new benefits under the UPS Retirement Plan, effectively freezing future benefit accruals for them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth on all key points. It accurately states that the UPS Retirement Plan ceased benefit accruals for non-union participants effective January 1, 2023, which matches the date specified in the original answer. The description of the prior structure—where non-union participants accrued benefits based on average compensation—is consistent with the 2022 plan description. The LLM correctly captures the core change: a freeze on future service and compensation-based accruals for non-union employees. However, the LLM answer omits some contextual details present in the ground truth, such as the plan’s noncontributory nature, eligibility cutoff (employees hired before July 1, 2016), and the fact that the freeze was pre-announced in 2022 and confirmed in 2023. While these omissions reduce completeness slightly, they do not detract from the central factual accuracy of the change. All entities (UPS Retirement Plan, non-union participants), dates (January 1, 2023), and plan modifications are correctly identified. The reasoning is sound and reflects proper synthesis of the evolution between years. The answer is semantically equivalent in conveying the key change, though less detailed than the original. Quantitative accuracy is perfect—no numerical errors or incorrect dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 372,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Amazon's short-term credit facilities evolved between 2022 and 2024 in several key ways. In 2022, the company had a $7.0 billion unsecured revolving credit facility with a term extending to June 2023, with an interest rate of 0.50% above the benchmark rate and a commitment fee of 0.04%. By 2024, this was replaced by a $15.0 billion unsecured revolving credit facility with a term extending to November 2028, with an interest rate of 0.45% above the benchmark rate and a commitment fee of 0.03%. Additionally, in October 2024, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility, replacing the prior 364-day agreement from November 2023. The interest rate for this new facility was 0.45% above the Secured Overnight Financing Rate with a commitment fee of 0.03%. Outstanding borrowings under these short-term credit facilities remained minimal, with no borrowings under the $15.0 billion and $5.0 billion facilities as of December 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key numbers are correct: $7.0 billion (2022), $15.0 billion (2024), $5.0 billion (364-day facility), interest rates (0.50% to 0.45%), commitment fees (0.04% to 0.03%), and SOFR plus 0.45%. The statement that no borrowings were outstanding under the main facilities as of December 31, 2024, is accurate. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates align with the original answer. The LLM correctly notes the October 2024 timing of the new 364-day facility. (3) The multi-hop reasoning is sound—comparing 2022 and 2024 credit structures, identifying expansions, rate reductions, and facility replacements. However, the LLM omits mention of the $147 million and $151 million in borrowings under other short-term facilities (included in 'Accrued expenses and other') for 2023 and 2024, which is a minor but notable omission affecting completeness. It also omits the increase in unused letters of credit from $7.2 billion (end of 2021) to $8.3 billion (end of 2024), which was part of the evolution in credit utilization. (4) Despite these omissions, the core structure, capacity, rates, and lack of drawdowns on the main facilities are correctly conveyed, and the answer remains contextually focused and highly relevant. The omission prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 388,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Between 2022 and 2023, Costco has maintained a consistent approach to managing commodity price risk by using a mix of fixed-price and variable-priced contracts for energy purchases, particularly for electricity and natural gas. The 2023 filing reiterates the company's use of variable-priced contracts for some purchases, including fuel for gas stations, on an index basis, similar to the 2022 disclosure. This strategy indicates that Costco seeks to partially mitigate price volatility through fixed-price contracts while retaining some flexibility with variable-priced contracts, which aligns with its broader risk management approach of balancing cost predictability and market responsiveness.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately reflects that Costco used variable-priced contracts for energy purchases in both 2022 and 2023, specifically mentioning electricity, natural gas, and fuel for gas stations on an index basis—consistent with the original answer. The years and entities (Costco, energy types) are correct. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of time periods (2022–2023), which are accurate. (3) The reasoning is sound: the LLM correctly infers that the strategy remained consistent year-over-year. However, it introduces the idea of a 'mix of fixed-price and variable-priced contracts' and states that the company 'seeks to partially mitigate price volatility'—a plausible interpretation but not explicitly supported in the ground truth, which makes no mention of fixed-price contracts or a dual strategy. This addition slightly distorts the focus, which in the original answer emphasizes continuity in reliance on variable-priced contracts without indicating a balancing strategy. (4) Despite this minor overinterpretation, the core facts, multi-hop synthesis across years, and conclusion about stable risk management are correct. The answer is highly relevant and factually accurate on key points, warranting a high score but not perfect due to the unsupported inference about fixed-price contracts and strategic balance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 411,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "NVIDIA AI Enterprise has evolved from being a complementary software offering within the data center segment in 2022 to a more central and comprehensive component of NVIDIA's data center strategy by 2024. In 2022, it was positioned as a suite of enterprise-grade AI software alongside vGPU, while by 2024, it was highlighted as a key element of NVIDIA's full-stack AI platform, integrated with tools like NVIDIA NIM, NeMo, and AI Blueprints to support generative AI development and deployment. This reflects a strategic shift toward emphasizing AI software solutions as a core differentiator in the data center market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA AI Enterprise evolved from a foundational software offering in 2022 to a central component of the data center strategy by 2024. The positioning shift from strategic initiative to commercial product is correctly captured, though the LLM does not explicitly mention 'monetization vehicle' or 'Compute & Networking segment' as in the original, but conveys the equivalent idea through 'central and comprehensive component' and 'core differentiator'. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across time (2022 to 2024), identifies the product's changing role, and integrates context about full-stack AI platform expansion, including specific tools like NIM, NeMo, and AI Blueprints, which are consistent with NVIDIA's 2024 direction. (4) Semantic equivalence is strong—while the LLM adds specific software tools not mentioned in the original (NIM, NeMo, AI Blueprints), these are factually aligned with NVIDIA’s 2024 enterprise AI strategy and enhance, rather than distort, the explanation. The only minor omission is the explicit reference to integration with DGX Cloud and expansion into CPUs/DPUs, which slightly reduces completeness but does not undermine the core accuracy. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 439,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer's contractual obligations related to Paxlovid significantly decreased between 2023 and 2024. In 2023, deferred revenues for Paxlovid totaled $5.1 billion, while in 2024, this amount dropped to $2.2 billion. This decline was primarily due to the recognition of $2.9 billion in revenue from prior deferred balances and the favorable adjustment of $771 million in Q1 2024 from returned EUA-labeled treatment courses. The reduction in deferred revenues indicates a shift from government contracts to commercial market sales, as highlighted by the amended agreement with the U.S. government in late 2023. This transition, along with the minimal deferred revenue balance remaining, suggests that future revenue expectations for Paxlovid are likely to be lower compared to the high levels seen in 2022 and 2023, as the product moves toward a more traditional commercial sales model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million treatment courses under EUA, but the LLM claims $5.1 billion in deferred revenues in 2023 and a drop to $2.2 billion in 2024—figures not present in the original answer. The $2.9 billion revenue recognition and $771 million favorable adjustment in Q1 2024 are also not mentioned in the ground truth. These numbers are either fabricated or misattributed. (2) The calculation of a $2.9 billion difference between $5.1B and $2.2B is mathematically correct, but since the base figures are incorrect, the entire quantitative framework is invalid. The ground truth reports a $3.5B reversal in 2023 and $1B in remaining performance obligations as of December 31, 2024—data entirely missing from the LLM response. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that declining deferred revenue indicates lower future expectations and a shift to commercial sales, while the ground truth emphasizes that the $1B in remaining obligations signals stabilization and improved demand forecasting after prior uncertainty. The LLM misinterprets the trend and its implications. (4) While the answer addresses the general theme of contractual evolution and revenue expectations, it does so with incorrect data and opposite conclusions. The contextual relevance is moderate because it discusses the right topic (Paxlovid obligations and revenue outlook), but the factual foundation is unsound, leading to a misleading interpretation. The conclusion contradicts the ground truth: instead of indicating stabilization, the LLM suggests declining future expectations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 481,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on evolving foreign policy landscapes, data privacy regulations (e.g., GDPR and CCPA), and potential litigation risks due to geopolitical tensions and new customer requirements. By 2024, the regulatory challenges expanded to include more specific and stringent laws, such as the EU's Digital Markets Act and Data Act, as well as increased scrutiny of AI technologies and their data usage. Additionally, the 2024 disclosures emphasized the impact of geopolitical conflicts (e.g., in the Middle East and Ukraine) on business continuity and regulatory compliance, highlighting a broader and more complex regulatory environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges from the ground truth in key qualitative aspects. (1) Correct elements: The answer correctly identifies an evolution in Google's regulatory exposure between 2022 and 2024, noting broader challenges over time and referencing geopolitical tensions and data privacy. The timeframes (2022 vs 2024) are accurate, and there are no numeric inaccuracies (quantitative accuracy is high). (2) However, the specific regulatory developments cited—such as the EU's Digital Markets Act, Data Act, and AI scrutiny—are not mentioned in the original ground truth answer derived from the knowledge graph. While these may be real-world developments, they were not part of the documented disclosures in the filings used to generate the ground truth. (3) The multi-hop reasoning is partially sound: the LLM infers expansion in regulatory scope, which aligns with the ground truth, but it substitutes specific examples not present in the source material (e.g., GDPR, CCPA, DMA) instead of accurately reflecting the actual cited concerns like data transfers between the EU and UK, uncertainty in regulatory outcomes, and lack of due process in local laws. (4) The ground truth emphasizes a shift from data transfer issues in 2022 to broader systemic legal risks (e.g., unclear legal precedent) in 2024—nuances missing in the LLM response. Thus, while the general direction of evolution is correct, the specific nature and scope of challenges are inaccurately represented, leading to a moderate correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 434,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits remained consistent in terms of sources for expected benefit payments. For both years, expected benefit payments for postretirement medical benefits were to be funded from plan trusts and corporate assets. However, the 2023 disclosures emphasize that expected benefit payments will continue to be paid from these same sources, with no indication of a shift in strategy or funding mix compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately states that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments funded from both plan trusts and corporate assets in both years. (2) There are no numerical values requiring calculation, but the temporal references (2022 and 2023) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound—comparing disclosures across two years to assess evolution in funding approach—and correctly concludes there was no change. (4) The answer is contextually relevant, directly addressing the question about evolution in funding sources and synthesizing information appropriately across the two years. Minor elaboration in the LLM answer (e.g., 'no indication of a shift in strategy') adds clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 266,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as part of NVIDIA's Compute & Networking segment, has evolved significantly by 2024 to become a more comprehensive and integrated solution. Initially focused on providing a suite of software tools for AI development and deployment, by 2024 it includes advanced components such as NVIDIA NIM for improved token throughput, NVIDIA NeMo for model curation and safeguarding, and AI Blueprints for pre-built templates. This evolution reflects NVIDIA's strategy to offer a complete, end-to-end platform for generative AI applications, supported by a growing ecosystem of developers and partners, and integrated with cloud and on-premises infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 under the Compute & Networking segment as a software suite for AI deployment, and by 2024 evolved into a full-stack generative AI platform. The inclusion of NVIDIA NIM, NVIDIA NeMo, and AI Blueprints is accurately stated. (2) Quantitative accuracy is perfect: while the LLM does not explicitly mention the '2.5x increase in token throughput' from the ground truth, it correctly references 'improved token throughput' in connection with NIM, which is semantically consistent and does not misstate any numbers. No incorrect figures or dates are presented. (3) The multi-hop reasoning is sound—information is correctly synthesized across time (2022 to 2024) and scope (from initial release to expanded integration), capturing the evolution in functionality and strategic positioning. (4) The answer is contextually relevant and fully addresses the question about the evolution in role and scope. The only minor omission is the lack of explicit mention of the 2.5x performance improvement, which slightly affects completeness but not overall correctness. Wording differs but meaning is equivalent. Thus, a high score is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 355,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased significantly, with oil-equivalent total all products rising from 1,481 million barrels in 2022 to 1,481 million barrels in 2024, while the undeveloped equity company reserves grew from 1,512 million barrels in 2022 to 1,512 million barrels in 2024. This indicates a strategic focus on maintaining and expanding reserves in equity partnerships, particularly in Asia and Africa, suggesting a long-term commitment to these regions for resource development and operational growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative data. The ground truth states that in 2022, ExxonMobil's total proved reserves from equity companies were 14 million barrels gross (1 million net), but the LLM claims 1,481 million barrels for both 2022 and 2024, which is over 100 times higher and completely inaccurate. Furthermore, the LLM reports no change in reserves (same number in both years), contradicting the ground truth which shows a massive increase by 2024 to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas. The LLM also introduces 'undeveloped equity company reserves' at 1,512 million barrels in both years, which is not mentioned in the original answer and appears fabricated. (2) Calculations and comparisons are entirely flawed—there is no numerical evolution presented, and the values themselves are factually wrong. (3) The reasoning is partially sound in identifying a strategic focus on equity partnerships and highlighting Asia and Africa, which aligns with the ground truth's emphasis on Asia. However, the conclusion is not supported by accurate data, and the multi-hop synthesis fails because the model does not correctly retrieve or represent the actual reserve figures across years and regions. (4) The contextual relevance is moderate because the answer addresses the general theme of strategic positioning through equity reserves and regional focus, but the severe factual and numerical inaccuracies drastically reduce its correctness. Thus, the correctness score is low at 2, quantitative accuracy is 1 due to gross numerical errors, qualitative accuracy is 3 for partial reasoning, and contextual relevance is 6 for staying on-topic despite inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 485,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners between 2022 and 2024 shows that they continued to play a significant role in revenue generation, primarily through advertising on Google Network properties. In 2024, the Total Acquisition Cost (TAC) paid to partners increased by $4.0 billion compared to 2023, driven by growth in revenues subject to TAC. However, the TAC rate decreased slightly from 21.4% to 20.7% due to a revenue mix shift from Google Network properties to Google Search & other properties, which carry higher TAC rates, particularly for mobile searches. This indicates that while the cost structure increased due to higher TAC payments, the cost efficiency (as a percentage of revenue) improved slightly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—$4.0 billion TAC increase from 2023 to 2024, TAC rate dropping from 21.4% to 20.7%—that are not present in the original answer (ground truth) and cannot be verified from the provided context. These numbers appear fabricated or sourced from external data not referenced in the ground truth. The original answer does not mention TAC, specific percentages, or year-over-year comparisons involving 2023 or 2024 dollar amounts. (2) There is a complete mismatch in quantitative accuracy: no dollar figures, percentages, or TAC metrics are mentioned in the ground truth for 2022–2024, so the LLM’s detailed financials fail verification. The original focuses on accounting treatment and reporting emphasis, not cost rates or efficiency. (3) The multi-hop reasoning is flawed—the LLM interprets the relationship through cost efficiency and revenue mix shifts, which is a plausible financial lens but not supported by the ground truth. The original answer emphasizes a shift in financial reporting framing: from gross revenue reporting with partner payments as cost of revenue (2022) to highlighting partner payments as a major use of operating cash flow (2024). This conceptual evolution in disclosure and emphasis is missed entirely by the LLM. (4) While the LLM correctly identifies Google Network Partners’ ongoing role in revenue generation via advertising, it fails to capture the core evolution described in the original: a shift in financial reporting perspective from revenue-centric (gross reporting) to cost- and cash flow–centric framing. The contextual relevance is moderate because it discusses related themes (partner payments, cost structure), but the factual and conceptual alignment with the ground truth is weak, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 495,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, the financial impact of undesignated foreign currency forward contracts on UPS's earnings volatility significantly decreased. In 2022, these contracts resulted in a loss of $69 million recognized in income, while in 2023, the loss was reduced to $7 million, indicating a more stable earnings performance and an improved foreign currency exchange risk management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The numbers cited—$69 million loss in 2022 and $7 million loss in 2023—are not present in the original answer (ground truth) and are factually unsupported by the provided information. The ground truth does not provide any specific dollar amounts related to gains or losses from undesignated foreign currency forward contracts for either year. (2) The claim that the financial impact 'significantly decreased' and led to 'more stable earnings performance' is a misinterpretation; the original answer focuses on evolution in disclosure practices and transparency, not actual reduction in losses or improved risk management outcomes. (3) The multi-hop reasoning is flawed: the question asks about evolution in risk management strategy and its impact on earnings volatility, particularly through undesignated contracts. The ground truth emphasizes changes in disclosure structure, transparency, and explicit linkage of undesignated derivatives to earnings volatility—not actual P&L figures or improvements in volatility. (4) While the LLM correctly identifies the topic (foreign currency forward contracts and earnings volatility), it fabricates specific financial data and draws incorrect conclusions about strategy effectiveness, missing the core point about enhanced disclosure and reporting structure in 2023. Thus, despite being contextually relevant, the answer fails on factual accuracy and correct synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 410,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating consistent fee revenue. The company emphasized growth in its membership base and increasing penetration of Executive memberships, which contribute higher fees. While 2022 noted potential challenges to membership growth from warehouse openings in existing markets, 2023 reaffirmed the importance of sustaining high renewal rates, especially in newer markets, to maintain profitability. The membership model remains a key driver of recurring revenue and long-term customer retention.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Costco's membership format in its profitability strategy between 2022 and 2023. It correctly identifies the continued centrality of the membership model to profitability, the emphasis on Executive membership penetration, and the importance of renewal rates. The answer accurately reflects that in 2023, Costco highlighted concerns about sustaining high renewal rates, particularly in newer markets, which aligns with the ground truth. However, it misses a key nuance: the shift in language from 'has a significant effect on our profitability' (2022) to 'is an integral part of our business and profitability' (2023), which indicates a more consolidated and embedded role in the financial model. This subtle but important evolution in framing is not mentioned. Additionally, the LLM incorrectly states that in 2022, the challenge was 'warehouse openings in existing markets' affecting growth—this is not supported by the ground truth, which does not mention such a concern in 2022. Instead, the ground truth notes that in 2023, there was a new concern about lower renewal rates in newer markets affecting the worldwide rate, which was not explicitly mentioned in 2022. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the answer remains contextually relevant and well-reasoned, with only minor gaps in qualitative precision and completeness of multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 410,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's approach to CUDA between 2022 and 2024 has evolved to become more deeply integrated within its broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational element of NVIDIA's AI and computing platforms, supporting a growing ecosystem of developers and partners. By 2024, CUDA's role expanded as part of a full-stack solution, including the CUDA-X collection of acceleration libraries, APIs, and SDKs, which are now central to NVIDIA's data center-scale computing solutions. Additionally, CUDA's integration with new architectures like the Blackwell platform and AI Enterprise software underscores its critical role in enabling generative AI and accelerated computing across diverse applications and industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: CUDA's evolution from a developer-focused tool in 2022 to a full-stack infrastructure layer by 2024 is accurately described. The mention of CUDA-X, APIs, SDKs, and integration into data center-scale solutions matches the original answer. (2) There are no numeric values (e.g., developer counts, financial figures) in the LLM answer, but it does not introduce any incorrect numbers, and the absence of the 'nearly 3 million developers' figure from the ground truth is a minor omission rather than an error. (3) The multi-hop reasoning is sound—correctly synthesizing CUDA’s strategic shift across time (2022 to 2024), its deepening integration with enterprise platforms, and its role in broader computing ecosystems. The addition of 'Blackwell platform' and 'AI Enterprise software' is contextually accurate and enhances the answer without contradicting the ground truth. (4) Semantic equivalence is strong: the core message—that CUDA evolved from a foundational developer tool to a core infrastructure layer in NVIDIA’s full-stack data center platform—is preserved. The only reason for not scoring a 10 is the omission of specific program names like the Deep Learning Institute and Inception program, which were part of the 2022 ecosystem description in the original. However, this does not detract significantly from the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 400,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid generated $1,279 million in revenue, with a large portion tied to government contracts, particularly in the U.S., where the product was initially distributed under an Emergency Use Authorization (EUA). A major shift occurred in October 2023 with an amended agreement with the U.S. government, transitioning Paxlovid to traditional commercial markets starting in November 2023. This led to a non-cash revenue reversal of $3.5 billion in Q4 2023 due to expected returns of EUA-labeled inventory. By 2024, Paxlovid revenue surged to $5,716 million as the product transitioned to commercial sales, supported by negotiated pricing and a copay assistance program. Remaining performance obligations for Paxlovid totaled $1 billion as of December 31, 2024, with expected deliveries from 2025 through 2028. Additionally, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost in Q3 2024, recognizing $442 million in revenue for this contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly undermine its correctness. While it correctly identifies the $3.5 billion non-cash revenue reversal in Q4 2023 related to expected returns of EUA-labeled Paxlovid from U.S. government inventory, it fabricates or misrepresents key financial figures. The claim that Paxlovid generated $1,279 million in revenue in 2023 and $5,716 million in 2024 is not supported by the ground truth and contradicts publicly available Pfizer financial reports. The ground truth does not provide annual Paxlovid revenues for 2023 or 2024, so these specific numbers are unsupported. Additionally, the LLM states that Pfizer recognized $442 million in revenue for supplying 1.0 million treatment courses to the SNS at no cost in Q3 2024, which is logically and factually inconsistent—'no cost' should imply zero revenue. This suggests a serious error in reasoning or data sourcing. (2) The only verified correct numbers are the $3.5 billion non-cash reversal in Q4 2023 and the $1 billion remaining performance obligations as of end-2024 with delivery expected from 2025–2028. All other numeric values (e.g., $1,279M, $5,716M, $442M) are either incorrect or not present in the ground truth. (3) The multi-hop reasoning is partially sound in structure—linking the transition from EUA to commercial sales to revenue changes—but the synthesis relies on fabricated data. The model attempts to connect contractual evolution, revenue recognition, and future obligations, but does so with inaccurate inputs. (4) The contextual relevance is high because the answer addresses the evolution of financial commitments, revenue, and delivery timelines as asked. However, due to major quantitative inaccuracies and unsupported claims, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual framework (transition from government to commercial, revenue reversal, future obligations) aligns with the truth, but execution is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 549,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil has significantly elevated Guyana's strategic importance between 2022 and 2024, as evidenced by its reporting of reserves development and inclusion of Guyana as an \"advantaged asset\" in its earnings driver framework introduced in 2024. In 2022 disclosures, Guyana was highlighted as part of the Corporation's future development plans, with investments progressing on proved undeveloped reserves, particularly in the Stabroek Block. By 2024, Guyana is explicitly categorized as a key advantaged asset driving volume growth, reflecting its role in ExxonMobil's disciplined capital allocation and long-term production strategy. This evolution underscores Guyana's growing contribution to ExxonMobil's high-return projects and overall strategic focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2022 to 2024. It accurately reflects that in 2022, Guyana was highlighted for reserves development (specifically proved undeveloped reserves in the Stabroek Block), and by 2024, it was elevated to a core 'advantaged asset' in the earnings driver framework. While the exact number '1.3 billion oil-equivalent barrels (GOEB)' from the ground truth is not included, all other qualitative and contextual elements are correct. (2) There are no incorrect numbers, dates, or calculations in the LLM response. The absence of the 1.3 GOEB figure is a minor omission but does not introduce inaccuracy—rather, it reduces quantitative completeness slightly. The years (2022 and 2024) and the concept of proved undeveloped reserves are correctly used. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024 disclosures), identifies the shift from reserves growth to advantaged production and earnings visibility, and correctly links Guyana to strategic capital allocation and volume growth. The conclusion that Guyana transitioned to a high-return, strategically central asset is logically supported. (4) The answer is contextually fully relevant, directly addressing the question about strategic evolution based on reserves and advantaged asset reporting. The omission of the precise 1.3 billion BOE number prevents a perfect score, but the semantic meaning and strategic interpretation align closely with the ground truth. Hence, correctness is rated 9/10, with high marks across all other dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 450,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreased from 24 planned deliveries by 2022 to 10 planned deliveries by 2024, according to the aircraft purchase commitments in FDX_10k_2022.pdf (page 114) and FDX_10k_2024.pdf (page 117). This reduction indicates a diminished role for the ATR 72-600F in the company's fleet strategy over this period, suggesting a shift in focus toward other aircraft types or operational priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the ATR 72-600F was projected to decline from 11 units in 2023 to 1 by 2026 in 2022's plan, but by 2024, the projection shifted to 7 units in 2025 and 3 in 2026—indicating a slower phase-out. The LLM instead claims '24 planned deliveries by 2022' and '10 planned deliveries by 2024', which are not supported by the ground truth and misrepresent the data. These numbers do not align with fleet utilization or projections described in the original answer. (2) The cited numbers (24 and 10) are factually wrong; there is no mention of 'deliveries' in the ground truth—rather, the context is about planned fleet units over time. The LLM confuses purchase commitments or deliveries with fleet size projections, leading to significant quantitative inaccuracy. (3) The reasoning is flawed: the LLM concludes a 'diminished role' due to fewer deliveries, while the ground truth shows a strategic reversal in phase-out pace—indicating a more sustained role than initially planned. This is a critical misinterpretation of the trend. The model fails to perform the correct multi-hop synthesis between 2022 and 2024 projections regarding fleet size evolution. (4) Despite referencing specific documents and pages, the LLM misrepresents the data and misses the core insight: the aircraft’s phase-out was slowed, not accelerated. The answer is contextually relevant in discussing fleet strategy but fails on factual correctness and logical reasoning, warranting low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 448,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to offering Omniverse evolved to emphasize deeper integration with AI and simulation platforms. In 2022, Omniverse was described as a 3D design and virtual world simulation platform used for enterprise applications such as virtual car showrooms and architectural walkthroughs. By 2024, Omniverse had expanded its role as a development platform and operating system for building and running virtual world simulation applications, with a stronger focus on integration with NVIDIA's AI infrastructure and accelerated computing solutions. It was also highlighted as a key component in NVIDIA's autonomous vehicle and data center simulation solutions, enabling real-time 3D collaboration and digital twin technologies across industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: the description of Omniverse in 2022 as a 3D/virtual world simulation platform for enterprise use (e.g., virtual car showrooms) matches the original answer. The evolution by 2024 into a development platform and operating system for virtual world simulations is correctly captured. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—both reference 2022 and 2024 appropriately, and no financial figures are involved, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the shift in NVIDIA's strategy from general 3D collaboration to a more integrated, AI-powered simulation and digital twin platform, particularly emphasizing integration with NVIDIA's own AI and accelerated computing infrastructure. It also correctly identifies use cases like autonomous vehicles and digital twins. (4) Minor omission: the original answer specifically mentions surgical training and on-premises/cloud deployment powered by accelerated computing, which the LLM answer does not explicitly include. Also, the ground truth emphasizes the shift to a 'specialized, enterprise-focused simulation and digital twin platform,' which is implied but not directly stated in the LLM response. However, these are minor gaps in detail rather than errors. Overall, the LLM answer conveys the same core evolution and strategic shift with high fidelity, just slightly less specificity in examples and deployment scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 435,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue remained a key contributor, primarily through sales of apps, in-app purchases, and digital content. In both years, Google Play is described as a core component of Google's non-advertising revenue streams, which also include Google Cloud, hardware, and YouTube subscriptions. While specific revenue figures are not provided in the pages, the 2023 filing emphasizes continued growth in non-advertising revenue, with Google Play maintaining its position as a significant revenue driver. The 2023 document also highlights the importance of platforms like Google Play in Alphabet's broader strategy to diversify beyond advertising.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in describing Google Play as a key contributor to non-advertising revenue in both 2022 and 2023, and correctly identifies its revenue sources (apps, in-app purchases, digital content). It also accurately situates Google Play within Alphabet's broader diversification strategy. However, it fails to capture the key evolution highlighted in the ground truth: the strategic repositioning of Google Play from a diversification initiative in 2022 to a more structured and defined revenue stream under 'platforms' in 2023. The original answer emphasizes a shift in categorization and strategic importance—indicating a maturation in how Google Play contributes to revenue stability—which the LLM answer does not reflect. While no numbers are misstated (hence full quantitative accuracy), the qualitative analysis lacks depth in capturing this strategic transition, resulting in a partially correct response. The reasoning is sound but incomplete, missing the multi-hop synthesis between structural changes in reporting and strategic intent across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 309,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business showed a shift in emphasis. In 2022, expected loss ratio methods were given significant weight only in the most recent accident year for guaranteed cost business, while for excess of deductible business, they were weighted heavily in the most recent five accident years. By 2023, the proportion of large deductible business had increased, slowing claim reporting patterns, and expected loss ratio methods continued to be applied to excess of deductible business in the most recent five accident years. Additionally, adjustments were made for updated payout patterns and changes in discount rates due to increased U.S. Treasury rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of AIG's use of expected loss ratio methods between 2022 and 2023, with accurate entity and time period references. It correctly states that in 2022, expected loss ratio methods were given significant weight only in the most recent accident year for guaranteed cost business, and in the most recent five accident years for excess of deductible business—this matches the ground truth exactly. It also correctly notes that in 2023, the methodology remained consistent for excess of deductible business and that increased large deductible business continued to slow claim reporting, which aligns with the original answer. However, the LLM introduces two unverified elements not present in the ground truth: (1) it claims that in 2023 there were adjustments for 'updated payout patterns' and (2) changes in discount rates due to U.S. Treasury rates. The original answer mentions that losses are now presented net of reinsurance and undiscounted in 2023, which contradicts any emphasis on updated discount rate adjustments—this is a significant qualitative inaccuracy. Additionally, the LLM fails to mention the key 2023 reporting change: that incurred and paid losses are now presented net of reinsurance and undiscounted, an important transparency refinement. While the core structure and multi-hop synthesis (comparing 2022 vs 2023 treatment across business lines) is sound and contextually relevant, the omission of a key factual update and introduction of unsupported new reasoning points reduces qualitative accuracy. Quantitative accuracy is high as no incorrect numbers are cited (the years and business types are correct), and the answer remains highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 469,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024 by consolidating and reorganizing its categories to better align with strategic priorities. In fiscal 2022, the categories were Secure, Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, these were restructured into Networking, Security, Collaboration, and Observability. The Collaboration category saw a 2% increase in fiscal 2024 compared to 2023, driven by growth across most offerings except Meetings, following a 9% decline in fiscal 2023 compared to 2022 due to declines in Collaboration Devices and Meetings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cisco's product category segmentation in fiscal 2022 and the restructured four-category framework in fiscal 2024, including the retention of 'Collaboration' and the introduction of 'Observability'. This demonstrates accurate entity identification and partial multi-hop synthesis. However, the LLM introduces quantitative claims not present in the ground truth: specifically, a '2% increase in fiscal 2024 compared to 2023' and a '9% decline in fiscal 2023 compared to 2022'. These figures are not mentioned or inferable from the original answer and thus constitute factual inaccuracies. (2) The original answer contains no financial metrics or performance data about Collaboration revenue changes, so the inclusion of percentages represents unsupported additions. There are no calculations in the ground truth to validate these numbers, making the quantitative accuracy low. (3) The reasoning for the structural evolution of product categories is sound and correctly synthesizes the reorganization from six to four categories, showing understanding of the consolidation. However, the model goes beyond the provided information by inserting performance trends, which undermines the factual correctness. (4) The contextual relevance is high because the answer directly addresses the evolution of product segmentation and focuses on Collaboration. The qualitative accuracy is moderate because the core structural changes are correctly described, but the erroneous addition of performance metrics reduces overall reliability. Correctness is penalized due to the introduction of false quantitative data, even though the categorical evolution is accurately portrayed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 465,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of financial presentation from 2022 to 2023, with the carrying value of $1,000 million noted in both years. In 2023, the associated interest rate framework was updated to reflect an effective interest rate of SOFR + 2.1% through an interest rate swap, whereas in 2022, no specific effective interest rate was disclosed for this note. This indicates a shift in 2023 to explicitly align the note with a floating-rate mechanism tied to SOFR.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1,000 million carrying value in both 2022 and 2023, which matches the ground truth. It also correctly states that no specific interest rate was disclosed in 2022 and that SOFR + 2.1% was introduced in 2023. However, the LLM introduces the concept of an 'interest rate swap' and describes the rate as an 'effective interest rate' due to the swap, which is not mentioned or supported in the original answer. This adds speculative financial engineering not present in the ground truth. (2) All numeric values (dollar amount, percentage spread) are accurate and correctly attributed to the right years. Format is consistent and acceptable. (3) The multi-hop reasoning is mostly sound—comparing disclosures across years and identifying increased detail in 2023—but the inference about an interest rate swap goes beyond the provided data. The original answer only states that the interest rate mechanism was disclosed as SOFR + 2.1%, not that it resulted from a swap. This misattributes the source of the rate framework. (4) The answer is contextually relevant and addresses both financial presentation and interest rate framework evolution. The core facts are correct, but the added detail about a swap reduces qualitative accuracy. Hence, correctness is reduced to 7 due to unsupported inference, though quantitative accuracy remains high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 384,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 billion cubic feet (BCF) at the end of 2022 to 296 BCF at the end of 2024, indicating a slight decline. This suggests a strategic shift or reduced focus in the region, potentially due to geopolitical uncertainties, operational challenges, or reallocation of resources to other high-potential areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that natural gas reserves 'increased' from 326 BCF in 2022 to 296 BCF in 2024, when in fact this is a decrease. This fundamental error in directionality severely undermines the factual accuracy. The numbers themselves (326 BCF in 2022 and 296 BCF in 2024) are correct and match the ground truth, but the interpretation is reversed. (2) Quantitative accuracy is partially correct—values and years are accurate, but the comparison (increase vs. decrease) is wrong, which constitutes a critical calculation/logic error in trend analysis. The magnitude of the change (30 BCF decrease) is implied but mischaracterized. (3) The qualitative reasoning about a 'strategic shift or reduced focus' is consistent with the ground truth and plausible given the decline, so the inference is sound once the correct trend is acknowledged. However, the multi-hop reasoning fails because the model draws the right kind of conclusion but from an incorrect premise (increase vs. actual decrease). (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of reserves and strategic implications) and stays focused on COP and the Asia Pacific/Middle East region. Overall, the answer contains correct raw data but misinterprets the trend, leading to a partially correct but fundamentally flawed response. Correctness score reflects significant factual error in interpretation despite accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 403,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Between 2022 and 2023, Alphabet increased its repurchase activity of Class C Capital Stock, spending $52.577 billion in 2022 and $52.868 billion in 2023. This slight increase indicates that Alphabet remained committed to returning value to shareholders and managing its capital efficiently, suggesting confidence in its financial position and long-term growth prospects.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023 across Class A and Class C shares. However, the LLM states $52.577 billion in 2022 and $52.868 billion in 2023, which are both incorrect and substantially lower. Additionally, the LLM focuses only on Class C shares, while the original answer specifies that repurchases included both Class A and Class C shares. The LLM also omits the critical information about the April 2023 $70.0 billion authorization and the $36.3 billion remaining as of year-end 2023, which are key to understanding the strategic shift. (2) The numbers provided by the LLM are quantitatively wrong—neither the 2022 nor 2023 repurchase amounts match the ground truth. The increase from $52.577B to $52.868B is only ~$291M, implying a minimal change, whereas the actual increase was $62.2B - $59.3B = $2.9B, a much more significant year-over-year growth. (3) The reasoning is partially sound in interpreting increased buybacks as a sign of shareholder value return and financial confidence, but it fails the multi-hop synthesis: it does not incorporate the new authorization or the remaining capacity, which are essential for assessing capital allocation strategy. (4) The contextual relevance is moderate because the answer addresses the general theme of repurchases and capital allocation, but due to major factual errors and omissions, the qualitative and quantitative accuracy scores are low. The correctness score is 3 due to mostly incorrect numbers and missing key strategic developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 448,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG expanded the use of frequency/severity methods to additional lines of business, particularly in U.S. Workers' Compensation, where they are now applied alongside loss development and expected loss ratio methods. This evolution reflects a more nuanced approach to reserving, especially for long-tail lines, where frequency/severity methods help better capture emerging claim trends and risk-sharing features like high deductibles. The reasoning behind this usage includes improved accuracy in estimating ultimate losses, adapting to changes in claim reporting patterns, and incorporating updated assumptions about inflation and claim severity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the expansion of frequency/severity method usage from 2022 to 2023, specifically noting the inclusion of U.S. Workers' Compensation, a long-tail line, which matches the original answer. It also correctly states that these methods are now used in combination with loss development and expected loss ratio methods. The reasoning about risk-sharing features and large deductibles is accurately reflected, though the LLM rephrases it as 'high deductibles' and 'emerging claim trends,' which is semantically equivalent. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution over time (2022 vs 2023), identifies the shift from short-tail to long-tail lines (implied by Workers' Compensation), and provides valid rationale tied to business changes. The only minor omission is that the 2022 usage was explicitly limited to short-tail classes like U.S. Property and excluded aviation—a detail not mentioned in the LLM answer—slightly reducing completeness. (4) Despite this, the answer captures the core evolution and strategic shift, making it contextually relevant and factually correct overall. The slight deduction from 10 to 9 in correctness and qualitative accuracy accounts for the missing detail about 2022 limitations, but all other aspects are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 413,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "Amgen's financial relationship with BeiGene evolved from 2022 to 2023 as follows: \n\n- **Cost Recovery**: Net costs recovered from BeiGene decreased from $199 million in 2022 to $109 million in 2023, reflecting reduced R&D cost-sharing contributions.  \n- **Product Sales**: Sales of products to BeiGene increased from $64 million in 2022 to $125 million in 2023, indicating expanded commercial activity under the collaboration.  \n- **Profit and Loss Sharing**: Profit and loss share expenses declined from $53 million in 2022 to $40 million in 2023, suggesting lower joint commercialization costs during the initial product-specific periods.  \n\nThese changes highlight a shift toward higher product sales and lower shared costs in 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: cost recovery decreased from $199M to $109M, product sales increased from $64M to $125M, and profit and loss sharing expenses declined from $53M to $40M—each figure exactly matches the original answer. (2) Quantitative accuracy is perfect; all dollar amounts and year labels are correct, and the comparisons (increases/decreases) are properly described. (3) The multi-hop reasoning is sound: the model correctly synthesized data across two years and three financial dimensions (cost recovery, product sales, profit/loss sharing), drawing a valid conclusion about the maturation of the collaboration. (4) The answer is contextually relevant, addressing every part of the question with clear, well-structured explanations. Minor wording differences (e.g., 'net costs recovered' vs 'cost recovery') do not affect meaning and are semantically equivalent. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 288,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region decreased from 764 billion cubic feet (BCF) at the end of 2021 to 296 BCF at the end of 2024. During this period, specific changes included downward revisions of 748 BCF, primarily due to factors like changes in development timing and lower prices. However, this decline was partially offset by purchases of 479 BCF in 2022 and 1,075 BCF in 2023, as well as extensions and discoveries of 58 BCF in 2022 and 1,230 BCF in 2023. Production reductions also contributed to the overall decline in reserves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that COP's natural gas reserves in the Asia Pacific/Middle East region were 326 billion cubic feet (BCF) in 2022 and decreased to 296 BCF in 2024. However, the LLM claims reserves were 764 BCF in 2021 and only mentions 2024 (296 BCF), omitting the correct 2022 figure and introducing an incorrect earlier value. The LLM also fabricates large purchases (479 BCF in 2022, 1,075 BCF in 2023) and extensions/discoveries (58 BCF in 2022, 1,230 BCF in 2023), which are not present in the ground truth. The only correct number is the 2024 reserve level (296 BCF). The revisions mentioned in the LLM answer (-748 BCF) are entirely incorrect; the ground truth reports a positive revision of +9 BCF in 2023. Production is mentioned correctly as reducing reserves, but the LLM does not specify the 25 BCF subtraction in 2024 as per the original. (2) Quantitative accuracy is very low: only one number (296 BCF in 2024) is correct. All other figures (764, 479, 1,075, 58, 1,230, -748) are fabricated or incorrect. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution from 2022 to 2024, introduces a non-asked-for year (2021), and invents data points not present in the source. It misrepresents the nature of changes (e.g., claiming large purchases when the original explicitly states 'no purchases reported' in 2024). (4) Contextual relevance is moderate because the answer addresses the general topic (reserves evolution, revisions, production, purchases) and region, but the factual foundation is unsound. The structure follows the question's intent, but the content is largely incorrect. Thus, the correctness score is low due to pervasive factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 502,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "FedEx's planned usage of the B767F aircraft decreased from 2022 to 2024, with commitments dropping from 38 deliveries planned in 2023 and 36 in 2024 in 2022 to just 14 deliveries planned in 2025 in 2024. This indicates a strategic shift in fleet planning, likely driven by evolving operational needs, cost considerations, or a focus on alternative aircraft types to optimize efficiency and capacity in its global network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that FedEx projected using 14 B767F aircraft in 2023 and 2024 (as of 2022), with a reduction to 10 by 2025. By 2024, projections changed to 11 in 2025 and only 3 by 2026. The LLM incorrectly refers to 'deliveries' (e.g., 38 in 2023, 36 in 2024) which are not in the original answer and factually wrong—these numbers do not appear in the ground truth. The LLM also misrepresents the timeline, claiming 14 deliveries planned in 2025 in 2024, which contradicts the ground truth that usage (not deliveries) was projected to drop to 11 in 2025 and 3 in 2026. (2) The quantitative inaccuracies are severe: the numbers 38, 36, and 14 (as deliveries) are entirely fabricated and not supported by the ground truth. The correct figures are about projected aircraft usage (14 → 10, then revised to 11 → 3), not deliveries. (3) The reasoning is partially sound in identifying a strategic shift toward reducing B767F reliance, which aligns with the ground truth’s conclusion. However, the multi-hop synthesis fails because the model misinterprets 'planned usage' as 'deliveries' and invents numbers not present in the source. It also fails to capture the evolution from 2022 to 2024 correctly—no mention of the 2026 projection dropping to 3, a key indicator of acceleration. (4) Correctness is low (3/10) due to major factual and numerical errors. Quantitative accuracy is very poor (2/10) because all key numbers are wrong. Qualitative accuracy is moderate (4/10) as the general direction of strategic shift is noted, but reasoning is flawed. Contextual relevance is acceptable (6/10) because the answer addresses fleet planning strategy, though based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 477,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of Expected Loss Ratio Methods evolved by applying them more selectively to specific lines of business, particularly in short-tail lines such as U.S. Property and casualty lines with low frequency/high severity losses. The reasoning behind their application included adjusting for emerging claim experience, rate changes, loss trends including inflation, and changes in reinsurance programs. Additionally, AIG continued to use a combination of methods, including Expected Loss Ratio methods, for the latest accident years to determine loss reserves, reflecting a strategic approach to enhance the accuracy of loss reserve estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as AIG's use of Expected Loss Ratio Methods in combination with other methods and the general reasoning involving inflation, rate changes, and reinsurance. However, it misrepresents the evolution between 2022 and 2023. The original answer states that in 2022, AIG used the method primarily for the latest accident year and in aviation (high severity), but by 2023 expanded into long-tail lines like U.S. Workers' Compensation. The LLM incorrectly claims the method was applied more selectively in 2023 to short-tail lines like Property and casualty, which contradicts the ground truth showing a broadening of use into long-tail, structurally complex lines. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not heavily applicable; however, the years 2022 and 2023 are correctly referenced, and no incorrect figures are introduced, warranting a high score here. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from short-term, high-severity contexts (2022) to broader use in long-tail lines (2023). Instead, it suggests increased selectivity and focuses on short-tail lines, which is the opposite of the truth. This represents a significant error in qualitative reasoning and entity-context linkage. (4) The contextual relevance is moderate because the answer discusses relevant concepts (loss reserves, inflation, reinsurance) and the correct company and time frame, but it mischaracterizes the core evolution in methodology application, leading to a low overall correctness score despite some accurate supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 456,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Between 2022 and 2024, Cisco's positioning around Enterprise Data Center Transformation has evolved to emphasize the convergence of computing, networking, storage, and software, driven by advancements such as cloud computing, virtualization, and scalable microprocessors. In 2022, the company highlighted the transformation as a result of converging technologies and noted increased competition from entities, including some strategic alliance partners, expanding into end-to-end solutions. By 2024, Cisco continued to emphasize the competitive landscape, noting that companies with which it has strategic alliances in some areas may be competitors in others, and that the enterprise data center transformation is intensifying competition from both existing and new market players. This evolution reflects Cisco's strategic focus on maintaining leadership in a rapidly converging and competitive market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Cisco's positioning from 2022 to 2024 around Enterprise Data Center Transformation, emphasizing technological convergence and shifting alliance-competition dynamics. It accurately reflects that in 2022, strategic partners were becoming competitors, increasing competitive pressure—a key point in the ground truth. By 2024, the LLM notes ongoing intensification of competition and complex relationships with alliance partners, which aligns with the original answer’s emphasis on evolving competitive dynamics. However, the LLM omits the specific mention of Nvidia Corporation as a new entrant in the competitive landscape, which is a notable detail in the ground truth and reflects a concrete shift in market dynamics. This omission prevents a perfect score but does not invalidate the overall accuracy. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM synthesizes Cisco’s strategic positioning across two time points and connects alliance and competitive trends appropriately. It correctly identifies the dual role of partners as both collaborators and competitors, a nuanced point requiring cross-year and cross-relationship analysis. The only gap is the lack of specific identification of Nvidia as a new competitor in 2024, which weakens the completeness of the competitive landscape update. (4) The answer is highly contextually relevant, directly addressing Cisco’s evolving strategy, alliances, and competition. The qualitative accuracy is high but docked slightly for missing the Nvidia reference, which is a material detail in signaling market shift. Overall, the answer is factually consistent, well-reasoned, and semantically close to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 514,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes increased from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a shift from LIBOR to SOFR as the benchmark rate. The notional amount associated with these notes remained unchanged at $1,000 million in both 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the notional amount was $5.2 billion (not $1.0 billion), and there is no mention of an effective rate of LIBOR + 1.8% in that year. The LLM incorrectly states that the notional amount remained unchanged at $1,000 million in both years, when in fact it decreased from $5.2 billion to $1.0 billion. The only correct quantitative detail is the 2023 effective interest rate of SOFR + 2.1% and the 2023 notional amount of $1.0 billion. (2) The numbers are largely incorrect: $5.2 billion in 2022 is misrepresented as $1.0 billion, and the introduction of LIBOR + 1.8% has no support in the original answer. The calculation or comparison of notional amounts is therefore flawed. (3) The reasoning is unsound: the LLM implies a benchmark shift from LIBOR to SOFR, which may be contextually plausible, but this transition is not mentioned in the original answer for these notes in 2022. The original answer emphasizes a reduction in hedged notional exposure due to a dynamic hedging strategy amid low interest rates, which the LLM fails to capture. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of rate and notional) and correctly reports the 2023 data, but major factual errors in the 2022 figures and missing the key point about hedging strategy evolution severely undermine correctness. Hence, scores are low on quantitative and qualitative accuracy, pulling the overall correctness score down to 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 428,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics within its product portfolio has evolved to emphasize its role in the Observability offerings. From 2022 to 2024, AppDynamics has been increasingly integrated into Cisco's full-stack observability strategy, which spans from applications to infrastructure. In 2022, AppDynamics was highlighted as a key element for application performance monitoring, while by 2024, it was positioned as a core component of Cisco's broader Observability suite, contributing to growth in this category and aligning with Cisco's focus on providing end-to-end insights for hybrid and multicloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, AppDynamics was positioned as a key component of Cisco's observability strategy, specifically for application performance monitoring. By 2024, it notes the increased integration into a broader Observability suite, which matches the ground truth's mention of a new 'Observability' revenue category subsuming AppDynamics. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024) and strategic positioning (from standalone APM tool to integrated observability pillar). The only minor omission is that the ground truth specifically names Intersight and ThousandEyes as co-components in 2022 and emphasizes the formal revenue reporting change in 2024, which the LLM answer implies but does not explicitly state. This slight lack of specificity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of AppDynamics' strategic positioning within Cisco’s portfolio with respect to observability. Overall, the semantic meaning matches the original answer closely, with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 383,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes increased from 5.6% in 2022 to 5.6% in 2023, remaining unchanged. The notional amount associated with these notes was $1,500 million in both 2022 and 2023, indicating no change in the notional amount over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio, with swaps terminated and replaced at current rates, but no specific notional amount or effective rate for the 2051 Notes alone was disclosed for 2022. In contrast, the LLM claims a notional amount of $1,500 million and an effective interest rate of 5.6% in both years, which contradicts the ground truth. The actual 2023 data shows a notional amount of $1.5 billion and an effective rate of SOFR + 4.3%, not 5.6%. (2) The numbers provided by the LLM—$1,500 million in both years and 5.6% effective rate—are factually wrong. The ground truth does not support a $1.5 billion notional in 2022, nor any specific effective rate for the 2051 Notes in 2022. The 5.6% figure appears fabricated. (3) The multi-hop reasoning is flawed: the LLM failed to recognize that the 2022 information was about a broader $5.2 billion hedged portfolio, not the 2051 Notes specifically, and incorrectly assumed continuity of notional and rate. It missed the key evolution—termination and replacement of swaps and updated terms in 2023. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of rate and notional), but factual inaccuracies and missing synthesis of hedging strategy changes severely undermine correctness. Hence, low scores on quantitative (2), qualitative (2), and overall correctness (2).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 420,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has shown refinement in segmentation and application across lines of business. In 2023, the company further segmented U.S. Workers' Compensation by deductible size and claim handling (AIG vs. third-party administrators), reflecting a more granular approach to risk assessment. Additionally, the use of expected loss ratio methods was emphasized for excess of deductible business in the most recent five accident years, with adjustments for rate changes, loss trends, and market conditions. This evolution indicates a more nuanced application of expected loss ratios, particularly in long-tail lines, to improve accuracy and responsiveness to emerging trends.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's use of expected loss ratio methods from 2022 to 2023. It accurately captures the increased granularity and more structured application in 2023, particularly for U.S. Workers' Compensation, a long-tail line of business. The mention of segmentation by deductible size and claim handling (AIG vs. third-party administrators) matches the ground truth's reference to 'deductible size' and 'claim handling entities.' Additionally, the LLM correctly identifies the refinement in risk assessment and responsiveness to trends. However, the LLM omits some specific segmentation criteria mentioned in the original answer—namely risk-sharing features, state and industry subsets—which were explicitly introduced in 2023. While the LLM references 'excess of deductible business in the most recent five accident years' and adjustments for rate changes and loss trends, these details, though plausible, are not present in the ground truth and slightly extend beyond the provided information. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (AIG, U.S. Workers' Compensation, 2022–2023 timeframe) are correct. The reasoning is sound and reflects appropriate multi-hop synthesis across years and business lines. The answer is highly relevant and conveys the core evolution accurately, warranting a high score but not full marks due to minor omissions and slight over-enrichment of details not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 420,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.850% Senior Notes due 2026 remained consistent as part of its broader debt issuance strategy. In 2023, the notes were explicitly listed as authorized in the Board of Directors Resolutions, and by 2024, they were included again in a similar context, indicating their ongoing role in the company's capital structure. The 2024 filings also reflect the introduction of additional notes, such as the 4.500% Senior Notes due 2029, 4.800% Senior Notes due 2034, and 5.250% Senior Notes due 2054, suggesting a diversification of maturities and coupon rates to manage interest costs and optimize its debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained its engagement with the 2.850% Senior Notes due 2026 between 2023 and 2024 and contextualizes them within the broader debt strategy. However, there is a significant discrepancy in the specific notes introduced in 2024. The ground truth states that PepsiCo introduced higher-yielding instruments such as the 7.00% Senior Notes due 2029 and 5.50% due 2035, while the LLM claims the introduction of 4.500% due 2029, 4.800% due 2034, and 5.250% due 2054—these exact notes and maturities do not match the ground truth. This represents a major factual error in quantitative details. (2) The percentages and maturity dates are incorrect: 7.00% vs 4.500%, 5.50% vs 4.800% and 5.250%, and maturities like 2054 are not mentioned in the original. These are not minor variations but different instruments altogether, undermining quantitative accuracy. (3) The reasoning is sound in structure—recognizing multi-hop evolution in debt strategy, continuity of the 2.850% notes, and strategic diversification of maturities and coupons. The logic of using new notes to manage interest costs and optimize debt profile aligns semantically with the original’s conclusion about diversified, long-term strategy. However, the incorrect instruments weaken the synthesis. (4) Contextual relevance is high—the answer addresses both parts of the question: evolution of engagement with the 2026 notes and broader strategy via new issuances. While the conceptual interpretation is accurate, the factual foundation is compromised by wrong note details, justifying a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 449,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, while the volume of channel partner financing slightly decreased from $27.9 billion in 2022 to $27.1 billion in 2024. This reduction in guaranteed exposure, despite relatively stable financing volumes, indicates a more conservative approach to risk management, likely aimed at reducing potential financial liabilities and enhancing the stability of the company's balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal year 2022, the balance of financing subject to guarantees was $1.4 billion — not $1.7 billion in 2023 as claimed. Moreover, the LLM asserts specific figures for 2024 ($1.2 billion in guarantees and $27.1 billion in financing volume), but the original answer explicitly states that by fiscal year 2024, Cisco no longer disclosed these quantitative figures. Therefore, any precise numbers for 2023 or 2024 are unsupported and incorrect. (2) The calculation of a decrease from $1.7B to $1.2B and $27.9B to $27.1B is entirely fabricated and contradicts the ground truth, which emphasizes the absence of updated disclosures. The only accurate number mentioned — $27.9 billion in channel partner financing in 2022 — is correctly cited, but the rest are not. (3) The reasoning is flawed because it assumes a trend based on non-existent data. The original answer highlights a lack of transparency and inability to draw definitive conclusions due to missing disclosures, whereas the LLM confidently infers a strategic reduction in risk, which is not supported. The multi-hop synthesis fails because it invents data points instead of recognizing the absence of information as a key insight. (4) The contextual relevance is moderate because the answer addresses the right topic (Cisco’s channel financing guarantees and risk management), but the qualitative and quantitative inaccuracies severely undermine correctness. The conclusion about conservative risk management is speculative and contradicts the cautious interpretation warranted by the lack of disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes had a notional amount of $1,250 million in both 2022 and 2023, indicating no change in the principal amount outstanding. In 2023, an interest rate swap was in place for a notional amount of $1,000 million on these notes, effectively converting the fixed-rate coupon to a floating rate of SOFR + 1.3%. No such swap details were explicitly mentioned for 2022, suggesting the swap was newly entered into in 2023. The interest rate structure thus evolved with the addition of a floating-rate hedge in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states the notional amount of the 2.45% 2030 Notes was $1,250 million in both years, but the ground truth specifies $1.0 billion. This is a major quantitative error. Additionally, the LLM claims the interest rate swap was 'newly entered into in 2023' because 'no such swap details were explicitly mentioned for 2022', which directly contradicts the ground truth stating that Amgen entered into swaps in 2022. (2) The ground truth confirms a $1.0 billion notional swap in 2022 converting fixed rate to LIBOR-based floating rate, and in 2023, the benchmark shifted from LIBOR to SOFR + 1.3%. The LLM incorrectly implies the swap started in 2023 and omits the 2022 LIBOR conversion entirely. While the SOFR + 1.3% rate in 2023 is correctly noted, the evolution narrative is flawed. (3) The multi-hop reasoning is partially sound—linking the existence of the note and the swap to changes in interest rate structure—but fails on temporal accuracy and synthesis across years. The model does not correctly track the evolution from fixed → LIBOR (2022) → SOFR (2023), instead suggesting no swap in 2022 and a new swap in 2023. (4) Scores reflect major factual and quantitative errors (especially the $1.25B vs $1.0B discrepancy and incorrect timing of swap), but the answer remains contextually relevant and captures part of the interest rate transition in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 396,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In 2022, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034, and these were fully and unconditionally guaranteed by FedEx. By 2023, the structure and nature of these guarantees did not change, as the Certificates remained secured by 19 Boeing aircraft and were still not direct obligations of FedEx or FedEx Express. No new Pass-Through Certificates were issued in 2023, and the existing guarantees remained in place without material modifications.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct factual elements, such as the $970 million issuance of Pass-Through Certificates, Series 2020-1AA, the 1.875% interest rate, February 2034 maturity, and the fact that 19 Boeing aircraft secured the certificates. These quantitative details are accurate and match the context. However, the core claim—that FedEx's relationship remained 'consistent' and that guarantees 'remained in place'—is factually incorrect. The ground truth states that in 2023, FedEx clarified that these certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express, marking a significant shift from the 2022 position where they *were* fully and unconditionally guaranteed. The LLM incorrectly asserts continuity, directly contradicting the key evolution in FedEx's financial obligations. (2) Quantitative accuracy is high: dollar amounts ($970M), asset backing (19 aircraft), and interest rate (1.875%) are correct. No calculation errors. (3) Multi-hop reasoning fails: the model does not correctly synthesize the change in guarantee status between 2022 and 2023. It incorrectly treats the 2023 disclosure as confirming the prior guarantee structure, when in fact it retracts it. This reflects a failure in logical and factual synthesis across years. (4) Correctness score is low (2) due to the central factual error about financial guarantees, despite accurate numbers. Qualitative accuracy is poor due to flawed reasoning and misrepresentation of the relationship evolution. Contextual relevance is moderate because the answer discusses the right instruments and entities but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 452,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard increased its risk mitigation arrangements from $12,167 million in 2023 to $13,466 million in 2024, while gross settlement exposure rose from $75,023 million to $78,385 million during the same period. This indicates that the company is proactively enhancing its risk management strategy by applying more extensive mitigation measures to address growing settlement exposure, reflecting a cautious approach to managing financial risks.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: gross settlement exposure increased from $75,023 million in 2023 to $78,385 million in 2024, and risk mitigation arrangements rose from $12,167 million to $13,466 million. These values match the original answer exactly, with correct formatting and units. (2) All numeric values are accurate and consistent with the ground truth. The increases in both gross exposure and mitigated amounts are correctly presented, and no calculations are required beyond these comparisons, which are handled appropriately. (3) The multi-hop reasoning is sound—LLM synthesizes data across two years and two financial metrics (gross exposure and mitigation) to infer a strategic shift in risk management. The conclusion that Mastercard is 'proactively enhancing its risk management strategy' aligns semantically with the original answer's claim that the strategy became 'more robust over time.' (4) The answer is fully relevant, complete, and factually precise, capturing both quantitative evolution and qualitative implications. Minor wording differences (e.g., 'cautious approach' vs. 'more robust') do not affect semantic equivalence and are acceptable under flexible interpretation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 368,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $145 million as of May 31, 2022, to $146 million as of May 31, 2023, and further to $110 million as of May 31, 2024. This decline suggests a reduction in the company's hedging activities or exposure to foreign currency fluctuations over this period, potentially indicating a more stable foreign exchange environment or a strategic shift in how the company manages its currency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. However, the LLM claims a decrease from $145 million in 2022 to $110 million in 2024, which contradicts the actual data. The LLM also introduces a 2023 figure ($146 million) not present in the ground truth and misrepresents the trend entirely. (2) Number verification: Ground truth reports $37M (accrued liabilities) + $11M (deferred taxes) = $48M total in 2022; LLM reports $145M — a significant overstatement. In 2024, ground truth is $110M + $5M = $115M; LLM reports $110M — underreporting by $5M and misallocating the total. The LLM omits the $5M in deferred liabilities in 2024 and fails to report the correct total. (3) Multi-hop reasoning assessment: The question requires synthesizing data across two balance sheet categories and two years. The LLM fails this synthesis, likely due to hallucinated or incorrect data retrieval. It incorrectly infers a declining trend and draws conclusions about reduced exposure, which contradicts the ground truth indicating increased liability and potentially higher hedging activity or exposure. (4) Justification for scores: Correctness is low (2/10) due to major factual and directional errors. Quantitative accuracy is poor (2/10) — all key figures are wrong. Qualitative accuracy is slightly higher (3/10) because the LLM attempts to interpret the trend in strategy, albeit based on false data. Contextual relevance is moderate (6/10) — it addresses the right topic and time frame but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 471,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between 2022 and 2023, the representation of Bounty within P&G's Baby, Feminine & Family Care segment remained consistent as a major brand under the Family Care sub-category, specifically noted alongside Charmin. However, in 2023, the segment description provided more detailed market share information for Family Care, stating that North American market shares were over 40% for Bounty. This suggests that while Bounty's role within the segment did not change structurally, its brand visibility was emphasized more in 2023 through specific market share metrics, highlighting its strong position in the North American paper towel market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its factual claims. The ground truth states that Bounty was not explicitly listed as a key brand in the 2022 10-K but was explicitly included in 2023, indicating increased visibility. The LLM incorrectly claims Bounty was consistently described as a major brand in both years and was mentioned alongside Charmin, which is not supported by the evidence. (2) The LLM introduces a specific quantitative claim—'over 40% North American market share for Bounty in 2023'—that is not present in the original answer or implied by the ground truth. This number is entirely fabricated or misattributed, as the ground truth explicitly states that no market share or sales figures were provided in the filings. This is a critical error in quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key evolution—Bounty's explicit elevation to a named brand in 2023—and instead invents a narrative around market share data that does not exist in the evidence. The conclusion about increased visibility is partially aligned with the ground truth, but it is based on incorrect reasoning and fabricated data. (4) The contextual relevance is moderate because the answer addresses brand visibility and the Baby, Feminine & Family Care segment, but the qualitative and quantitative inaccuracies severely undermine correctness. The answer suggests a plausible interpretation but is not grounded in the actual filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 411,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, remained relatively consistent between fiscal 2022 and 2023 in terms of revenue recognition, with revenues for hardware products and related software generally recognized at the point of delivery when ownership transfers to the customer. However, there was a slight strategic shift in emphasis, as Oracle continued to focus on transitioning customers from on-premise solutions to the Oracle Cloud, which could indirectly affect the demand for hardware. Additionally, Oracle highlighted the importance of its hardware support offerings, which are recognized ratably over the contractual term, and noted the impact of factors like customer demand for cloud infrastructure and competitor offerings on hardware revenues.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key aspects of the evolution in Oracle's approach between fiscal 2022 and 2023. While it correctly states that revenue for hardware and related software is recognized at the point of delivery, it fails to highlight the significant change in fiscal 2023 where Oracle explicitly treated hardware and related software as a combined performance obligation—a key shift from 2022. The original answer notes that in 2022, the focus was on contractual activities and timing of revenue recognition for cloud and license contracts, whereas in 2023, a more integrated and detailed revenue recognition framework was introduced. This evolution in accounting treatment is not captured in the LLM response. Additionally, the LLM does not mention Oracle’s increased strategic emphasis on R&D investments in hardware innovation in 2023, which was absent in 2022 and is a critical part of the strategic shift. Instead, the LLM focuses on Oracle’s cloud transition and support offerings, which, while contextually relevant, do not directly reflect the evolution in the hardware business itself. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the LLM connects hardware revenue recognition with delivery timing and mentions support revenue recognition over time, but it fails to synthesize the key change in performance obligation treatment and the new emphasis on R&D and product development in 2023. This represents a failure in cross-year, cross-strategy synthesis required by the question. (4) The correctness score is 5 due to partial factual accuracy—core revenue recognition timing is correct, but major strategic and accounting changes are omitted. Quantitative accuracy is 10 because no numbers are involved. Qualitative accuracy is 5 due to missing key reasoning and entity-level shifts. Contextual relevance is 8 because the answer discusses related topics (cloud transition, support revenue) but drifts from the specific evolution in hardware strategy and accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 576,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, ERLEADA (apalutamide) sales increased by 26.9%, from $1.881 billion to $2.387 billion. This growth was driven by continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer. The strong sales performance indicates a positive market trajectory for ERLEADA, reflecting its growing acceptance and effectiveness in its therapeutic area.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures for 2022 ($1.881 billion = $1,881 million) and 2023 ($2.387 billion = $2,387 million) are accurate, and the calculated growth rate of 26.9% is correct: (2,387 - 1,881) / 1,881 ≈ 0.269 or 26.9%. (2) The answer addresses both parts of the question: it describes the sales evolution (increase from 2022 to 2023) and interprets the market trajectory (positive, growing acceptance). (3) Entity accuracy is correct: ERLEADA (apalutamide) is properly identified, and the years 2022 and 2023 are correctly referenced. (4) The reasoning is sound and adds contextual insight (market expansion, share gains in mCRPC) that aligns with the implication of strong commercial performance. While the LLM provides additional context not in the original answer (e.g., therapeutic area details), it does not introduce inaccuracies and enhances relevance. All information is semantically equivalent and factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 296,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA's relationship with local broadcast television stations has shifted as the company faces increased competition from direct-to-consumer (DTC) streaming services and evolving media distribution models. The company's dependency on traditional distribution channels, such as local broadcast stations, has decreased as more content owners, including CMCSA through Peacock, deliver content directly to consumers. This shift has disrupted traditional media distribution business models and reduced the importance of securing affiliations with local broadcast stations for content distribution. Additionally, CMCSA has experienced declining linear television network subscriber fees and advertising revenue, further emphasizing the reduced reliance on local broadcast stations compared to prior years.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its characterization of CMCSA's relationship with local broadcast television stations from 2023 to 2024. While it correctly references CMCSA and relevant industry trends like DTC streaming and declining linear revenues, it asserts a decreasing dependency on local broadcast stations, which directly contradicts the ground truth. The original answer states that by 2024, CMCSA's linear networks became *more* dependent on local broadcast stations due to retransmission consent requirements—marking a shift from competition to dependency. The LLM instead claims dependency has decreased due to direct-to-consumer distribution via Peacock, which misrepresents the nature of the relationship evolution. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default for absence of incorrect numbers. Qualitative accuracy is very low because the core entities (CMCSA, local broadcast stations) and the directional change in their relationship (from competitive to interdependent/dependent) are misrepresented. Contextual relevance is low because the answer focuses on broader industry trends rather than the specific shift in CMCSA’s operational and strategic relationship with local broadcasters. The multi-hop reasoning fails: the model does not synthesize the correct shift in business dynamics (competition → dependency via retransmission consent), instead inferring an opposite trend based on general market shifts. Thus, despite some contextual awareness, the answer is factually and conceptually incorrect on the key point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 443,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly from $306 million in 2023 to $38 million in 2024. This decline suggests a strategic shift in the company's investment approach, likely reallocating funds from short-term, interest-bearing time deposits to other investment vehicles such as available-for-sale securities, which increased from $286 million in 2023 to $292 million in 2024. This shift may indicate a pursuit of higher returns or a realignment of liquidity and risk management priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the quantitative change in HTM securities from $306 million in 2023 to $38 million in 2024, matching the ground truth exactly. These numbers are accurate and properly attributed to MA (Mastercard) and the correct years. (2) The quantitative accuracy is perfect—both values are correct, and the significant drop is accurately portrayed. (3) However, the qualitative reasoning introduces unsupported claims. The LLM states that funds were reallocated from 'short-term, interest-bearing time deposits'—but the original answer and ground truth do not mention time deposits. Additionally, the LLM cites an increase in available-for-sale (AFS) securities from $286M to $292M, which is not present in the ground truth and cannot be verified from the provided information. This represents a fabrication or incorrect inference, undermining the reasoning. The ground truth only states the drop in HTM indicates a shift toward more liquid or short-term positions, not a specific reallocation to AFS securities. (4) While the core fact (the drop in HTM) is correct and the general interpretation of a strategic shift is reasonable, the addition of unverified details and incorrect multi-hop synthesis (linking HTM decline to AFS increase without evidence) reduces the qualitative accuracy. The answer remains contextually relevant and addresses both parts of the question, but with speculative elements. Thus, correctness is reduced to 7 for minor factual overreach despite solid number accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 420,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Feminine Care sub-category of the Baby, Feminine & Family Care segment at Procter & Gamble. In 2022, Always was positioned under the Feminine Care category, which also included Adult Incontinence, while in 2023, the categorization remained consistent, with Always and Tampax leading the Feminine Care sub-category. Additionally, Always Discreet continued to represent the brand in the Adult Incontinence sub-category in both years. No significant repositioning or reclassification of the Always brand occurred during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of Always' positioning, despite being contextually relevant and free of numerical errors. (1) The original answer states that in 2023, Always was more specifically aligned with 'Menstrual Care' under an updated Feminine Care sub-category, indicating a strategic repositioning. However, the LLM answer asserts that 'no significant repositioning or reclassification occurred,' which directly contradicts the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats, earning full marks by default. (3) The multi-hop reasoning fails: the model should have synthesized changes in categorization between 2022 and 2023 but instead reported continuity. It incorrectly groups Always and Tampax under unchanged Feminine Care without acknowledging the shift to 'Menstrual Care' as a more targeted sub-category. It also mentions Always Discreet in Adult Incontinence, which may be factually valid but distracts from the main evolution in the core Always brand’s positioning. (4) While the answer addresses the right segment and brand, it misses the key strategic shift, leading to a low correctness and qualitative accuracy score. Contextual relevance is high because it discusses the correct segment, brand, and time frame, but the conclusion is factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 390,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's Oracle Engineered Systems, part of its hardware business, represented 6% of total revenues in both fiscal 2024 and 2023. Revenue recognition for these systems occurs at the point of delivery when ownership transfers to the customer. The strategic emphasis on Engineered Systems remains tied to Oracle's broader cloud and infrastructure offerings, though the hardware segment generally has lower operating margins due to production and support costs. There is no indication of a significant shift in strategic emphasis between 2022 and 2023, but Oracle continues to invest in research and development to enhance its hardware products and services.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Oracle Engineered Systems, as part of the hardware business, represented 6% of total revenues in fiscal 2023 and 2024, which matches the ground truth. It also accurately describes revenue recognition occurring at the point of delivery, consistent with the 2023 disclosure. However, the LLM omits a key point from the original answer: in 2022, no specific percentage of revenue was disclosed for Engineered Systems, which represents a missing contrast in transparency evolution between years. This omission slightly weakens completeness. (2) All numeric values (6%, fiscal 2023 and 2024) are correct and properly contextualized. There are no calculation errors. The answer correctly avoids assigning a percentage to 2022, though it fails to explicitly note the absence of such data in that year. (3) The multi-hop reasoning is mostly sound—linking Engineered Systems to hardware, identifying revenue share and recognition, and noting R&D investment. However, the answer does not fully capture the strategic evolution highlighted in the ground truth, such as increased emphasis on factors affecting predictability (e.g., manufacturing partners, competition with cloud infrastructure). While it mentions ongoing R&D, it downplays the shift in strategic communication by stating there was 'no significant shift,' which contradicts the ground truth's indication of clearer measurement and enhanced disclosure. (4) Despite these nuances, the answer remains factually accurate on core financial contribution and revenue recognition, and is highly relevant to the question. The scores reflect high correctness with minor gaps in completeness and qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 466,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales strategy between 2023 and 2024 remained consistent, with the company continuing to work with representation firms as an extension of its sales force to sell a portion of allocated advertising units. Revenue from these arrangements is recorded net of agency commissions, as outlined in both the 2023 and 2024 filings, indicating no significant strategic changes in this area during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Comcast's relationship with representation firms remained consistent between 2023 and 2024. The ground truth states there was a strategic evolution—from using representation firms as an extension of the sales force in 2023 (co-selling model, revenue net of commissions) to formal representation agreements in 2024 where Comcast sells advertising on behalf of third parties, indicating a deeper strategic shift. The LLM incorrectly concludes 'no significant strategic changes,' which directly contradicts the documented evolution. (2) There are no numeric values in this question, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, and the description of revenue recognition (net of commissions) is accurate for 2023, though misapplied to 2024 without acknowledging the shift. (3) The multi-hop reasoning fails: the model should have synthesized changes across the two years’ filings to identify a strategic shift but instead treated both years as equivalent, missing the evolution entirely. (4) While the answer addresses the topic and timeframe, it conveys the opposite of the correct conclusion, warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right entities and topic but draws an incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 388,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's approach to its industry-specific hardware offerings has shown a continued emphasis on integration with its cloud infrastructure and a shift in revenue recognition. In fiscal 2022, hardware offerings were described as highly interdependent with related software, with revenue recognized at the point of delivery when ownership transfers. By fiscal 2023, the strategic emphasis had evolved to highlight Oracle's investment in improving hardware products and services to align with cloud infrastructure, particularly through Oracle Cloud Infrastructure (OCI). Additionally, hardware support contracts are recognized ratably over the contractual term, reflecting a continued focus on long-term customer relationships and recurring revenue streams. This evolution underscores Oracle's broader strategy of integrating hardware with cloud services to enhance performance and customer value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle recognized hardware revenue at the point of delivery in both fiscal 2022 and 2023, which aligns with the ground truth. It also accurately notes the continued interdependence of hardware and software. The mention of ratable recognition for hardware support contracts is factually consistent with Oracle's revenue recognition policies and adds relevant context not contradicted by the ground truth. However, the LLM introduces a strategic emphasis on integration with Oracle Cloud Infrastructure (OCI) and 'aligning with cloud infrastructure'—a point not present in the original answer. While Oracle may have cloud integration efforts, the ground truth specifically highlights increased R&D investment and innovation in hardware as the strategic shift in 2023, not cloud integration. This misrepresents the nature of the strategic emphasis. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes revenue recognition practices across years and identifies a shift in strategic tone. However, it substitutes the actual strategic evolution (R&D and product innovation) with a different emphasis (cloud alignment), which reflects a failure to accurately capture the specific strategic shift documented in the ground truth. (4) The correctness score is 7 because core facts about revenue recognition are accurate and the answer is contextually relevant, but the strategic emphasis is misrepresented, constituting a meaningful qualitative inaccuracy. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to correct reasoning structure but incorrect strategic detail. Contextual relevance is 9 as the answer stays focused and adds plausible, related context without straying from the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 529,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.78 billion to $3.26 billion. This decrease was primarily attributed to global competitive pressures, as mentioned in the 2023 report. In 2022, IMBRUVICA had already faced competitive challenges, but the decline in 2023 indicates an intensification of these pressures, impacting its market share and sales performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sales decline of IMBRUVICA from $3.78 billion in 2022 to $3.26 billion in 2023, which aligns with the ground truth values of $3.784 billion and $3.264 billion (rounded appropriately). The calculated 13.7% decline is accurate and matches the ground truth. (2) All numeric values are correct within acceptable rounding: $3.784B rounded to $3.78B and $3.264B to $3.26B is standard and acceptable. The percentage change is precisely calculated: (3.784 - 3.264) / 3.784 ≈ 13.7%. (3) The reasoning correctly captures the multi-hop nature of the question by noting competitive pressures in both years, with intensification in 2023. It references the 2022 context of competition and links it to the continued decline in 2023, demonstrating sound synthesis. However, the LLM omits mention of pandemic-related delays in new patient starts in 2022 and does not reference market saturation or treatment shifts in oncology in 2023, which are part of the full causal picture in the ground truth. This minor omission reduces completeness slightly but does not invalidate the core explanation. (4) The answer is contextually fully relevant, directly addressing both parts of the question—sales evolution and contributing factors. The qualitative accuracy is high but not perfect due to the missing contextual factors. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 413,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort from 2023 to 2024 shows a slight reduction in debt levels, from $3.5 billion in 2023 to $3.4 billion in 2024, with the debt primarily consisting of a term loan. Ownership structure remains unchanged, with Comcast maintaining a 30% interest and consolidating the resort as a variable interest entity (VIE). Financial risk exposure is limited to Comcast's 30% ownership stake, with no liquidity arrangements, guarantees, or additional financial commitments between Comcast and Universal Beijing Resort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, term loan reduced from $3.1 billion to $3.0 billion (implied by 'slight reduction' and context), Comcast maintains a 30% ownership stake, and continues to consolidate Universal Beijing Resort as a VIE. The financial risk exposure is correctly stated as limited to the 30% equity interest. (2) Quantitative accuracy is perfect: all dollar amounts and percentages match the original answer. The slight reduction in debt and term loan is consistent with the ground truth, even though the $3.0 billion figure is not explicitly stated, it is reasonably inferred from the $3.4 billion total debt and context. (3) Multi-hop reasoning is sound—information is synthesized across time (2023 to 2024), entities (Comcast, Universal Beijing Resort), and financial dimensions (debt, ownership, risk). The answer correctly identifies the stability in ownership and risk structure despite debt changes. (4) The only minor omission is the explicit mention that the maximum financial risk exposure 'remains limited' due to no guarantees or liquidity arrangements—though this is effectively conveyed by stating there are 'no liquidity arrangements, guarantees, or additional financial commitments.' Wording differs slightly but meaning is semantically equivalent. No factual errors; completeness is high. Thus, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and near-perfect qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 434,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, FedEx's financial commitment for future lease payments on build-to-suit facilities and equipment decreased significantly. In 2022, the undiscounted future payments for such leases were approximately $3.4 billion, with commencement dates from 2023 to 2024. By 2023, this amount dropped to approximately $0.9 billion, with expected commencement dates from 2025 to 2027. This indicates a strategic shift or delay in expanding build-to-suit facilities, potentially reflecting a more cautious approach to capital commitments or a reallocation of resources to other priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key financial figures: $3.4 billion in 2022 and $0.9 billion in 2023 for future undiscounted lease payments related to build-to-suit facilities and equipment. The commencement date ranges (2023–2024 in 2022, shifting to 2025–2027 in 2023) are accurately reflected. These numbers match the ground truth exactly, with acceptable formatting. (2) All quantitative elements are correct—no calculation errors, and the significant reduction (~73.5%) is implied appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time (2022 to 2023) and infers strategic implications. The conclusion about a strategic shift or delay aligns with the ground truth’s interpretation of reduced long-term commitments and extended timelines. The only minor difference is that the LLM frames the shift as potentially reflecting caution or resource reallocation, while the original emphasizes fewer long-term commitments and extended asset utilization timelines. This is a nuance in emphasis, not a factual error. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of financial commitments and the implication for FedEx's leasing strategy. Overall, the answer is factually accurate, complete, and logically sound, warranting a high score with only a slight deduction in qualitative accuracy due to slightly less precise strategic characterization compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 411,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard acquired Dynamic Yield LTD in 2022 for $325 million, and there is no indication of any changes to this relationship in 2023 or 2024 based on the provided information. This suggests that the acquisition has been fully integrated and is contributing to Mastercard's strategy to grow, diversify, and build its business, particularly in areas like data and services.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Mastercard acquired Dynamic Yield LTD in 2022 for $325 million, which aligns with the ground truth. However, it fails to mention the key detail from 2023 that $200 million of goodwill was attributed to expected synergies, which is a significant omission in the evolution of the relationship. Also, while the LLM notes no changes in 2023–2024, it misses the critical strategic signal in 2024: Mastercard’s pivot to cybersecurity via the acquisition of Recorded Future, which contrasts with the stable Dynamic Yield relationship and explains the shift in strategic focus. (2) Quantitatively, the $325 million acquisition amount is accurate, and no incorrect numbers are presented—minor point: the April 2022 acquisition date is omitted but not misstated. (3) The reasoning is partially sound—while the LLM correctly infers integration completion, it does not perform the necessary multi-hop synthesis between Dynamic Yield’s stable status and the new Recorded Future acquisition to infer a strategic pivot. This weakens the qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution and strategic implications, but lacks completeness in synthesizing the full strategic shift, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 361,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was amended and restated on May 29, 2020, as disclosed in the 2022 filing (LOW_10k_2022.pdf, page 90). By 2024, the plan was further amended and restated on May 26, 2022, as noted in the 2024 filing (LOW_10k_2024.pdf, page 79). The 2022 amendment was filed under Form 10-Q on November 27, 2024. This indicates an evolution in the plan's structure and terms over the 2022–2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key amendment dates (May 29, 2020, and May 26, 2022) and associates them with the correct filings (2022 and 2024 10-Ks). The filing date of November 27, 2024, for the updated plan is accurately reported. However, the LLM incorrectly states that the 2022 amendment was filed under Form 10-Q, while the ground truth specifies it was filed as Exhibit 10.28 in a later filing (likely a 10-K or 8-K), not a 10-Q. This is a minor error in document type but does not affect the core factual timeline. (2) All numeric values—dates (May 29, 2020; May 26, 2022; November 27, 2024)—are correct. Page numbers (90 and 79) are consistent with source references. No calculations are required, and all dates match the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to show evolution in the plan, identifying both the prior version and the update. It correctly infers that the plan evolved between 2022 and 2024 based on the amendment and restatement. (4) The answer is semantically equivalent to the ground truth, with only a minor inaccuracy regarding the form type (10-Q vs. unspecified filing). The core facts—amendment dates, filing dates, and evolution of the plan—are all correct. Thus, the answer is highly accurate with only a small qualification on filing form type.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 385,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million as of December 31, 2021, to $872 million as of December 31, 2023. This increase indicates that market perceptions of Netflix's debt improved over this period, likely reflecting greater confidence in the company's financial stability and creditworthiness, or a general decline in market interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the fair value of Netflix's 6.375% Senior Notes decreased from $999 million on December 31, 2021, to $872 million on December 31, 2023. However, the LLM incorrectly states that the value increased from $830 million to $872 million. Both the starting value ($830M vs $999M) and the direction of change (increase vs decrease) are wrong. (2) The quantitative inaccuracies are severe: the initial fair value is off by $169 million, and the conclusion about an 'increase' contradicts the actual decrease of $127 million over the period. The ending value ($872M) is correct, but the rest is not. (3) The reasoning is flawed due to incorrect data. The LLM infers improved market perception and greater confidence, but the actual decline in fair value suggests the opposite—potentially deteriorating market confidence or rising required yields. The model fails to correctly synthesize the correct multi-hop information across time points and misinterprets the trend. (4) The contextual relevance is high because the answer addresses the right metric, company, and time frame, and attempts proper interpretation. However, due to major quantitative and qualitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 366,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline, attributed to global competitive pressures, indicates a weakening market position for IMBRUVICA within the oncology segment, despite overall oncology product growth driven by other key therapies like DARZALEX and ERLEADA.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the 2022 sales figure and the calculated percentage decline. The ground truth states IMBRUVICA sales were $4,369 million in 2022, but the LLM incorrectly reports $3.784 billion ($3,784 million), which is $585 million lower than actual. This leads to an incorrect decline calculation: the LLM reports a 13.7% drop, but the correct decline from $4,369M to $3,264M is 25.2%, as stated in the original answer. The 2023 sales figure ($3,264 million) is correct. (2) The quantitative inaccuracies are critical because they misrepresent the severity of the sales decline, which directly impacts the interpretation of market position. While the direction (decline) is correct, the magnitude is severely understated. (3) The qualitative reasoning is sound: the LLM correctly infers that declining sales amid growth in competing products like DARZALEX and ERLEADA indicate a weakening market position, which aligns with the multi-hop logic in the ground truth. It also correctly identifies competitive pressures as a cause. (4) Contextual relevance is high—the answer addresses both parts of the question (sales evolution and market position implication) and references relevant comparator products. However, due to the major error in the key financial data and resulting miscalculation, the correctness score is limited to 5, reflecting partial accuracy with significant factual shortcomings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 400,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve decreased from $168 million to $222 million. The increase in the shrink reserve implies higher estimated inventory shrinkage, which could negatively impact net earnings by approximately $32 million in 2024 if actual shrinkage rates varied by 10%. Conversely, the LCNRV reserve reduction suggests improved inventory valuation, though a 10% change in markdown assumptions could have affected net earnings by approximately $17 million in 2024. Overall, these reserves reflect management's estimates and assumptions, which could influence financial results if actual outcomes differ.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the LCNRV reserve 'decreased from $168 million to $222 million', which is incorrect—the reserve actually increased from $168M to $222M. This misstatement undermines the accuracy of the qualitative interpretation. All other numbers are correct: the shrink reserve increase from $414M to $427M is accurate, and the $32M and $17M impacts on net earnings from 10% changes in shrinkage and LCNRV assumptions are correctly reported. (2) Quantitative accuracy is partially compromised due to the incorrect directional characterization of the LCNRV reserve change, even though the dollar amounts themselves ($168M and $222M) are correct. The calculations and figures related to earnings sensitivity are accurate. (3) The multi-hop reasoning is mostly sound—LLM correctly links reserve changes to implications for net earnings and understands the role of assumptions in inventory valuation. However, the erroneous claim of a 'decrease' in LCNRV reserve despite higher dollar value indicates flawed synthesis or typo that affects logical coherence. (4) Contextual relevance is high as the answer addresses both reserve trends and earnings implications. Correctness and qualitative accuracy are scored mid-range due to the significant error in interpreting the LCNRV trend, despite correct numbers and reasonable logic otherwise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 388,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta experienced significant commercial growth from 2022 to 2023. In 2022, Qulipta generated total net revenues of $158 million, while in 2023, its total net revenues surged to $405 million, representing a growth rate exceeding 100%. This indicates substantial progress in both the development and commercialization of Qulipta, with a notable increase in market adoption and sales performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Qulipta did not generate $158 million in revenue in 2022; instead, it was part of a broader reclassification of $1.0 billion in R&D assets upon regulatory approval, not individual revenue reporting. The 2023 revenue figure of $405 million in the U.S. is correct, but the LLM incorrectly presents this as 'total net revenues' without mentioning the additional $3 million internationally, and falsely claims 2022 revenues of $158 million, which is unsupported by the original answer. (2) The calculation of 'over 100% growth' is based on incorrect input data and is therefore invalid. The ground truth does not provide 2022 revenue for Qulipta, so no growth rate can be accurately computed. (3) The multi-hop reasoning is flawed: the model fails to recognize that the 2022 information is about asset reclassification due to regulatory approval, not revenue generation, and incorrectly infers commercial performance from non-revenue financial events. It also omits the key point about transition from indefinite-lived intangible assets to developed product rights, which is central to Qulipta's status change. (4) While the LLM correctly identifies progress in commercialization and increased revenue in 2023, it fabricates 2022 revenue numbers and misrepresents the nature of the 2022 financial event, leading to a low correctness score. Contextual relevance is moderate because the answer addresses commercialization progress but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 427,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities increased slightly between 2022 and 2023, with reimbursements from Resideo remaining at $140 million in both years, but the receivable from Resideo rising from $157 million in 2022 to $187 million in 2023. This indicates that Honeywell's exposure to environmental liabilities has remained stable, with Resideo continuing to cover 90% of Honeywell's annual net spending up to the $140 million cap. The continued reliance on Resideo suggests that Honeywell's risk exposure related to these liabilities is mitigated, as the subsidiary bears the majority of the financial burden under the indemnification agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo is obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year, and this arrangement remained consistent between 2022 and 2023. However, the LLM incorrectly claims that 'reimbursements from Resideo remained at $140 million in both years' and that the 'receivable from Resideo rose from $157 million in 2022 to $187 million in 2023'—these specific receivable figures and the characterization of increased dependency are not supported by the ground truth and contradict the stated consistency. (2) The quantitative inaccuracies are critical: the $157M and $187M receivable figures are fabricated or misattributed, and while $140 million as a cap is correctly mentioned, implying it was paid in full both years is unsupported. The core financial mechanism (90% up to $140M) is correctly noted, but the erroneous receivable data undermines the conclusion. (3) The multi-hop reasoning is partially sound—linking Resideo’s indemnification to Honeywell’s risk exposure—but incorrectly infers an increase in dependency due to the false receivable data. The conclusion that risk exposure is mitigated is aligned with the ground truth, but the reasoning path is flawed. (4) Correctness is scored low (4) due to major factual errors in numbers and trend assessment. Quantitative accuracy is poor (3) because of invented figures. Qualitative accuracy is moderate (5) as the general structure and concept of indemnification are correct. Contextual relevance is high (8) because the answer addresses the right entities, time frame, and risk implications, despite factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 469,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of cash and cash equivalents has shifted, with a notable decrease in short-term investments from $4,985 million in 2022 to $3,893 million in 2024. This suggests a potential shift in cash management strategy toward maintaining higher liquidity or reallocating funds to other short-term opportunities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Target's definition of 'original maturity' for cash equivalents remained at three months or less from 2022 to 2024, which aligns with the ground truth. However, the LLM introduces financial figures—short-term investments decreasing from $4,985 million in 2022 to $3,893 million in 2024—that are not present in the original answer and were not mentioned in the context provided. There is no indication in the ground truth that these numbers were part of the knowledge graph or relevant to the definition or treatment of 'original maturity.' Thus, while the consistency in definition is correctly identified, the introduction of unverified quantitative data undermines factual accuracy. (2) The numbers cited ($4,985M and $3,893M) cannot be verified against the ground truth, which contains no such figures. This raises concerns about hallucination or incorrect sourcing. Even if the trend were accurate, it was not part of the original evidence, making its inclusion factually unsupported. (3) The reasoning incorrectly shifts focus from the definition and disclosure practices around 'original maturity' to changes in portfolio composition. The ground truth emphasizes a qualitative evolution in disclosure—specifically, the addition of broader fair value discussions in 2024—as indicative of a more comprehensive financial framework. The LLM fails to mention this key point and instead infers a strategic shift based on unsupported numerical trends, missing the actual multi-hop insight about disclosure maturity and financial reporting depth. (4) The correctness score is 5 due to partial factual accuracy on the definition but significant error in introducing unsupported data and missing the core qualitative evolution. Quantitative accuracy is 6 because the numbers may be plausible but are unverified and irrelevant to the actual question about definition changes. Qualitative accuracy is 5 because the model captures part of the definition but fails the deeper reasoning about disclosure and reporting strategy. Contextual relevance is 7 because the answer stays on topic regarding cash management but misdirects with tangential financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 587,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 decreased slightly from $870 million in 2023 to $851 million in 2024, while the classification remained as Level 2 liabilities. In 2025, the notes were reported at $1,000 million, indicating a potential revaluation or issuance. This consistency in classification and the long-term nature of the notes suggest that NVDA maintains a stable long-term debt strategy, leveraging fixed-rate debt to manage its capital structure over extended periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, the carrying value of NVDA's 3.50% Notes Due 2040 was $851 million as of January 28, 2024 (reported in the 2023 fiscal year filing), not $870 million in 2023 as claimed. The LLM incorrectly states a decrease from $870M to $851M, when the ground truth shows no prior value—only $851M as of early 2024. Then, the LLM claims the value was $1,000 million in 2025, which aligns with the ground truth ($1,000M as of January 26, 2025, reported in the 2024 filing), but misattributes the timing and omits the key detail that this reflects a valuation increase with updated disclosures (effective rate 3.54%, remaining term 15.2 years), not necessarily a revaluation or new issuance. (2) The quantitative inaccuracies are critical: the starting value is fabricated ($870M), the direction of change is misleading (decrease vs actual increase from $851M to $1,000M), and the effective interest rate and maturity details are omitted. (3) The reasoning is partially sound—linking stable classification (Level 2) and long-term notes to a consistent debt strategy is reasonable—but fails the multi-hop synthesis because it misrepresents the evolution of valuation and omits key financial disclosures that support the conclusion. (4) Contextual relevance is high as the answer addresses valuation, classification, and strategic implications, but correctness is undermined by core factual errors in numbers and timeline, warranting a low correctness and quantitative accuracy score despite plausible interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 445,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased from $2,009 million to $2,288 million, representing a growth rate of 13.9%. This growth was driven by a 7.8% increase in U.S. revenue and a 20.1% increase in international revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total global revenue for Venclexta in 2022 ($2,009 million) and 2023 ($2,288 million), which matches the ground truth. The growth rate from 2022 to 2023 is stated as 13.9%, which is accurate based on the revenue figures ((2,288 - 2,009) / 2,009 ≈ 13.9%). However, the original answer also specifies that the 2022 growth rate was 10.4%, which the LLM omits. This is a minor omission in completeness, as the question asks about the evolution of financial performance 'between 2022 and 2023' and specifically mentions 'growth rate' (plural), implying both years' growth rates should be addressed. (2) All provided numbers are quantitatively accurate. The 13.9% growth rate is correctly calculated. The additional breakdown into U.S. (7.8%) and international (20.1%) revenue growth is factually consistent with the knowledge graph (if present in source data), but not required for answering the core question. (3) The reasoning is sound and demonstrates multi-hop synthesis (aggregating revenue and deriving growth trends), but fails to fully address the multi-year growth rate comparison, which is a key part of the question. (4) The answer is contextually relevant and adds useful detail, but loses minor points for not explicitly stating the 2022 growth rate, making the response slightly less complete than the ground truth. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 392,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Netflix amended its Executive Severance and Retention Incentive Plan, with the most recent amendment effective January 1, 2024, as disclosed in the 2023 SEC filing. This represents an update from the prior version, which was amended and restated on September 10, 2021, as noted in the 2022 filing. The 2023 filing also references a new plan document titled \"Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,\" indicating a substantive revision to the terms of the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 filing references the plan amended on September 10, 2021, and the 2023 filing introduces a new amendment effective January 1, 2024, filed on December 8, 2023. The LLM correctly identifies both the prior and updated plan names and effective dates. (2) Quantitative accuracy is perfect: both dates (September 10, 2021, and January 1, 2024) are correctly reported, and the filing year context (2022 vs. 2023) matches the source disclosures. (3) The multi-hop reasoning is sound—comparing the two years’ filings to show evolution in the plan structure. The only minor omission is that the LLM does not explicitly mention the December 8, 2023, filing date of the 2024-effective plan, which is included in the ground truth. This does not affect the core conclusion but slightly reduces completeness. (4) The answer is semantically equivalent to the original, uses appropriate terminology, and directly addresses the question about evolution, plan amendments, and effective dates. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 317,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's Benefit Restoration Plan was amended and restated as of January 1, 2025, as noted in the 2024 filing. This indicates that the company updated the plan's documentation to align with evolving regulatory or internal compensation strategies, reinforcing its commitment to providing supplemental retirement benefits for employees whose 401(k) benefits are limited by IRS provisions. This evolution suggests a continued focus on supporting high-level employee retention and compensation flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that the Benefit Restoration Plan was amended and restated effective January 1, 2025, as reflected in the 2024 10-K filing, which matches the original answer's reference to the updated exhibit (10.3) in the 2024 filing. The date and effective year are correct, and the explanation about IRS limitations on 401(k) benefits is consistent. The answer captures the core implication: Lowe's is reinforcing its commitment to supplemental retirement benefits for high-earning employees, indicating strategic management of executive compensation. The only minor shortcoming is that it does not explicitly mention the inclusion of both employee deferrals and employer match components under the plan (noted in the original answer), which slightly reduces completeness in qualitative detail. However, this does not undermine the overall correctness. The reasoning is sound, entities (Lowe's, Benefit Restoration Plan, 401(k), IRS limits) are accurate, and the multi-hop synthesis across years and filings is appropriately handled. Wording differs but meaning is semantically equivalent. Quantitative elements (dates: 2022–2024, effective date January 1, 2025) are precise and correctly reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 357,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's 0.584% Notes Due 2024 had a balance of $1,250 million as of January 28, 2023, and were fully repaid in fiscal year 2025, with a balance of $0 as of January 26, 2025. This indicates that the financial obligation related to these notes was settled in fiscal 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVDA reported a liability of $1,185 million in fiscal year 2023 for the 0.584% Notes Due 2024, but the LLM states $1,250 million as of January 28, 2023 — this number is incorrect. Additionally, the ground truth confirms the notes were fully repaid by fiscal year 2024, as per the 2024 10-K filing. However, the LLM claims repayment occurred in fiscal year 2025, with a zero balance as of January 26, 2025, which contradicts the original timeline. (2) The quantitative inaccuracies are critical: the initial liability amount is off by $65 million, and the repayment date is shifted by a full fiscal year. These errors affect the core of the financial timeline and obligation tracking. (3) While the LLM demonstrates an understanding of the concept — that these notes were eventually repaid — the multi-hop reasoning fails because it does not correctly align the fiscal years and corresponding balances from the correct filings. The synthesis across time points and documents is flawed. (4) Despite the incorrect numbers and timeline, the answer is contextually relevant — it addresses the evolution of the debt obligation and attempts to show a before-and-after. Hence, contextual relevance is high, but correctness and accuracy scores are low due to major factual and temporal errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 385,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue decreased by 7.2% (from $1,541 million in 2022 to $1,430 million in 2023). In the United States, revenue for Mavyret declined by 12.7% (from $755 million in 2022 to $659 million in 2023), while international markets saw a slight decline of 1.9% (from $786 million in 2022 to $771 million in 2023). At constant currency rates, the global decline was less pronounced at 5.7%, with the U.S. market declining by 12.7% and international markets showing a slight increase of 1.0%.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core quantitative data and trends. It accurately reports the 2022 and 2023 global revenue figures ($1,541 million and $1,430 million), U.S. revenue decline from $755 million to $659 million (12.7%), and international revenue decline from $786 million to $771 million (1.9%). The overall global decline of 7.2% is correctly calculated ((1,541 - 1,430)/1,541 ≈ 7.2%). However, the LLM introduces additional information about 'constant currency' adjustments—specifically, a 5.7% global decline and a 1.0% international increase—which are not present in the original ground truth and cannot be verified from the provided data. Since the original answer does not mention constant currency, this addition introduces unverified detail, potentially misleading the user. While the primary facts and calculations are accurate, the inclusion of unsupported metrics reduces quantitative and qualitative accuracy slightly. The reasoning is otherwise sound, with correct multi-hop synthesis across U.S. and international markets and proper calculation of percentage changes. The answer fully addresses all parts of the question and remains contextually relevant. Minor deduction from correctness due to unverified constant currency claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 352,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with all covenant limitations related to its Senior Notes. The covenants primarily restricted the Company's ability to create liens, engage in sale and lease-back transactions, and consolidate or merge with other entities. As of December 31, 2024, Netflix continued to meet all covenants, and there were no material changes in the scope of restrictions compared to 2022. Additionally, the Company repaid $400 million of its 5.750% Senior Notes upon maturity in 2024, demonstrating its ability to meet repayment obligations without defaulting on covenants.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Netflix remained in compliance with covenant limitations in both 2022 and 2024 and accurately reports the $400 million repayment of the 5.750% Senior Notes upon maturity in 2024. These quantitative details—amount, interest rate, and timing—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: the $400 million repayment is correctly cited, and no incorrect numbers are introduced. There are no calculation errors. (3) However, the LLM fails to capture a key qualitative evolution in the covenant scope: the ground truth notes that by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions, indicating a narrowing of covenant scope. The LLM explicitly states there were 'no material changes in the scope of restrictions,' which contradicts the ground truth and misses a critical multi-hop insight about evolving covenant terms. This omission affects the depth of reasoning and accuracy of the synthesis across years. (4) Despite this, the answer is contextually relevant, well-structured, and correctly identifies the core compliance status and repayment event. The correctness score is reduced to 7 due to the significant qualitative inaccuracy regarding covenant evolution, even though key facts and all numbers are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 377,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell restructured its Safety and Productivity Solutions segment by merging the Safety and Retail business unit with the Advanced Sensing Technologies unit to form the Sensing and Safety Technologies business unit. This structural change, announced in July 2022, reflects a strategic shift to consolidate and streamline safety-related offerings under a unified business unit, enhancing operational focus and efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key structural change—merging Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies—and notes the July 2022 announcement, which aligns with the ground truth. The strategic rationale of streamlining operations and enhancing focus is accurately conveyed, though the LLM omits the specific 2022 revenue figure ($2,387 million) for the Safety and Retail unit, which was included in the original answer and directly responsive to the question's request for evolution between 2022 and 2023. (2) All mentioned dates (July 2022) are correct; no numerical inaccuracies are present. The LLM does not include the $2,387 million revenue number, which is a factual omission affecting completeness but not contradicting any data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about organizational changes across time (2022 to 2023) and links the structural change to strategic intent. The only gap is the missing revenue metric from 2022, which weakens the full evolution narrative slightly. (4) Scores reflect high accuracy: full quantitative correctness (10), excellent qualitative reasoning with minor omission (9), and perfect relevance to the question's context (10). The correctness score is 9 because the core facts and synthesis are correct, but the absence of the financial figure from 2022 prevents a perfect score despite semantic proximity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 406,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, the Class B-2 Common Stock emerged as a new class following the Class B-1 Common Stock exchange offer in May 2024, where 241 million shares of Class B-1 Common Stock were exchanged for 120 million shares of Class B-2 Common Stock and 48 million shares of Class C Common Stock. Class B-2 Common Stock is subject to the same transfer restrictions and conversion features as Class B-1 Common Stock, with conversion rates affected by developments in the U.S. covered litigation. This evolution impacts corporate governance by influencing the potential dilution of Class A Common Stock and the voting dynamics among different stockholder classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that Class B-2 Common Stock 'emerged as a new class' in May 2024 as part of an exchange offer involving Class B-1 stock, whereas the original answer clearly states that by 2024, *no shares of Class B-2 were outstanding* prior to any exchange offer—indicating it had already been eliminated or retired. This is a direct contradiction. (2) The LLM claims 241 million Class B-1 shares were exchanged for 120 million Class B-2 and 48 million Class C shares, but this quantitative detail is not supported by the ground truth, which does not mention any such exchange creating Class B-2 shares. There are no numbers in the original about share exchanges involving Class B-2 in 2024. (3) The reasoning is flawed: the LLM suggests Class B-2 became active in 2024, while the truth is it ceased to be outstanding, marking a reduction in governance role. The multi-hop synthesis fails—the question asks about the evolution from active (2023) to non-outstanding (2024), but the LLM reverses the trajectory, suggesting creation rather than elimination. (4) While the mention of convertibility and governance impact aligns thematically, the core facts—existence, timing, direction of change—are incorrect. The answer is contextually relevant in discussing convertibility and governance but fundamentally wrong in execution. Minor score for addressing the right topic areas, but severe penalties for factual inversion and fabricated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 421,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced its ease of shopping experience by further integrating digital and in-store capabilities. In 2023, the company focused on merchandising resets, store navigation improvements, and digital investments to create a more interconnected shopping experience. By 2024, these efforts evolved to include significant enhancements to digital platforms, such as improved mobile app functionality, product \"shopability,\" and fulfillment options, aiming to provide a seamless journey from research to post-purchase support. Additionally, in-store experiences were bolstered with self-service tools, electronic shelf labels, and expanded self-checkout options to increase convenience and speed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in describing The Home Depot's evolution in shopping experience from 2023 to 2024, with accurate timeframes and relevant initiatives. Quantitatively, there are no numeric inaccuracies, as the question and answer do not involve specific figures (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10. Contextual relevance is high—the response directly addresses the question about digital and in-store enhancements across both years. However, the qualitative accuracy is slightly lower because while the LLM captures the general direction of improvements, it omits key specifics from the ground truth. For example, in 2023, the original answer specifies mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout—elements only partially reflected in the LLM response (electronic shelf labels and self-checkout are mentioned, but reconfigured service desks are missing). In 2024, the ground truth emphasizes personalized digital experiences such as customer product review summaries and use of customer data for personalization, which the LLM answer does not mention. Instead, it refers more broadly to 'improved mobile app functionality' and 'fulfillment options,' which are not highlighted in the original. The multi-hop reasoning is sound in structure—comparing two years’ strategies—but misses the deeper synthesis of the shift toward data-driven personalization in 2024. Thus, while the core facts about digital and in-store improvements are present, the absence of specific, differentiating 2024 initiatives reduces completeness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 454,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "The Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024 by introducing new forms of equity awards. In 2022, the plan included awards such as Restricted Stock Units, Performance-Based Restricted Stock Units, and Performance Share Units. By 2024, the plan expanded to include additional award forms, such as Cliff-Vested Restricted Stock Units and Performance Award Performance Share Units, reflecting a more diverse structure to incentivize employees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of the Target Corporation Long-Term Incentive Plan from 2022 to 2024, noting the introduction of new equity award forms such as Cliff-Vested Restricted Stock Units and Performance Award Performance Share Units. These additions match the ground truth, which specifies the inclusion of the 'Cliff-Vested Restricted Stock Unit Agreement' and 'Performance Award Performance Share Unit Agreement' by 2024. However, the LLM omits several award types present in 2022 according to the original answer, including Non-Qualified Stock Options, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. While the core forms (RSUs, PBRSUs, PSUs) are correctly mentioned, the omission of director-specific and option-based awards reduces completeness. (2) There are no numerical values, dates, or calculations in the response beyond the correct years 2022 and 2024, which are accurate. No quantitative errors exist. (3) The multi-hop reasoning is sound—the model correctly infers an expansion in award types over time and synthesizes changes across years. The logic that the plan became more diverse is supported by the data. (4) The answer is contextually relevant and conveys the main point of structural expansion. Due to missing some 2022 award types, it falls short of full qualitative and factual completeness, warranting a score of 8 for correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are unaffected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 431,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta's commercial performance showed significant growth from its FDA approval in September 2021 through 2023. In 2021, Qulipta had no revenues as it was newly approved. By 2022, it generated $158 million in U.S. revenues, and by 2023, its U.S. revenues increased to $405 million, representing a growth of over 150% from 2022. Internationally, Qulipta also saw substantial growth, moving from $0 in 2021 to $158 million in 2022 and $408 million in 2023. Overall, Qulipta's total revenues increased by more than 100% in both 2022 and 2023 compared to the previous year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the international revenue figures. According to the ground truth, Qulipta generated $3 million internationally in 2023, not $408 million as stated in the LLM answer. Additionally, the LLM incorrectly claims $158 million in international revenue in 2022, while the ground truth reports no international revenue in 2022. The U.S. revenue figures are correct: $0 in 2021, $158 million in 2022, and $405 million in 2023. However, the LLM incorrectly states total 2023 revenue as $408 million from international sales alone, when in fact total revenue (U.S. + international) was $408 million. (2) Calculations are flawed: the LLM claims international revenue grew to $408 million in 2023, which is actually the total global revenue, not international alone. The claim that total revenues increased by over 100% in both 2022 and 2023 is misleading—while growth from 2022 to 2023 was significant (~156% in U.S. revenue), the 2021 to 2022 growth was from zero to $158M, which is infinite percentage growth, but the LLM misrepresents this. (3) Multi-hop reasoning is partially sound—the model correctly identifies the timeline and U.S. revenue progression, but fails to accurately synthesize international revenue data, leading to a distorted overall picture. (4) Despite strong contextual relevance and correct identification of the drug, company, approval date, and general growth trend, the severe quantitative inaccuracies in international revenue and totals significantly undermine the factual correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 446,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix's 2020 Stock Plan, as disclosed in the 2022 and 2024 SEC filings, has seen a significant reduction in activity. In 2022, the plan included active stock options with grants of 1.7 million shares and exercises of 1.9 million shares, while in 2024, grants dropped to 576,000 shares and exercises surged to 4.8 million shares, indicating a shift toward option utilization rather than issuance. Additionally, the 2024 filing highlights that no stock options were granted in 2022, and the focus shifted to RSUs and PSUs, with the 2020 Stock Plan emphasizing market-based performance targets for PSUs. This evolution reflects a strategic shift in equity compensation toward performance-based incentives and a decline in traditional stock option usage.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual errors. (1) The Original Answer (ground truth) states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list with no detailed description or activity disclosed, while in 2024 it was described in detail with specific equity instruments and vesting criteria. The LLM answer fabricates quantitative data: there is no mention in the ground truth of 1.7 million or 576,000 share grants, 1.9 million or 4.8 million exercises, or any claims about stock option activity in 2022 or 2024. These numbers are entirely unsupported and incorrect. (2) The LLM incorrectly asserts that 'no stock options were granted in 2022' and that the focus shifted to RSUs and PSUs with market-based targets—this level of detail is not present in the ground truth for 2022, and the shift described is misrepresented. The ground truth emphasizes a change in disclosure depth (from minimal to detailed), not a change in the volume or type of grants. (3) The multi-hop reasoning is flawed: the LLM invents a narrative about declining issuance and rising exercises based on non-existent data, failing to capture the actual evolution—which is in disclosure transparency and descriptive detail, not in quantitative activity. (4) While the LLM attempts to address equity compensation evolution, it misrepresents both the nature and direction of change. The contextual relevance is moderate because it discusses equity plans and disclosure trends, but the factual foundation is entirely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 432,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company's approach to aluminum purchase agreements evolved by continuing to classify them as derivative instruments for accounting purposes, as these agreements were tied to prevailing market prices and used to address long-term strategic sourcing needs. However, these agreements did not qualify for hedge accounting treatment, meaning changes in their fair value were directly recognized in earnings rather than being deferred in accumulated other comprehensive income (AOCI). This reflects a strategic use of derivatives to manage commodity price risks without the benefits of hedge accounting, which could have smoothed earnings volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces information not present in the ground truth, specifically that the aluminum purchase agreements 'did not qualify for hedge accounting treatment' and that changes in fair value were recognized in earnings. This detail is absent from the original answer and cannot be verified from the provided ground truth, making it a significant factual overreach. Additionally, the LLM fails to mention the key evolution noted in the original answer: that by 2023, the quantities of aluminum in the contracts offset each other and are priced at prevailing market prices—a central point about the strategic refinement in their approach. Instead, the LLM focuses on the lack of hedge accounting, which shifts the emphasis away from the actual evolution described. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable; however, no incorrect numbers are introduced, so this dimension is neutral. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the continuity of classifying aluminum agreements as derivatives and their strategic use. However, it fails to synthesize the correct evolution between 2022 and 2023 as described in the ground truth—specifically the offsetting quantities and market pricing alignment—indicating a failure in accurate cross-year synthesis. (4) The correctness score is 4 due to significant omissions of key strategic developments and the introduction of unverified accounting details. Qualitative accuracy is low for the same reasons. Contextual relevance is moderate because the answer addresses the general topic of derivative use in aluminum procurement but misses the specific evolution highlighted in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 487,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible via the company's website, with no changes to its availability. In both years, the Code was posted online at a dedicated link under investor relations. However, in 2024, there was a slight refinement in the description of the Directors' Code of Conduct, explicitly stating that it applies to all directors of BNY Mellon, reinforcing its scope. No amendments or waivers were disclosed during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. While it correctly states that the Directors' Code of Conduct remained accessible online in both years, it fails to note the significant change in the URL between 2023 and 2024, which reflects a reorganization of the document's location and categorization (e.g., domain change from 'bnymellon.com' to 'bny.com', path updates). More critically, the LLM claims there was only a 'slight refinement in the description' in 2024, whereas the ground truth reveals the addition of an entirely new section titled 'INSIDER TRADING POLICIES AND PROCEDURES'—a substantive expansion of scope, not a minor wording update. The LLM also omits any mention of the new compliance focus, which is central to the evolution of the document. (2) There are no numeric values to assess, so quantitative accuracy is not applicable; however, the years (2023, 2024) are correctly referenced, earning full marks here. (3) The reasoning is flawed: the model fails to synthesize the multi-hop evidence showing both a structural change (URL shift indicating accessibility changes) and a content expansion (new insider trading section). Instead, it minimizes the changes, contradicting the ground truth. (4) Contextual relevance is moderate—the answer addresses accessibility and scope as asked, but with incorrect details and omissions, reducing its usefulness. Overall, major factual inaccuracies and missing key developments justify a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 413,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "The structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024 with the issuance of new tranches, indicating a strategic approach to long-term debt management. In November 2023, HD issued $750 million of 4.95% Senior Notes due September 30, 2026, and in June 2024, HD issued $1.75 billion of 4.95% Senior Notes due June 25, 2034. These issuances suggest that HD is extending the maturity profile of its debt and accessing capital markets to finance acquisitions and manage liquidity, reflecting a strategy to diversify debt maturities and secure long-term funding at favorable interest rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, HD issued $750 million of 4.95% senior notes due 2026 in 2023 and later reported a separate $980 million of 4.95% senior notes due 2052. However, the LLM incorrectly states that HD issued $1.75 billion of 4.95% notes due June 25, 2034, in June 2024—this issuance does not match the ground truth data. Additionally, the LLM omits the 2052 notes entirely and fabricates a maturity date (June 25, 2034) and amount ($1.75 billion) not present in the original answer. The carrying amount of $747 million as of February 2, 2025, for the 2026 notes is also missing from the LLM response. (2) Quantitative accuracy is low: the $1.75 billion figure and June 2034 maturity are incorrect; the $980 million 2052 notes are omitted; the $1.6 million discount and updated carrying value are not mentioned. Only the $750 million 2026 note issuance is correct. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that extending maturities suggests a long-term debt strategy—but it does so based on fabricated data. The actual strategy implied by the ground truth (extending to 2052, not 2034) is misrepresented. (4) Contextual relevance is high because the answer addresses the evolution of the note structure and interprets strategic intent, but the factual foundation is flawed, undermining correctness and qualitative accuracy. The conclusion about diversifying maturities is plausible but based on incorrect inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 420,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its investment in Beijing Unisoc Technology Ltd. in 2021, and as of December 30, 2023, the net book value of the investment remained at $1.1 billion, unchanged from December 31, 2022. No observable price adjustments were noted for Unisoc in 2022 or 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $471 million observable price adjustment in 2021 and the $1.1 billion net book value as of December 30, 2023 (unchanged from December 31, 2022) are accurately reported. The dates and dollar amounts match the original answer, with acceptable formatting. (2) The answer is complete, addressing both the 2021 observable price adjustment and the 2023 net book value, along with the stability of valuation over the period. It correctly notes the absence of observable price adjustments in 2022 and 2023, which is consistent with the implication in the original answer that no further adjustments occurred. (3) Entity accuracy is perfect: Intel, Beijing Unisoc Technology Ltd., and the correct fiscal dates are used. The financial terms—'observable price adjustments,' 'net book value,' and 'non-marketable equity security' (implied by lack of adjustments and stable book value)—are contextually appropriate. (4) The reasoning is sound: the LLM correctly synthesizes the evolution of the investment over time, inferring that the absence of new adjustments and the stable book value indicate consistent accounting treatment as a non-marketable security. The semantic meaning is equivalent to the original answer, with slightly more explicit detail (e.g., stating no adjustments in 2022/2023), enhancing clarity without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 394,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022, Qulipta had not yet received regulatory approval, as it was still in the development phase, with its status as indefinite-lived intangible assets noted in AbbVie’s 10-K filing. By April 2023, AbbVie achieved a key milestone when the FDA approved Qulipta for the preventive treatment of chronic migraine in adults. Additionally, in August 2023, the European Commission approved Aquipta (Qulipta) for the preventive treatment of migraine in adults with four or more migraine days per month. This transition from development to regulatory approval marked significant progress in Qulipta’s commercialization, positioning it for market entry and revenue generation in both the U.S. and Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory milestones for Qulipta in 2023—FDA approval in April 2023 for chronic migraine prevention in adults and EC approval in August 2023 for adults with four or more migraine days per month—matching the ground truth. It also accurately reflects the 2022 status, noting Qulipta was still in development and classified as an indefinite-lived intangible asset. However, the ground truth specifically mentions the reclassification of $1.0 billion in R&D intangible assets to developed product rights due to regulatory approvals, a financial detail omitted in the LLM response. This is a minor but notable omission in completeness. (2) All dates (April 2023, August 2023) and regulatory bodies (FDA, EC) are correct. No numerical calculations are required, but the reference to the $1.0 billion asset reclassification in the original answer is missing in the LLM response, which slightly affects quantitative completeness. (3) The multi-hop reasoning is sound: the LLM correctly infers progression from development (2022) to regulatory approval (2023) and links this to commercial development. It synthesizes regulatory and commercial timelines accurately across years, though it does not incorporate the financial accounting impact (asset reclassification), which is part of the full evolution. (4) The answer is highly factually accurate, contextually relevant, and well-reasoned. The omission of the $1.0 billion asset reclassification prevents a perfect score, but all other elements—regulatory status, timeline, and commercial implications—are correctly conveyed with semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 452,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Based on the provided document pages, Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment remained consistent between 2022 and 2023. In both years, the segment is described as providing services that include \"upgrades and conversions\" as part of a full spectrum of offerings to sustain aerospace platforms and systems for commercial and defense customers. There is no notable evolution in the language or strategic emphasis on this specific service area between the two filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, which directly contradicts the ground truth. While there are no numeric figures to verify (so quantitative accuracy is 10 by default), the qualitative analysis fails significantly. The original answer identifies a clear evolution in Boeing's strategic framing of 'upgrades and conversions' from a general service offering in 2022 to a more integrated and strategically emphasized capability in 2023. The LLM, however, claims there is 'no notable evolution,' which is incorrect. This misrepresents the multi-hop synthesis required: comparing the contextual language and positioning of the service across two years. The ground truth notes a shift from being listed among other services (2022) to being embedded within a 'structured narrative' emphasizing system sustainment (2023), indicating strategic elevation. The LLM overlooks this nuance, failing to detect the qualitative shift in emphasis. Contextual relevance is moderate because the answer addresses the right segment and service, but it draws the wrong conclusion about change over time. Thus, correctness is low due to a major factual inaccuracy in interpretation despite correct entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 342,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. was valued at $1.1 billion as of both December 30, 2023, and December 31, 2022, indicating no significant change in its net book value during this period. During 2021, Intel recognized $471 million in observable price adjustments for its investment in Unisoc, reflecting changes in valuation based on market conditions. The consistent valuation in 2022 and 2023 suggests that the investment's fair value remained stable or that adjustments were offset by impairments or other factors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion net book value of Intel's investment in Beijing Unisoc Technology Ltd. and accurately reports the $471 million observable price adjustment recognized in 2021. However, it incorrectly states the 2022 date as December 31, 2022, while the ground truth uses data from the 2022 filing referencing December 25, 2021, and the 2023 filing referencing December 30, 2023. The LLM misaligns the fiscal year reporting, implying stability between 2022 and 2023 when the original answer compares 2021 and 2023 directly. This is a minor but notable date misattribution. (2) Quantitatively, all dollar amounts ($1.1 billion and $471 million) are correct and properly contextualized. The valuation figures match the ground truth, though the time points are slightly misaligned. (3) The multi-hop reasoning is mostly sound: the model correctly infers that consistent book value suggests valuation stability and connects the 2021 adjustment to market-based revaluation. However, it fails to note that the 2023 filing does not mention any observable price adjustments, which the original answer highlights as a meaningful absence suggesting stabilization or lack of change. This nuance is missing. (4) Despite the date discrepancy and slight omission regarding the absence of 2023 adjustments, the core facts and synthesis are accurate. The answer remains contextually relevant and conveys a largely correct interpretation, warranting a high score but not perfect due to the fiscal date misstatement and incomplete contrast between 2021 and 2023 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 440,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has expanded as part of the company's ongoing investments to improve customer convenience and efficiency. In fiscal 2023, Home Depot introduced self-service lockers, online order storage areas, and curbside service to enable convenient online order pickup options. By 2024, these lockers were further integrated into the store experience, supporting the seamless blend of digital and physical shopping by allowing customers to easily retrieve online orders. This enhancement reflects Home Depot's focus on delivering a frictionless, interconnected experience across all customer touchpoints.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Self-Service Lockers from 2023 to 2024 as part of Home Depot's customer experience improvements, noting their role in online order pickup and integration into the digital-physical shopping experience. However, it omits key strategic developments highlighted in the ground truth, particularly the explicit positioning of lockers within Home Depot's broader fulfillment network and their integration with specific omnichannel programs like BOSS, BOPIS, BODFS, and BORIS. Additionally, the critical quantitative insight that approximately 50% of U.S. online orders were fulfilled through stores in 2024 — a key indicator of operational integration — is missing entirely. (2) There are no numeric inaccuracies because the LLM answer does not include any numbers or percentages; thus, quantitative accuracy is high by default. (3) The multi-hop reasoning is partially sound: the model correctly infers increased integration from 2023 to 2024, but fails to synthesize the full scope of operational and strategic shifts involving fulfillment networks and specific retail programs, which represent essential multi-hop connections in the ground truth. (4) The answer remains contextually relevant and conveys a plausible narrative, but lacks completeness in capturing the depth of the shift from a convenience feature to a core fulfillment component, which limits the correctness and qualitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 406,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities in 2024 (page 31) provides a more detailed explanation compared to 2023 (page 46). In 2024, the company explicitly mentions that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions, and it highlights the unpredictability of claim costs due to factors like inflation and regulatory changes. In contrast, the 2023 disclosure is more general, stating that the company uses risk management mechanisms like a captive insurance subsidiary and reinsurance but does not elaborate on the specific estimation factors. Thus, the 2024 disclosure offers greater specificity and transparency in its estimation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Costco provided a general description of its self-insurance practices, including the use of a captive insurance subsidiary and reinsurance, without specifying estimation factors—this matches the original answer. In 2024, it accurately states that the company added specificity by detailing the use of historical claims experience, demographic factors, severity factors, and actuarial assumptions. It also correctly notes the new discussion of unpredictability in claim costs due to inflation and regulatory changes, which reflects the increased transparency mentioned in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2023, 2024), which are correct. Page numbers (31 and 46) are additional details not in the ground truth but do not contradict it and may reflect actual filing locations; they do not affect factual accuracy. (3) The multi-hop reasoning—comparing disclosures across two years and identifying evolution in specificity—is sound and well-executed. The LLM correctly synthesizes changes in disclosure depth and attributes them to increased transparency. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 disclosure's note about the potential for significant differences between actual and recorded liabilities, which is included in the ground truth. This is a small omission but does not undermine the overall correctness. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 467,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from 2022 to 2023 as follows: In 2021, the acquisition of Aldevron resulted in $30 million of non-recurring acquisition date fair value adjustments to inventory. In 2022, there were no specific inventory-related costs mentioned directly tied to Aldevron. However, in 2023, a $87 million charge was incurred primarily related to excess inventory in the Biotechnology segment due to reduced demand, which indirectly reflects the ongoing impact of integration and market adjustments post-acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the Aldevron acquisition occurred in 2021 with a $30 million adjustment, while the ground truth specifies a $59 million increase in cost of sales in 2022 due to fair value adjustments. The LLM also claims there were no specific inventory-related costs tied to Aldevron in 2022, which directly contradicts the original answer. The only correct quantitative point is the $87 million charge in 2023 related to excess inventory in the Biotechnology segment. (2) Number verification: $30 million (incorrect, should be $59M in 2022), 2021 acquisition date (incorrect, acquisition impact was reported in 2022), absence of 2022 Aldevron costs (false, $59M was explicitly due to Aldevron). The $87 million figure is correctly cited. (3) Multi-hop reasoning is flawed: the model fails to correctly link the 2022 inventory cost to Aldevron and misattributes the 2023 charge as an 'indirect' impact of Aldevron, whereas the original answer clearly distinguishes the 2023 charge as a new operational issue unrelated to acquisition accounting. (4) Scores reflect major factual errors in timing, magnitude, and causality. The contextual relevance is moderate because the answer discusses inventory costs and the Biotechnology segment, but the core financial evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 381,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco has consistently recognized shop card liabilities as a liability net of estimated breakage, with no material changes in the accounting treatment. The Company accounts for outstanding shop card balances as a \"shop card liability,\" included in other current liabilities in the consolidated balance sheets, and recognizes revenue upon redemption. The absence of notable changes in treatment indicates that Costco maintains a consistent and conservative approach to unclaimed balances, factoring in historical redemption data to estimate breakage. This suggests a reliable and transparent method for managing shop card liabilities and recognizing potential unclaimed balances as income.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's accounting treatment of shop card liabilities in both 2023 and 2024, correctly stating that revenue is recognized upon redemption and that liabilities are recorded net of estimated breakage. All entities (Costco, shop card liability, breakage, redemption) and years (2023, 2024) are correct, and there are no numerical inaccuracies—though no specific dollar amounts are mentioned, which is acceptable given the qualitative nature of the question. The reasoning is sound and reflects a proper synthesis of accounting practices across the two years. However, the LLM states there were 'no material changes' and 'absence of notable changes,' which downplays the evolution highlighted in the ground truth: the increased emphasis on 'estimated breakage' and methodology tied to redemption data in 2024, indicating a more refined approach. The original answer interprets this as a sign of improvement in estimation techniques, while the LLM interprets consistency, missing the nuance of a more formalized or emphasized methodology in 2024. This is a minor but meaningful distinction in qualitative interpretation, especially for assessing the evolution in approach. Thus, while the core facts are correct and the answer is highly relevant, the LLM underrepresents the degree of evolution in Costco's approach, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 389,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2022, Intel launched the IFS Accelerator Ecosystem Alliance program, which doubled in size by 2023 to over 40 strategic agreements, including multigenerational agreements with ARM and a definitive agreement with Synopsys to enhance IP development on advanced nodes. In 2023, Intel secured four design wins on Intel 18A, expanded partnerships under the RAMP-C program with major customers like Nvidia and Microsoft, and announced a commercial agreement with Tower to provide foundry services in New Mexico. These initiatives reflect a stronger ecosystem collaboration and increased customer commitment to Intel's foundry offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's Foundry Services from 2022 to 2023 with accurate key developments. It correctly states that the IFS Accelerator Ecosystem Alliance grew to over 40 strategic agreements by 2023 and highlights multigenerational agreements with ARM and Synopsys, aligning with the ground truth. It accurately notes four design wins on Intel 18A in 2023. However, it introduces 'RAMP-C program' partnerships with Nvidia and Microsoft, and a commercial agreement with Tower, which are not mentioned in the original answer and cannot be verified from the provided ground truth, constituting minor hallucinations. (2) Quantitatively, all numbers (four design wins, over 40 agreements) are correct and match the original answer. The timeline (2022 launch, 2023 expansion) is accurate. (3) The multi-hop reasoning is sound in connecting 2022 strategic intent to 2023 customer engagements, and in synthesizing ecosystem growth with specific partnerships. The inclusion of unverified partnerships (Nvidia, Microsoft, Tower) slightly undermines the qualitative accuracy, but the core synthesis of Intel’s progression is valid. (4) The answer is highly contextually relevant, directly addressing strategic partnerships and customer engagement evolution. The core facts are correct, but the addition of unsupported details prevents a top score. Thus, correctness is rated 8 due to minor factual overreach, despite strong alignment with the main developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 414,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron, primarily in terms of goodwill and net cash consideration, remained stable. In 2021, the Aldevron acquisition resulted in approximately $6.1 billion of goodwill being recorded. By 2023, there was no significant adjustment or impairment noted for this goodwill. Additionally, the net cash consideration for the Aldevron acquisition in 2021 was approximately $9.56 billion, and there were no material changes to this amount in the subsequent years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the $6.1 billion goodwill was recorded in 2021, while the ground truth specifies 2022. Similarly, it claims the $9.56 billion net cash consideration occurred in 2021, but the original answer states that the net cash consideration increased to $9.561 billion in 2023. These misattributions of key financial figures to the wrong years severely undermine factual correctness. (2) Quantitatively, the numbers themselves ($6.1 billion and ~$9.56 billion) are close to the ground truth, but their assignment to incorrect years makes them misleading. The LLM also rounds $9.561 billion to $9.56 billion, which is acceptable, but the timing error is critical. (3) The reasoning is flawed: the question asks about the evolution between 2022 and 2023, but the LLM incorrectly frames the acquisition as occurring in 2021 and claims no changes since then, contradicting the ground truth which shows a progression from initial goodwill in 2022 to increased cash consideration in 2023. The model fails to capture the multi-hop evolution of financial impact over time. (4) Contextual relevance is moderate because it discusses the right entities (DHR, Aldevron, goodwill, net cash consideration) and the general topic of financial impact, but the incorrect timeline and static interpretation result in a substantially inaccurate narrative. The core of the question—how the financial impact evolved—is fundamentally misunderstood.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 415,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes changed from September 14, 2039 (2022 filing) to September 5, 2026 (2024 filing). This indicates that AT&T refinanced or replaced the long-term debt with a shorter-term obligation, suggesting a shift toward managing near-term liquidity and potentially reducing long-term debt exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in terms of factual content. It reverses the maturity dates between the 2022 and 2024 filings. According to the ground truth, the 2022 filing listed the maturity date as September 5, 2026, and the 2024 filing updated it to September 14, 2039—indicating a significant extension of debt maturity. The LLM incorrectly states the opposite: that the date changed from 2039 to 2026, implying a shortening of maturity, which is factually wrong. (2) The dates are quantitatively inaccurate—both the starting and ending dates are swapped. This leads to a false conclusion about the direction of change in the debt structure. (3) The multi-hop reasoning is flawed because the model failed to correctly identify and compare the same class of notes across two filings. Instead of recognizing a long-term refinancing or extension of debt (which would suggest improved long-term stability), the model incorrectly infers a shift toward near-term obligations, which contradicts the actual data. (4) The contextual relevance is partially preserved because the answer attempts to interpret the implication for debt structure, but the reasoning is based on reversed facts, rendering the conclusion invalid. Due to complete factual inversion of key dates and resulting incorrect analysis, the correctness score is very low at 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 379,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024. In 2024, the company secured a new $1.0 billion 364-day unsecured revolving credit facility expiring in October 2025, replacing the prior 364-day facility, and extended its existing $3.0 billion unsecured credit facility to October 2028. These structural changes to its credit facilities provided continued liquidity support and flexibility, ensuring compliance with covenants without any material impact on its financial operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $1.0 billion 364-day facility renewed to October 2025, $3.0 billion five-year facility extended to October 2028—this matches the original answer, though the original notes the prior 364-day facility was set to expire in October 2024, which the LLM correctly implies by stating it was replaced. (2) The LLM correctly identifies Target’s continued compliance with the debt leverage covenant in both years, addressing the first part of the question. (3) Regarding credit facility changes, the LLM accurately captures the renewal and extension of facilities, though it slightly mischaracterizes the $3.0 billion facility as having been 'extended' in 2024, while the original answer states it was already set to expire in 2028 (implying it was not newly extended in 2024). This is a minor inaccuracy in timing interpretation but does not materially distort the facts. (4) The reasoning is sound: the LLM correctly infers that the renewal of the 364-day facility supports covenant compliance, demonstrating proper multi-hop synthesis between facility structure and covenant adherence. (5) Semantic equivalence is strong—wording differs but meaning is preserved. The answer is fully relevant and responsive. Deducted 1 point from correctness and qualitative accuracy due to the slight misrepresentation of the $3.0 billion facility extension timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 404,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "From 2022 to 2023, Intel's approach to expanding digital readiness for global populations under its RISE strategy has evolved by deepening its focus on external collaboration and inclusive initiatives. In 2022, Intel emphasized its RISE strategy goals, including expanding digital readiness through partnerships like the Alliance for Global Inclusion and the development of an Inclusion Index to benchmark diversity and inclusion practices. By 2023, Intel expanded on these efforts by actively participating in global initiatives that aim to close persistent gaps in digital access and workforce inclusivity, while also embedding inclusive leadership practices and collaborating on programs to expand the diverse talent pipeline and advance social equity. These efforts reflect a more strategic and collaborative approach to leveraging Intel's scale and expertise to drive broader societal impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of Intel's evolution in digital readiness under the RISE strategy and correctly identifies the Alliance for Global Inclusion and the Inclusion Index as key components. However, it omits critical quantitative and outcome-specific details present in the ground truth. Notably, it fails to mention the publication of the third global inclusion index survey in 2023, the benchmark of 50% for recognition, the fact that 18 out of 27 organizations were recognized, and that Intel was one of them—key evidence of the shift to a performance-based system. These omissions significantly affect factual completeness and accuracy. (2) Quantitative accuracy is low because the answer does not include any of the specific numbers (e.g., 50%, 18 out of 27) that anchor the evolution from framework-building to measurement and recognition. While no incorrect numbers are stated, the absence of these metrics—central to the 2023 development—undermines the answer's precision. (3) The multi-hop reasoning is partially sound: the model correctly links Intel’s RISE strategy to external collaboration and digital readiness, and infers a progression toward more strategic impact. However, it does not fully synthesize the evolution from creating a framework (2022) to implementing a measurable, outcome-driven recognition system (2023), which is the core of the ground truth. (4) Contextual relevance is high because the response stays focused on Intel, the RISE strategy, digital readiness, and collaboration. The qualitative accuracy is moderate—while the entities and general strategy are correct, the lack of specific milestones and results limits the depth and factual fidelity of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 473,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson initially agreed to acquire Micromine in 2022 but terminated the agreement in August 2023 due to regulatory uncertainties, particularly in Russia. This termination resulted in the cancellation of foreign currency forward contracts previously used to hedge the transaction. Financially, the termination had minimal direct cost to Emerson, as no termination fee was paid. However, it reflects a strategic shift and potential missed opportunity in expanding into the mining solutions market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. It incorrectly states that Emerson agreed to acquire Micromine in 2022, while the ground truth specifies the agreement was in 2023. The termination date (August 2023) is plausible but not confirmed in the ground truth. The LLM claims 'no termination fee was paid' and 'minimal direct cost,' but the ground truth highlights a $24 million mark-to-market gain in 2023 from foreign currency forward contracts—this is a key financial implication that the LLM omits. Instead, the LLM incorrectly frames the financial impact as 'minimal,' missing the positive gain entirely. Additionally, the LLM fails to mention that AspenTech (an Emerson subsidiary) was the acquirer, reducing entity accuracy. (2) Quantitatively, the LLM omits the AU$900 million (~$623M USD) acquisition value and the $24M gain—both critical figures. The absence of these numbers severely undermines quantitative accuracy. (3) The reasoning partially captures the strategic shift but fails to synthesize the financial consequences correctly. The termination of the forward contracts is mentioned, but their prior existence and the resulting gain in 2023 are not connected accurately. The multi-hop synthesis between Emerson, AspenTech, the acquisition attempt, hedging instruments, and financial outcomes is incomplete. (4) Despite missing key facts and numbers, the answer remains contextually relevant by addressing the evolution of the relationship and hinting at strategic implications. However, the lack of precise financial data and incorrect timeline reduce correctness. The answer is not irrelevant but is significantly incomplete and partially misleading on financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 466,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from approximately 17 million shares in 2022 to approximately 15 million shares in 2023. The average purchase price of shares under the ESPP also decreased from $305.14 in 2022 to $277.19 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the share availability decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price decreased from $305.14 to $277.19. These values are reported exactly as in the original answer, with no calculation or transcription errors. (2) The answer is complete, addressing both parts of the question—changes in share availability and average purchase price—across the two fiscal years. (3) Entity accuracy is correct: The Home Depot, U.S. ESPP, and the fiscal years 2022 and 2023 are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers trends (decreases in both share availability and purchase price) by comparing data across years. While the LLM answer is more concise than the original, it retains all key factual content and conveys the same semantic meaning. No errors in logic, numbers, or relevance are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 292,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, the pattern of impairment triggers and associated charges across DHR's business segments shows a notable shift. In 2022, there were no impairment charges recorded, while in 2023, the Company recorded $77 million in impairment charges, primarily triggered by challenges in the Biotechnology and Diagnostics segments. This indicates a growing risk in the intangible asset portfolio, particularly in technology-based and long-lived assets, as certain segments face performance pressures or market changes. The shift suggests increased vulnerability in specific high-growth areas of DHR's business, reflecting evolving market dynamics and operational challenges.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 filing. It claims 'no impairment charges recorded' in 2022, which contradicts the ground truth stating a $10 million charge in the Diagnostics segment in Q1 2021 (disclosed in the 2022 filing). This is a critical error in both entity timing and quantitative reporting. The $77 million charge in 2023 is correctly reported. (2) Quantitative accuracy is partially correct: the $77 million 2023 charge is accurate, but the omission and mischaracterization of the 2022/2021 $10 million charge undermines the comparison. The answer incorrectly implies no prior impairments, distorting the evolution. (3) Qualitatively, the reasoning about increasing risk in the intangible asset portfolio, particularly in Biotechnology and Diagnostics, aligns with the ground truth. The identification of shifting risks and market dynamics shows sound high-level interpretation. However, it fails to note that the Biotechnology segment was previously uninvolved in impairments, a key multi-hop insight from the ground truth. The answer also omits the multi-quarter and multi-segment pattern in 2023 (Q2 and Q4), reducing completeness. (4) Contextual relevance is strong—the answer addresses the core question about evolving patterns and implications for intangible asset risks. Despite factual flaws, it maintains focus and draws a reasonable, albeit oversimplified, conclusion. The score reflects partial correctness with major omissions in key facts and timeline accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 428,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This increase indicates a higher level of the company's involvement in business transactions tied to trade contracts, insurance programs, and construction contracts during 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the increase in the value of outstanding letters of credit from $362 million in 2022 to $598 million in 2023, matching the ground truth exactly in both numbers and years. (2) Quantitative accuracy is perfect—both values are correct, and the direction of change (increase) is accurately described. (3) The reasoning is mostly sound: the increase is correctly interpreted as indicating greater involvement in trade-related transactions. However, the LLM adds 'insurance programs, and construction contracts,' which were not mentioned in the original answer or implied by the ground truth. This introduces extraneous information not supported by the source, slightly reducing qualitative accuracy. (4) Despite this minor overextension, the core multi-hop synthesis—linking the increase in letters of credit to heightened trade contract activity—is valid and relevant. The answer remains highly accurate and contextually appropriate, warranting a high correctness score with a small deduction for the unsupported expansion of transaction types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 309,
        "total_tokens": 1475
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The status of the 0.300% Notes due 2028 is consistently disclosed in both the 2023 and 2024 SEC filings, with the 2024 filing specifying that the instruments defining the rights of holders are incorporated by reference from a Form 8-K filed in 2020, just as in the 2023 filing. This consistency indicates that IBM maintains thorough and stable financial instruments disclosures, ensuring transparency and traceability for investors by referencing the original filings where the terms of these notes were initially detailed.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that there was a significant evolution in the status of the 0.300% Notes due 2028 between the 2023 and 2024 filings — from being disclosed via Exhibit 4.1 in a 2020 Form 8-K to being listed as an actively traded instrument (IBM28B) on the NYSE in 2024. However, the LLM incorrectly asserts that the status was 'consistently disclosed' with no change, which contradicts the ground truth. (2) Quantitatively, the LLM correctly references the 2020 Form 8-K and the incorporation by reference, which aligns with the original answer’s mention of Exhibit 4.1 filed on February 10, 2020. There are no numerical values to verify (e.g., dollar amounts), but dates and percentages (0.300%, 2028 maturity) are correctly used. (3) The multi-hop reasoning is flawed: the question requires comparing two filings across time to detect a change in disclosure status (from static legal reference to active trading symbol), but the LLM fails to identify this shift and instead asserts consistency. This indicates a failure in synthesizing the evolution across filings. (4) Contextual relevance is moderate — the answer discusses SEC disclosures and references correct document types and years, so it stays on topic, but it misses the key interpretive point about increased market engagement or liquidity signaled by the new trading symbol. The conclusion about 'stable disclosures' is misleading given the actual progression toward active market recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 422,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In 2023, the 1.750% Notes due 2031 were disclosed as being listed on the New York Stock Exchange under the trading symbol \"IBM31,\" as noted in the 2023 filing. In 2024, the same disclosure appears in the 2024 filing, confirming continued registration on the New York Stock Exchange under the same symbol. There is no indication of any material change in the treatment, registration, or exchange listing of these notes between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the 1.750% Notes due 2031 were already listed on the New York Stock Exchange under the symbol 'IBM31' in 2023, which contradicts the ground truth. According to the original answer, in 2023 the notes were only disclosed with the instrument incorporated by reference from a 2019 filing—there was no mention of NYSE listing at that time. The listing under 'IBM31' occurred in 2024, representing a material change from disclosure to formal registration. The LLM answer falsely claims there was 'no material change' between 2023 and 2024, which is factually incorrect. (2) Quantitatively, the note details (1.750%, due 2031) and the trading symbol 'IBM31' are accurate, and the years (2023, 2024) are correctly referenced, so numeric and symbolic elements are mostly correct. However, the misattribution of the listing timeline undermines factual accuracy. (3) The multi-hop reasoning fails: the question asks about the evolution between years, requiring comparison across filings. The LLM incorrectly asserts continuity when the ground truth describes progression—from disclosure to active listing—indicating a failure in synthesizing the change over time. (4) Contextual relevance is fair because the answer addresses disclosure and listing, but the core conclusion is wrong. Due to the significant factual error regarding the timing of the NYSE registration, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 406,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Lilly recognized $1.45 billion in revenue from this transaction, marking a strategic shift in its business model by divesting certain legacy assets. In 2024, while no further revenue from Zyprexa was reported, the business model transitioned to a post-sale arrangement, with the focus shifting to new product development and collaborations. This move reflects a broader strategy to streamline operations and invest in innovative therapies rather than relying on revenue from older products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.45 billion revenue figure from the 2023 sale of the olanzapine portfolio (including Zyprexa) is correctly stated, and the years 2023 and 2024 are accurately referenced. (2) The answer correctly identifies the shift in revenue recognition: from direct product sales in 2023 to no reported sales in 2024, with revenue now falling under collaboration and other arrangements. While the LLM does not explicitly name the new revenue category (i.e., 'collaboration and other arrangements revenue'), it accurately describes the transition to a 'post-sale arrangement' and implies the move to licensing/royalty models. (3) The reasoning is sound and reflects multi-hop synthesis: recognizing that the 2023 sale led to a structural change in how Zyprexa contributes to revenue by 2024. (4) The LLM adds contextual interpretation about Eli Lilly's broader strategy to focus on innovation, which is reasonable and consistent with the business logic, though slightly beyond the ground truth. This does not detract from accuracy but adds inferred context. The only minor omission is the lack of explicit mention that 2024 revenue from Zyprexa is now embedded in 'collaboration and other arrangements'—a detail present in the original answer. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 392,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023, all outstanding Mobility preferred interests were repurchased by AT&T by April, leaving none outstanding at December 31, 2023. This repurchase eliminated any redemption obligations related to these interests. As a result, there was no financial impact on earnings per share calculations in 2024, as the Mobility preferred interests were no longer outstanding and thus did not affect either basic or diluted earnings per share. Prior to their repurchase, these interests were included in diluted earnings per share calculations, but they were excluded in 2024 due to their full redemption.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AT&T repurchased all Mobility Preferred Interests by April 2023 and that no interests remained outstanding at year-end 2023, which aligns with the ground truth. However, it incorrectly states that there was 'no financial impact on earnings per share calculations in 2024' due to the redemption. This contradicts the original answer, which clarifies that although the interests were retired, their treatment under ASU 2020-06 still affected diluted earnings per share calculations for periods prior to repurchase — a retrospective accounting effect that persists in financial reporting context. The LLM fails to capture this key nuance, implying a complete elimination of impact rather than a shift in nature from active obligation to retrospective treatment. (2) Quantitatively, the LLM omits specific liability reclassification amounts ($2,670 in current and $2,670 in noncurrent liabilities) and the total repurchase cost of $5,414, including accrued distributions. While the absence of dollar figures isn't outright incorrect, it reduces completeness and precision expected in a full financial analysis. Dates (April 2023 repurchase) are accurate. (3) The multi-hop reasoning is partially sound — the model connects redemption to removal from EPS calculations — but fails the second hop: understanding that accounting standards (ASU 2020-06) require inclusion in diluted EPS for prior periods, even after retirement. This reflects a gap in synthesizing post-redemption accounting implications. (4) Scores reflect partial factual correctness (core event timing and redemption status correct), but significant qualitative and completeness gaps in capturing the full evolution of financial impact, especially the ongoing relevance in EPS methodology due to accounting rules.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 496,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In 2023, IBM's 0.875% Notes due 2030 were listed on the New York Stock Exchange under the trading symbol IBM30A, as disclosed in the 2023 10-K. In 2024, the Notes remained listed on the New York Stock Exchange under the same trading symbol, as noted in the 2024 10-K. There is no indication of a change in their registration status between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims. According to the ground truth, in 2023 the 0.875% Notes due 2030 were not explicitly listed with a trading symbol or confirmed as NYSE-listed; instead, they were disclosed by reference to Exhibit 4.1 of a February 8, 2022 Form 8-K. The key evolution in 2024 was their explicit inclusion in the table of registered securities with trading symbol IBM30A and confirmation of NYSE registration—marking a transition from referenced to fully registered status. The LLM incorrectly states that the notes were already listed under IBM30A in 2023, which contradicts the ground truth. This misrepresents the evolution entirely, failing the multi-hop reasoning required to compare disclosure practices across years. While the mention of IBM30A and the NYSE in 2024 aligns with the truth, the erroneous 2023 claim undermines the analysis. Quantitative accuracy is partially preserved (correct note rate: 0.875%, correct maturity: 2030, correct symbol: IBM30A), but the critical timeline and registration status evolution are wrong. Contextual relevance is moderate as the answer addresses the right instrument and question scope but draws incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 339,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of AT&T's Telco Preferred Interests evolved with adjustments to reset mechanisms and distribution rates. In 2023, the Telco Class A-1 and A-2/A-3 preferred interests carried initial distributions of 4.25% and 6.85%, respectively, with resets every seven years. By 2024, the Telco Class A-2 and A-3 interests maintained the 6.85% rate, with a reset scheduled for November 1, 2027, and every seven years thereafter. This evolution reflects AT&T's strategic use of preferred equity instruments to access long-term, stable financing while retaining flexibility to adjust terms in response to market conditions. It also indicates a focus on maintaining financial flexibility, as the preferred interests do not restrict cash flows for dividends or share repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core structure and distribution terms of the Telco Preferred Interests, correctly identifying the 4.25% rate for Class A-1 and 6.85% for Class A-2/A-3 interests. However, it omits the dollar amounts of the preferred interests—$2,000 for Class A-1 and $5,250 for Class A-2/A-3 in 2023, and the total of $7,250 in 2024—which are critical quantitative details from the ground truth. The reset date of November 1, 2027, is mentioned in the LLM answer but not in the original answer, introducing a specific date not present in the source, which may be an overprecision or fabrication. (2) The ground truth emphasizes the expansion of the instrument from $7,250 (implied sum of $2,000 + $5,250) to $7,250 in 2024 (no actual increase), but the LLM incorrectly implies growth by stating 'evolved' and 'by 2024...maintained', failing to clarify that the amounts remained the same. The original answer notes no change in principal amounts year-over-year, only continuity. (3) The reasoning about AT&T's financing strategy is sound and aligns with the ground truth—highlighting financial flexibility and lack of restrictions on dividends or repurchases. The LLM correctly infers strategic use of preferred equity, though it misses the explicit 2024 clarification about distribution payment failure not restricting cash movements, which is a key qualitative update. (4) The answer is contextually relevant and well-structured, but the missing dollar amounts and incorrect implication of structural evolution (rather than continuity) reduce quantitative and overall correctness. The reasoning is strong, but factual omissions and a potentially fabricated reset date prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 468,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's involvement in multifamily commercial real estate loans under loss sharing agreements with government-sponsored enterprises (GSEs) evolved between 2022 and 2023, with the liability related to these agreements increasing from $82 million as of December 31, 2022, to $137 million as of December 31, 2023. This increase indicates a rise in risk exposure under these agreements. Additionally, the company elected the fair value option for new loss sharing agreements beginning in 2020, leading to the recognition of unrealized gains and losses in other non-interest income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the liability increased from $82 million as of December 31, 2022, to $137 million as of December 31, 2023, matching the original answer exactly. There are no calculation errors. (2) The answer is complete in addressing the evolution of risk exposure through loss sharing agreements with GSEs, correctly identifying the increase in liability as an indicator of rising risk exposure. (3) Entity accuracy is strong: Capital One, multifamily commercial real estate loans, GSEs, and the relevant time periods (2022–2023) are all correctly referenced. (4) The reasoning is sound—increased liability implies greater risk exposure, which reflects deeper involvement. The only minor addition not in the original answer is the mention of the fair value option elected in 2020 and its impact on unrealized gains/losses. While this information may be factually correct and contextually relevant, it was not part of the ground truth and does not directly address the question about evolution between 2022 and 2023. However, it does not detract from correctness. Overall, the core multi-hop synthesis—linking Capital One’s loan activity to GSE loss sharing liabilities and interpreting the increase in liability as increased risk—is accurately and logically presented. Hence, a score of 9 is justified, with full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 407,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "Amazon's co-branded credit card programs faced increased regulatory scrutiny and compliance obligations from 2022 to 2023, driven by evolving payment card association rules and data security requirements. These obligations, including enhanced authentication processes, raised compliance costs and could reduce the ease of use for customers. The potential for non-compliance or data breaches could result in fines, higher transaction fees, or loss of payment processing capabilities, all of which could negatively impact operating results. Additionally, the risk of these programs being renewed on less favorable terms or terminated further heightened their strategic significance and associated financial risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but misses key qualitative distinctions present in the ground truth, particularly regarding the evolution of regulatory risks from 2022 to 2023. (1) Correct elements: The answer correctly identifies that Amazon's co-branded credit card programs faced increasing regulatory scrutiny, compliance costs, and risks related to data security and renewal terms. It appropriately notes potential impacts on operating results such as fines, higher fees, or loss of processing capabilities. (2) Quantitative accuracy: There are no numeric values in the question or answer, so this dimension is neutral; no errors. (3) Multi-hop reasoning assessment: The model fails to capture the specific shift in regulatory focus—namely, the introduction of *data localization rules* and *cross-border data transfer concerns* in 2023, which were not present in 2022. This is a critical omission because the ground truth emphasizes that the *type* of regulatory risk expanded beyond traditional payment association rules to include international data governance laws. The LLM instead generalizes 'enhanced authentication processes' and 'evolving rules' without specifying this strategic broadening. (4) The answer also does not clearly differentiate between the 2022 and 2023 risk profiles, which is central to the question about *shifts* in strategic significance and regulatory exposure. While the overall direction of increased risk is correct, the lack of specificity on new compliance obligations (data localization) reduces qualitative accuracy. Thus, while the answer is coherent and relevant, it falls short on precise multi-hop synthesis across years and regulatory domains, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 477,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, RBH has remained deconsolidated from PM's consolidated financial statements following its placement under the CCAA proceedings in March 2019. In 2022, PM's 10-K filing noted the deconsolidation of RBH and the comprehensive stay of tobacco-related litigation in Canada. By 2024, PM continued to treat RBH as a deconsolidated entity, with its financial results no longer included in PM's consolidated statements. Valuation considerations for RBH involved significant judgment by management, particularly in estimating the fair value of PM's investment in RBH, which was subject to audit scrutiny due to the complexity of assumptions related to future cash flows, discount rates, and potential settlement impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RBH was deconsolidated in 2019 under CCAA proceedings, remained deconsolidated in 2022 and 2024, and PM's financial statements excluded RBH's results. The 2024 valuation considerations involving fair value estimation, audit scrutiny, and key assumptions (discount rates, cash flows, settlement impacts) are accurately described. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (March 2019 CCAA), or dollar amounts are cited, and none are misrepresented. The CAD 3.1 billion damage allocation is not mentioned in the LLM answer, which is a minor omission but does not distort the overall financial relationship. (3) Multi-hop reasoning is sound—correctly linking deconsolidation in 2019 to ongoing status in 2022–2024 and evolving valuation treatment. The shift from subsidiary to equity investment requiring impairment analysis is implied through discussion of fair value estimation, though the explicit term 'equity investment' is missing. (4) Contextual relevance is excellent—the response directly addresses consolidation status and valuation considerations across the period. The only reason for not scoring 10 is the omission of the explicit characterization of PM's 2024 position as an 'equity investment' subject to impairment, which slightly weakens qualitative completeness. However, the substance of impairment analysis is conveyed via fair value estimation discussion, supporting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 418,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi's financial performance and strategic positioning within LLY's product portfolio shifted significantly due to its sale. In 2023, Baqsimi contributed $677.6 million in revenue, with $579.0 million attributed to the net gain on the sale of rights to Amphastar in June 2023. The transaction brought $500.0 million in cash in 2023 and an additional $125.0 million in 2024. By 2024, Baqsimi was no longer part of LLY's ongoing product portfolio, as the rights had been transferred, and its role was effectively eliminated from LLY's revenue contributions. LLY remained eligible for up to $450.0 million in future sales-based milestones, but these were not included in the 2024 financials. Thus, Baqsimi transitioned from a revenue-generating asset in 2023 to a non-operational asset in 2024, marking a strategic divestiture to focus on other core products.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the breakdown of Baqsimi's 2023 revenue. The ground truth states that Baqsimi generated $677.6 million in total revenue ($645.7M U.S., $31.9M ex-U.S.) from product sales, not from a net gain on sale. However, the LLM incorrectly attributes $579.0 million of this to a 'net gain on the sale of rights to Amphastar,' which contradicts the original answer stating that Baqsimi was part of collaboration and other arrangements post-sale but does not mention a $579M gain. Additionally, while the $500M cash in 2023 and $125M in 2024 are plausible figures related to the transaction, they are not present in the ground truth and thus cannot be verified; their inclusion as specific components of revenue misrepresents the financials. (2) The original answer makes no mention of Amphastar, milestone payments, or a $450M future payout—these are fabrications or hallucinations. The absence of Baqsimi from 2024 product revenue is correctly noted, but the reasoning is flawed due to incorrect financial structuring. (3) The multi-hop reasoning is partially sound: the model correctly infers that Baqsimi transitioned from a direct revenue contributor to a divested asset, which aligns with the strategic shift described. However, the synthesis is undermined by incorrect financial attribution and invented entities/figures. (4) Despite these issues, the answer captures the high-level strategic shift—Baqsimi moving out of LLY's active portfolio—so some credit is due for qualitative direction and relevance. Contextual relevance is high because it addresses both financial performance and strategic positioning across years, even if factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 471,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly in terms of owned versus leased containers and chassis. In 2022, the company owned 48,962 containers (97.1% of total containers) and 29,875 chassis (67.9% of total chassis). By 2024, the number of owned containers decreased to 46,375 (99.4% of total containers), while leased containers increased from 1,856 to 288. For chassis, owned units dropped from 29,875 to 4,356 (87.4% of total chassis in 2024), and leased chassis rose from 14,148 to 1,197. This indicates a substantial shift from owned to leased chassis, while container ownership remained high but slightly reduced.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in numbers and trends. According to the ground truth, Union Pacific owned 78,837 total units and leased 16,004 in 2022, but the LLM incorrectly reports only container and chassis breakdowns without matching totals. The LLM claims in 2022 Union Pacific owned 48,962 containers and 29,875 chassis, which sums to 78,837—matching the total owned equipment—but misattributes chassis as part of owned equipment without clarifying that chassis are a subset. More critically, the LLM states that leased containers 'increased from 1,856 to 288', which is factually wrong: 288 is less than 1,856, so this is a decrease, not an increase. Similarly, the LLM claims leased chassis 'rose from 14,148 to 1,197', which is also incorrect—this is a sharp decline. The ground truth states leased units dropped from 16,004 to 1,485, with leased containers falling from 1,856 to 288 and leased chassis decreasing significantly. The LLM reverses the direction of change. (2) Calculations and percentages are fabricated. For example, the LLM states that in 2024, owned containers were 46,375 (99.4% of total containers), but if leased containers were 288, total containers would be ~46,663, making 46,375 about 99.4%—this calculation is numerically plausible but based on incorrect underlying data. However, the ground truth does not provide total container counts, so this inference may not be valid. The 97.1%, 67.9%, and 87.4% ownership percentages are not supported by the original answer and appear invented. (3) Multi-hop reasoning is flawed. The original answer indicates a strategic reduction in both owned and leased assets, especially in chassis and leased containers. The LLM incorrectly interprets this as a shift toward leasing chassis, when in fact leasing dropped dramatically. This misrepresents the core trend. (4) Contextual relevance is moderate—the answer addresses the right topic (owned vs. leased containers and chassis) and time frame, and attempts a comparative analysis. However, due to severe quantitative inaccuracies and reversed trends, the qualitative and correctness scores are very low. The answer contradicts the ground truth on the direction of change, which is fundamental.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 601,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations slightly increased, from $16,973 million as of December 31, 2022, to $18,043 million as of December 31, 2023. This reflects a $1,070 million growth in securitized debt obligations, indicating a modest expansion in their role within the company's funding structure. Securitized debt obligations remained a relatively smaller portion of the overall funding mix compared to deposits and other debt, but their increase suggests Capital One continued leveraging securitization programs as part of its diversified funding strategy during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in securitized debt obligations from $16,973 million in 2022 to $18,043 million in 2023, which aligns with the ground truth carrying value of $18.043 billion in 2023. The $1,070 million growth calculation is accurate (18,043 - 16,973 = 1,070), so quantitative accuracy is high. Minor formatting variation ($16,973 million vs. $18,043 million) is acceptable and matches the ground truth when converted. (2) However, the original answer emphasizes a qualitative shift in the role of securitized debt—specifically, the reclassification to Level 2 in the fair value hierarchy in 2023, indicating more standardized valuation and a more structured role in funding. This key evolution in risk management and accounting treatment is entirely missing in the LLM response. Instead, the LLM focuses on the numerical increase as evidence of 'modest expansion,' which is plausible but does not capture the nuanced shift in strategic role emphasized in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly pulls and compares two years of balance sheet data, but fails to incorporate the additional layer from the footnotes about fair value hierarchy changes, which is critical to fully answering how the role evolved. (4) Therefore, while the quantitative and contextual elements are strong, the qualitative accuracy is reduced due to omission of a key conceptual development, leading to a correctness score of 7—core facts are right, but important contextual and interpretive depth is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 433,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The nature of LLY's revenue from Zyprexa evolved significantly between 2023 and 2024. In 2023, Zyprexa revenue was primarily generated through product sales, with $79.4 million recognized in the U.S. and $1,615.4 million from international sales. However, in 2024, the revenue source shifted due to the sale of the rights for the olanzapine portfolio, which includes Zyprexa. This transaction, completed in December 2023, generated a $1.45 billion net gain in 2023 and additional milestone payments, altering the recognition method from ongoing product sales to a one-time gain on the sale of rights.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The reported 2023 Zyprexa product sales ($79.4M U.S., $1,615.4M international) are not supported by the ground truth and appear fabricated. The $1.45 billion net gain in 2023 from the sale of rights is also not mentioned in the original answer, which only states that the sale occurred in 2023 and impacted 2024 revenue recognition. (2) The original answer does not provide any specific revenue figures for Zyprexa, nor does it mention a $1.45B gain, so these numbers fail verification. The shift in revenue recognition is correctly identified as moving from product sales to collaboration revenue, but the LLM mischaracterizes the 2024 revenue as stemming from milestone payments rather than being recognized under collaboration and other arrangements due to the prior sale. (3) The multi-hop reasoning is partially sound—the model correctly infers a change in revenue nature due to the sale of rights—but it incorrectly frames the 2024 revenue as ongoing milestone payments rather than a reclassification of revenue recognition method post-sale. It also invents precise financial figures absent in the source. (4) The contextual relevance is high because the answer addresses the evolution of revenue source and recognition method. However, the correctness score is low due to major quantitative errors and incomplete qualitative alignment with the ground truth. The original answer emphasizes a categorization shift in 2024 (to collaboration revenue), which the LLM overlooks in favor of an unsupported 'one-time gain' narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 450,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology and classification of Federal Government Securities in the pension plan have remained consistent from 2022 to 2024. In both years, these securities are classified as Level 2 investments and are valued using a bid evaluation process with bid data provided by independent pricing sources. There is no indication of a change in this methodology or classification during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Federal Government Securities were classified as Level 2 investments in both 2022 and 2024 and that valuation uses a bid evaluation process with independent pricing sources. The dollar amount ($742 million in 2022) is not mentioned in the LLM answer, which is a minor omission affecting completeness. (2) There are no numerical inaccuracies—since the LLM did not include any incorrect numbers, and the methodology description aligns with the ground truth, quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in classification (Level 2), but it fails to acknowledge the evolution in disclosure specificity—namely, that the 2024 filing added clarity about the use of bid data and independent sources, whereas in 2022 only the Level 2 classification was stated. The ground truth emphasizes this added specificity as part of the evolution, which the LLM overlooks by stating there is 'no indication of a change,' thus missing a qualitative nuance. (4) The answer is contextually relevant and factually aligned on core points, but the lack of recognition of enhanced methodological disclosure in 2024 reduces qualitative accuracy. Correctness is therefore scored as 7 due to accurate facts but incomplete synthesis of the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 383,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's utilization of credit score data for product segmentation decisions remained consistent from 2022 to 2023, as both years indicate that credit scores were used in some cases to drive such decisions. The credit score distribution data for domestic credit card and auto loan portfolios shows only minor changes between the two years, with the percentage of credit card portfolios with FICO scores greater than 660 slightly decreasing from 69% in 2022 to 68% in 2023, and the auto loan portfolios showing no change. This suggests a stable credit risk modeling strategy, where Capital One continues to rely on credit scores as a key factor in assessing borrower risk and making segmentation decisions, without significant shifts in their approach during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer states that Capital One updated its credit score data usage from 2020–2021 distributions (used in 2022) to 2022–2023 distributions (used in 2023), indicating a shift to more current data. The LLM incorrectly claims the approach 'remained consistent' and interprets minor portfolio percentage changes as evidence of stability, which contradicts the ground truth about a strategic update in data recency. (2) Quantitatively, the LLM introduces specific percentages (69% to 68%) not present in the original answer, which does not mention these figures. There is no verification that these numbers are from the actual filings, and their inclusion misrepresents the source data. The original answer focuses on the time periods used for modeling (2020–2021 vs. 2022–2023), not portfolio composition changes. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the evolution lies in the data vintage used for segmentation (a methodological update), not in the stability of portfolio metrics. It misinterprets the strategic implication, concluding 'stable strategy' instead of 'more dynamic and proactive' as stated in the ground truth. (4) Contextual relevance is moderate because the answer discusses credit score usage in product segmentation, which is relevant, but misses the key evolution in data timeliness and its strategic significance. The incorrect reasoning and fabricated percentages severely undermine factual accuracy and qualitative correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 429,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "Amazon's strategic positioning of AWS from 2022 to 2023 has emphasized its role as a core driver of technological innovation and infrastructure investment. In 2022, AWS was highlighted as a key area for investment in technology and content, supporting a variety of product and service offerings through geographic expansion and cross-functional systems. By 2023, AWS remained a central focus, with increased emphasis on leveraging advances in processing power, data storage, analytics, artificial intelligence, and machine learning to enhance customer experiences and operational efficiency. This evolution reflects AWS's growing importance within Amazon's broader business strategy, as it continues to serve developers, enterprises, and other customers with on-demand technology services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AWS as a key investment area in 2022 and its continued strategic importance in 2023, with accurate emphasis on technology services like compute, storage, analytics, and machine learning. However, it omits a critical factual evolution highlighted in the ground truth: AWS's formal repositioning as one of Amazon's three core business segments (alongside North America and International) in 2023. This structural reclassification is a major qualitative shift that the LLM answer fails to mention, despite referencing AWS's growing importance. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes AWS’s role in infrastructure and innovation across years, but fails to make the key inference about organizational segmentation and structural elevation within Amazon’s reporting segments, which is central to the question about strategic positioning. (4) The answer is contextually relevant and well-articulated, but the omission of AWS becoming a core reporting segment—a major strategic shift—reduces the qualitative and overall correctness scores. Semantic equivalence is mostly achieved but lacks a pivotal detail, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 389,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly, primarily due to ongoing Canadian CCAA proceedings and litigation. RBH's financial results were deconsolidated from PMI's consolidated financial statements in March 2019, reducing direct financial exposure. However, in 2024, PMI recorded a non-cash impairment charge of $2,316 million related to its investment in RBH, driven by a proposed CAD 32.5 billion settlement in Canadian tobacco litigation. This charge reflects the estimated fair value of PMI's RBH investment being lower than its carrying value, highlighting increased potential financial exposure from the unresolved litigation and settlement allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial event in 2024—a $2,316 million non-cash impairment charge due to a proposed CAD 32.5 billion settlement in Canadian tobacco litigation. This matches the ground truth in both amount and context. However, the LLM incorrectly states that deconsolidation occurred in March 2019, while the ground truth specifies deconsolidation in 2022 due to CCAA restructuring. This is a significant factual error affecting the timeline of accounting treatment evolution. (2) Quantitatively, the $2,316 million impairment and CAD 32.5 billion settlement figures are accurate and correctly formatted. The error lies in the deconsolidation date (2019 vs. 2022), which is a critical timeline discrepancy. (3) The reasoning correctly links the litigation settlement to the impairment charge and recognizes the shift from deconsolidation to equity investment accounting. However, it fails to mention that RBH was no longer consolidated starting in 2022 (not 2019), undermining the multi-hop synthesis of how the relationship evolved specifically between 2022 and 2024. The answer also omits the detail about the stay of litigation until March 31, 2022, and the inability to estimate losses at that time, which is contextually important. (4) Despite the timeline error, the answer captures the core financial exposure shift and correctly reports the 2024 impairment, warranting a score of 7 for correctness. Quantitative accuracy is high (8) due to correct numbers but penalized for wrong date. Qualitative accuracy is reduced due to incorrect entity timeline. Contextual relevance is full—answer directly addresses the question's focus on accounting treatment and financial exposure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 473,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "Biktarvy's commercial significance for Gilead (GILD) grew from 2022 to 2024, as its revenue contribution increased from $7,049 million in 2022 to $7,649 million in 2024, reflecting its continued dominance in the HIV treatment market. However, associated product risks include heightened competition, potential market share losses due to generic alternatives, and evolving treatment paradigms that could reduce demand for nucleoside-based therapies like Biktarvy. Additionally, regulatory and reimbursement pressures, such as state-level drug affordability reviews and complex international pricing approvals, pose ongoing challenges to maintaining its commercial success.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in revenue figures. The ground truth states Biktarvy generated $8,624 million in 2022, but the LLM claims $7,049 million, which is incorrect. Additionally, the LLM asserts a 2024 revenue of $7,649 million, but the original answer explicitly states that specific 2024 revenue figures are not provided in the data, making this number fabricated. These quantitative errors severely undermine the factual basis of the response. (2) The calculation of revenue growth from $7,049M to $7,649M is internally consistent but based on false inputs; no actual revenue trend can be confirmed due to lack of 2024 data in the ground truth. (3) Qualitatively, the LLM correctly identifies key risks such as competition, generic threats, evolving treatment paradigms, and regulatory/reimbursement pressures, which aligns with the original answer's emphasis on heightened risks related to TAF-based therapies and shifting treatment standards. It also correctly situates Biktarvy as a dominant HIV product, capturing the evolving risk profile. However, it fails to mention the specific concern about reliance on TAF-based therapies, a key detail in the ground truth. (4) Contextually, the answer addresses both revenue contribution and product risks as required by the question and synthesizes information plausibly across time periods, even if with incorrect numbers. The reasoning structure is sound and relevant, but the core financial data is wrong, leading to a partial correctness score. Overall, while the qualitative risk assessment is reasonably accurate and contextually appropriate, the quantitative inaccuracies are severe enough to significantly reduce the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 474,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's (UPRR) financial stake in TTX increased from $1.8 billion in 2023 to $1.9 billion in 2024, reflecting a rise in the value of its 37.03% economic interest in TTX. Additionally, UPRR's car hire expenses with TTX rose from $399 million in 2023 to $432 million in 2024, indicating higher operational usage of TTX rail cars.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and timeframes compared to the ground truth. The financial stake increase is reported as from $1.8B in 2023 to $1.9B in 2024, but the original answer states it increased from $1.6B in 2021 (referenced in 2022 filing) to $1.9B in 2024. This misrepresents both the starting value and the timeline of growth. Similarly, car hire expenses are said to rise from $399M in 2023 to $432M in 2024, while the ground truth reports an increase from $375M in 2021 to $432M in 2024. The ending values ($1.9B and $432M) are correct, but the starting points and years are wrong. (2) Quantitative accuracy is compromised because the model fails to report the correct baseline figures and years, which affects the interpretation of the trend. The 2021–2024 evolution is misrepresented as a one-year change (2023–2024), undermining the multi-year analysis requested. (3) The reasoning is partially sound—UPRR’s growing involvement with TTX is correctly inferred from rising investment and expenses—but the multi-hop synthesis across years is flawed. The model appears to have used only recent data (2023–2024) rather than tracing the full evolution from 2022 to 2024 as required. (4) Contextual relevance is high because the answer addresses both financial stake and operational expenses, uses correct entities (UPRR, TTX, car hire), and interprets the trend correctly as indicating increased involvement. However, due to significant quantitative and temporal inaccuracies, the overall correctness score is limited to 5—partially correct but with key factual errors in the data trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 449,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla enhanced its approach to scaling Solar Roof production by expanding installer training initiatives and improving supply chain risk management. In 2022, Tesla focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, Tesla emphasized maintaining adequate battery cell supply for energy storage products and continued to prioritize hiring skilled personnel, particularly electricians, to support the Solar Roof production ramp. Additionally, Tesla worked to strengthen supply chain resilience by sourcing responsibly produced materials and ensuring supplier compliance with sustainability and labor standards.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla and the relevant time frame (2022–2023), and accurately notes the 2022 focus on installer training, onboarding, and collaboration with real estate developers to reduce costs and installation time. However, it misrepresents Tesla's 2023 priorities. While the ground truth states that Tesla shifted focus to managing supplier reliability, global component constraints, and cost-effective manufacturing processes—highlighting production ramp risks—the LLM incorrectly emphasizes battery cell supply for energy storage products, which is not mentioned in the original answer in this context. Additionally, the LLM introduces new elements—'responsibly produced materials' and 'sustainability and labor standards'—that are not present in the ground truth and mischaracterize the nature of Tesla’s 2023 supply chain focus, which was on reliability and constraints, not ethical sourcing. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is partially sound: the model correctly contrasts 2022 and 2023 initiatives but fails to accurately synthesize the shift from installer-focused growth to supply chain risk management. Instead, it conflates Solar Roof challenges with energy storage supply issues and introduces irrelevant sustainability criteria. (4) The correctness score is 5 due to significant factual inaccuracies in the 2023 strategy description, despite correct identification of 2022 initiatives. Quantitative accuracy is 10 because no numbers are involved. Qualitative accuracy is 5 due to incorrect entity-linking in the supply chain focus and introduction of unsupported details. Contextual relevance is 8 because the answer stays on topic and addresses both years and the general theme of scaling, even if with inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 514,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company continued to manufacture and sell fountain syrups in the United States, as it does not authorize U.S. bottlers to produce fountain syrups. Instead, the Company sells fountain syrups directly to authorized fountain wholesalers and some fountain retailers, who then distribute them to restaurants and retailers for immediate consumption. There is no indication of significant changes to this structure in the provided documents, suggesting that the relationship with fountain retailers remained consistent during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in The Coca-Cola Company's relationship with fountain retailers between 2022 and 2023. (1) It correctly states that the Company manufactures fountain syrups and does not authorize U.S. bottlers to produce them, and that syrups are sold to authorized fountain wholesalers and some retailers—this aligns with the 2022 structure. However, it fails to identify the important shift in 2023 where the Company explicitly acknowledges selling to bottling partners who then distribute to fountain retailers, indicating a more formalized or clarified tiered distribution model. (2) There are no numerical values in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default for absence of errors. (3) The multi-hop reasoning is flawed: the question asks for changes between 2022 and 2023, but the LLM concludes there was 'no significant change,' which contradicts the ground truth that shows a clearer articulation of bottling partners' role in distribution in 2023. This omission represents a failure in synthesizing the evolution across years. (4) Contextually, the answer is relevant and describes the general structure accurately, but it lacks the comparative analysis required by the question, reducing its qualitative accuracy. The correctness score reflects that core facts are right but the critical evolution is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 389,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "From 2022 to 2024, IBM's 0.950% Notes due 2025 have consistently been classified as financial instruments and registered on the New York Stock Exchange under the trading symbol \"IBM25B.\" In 2022, the notes were disclosed in the context of IBM's broader debt instruments in the 10-K, with references to their incorporation by reference from prior filings. By 2024, the notes were explicitly listed in the registration details on the cover page of the 10-K, affirming their continued classification as a registered debt security under Section 12(b) of the Exchange Act, with no material changes in their classification or registration details observed.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that deviate from the ground truth. (1) Quantitatively, the claim that the 0.950% Notes due 2025 were 'registered on the New York Stock Exchange under the trading symbol IBM25B' in 2022 is incorrect — the original answer states that the listing under 'IBM25B' was only confirmed by 2024, not in 2022. The 2022 disclosure was limited to being referenced in Form 8-K filings (specifically Exhibit 4.1 filed May 22, 2017), not active listing. (2) The LLM incorrectly asserts that the notes were 'explicitly listed in the registration details on the cover page of the 10-K' in 2024; the ground truth does not mention the 10-K cover page, but rather emphasizes the evolution to being actively traded under a symbol, indicating formal registration and listing. (3) The reasoning is flawed in suggesting 'no material changes' occurred, when the ground truth explicitly describes an evolution from mere disclosure in filings to active listing — a significant change in status. (4) While the LLM correctly identifies the instrument and its due date, and captures the general idea of registration under Section 12(b), it misrepresents the timeline and nature of the evolution. The answer is contextually relevant and attempts multi-hop synthesis, but the factual inaccuracies in entity status over time and mischaracterization of the disclosure-to-listing progression reduce its correctness. Minor formatting differences are acceptable, but the core error lies in attributing 2024-level registration status retroactively to 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 427,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "GILD's strategic positioning of Biktarvy from 2022 to 2024 has evolved to address competitive differentiation and financial risk exposure in the HIV treatment market. In 2022, GILD resolved litigation with ViiV Healthcare over bictegravir, the active ingredient in Biktarvy, by paying a $1.25 billion settlement and agreeing to a 3% royalty on U.S. sales until 2027. This resolution mitigated legal risks and provided clarity for Biktarvy's market position. By 2024, Biktarvy remained a key HIV treatment, leveraging its competitive differentiation through efficacy and convenience, though ongoing royalty obligations and potential pricing pressures from state and federal drug pricing initiatives increased financial risk exposure. Additionally, evolving reimbursement structures and 340B program challenges continued to impact pricing and profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific details not present in the ground truth, such as a $1.25 billion settlement with ViiV Healthcare and a 3% royalty on U.S. sales until 2027. These figures and agreements are not supported by the original answer and appear to be hallucinated or derived from external knowledge not reflected in the provided truth. The ground truth does not mention litigation, settlements, or royalty payments, making these factual inaccuracies. (2) Quantitatively, the $1.25B settlement and 3% royalty are incorrect per the ground truth, which contains no numeric financial terms related to legal settlements or royalties. There is no verification possible for these numbers, and they contradict the focus of the original answer, which centers on financial risk from treatment paradigm shifts and generic competition, not legal liabilities. (3) The multi-hop reasoning is partially sound in that the LLM attempts to connect Biktarvy’s strategic positioning to financial risk and competitive differentiation over time. However, it fails to correctly synthesize the actual evolution described in the ground truth—namely, the increasing risk due to reliance on TAF-based therapies and potential obsolescence amid changing treatment paradigms. Instead, it redirects to royalty obligations and drug pricing initiatives, which are contextually relevant but not the core drivers identified in the original answer. (4) The contextual relevance is moderate because the answer stays within the domain of Biktarvy’s market position and financial risks, but it misses the key point about nucleoside-based therapy dependence and the threat from shifting therapeutic standards. While it correctly identifies Biktarvy as a key product and notes ongoing financial pressures, it omits the central concern about long-term competitive differentiation due to scientific and market evolution. Thus, the answer is partially correct in theme but significantly flawed in factual content and reasoning alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 549,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to shift its focus from defined benefit pension plans to defined contribution retirement savings plans. In 2022, the company transferred $4.3 billion of gross defined benefit pension obligations and related assets to an insurance company for approximately 13,600 U.S. retirees and beneficiaries, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, the company made a voluntary offering to former employees who had not yet started receiving their vested benefits, resulting in $414 million in settlement payments for approximately 6,500 participants. These actions reduced the volatility and size of the company's net pension obligations, reflecting a continued strategy to mitigate financial risks associated with defined benefit plans. Contributions to defined contribution retirement savings plans increased to $1.2 billion in 2023 from $1.1 billion in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via annuity contracts, recognizing a $1.5 billion noncash settlement charge; in 2023, it made $414 million in settlement payments to ~6,500 former employees. These numbers match the original answer exactly. (2) The LLM adds contextual details not in the ground truth but consistent with likely public filings—such as specifying the 13,600 U.S. retirees in 2022 and describing the 2023 payments as a 'voluntary offering'—which enhances clarity without introducing inaccuracies. (3) The multi-hop reasoning is sound: it correctly contrasts the 2022 insurer-based annuity transfer with the 2023 direct participant settlements, capturing the strategic evolution. (4) The LLM adds that defined contribution plan contributions rose from $1.1B to $1.2B, which is plausible and relevant to the question about 'defined contribution retirement savings plans,' though this specific detail is not in the ground truth. Since the question asks about evolution 'particularly in terms of pension obligation transfers and associated financial impacts,' this additional context does not detract from accuracy but slightly extends beyond the provided truth. No contradictions or calculation errors exist. The answer is semantically equivalent and factually precise, warranting a 9/10 for correctness (not 10 due to the minor addition of unverified contribution figures). Quantitative accuracy is perfect (10/10), qualitative reasoning is strong (9/10), and relevance is complete (10/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 448,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "The 2.875% Notes due 2025 were listed in IBM's 2022 10-K under the \"Securities registered pursuant to Section 12(b) of the Act\" with the trading symbol IBM25A, maturing in 2025. In the 2024 10-K, these notes remain listed with the same details, indicating no material change in their composition or terms between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.875% Notes due 2025 (IBM25A) as present in both the 2022 and 2024 10-K filings, with consistent details, which is factually accurate. The trading symbol and maturity year are correctly reported. However, the LLM fails to mention the broader composition of IBM's debt instruments due in 2025 as required by the question. Specifically, the original answer notes that in 2022, IBM had three sets of notes due 2025: the 2.875% (IBM25A), 0.950% (IBM25B), and 0.875% (IBM25C), but by 2024, the 0.875% Notes (IBM25C) were no longer listed. This change in composition is a key part of the evolution and is entirely omitted in the LLM answer. (2) Quantitatively, all numbers (2.875%, 2025 maturity, IBM25A symbol) are correct and consistent with the ground truth. There are no calculation errors. (3) The multi-hop reasoning is incomplete. The question asks about the evolution of the composition of debt instruments maturing in 2025 between 2022 and 2024, which requires comparing the full set of notes across years. The LLM only confirms the persistence of one instrument but does not compare or contrast the full portfolio, missing the removal of IBM25C. This represents a failure in synthesizing the full set of entities across time. (4) The contextual relevance is high because the answer addresses the specific instrument mentioned and the time frame, but it lacks completeness in addressing the compositional shift. The correctness score is 6 due to accurate facts but significant omission of key comparative information required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 438,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy has remained a cornerstone of Gilead's HIV portfolio, with continued growth in sales across all geographies. However, its strategic importance and risk profile have evolved due to increasing competitive pressures, including the threat of generic competition and the potential shift away from nucleoside-based regimens like TAF, which is a key component of Biktarvy. Additionally, the risk of pricing pressures has intensified due to regulatory and legislative actions, such as state-level affordability reviews and expanded 340B program impacts. These factors pose challenges to maintaining market share and pricing, thereby increasing the risk profile for Biktarvy within Gilead's HIV portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and overall narrative. (1) It accurately captures the evolution of Biktarvy from a growth driver in 2022 to a product with increasing risk in 2024 due to competitive and treatment paradigm shifts. The mention of TAF as a key component and the risk of moving away from nucleoside-based therapies matches the original answer. (2) There are no explicit numbers (e.g., 11% revenue increase) in the LLM answer, but it does not introduce any incorrect figures, so quantitative accuracy is not penalized—format variations are acceptable, and absence of specific percentages does not constitute inaccuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information about Biktarvy’s strategic role, competitive threats (generics, pricing), and treatment paradigm shifts across time, correctly inferring increased risk by 2024. However, it adds details not present in the ground truth—specifically 'state-level affordability reviews' and 'expanded 340B program impacts'—which, while plausible, are not mentioned in the original 10-K-based answer and represent unsupported elaboration. (4) Despite these additions, the core qualitative assessment matches: Biktarvy remains important but faces heightened risk. The answer is fully contextually relevant, addressing all aspects of the question. The correctness score is 8 due to the accurate core content but minor overreach in unsupported risk factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 410,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1,764 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During fiscal year 2023, the Company deposited $1,000 million into the account, while payments to opt-out merchants (net of interest earned) amounted to $685 million. In fiscal year 2022, the balance was $1,449 million at the beginning of the period, with $1,000 million deposited and $685 million in payments made.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the starting balance for fiscal year 2022. The ground truth states the balance at the end of fiscal year 2022 was $1,449 million, but the LLM incorrectly reports it as $1,764 million. The ending balance for fiscal year 2023 is correct at $3,089 million. (2) Regarding deposits, the LLM correctly states that $1,000 million was deposited in fiscal year 2022, matching the ground truth. However, it incorrectly states that $1,000 million was deposited in fiscal year 2023, while the ground truth specifies $1,500 million. This is a significant quantitative error. The LLM also introduces details not in the original answer—payments to opt-out merchants ($685 million) and interest—making the explanation more detailed but factually divergent. (3) The multi-hop reasoning is partially sound: the model attempts to explain the account evolution by breaking down deposits and payments, but it fails to accurately reflect the deposit increase from $1,000M to $1,500M, a key point in the original answer. The synthesis is plausible but based on incorrect data. (4) The contextual relevance is high—the answer addresses the evolution of the escrow balance and deposit contributions as asked. However, due to two major numerical inaccuracies (ending 2022 balance and 2023 deposit amount), the correctness and quantitative accuracy scores are reduced. The qualitative reasoning is logically structured but based on flawed inputs, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 416,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent in terms of manufacturing and distribution responsibilities. The company continues to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized wholesalers and bottling partners, who then distribute them to fountain retailers. No significant changes were indicated in the provided pages regarding the company's direct involvement in the production or distribution of fountain syrups during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but omits a critical nuance present in the original answer. (1) Correctly identifies that Coca-Cola continued manufacturing fountain syrups in the U.S. and selling them to retailers, wholesalers, or bottling partners in both 2022 and 2023—this aligns with the ground truth and addresses the core of the question. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in North America, but it fails to mention the important 2023 shift where Coca-Cola indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This evolution in policy—especially the authorization of external manufacturing outside the U.S.—represents a meaningful change in the operating model that the LLM overlooks. While the focus is on North America, the original answer uses the contrast with international operations to highlight the relative stability in North America, which strengthens the conclusion. (4) The omission of this comparative context reduces qualitative accuracy, as it misses an opportunity to explain the nuanced evolution in the company’s strategy. However, the answer remains contextually relevant and factually correct within its narrower scope, hence a correctness score of 7 rather than lower. The LLM does not introduce errors but provides an incomplete picture compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 440,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 0.950% Notes due 2025 (IBM25B), as it was listed in both the 2022 and 2024 SEC filings. However, the 2024 filing introduced new debt instruments maturing in 2025, such as the 2.875% Notes due 2025 (IBM25A), indicating an expansion in the composition of IBM's 2025 debt offerings. The 0.950% Notes due 2025 were present in both years, suggesting no material change in this specific instrument's status during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 IBM had three notes maturing in 2025: 2.875% (IBM 25A), 0.950% (IBM 25B), and 0.875% (IBM 25C). By 2024, the 0.875% Notes were no longer listed, indicating a reduction in diversity. However, the LLM incorrectly states that the 2.875% Notes were 'introduced' in 2024, implying they were not present in 2022, which contradicts the ground truth. This misrepresents the evolution as an expansion rather than a contraction. (2) The percentages (0.950%, 2.875%) and note identifiers (IBM25B, IBM25A) are correctly cited, so some numeric and entity data are accurate, but their temporal presence is misstated. There are no calculations in this question, so quantitative accuracy hinges on correct attribution over time, which fails. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the change in composition over time. Instead of identifying the removal of the 0.875% note, it falsely claims the addition of the 2.875% note in 2024, reversing the actual trend. This indicates a failure in cross-year document comparison. (4) Contextual relevance is moderate because the answer addresses the right topic (debt instruments maturing in 2025, focusing on the 0.950% note) and uses appropriate terminology, but the core conclusion about evolution is factually wrong. Thus, correctness is severely compromised despite some accurate surface-level details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 409,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney's strategic approach to cruise ships evolved between 2022 and 2024 by shifting from recovery and resumption of operations post-pandemic to planning for future expansion. In 2022, the focus was on resuming cruise ship operations after pandemic-related suspensions and addressing challenges like health and safety measures and capacity restrictions. By 2024, Disney announced plans for additional expansion of its cruise ship fleet, reflecting a strategic shift toward growth and investment in its cruise operations as part of its broader Experiences segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Disney's cruise ship approach between 2022 and 2024. (1) It accurately captures the shift from a recovery/resumption focus in 2022—mentioning pandemic-related suspensions and operational challenges—to a growth-oriented strategy in 2024 centered on fleet expansion. This matches the ground truth's characterization of a move from passive dependence on consumer demand to active investment. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly referenced, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and infers a strategic shift based on changes in tone and disclosure focus in the 10-K filings. However, the LLM omits a key nuance present in the original answer: the 2024 filing’s explicit mention of increased costs and uncertain returns associated with new cruise offerings, which highlights risk awareness and capital intensity. This omission slightly weakens completeness and qualitative depth. (4) Despite this, the answer remains contextually relevant and semantically equivalent in its core claim—a strategic pivot toward expansion. Wording differs but meaning is preserved. Hence, a score of 8 is justified: factually accurate and complete on main points, but missing a subtle yet important element of strategic risk disclosure in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 432,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin continued its strategy of mitigating pension risk through risk transfer transactions, specifically purchasing group annuity contracts (GACs) to shift defined benefit pension obligations to insurance companies. In 2022, the company emphasized its intention to continue evaluating such transactions to manage pension liabilities, acknowledging potential noncash settlement charges as a possible financial impact. In 2023, the company made no new pension contributions and maintained its focus on using pension risk transfer strategies, leveraging assets from its master retirement trust to execute these transactions. The financial impact of these transactions remained consistent with prior years, with no additional contributions required and no material changes to pension costs under Cost Accounting Standards (CAS) or Financial Accounting Standards (FAS).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key details from the ground truth. It incorrectly states that in 2023, Lockheed Martin made no new pension contributions and leveraged assets from its master retirement trust—information not present in the original answer and potentially misleading. The original answer does not mention funding source or contribution activity in 2023, only strategic framing changes. The LLM also fails to mention the specific 2021 transaction ($4.9B transferred, $1.7B noncash charge) detailed in the 2022 filing, which is central to the evolution of the strategy. (2) Quantitative accuracy is low: the LLM omits all specific numbers—$4.9B obligation transfer, $1.7B settlement charge, $11.6B total transferred since 2018, 95,000 retirees affected—which are critical to the financial impact. No calculations are attempted, but the absence of these figures severely undermines the response. (3) Multi-hop reasoning is weak: the question asks for evolution between 2022 and 2023, requiring synthesis of strategic intent and financial impact across years. The LLM correctly identifies continued use of GACs but misses the key shift in 2023 toward acknowledging residual liability risk (insurer default) and broader financial implications, which represents a more cautious tone not emphasized in 2022. This nuanced evolution in risk framing is entirely omitted. (4) Contextual relevance is moderate—the response stays on topic regarding pension risk transfers and strategic intent, but fails to capture the actual evolution described in the ground truth, instead introducing unsupported claims about funding mechanics. While it recognizes the ongoing strategy, it lacks the depth and factual basis needed for a correct multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 489,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has shown some evolution, particularly in accounts receivable management and leasing program risks. In 2022, Tesla highlighted the variability in accounts receivable due to factors such as government rebates with long collection periods and timing of payments from financing partners. By 2023, the company continued to face similar challenges, but there was a greater emphasis on managing residual value risks in its leasing programs, especially as vehicle leasing grew. Tesla noted that the profitability of its leasing program depends on accurately projecting residual values, which can be impacted by market dynamics and pricing strategies. Additionally, the company emphasized the importance of securing adequate financing and partnerships to support the growth of its leasing initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 2022 focus on accounts receivable timing, mentioning variability due to government rebates and financing partner payment timing, which matches the original answer's emphasis on up to two weeks of settlement time affecting liquidity. In 2023, it accurately captures the increased focus on residual value risks and the need for adequate financing partners as leasing programs scaled. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes information across years and themes (receivables in 2022, leasing risks in 2023) and correctly infers a shift in risk focus from cash flow timing to broader financial and market risks. The only minor omission is the explicit mention of 'credit and compliance risks' in 2023, which is present in the original answer but not in the LLM version; however, 'residual value risks' and 'securing adequate financing' are correctly emphasized. (4) The answer is fully contextually relevant, directly addressing both parts of the question—accounts receivable management and leasing program risks—and their evolution across the two years. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight gap in completeness regarding the full scope of 2023 risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 417,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola continued to refine its fountain syrup distribution strategy, with the roles of bottlers and fountain wholesalers evolving as part of the broader system efficiency initiatives. In the United States, the Company retained its role in manufacturing fountain syrups and selling them to authorized fountain wholesalers (including certain bottlers) and directly to fountain retailers. Fountain wholesalers then distributed the syrups to restaurants and retailers. Outside the U.S., bottlers were generally authorized to manufacture fountain syrups using Coca-Cola's concentrates and sell them to fountain retailers or authorized fountain wholesalers, who in turn distributed the syrups. The evolution of these roles was likely influenced by the Company's focus on optimizing its bottling system and enhancing operational efficiencies, as outlined in its bottler agreements and strategic initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the 2022 model where Coca-Cola manufactured and sold fountain syrups to authorized fountain wholesalers (including certain bottlers), and the 2023 evolution where outside the U.S., bottlers were authorized to manufacture syrups using concentrates and sell to retailers or wholesalers. The distinction between U.S. and international operations is preserved. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023) and roles are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes changes over time and differences by geography, correctly attributing manufacturing authority shifts to bottlers internationally. It accurately reflects the shift from a centralized to a more integrated model. (4) The only minor shortcoming is that the LLM slightly softens the definitiveness of the change by saying the strategy was 'refined' and 'likely influenced' by efficiency initiatives, which introduces a small degree of speculation not present in the factual, descriptive tone of the original. However, this does not detract from factual correctness. All key entities—Coca-Cola, bottlers, fountain wholesalers, retailers, U.S. vs. international markets—are accurately represented. The answer fully addresses both parts of the question: changes in distribution strategy and the evolving roles of bottlers and wholesalers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 420,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with an increase in receivables and new investment activities. Receivables from the ATMP JV rose from $9 million as of December 30, 2023, to $12 million as of December 28, 2024. Additionally, AMD made a $17 million equity contribution to the ATMP JV in 2024, raising the carrying value of its investment from $99 million in 2023 to $149 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that receivables from the ATMP JV increased from $9 million in 2023 to $12 million in 2024, it incorrectly claims that AMD made a $17 million equity contribution to the JV in 2024 and that the carrying value of its investment increased from $99 million to $149 million. According to the ground truth, there was no equity investment or direct contribution by AMD in 2023 or 2024. Instead, AMD entered into a new $100 million one-year term loan agreement with one of the ATMP JVs in 2024, which the LLM completely omits. (2) The quantitative inaccuracies are severe: the $17 million equity contribution and the $149 million carrying value are entirely incorrect and not supported by the original answer. The correct new financial activity is a $100 million loan, not an equity investment. (3) The multi-hop reasoning is flawed. The LLM misidentifies the nature of the financial relationship shift—portraying it as an equity stake increase rather than a move into creditorship via a term loan. This reflects a failure to correctly synthesize the type of financial involvement (debt vs. equity) and the actual instruments used. (4) Despite these major errors, the answer is contextually relevant—it addresses the evolution of the financial relationship and correctly reports the increase in receivables. However, the core new investment activity is entirely misrepresented, leading to a low correctness score. The contextual relevance is moderate because the structure and intent align with the question, but the facts are largely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 446,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued its strategy of reducing pension obligations through settlements. In 2022, the company recognized a noncash pension settlement charge of $1.5 billion related to transferring $4.3 billion of pension obligations to an insurance company for approximately 13,600 retirees. In 2023, the company made voluntary settlement payments of $414 million to approximately 6,500 participants, reducing the pension obligation by a corresponding amount. These actions reflect an ongoing effort to mitigate the financial impact of defined benefit pension plans by transferring risk and reducing net pension liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in voluntary settlement payments to approximately 6,500 former employees. These numbers exactly match the ground truth, with acceptable phrasing variations (e.g., 'participants' instead of 'former employees'). (2) Quantitative accuracy is perfect—dollar amounts, participant counts, and years are all correct. (3) The reasoning is sound: the LLM correctly identifies a continued risk mitigation strategy and implies a shift in scale and method from large annuity transfers to smaller individual settlements, though it does not explicitly state the contrast in scale or the strategic evolution as clearly as the original answer. (4) The answer is fully relevant, directly addressing the evolution of Lockheed Martin's approach to nonqualified defined benefit pension plans. The only minor shortcoming is the lack of explicit characterization of the 2023 action as 'significantly smaller in scale' or a 'shift to a more targeted approach,' which slightly weakens the qualitative synthesis. However, the core multi-hop reasoning—comparing two years of actions and inferring ongoing liability reduction—is logically sound and factually supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 387,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved as follows: AMD's investment in the ATMP JV increased from $99 million as of December 30, 2023, to $149 million as of December 28, 2024, following an additional $17 million contribution in August 2024. Additionally, AMD's equity income from the ATMP JV rose from $16 million in 2023 to $33 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2023 carrying value ($99M), 2024 carrying value ($149M), additional contribution ($17M), and equity income figures ($16M in 2023, $33M in 2024) are correctly reported. The implied calculation (99M + 17M = 116M, with the remainder of the increase due to equity income and other adjustments) is consistent with accounting principles, and the final carrying value of $149M aligns with the ground truth. (2) The answer is complete, addressing both AMD's investment evolution and equity income changes, which were the two key components of the question. (3) Entity accuracy is perfect: AMD, ATMP JV, correct fiscal years (2023 and 2024), and financial metrics (carrying value, equity income, contribution) are all correctly identified. (4) The multi-hop reasoning is sound—information from two different time points and financial metrics is synthesized correctly to show the evolution of the financial relationship. (5) The semantic meaning is equivalent to the original answer, with slightly more precise dates (December 30, 2023, and December 28, 2024) that are plausible for fiscal year-ends and do not contradict the ground truth. No factual or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 362,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's ownership in Kenvue evolved significantly. In May 2023, Kenvue completed an IPO, after which Johnson & Johnson retained 89.6% ownership. On August 23, 2023, Johnson & Johnson further reduced its stake by 80.1% through an exchange offer, leaving it with a 9.5% ownership in Kenvue, valued at $4.3 billion as of August 23, 2023. By May 2024, Johnson & Johnson fully divested its remaining shares via a Debt-for-Equity Exchange, resulting in a $0.4 billion loss recorded in Other (income) expense. The retained stake in 2023 experienced an unfavorable fair value change of $0.4 billion, and the separation of Kenvue generated a one-time non-cash gain of $21.0 billion in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has key factual inaccuracies. It correctly states that Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after the August 2023 exchange offer and that a $21.0 billion non-cash gain was recorded in 2023. It also correctly notes the full divestment in 2024 via a Debt-for-Equity Exchange and a $0.4 billion loss. However, it incorrectly claims that J&J retained 89.6% ownership post-IPO and then reduced it by 80.1%—this is not supported by the ground truth, which does not mention post-IPO ownership percentage or a percentage reduction. The 89.6% and 80.1% figures are factually incorrect and introduce confusion. Additionally, the LLM mentions a 'May 2024' divestment, while the ground truth only specifies 'by the end of 2024'—a minor but notable date imprecision. (2) The $4.3 billion valuation, $21.0 billion gain, and $0.4 billion loss are all quantitatively accurate. However, the inclusion of fabricated percentages (89.6%, 80.1%) and the claim of a $0.4 billion 'unfavorable fair value change' on the retained stake—while the ground truth attributes the $0.4 billion loss to the final divestment, not a separate fair value change—introduces quantitative errors. (3) The multi-hop reasoning is generally sound: the model connects the 2023 partial divestment with the 2024 full exit and links financial impacts. However, the incorrect intermediate ownership percentages suggest flawed synthesis or hallucination of data. (4) Despite inaccuracies, the answer addresses all key aspects of the question—evolution of ownership, retained equity, gains/losses—and remains contextually relevant. The core narrative of reducing stake in 2023 with a gain and exiting in 2024 with a loss aligns with the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 500,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, as both years reference the same historical guaranty agreement under Exhibit 4-c, which includes obligations from Southwestern Bell Telephone Co. There is no indication of new or modified guarantee agreements involving Southwestern Bell Telephone Co. in the 2023 filing compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained unchanged between 2022 and 2023, with both years referencing Exhibit 4-c as the location of the guarantee. The inclusion of Southwestern Bell Telephone Co. in the same exhibit across both years is correctly noted, and there is no indication of modifications, which matches the original answer. All entities (AT&T, Southwestern Bell Telephone Co., Exhibit 4-c) and years (2022, 2023) are accurate. The reasoning is sound and reflects proper multi-hop synthesis across the two years' filings. The only minor limitation is that the LLM does not explicitly mention that the 2022 and 2023 exhibits contain the same list of guaranteed entities, which adds a small nuance to the consistency claim, but the overall conclusion of no change is well-supported. There are no numerical inaccuracies, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 293,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2023 has seen a continued strategic emphasis, with the company maintaining its role in designing, developing, and building hypersonic strike weapons for the U.S. Army, Navy, and Air Force. In 2022, the hypersonics programs were highlighted as a key component of the Space and Missiles and Fire Control segments, focusing on advanced strike capabilities. By 2023, the company continued this focus, with hypersonics being explicitly mentioned under both the Missiles and Fire Control and Space segments, indicating an expanded or reinforced strategic positioning across multiple business units. This evolution reflects a growing emphasis on hypersonic technologies as a critical element of national defense and future military capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's continued strategic focus on hypersonics and its role in designing and developing hypersonic weapons, which aligns with the general direction of the ground truth. However, it introduces inaccuracies regarding the segmentation and evolution of the program. The original answer specifies that in 2022, hypersonics were described as a potential growth area dependent on government funding and listed among other development areas, not as an active program already under execution. By 2023, the shift was to being explicitly listed as a major program under the Space segment, indicating a concrete operational role. In contrast, the LLM claims hypersonics were already a 'key component' of Space and Missiles and Fire Control segments in 2022 and were mentioned in both segments in 2023, which overstates the 2022 status and misrepresents the organizational placement. Additionally, the LLM adds involvement with the Air Force, which is not mentioned in the ground truth (only Army and Navy are specified). (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model recognizes a progression in strategic positioning, but fails to accurately capture the nature of the evolution—from a contingent growth area in 2022 to an active, defined program in 2023. The synthesis across years is present but flawed in detail. (4) The correctness score is 6 due to significant qualitative inaccuracies in entity roles and timeline portrayal, despite correct contextual framing and relevance to the topic. The answer is plausible and relevant but contains key factual deviations from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 487,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1.4 billion to $1.764 billion. In fiscal year 2022, $850 million was deposited into the account, while $1.0 billion was deposited in fiscal year 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fiscal year 2022 starting balance ($1.4 billion) and the deposit amounts for both years ($850 million in FY2022 and $1.0 billion in FY2023), which are factually accurate. However, it incorrectly states the ending balance for FY2023 as $1.764 billion, whereas the ground truth reports $3.089 billion. This is a significant quantitative error. (2) The calculation of the ending balance should be: $1.4B + $850M + $1.0B = $3.25B (before any withdrawals or adjustments), but the actual reported balance is $3.089B, suggesting some activity beyond simple deposits. The LLM’s reported $1.764B does not align with any verifiable sum from the correct inputs and appears to be a factual error, not a rounding or formatting issue. (3) The multi-hop reasoning is partially sound—deposits are correctly attributed to each fiscal year, and the direction of change (increase) is correct—but the failure to report the correct final balance undermines the quantitative synthesis across years. (4) Scores reflect that core data points (deposits, initial balance) are correct (warranting partial credit), but the key metric—the evolved balance—is wrong, reducing correctness and quantitative accuracy. Contextual relevance is high as all parts of the question are addressed in structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 372,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden has remained a distinct merchandising department within the Hardlines major product line, indicating a consistent classification in HD's product strategy. In 2022, Outdoor Garden accounted for 6.8% of total net sales, with a slight decline in its percentage share observed in 2024 to 6.8% as well, despite overall sales growth. This suggests that while Outdoor Garden has maintained its positioning within the broader Hardlines category, its relative contribution has remained stable, reflecting a strategic emphasis on sustaining its role rather than significant expansion or repositioning during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Outdoor Garden was a distinct product line with $10,317 million in net sales (6.8% of total). However, by 2024, it was no longer reported as a standalone category but was instead grouped under the broader 'Hardlines' department, indicating a strategic repositioning. The LLM incorrectly states that Outdoor Garden remained a 'distinct merchandising department' within Hardlines in both years, which contradicts the ground truth that shows a shift from standalone to integrated. (2) Quantitatively, the LLM correctly cites the 6.8% sales contribution in 2022, but falsely claims the percentage remained at 6.8% in 2024 'despite overall sales growth'—this is unsupported by the ground truth, which does not provide 2024 sales figures or percentages, only the reclassification. Thus, asserting the same percentage in 2024 is an incorrect extrapolation. (3) The multi-hop reasoning is flawed: the question asks about evolution in role and positioning, which requires recognizing the change in classification from standalone to consolidated. The LLM fails this synthesis, instead asserting consistency where there was change. (4) Contextual relevance is moderate—the answer discusses the right company (HD), product line (Outdoor Garden), and time frame (2022–2024), and touches on strategic positioning, but draws the opposite conclusion from the evidence. Hence, correctness is low due to core factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 422,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by reinforcing its inclusive and innovative culture, as reflected in high employee engagement scores and continued investment in diversity, equity, and inclusion initiatives. The company also prioritizes employee development, flexible work arrangements, and competitive total rewards to attract and retain top talent. This suggests that AMD's talent retention strategy centers on fostering a supportive and dynamic workplace culture, which is critical in the competitive semiconductor industry to retain skilled professionals and drive innovation.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in spirit but factually inaccurate in key aspects. It introduces specific initiatives such as 'high employee engagement scores,' 'investment in diversity, equity, and inclusion initiatives,' 'employee development,' 'flexible work arrangements,' and 'competitive total rewards' that are not present in the original answer or supported by the provided ground truth. These details were not mentioned in AMD's reported statements for 2023 or 2024 in the knowledge graph. (2) Quantitatively, the LLM fails to include or reference the actual workforce numbers (26,000 in 2023, 28,000 in 2024) or the 7.7% growth, which are central to the original answer. There are no calculations or numbers in the LLM response, making the quantitative accuracy very low. (3) The multi-hop reasoning is flawed: while the original answer infers AMD’s talent retention strategy based on consistent cultural messaging despite workforce growth, the LLM fabricates supporting programs rather than drawing inference from the repetition of cultural language across years. The correct reasoning path requires recognizing that identical phrasing across filings amid growth implies intentional cultural preservation. (4) Despite inaccuracies, the LLM answer is contextually relevant and addresses both parts of the question—how AMD maintained its culture and what it suggests about talent retention. The overall suggestion about culture being central to retention aligns semantically with the ground truth, but the lack of factual grounding in the data severely undermines correctness. Hence, the correctness score is low (4), quantitative accuracy is poor (1), qualitative reasoning is partially sound but flawed (5), and relevance is high (8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 479,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided document pages, there is no specific information indicating any changes or developments in AT&T's relationship with The Ohio Bell Telephone Company between 2022 and 2023 in terms of guarantee obligations. The references to The Ohio Bell Telephone Company are found in the context of historical guaranty obligations listed in the exhibits, but no updates or modifications to these obligations are detailed in the 2022 or 2023 filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually neutral and does not contradict the ground truth, but it fails to provide the specific evolution described in the original answer. While it correctly notes that The Ohio Bell Telephone Company is mentioned in the context of historical guaranty obligations and that no explicit changes are detailed, it omits the key point from the ground truth: that the exhibit reference was updated from 'Exhibit 4-c (originally filed in 2011)' in 2022 to a current documentation format in 2023, indicating a continuation of the guarantee under updated reporting standards. This update in exhibit referencing is a documented change reflecting ongoing maintenance of the guarantee, which the LLM answer overlooks. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative reasoning is incomplete—it fails to synthesize the implication of exhibit updates as evidence of continued obligation. The answer is contextually relevant but incomplete, treating absence of explicit change as absence of information rather than interpreting documentation updates as part of the evolving relationship. Thus, while not factually wrong, it misses the multi-hop nuance that updated exhibit references imply active maintenance of the guarantee, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 365,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap showed a significant decline in gains on retained and sold ownership interests. In 2023, GE reported gains of $5,778 million, primarily from the monetization of its AerCap shares. However, in 2024, these gains dropped by $5.2 billion, contributing to a decrease in continuing earnings. This decline reflects a shift in the value and strategic positioning of GE's investments in AerCap during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the significant decline in gains on retained and sold ownership interests between 2023 and 2024, primarily tied to AerCap and GE HealthCare, which aligns with the ground truth. The directional trend and qualitative interpretation are accurate. (2) However, there is a minor quantitative inaccuracy: the LLM states that GE reported gains of '$5,778 million' in 2023, which is $5.778 billion, whereas the ground truth specifies a $5.7 billion increase in corporate operating profit due to gains. While close, $5.778 billion is not equivalent to $5.7 billion (a ~$78 million difference), and the source does not support this precise figure. Additionally, the LLM attributes the 2023 gains solely to AerCap, while the original answer notes they were driven by both AerCap and GE HealthCare, leading to incomplete attribution. (3) The multi-hop reasoning is sound—correctly comparing year-over-year changes in gains and linking them to strategic shifts in investment value. The synthesis across years and entities (GE, AerCap) is logical and relevant. (4) Scores reflect high correctness due to accurate trend and context, but quantitative accuracy is slightly reduced due to the incorrect specific figure and partial omission of GE HealthCare's role in the gains. Qualitative and contextual accuracy remain high as the explanation is coherent and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 389,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot has strategically evolved its use of HD Supply between 2022 and 2024 by expanding its focus on professional customers and MRO (Maintenance, Repair, and Operations) services. In 2024, HD Supply plays a key role in providing MRO products and value-added services to sectors like multifamily, hospitality, healthcare, and government housing, reflecting a deeper integration into Home Depot's Pro customer initiatives. This evolution aligns with Home Depot's broader strategy to enhance its offerings for Pros, including the acquisition of SRS in fiscal 2024, which further strengthens its position in serving complex Pro needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly captures the evolution of HD Supply's role from a post-integration phase to a strategic asset for professional (Pro) customers through MRO services by 2024. The sectors mentioned—multifamily, hospitality, healthcare, and government housing—are accurately identified. The reference to deeper integration into Pro initiatives reflects the shift noted in the original answer from integration concerns in 2022 to strategic importance in 2024. The mention of SRS acquisition in fiscal 2024 is contextually relevant and consistent with Home Depot’s broader Pro strategy, though it is not part of the original answer; however, this does not introduce inaccuracy but adds supplementary context. There are no numerical values to verify, so quantitative accuracy is scored as 10. The qualitative reasoning is sound and reflects proper multi-hop synthesis across years and strategic themes. The only minor shortcoming is that the LLM does not explicitly mention the 'integration risks and uncertainties' emphasized in 2022, which slightly weakens the contrast between 2022 and 2024. However, the implication of evolution implies that earlier challenges have been overcome. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 376,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio grew slightly, with approximately 18,500 worldwide patent matters as of December 30, 2023, increasing to approximately 18,800 by December 28, 2024. The company continues to rely on cross-licensing and technology exchange agreements with other companies, which support its ability to innovate and integrate third-party technologies into its products. This evolution in patent portfolio size and continued reliance on cross-licensing agreements indicate AMD's ongoing commitment to fostering technology exchange while protecting its intellectual property rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total patent matters for AMD in both 2023 (18,500) and 2024 (18,800), matching the ground truth. It also accurately reflects the slight growth in the portfolio. While the LLM does not explicitly break down issued vs. pending patents (12,800 issued and 5,600 pending in 2023; 13,200 issued and 5,600 pending in 2024), the total numbers are correct, and the implication of a growing issued patent base is indirectly supported by the overall increase. (2) All numeric values for total patent matters and years are accurate. The dates (December 30, 2023, and December 28, 2024) are plausible fiscal year-end dates and align with typical SEC filing timelines, though not specified in the original answer—this is a minor detail and does not affect factual correctness. No calculations are required beyond the comparison of totals, which is handled correctly. (3) The reasoning is sound: the LLM correctly infers that the growing patent portfolio, combined with continued reliance on cross-licensing, supports technology exchange and innovation. It captures the strategic importance of these agreements, consistent with the original answer’s emphasis on their critical role. However, it misses the explicit point that the increased issued patents enhance AMD’s leverage in cross-licensing negotiations—a key qualitative insight in the ground truth. (4) The answer is contextually highly relevant, addressing both the evolution of the patent portfolio and its implications for cross-licensing and technology exchange. The omission of the issued/pending breakdown slightly reduces completeness but does not undermine the core factual accuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent in intent and substance, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 494,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake and strategic relationship with Kenvue evolved significantly. In 2023, J&J retained a 9.5% stake in Kenvue after an exchange offer, recording the shares at fair market value of $4.3 billion. By 2024, J&J executed a debt-for-equity exchange on May 17, 2024, using its remaining shares of Kenvue to satisfy $3.6 billion in commercial paper, thereby fully disposing of its ownership in Kenvue and recording a $0.4 billion loss on the transaction. This marked the end of J&J's direct financial stake in Kenvue and formalized the separation of the former Consumer Health business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies the 9.5% stake retained in 2023 valued at $4.3 billion, the $0.4 billion loss in 2024, and the use of 182.3 million Kenvue shares to satisfy $3.6 billion in commercial paper via a debt-for-equity exchange. The May 2024 transaction date is correctly noted (May 17, 2024), aligning with the 'by 2024' timeframe. (2) All numeric values match: 9.5%, $4.3B, $3.6B, $0.4B loss. The only minor omission is the exact share count (182,329,550), which is not included in the LLM answer—this is a small detail but not critical to the overall meaning. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from partial retention in 2023 to full disposal in 2024, linking the financial and strategic implications. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'recorded a $0.4 billion loss' vs. 'resulted in a $0.4 billion loss') but meaning is preserved. The strategic conclusion about the formal separation is a reasonable inference. The answer is fully contextually relevant. Score is 9 instead of 10 due to the omission of the precise share number, though this does not undermine the factual correctness of the financial and strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 361,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Between 2022 and 2023, Indiana Bell Telephone Co. Inc. remained included in AT&T's guarantee disclosures, as it was listed among the subsidiaries with guaranteed obligations in both years. Specifically, in 2022 (page 141) and 2023 (page 103), Indiana Bell Telephone Co. Inc. was referenced in the guaranty of certain obligations under the same exhibit references, indicating no change in its inclusion in these disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Indiana Bell Telephone Co. Inc. remained included in AT&T's guarantee disclosures in both 2022 and 2023, with no change in status—matching the original answer's conclusion. (2) The inclusion of specific page numbers (2022: p.141, 2023: p.103) adds precision not in the ground truth but does not contradict it; no numeric or date inaccuracies are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and filings, identifying consistent inclusion under the same exhibit (Exhibit 4-d, implied by 'same exhibit references') to conclude no change occurred. (4) All entities—AT&T, Indiana Bell Telephone Co. Inc., and the relevant disclosure context—are correctly identified and analyzed. The answer is concise, factually accurate, and fully addresses the evolution (or lack thereof) in the relationship regarding guarantee disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 286,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved as follows: In 2023, GE reported a $50 million pre-tax loss from discontinued operations related to AerCap, but after tax benefits, it resulted in a $1,656 million net earnings benefit. By 2024, GE had ongoing involvement with AerCap primarily through a note receivable and other transactions, with net cash outflows of $203 million. However, no specific investment gains were reported in 2024, indicating a shift from gains to operational cash outflows in the relationship.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that in 2023, GE reported a $50 million pre-tax loss and a $1,656 million net earnings benefit from discontinued operations related to AerCap — this is not supported by the ground truth. The original answer mentions no such loss or earnings benefit. Instead, in 2023, GE had a continuing financial involvement with AerCap involving a $203 million net cash payment to AerCap, which the LLM misplaces in time by attributing it to 2024 as an outflow, when it was part of 2023 activity. (2) The LLM reverses the timeline: it claims ongoing involvement in 2024 through note receivable and $203M outflows, but the ground truth states that by 2024, GE no longer had operational involvement and instead held an investment stake. The $203M cash payment was in 2023, not 2024. Additionally, the LLM claims no investment gains were reported in 2024, but the ground truth explicitly states that GE reported a $5.2 billion decrease in gains on retained and sold ownership interests — meaning there were gains, but lower than prior periods — which is a critical misrepresentation. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the transition from operational involvement (2023) to investment-based relationship (2024), instead suggesting the opposite — ongoing operational ties in 2024. It also fabricates financial figures not present in the original. (4) Due to major factual, numerical, and directional errors in both quantitative data and strategic interpretation, the correctness score is very low. Contextual relevance is moderate because the answer addresses the general topic of GE-AerCap financial evolution, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 477,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "The Home Depot has evolved its approach to store appearance and competition from 2022 to 2024 by enhancing the interconnected shopping experience and integrating digital tools to improve customer experience. In 2022, the focus was on store refresh packages, self-service lockers, and electronic shelf labels to improve navigation and convenience. By 2024, the company expanded on this by investing in mobile app-enabled store navigation, optimizing store layouts, and enhancing digital platforms for a seamless, personalized experience across online and in-store interactions. These efforts aim to differentiate The Home Depot in a competitive market by combining store appearance with digital integration to meet evolving customer expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of The Home Depot's approach from 2022 to 2024, noting a shift from physical store enhancements to a more integrated digital and in-store experience. It accurately identifies that in 2022, store appearance and convenience features (like self-service lockers and electronic shelf labels) were emphasized, which aligns with the ground truth's focus on store appearance and ease of shopping. By 2024, the LLM correctly notes a broader integration of digital platforms and mobile app navigation, supporting the ground truth's claim of an 'interconnected shopping experience.' However, the LLM introduces specific initiatives (e.g., self-service lockers, electronic shelf labels, mobile app navigation) not explicitly mentioned in the ground truth, which, while plausible, are not verifiable from the provided source. This adds detail but risks over-specificity without grounding. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 vs 2024), connects store appearance to competition, and integrates digital transformation as a strategic evolution. It correctly infers that digital integration became a core component, matching the ground truth’s emphasis. (4) The correctness score is 8 because the core factual trajectory and strategic shift are accurately conveyed, with only minor additions of unverified specifics. Qualitative accuracy is slightly reduced for unsupported details, but contextual relevance and quantitative accuracy are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 464,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. Resales to the ATMP JV rose from $14 million in 2023 to $121 million in 2024. Additionally, in October 2024, AMD provided a $100 million one-year term loan to one of the ATMP JVs, secured by the ATMP JV's receivable balance due from AMD. This loan bears interest at the three-month SOFR plus 50 basis points and is recorded within Receivables from related parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: resales increased from $14 million in 2023 to $121 million in 2024, and a $100 million one-year term loan was established in October 2024. These figures match the ground truth exactly. (2) Quantitative accuracy is perfect—dollar amounts and the date (October 2024) are correct, with no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across years and identifies both the increase in resales and the new loan arrangement. However, the LLM adds details not present in the ground truth—specifically, that the loan is 'secured by the ATMP JV's receivable balance due from AMD' and that it 'bears interest at the three-month SOFR plus 50 basis points' and is 'recorded within Receivables from related parties.' These specifics, while plausible, are not confirmed in the original answer and represent over-specification. (4) Despite these minor additions, the core evolution of the financial relationship—increased resales and new direct financial support—is accurately conveyed, maintaining semantic equivalence. The answer remains highly relevant and factually correct on all critical points, warranting a high score with a slight deduction for unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 358,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson enhanced its privacy compliance programs by expanding its structured controls to address evolving privacy laws and international data flow regulations. The company emphasized compliance with global data protection laws, including data localization and cross-border data transfer requirements, and reinforced its privacy compliance programs across its businesses. Additionally, the frequency of CISO updates to the Regulatory Compliance & Sustainability Committee increased from twice a year in 2023 to quarterly in 2024, reflecting a heightened focus on regulatory changes and cybersecurity risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct and captures key aspects of Johnson & Johnson's evolving privacy compliance programs between 2023 and 2024, with accurate qualitative details and strong contextual relevance. It correctly identifies the expansion of privacy controls to address evolving laws and international data flows, including data localization and cross-border transfers. The mention of increased CISO reporting frequency—from twice a year to quarterly in 2024—is factually accurate and reflects a real change indicating heightened oversight, which supports the narrative of enhanced compliance focus. However, the original answer emphasizes a shift in scope from 'other territories' in 2023 to 'globally' in 2024, signaling a broader anticipatory posture toward global regulations, and highlights the integration of privacy compliance with evolving technology and data-driven initiatives involving third parties—details not mentioned in the LLM response. While the LLM includes a relevant governance update (CISO reporting), it omits the nuanced evolution in geographic scope and the growing complexity due to third-party involvement and technological change. There are no numerical inaccuracies (quantitative accuracy is high, hence 9), and all entities (Johnson & Johnson, privacy compliance, international data flows) are correctly identified. The reasoning is sound but incomplete in synthesizing the full multi-hop evolution described in the ground truth. Thus, the answer is factually solid but lacks completeness in capturing the full qualitative shift, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 441,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH decreased significantly. As of December 31, 2023, the total estimated losses related to borrower litigation were $2,669 million, while by December 31, 2024, this amount had reduced to $2,461 million. Additionally, valuation allowances against financing receivables held for sale related to Bank BPH were $1,712 million in 2023 and $1,517 million in 2024, indicating a reduction in estimated borrower litigation losses and related allowances over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: total estimated losses decreased from $2,669 million in 2023 to $2,461 million in 2024, valuation allowances decreased from $1,712 million to $1,517 million, and other liabilities were accurately implied through subtraction (though not explicitly stated). All numbers match exactly and are presented with correct time references (December 31, 2023 and 2024). (2) Quantitative accuracy is perfect—values are correct, and the direction of change (decrease) is properly conveyed. The reduction in total losses ($208 million) and valuation allowances ($195 million) aligns with ground truth. (3) The reasoning is sound and captures the core multi-hop elements: it identifies GE’s exposure to Bank BPH, tracks changes in litigation losses and valuation allowances across two years, and infers a reduction in exposure. However, it omits the qualitative insight about the valuation allowance fully offsetting the financing receivables balance by end of 2024 and the mention of a settlement program indicating a strategic shift—this contextual nuance is missing, slightly weakening the qualitative completeness. (4) Despite this omission, the answer remains highly relevant and factually accurate. The core of the question—how exposure evolved quantitatively—is fully addressed with precise data and correct interpretation. The missing strategic context prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 415,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining its categorization under the \"Hardlines\" merchandising department, as noted in both 2022 and 2024 disclosures. However, in 2024, the company reorganized its merchandising departments, grouping Indoor Garden with Hardware, Outdoor Garden, and Tools under the Hardlines major product line, indicating a potential strategic consolidation or repositioning for operational efficiency or marketing purposes. Financially, while specific performance data for Indoor Garden is not provided, its consistent inclusion in annual sales breakdowns suggests it remains a stable contributor to HD's overall sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that the Indoor Garden product line was categorized under 'Hardlines' in 2022, while the ground truth indicates it was a standalone category with $15,546 million in net sales (10.3% of total revenue), not part of Hardlines. The LLM also fails to report these key financial figures, instead stating that 'specific performance data for Indoor Garden is not provided,' which directly contradicts the ground truth. (2) Quantitative accuracy is very low: the correct net sales ($15,546 million) and percentage of total revenue (10.3%) are entirely omitted, and no correct numbers are presented. The claim that financial data is unavailable is false. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from a high-performing standalone category in 2022 to a reclassified sub-category under Hardlines in 2024. Instead, it falsely asserts continuity in categorization, undermining the core insight about strategic repositioning. The reasoning about 'reorganization' is partially aligned with the 2024 change but is undermined by incorrect premises. (4) Contextual relevance is moderate because the answer addresses the general theme of categorization change and strategic positioning, but due to major factual errors and omission of critical financial performance data, the response is substantially misleading. Correctness score is low due to fundamental errors in both quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 427,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has continued to manage cost volatility through sourcing strategies, particularly in response to commodity price fluctuations. In 2022, the company emphasized sourcing strategies as part of its approach to mitigate raw material cost volatility, alongside cost containment measures and productivity initiatives. By 2024, the company maintained a similar approach, using sourcing strategies in combination with price increases, cost efficiencies, and limited commodity hedging contracts to manage exposure to fluctuating commodity prices. However, the 2024 filing highlights increased challenges due to geopolitical conflicts and climatic events, underscoring the need for ongoing adaptation in sourcing and cost management strategies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Colgate-Palmolive used sourcing strategies to manage cost volatility from 2022 to 2024 and notes the ongoing challenge of commodity price fluctuations. It accurately reflects the continuity in strategy and the increased external pressures from geopolitical and climatic factors in 2024. However, there are subtle but important discrepancies in emphasis and detail compared to the ground truth. The original answer specifies that in 2022, Colgate used derivative instruments and local currency borrowings as part of its risk management framework—not just for raw materials but also for foreign exchange and interest rates—whereas the LLM answer incorrectly frames sourcing strategies in 2022 primarily around raw material cost volatility, which is more characteristic of the 2024 approach. Additionally, the LLM mentions 'limited commodity hedging contracts' in 2024, while the ground truth emphasizes proactive cost containment and productivity initiatives, with no mention of hedging being limited. The specific commodities called out in 2024 (resins, essential oils, soybeans) are missing in the LLM response, reducing precision. (2) There are no numerical values, percentages, or dates requiring quantitative verification; all timeframes (2022, 2024) are used correctly. (3) The multi-hop reasoning is partially sound—the model connects sourcing strategies across years and recognizes evolving external risks—but it misattributes the focus of 2022 strategies and omits key components (derivatives, local currency borrowings) that reflect a broader risk management scope. The synthesis is therefore incomplete. (4) The correctness score is 7 because the core idea of evolving sourcing strategies under cost and commodity pressures is preserved, and the contextual relevance is high. However, the qualitative accuracy is reduced due to misalignment in strategic emphasis and missing specifics, though no outright factual errors are present. Quantitative accuracy is 10 because no numbers are misstated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 553,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA's sales increased by 16.6% in 2024 compared to 2023, driven by market growth and continued strength in psoriasis and psoriatic arthritis (PsO/PsA). Despite a negative currency impact of 1.5%, operational growth of 18.1% highlights the product's strong performance. This growth reflects TREMFYA's expanding market share and positive patient mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 16.6% sales increase in 2024 compared to 2023, the $3,147 million and $3,670 million sales figures (implied through the percentage change), the 18.1% operational growth, and the negative 1.5% currency impact—all of which match the ground truth. These numbers are quantitatively accurate and correctly reflect the calculation: ($3,670M - $3,147M) / $3,147M ≈ 16.6%. (2) The key drivers—market growth, strength in PsO/PsA, positive patient mix, and operational growth despite currency headwinds—are all accurately mentioned. (3) The multi-hop reasoning is sound: the model synthesizes performance across two years and attributes changes to operational and currency factors, correctly inferring that strong operational performance drove growth. (4) The only minor omission is that the 2023 sales figure ($3,147M) is not explicitly stated in the LLM answer, though the 16.6% increase implies it was derived from accurate data. Additionally, the phrase 'expanding market share' is a slight rephrasing of 'market expansion' and 'maintained its market position' from the original, but remains semantically consistent. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 353,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023, as outlined in the provided documents, did not significantly alter Disney's financial stake in the partnership, as it continues to hold a 50% equity interest in A+E. However, the reporting of subscriber numbers for A+E channels appears to have shifted slightly in terms of methodology or presentation. In 2022, the document listed individual subscriber counts for A+E channels like A&E, HISTORY, and Lifetime, while in 2023, the subscriber numbers for these channels were consolidated into a single figure of 58 million for each channel. This suggests a change in how subscriber data is aggregated or disclosed, but the financial stake and reporting of equity income remain consistent.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical factual errors and misrepresents the structural change in Disney's relationship with A&E. (1) The claim that Disney 'continues to hold a 50% equity interest' in 2022 is incorrect: the ground truth states that in 2022, Disney reported A&E as a partner with 69 million subscribers, indicating a non-equity or arms-length relationship, not a 50% stake. The 50% equity stake began in 2023, marking a significant change in financial ownership, not continuity. (2) The LLM incorrectly states that in 2023, each A+E channel (A&E, HISTORY, Lifetime) had 58 million subscribers individually, claiming 'a single figure of 58 million for each channel.' This is false: the ground truth specifies that A+E's channels collectively had 58 million domestic subscribers in total, not per channel. (3) The LLM claims there was 'no significant alteration' in financial stake, directly contradicting the ground truth that the shift to a 50% equity stake changed Disney's reporting to include A+E’s financial results under 'Equity in the income of investees'—a major change in accounting treatment. (4) The subscriber decline from 69M to 58M is not addressed in terms of significance, and the LLM falsely attributes the change to 'methodology or presentation' without evidence. (5) Multi-hop reasoning fails: the model does not correctly synthesize the shift from partnership to equity investment as a transformative change affecting both financial reporting and subscriber disclosure. While the answer is relevant to the topic and mentions equity income, the core facts—timing of the stake change, subscriber numbers, and reporting implications—are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 465,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap shifted significantly. In 2023, GE reported a realized and unrealized gain of $129 million from its investment in and note with AerCap. However, by 2024, GE had fully sold its remaining AerCap shares, leaving only a senior note as the remaining position, and the related gains or losses from this relationship were no longer reflected as a separate line item, indicating the conclusion of this investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies compared to the ground truth. It correctly identifies the $129 million gain in 2023, aligning with the original answer, though it incorrectly labels it as both 'realized and unrealized' when the ground truth specifies it was an 'unrealized gain' only. This mischaracterization affects qualitative accuracy. The major error lies in the 2024 description: the LLM claims GE fully sold its AerCap shares and no longer reports gains separately, implying the financial impact ended. However, the ground truth states that GE recognized a $5.2 billion decrease in gains on retained and sold ownership interests in 2024 compared to 2023, with AerCap being a primary contributor—indicating a substantial negative financial shift, not just a cessation of reporting. The $5.2 billion drop is a critical quantitative and qualitative omission. (2) The $129 million figure is accurate in amount but misrepresented in nature (unrealized vs. realized and unrealized). The $5.2 billion year-over-year decline in gains is completely missing from the LLM answer, which is a major quantitative and factual gap. (3) The multi-hop reasoning fails because the model does not connect the 2023 gain to the 2024 deterioration in financial performance. Instead of showing a negative evolution (gain to large drop), it suggests the relationship simply concluded, which is not supported by the ground truth. The synthesis across years is flawed. (4) Correctness is scored at 4 due to one correct number but a missing major financial impact and incorrect characterization of the 2024 situation. Quantitative accuracy is 5 because one number is correct but a more significant one is omitted. Qualitative accuracy is 5 due to correct entity and year identification but flawed reasoning and misrepresentation of financial outcomes. Contextual relevance is 8 because the answer addresses the right companies and time frame and attempts the evolution narrative, even if incorrectly resolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 552,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by strengthening protections for third-party service providers and expanding proactive risk management practices. In 2022, the company emphasized its layered security framework, including monitoring threats from third-party services and ensuring compliance through assessments and benchmarking. By 2024, Mastercard explicitly outlined processes for evaluating the privacy, data protection, and information security infrastructure of third-party providers, including monitoring during engagements and off-boarding procedures. This evolution reflects a strategic response to emerging cybersecurity threats by prioritizing third-party risk management, continuous system testing, and aligning with global security standards to safeguard the payments ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative but contains a key factual inaccuracy regarding 2022. The ground truth states that in 2022, there was *no explicit mention* of addressing risks related to third-party service providers, while the LLM claims Mastercard was already 'monitoring threats from third-party services' and ensuring compliance through assessments—this overstates the 2022 posture. In 2024, both the LLM and ground truth agree that Mastercard explicitly integrated third-party risk management, including monitoring and off-boarding procedures, which is accurate. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the evolution from a general security framework to a more explicit third-party focus by 2024. However, it incorrectly attributes third-party monitoring to 2022, undermining the contrast and misrepresenting the evolution. This affects the qualitative accuracy. (4) Contextual relevance is high—the answer addresses all parts of the question, uses appropriate terminology, and draws a reasonable strategic conclusion about ecosystem-wide resilience, albeit based on a slightly flawed premise. The conclusion about prioritizing third-party risk management aligns with the ground truth’s interpretation of strategic response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 403,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation remained in compliance with its debt leverage covenant, despite changes to its credit facilities. In October 2023, Target obtained a new $1.0 billion 364-day unsecured revolving credit facility and extended its existing $3.0 billion five-year facility to October 2028. These updates reflect a strategic effort to maintain liquidity and access to capital markets. The company confirmed it was in compliance with all covenants as of February 3, 2024, and expects to remain so.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target remained in compliance with its debt leverage covenant in both 2022 and 2023; it obtained a new $1.0 billion 364-day unsecured revolving credit facility in October 2023 (expiring October 2024); and extended its $3.0 billion five-year facility to October 2028. These details match the original answer exactly. (2) Quantitative accuracy is perfect: dollar amounts ($1.0 billion, $3.0 billion), timeframes (364-day, October 2028 extension), and dates (October 2023) are all correct. The mention of compliance as of February 3, 2024, is consistent with 2023 reporting and adds slightly more detail than the original, but does not contradict it. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 to 2023), identifies changes in credit facilities, and links them to ongoing covenant compliance. The only minor shortcoming is that the original answer notes the prior $3.0 billion facility was set to expire in October 2026 before extension, which the LLM omits. This contextual detail about the prior expiration is relevant to the evolution of the credit facilities but is not critical to the core conclusion. (4) The answer is semantically equivalent and highly relevant, clearly addressing how compliance evolved alongside facility changes. The omission of the original 2026 expiration date prevents a perfect 10, but the core facts, reasoning, and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 418,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of risks associated with Salesforce's AI offerings, including generative AI like Agentforce, has evolved to include increased regulatory scrutiny, ethical concerns, and operational complexities. In 2023, the risks primarily focused on potential reputational harm, legal liability from misuse of AI by customers, and the challenges of ensuring AI systems are free from bias, inaccuracies, and security vulnerabilities. By 2024, the risks expanded to include heightened regulatory frameworks, such as the EU's AI Act and the Data Privacy Framework, which impose stricter compliance obligations and increase the cost of cross-border data transfers. Additionally, the move toward generative AI content creation brought new challenges around data provenance, copyright, and the need for more robust governance and compliance measures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Salesforce's AI-related risks from 2023 to 2024 with high accuracy. It correctly identifies the expansion of risk from general concerns like bias, inaccuracies, and liability in 2023 to more specific 2024 risks including regulatory scrutiny (e.g., EU AI Act, Data Privacy Framework), ethical concerns, copyright, data provenance, and increased compliance costs. These align well with the ground truth, which emphasizes new 2024 risks around AI-generated content, legal liabilities, ethical issues, and governance costs. The LLM adds specific regulatory examples (EU AI Act, Data Privacy Framework) not explicitly mentioned in the original answer, but these are contextually plausible and consistent with the broader trend of increased regulatory scrutiny. However, the LLM slightly mischaracterizes the 2023 risk focus: the ground truth emphasizes third-party integration liabilities and warranty expectations, not AI misuse or bias, which were not yet central in 2023. This is a notable but not critical omission. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects multi-hop synthesis across years and risk domains. The answer is fully contextually relevant and well-structured. The qualitative accuracy is slightly reduced due to the misattribution of 2023 AI-specific risks that were not yet prominent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 398,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's delivery capability for parcel-eligible items improved significantly. In fiscal 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal 2024, delivery was enhanced to \"two business days or less\" for most items, and same-day delivery was expanded nationwide through gig provider networks. Additionally, Lowe's achieved next-day delivery for major appliances in nearly every U.S. zip code by 2024. These improvements were driven by the completion of the market-based delivery model rollout and expanded fulfillment network capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's delivery capabilities from fiscal 2023 to 2024, stating that delivery improved from 'within two business days' to 'two business days or less' for most parcel-eligible items, which aligns with the ground truth. It also accurately notes the expansion to next-day delivery for major appliances in nearly every U.S. zip code by 2024. However, the LLM introduces 'same-day delivery was expanded nationwide through gig provider networks,' which is not mentioned in the original answer and lacks support from the provided ground truth, representing an unsupported addition. (2) All timeframes (fiscal 2023 and 2024), delivery speed improvements, and geographic scope ('nearly every U.S. zip code') are factually consistent with the original. No numerical inaccuracies are present, though the mention of 'same-day delivery' introduces a new service tier not referenced in the ground truth. (3) The multi-hop reasoning is mostly sound—correctly comparing delivery speeds across years and identifying enhancements in geographic coverage and fulfillment infrastructure. The reference to 'market-based delivery model rollout' and 'expanded fulfillment network' is plausible context but not explicitly in the original answer, slightly reducing qualitative accuracy. (4) The answer is highly relevant and mostly accurate, but the unsupported claim about same-day delivery prevents a top score. The core facts and improvements are correct, warranting a high but not perfect correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 426,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. In 2021, the sale generated a $335 million pretax gain, which was included in Net Other (Income)/Expense. The Dermstore represented less than 1% of Target's consolidated revenues, operating income, and net assets in 2021, and there is no indication in the provided documents that its impact on these metrics significantly evolved in 2022 or 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the financial impact of the Dermstore LLC sale was minimal in both 2022 and 2023, consistent with the ground truth. It accurately notes the $335 million pretax gain from the 2021 sale and its classification in Net Other (Income)/Expense. The representation of Dermstore as less than 1% of Target's consolidated revenues, operating income, and net assets is correctly cited, although the original answer specifies this was true in both 2022 and 2023, while the LLM answer references 2021 and states there is no indication of change—this is a minor omission but does not contradict facts. (2) All numeric values—$335 million, less than 1%, and the 2021 sale date—are factually correct and match the ground truth. No calculations are required, and all figures are accurately reported. (3) The multi-hop reasoning is sound: the model correctly infers that because the sale occurred in 2021 and Dermstore was immaterial then, and no new data suggests a change, its impact remained negligible in 2022 and 2023. This aligns with the original answer’s conclusion, though it could have explicitly reaffirmed the <1% impact in both years for full completeness. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in financial impact on revenues and operating income. The slight softening of certainty ('no indication...') compared to the definitive 'remained minimal in both years' in the ground truth prevents a perfect score, but overall accuracy and relevance are very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 429,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud's strategic positioning evolved to become a more central and integrated component of Salesforce's broader service offerings. In 2023, Data Cloud was described as a key part of the Einstein 1 Platform, enabling companies to ingest and federate data to power automation and analytics across multiple service offerings. By 2024, Data Cloud was emphasized as a hyperscale, trusted data engine native to Salesforce, delivering a comprehensive, 360-degree view of customers and empowering teams with actionable insights. This evolution reflects a stronger integration of Data Cloud into Salesforce's AI-powered Customer 360 platform, enhancing cross-functional capabilities and supporting more personalized, intelligent customer experiences.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the strategic evolution of Data Cloud as outlined in the ground truth. (1) What was correct: The LLM correctly identifies Data Cloud as a 'hyperscale, trusted data engine native to Salesforce' and its role in delivering a 360-degree customer view, which aligns with the 2024 positioning. It also accurately reflects increased integration into Salesforce's broader platform, particularly with AI and Customer 360. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM fails to address the critical shift in strategic messaging from 2023 to 2024 related to competitive landscape and monetization risks. Specifically, the 2024 filing highlights that Salesforce acknowledges the market for Data Cloud as 'relatively new and uncertain,' faces increasing competition from evolving AI and data platforms, and has limited experience in pricing consumption-based models—key strategic concerns absent in the LLM response. Instead, the LLM emphasizes deeper integration and enhanced capabilities, which reflects a positive trajectory but omits the nuanced risk-aware positioning introduced in 2024. (4) Justification for scores: Correctness is scored 5 because while core product positioning facts are accurate, the answer fails to capture the essential strategic shift toward risk and uncertainty in 2024. Qualitative accuracy is 5 due to incomplete synthesis—missing critical competitive and monetization challenges. Quantitative accuracy is 10 because no numbers are involved and no factual inaccuracies in entities or dates. Contextual relevance is 8 because the response stays on topic and addresses the evolution of Data Cloud’s role, though it lacks depth on the competitive and strategic risk dimensions explicitly mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 519,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts show a shift in hedge designation and financial impact. In 2023, the company had $1,290 million in forward interest rate swap agreements designated as cash flow hedges, with gains or losses recorded in other comprehensive income. By 2024, these forward interest rate swap agreements were no longer present, indicating they had been settled. In connection with the 2023 note issuances, LOW settled forward interest rate swap contracts with a combined notional amount of $2.0 billion and received a payment of $247 million. This suggests that the company transitioned from using forward interest rate swaps as cash flow hedges to settling them, resulting in realized gains impacting earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $2.0 billion notional amount and $247 million settlement payment from the forward interest rate swaps related to the March 2023 Notes, which aligns with the ground truth. However, it incorrectly states that in 2023, LOW had $1,290 million in forward interest rate swap agreements, which contradicts the ground truth stating a $2.0 billion notional amount. This significant numerical discrepancy undermines quantitative accuracy. (2) The settlement details (notional $2.0 billion, $247 million received) are accurate and correctly tied to the 2023 note issuance, but the erroneous $1,290 million figure introduces confusion and suggests potential conflation with another instrument or misreading of data. (3) The reasoning partially captures the shift in accounting treatment—acknowledging the settlement of cash flow hedges in 2023—but fails to mention the key 2024 development: the use of fixed-to-floating interest rate swaps accounted for as fair value hedges under the shortcut method, which results in no earnings impact. This omission is critical because the question specifically asks about the evolution in accounting treatment, including hedge designation and financial impact. The LLM implies a transition due to settlement but does not identify the new hedge type or accounting method adopted in 2024. (4) While the answer is contextually relevant and addresses the general theme of change in swap treatment, it lacks completeness and precision in both quantitative and qualitative dimensions. The correctness score is moderate because core facts about the 2023 settlement are present, but major elements of the 2024 accounting evolution are missing or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 486,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to emphasize strengthening and expanding its portfolio to enhance differentiation and value. In 2022, owned and exclusive brands accounted for approximately one-third of sales, and the strategy focused on curating national brands and expanding signature partnerships. By 2023, the emphasis shifted to \"delighting with newness, style, and value\" by further strengthening the owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships. This evolution reflects a strategic objective to drive traffic, sales, and market share growth by leveraging higher-margin owned brands and enhancing the overall guest experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution from 2022 to 2023, noting the shift from a descriptive presence to a strategic focus on owned brands as a differentiator. It accurately reflects Target's 2023 emphasis on 'delighting with newness, style, and value' and the objective to drive traffic, sales, and market share. However, the claim that 'owned and exclusive brands accounted for approximately one-third of sales' in 2022 is not present in the ground truth and cannot be verified from the provided information, making this an unsupported quantitative addition. (2) There are no explicit numbers in the ground truth regarding sales percentage from owned brands, so introducing 'one-third' reduces quantitative accuracy. All other non-numeric elements (strategic themes, objectives) are consistent. (3) The multi-hop reasoning is sound—correctly synthesizing a shift in strategic emphasis across years and linking owned brand strength to broader business goals. The model infers the strategic deepening from descriptive to active leveraging, which aligns with the ground truth. (4) The correctness score is 8 because the core strategic narrative is accurate and complete, but the unverified 'one-third' figure introduces a factual risk. Qualitative accuracy is high due to strong reasoning and entity alignment (Target, owned brands, 2022–2023 timeline, strategic objectives). Contextual relevance is perfect—the answer directly addresses portfolio emphasis and strategic objectives as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 420,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has evolved significantly, with a stronger focus on expanding its service offerings and deploying scalable digital platforms. In 2023, GM emphasized its end-to-end software platform, which enables over-the-air delivery of software-defined features, apps, and services, enhancing customer ownership experiences. This includes features like Super Cruise, vehicle performance updates, and connectivity options. The rollout of this platform has expanded to more vehicles, including the 2024 Cadillac LYRIQ and Chevrolet Silverado EV, indicating a strategic push toward scalable digital solutions. This evolution reflects GM's increased investment in software capabilities to support its vision of a connected, electric, and autonomous future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution from general software-enabled services in 2022 to a specific end-to-end platform in 2023 is accurately described. Key features like Super Cruise, over-the-air updates, and the inclusion of the 2024 Cadillac LYRIQ and Chevrolet Silverado EV are correctly identified. (2) Quantitative accuracy is perfect: model years and vehicle names match the original answer, and no numerical claims are made that contradict or misrepresent the data. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the shift in GM's strategy across two years, linking platform deployment to investment in scalable digital solutions. (4) The only minor omission is that the 2022 description could more explicitly reference GM's integration of software services with AV and financing, as noted in the original answer, but this does not detract significantly from the overall correctness. The LLM captures the core evolution and strategic implication accurately, showing strong qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 317,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from fiscal 2022 to fiscal 2023. In fiscal 2022, revenue in this category grew 11% (or $75 million), driven by growth in ThousandEyes and Intersight offerings. In fiscal 2023, revenue in the Observability category increased 14% (or $80 million), with continued growth in ThousandEyes and monitoring and analytics offerings. This indicates a slight acceleration in ThousandEyes' contribution to the category's revenue growth between the two fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: the $75 million (11%) revenue growth in fiscal 2022 and $80 million (14%) growth in fiscal 2023 for the relevant product category, with ThousandEyes cited as a driver in both years. The entities (ThousandEyes, Intersight, monitoring and analytics), time periods (fiscal 2022 and 2023), and product category evolution (Optimized Application Experiences to Observability) are accurately represented. (2) Quantitative accuracy is perfect: dollar amounts ($75M, $80M) and percentages (11%, 14%) match the ground truth exactly, and the comparison showing increased growth is valid. (3) The multi-hop reasoning is sound—LLM correctly infers that ThousandEyes' contribution trended upward based on category-level growth attributed to it in both years. The conclusion about 'slight acceleration' is a reasonable interpretation of the increasing growth rate and absolute increase. (4) The only minor shortcoming is that the LLM slightly softens the conclusion by saying 'slight acceleration' rather than explicitly stating that both absolute and percentage growth increased, which the original answer emphasizes. However, this does not constitute a factual error, just a less emphatic phrasing. All core facts, calculations, and synthesis are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 377,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "The treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolved between the 2023 and 2024 10-K filings by being explicitly referenced in the 2024 filing as a separate exhibit (Exhibit 10.36), whereas it was not listed as a distinct exhibit in the 2023 filing. This indicates a shift in the company's disclosure strategy to provide more transparency and specificity regarding executive compensation-related amendments, likely in response to evolving regulatory expectations or internal governance standards.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. According to the ground truth, Amendment No. 4 was listed as a standalone exhibit (Exhibit 10.34) in the 2023 10-K, not absent as the LLM claims. Conversely, in the 2024 10-K, it was no longer a standalone exhibit but included as part of a sequence with other amendments, which contradicts the LLM's assertion that it was 'explicitly referenced as a separate exhibit (Exhibit 10.36)' in 2024. These errors invert the actual evolution of disclosure treatment. (2) The exhibit numbers and years are incorrect: the LLM cites Exhibit 10.36 in 2024, but the ground truth does not specify this number and emphasizes the removal of Amendment No. 4 as a standalone exhibit. The September 2022 10-Q incorporation is correctly noted in the ground truth but misrepresented in context by the LLM. (3) The multi-hop reasoning is flawed: the question requires comparing the disclosure strategy across two filings, but the LLM misrepresents both years’ treatments and thus fails to correctly synthesize the evolution. Instead of identifying a shift from highlighted to consolidated disclosure, it incorrectly infers increased transparency, when the actual trend suggests integration into a broader historical context. (4) The contextual relevance is moderate because the answer addresses the general topic of disclosure strategy evolution, but due to fundamental factual inaccuracies in entity treatment, timing, and exhibit status, the conclusion is unsupported. The reasoning and factual base are unsound, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 438,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's compliance with capital ratio requirements showed slight improvements. Under the Basel III Standardized approach, the Standardized CET1 capital ratio increased from 15.0% in 2023 to 15.7% in 2024, exceeding the minimum requirement of 12.3%. The Tier 1 leverage ratio remained stable at 7.2% for both years, well above the 4.0% minimum requirement. These figures indicate that JPMorgan maintained strong capital adequacy during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative metrics. While it correctly states JPMorgan's 2023 Standardized CET1 ratio as 15.0% and the 2024 Tier 1 leverage ratio as 7.2%, it incorrectly claims the 2024 Standardized CET1 ratio increased to 15.7% (ground truth does not provide this number) and misstates the 2024 minimum requirement as 12.3% (ground truth states 11.4% in 2023, no 2024 requirement specified). It also falsely claims the Tier 1 leverage ratio was 7.2% in both years, while the ground truth only reports 2024 data (7.2%) and does not mention 2023. (2) Number verification: 2023 CET1 = 15.0% ✓, 2024 Tier 1 leverage = 7.2% ✓, but 2024 CET1 = 15.7% ✗ (not in truth), 2024 requirement = 12.3% ✗ (truth says 11.4% in 2023), and 2023 Tier 1 leverage = 7.2% ✗ (not reported). (3) Multi-hop reasoning is partially sound—LLM attempts to compare ratios across years and against requirements—but introduces unverified data, undermining synthesis validity. (4) Scores reflect major quantitative errors (correctness 4/10, quantitative accuracy 3/10), moderate qualitative reasoning (5/10 for correct structure but incorrect data), and high contextual relevance (8/10 for addressing the right metrics and compliance trend).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 357,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct segment within General Motors' consolidated financial statements, providing automotive financing services and reporting its own net sales and revenue. The integration of GM Financial into the consolidated financial statements continued to involve adjustments for deferred tax positions and income taxes due to its inclusion in the consolidated tax return, ensuring that the amounts presented reflect eliminations of intercompany transactions. There were no significant changes in its role or financial presentation in 2023 compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant inaccuracy in reasoning and interpretation. (1) Quantitatively, there are no numeric values in the question or ground truth to verify, so the answer does not introduce any incorrect numbers—this aspect is acceptable by default (score 10). (2) However, the key issue lies in the qualitative assessment: the LLM claims 'there were no significant changes in its role or financial presentation in 2023 compared to 2022,' which directly contradicts the original answer stating that the 2023 description became 'more detailed' and reflected a 'more explicit focus on integration' regarding tax adjustments and consolidation impacts. This evolution in disclosure represents a meaningful change in financial presentation, even if structural integration remained consistent. (3) The multi-hop reasoning is flawed because the model fails to recognize that increased disclosure detail and emphasis on tax-related adjustments (e.g., deferred tax positions and income tax provisions) indicate an evolved level of transparency and integration within the consolidated statements. The LLM incorrectly interprets continuity in segment status as no change, missing the nuance of enhanced financial reporting clarity. (4) Contextually, the answer addresses the right entities (GM Financial, consolidated statements, tax adjustments) and time frame, so relevance is high. However, due to the central error in assessing the evolution of GM Financial’s presentation, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 431,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure of step-rent provisions in lease accounting at Costco remained consistent in recognizing such provisions on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised. In both periods, leases with periodic rent increases based on price indices or sales volume were accounted for as variable lease payments. There is no indication of material changes in the accounting treatment or additional disclosures related to these provisions during the specified timeframe.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about accounting treatment. According to the ground truth, there was a clear shift between 2022 and 2024: in 2022, step-rent provisions based on price indices or sales volume were accounted for on a straight-line basis, but by 2024, these were reclassified as variable lease payments and no longer straight-lined. The LLM incorrectly states that the treatment remained consistent and that such increases were accounted for as variable lease payments in both periods, which contradicts the original answer. This misrepresents a key change in accounting policy. There are no numerical values to verify, so quantitative accuracy is not heavily penalized beyond the incorrect characterization of timing and treatment. The reasoning is flawed because it fails to recognize the multi-hop evolution across years and instead asserts consistency where there was a material change. Contextual relevance is moderate because the answer addresses lease accounting and step-rent provisions, but the substantive conclusion is wrong. The mention of Costco is not in the original answer and introduces an unverified entity, reducing entity accuracy. Overall, the answer misses the central point of evolution in treatment and thus scores low on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 365,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a decrease in the expected 2025 payout, from $1,860 million in 2023 to $1,800 million in 2024. Additionally, the long-term obligations from 2029 to 2033 are slightly lower in 2024 ($9,990 million) compared to 2023 ($10,020 million). Notably, no contributions were expected in 2025 for 2023 projections, and this remained consistent for 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, the projected 2025 payout remained unchanged at $1,860 million from 2023 to 2024, but the LLM incorrectly states it decreased to $1,800 million. This is a major quantitative error. The long-term obligation decrease from $10,020 million (2029–2033) to $9,990 million (2030–2034) is partially correct in amount but incorrect in time period alignment—LLM compares 2029–2033 to itself in 2024, while the actual shift is from 2029–2033 (in 2023 projection) to 2030–2034 (in 2024 projection), which the LLM fails to note. (2) The claim that 'no contributions were expected in 2025' contradicts the ground truth, which explicitly projects $1,860 million for 2025. This is a critical factual error. (3) The multi-hop reasoning is flawed: the model fails to correctly align the shifting five-year windows (2029–2033 vs. 2030–2034) and misrepresents the trend in near-term obligations. It also introduces false information about no expected contributions. (4) Despite these issues, the answer is contextually relevant—addressing the right company, pension plans, and general timeframes—and correctly identifies a slight decrease in long-term obligations in magnitude, though not in the correct period. Hence, low scores for correctness and quantitative accuracy, moderate for qualitative reasoning due to partial trend recognition, and high for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 406,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations highlighted a more detailed emphasis on liquidity risk management strategies and funding cost considerations. In 2023, the focus was on general liquidity risks, such as market-wide illiquidity, regulatory changes, and the need to address obligations under its resolution plan. By 2024, the disclosures expanded to include specific actions JPMorgan Chase may take to manage liquidity, such as satisfying liquidity coverage and net stable funding ratio requirements, addressing resolution plan obligations, and adhering to international regulatory liquidity pre-positioning requirements. Additionally, 2024 emphasized how these actions could increase funding costs, particularly if alternative funding sources were required due to reduced access to traditional, lower-cost funding. This evolution reflects a more granular and forward-looking approach to liquidity risk and funding cost management in the context of regulatory expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general evolution in JPMorgan Chase's disclosures between 2023 and 2024 regarding resolution plan obligations, liquidity risk management, and funding costs. It accurately notes the focus on liquidity coverage ratio (LCR) and net stable funding ratio (NSFR) requirements, international liquidity pre-positioning, and the risk of higher funding costs due to reliance on alternative funding sources. However, it mischaracterizes the direction of evolution: the original answer states that in 2023, JPMorgan already discussed LCR/NSFR and international pre-positioning, while in 2024 it expanded to include dynamic regulatory expectations and systemic events. The LLM incorrectly implies that these specific regulatory ratios and international requirements were newly introduced in 2024 disclosures, when they were actually part of the 2023 discussion. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the idea of evolving disclosures around liquidity and funding, but fails to accurately represent the temporal progression—specifically, it reverses the chronology of detail by suggesting that 2024 added specifics that were already present in 2023. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the core themes of resolution plans, liquidity risk, and funding costs, and frames them within regulatory context. The main shortcoming is the misattribution of when certain disclosures appeared, which prevents a higher correctness score. Overall, the answer captures the gist but misses key nuances in the timeline and depth of disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 499,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, Optum Rx's revenue recognition remained consistent, with product revenues recognized when prescriptions are dispensed and services revenue recognized over time based on service delivery. Accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, reflecting higher pharmacy care services and script volumes driven by growth in people served and increased utilization. No material bad-debt expense was recorded in either year, indicating stable credit quality.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key elements of Optum Rx's financial structure evolution between 2022 and 2023. Quantitatively, the accounts receivable figures are accurate: $7.1 billion in 2022 and $8.6 billion in 2023, matching the ground truth exactly. These numbers are critical and correctly reported with proper year alignment. (2) The explanation of revenue recognition is mostly accurate—while the ground truth emphasizes the gross revenue model due to Optum Rx's primary obligation to pay pharmacies, the LLM describes the timing of revenue recognition (at dispensing for products, over time for services), which is consistent with gross reporting but does not explicitly mention the 'gross' model or the primary obligation rationale. This is a minor omission in qualitative depth but does not make the statement incorrect. (3) The reasoning is sound: the increase in receivables is correctly tied to growth in script volumes and people served, which aligns with the ground truth's implication of increased transaction volume or timing changes. The addition of 'no material bad-debt expense' is consistent with stable credit quality and adds relevant context not contradicted by the original. (4) The answer is contextually complete and relevant, addressing both revenue recognition and accounts receivable trends. The only slight gap is the lack of explicit mention of the gross revenue model's structural rationale, which slightly affects qualitative accuracy. However, the core facts, numbers, and synthesis across years and metrics are correct and well-reasoned, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 449,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps has significantly evolved. In 2022, the notional amount of Floating to Fixed Interest Rate Swaps was $778 million, while by 2024, this figure had decreased to $8 million. This reduction suggests a strategic shift toward a more fixed-rate debt structure or a decreased need for hedging floating-rate exposures during this period. Additionally, UPS continues to use these swaps as cash flow hedges to manage forecasted interest payment obligations, aligning with its broader risk management objective of maintaining an optimal interest rate mix and controlling borrowing costs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, UPS's notional amount for Floating to Fixed Interest Rate Swaps was $28 million in 2022, not $778 million as stated in the LLM answer. Furthermore, the LLM claims the amount decreased to $8 million in 2024, which directly contradicts the ground truth that does not provide a 2024 notional amount but instead emphasizes a strategic shift in approach. These numerical errors are severe and fundamentally undermine the answer's validity. (2) The quantitative inaccuracies are critical: the LLM reports a $778M notional in 2022 (vs. $28M true value) and $8M in 2024 (vs. no specific number provided in ground truth). These figures are not only wrong but lead to an incorrect interpretation of a 'reduction' in swap usage, when the ground truth suggests an expansion in strategic importance. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that UPS uses swaps to manage interest rate risk and borrowing costs, it misrepresents the evolution: the ground truth indicates a shift from limited use in 2022 to a more comprehensive strategy in 2024, whereas the LLM infers a drawdown in activity based on fabricated numbers. The qualitative insight about strategic objectives is partially aligned but is undermined by incorrect data. (4) Correctness and quantitative accuracy are scored very low due to completely incorrect numbers. Qualitative accuracy is low because the reasoning is based on false premises. Contextual relevance is moderate because the answer addresses the right topic and risk management framework, but with incorrect evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 454,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved primarily through the resolution of commercial matters tied to the Chevrolet Bolt recall and the Ultium Cells joint venture. By December 31, 2023, GM had accrued a total of $2.6 billion and recognized $1.6 billion in receivables from LGES for recall-related costs and other commercial matters. The remaining accrual for these matters was $0.6 billion as of December 31, 2023. This reflects a resolution of disputes and agreements with LGES, indicating a shift from ongoing recall costs to a more settled financial arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.6 billion accrued, $1.6 billion recognized as receivables from LG Energy Solution, and the remaining $1.0 billion - $1.6 billion = $1.0 billion? Wait: $2.6B total accrual minus $1.6B receivable implies $1.0B retained liability, but the LLM states 'remaining accrual... was $0.6 billion', which is inconsistent. This is a critical error. The ground truth does not specify a $0.6B remainder, and no public 10-K data supports that exact residual. Thus, the $0.6B figure is incorrect or unsupported. (2) Despite this, the core financial figures ($2.6B and $1.6B) are accurately reported with correct dates (by December 31, 2023). (3) Qualitatively, the LLM captures the shift from joint venture collaboration (Ultium Cells LLC) to a cost-recovery relationship due to the Bolt recall, which matches the multi-hop reasoning in the original answer. However, it omits explicit mention of the strategic importance of Ultium in 2022, focusing more on 2023 resolution. (4) Contextually, the answer is fully relevant, addressing both joint venture context and recall-related financial evolution. The $0.6B error prevents a perfect score, but overall reasoning and entity identification (GM, LG Energy Solution, Ultium Cells, Bolt recall) are sound. Deduction is primarily on quantitative accuracy due to the unsupported residual amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 398,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability product category grew by 14%, or $80 million, in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Observability revenue grew by 14%, or $80 million, in fiscal 2023, which is incorrect. According to the ground truth, the $80 million increase occurred in fiscal 2022, not 2023. In fiscal 2023, the revenue increase was $176 million (27% growth), not $80 million. The LLM incorrectly attributes the $80 million figure to 2023 and misstates the growth percentage. (2) The quantitative errors are severe: the dollar amount and percentage growth are both wrong for the period in question. The model reverses the timeline, assigning 2022 data to 2023. Additionally, it omits key information about Splunk's inclusion and the 15% organic growth excluding Splunk, which is critical to understanding ThousandEyes' true contribution. (3) The multi-hop reasoning is flawed. The question asks for the evolution of ThousandEyes' revenue contribution from 2022 to 2023, requiring comparison across years and isolation of ThousandEyes' impact. The LLM fails to show this evolution, instead providing a single incorrect data point. It does not acknowledge the increased contribution in 2023 relative to 2022 or the context of Splunk's acquisition affecting growth. (4) The contextual relevance is moderate because the answer discusses the right product category and mentions ThousandEyes as a driver, but the incorrect numbers and missing comparative analysis severely undermine factual correctness. Hence, low scores for correctness and quantitative accuracy, moderate for qualitative reasoning, and acceptable relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 437,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% Debentures, with a principal amount of $276 million and a maturity date of April 1, 2030, have maintained consistent redemption terms and interest payment structures between 2022 and 2024. The debentures are redeemable in whole or in part at UPS's option, with the redemption price set as the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October, and no changes to these terms were noted in the 2024 filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the principal amount ($276 million), maturity date (April 1, 2030), redemption terms (greater of principal plus accrued interest or present value of remaining payments discounted at benchmark Treasury yield plus five basis points), and semi-annual interest payment schedule (April and October), all of which align with the ground truth. These quantitative elements are accurate and match the original answer. (2) However, the key error lies in the interpretation of how the relationship evolved. The ground truth states that in 2022, only basic details (principal, maturity, carrying value) were reported, while in 2024, UPS provided a more detailed clarification of the redemption flexibility and interest payment structure. The LLM incorrectly asserts that 'no changes to these terms were noted' and that the terms 'have maintained consistent' wording, which contradicts the evolution described in the original answer — namely, an increased level of disclosure and specificity in 2024, even if the underlying contractual terms did not change. (3) The multi-hop reasoning is flawed because the model fails to recognize that the evolution is in disclosure depth and clarity, not necessarily in contractual changes. The question asks how the relationship evolved in terms of redemption and interest structure, implying a comparison of reporting and transparency over time, which the LLM overlooks. (4) Therefore, while all numbers and technical terms are correct (justifying a 10 in quantitative accuracy), the qualitative misunderstanding of the nature of 'evolution' — from general to more detailed disclosure — reduces the correctness and qualitative accuracy scores. Contextual relevance is high because the answer addresses the right instruments and time frame, but misses the analytical nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 500,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET remained relatively stable, with U.S. pension benefits assets at $8,270 million in 2023 compared to $8,294 million in 2022. The composition shifted slightly, with a decrease in U.S. government bonds from $1,507 million in 2022 to $1,575 million in 2023, and an increase in corporate securities from $3,001 million to $3,083 million. This indicates a modest reallocation toward corporate securities and away from U.S. government bonds within the Fixed Maturity Securities AFS portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total fair value of Fixed Maturity Securities AFS did not remain stable—it increased dramatically from $2,164 million (as of Dec 31, 2021, reported in 2022) to $6,714 million in 2023, not from $8,294M to $8,270M as claimed. The LLM incorrectly references 'U.S. pension benefits assets' instead of 'Fixed Maturity Securities AFS,' conflating different financial line items. While the LLM correctly reports the 2023 fair values for corporate securities ($3,083M) and U.S. government bonds ($1,575M), it fabricates 2022 values ($1,507M and $3,001M) not present in the ground truth. The ground truth does not provide 2022 breakdowns, only a total carrying amount as of 2021. (2) Quantitative accuracy is low: the LLM invents numbers, misrepresents the total portfolio size, and uses incorrect years for comparison. The only correct numbers are the 2023 values for corporate and government securities. (3) Multi-hop reasoning fails—the LLM does not correctly trace the evolution from 2022 reporting (with 2021 data) to 2023 data. It assumes 2022 portfolio composition without evidence and misidentifies the metric being tracked. (4) Contextual relevance is moderate because it addresses the right topic (composition changes in AFS securities) and mentions correct entities (MET, corporate securities, U.S. government bonds), but the incorrect framing and numbers undermine the response. The conclusion about 'modest reallocation' is unsupported given the ground truth shows a tripling of total fair value, indicating a major shift, not a modest one.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 442,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "General Motors' relationship with Ultium Cells LLC evolved in 2023 with regulatory implications arising from a settlement with the EPA related to potential violations of TSCA requirements at the joint venture. This resulted in civil penalties estimated at approximately $5.1 million, jointly and severally assessed to GM and Ultium Cells LLC. Financial involvement is evident from GM's $0.5 billion investment in Ultium Cells LLC in 2021, as disclosed in the 2022 filing, reflecting ongoing collaboration to support EV battery production.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.5 billion investment in Ultium Cells LLC and the $5.1 million civil penalties from the EPA settlement related to TSCA violations. However, it inaccurately states the investment was made in 2021, while the ground truth specifies the $0.5 billion was reported in 2022 as part of that year's investing activities. This misstatement of timing slightly affects factual precision. (2) Quantitatively, both key figures—$0.5 billion and $5.1 million—are accurate in amount and context. The error lies only in the ascribed year of the investment, not the value itself. (3) The multi-hop reasoning is largely sound: the answer connects GM's financial involvement with its later regulatory entanglement in 2023, correctly inferring a deepening relationship. It captures the shift from investment to operational integration through the lens of shared liability, though it does not explicitly frame the evolution as a transition from passive to active involvement as clearly as the original answer. (4) The answer is highly relevant and conveys most of the key information, with only minor inaccuracies in temporal attribution. The core facts—financial commitment and regulatory consequences—are correct and well-synthesized, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 366,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Between 2022 and 2024, the company has continued to use variable-priced contracts for natural gas and fuel purchases, primarily for natural gas and fuel at its gas stations, with pricing based on an index. There is no indication of a significant change in this strategy during the period, as these contracts have consistently met the criteria for the 'normal purchases and normal sales' exception and have not required mark-to-market adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the use of variable-priced contracts for natural gas and fuel purchases based on an index, and correctly notes that these contracts qualify for the 'normal purchases and normal sales' exception and do not require mark-to-market adjustments. Quantitatively, there are no numbers or dates in dispute, and all referenced years (2022–2024) are accurate. However, the LLM answer misses a key qualitative evolution highlighted in the original answer: by 2024, the company had more formally recognized these contracts as meeting the characteristics of derivative instruments, indicating a more strategic or formalized accounting treatment. The LLM incorrectly states there was 'no indication of a significant change,' which contradicts the ground truth's implication of a shift toward more structured use and accounting alignment with derivatives frameworks. This omission represents a failure in multi-hop reasoning—synthesizing the progression from basic use in 2022 to a more deliberate, accounting-aware approach in 2024. While contextually relevant and factually sound on surface details, the answer underrepresents the evolution in strategy and accounting sophistication, reducing its qualitative accuracy. Hence, correctness is partially compromised despite strong performance on quantitative and relevance metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 383,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. Both years excluded research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges from the gross margin calculations for the APJC segment. No new exclusions were introduced in fiscal 2023 compared to fiscal 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and 2023, with no changes in excluded expense categories—this matches the original answer's conclusion. (2) The expense categories listed—research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and certain other charges—are all correctly identified and align with the ground truth, which confirms the same exclusions applied in both years. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the exclusions in 2022 carried over unchanged into 2023, demonstrating accurate cross-year comparison. (4) All entities (Cisco, APJC segment, fiscal years 2022 and 2023) are correct, and the answer directly addresses the evolution (or lack thereof) in reporting approach. No numeric inaccuracies exist, as the response is qualitative and all assertions are factually consistent with the source. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 349,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "From 2022 to 2023, UNH has increasingly focused on addressing rising outpatient procedure costs for seniors by emphasizing value-based care models and care coordination. In 2023, the company observed elevated care activity related to outpatient procedures for seniors and highlighted efforts to mitigate these increases by engaging physicians and consumers to make clinically sound, cost-effective choices. Additionally, UNH is accelerating the transition from fee-for-service to fully accountable value-based care, which includes investments in integrated care coordination technology and enhanced clinical engagement to improve health outcomes and reduce long-term system costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution in UNH's approach from 2022 to 2023, noting a shift toward more proactive, data-driven strategies to manage rising outpatient procedure costs for seniors. While the original answer emphasizes a transition from general concern in 2022 (e.g., deferred care, chronic conditions) to targeted interventions in 2023 (e.g., physician and consumer engagement via data insights), the LLM answer reflects this progression by highlighting value-based care models, care coordination, and clinical engagement. The mention of transitioning from fee-for-service to accountable value-based care and investing in technology is consistent with UNH’s strategic direction, even if not explicitly detailed in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (UNH, seniors, outpatient costs, 2022–2023 timeframe) are correct. The reasoning is sound and synthesizes multi-hop information appropriately. The only minor gap is that the LLM does not explicitly reference UNH’s 2022 concern about pandemic-related deferred care or the expectation that 2023 trends would persist into 2024—details present in the original. However, the core factual content and strategic evolution are accurately conveyed, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 390,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded its time-definite delivery services by insourcing UPS SurePost residential ground delivery beginning in 2025 to enhance control and service quality, and by integrating advanced technologies like RFID-enabled Smart Package Smart Facility to improve network efficiency and visibility. Additionally, UPS broadened service scope through its global smart logistics network, combining all package services into a single, integrated system to optimize delivery options and support higher-yielding volume growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, it states that UPS began insourcing UPS SurePost 'beginning in 2025', which is factually incorrect—the ground truth specifies this change occurred in 2024. This is a major error in temporal accuracy. Additionally, the LLM mentions 'RFID-enabled Smart Package Smart Facility' and 'global smart logistics network' as key developments, which are not mentioned in the original answer and lack corroboration in the context provided. While the idea of network integration is thematically consistent with the 2022 description, the specific technologies cited are not supported. The LLM correctly identifies the insourcing of SurePost as a strategic move to improve control and service quality, which aligns with the ground truth. It also captures the general idea of integration between air and ground services. However, it omits key 2024 expansions such as same-day pickup seven days a week and returns services in approximately 150 countries—important elements of the expanded service scope. (2) The date error (2025 vs. 2024) is a critical quantitative inaccuracy. No financial figures are present, but the misstatement of the year undermines the answer's reliability. (3) The multi-hop reasoning is partially sound—linking insourcing SurePost to greater control reflects valid inference—but the introduction of unsupported technological initiatives (e.g., RFID) indicates flawed synthesis or hallucination. The answer fails to connect the evolution across 2022 and 2024 with full fidelity. (4) Correctness is scored at 5 due to partial factual alignment but significant errors in timing and unsupported additions. Quantitative accuracy is low due to the incorrect year. Qualitative accuracy is moderate because core concepts like integration and control are present but distorted. Contextual relevance is high as the response stays focused on UPS's delivery evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 524,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 filing, Lowe's 2.50% Notes maturing in April 2026 were referenced in the Thirteenth Supplemental Indenture dated April 20, 2016. In the 2023 filing, these notes were superseded by the Twenty-Second Supplemental Indenture dated March 30, 2023, which introduced new 4.800% Notes due April 1, 2026, indicating a refinancing or replacement of the original 2026 notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2.50% Notes maturing in April 2026 and their reference in the Thirteenth Supplemental Indenture dated April 20, 2016, in the 2022 filing, it incorrectly claims that these notes were 'superseded' by the Twenty-Second Supplemental Indenture dated March 30, 2023, which introduced '4.800% Notes due April 1, 2026'. This contradicts the ground truth, which states that the 2.50% Notes were not replaced but rather more explicitly recognized in the 2023 filing under the same indenture. There is no mention of refinancing or replacement in the original answer, and the introduction of a 4.800% Note is factually incorrect and unsupported by the ground truth. (2) Quantitative accuracy is partially correct: the interest rate (2.50%), maturity (April 2026), and original indenture date (April 20, 2016) are accurate. However, the introduction of a new 4.800% Note with a different maturity date (April 1, 2026) and a new indenture (Twenty-Second) is entirely fabricated and incorrect. (3) The multi-hop reasoning is flawed. Instead of identifying a shift in disclosure treatment—from historical reference in 2022 to active recognition in 2023—the model invents a refinancing event that did not occur. This shows a failure to synthesize the correct evolution in accounting or disclosure treatment. (4) The contextual relevance is moderate because the answer addresses the topic of debt instruments and indentures related to Lowe's, but the core conclusion about replacement/refinancing misrepresents the actual evolution described in the ground truth, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 462,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 is primarily discussed in the context of broader economic and geopolitical risks. In 2022, Costco noted that general economic factors, including sovereign debt crises, could affect demand for products, require changes in product mix, or impact the cost and availability of inventory. By 2024, the company expanded on these concerns, emphasizing that economic factors such as sovereign debt crises, combined with inflation, tariffs, and supply chain disruptions, could increase merchandise costs and affect the ability to source quality products at competitive prices. Costco highlighted its reliance on global suppliers and the potential for supplier disruptions due to economic and political instability, which could lead to higher costs or out-of-stock positions. Overall, the evolving risk environment from 2022 to 2024 has increased Costco's exposure to merchandise sourcing and cost volatility due to global economic uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: the 2022 framing of sovereign debt crises as part of broader macroeconomic risks affecting demand, product mix, and inventory costs is accurately represented. The 2024 evolution—where sovereign debt crises are explicitly stated to 'negatively impact' business, financial condition, and operations—is correctly captured in substance, though the exact phrase 'negatively impact' is not quoted verbatim, but the meaning is preserved through equivalent phrasing about increased risks and impacts on sourcing and costs. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the years 2022 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning—comparing the evolution of risk disclosure across two years and synthesizing how the nature of the threat to sourcing and cost structure has intensified—is sound and well-executed. The LLM correctly infers heightened concern in 2024 due to compounding factors like inflation, tariffs, and geopolitical instability, which matches the original answer’s emphasis on broader supply chain risks. (4) The answer is contextually excellent, directly addressing the evolution of impact on sourcing and cost structure. The only minor shortcoming is that it does not explicitly mention 'tariff rates' and 'type of goods' as variables affecting exposure (mentioned in the 2022 context), nor does it note the shift in tone from potential to explicit negative impact with stronger language in 2024. However, the overall qualitative meaning and risk trajectory are correctly conveyed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 485,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued a portion of its authorized share-based awards over this period, which may suggest active use of its equity compensation programs to incentivize employees, though it also implies a diminishing capacity to issue new awards without additional shareholder approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The quantitative change (a decrease of 11 million shares) is accurately implied. (2) All numeric values and years are correct, with no calculation errors. Format is consistent and clear. (3) The multi-hop reasoning is sound: the model correctly infers that the reduction in available shares indicates issuance of awards under the plan. It goes beyond the ground truth by offering additional context—namely, that this reflects active use of equity compensation and may imply a need for future shareholder approval—while not contradicting any facts. This added interpretation is reasonable and well-aligned with typical corporate behavior, thus enhancing qualitative accuracy without introducing error. (4) The answer fully addresses both parts of the question: the change in share availability and its implication for UnitedHealth Group's capacity to issue new awards. The only reason for not scoring a perfect 10 is that the original answer focuses strictly on the reduced capacity, while the LLM adds interpretive nuance (e.g., 'active use...to incentivize employees') that, while plausible, is not explicitly confirmed in the ground truth. However, this does not detract from factual correctness. All entities—UnitedHealth Group, the 2020 Stock Incentive Plan, and the relevant years—are accurately identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 411,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan collective bargaining agreement with UPS was extended from July 31, 2024 to July 31, 2029. During this period, UPS continued to contribute to the plan, with contributions increasing from $48 million in 2022 to $53 million in 2024. The plan remained in the \"Red\" zone (less than 65% funded) and had an implemented rehabilitation plan (RP) throughout the period, with UPS fulfilling its contractual obligations without surcharges. In 2024, UPS also finalized its withdrawal from the IAM Fund, transferring affected employees to its own pension plan and recording a $19 million withdrawal liability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the expiration date was extended from July 31, 2024 to July 31, 2029 — this part is correctly stated. However, the ground truth does not mention any dollar amounts for UPS contributions (e.g., $48M in 2022 or $53M in 2024), nor does it state that UPS finalized a withdrawal from the IAM Fund in 2024. On the contrary, the original answer emphasizes UPS's continued significant contributions (over 5% of total plan contributions) for 2022–2024, indicating ongoing participation, not withdrawal. The claim about a $19 million withdrawal liability contradicts the sustained contribution narrative. (2) The numbers provided in the LLM answer (dollar amounts, 'Red' zone status, rehabilitation plan) are not present in the ground truth and appear fabricated or misattributed. There is no mention of funding status or surcharges in the original answer, making these additions incorrect. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize changes over time, it incorrectly infers a withdrawal and associated liabilities, which directly contradicts the original answer’s indication of an extended agreement and continued significance. The model fails to correctly represent the evolution as one of strengthening (extension + sustained contributions), instead portraying it as a phase-out. (4) Due to major factual errors, especially around UPS's role and financials, the correctness and quantitative accuracy scores are low. Qualitative accuracy is also low due to incorrect entity relationships and reasoning. Contextual relevance is moderate because the answer addresses the general topic and timeframe but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 477,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In September 2023, the 2020 Credit Agreement was amended and restated to extend its term from March 2025 to September 2028. Additionally, the combined aggregate availability under the Credit Agreements (including the Third Amended and Restated Credit Agreement) remained at $4.0 billion as of February 2, 2024, with the potential to increase by an additional $1.0 billion if commitments from lenders were obtained and conditions met.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of LOW's credit agreement terms between fiscal years 2022 and 2023. It correctly identifies that the 2020 Credit Agreement was amended and restated in September 2023, extending the maturity from March 2025 to September 2028, which aligns with the ground truth. The $2.0 billion availability under the 2020/2023 Credit Agreement is implied by the context, though not explicitly stated in the LLM answer—this is a minor omission. The combined availability of $4.0 billion is correctly reported as unchanged from 2022 to 2023, matching the ground truth. However, the LLM introduces a detail not present in the original answer: the potential to increase availability by $1.0 billion with lender commitments. While this may be factually accurate in the actual filing, it was not part of the ground truth derived from the knowledge graph, making it an over-addition that slightly affects quantitative and qualitative accuracy. The fiscal year-end date (February 2, 2024) is correctly used as the reporting date for 2023, showing proper alignment with LOW's fiscal calendar. The reasoning is sound and synthesizes multi-hop information (amendment, maturity change, availability continuity), but the extra detail on expandable capacity reduces precision relative to the original answer. Overall, the answer is semantically very close and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 392,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amount for Net Investment Hedge (NIH) Derivative Contracts increased from $3,915 million in 2021 to $8,647 million in 2024. This significant growth indicates an expanded use of NIH contracts to hedge against exchange rate fluctuations related to non-U.S. operations. Additionally, the notional amounts for non-U.S. dollar debt designated as NIH hedges, such as Euro, Swiss Franc, and Canadian Dollar notes, also show changes over the period, with Euro notes decreasing from $3,622 million in 2021 to $3,298 million in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates. The ground truth states that the $3,915 million notional amount was reported in 2022 for December 31, 2021 (i.e., 2021 value), but the LLM incorrectly presents it as 'in 2021' without clarifying it's the year-end 2021 value reported in 2022. More critically, the LLM claims the 2024 notional amount is $8,647 million as of December 31, 2024 — however, since the filing year is 2024, it would report up to December 31, 2023, not 2024. The ground truth correctly states $8,647 million as of December 31, 2024, reported in 2025, which is not available in a 2024 filing. Thus, the LLM misrepresents the timeline. Additionally, the LLM introduces Euro-denominated debt figures ($3,622M to $3,298M) that are not present in the original answer and were not part of the question about total notional amounts. (2) While the final notional amount of $8,647 million appears in the ground truth as a forward-looking figure, it is incorrectly attributed to 2024 reporting, when in reality, MDLZ could not report Dec 2024 data until 2025. The correct progression per filings should be: 2020 ($4,551M), 2021 ($3,915M), 2023 ($7,456M), and projected 2024 ($8,647M). The LLM skips the 2023 value entirely and falsely implies a direct jump from 2021 to 2024. (3) The multi-hop reasoning is partially sound — the model identifies a trend of increasing notional amounts, which aligns with the ground truth. However, it fails to accurately represent the time-series data across reported years and introduces extraneous, unsupported details about currency-specific debt. (4) The contextual relevance is high because the answer addresses the evolution of NIH hedge usage and links it to hedging strategy. Qualitative accuracy is moderate due to correct identification of trend and purpose, but quantitative accuracy is low due to incorrect dates, missing intermediate values, and fabricated breakdowns. Correctness score reflects partial accuracy with significant factual and temporal errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 553,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies has significantly evolved, with 2024 introducing several new capabilities to enhance productivity and collaboration. In 2024, Microsoft 365 became an \"AI first platform,\" incorporating Copilot to bring AI-powered assistance into Office, Windows, and Enterprise Mobility + Security. New features such as Copilot for Microsoft 365, powered by the Microsoft Graph and business data, streamline workflows and offer role-specific insights through Copilot for Sales, Copilot for Service, and Copilot for Finance. Additionally, Copilot Studio allows for customization, while Copilot Pro provides enhanced AI assistance for both Microsoft 365 apps and the web, significantly improving user efficiency and collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Microsoft 365 evolved into an 'AI first platform' by 2024, Copilot for Microsoft 365 was introduced, and role-specific extensions like Copilot for Sales, Service, and Finance were launched. The integration with Microsoft Graph and business data is correctly noted. (2) There are no numeric values requiring verification (e.g., dates like 2022 and 2024 are correct and consistent with the original answer), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution from 2022’s AI-backed tools to 2024’s AI-first platform with Copilot. The LLM adds minor details not in the original (Copilot Studio, Copilot Pro) that are factually accurate and contextually relevant, enhancing completeness without introducing errors. (4) Semantic equivalence is strong; the core message about enhanced AI integration for productivity and collaboration is preserved. The only reason for not scoring a 10 is that the original answer emphasizes the 2022 state more clearly as a foundation (integration of Office 365, Windows, EMS with AI), while the LLM slightly downplays that baseline. However, this does not detract significantly from correctness. All entities (Microsoft 365, Copilot variants, Microsoft Graph) are accurate and correctly contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 385,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from identifying and disclosing incomplete PFAS discharge characterization in its NPDES permit to implementing corrective measures. In 2022, 3M acknowledged the issue, submitted an application to amend the permit, and installed wastewater treatment controls. By 2024, the company had entered into an interim Consent Order with ADEM, committing to ongoing operational improvements, analytical studies, and remediation activities, reflecting a more structured and regulated approach to compliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's approach to PFAS discharge characterization at the Decatur facility between 2022 and 2024, correctly noting the shift from disclosure and application for permit amendment to implementation of treatment controls. The dates (2022 and 2024) and entities (3M, Decatur facility, ADEM) are accurate, satisfying quantitative and contextual accuracy. However, there are key factual discrepancies in the qualitative details: the original answer states that by 2024, 3M had installed and was upgrading PFAS-specific wastewater treatment controls that were being optimized, while awaiting ADEM’s action on its permit modification. The LLM answer incorrectly claims that 3M had entered into an 'interim Consent Order' with ADEM by 2024, which is not supported by the ground truth and represents a significant addition not present in the original. This misrepresents the regulatory status and introduces a new procedural development (Consent Order) that was not disclosed. Additionally, the original answer emphasizes that ADEM had not yet acted on the permit modification—a key point about regulatory delay—that the LLM omits. While the overall direction of progress (from identification to implementation) is correctly synthesized, the inclusion of unsupported details and omission of critical context about the pending permit action reduce the factual accuracy. Thus, the answer is partially correct but contains significant qualitative errors affecting the correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 416,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes on April 5, 2019, as indicated in the Fifteenth Supplemental Indenture (page 76 of the 2022 filing). There is no mention of any changes, refinancing, or new issuance related to these specific 4.550% Notes in the 2023 filing, indicating that the issuance remained unchanged between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that the 4.550% Notes were issued on April 5, 2019, under the Fifteenth Supplemental Indenture, and that there was no mention of changes, refinancing, or new issuance in the 2023 filing—confirming the terms remained unchanged between 2022 and 2023. All dates and percentages are correct, and the reasoning correctly infers continuity based on absence of modifications in the 2023 filing. The only minor shortcoming is that it does not explicitly state the maturity date (April 5, 2049), which is included in the ground truth and relevant to completeness. However, since the question focuses on the evolution of the issuance and not the maturity details, this omission does not significantly detract from the answer. The multi-hop reasoning—linking the 2019 issuance to 2022 and 2023 filings—is sound and contextually appropriate. Semantic equivalence is maintained, and all entities (Lowe's, 4.550% Notes, Fifteenth Supplemental Indenture) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 302,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved in terms of gains recognized from changes in accounting for the investment as follows: In 2023, MDLZ recorded a pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. No specific gains related to KDP were mentioned for 2022 or 2024 in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual errors. It correctly identifies the $493 million pre-tax gain and $368 million after-tax gain, but incorrectly attributes this to 2023 instead of 2024 as stated in the ground truth. Additionally, it falsely claims that 'no specific gains related to KDP were mentioned for 2022 or 2024,' which contradicts both the original answer and the actual data—2022 did include a $71 million pre-tax ($54 million after-tax) gain. (2) Quantitative accuracy is partially correct: the $493M and $368M figures are accurate, but the $71M and $54M gains from 2022 are omitted. The misplacement of the 2024 gain into 2023 undermines temporal accuracy. (3) The multi-hop reasoning is flawed—the question asks for an evolution between 2022 and 2024, requiring synthesis of gains across both years. The LLM fails to compare the two periods and incorrectly states that no data was available for 2022 and 2024, showing poor information synthesis. (4) Contextual relevance is moderate because the answer discusses the right companies and type of financial event (gains from accounting changes), but omits key comparative insights and misstates the timeline, reducing its overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 352,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale of Xbox Game Pass significantly expanded, with the number of available titles increasing from over 100 to over 400 first- and third-party console and PC titles. Microsoft's strategic emphasis also evolved, positioning Xbox Game Pass as a central gaming community and subscription service, highlighting its role in attracting and engaging gamers across diverse endpoints, while leveraging exclusive content and expanding into new ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the number of titles from over 100 in 2022 to over 400 in 2024, matching the ground truth exactly in quantitative terms. The strategic emphasis is accurately portrayed as evolving toward being a central or 'cornerstone' element of Microsoft's gaming platform, with correct references to subscriptions, community engagement, and ecosystem expansion. (2) All numeric values (100+, 400+) are correct and consistent with the original answer; no calculations were required, but the comparison across years is accurate. (3) The multi-hop reasoning is sound: the model synthesizes information about scale (title count) and strategic positioning across two time points (2022 vs 2024), correctly inferring increased importance. The only minor gap is that the LLM does not explicitly use the term 'cornerstone'—a key descriptor in the ground truth—which slightly weakens the qualitative precision, though the meaning is semantically close. (4) Scores reflect near-perfect factual accuracy, full contextual relevance, and strong reasoning, with a minor deduction in qualitative accuracy due to the absence of the exact strategic framing ('cornerstone') from the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 346,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan has not changed from 2022 to 2024. In both the 2022 and 2024 filings, the form of the Deferred Stock Unit Award Agreement for non-employee directors is referenced as being incorporated by reference from the Form 10-K for the year ended December 31, 2018. This indicates that the specific terms and structure of the agreements remained consistent during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error regarding the incorporation by reference. The ground truth states that in 2022, the Deferred Stock Unit Award Agreement was incorporated by reference from the 2018 10-K for grants on or after January 1, 2019, and by 2024, the disclosure reflects an updated reference tied to the May 8, 2023 amendment (via the 2023 10-K), indicating ongoing maintenance of the plan. However, the LLM incorrectly claims that both 2022 and 2024 filings reference the 2018 10-K, which contradicts the ground truth that the 2024 disclosure updated the incorporation by reference from the 2023 10-K. This misrepresents the evolution of the disclosure. While the LLM correctly identifies that the structure of the agreement itself did not change (consistent terms for grants on or after Jan 1, 2019), it fails to acknowledge the updated referencing in 2024, which is a key part of the disclosure evolution. Thus, the quantitative accuracy is low due to the incorrect date (2018 vs updated 2023 reference), qualitative accuracy is moderate because the core reasoning about structural consistency is sound but synthesis across years is flawed, and contextual relevance is high as the response directly addresses the question's focus on structural and disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 365,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the total First Mortgages and HELOCs portfolio for Charles Schwab Bank slightly decreased from $26,632 million to $27,813 million. The geographic concentration in California remained stable at 43% in 2023 and 42% in 2024. Origination costs, represented by unamortized premiums, discounts, and direct origination costs, increased slightly from $100 million in 2023 to $112 million in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect quantitative information. Correctly identifies that unamortized premiums, discounts, and direct origination costs increased from $100 million in 2023 to $112 million in 2024, and that California concentration decreased from 43% to 42%, matching the ground truth. However, the LLM incorrectly states that the portfolio 'slightly decreased' from $26,632 million to $27,813 million — this is factually wrong as $27,813M is actually an increase from $26,632M, and more importantly, these total portfolio values are not present in the ground truth at all. The original answer does not mention total portfolio size, so this addition appears to be hallucinated or misattributed data. (2) The core financial figures for origination costs and geographic concentration are accurate, but the inclusion of unsupported total portfolio amounts undermines quantitative accuracy. The direction of change in California concentration (stable/slight decrease) is correctly interpreted. (3) The reasoning is partially sound — the model correctly tracks changes in origination costs and geographic concentration over time, showing multi-hop understanding across 2023 and 2024. However, introducing unverified total portfolio values suggests flawed data synthesis or confusion with another source. (4) Despite the factual error in total portfolio size, the answer addresses the key aspects of origination costs and California concentration with correct numbers and trend descriptions, earning moderate scores in qualitative accuracy and high relevance. The correctness score is limited by the significant quantitative inaccuracy in the total portfolio figures, even though the specific metrics asked about (origination costs, CA concentration) are mostly right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 490,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike's strategic emphasis on Dri-FIT technology between fiscal 2023 and fiscal 2024 reflects a continued focus on innovation and leveraging existing technologies to meet consumer preferences. In both years, Dri-FIT is highlighted as one of the key technologies among Nike's portfolio, indicating its ongoing importance in product development. However, the 2024 filing emphasizes a broader strategy of integrating new and existing technologies across product categories to respond to evolving consumer demands, suggesting a more holistic and adaptive approach to Dri-FIT and other innovations in fiscal 2024 compared to fiscal 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in noting that Dri-FIT remains a key technology in both fiscal 2023 and 2024, which aligns with the ground truth. However, it introduces a qualitative claim that the 2024 filing emphasizes a 'broader strategy of integrating new and existing technologies' and a 'more holistic and adaptive approach' in 2024 compared to 2023, which contradicts the ground truth stating that the *exact same language* was used in both years. This suggests no evolution or shift in emphasis, making the LLM's inference about a strategic change factually incorrect. There are no numeric values to evaluate, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is flawed because it assumes a change in emphasis based on inferred tone rather than actual textual differences, failing the multi-hop requirement to compare the actual language in the filings. While the entities (Nike, Dri-FIT, fiscal years) are correct and contextually relevant, the conclusion misrepresents the data, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 309,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2024, the company emphasized augmenting its cybersecurity program with improved identity and access management, multi-factor authentication, network security, and 24/7 security operations to monitor and detect threats. These efforts reflect a proactive approach to mitigating risks from increasingly sophisticated cyber threats and ensuring business continuity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Mondelez International's increased investment in backup and disaster recovery from 2022 to 2024 in response to growing cybersecurity threats, which aligns with the ground truth. The years 2022 and 2024 are accurately referenced, and the context of rising cyber threats is properly acknowledged. However, the LLM omits specific details about the 2022 heightened alert due to the pandemic and the focus on backup and disaster recovery during that period. Additionally, while the 2024 enhancements are mentioned, the LLM shifts focus to other cybersecurity measures (e.g., identity and access management, multi-factor authentication, network security, 24/7 monitoring) that are not explicitly tied to backup and disaster recovery in the original answer. The ground truth emphasizes that in 2024, Mondelez explicitly continued to invest in 'enhanced backup and disaster recovery solutions' as a core component, including in response to state-sponsored actors and AI-driven threats—details missing in the LLM response. (2) There are no numeric values, dollar amounts, or calculations in either answer, so quantitative accuracy is not compromised; thus, a score of 10 is justified. (3) The multi-hop reasoning is partially sound: the model correctly infers increased investment over time and links it to cybersecurity threats, but fails to fully synthesize the specific evolution of backup and disaster recovery efforts across the two time points. The emphasis shifts slightly to broader cybersecurity improvements rather than the specific domain of backup and disaster recovery. (4) Despite missing key nuances, the answer remains contextually relevant and factually aligned in direction and intent, warranting high scores in contextual relevance and qualitative accuracy, though not perfect due to omissions in specificity and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 509,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment to Black and African American-owned suppliers significantly evolved from fiscal year 2022 to 2024. In 2022, the company reported reaching more than 90% of its goal to spend $500 million with double the number of Black- and African American-owned suppliers. By 2024, Microsoft achieved its goal, spending $500 million with double the number of these suppliers. Additionally, in 2024, the company provided 162 low- or no-interest loans to small to medium-sized partners and increased its deposits with Black- and African American-owned minority depository institutions, further supporting local communities and small businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Microsoft's financial commitment from FY2022 to FY2024. It accurately states that in 2022, Microsoft reached more than 90% of its $500 million goal with double the number of Black and African American-owned suppliers. It also correctly notes that by 2024, the $500 million goal was achieved. However, the LLM introduces new details not present in the ground truth: specifically, '162 low- or no-interest loans' and 'increased deposits' without specifying the $150 million allocation to Minority Depository Institutions and funds supporting Black-owned small businesses, which is a key quantitative commitment in the original answer. While the general direction of support is correctly conveyed, the substitution of specific programs (loans vs. deposits/funds) and the introduction of an unverified number (162 loans) reduce quantitative and qualitative accuracy. The reasoning is sound in showing progression and deepening commitment, and the answer remains contextually relevant and well-aligned with the question's intent. Minor factual deviation prevents a top score, but the core multi-hop synthesis across years and initiatives is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 339,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction indicates that Abbott has utilized shares under this plan over the period, likely reflecting ongoing employee participation and purchases. The continued operation of the plan, now under the 2017 restated version, suggests Abbott remains committed to offering stock-based incentives to non-U.S. employees as part of its broader compensation strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of available shares as 10,638,639 as of December 31, 2021, and 8,565,087 as of December 31, 2023, matching the ground truth exactly. These figures are accurate in both value and date reference, satisfying quantitative accuracy. (2) The calculation of a reduction in available shares is implied and correct, though no explicit arithmetic is performed. The dates are properly interpreted: the 2022 filing reports availability as of the end of 2021, and the 2023 filing reports as of end of 2023, which aligns with SEC reporting conventions. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years and filings to show a trend. However, the interpretation diverges slightly from the ground truth: while the LLM suggests the reduction reflects employee utilization and ongoing commitment, the original answer interprets it as a potential tightening or adjustment in strategy. Both are plausible, but the LLM's interpretation leans more positively without acknowledging possible strategic restraint. (4) Despite this nuanced difference in qualitative inference, the core facts, numbers, and relevance to the question about evolution and strategic indication are fully addressed. The answer is contextually relevant and factually correct, warranting a high score, though not perfect due to the slightly divergent strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 395,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Nike has continued to integrate Nike Air technology into its product development strategy in fiscal 2024, emphasizing innovation and leveraging it across various product categories. The proliferation of Nike Air, along with other technologies like Zoom, Air Max, and React, remains central to Nike's dedication to designing innovative products that enhance athletic performance and meet consumer preferences. There is no indication of a strategic shift in the treatment of Nike Air technology between fiscal years 2023 and 2024; instead, it remains a key component of Nike's ongoing innovation efforts.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in stating that Nike Air remains a key part of Nike's innovation strategy in both fiscal years 2023 and 2024. However, it fails to capture the core strategic evolution identified in the ground truth. The original answer highlights a nuanced but important shift: in 2023, Nike Air was presented as an emblem of innovative dedication, suggesting it was still being actively promoted as a distinct innovation. By 2024, it was grouped with mature technologies like Zoom, Free, and React, indicating it had transitioned from a standalone growth driver to a foundational, integrated component of Nike’s broader innovation platform. The LLM answer incorrectly states there is 'no indication of a strategic shift,' which directly contradicts the ground truth's central claim of a shift in treatment from emerging innovation to standard offering. While all entities (Nike Air, Zoom, React) and years (2023, 2024) are correctly referenced, and no numerical data is misstated (so quantitative accuracy is high), the qualitative reasoning and synthesis across years is flawed. The model missed the multi-hop insight that the change in contextual framing—how Nike Air is categorized relative to other technologies—signals a strategic evolution. Thus, despite good contextual relevance and correct terminology, the answer lacks the critical analytical depth and factual precision on the strategic shift, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 402,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Abbott has maintained Osmolite as a key component of its enteral feeding portfolio within the Nutritional Products segment in both 2022 and 2023, with no significant changes in its positioning noted between the two years. In both periods, Osmolite is listed among the nutritional products used in enteral feeding in healthcare institutions, alongside other products like Jevity, Glucerna, Oxepa, and Freego. The 2023 filing continues to emphasize Abbott's focus on enteral feeding solutions for institutional use, indicating that Osmolite remains a core product in this category without any indication of strategic shifts or portfolio repositioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that Osmolite remained a consistent part of Abbott's enteral feeding portfolio in both 2022 and 2023, with no significant repositioning. The listed co-products (Jevity, Glucerna, Oxepa, Freego) match the original answer, though the LLM omits Nepro and Vital, which were mentioned in the 2022 lineup. This is a minor omission and does not affect the core conclusion about Osmolite's stable strategic positioning. There are no numerical values in this question, so quantitative accuracy is scored based on correct use of years (2022 and 2023), which are accurate. The reasoning is sound: the model correctly infers from the consistency in product listings that there was no strategic shift, which reflects valid multi-hop synthesis across the two years. The answer is semantically equivalent to the original, with slightly more emphasis on 'key component' and 'core product,' which is a reasonable interpretation but slightly stronger than the neutral tone of the original. Contextual relevance is excellent, as the response directly addresses the evolution (or lack thereof) in Osmolite's positioning within the enteral feeding and institutional nutrition strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 352,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have intensified. In Minnesota, the company faced an updated regulatory landscape, including more stringent health-based values for PFOA and PFOS issued by the Minnesota Department of Health in 2024 and a revised draft Clean Water Act permit for the Cottage Grove facility with significantly reduced effluent limits. 3M also addressed a 2023 alleged violation at its Hutchinson facility and a 2021 Notice of Violation at Cottage Grove, while continuing compliance efforts under the 2007 Settlement Agreement and Consent Order. In Alabama, 3M worked under the July 2020 interim Consent Order with ADEM, committing to ongoing site operations and remediation activities at the Decatur facility, including capital improvements and investigations. These developments reflect increased regulatory scrutiny and evolving obligations for 3M in both states.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024. It correctly identifies the ongoing effect of the 2007 Settlement Agreement and Consent Order in Minnesota and the July 2020 Interim Consent Order with ADEM in Alabama. It accurately notes the increased regulatory scrutiny by 2024, including the revised draft Clean Water Act permit for Cottage Grove with stricter effluent limits and the issuance of updated health-based values (HBVs) by MDH in 2024. The mention of 3M addressing a 2023 alleged violation at Hutchinson and a 2021 Notice of Violation at Cottage Grove adds context not in the original answer but does not contradict it; however, these specific enforcement actions are not part of the ground truth and may overextend slightly beyond the provided knowledge. The LLM omits the December 2024 revised draft permit update from MPCA and does not explicitly state that some proposed limits were below quantification levels, which is a notable detail in the original answer. Additionally, the LLM does not mention the multilayer cap completion at Decatur or the expectation of additional operating costs and capital expenditures over multiple years under ongoing investigations in Alabama, which are key elements of the original answer. Quantitatively, all dates and references (2007, 2020, 2024) are accurate, and no incorrect numbers are presented. The reasoning is sound, showing multi-hop synthesis across time, locations, and regulatory bodies (MPCA, ADEM, MDH). The answer is contextually highly relevant and well-structured. The minor omissions and slight addition of unverified enforcement details prevent a top score, but the core facts and evolution of obligations are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 497,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's investment in Coca-Cola HBC AG remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, down from a higher percentage in prior years due to refranchising and divestiture activities. The carrying value of the investment was $1,147 million in 2024, significantly lower than its fair value of $2,675 million based on quoted market prices, indicating a substantial unrealized gain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that The Coca-Cola Company's investment in Coca-Cola HBC AG remained under the equity method from 2022 to 2024 and accurately states the 22% ownership stake as of December 31, 2024, which aligns with the ground truth. However, it introduces a claim not present in the original answer or supported by the provided evidence: that the stake was 'down from a higher percentage in prior years due to refranchising and divestiture activities.' The original answer explicitly states that the 2022 ownership percentage was not disclosed, so any assertion about a prior higher percentage or reasons for change is speculative and unsupported. Additionally, the LLM introduces new financial figures—the carrying value ($1,147 million) and fair value ($2,675 million)—which are not mentioned in the ground truth and cannot be verified from the provided evidence. (2) While the 22% stake is correct, the inclusion of unverified dollar amounts and the unsupported downward trend claim significantly reduce quantitative accuracy. (3) The reasoning correctly maintains the equity method classification over time and notes increased transparency in disclosure, but the addition of unverified causal explanations and financial metrics reflects flawed multi-hop synthesis, as it goes beyond the evidence. (4) Despite the factual overreach, the answer remains contextually relevant by addressing investment classification and stake percentage evolution. The core correct elements are the equity method continuity and the 22% 2024 stake, but the unsupported details drag down correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 449,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments between fiscal 2022 and fiscal 2024 has evolved to prioritize flexibility and integration across deployment models. In fiscal 2022, Oracle highlighted its commitment to hybrid deployments, including cloud-based, on-premise, and hybrid models such as Oracle Cloud@Customer, emphasizing interoperability and customer choice. By fiscal 2024, Oracle further integrated hybrid deployment capabilities into its cloud infrastructure, particularly through investments in second-generation cloud infrastructure and the development of Oracle Cloud Services. Additionally, Oracle's restructuring efforts in fiscal 2024 were aimed at enhancing its cloud-based offerings, including hybrid solutions, reflecting a stronger focus on hybrid deployment integration to meet evolving customer needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Oracle's strategic evolution toward hybrid deployments from fiscal 2022 to 2024, emphasizing integration, interoperability, and customer choice. It accurately references Oracle Cloud@Customer and the broader hybrid deployment strategy. However, it omits the specific $7.2 billion R&D investment figure from fiscal 2022, which is a key quantitative detail in the ground truth. This omission affects quantitative accuracy but does not distort the overall narrative. (2) No incorrect numbers are stated, but the absence of the $7.2 billion figure—central to the original answer’s characterization of product development investment—represents a significant missing data point. The LLM mentions 'investments' generally but fails to quantify them, reducing precision. (3) The multi-hop reasoning is sound: the model synthesizes Oracle’s shift from development focus (2022) to integrated deployment models (2024), correctly identifying continuity in strategy and increased integration into core offerings. It also appropriately links restructuring and infrastructure development to hybrid deployment goals. (4) Despite the missing R&D figure, the answer remains contextually accurate and relevant, with strong qualitative reasoning and correct entity identification (Oracle, Cloud@Customer, fiscal years). The omission prevents a top score, but the core strategic evolution is well-conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 397,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The Mandatory Clawback Policy for Wells Fargo & Company was filed herewith in the 2023 SEC 10-K (page 18 of WFC_10k_2023.pdf) and incorporated by reference to the 2023 Annual Report. In the 2024 SEC 10-K (page 21 of WFC_10k_2024.pdf), the policy is again listed as Exhibit 97, with the same effective date of October 2, 2023, indicating no change in the policy's filing status between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct details but fundamentally misrepresents the evolution of the filing status of the Mandatory Clawback Policy between 2023 and 2024, which is the core of the question. It correctly identifies that the policy was filed as Exhibit 97 in both years and notes the effective date of October 2, 2023, which aligns with the ground truth. However, it incorrectly states that there was 'no change in the policy's filing status between the two years,' directly contradicting the ground truth. In reality, the key evolution is procedural: in 2023, the policy was filed directly (herewith) as part of the 10-K, while in 2024, it was incorporated by reference from the prior year’s filing rather than being filed anew. This procedural shift is the central point of the original answer, but the LLM fails to recognize or report it, instead asserting no change. The mention of 'incorporated by reference to the 2023 Annual Report' in the 2023 context is confusing and potentially inaccurate—incorporation by reference typically applies to prior filings when not re-filed, which better describes the 2024 case. The page numbers (18 and 21) and document references add specificity but do not compensate for the incorrect conclusion about the filing status. While entities (Wells Fargo, Exhibit 97, years) and dates are accurate, the reasoning is flawed, leading to a wrong synthesis. The answer is contextually relevant and includes some accurate elements, but the failure to correctly describe the procedural change in filing method results in a partially correct (score 4) assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 437,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific acquired CorEvitas, LLC on August 14, 2023, within the Laboratory Products and Biopharma Services segment. This acquisition added real-world evidence solutions to enhance drug development and decision-making. The financial implications included a cash outflow of $0.91 billion in 2023 for the acquisition, as noted in investing activities. The integration of CorEvitas likely contributed to the segment's revenue and operational capabilities in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the acquisition date (August 14, 2023), the $0.91 billion cash outflow, and the integration into the Laboratory Products and Biopharma Services segment, all of which align with the ground truth. The financial outflow and acquisition amount are accurately reported. (2) Quantitatively, all numbers and dates are correct: $0.91 billion acquisition cost in 2023 is accurately stated; no incorrect figures are presented. The format matches the ground truth. (3) The multi-hop reasoning is mostly sound—Thermo Fisher’s acquisition of CorEvitas and its financial impact are correctly synthesized. However, the LLM omits a key detail from the original answer: the amortization of definite-lived intangible assets over 18 years in 2024, which is a specific financial implication of the acquisition. Additionally, while the LLM mentions the acquisition’s strategic benefit, it does not reference the broader financial context (e.g., issuance of $5.94 billion in senior notes or stock repurchases) that contextualizes the funding of the acquisition. (4) Despite these omissions, the core facts—acquisition date, amount, segment, and integration—are correct and relevant. The answer is concise and contextually appropriate, but the lack of the amortization detail and broader financial strategy slightly reduces completeness and qualitative accuracy. Hence, a score of 8 is justified for correctness and qualitative accuracy, while quantitative accuracy and relevance remain perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 418,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce remained contingent on the hours flown by V2500-powered aircraft in service as of the acquisition date, with payments due through June 2027. In 2023, these flight hour payments were categorized under \"Other commercial aerospace commitments\" and totaled $10,015 million, with $687 million expected in 2027. The payments are capitalized as collaboration intangible assets as they are made, and the collaboration partners' share was $2,488 million as of December 31, 2023. In 2022, similar commitments were $11,014 million, with $739 million expected in 2025, and the collaboration partners' share was $2,902 million. Thus, the obligations evolved with updated expected timing and continued capitalization treatment as intangible assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($10,015 million in 2023 and $11,014 million in 2022) and expected payments in specific years ($687M in 2027, $739M in 2025), as well as collaboration partners' shares ($2,488M and $2,902M), none of which appear in the original ground truth answer. The ground truth makes no mention of any numerical values for the total commitments or expected annual payments, nor does it provide collaboration partner shares. These figures are therefore factually unsupported and likely hallucinated. (2) The quantitative inaccuracies are severe: the LLM fabricates precise financial data not present in the source, including multi-billion-dollar figures and year-specific breakdowns. There is no indication in the ground truth that obligations decreased from $11,014M to $10,015M or that partner shares declined from $2,902M to $2,488M. These numbers suggest a level of detail and change over time that contradicts the ground truth, which explicitly states there was 'no indication of a change in the magnitude or timing' of obligations. (3) Qualitatively, the LLM correctly identifies the core structure of the agreement: payments are contingent on flight hours through June 2027 for V2500-powered aircraft, and they are capitalized as collaboration intangible assets. It also correctly notes the categorization under 'Other commercial aerospace commitments.' However, the reasoning about 'evolution' is flawed—the LLM infers evolution based on fabricated numbers, while the ground truth emphasizes stability. The multi-hop synthesis is partially sound in terms of conceptual understanding but undermined by invented data. (4) Contextual relevance is fair because the answer addresses the right agreement, companies, time frame, and accounting treatment. However, the inclusion of false quantitative details severely undermines correctness. The answer creates a misleading impression of evolving obligations when the truth is stasis. Thus, while the framework is relevant, the factual core is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 553,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's financial relationship with fairlife, particularly regarding contingent payments tied to performance milestones, evolved from 2022 to 2024 as follows: In 2020, the Company acquired the remaining ownership interest in fairlife, and as of December 31, 2024, the remaining milestone payment related to this acquisition is contingent on fairlife achieving certain financial targets through 2024, with the payment due in 2025. This contingent consideration liability is classified under Level 3 fair value measurements and amounted to $6,126 million as of December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core timeline and structure of Coca-Cola's acquisition of fairlife and the existence of a contingent milestone payment tied to performance through 2024 with a payout in 2025. This aligns with the ground truth's key point about the evolution from a completed 2020 acquisition to an ongoing contingent obligation. However, a critical factual error undermines the answer: the contingent payment amount is stated as $6,126 million ($6.126 billion), which is grossly inaccurate and not supported by the original answer or known public disclosures. No such figure appears in Coca-Cola’s 10-K filings for 2024 related to fairlife; the actual contingent liability, if disclosed, is far smaller. This number is likely a hallucination or confusion with another figure. (2) The dates (2020 acquisition, 2024 performance period, 2025 payment) are correct and consistent with the ground truth. However, the $6,126 million figure is factually wrong—there is no indication in the original answer or public records of a liability of this magnitude. Even allowing for format variation, this number is orders of magnitude too large for a dairy joint venture milestone. (3) The multi-hop reasoning is partially sound: the model connects the 2020 acquisition to later disclosures in 2024 about contingent payments, showing an understanding of how the financial relationship evolved. It correctly infers that the obligation remains active through 2024 and is performance-based. However, it fails to note that in 2022, no such contingent payments were mentioned—this contrast between 2022 silence and 2024 disclosure is a key part of the evolution, which the LLM omits. (4) The correctness score is 4 due to the major quantitative error, which severely impacts financial accuracy. Quantitative accuracy is scored 2 because the one specific number provided is wildly incorrect. Qualitative accuracy is 6 because the reasoning and entity identification (Coca-Cola, fairlife, 2020 acquisition, contingent milestone) are mostly correct, but key contextual nuance (2022 vs 2024 disclosure differences) is missing. Contextual relevance is 9 because the answer directly addresses the question’s focus on contingent payments and timeline evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 607,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle has enhanced its strategic positioning of Oracle Cloud Services by emphasizing deeper integration with enterprise applications and infrastructure technologies. Oracle has focused on delivering comprehensive, interoperable cloud solutions such as Oracle SaaS and Oracle Cloud Infrastructure (OCI), which are designed to be rapidly deployable, intuitive, and cost-effective. The company has also invested in second-generation cloud infrastructure and emphasized the use of machine learning capabilities, such as in the Oracle Autonomous Database, to enable automation and innovation for customers. These efforts reflect Oracle's commitment to providing flexible deployment models and strengthening the synergy between its cloud offerings and enterprise IT environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic focus on Oracle Cloud Services, including SaaS and OCI, and mentions key technologies like the Oracle Autonomous Database and machine learning for automation—elements present in the ground truth. It accurately reflects Oracle's emphasis on integration, interoperability, and flexible deployment models. However, it does not clearly capture the *evolution* in strategic positioning between 2022 and 2024 as described in the original answer. Specifically, the shift from promoting individual innovations (e.g., Autonomous Database in 2022) to positioning Oracle Cloud as a holistic, integrated platform (in 2024) is underemphasized. The LLM answer presents a more static view of Oracle’s strategy rather than a dynamic evolution. (2) There are no numeric values, dates, or calculations in either answer beyond the years 2022 and 2024, which are correctly referenced—so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning requirement—comparing Oracle’s strategic messaging across two time points from filings—is partially met. While the LLM mentions relevant technologies and goals, it fails to clearly contrast the 2022 and 2024 positioning, which is central to the question. The synthesis across time periods is weak. (4) The answer is contextually relevant and factually sound in isolation, but lacks the comparative depth needed to fully reflect the strategic evolution. Hence, correctness and qualitative accuracy are reduced due to omission of the core narrative shift, even though all mentioned facts are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 440,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in the 2023 SEC filing (WFC_10k_2023.pdf, page 17) as Exhibit 10(r), dated back to December 31, 2018. However, in the 2024 SEC filing (WFC_10k_2024.pdf, page 20), there is no mention of any amendments or updates to this policy, indicating that it remained unchanged in terms of documentation and incorporation by reference between the two periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Key/Specified Employee Policy was incorporated by reference in both the 2023 and 2024 filings and that there were no amendments or updates in 2024, which aligns with the ground truth. However, there is a discrepancy in the exhibit number: the LLM states Exhibit 10(r) in the 2023 filing, while the ground truth specifies Exhibit 10(v). This is a factual error affecting entity accuracy. Additionally, the LLM does not mention that the policy was 'newly introduced' in 2023 per the original answer, instead stating it was incorporated without clarifying its status as a new disclosure, missing a key qualitative distinction. (2) The dates (2018) and years (2023, 2024) are correct, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—the model correctly infers continuity from lack of amendment—but fails to capture the evolution in disclosure status (new in 2023 vs. continuing in 2024), which is central to the question about 'evolution' of the policy. (4) Scores reflect mostly correct facts with minor but notable errors in exhibit number and incomplete synthesis of the policy’s changing disclosure status, though the answer remains contextually relevant and largely accurate in overall message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 372,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 decreased from $400 million in 2022 to $285 million in 2023, indicating that RTX repaid a portion of this debt during the year. This repayment reflects a proactive debt management strategy aimed at reducing high-cost debt and optimizing the company's capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 was $115 million in 2022 and increased to $285 million in 2023. The LLM incorrectly states that the balance was $400 million in 2022 and decreased to $285 million, which misrepresents both the starting value and the direction of change. This error fundamentally undermines the answer's correctness. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $285 million (from $115M to $400M), and the trend is reversed (increase vs. decrease). The 2023 value ($285M) is correct, but the context is wrong. No calculations are required beyond comparison, but the comparison is incorrect. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the evolution of the debt balance. Instead of recognizing an increase—indicating a strategy of expanding or retaining debt—the model assumes a repayment, leading to an incorrect conclusion about debt management. The reasoning is internally consistent with its false premise but does not reflect reality. (4) The contextual relevance is moderate because the answer addresses the right type of analysis (debt management strategy) and refers to the correct instrument and company. However, due to the core factual errors, the qualitative and quantitative accuracy scores are low. The correctness score is 2 because the answer gets only the 2023 number right but misses the key trend and starting point, leading to a misleading interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 434,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $773 million in 2023 to $725 million in 2024, while the effective interest rate remained consistent at 2.07%.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the carrying value 'increased' from $773 million in 2023 to $725 million in 2024, when in fact it decreased. This misrepresents the direction of change. Additionally, the effective interest rate is inaccurately described as 'remaining consistent at 2.07%', whereas in 2023 it was 2.08% and only declined to 2.07% in 2024. (2) Quantitatively, the dollar amounts ($773M and $725M) and the 2024 interest rate (2.07%) are correct, but the 2023 rate is wrong in the LLM answer (it omits 2.08%). The direction of change in carrying value is also quantitatively incorrect. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years, misrepresenting both the trend in carrying value and the change in effective interest rate. It does not acknowledge the slight decline in the rate or the reduction in liability. (4) Contextual relevance is high because the answer addresses the right financial instrument, company (TMO), metric (carrying value, effective interest rate), and time frame (2023–2024), but the core facts are incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 345,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The 2024 SEC filing for BNY Mellon includes a more detailed and structured presentation of its Directors' Code of Conduct compared to the 2022 filing, indicating a heightened emphasis on transparency and accountability in corporate governance. This change suggests a commitment to aligning with evolving governance standards, potentially enhancing board oversight and stakeholder confidence.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. According to the ground truth, BNY Mellon's 2024 SEC filing actually presents the Directors' Code of Conduct with less visibility—removing the direct URL and specific mention of updates—compared to the more explicit 2022 disclosure. The LLM incorrectly states that the 2024 filing includes a 'more detailed and structured presentation,' suggesting improved transparency, when the opposite is true. There are no numeric values in the question or answers, so quantitative accuracy is not applicable and scores 10 by default (no errors). However, the qualitative accuracy is very low because the model misrepresents the nature of the change in disclosure, drawing an erroneous conclusion about increased transparency. The reasoning is flawed and contradicts the ground truth, failing the multi-hop synthesis of changes across years. Contextual relevance is low because while the topic (corporate governance implications) is addressed, the underlying facts are inverted, leading to a misleading interpretation of governance accountability and stakeholder engagement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 316,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways: \n\n- **Facility Size**: The facility size remained unchanged at $5.0 billion.\n- **Maturity Date**: The maturity date shifted from October 2024 (established in November 2023) to October 2025 (established in October 2024).\n- **Timing of Establishment**: The agreement was initially established in November 2023 and replaced in October 2024 with a new agreement that extended the maturity date by one year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: the facility size remained at $5.0 billion in both years, the 2023 agreement had a maturity date of October 2024, and the 2024 agreement has a maturity date of October 2025. The timing of establishment shifted from November 2023 to October 2024. (2) Quantitative accuracy is perfect: dollar amounts ($5.0 billion), maturity dates (October 2024 and October 2025), and establishment dates (November 2023 and October 2024) are all correct. There are no calculation errors. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years and two credit agreements, with accurate comparison of facility size, maturity, and timing. (4) The answer is contextually relevant and directly addresses all parts of the question: facility size, maturity date, and timing of establishment. The conclusion that this reflects a procedural renewal is implied through accurate presentation of facts, even if not explicitly stated. Minor wording differences do not affect semantic equivalence. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 327,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 to 2024, AMD's APU strategy evolved significantly by integrating dedicated AI processing capabilities, such as incorporating a neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This shift reflects a broader focus on enabling AI-driven performance at the edge and in end devices, targeting both consumer and commercial markets. The integration of AI capabilities into APUs positions AMD to capitalize on the growing AI PC segment, enhancing its revenue potential by offering differentiated, high-performance solutions tailored for AI workloads and immersive computing experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AMD's strategic shift from 2022 to 2024: moving from external GPU-based AI solutions to integrating a dedicated NPU into APUs for AI PCs. The key factual elements—integration of NPU on the same SoC as x86 CPU, targeting AI PCs, and the implication for revenue potential—are all correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years (2022–2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s earlier focus (implied by contrast) with its 2024 strategy, correctly inferring a pivot toward on-device AI via integrated APUs. The only minor omission is the lack of explicit mention of AMD being 'the first' company to do so and the specific product lines (Instinct MI200, Radeon PRO V620) from 2022, which adds contextual depth but does not undermine the core accuracy. (4) Despite this, the LLM captures the strategic evolution and its revenue implications accurately, using semantically equivalent language. The answer is fully relevant, focused on product integration, target markets, and revenue potential in the AI PC segment. Thus, the correctness score is 9 due to high factual and reasoning accuracy with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 395,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent between 2023 and 2024. Dividends paid to U.S. residents are generally not subject to Irish dividend withholding tax (25% rate) if the shareholder meets specific exemption criteria, such as providing a valid U.S. Certification of Residence (Form 6166) or having a U.S. address in DTC records. Additionally, if a U.S. shareholder is subject to withholding tax, the payment satisfies any Irish income tax liability, provided the shareholder reports the withholding to Irish Revenue authorities. No material changes to these rules were noted in the 2024 filing compared to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate, the exemption for U.S. residents via Form 6166 or equivalent documentation, and the principle that withholding tax payment discharges any Irish income tax liability if reported to Irish Revenue. There is no change between 2023 and 2024, which is correctly noted. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no incorrect figures are introduced. (3) The reasoning is sound and reflects proper multi-hop synthesis across years and tax jurisdictions. The only minor omission is that the original answer specifies the Irish Non-Resident Form V2 as an alternative to Form 6166, while the LLM mentions DTC records as a potential basis for exemption — a detail not in the ground truth and slightly less precise. However, this does not contradict the truth and aligns with common practice. (4) The answer is fully relevant, directly addressing the evolution (or lack thereof) in tax treatment. The slight simplification in documentation methods prevents a perfect 10, but overall the response is factually robust and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 344,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to specifically highlight the company's platforms operating model initiative. In 2022, the risk was broadly mentioned as the potential adverse impact of new lines of business or strategic initiatives. By 2024, the disclosure explicitly noted the risk that \"we may not realize some or all of the expected benefits of our transition to a platforms operating model,\" indicating a more focused and detailed acknowledgment of the associated risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in risk disclosure between 2022 and 2024 as described in the ground truth. It correctly identifies that in 2022, BNY Mellon broadly discussed risks related to new lines of business and strategic initiatives, and that by 2024, the disclosure specifically included the 'transition to a platforms operating model' as a distinct risk, quoting the exact phrase 'we may not realize some or all of the expected benefits.' All entities (BNY Mellon, platforms operating model, correct years) are accurately referenced. The reasoning is sound and reflects proper multi-hop synthesis across the two time points. The only minor shortcoming is that the LLM does not explicitly name the company (BNY Mellon) in the response, though context implies it. This does not detract significantly from the accuracy but slightly reduces qualitative precision. Quantitative elements (years 2022 and 2024) are correct, and there are no numerical calculations required. The answer is fully contextually relevant and directly addresses the question about the evolution of risk disclosures with respect to the platforms operating model initiative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 332,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Amazon's 3.600% Note due 2032 is disclosed in both the 2023 and 2024 10-K filings under the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). There is no new issuance or material change in the terms of the note between 2023 and 2024. The note remains part of Amazon's long-term debt instruments, and no additional information about its status or modifications is provided in the 2024 filing beyond what was previously disclosed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 3.600% Note due 2032 was disclosed under the same Supplemental Indenture (April 13, 2022) in both 2023 and 2024, with no changes to the note's terms or interest rate. The dates, percentages, and exhibit reference (4.2) are correct, satisfying quantitative accuracy. However, the LLM omits a key qualitative evolution highlighted in the ground truth: the trustee transition from Wells Fargo Bank, National Association (prior trustee) to solely Computershare Trust Company, National Association as successor trustee in 2024. This procedural change in the trustee relationship represents a material update in the debt instrument's administrative structure, which the LLM fails to mention, despite correctly noting no material changes to the note’s terms. The answer is contextually relevant and correctly identifies the entities and time periods, but the omission of the trustee shift reduces completeness and reasoning depth in the multi-hop synthesis between years. While the core facts are right, the absence of the trustee evolution limits the qualitative accuracy, as it was a central aspect of how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 332,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes from 2023 to 2024. In 2023, the notional value of NIH contracts was $7.5 billion, with a fair value of $219 million liability, primarily valued using Level 2 inputs based on observable market rates. By 2024, the notional value slightly increased to $7.5 billion, but the fair value shifted to a $255 million asset, still using Level 2 inputs. Financially, NIH contracts contributed an after-tax gain of $185 million in 2023, while in 2024, they had an after-tax gain of $148 million, both impacting other comprehensive earnings and net earnings. The presentation in the financial statements remained consistent, with NIH contracts disclosed under derivative instruments and their impacts detailed in accumulated other comprehensive earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed fair values of derivative assets and liabilities in specific balance sheet categories: $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. The LLM answer incorrectly introduces a notional value of $7.5 billion for 2023 and 2024 and reports a fair value liability of $219 million in 2023 and an asset of $255 million in 2024—none of which appear in the ground truth and directly contradict the disclosed amounts. Additionally, the LLM claims after-tax gains of $185 million and $148 million in 2023 and 2024, respectively, which are not supported by the original answer and represent fabricated data. (2) Quantitative accuracy is very low: none of the dollar amounts in the LLM answer match the ground truth. The ground truth does not mention notional values, after-tax gains from NIH hedges, or fair value shifts to an asset in 2024. The only correct element is the mention of Level 2 inputs, but even that detail is not in the original answer and cannot be verified. (3) The multi-hop reasoning is flawed. The question asks about the evolution in treatment and disclosure, particularly regarding financial impact and presentation. The ground truth highlights a shift from balance sheet-focused disclosure in 2023 (fair value by asset category) to income statement impact in 2024 (mention of 'Other income, net' including amounts excluded from hedge effectiveness). The LLM completely misses this conceptual shift and instead fabricates a narrative around notional and fair values and after-tax gains, failing to identify the actual change in disclosure emphasis. (4) Contextual relevance is moderate because the answer stays on topic—discussing NIH hedges and their financial statement treatment—but the substance is factually incorrect. Due to major factual and quantitative errors and failure to capture the actual evolution in disclosure, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 565,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, General Dynamics' Abrams Main Battle Tank modernization strategy has evolved with a focus on developing the next-generation M1E3 Abrams, which introduces significant engineering changes to enhance lethality, survivability, and mobility for future threats. Technologically, the M1E3 incorporates advanced systems architecture for easier upgrades and reduced sustainment requirements. Internationally, demand remains strong, with NATO members and allies in Europe, the Middle East, and the Indo-Pacific seeking procurements and upgrades, reflecting the tank's growing global installed base.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of the Abrams modernization strategy from 2023 to 2024, highlighting the development of the M1E3 Abrams with advanced systems architecture, reduced sustainment, and improved capabilities. It accurately reflects strong international demand across Europe, the Middle East, and the Indo-Pacific. However, it omits specific mention of the System Enhancement Package version 3 (SEPv3), which was a key focus in 2023 according to the ground truth. This omission reduces completeness, though the core technological and strategic trajectory is correct. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes technological development (M1E3 architecture) and international demand trends across regions. It correctly attributes the strategy to General Dynamics and aligns the M1E3 with future threat response. The missing reference to SEPv3 limits full qualitative accuracy, as the 2023 technical roadmap included both SEPv3 deliveries and M1E3 development. (4) The answer is contextually relevant and conveys the essential evolution in strategy, emphasizing next-gen development and global procurement momentum. While not fully complete, it captures the key shift from technical development (2023) to strategic deployment and demand (2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 404,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD has increasingly positioned APUs as a strategic cornerstone across multiple market segments, emphasizing their role in delivering integrated performance and efficiency. In 2022, APUs were primarily highlighted as cost-effective solutions for mainstream PCs, combining CPU and GPU capabilities on a single chip. By 2024, AMD expanded their strategic emphasis, showcasing APUs in commercial, embedded, and semi-custom markets, with a focus on enterprise-class solutions such as AMD Ryzen PRO mobile processors and tailored APU offerings for data center and cloud applications. This evolution reflects a broader market segmentation strategy, leveraging APUs for both consumer and professional use cases.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies a strategic evolution in AMD's APU positioning between 2022 and 2024, it misrepresents the nature and context of that evolution. In 2022, the ground truth states APUs were part of a broader 'Enterprise, Embedded and Semi-Custom' portfolio without specific segmentation—however, the LLM incorrectly frames them as 'cost-effective solutions for mainstream PCs,' which is not supported by the original data. By 2024, the ground truth explicitly notes APUs were integrated into two reportable segments—Data Center and Client—with specific product groupings. The LLM claims APUs were positioned in 'data center and cloud applications' and 'enterprise-class solutions,' but this overreaches: while APUs appear in the Data Center segment alongside AI accelerators and DPUs, the original does not confirm active deployment or strategic focus in data centers, only inclusion in the segment reporting structure. The mention of 'AMD Ryzen PRO mobile processors' and 'tailored APU offerings for data center' introduces specific product examples not present in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound—the model infers a strategic shift from general to segmented positioning, which aligns with the truth—but it fails to accurately reflect the source-based evolution (from being buried in a broad category to being explicitly listed in two segments). Instead, it fabricates market focus areas (e.g., commercial, enterprise, cloud) not stated in the original. (4) The contextual relevance is high because the answer addresses the evolution of APUs in market segmentation and strategic emphasis over time, which directly responds to the question. However, the factual inaccuracies in entity usage and reasoning reduce correctness significantly. The answer sounds plausible but introduces unsupported details, leading to a mid-range correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 564,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company explained that the Irish Minister for Finance has the authority to restrict financial transfers between Ireland and third countries under the Act, with restrictions currently in place for countries under United Nations or EU sanctions. The disclosure also noted that the list of restricted countries is subject to ongoing change. No significant evolution in the content or detail of this disclosure was observed between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in describing the Financial Transfers Act 1992 and the Irish Minister for Finance's authority, which aligns with the ground truth. There are no numeric inaccuracies, as the response does not include specific numbers, dates, or financial figures that could be incorrect—thus quantitative accuracy is high. However, the core of the question asks about the *evolution* of Medtronic's disclosure from 2023 to 2024, and here the LLM fails: it claims there was 'no significant evolution,' directly contradicting the ground truth, which states that while the regulatory framework was still disclosed in 2024, the emphasis on the dynamic nature of the restricted countries list was dropped, suggesting a shift in focus or stabilization. This change *is* the evolution. The LLM incorrectly asserts consistency, missing a key qualitative shift. This represents a failure in multi-hop reasoning—comparing disclosures across years to detect changes in emphasis or wording. While entities (Medtronic, Ireland, Financial Transfers Act 1992) and context are correctly identified and relevant, the answer does not accurately reflect the change in disclosure tone or focus, leading to a low correctness and qualitative accuracy score despite strong contextual relevance and no factual errors in the content it does report.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 372,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In 2023, GD disclosed that the G700 was expected to enter service following FAA certification in early 2024. By 2024, the G700 had achieved certification and began deliveries in the second quarter, with production ramping up and contributing to increased inventories and customer deposits. This indicates a successful transition from development to active production and delivery.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2023, the G700 was expected to enter service after FAA certification in early 2024; by 2024, it had achieved certification and began deliveries in Q2. (2) No numeric values are incorrect—dates (early 2024, Q2 2024) are consistent with the original answer. The mention of 'ramping up production' and 'increased inventories and customer deposits' adds contextual detail supported by typical 10-K disclosures and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and company disclosures to show progression from expected certification to actual delivery and production. (4) Entities (G700, GD, FAA) and time periods are accurate. The answer fully addresses the evolution of the G700’s status and production outlook. All scoring categories warrant top marks due to complete accuracy, correct synthesis, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 292,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G remained consistent in 2024, with the long-term collaboration established in 2023 continuing to provide PMI with exclusive, worldwide rights (excluding South Korea) to commercialize KT&G's innovative smoke-free devices and consumables. This collaboration, spanning until 2038, allows PMI to access KT&G's product-innovation pipeline, enhancing its smoke-free portfolio, including offerings for low- and middle-income markets. The strategic dependency on KT&G for heat-not-burn products persisted, as PMI's net revenues and shipment volumes for smoke-free products, including KT&G-licensed brands like Fiit and Miix, continued to grow significantly in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in the strategic relationship between PMI and KT&G from 2023 to 2024, which is central to the question. Quantitatively, the answer correctly identifies the 15-year agreement (through 2038), the exclusivity (worldwide, excluding South Korea), and references to KT&G's product pipeline and brands like Fiit and Miix. These details align with the ground truth, earning high marks for quantitative accuracy. However, the qualitative reasoning is flawed: the LLM claims the relationship 'remained consistent' in 2024, directly contradicting the ground truth that the partnership evolved from exclusive commercialization to deeper integration, with KT&G's products becoming part of PMI's core heat-not-burn portfolio. This shift reflects increased strategic dependency and operational integration, which the LLM fails to acknowledge. The answer also emphasizes revenue and shipment growth in 2024, which may be true but is not supported in the original answer and introduces unsupported claims. While the entities (PMI, KT&G, product names, time frame) are accurate and contextually relevant, the failure to capture the evolution in the relationship—specifically the move from distribution to strategic inclusion—represents a significant gap in multi-hop reasoning and conceptual accuracy. Thus, the correctness score is reduced to 6 due to this critical omission in qualitative synthesis, despite strong performance on factual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 409,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved by integrating these offerings more strategically into its broader AI and data center ecosystems. In 2022, AMD emphasized semi-custom SoC products as part of its diverse portfolio, with revenue tied to third-party customers' product success. By 2024, AMD positioned semi-custom SoCs as a component of its broader AI strategy, leveraging them alongside its Instinct accelerators and EPYC processors. This shift reflects AMD's focus on delivering end-to-end AI solutions and expanding its capabilities through acquisitions like Silo AI, which enhance AI model development and deployment on AMD hardware.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its high-level assessment of AMD's strategic evolution regarding semi-custom SoCs from 2022 to 2024, but misses or misrepresents key details present in the ground truth. (1) Correctly identifies the shift from a third-party dependency model in 2022 to a more integrated, strategic role by 2024, and correctly notes the integration with AI and data center ecosystems. However, it omits the specific architectural integration of a neural processing unit (NPU) alongside an x86 CPU for AI PCs, which is a critical technical and strategic detail in the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misrepresented. (3) The reasoning is sound in identifying a strategic shift and linking semi-custom SoCs to broader AI and data center strategies, but fails to fully synthesize the multi-hop insight that semi-custom SoCs are now embedded across gaming, cloud, and embedded systems as core components of a diversified ecosystem. Additionally, the mention of 'Silo AI' acquisition is not present in the ground truth and appears to be hallucinated or incorrectly inferred, which undermines entity accuracy and qualitative reasoning. (4) Contextual relevance is high, as the answer addresses the evolution in strategic positioning and ecosystem integration. However, due to the omission of key technical details (NPU integration) and the introduction of unsupported information (Silo AI), the qualitative accuracy and overall correctness are reduced. A score of 7 reflects that core facts are correct but significant strategic and technical nuances are missing or distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 471,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents has remained largely consistent, with dividends generally subject to a 25% Irish dividend withholding tax unless specific exemptions apply. U.S. residents holding shares through the Depository Trust Company (DTC) and meeting address requirements continue to be exempt from withholding tax. Additionally, U.S. residents who provide valid certification forms (Form 6166 or Irish Non-Resident Form V2) are also exempt. No significant changes in exemptions or withholding tax obligations were noted in the 2024 filing compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 25% Irish withholding tax rate, which matches the ground truth and remains unchanged between 2023 and 2024. It also correctly notes that exemptions exist for U.S. residents, particularly through DTC and proper certification (Form 6166 or Irish Form V2), which aligns with general practices. However, the LLM incorrectly states that 'no significant changes' occurred between 2023 and 2024, which directly contradicts the ground truth. The original answer highlights that Medtronic’s 2024 disclosure provided more structured conditions for exemption and clarified post-withholding procedures—specifically, that those subject to withholding can discharge further liability by furnishing a statement to Irish Revenue. This evolution in disclosure and procedure is a key qualitative difference that the LLM answer misses entirely. (2) Quantitatively, the 25% withholding tax rate is accurate, and no incorrect numbers are presented. The LLM does not fabricate figures but omits the nuanced procedural update in 2024. (3) The multi-hop reasoning is flawed: the question asks for evolution between years, requiring comparison of Medtronic’s disclosures in 2023 vs 2024. The LLM fails to recognize that the 2024 filing introduced clearer conditions and post-withholding mechanisms, which constitutes an evolution in treatment despite the unchanged rate. This reflects a failure in synthesizing the temporal development in policy interpretation and disclosure. (4) The correctness score is 4 due to major omissions in the evolution aspect—while core facts (rate, exemptions) are correct, the answer misses the key 2024 clarification that defines the change. Quantitative accuracy is high (8) because numbers are correct. Qualitative accuracy is low (4) due to incorrect conclusion about no changes and failure to reflect updated procedures. Contextual relevance is moderate (7) as the answer addresses the general topic but not the specific evolution asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 539,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "From 2023 to 2024, General Dynamics' Marine Systems segment faced cost pressures on the Virginia-class and DDG-51 programs, which contributed to a slight decline in operating earnings and a reduced operating margin in 2023. These challenges were primarily due to supply chain disruptions affecting the Virginia-class submarine schedule and cost growth on the DDG-51 program. However, the revenue outlook for the Columbia-class submarine initiative remained strong, with increased volume in 2023 driven by this program. For 2024, the Marine Systems segment projected revenue growth to approximately $12.8–12.9 billion, with an operating margin of about 7.6%, indicating continued focus and investment in ship construction to meet Navy demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the cost pressures on the Virginia-class and DDG-51 programs in 2023 due to supply chain disruptions and cost overruns are accurately described; the strong revenue outlook for the Columbia-class submarine program is correctly noted; and the 2024 revenue projection of $12.8–12.9 billion with a 7.6% operating margin is precisely stated. (2) Quantitative accuracy is perfect: the dollar range and percentage margin match the original answer exactly, and while the original specifies a 110 basis point margin decline in 2023, the LLM’s description of a 'slight decline' is a reasonable qualitative approximation that does not contradict the truth. (3) Multi-hop reasoning is sound—the LLM synthesizes information across programs (Virginia-class, DDG-51, Columbia-class) and years (2023 vs 2024), correctly inferring a strategic shift toward stabilization and growth. (4) The only minor shortcoming is the lack of explicit mention of the 110 basis point margin decline, which slightly reduces qualitative precision, but the overall trend is correctly conveyed. The answer is fully relevant, addressing all parts of the question with appropriate context and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 353,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided information, BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. Approximately 89% of the Company's revenues for both the years ended December 31, 2023 and 2022, were attributed to online accommodation reservation services. This indicates that the company's reliance on accommodation reservations, primarily driven by Booking.com, did not significantly change during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 89% of BKNG's revenues in both 2022 and 2023 were derived from accommodation reservations via Booking.com, which matches the ground truth exactly. There are no numerical or percentage inaccuracies. (2) Quantitative accuracy is perfect: the percentages (89%) and years (2022, 2023) are correct, and no calculations are required beyond accurate reporting. (3) The reasoning is sound and correctly identifies that the dependency remained stable, which aligns with the ground truth observation of 'slightly increased' but unchanged percentage—though the original answer interprets the unchanged 89% as a 'slight increase' in dependency, this is a nuanced interpretation; the LLM's characterization of 'relatively stable' or 'no significant change' is factually accurate given the identical percentages. The minor difference lies in interpretive tone: 'slightly increased' vs 'stable'—but since the data is numerically unchanged, the LLM’s conclusion is reasonable and not factually incorrect. (4) All entities (BKNG, Booking.com, accommodation reservations, revenue proportion) are correctly identified and contextualized. The answer is fully relevant and synthesizes the correct information across years. The correctness score is 9 instead of 10 because the original answer makes a subtle interpretive point about dependency 'slightly increasing' despite the same percentage, possibly due to broader context (e.g., growth in other segments not keeping pace), which the LLM does not reflect. However, without additional data, the LLM’s neutral interpretation is still valid. Thus, high accuracy with minor interpretive gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 457,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The company's Swiss Franc note, which had a value of $299 million at the end of 2023, was fully repaid by 2024, with no balance remaining at the end of 2024. This indicates that the company successfully managed and settled its Swiss Franc-denominated foreign currency obligation during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $299 million Swiss Franc note obligation in 2023 and its complete removal by the end of 2024, which matches the ground truth. The conclusion about the company settling its foreign currency obligation is factually consistent. (2) Quantitatively, the dollar amount ($299 million) and the time frame (2023 to 2024) are accurate, and the claim of 'no balance remaining' aligns with the original answer's statement that the obligation was 'completely removed.' No calculations are required, but the comparison across years is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2023 and 2024) and draws a logical inference about foreign currency obligation management. The only minor difference is that the original answer mentions the possibility of restructuring in addition to repayment, while the LLM specifies 'fully repaid.' This is a slight narrowing of possibilities but does not contradict the facts, as repayment is one valid way the obligation could have been removed. (4) The answer is contextually relevant, fully addressing both parts of the question: the evolution of the Swiss Franc note and its implication for foreign currency obligations. Scores reflect high accuracy with a minor deduction in qualitative accuracy due to the slightly narrower interpretation of how the obligation was resolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 396,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new forms of Non-Employee Director RSU Award Agreements in the 2024 10-K, including variations such as \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" and specific agreements for \"One-Time/Year-End RSU Award Agreements,\" which were not explicitly detailed in the 2023 10-K. These modifications suggest a more nuanced approach to structuring and categorizing director compensation in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in identifying that Goldman Sachs made changes to its Non-Employee Director RSU Award Agreements in the 2024 10-K filing compared to 2023, and that these changes reflect a more detailed or updated approach. However, the specific details provided are factually inaccurate. The ground truth states that the 2024 filing introduced Exhibit 10.18, 'Amendments to Certain Non-Employee Director Equity Award Agreements,' which was not present in 2023, while retaining the pre-2015 RSU agreement (Exhibit 10.8). The LLM incorrectly claims that new forms such as 'Cash-Settled' and 'One-Time/Year-End RSU Award Agreements' were introduced, which is not supported by the original answer or the knowledge graph. There are no specific numeric values to verify, so quantitative accuracy is acceptable by default (score 6), but the qualitative accuracy suffers due to incorrect entity identification (wrong exhibit names and agreement types). The reasoning is flawed because it invents specific agreement forms not mentioned in the ground truth, failing the multi-hop synthesis requirement—instead of correctly noting the addition of amendments as a new exhibit, it fabricates new agreement categories. Contextual relevance is moderate because the response addresses the evolution of RSU agreements but does so with incorrect specifics. Overall, the answer conveys a plausible but factually incorrect narrative, warranting a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 403,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PM's financial relationship with Swedish Match AB evolved as PM completed the acquisition and subsequently refinanced and reduced related debt obligations. In 2023, PMI financed the acquisition of Swedish Match AB through a €5.5 billion senior unsecured term loan facility, with a 3-year tranche maturing in 2025 and a 5-year tranche maturing in 2027. By November 2024, PMI prepaid the entire €3 billion 3-year tranche, reducing its long-term debt obligations tied to the acquisition. As of December 31, 2024, only the €2.5 billion 5-year tranche remained outstanding. This action reflects PMI's strategy to manage and reduce acquisition-related debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides a plausible narrative about PM's debt reduction related to the Swedish Match AB acquisition, including prepayment of a €3 billion tranche and retention of a €2.5 billion tranche. However, it conflicts with the ground truth on the actual long-term debt obligations: the original answer states $6,121 million in 2023 and $2,610 million in 2024, while the LLM reports a reduction from €5.5 billion to €2.5 billion. Although €2.5 billion (~$2.7B at typical EUR/USD rates) is close to the $2,610 million reported, the 2023 figure does not align—$6,121 million is significantly higher than €5.5 billion (~$5.9B), suggesting missing debt components or incorrect consolidation. (2) The LLM uses euros while the ground truth uses USD, but even with currency conversion (~1.08 in 2023–2024), the numbers do not reconcile: €5.5B ≈ $5.94B, still below $6.121B. Additionally, the LLM does not mention the exact figures from the knowledge graph, nor does it confirm the total long-term debt obligations as reported. (3) The reasoning is logically sound—refinancing and prepayment explain debt reduction—and the multi-hop synthesis (acquisition financing → repayment → updated obligations) is appropriate. However, the failure to report the correct quantitative figures from the source data undermines factual accuracy. (4) Contextual relevance is high, as the answer directly addresses the evolution of PM's financial relationship and debt obligations. Qualitative accuracy is moderate due to correct structure but flawed data. Quantitative accuracy is low due to mismatched numbers despite plausible narrative. Correctness score reflects partial accuracy with significant factual discrepancies in key financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 475,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "Bristol-Myers Squibb (BMY) significantly advanced its strategic positioning around KRAS inhibition from 2023 to 2024 through the acquisition of Mirati in January 2024, which brought Krazati (adagrasib) into its portfolio. Krazati, a best-in-class KRAS G12C inhibitor, received FDA accelerated approval in 2024 for metastatic KRAS-mutated colorectal cancer and demonstrated clinically meaningful results in non-small cell lung cancer (NSCLC) trials, including a statistically significant improvement in progression-free survival. The acquisition also provided access to additional KRAS inhibitors and preclinical assets, strengthening BMY’s long-term strategy in targeting KRAS-driven cancers.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies BMY's acquisition of Mirati in 2024 and the strategic importance of Krazati (adagrasib) in BMY's KRAS inhibition strategy. However, there are key factual inaccuracies: the acquisition was completed in November 2023 (not January 2024), and Krazati received FDA approval for second-line NSCLC prior to the acquisition (in 2022), not in 2024. Additionally, the FDA approval for colorectal cancer (in combination with cetuximab) occurred in 2024, which the LLM mentions but misattributes as 'accelerated approval' without specifying the indication or combination therapy. The LLM incorrectly refers to Krazati as 'adagrasib'—this is incorrect; adagrasib is Mirati’s competitor to sotorasib (Krazati is sotorasib, developed by Mirati, acquired by BMY). (2) The $4.8 billion acquisition price is omitted in the LLM answer, a significant quantitative detail from the ground truth. The claim about 'statistically significant improvement in PFS' is not supported in the original answer and introduces unverified clinical detail. (3) The multi-hop reasoning is partially sound—linking the acquisition to enhanced KRAS strategy is correct, and recognizing Krazati’s development in NSCLC and colorectal cancer aligns with the original. However, the misidentification of the drug (adagrasib vs sotorasib) undermines entity accuracy and suggests confusion between competing KRAS inhibitors. (4) Despite these errors, the answer captures the core strategic evolution and therapeutic expansion, earning a 7 for correctness. Quantitative accuracy is penalized due to missing acquisition cost and incorrect timing. Qualitative accuracy is reduced due to drug name error and unsupported clinical claims, but the overall reasoning structure is logical. Contextual relevance is full—directly addresses the question’s focus on strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 508,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs did not explicitly discuss the evolution of its Restricted Partner Compensation Plan between 2023 and 2024 in the provided pages. However, the 2024 filing references the \"Amended and Restated Restricted Partner Compensation Plan\" as incorporated by reference from a 2006 filing, indicating no new amendments were disclosed during this period. In contrast, the 2023 filing similarly references the same plan without indicating changes, suggesting continuity in the plan's structure. Newer compensation governance policies, such as the 2023 Clawback Policy, were introduced separately, but no direct modifications to the Restricted Partner Compensation Plan were disclosed in the provided pages.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the Restricted Partner Compensation Plan remained substantively unchanged between 2023 and 2024, accurately noting that both years reference the same plan without new amendments. This aligns with the ground truth, which confirms the plan was not substantively altered. The mention of the Clawback Policy in 2023 is partially accurate but misaligned in timing—ground truth states the Clawback Policy was introduced in 2024 as Exhibit 10.1, not in 2023. This is a significant factual error in entity-year linkage. Additionally, the LLM fails to capture the key evolution in disclosure positioning: the shift in exhibit order from early (2023, Exhibit 10.3) to later (2024, Exhibit 10.4), which signals a strategic repositioning in how compensation disclosures are prioritized. This omission undermines the multi-hop synthesis required to assess both structural continuity and presentational change. While the answer correctly infers continuity in the plan, it misses the nuanced shift in disclosure strategy and misattributes the timing of the Clawback Policy, weakening the reasoning. Quantitative accuracy is high—no numerical errors, and exhibit references are close but not fully accurate (Exhibit 10.3 in 2023 vs. 10.4 in 2024 is correct in the ground truth, but LLM does not explain the significance of the renumbering). Contextually, the answer addresses the core topic of compensation plan evolution and governance, but lacks depth on the strategic disclosure shift. Thus, the answer is partially correct but misses critical structural and temporal nuances required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 443,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has evolved its approach to heat-not-burn products by expanding their categorization and integration into broader business segments. In 2023, heat-not-burn products are explicitly included in the \"smoke-free products\" category, which is further divided into \"smoke-free products excluding Wellness and Healthcare\" and \"Wellness and Healthcare.\" This categorization reflects a more structured integration of heat-not-burn products into PMI's overall smoke-free strategy. Additionally, the 2023 financial data shows a significant increase in revenue from smoke-free products, including heat-not-burn, across multiple regions, indicating a stronger business focus and market expansion for these products compared to 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in categorization of heat-not-burn products from 2022 to 2023, noting their inclusion under 'smoke-free products' in 2023, which aligns with the ground truth. It also mentions the structured segmentation into 'Wellness and Healthcare' and other smoke-free products, which is consistent with PMI's reporting. However, the LLM omits a key detail from the original answer: the explicit inclusion of licensed KT&G heat-not-burn products in 2023, which reflects broader integration beyond internally developed offerings—a critical point in business integration. (2) There are no numeric values, percentages, or financial figures in the ground truth that require verification; the mention of 'significant increase in revenue' in the LLM answer is not contradicted by the ground truth but is not supported with specific data either—since the original answer does not include revenue figures, this addition is contextually acceptable but not required. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift in categorization and integration, but fails to synthesize the full scope of business integration involving third-party (KT&G) products, which represents a key evolution in PMI’s approach. (4) The correctness score is 7 due to accurate core facts but a notable omission in business integration details. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 7 due to missing synthesis on KT&G licensing. Contextual relevance is 9 as the response stays focused and relevant throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 443,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb reinforced its compliance with the SEC Consent Order by maintaining and enhancing the role of the business risk and disclosure group, which was established as part of the Consent. The group continued to support governance processes to monitor and limit sales to direct customers, ensuring compliance with the terms of the Consent. Additionally, procedures were in place to escalate potential compliance concerns to appropriate management levels for timely resolution, and compliance with the policy was regularly monitored. These measures reflect a continued commitment to SEC Consent Order compliance and risk governance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall message and contextually relevant, but lacks some key details from the original answer that affect completeness and precision in the multi-hop reasoning. (1) What was correct: The LLM correctly identifies that the business risk and disclosure group was established in response to the SEC Consent Order and remained active in 2024, supporting ongoing compliance. It accurately notes the group’s role in governance, escalation of compliance issues, and monitoring—consistent with the original answer. There are no incorrect dates, entities, or numerical values (though no specific numbers appear in this case), so quantitative accuracy is high. (2) Number/calculation verification: Not applicable—no numeric data in question or answers. (3) Multi-hop reasoning assessment: The LLM captures the continuity between 2023 and 2024 but omits critical specifics about the group’s initial establishment in 2023 and the integration into long-term governance by 2024. Notably missing are key actions such as implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting processes, and the explicit statement that the group became a permanent part of the compliance framework. These omissions reduce the depth of the synthesis across years and limit the completeness of the evolution narrative. (4) Justification for scores: Correctness is 7 because core facts are accurate and the direction of evolution is correctly implied (continued use and importance), but important details about structural changes and integration are missing. Qualitative accuracy is 7 due to partial reasoning and incomplete entity-level synthesis. Quantitative accuracy is 10 because no numbers are involved and no factual errors exist. Contextual relevance is 9—response stays on topic and addresses the central theme of risk governance evolution under the Consent Order.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 524,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent expected long-term rate of return on plan assets at 5.25%, indicating no change in the relationship between the pension plan's expected return and its asset allocation mix. However, the discount rate increased from 5.00% in 2024 to 5.61% in 2024, reflecting higher market interest rates, which influenced the actuarial assumptions but did not alter the asset allocation strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and fails to address the actual evolution in UNP's disclosure language regarding the relationship between expected return and asset allocation mix. Instead, it fabricates numerical values (e.g., 5.25% expected return, discount rate increasing from 5.00% to 5.61%) that are not present in the ground truth. The original answer makes no mention of specific expected return percentages or discount rate changes, so these numbers are unsupported and factually inaccurate. (2) Quantitative accuracy is low because the LLM introduces false figures: there is no mention of a 5.25% expected return or any change in discount rates in the ground truth. The actual return of 6% in 2023 is ignored, and no actual return for 2024 is disclosed—contrary to the LLM’s implication of consistency. (3) Qualitatively, the reasoning is flawed. The question asks about a shift in narrative and disclosure focus between 2023 and 2024, but the LLM incorrectly frames the response around unchanged quantitative assumptions, missing the qualitative shift entirely. It fails the multi-hop requirement to compare textual disclosures across years and instead invents a narrative based on non-existent numerical data. (4) Contextual relevance is moderate because the answer discusses pension plan assumptions and asset allocation, which are topically relevant, but it does not engage with the actual evolution in disclosure language, which is the core of the question. The focus on discount rates and fixed expected returns distracts from the real issue: a narrowing of explanatory factors in the expected return justification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 451,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly posting it on its website at https://www.bnymellon.com and ensuring it was referenced within the corporate governance reporting sections of its 10-K filing. In 2023, the Code was directly mentioned in the 10-K under the \"Code of Ethics\" section, emphasizing its availability and commitment to transparency. In 2022, while the Code was referenced, the disclosure was less prominent and integrated within broader corporate governance descriptions. This evolution reflects a more deliberate effort to centralize and highlight the Directors' Code of Conduct as part of the company's governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023, noting increased prominence and integration of the Directors' Code of Conduct in 2023. It accurately captures that in 2022 the Code was referenced within broader governance disclosures, while in 2023 it was more explicitly highlighted. However, the LLM adds a specific URL (https://www.bnymellon.com) not present in the original answer or typically included in 10-K filings, which introduces a factual overreach. Additionally, while the original answer emphasizes the Code being listed alongside other key governance documents (e.g., Corporate Governance Guidelines, committee charters), the LLM focuses on the 'Code of Ethics' section, which slightly misrepresents the organizational context. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers increased emphasis and accessibility from year-to-year, but fails to accurately reflect the structural integration (i.e., being grouped with other formal governance materials) as described in the ground truth. The reasoning is plausible but lacks precision in synthesis. (4) The answer is contextually relevant and addresses the core question about accessibility and integration. The score of 7 reflects minor but notable inaccuracies in entity representation and contextual framing, despite capturing the general trend correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 433,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems. Oracle has expanded deployment options for Oracle Database, including on-premise via Oracle Exadata Cloud@Customer, in OCI Dedicated Regions, and as a cloud service, enabling customers to run workloads across hybrid and multicloud environments. This evolution reflects Oracle's commitment to supporting cloud migration and hybrid IT environments by offering seamless integration with Oracle Engineered Systems like Exadata, which combine database, storage, and hardware for optimized performance and scalability. The focus on automation, AI-driven capabilities, and consumption-based pricing further underscores Oracle's strategy to simplify cloud adoption while maintaining flexibility for diverse customer needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately captures Oracle's strategic emphasis on deployment flexibility in 2023–2024, mentioning key offerings like Oracle Exadata Cloud@Customer and hybrid/multicloud deployment models. The integration with engineered systems, particularly Oracle Exadata, is correctly highlighted as a core part of Oracle’s strategy. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses reference 2023 and 2024 appropriately, and all named products (Exadata, OCI Dedicated Regions) are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information about deployment evolution and engineered systems to infer Oracle’s broader strategy around cloud migration and hybrid IT. However, it omits the specific mention of 'Oracle Roving Edge Infrastructure' from 2023 and does not explicitly note the strategic *shift* from flexible standalone deployment to tightly integrated engineered systems—a key nuance in the original answer. Instead, it presents the evolution more as an expansion than a pivot, slightly underrepresenting the depth of strategic change. (4) Despite this, the answer remains contextually rich, relevant, and factually accurate overall, earning high marks for relevance and qualitative accuracy, with a minor deduction for missing the emphasis on strategic evolution toward holistic infrastructure packages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 419,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMS) enhanced its formal review and certification process for annual and quarterly SEC reports by reinforcing compliance monitoring and governance procedures. The company established a business risk and disclosure group to oversee reporting accuracy and transparency. Additionally, BMS retained an outside consultant to re-engineer its accounting and financial reporting processes, ensuring alignment with the terms of its 2004 SEC Consent Order. These measures reflect a continued commitment to strengthening internal controls and governance frameworks to maintain regulatory compliance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in multiple critical aspects. (1) The company in question is not identified in the original answer, but the LLM incorrectly attributes the actions to 'Bristol-Myers Squibb (BMS)' and references a '2004 SEC Consent Order', which is entirely absent from the original answer and irrelevant to the 2023–2024 timeframe. This is a major factual error. (2) The original answer states that the formal review and certification process was established in 2023 as part of a Consent agreement, with continued emphasis and integration into sales policies in 2024. The LLM answer fabricates details such as a 'business risk and disclosure group' and hiring an 'outside consultant to re-engineer accounting processes', which are not mentioned in the ground truth. (3) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond dates; however, the LLM's reference to 2004 is a severe date inaccuracy. (4) The multi-hop reasoning is flawed: instead of tracing the evolution from 2023 (implementation) to 2024 (integration and sustained monitoring), the LLM invents a narrative around a different company and outdated regulatory event. (5) The semantic meaning does not match the original: the core evolution—initial implementation in 2023 followed by integration into broader operational policies in 2024—is missing and replaced with irrelevant details. The answer is partially relevant to the topic of SEC report governance but factually and contextually inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 429,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) expanded its market positioning for heat-not-burn products by integrating them into its broader smoke-free product strategy, emphasizing their role as reduced-risk alternatives to combustible tobacco. In terms of product categorization, PMI continued to classify its heat-not-burn products (e.g., HEETS, Marlboro HeatSticks) under \"smoke-free products,\" distinct from combustible tobacco, and included them in the \"heated tobacco units\" (HTU) category. The 2023 data shows a significant increase in HTU shipments, rising from 109,169 million units in 2022 to 125,263 million units in 2023, reflecting stronger market adoption and strategic focus on this product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic shift of Philip Morris International (PMI) in positioning heat-not-burn products as part of its smoke-free portfolio, which aligns with the ground truth. It correctly identifies the categorization of heat-not-burn products under smoke-free offerings and notes increased market focus. However, there are significant quantitative inaccuracies: the LLM states that heated tobacco unit (HTU) shipments increased from 109,169 million in 2022 to 125,263 million in 2023. These numbers are incorrect—actual HTU shipments were approximately 109.2 billion units in 2022 and 125.3 billion units, meaning the LLM misrepresents billions as millions (off by a factor of 1,000), a critical error in financial/operational context. This undermines the quantitative accuracy score. Additionally, the LLM fails to mention key qualitative developments from the ground truth, such as the inclusion of licensed KT&G products in PMI’s portfolio in 2023, which reflects an expansion in partnership strategy. It also omits the shift from 'Reduced-Risk Products (RRPs)' as an umbrella category in 2022 to a more refined 'smoke-free product segment' integration in 2023. While the core idea of strategic evolution is present, the missing nuance and major numerical error reduce the correctness score. The reasoning is partially sound but lacks full multi-hop synthesis across years and product categorization changes. Contextually, the response is well-framed and relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 413,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. The company has expanded deployment options for Oracle Database, offering on-premise, cloud (OCI), and hybrid cloud solutions, as seen in Oracle Engineered Systems like the Oracle Exadata Database Machine. Additionally, Oracle has reinforced integration with its middleware, storage, and cloud services, enabling seamless performance, scalability, and operational efficiency across diverse IT environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Oracle Database's strategic positioning with respect to deployment flexibility and integration with Oracle technologies. It accurately notes expanded deployment options (on-premise, cloud/OCI, hybrid) and integration within engineered systems like Oracle Exadata. However, it omits the specific 2023 emphasis on perpetual licensing and customer choice, which is a key differentiator in the ground truth. While Exadata is mentioned, the 2024 shift toward positioning the database as a foundational component of engineered systems—integrated with storage, OS, and hardware—is implied but not explicitly detailed. (2) There are no numeric values, dates, percentages, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable but assumed correct by default. (3) The multi-hop reasoning is mostly sound: the model connects deployment models across years and links Oracle Database to broader Oracle technologies like Exadata and cloud infrastructure. However, it does not clearly contrast the 2023 standalone flexibility focus versus the 2024 integrated systems strategy, weakening the comparative evolution. (4) Scores reflect high accuracy in context and entities, with minor loss in qualitative accuracy due to missing nuance in strategic shift; correctness is strong but not complete due to omitted details about licensing and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 402,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024, marked by the acquisition of Mirati, a commercial-stage targeted oncology company, on January 23, 2024. This acquisition provided BMY with the rights to commercialize Krazati, a KRAS G12C inhibitor approved for second-line non-small cell lung cancer (NSCLC) and advanced or metastatic KRAS-mutated colorectal cancer in combination with cetuximab. Additionally, Krazati is in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. The specific financial commitment for this acquisition was a total consideration of $4.8 billion, with $4.1 billion net of cash acquired, and the inclusion of contingent value rights (CVRs) potentially worth up to $1.0 billion, subject to the FDA acceptance of an NDA for the PRMT5 Inhibitor within seven years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of BMY's relationship with Krazati from 2023 to 2024, noting the acquisition of Mirati in 2024 as a pivotal development. It accurately states the $4.8 billion total consideration and the $1.0 billion contingent value rights (CVRs) tied to the PRMT5 Inhibitor, matching the ground truth. The date of acquisition (January 23, 2024) is specific and correct. (2) All numeric values are accurate: $4.8 billion total consideration, $1.0 billion CVRs, and the net $4.1 billion after cash acquired is an acceptable detail not contradicting the ground truth. Format variations are consistent and acceptable. (3) The multi-hop reasoning is sound—linking BMY’s 2023 strategic interest in Krazati to the 2024 acquisition of Mirati, and connecting the financial commitments to long-term development goals. The LLM adds slightly more detail on indications (e.g., colorectal cancer combination use) and clinical development in first-line NSCLC with a PD-1 inhibitor, which are factually consistent with public data but not in the original answer; this does not reduce accuracy. (4) The only minor deviation is that the original answer emphasizes Krazati’s FDA and EMA approvals in second-line NSCLC, while the LLM includes additional indications without explicitly mentioning EMA approval. However, this does not constitute an error, just a difference in focus. All core facts, numbers, and strategic implications are correctly conveyed. Hence, the answer is highly accurate with only slight variation in emphasis, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 445,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV are listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2023 10-K filings, with the trading symbol \"BK/P\" on the New York Stock Exchange. There is no indication of any material change in their status or treatment between 2022 and 2023, as they remain fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the securities are registered under Section 12(b) of the Exchange Act, listed on the NYSE under symbol BK/P, and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric values requiring calculation in this question, but the percentage (6.244%) and trading symbol (BK/P) are correctly stated. (3) The multi-hop reasoning—comparing the status of the securities across two years using BK's SEC filings—is sound: the LLM correctly identifies that there is no material change in status or treatment between the years, synthesizing information from both filings. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in treatment or status. Wording differs slightly from the original answer but conveys the same factual conclusion. No errors in entities, years, or financial terms. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 299,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $1.9 billion to $2.7 billion. Additionally, borrowings under these arrangements rose slightly from $295 million to $283 million. This expansion in credit capacity, coupled with the continued availability of committed credit facilities, suggests that PMI has maintained a strong near-term liquidity posture, ensuring access to sufficient short-term funding to meet operational and strategic needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in PMI's short-term credit capacity from $1.9 billion in 2022 to $2.7 billion in 2023, which matches the ground truth. However, it incorrectly states that borrowings 'rose slightly from $295 million to $283 million', which is factually wrong — $283 million is less than $295 million, so utilization actually decreased. The direction of change is therefore misrepresented. (2) Quantitative accuracy is compromised because while the dollar amounts themselves are correct ($1.9B, $2.7B, $295M, $283M), the comparative description ('rose slightly') is incorrect — the correct interpretation is a slight decrease, as in the original answer. This affects the reasoning about liquidity posture. (3) The multi-hop reasoning is partially sound: the model recognizes that increased capacity with stable utilization supports strong liquidity. However, because it mischaracterizes utilization as increasing when it actually decreased, the conclusion misses the nuance of a more conservative financing approach despite lower drawdown. The original answer emphasizes that higher capacity with lower utilization suggests conservatism; the LLM answer instead implies stability or continued drawdown, weakening the insight. (4) Contextual relevance is high — the response addresses both capacity and utilization changes and draws a conclusion about liquidity. Qualitative accuracy is moderate because the logic is coherent but based on a flawed interpretation of the data trend. Quantitative accuracy is low due to the incorrect characterization of a numerical trend, even if raw numbers are present. Correctness score is 6 due to mostly accurate data and relevant structure but significant error in interpreting the direction of utilization change, which impacts the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 495,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by emphasizing deeper integration with other Oracle Cloud services and expanding automation capabilities. In 2024, the Autonomous Database is highlighted as being engineered to work seamlessly with services like Java Cloud and Oracle APEX, providing a modern platform for cloud-native application development. Additionally, automation capabilities have been expanded to include machine learning-driven diagnostics for fault prediction, automatic threat detection and remediation, and on-demand resource scaling. These advancements aim to further reduce administrative overhead and improve operational efficiency for users.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle's 2024 positioning emphasizes deeper integration with Java Cloud and Oracle APEX, which is explicitly mentioned in both the original and LLM answers. Automation enhancements powered by machine learning—including fault prediction, threat detection, and diagnostics—are accurately reported. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all temporal references (2023 to 2024 evolution) are correct, warranting a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in positioning across years and connects integration and automation developments to strategic cloud service alignment. (4) The LLM answer is semantically equivalent to the original, though it omits a few details present in the ground truth, such as 'open interfaces', 'native machine learning capabilities', and specific use cases like 'data lake houses' and 'real-time analysis of transactional data'. It also does not mention the 2023 hybrid deployment emphasis. These omissions are minor and do not detract from the core accuracy. Overall, the response is focused, factually correct, and contextually appropriate, justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 388,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC evolved as GM increased its capital involvement in the joint venture. In 2023, GM's investment in Ultium Cells Holdings LLC was $0.7 billion, and by 2024, this investment had grown to $0.9 billion. This increase reflects GM's strategic positioning to strengthen its supply chain for battery cell manufacturing, ensuring production needs are met and supporting its transition to electric vehicles. However, GM does not have the power to direct the activities of Ultium Cells Holdings LLC that most significantly affect its economic performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 GM had a contingent commitment of $0.8 billion, not a realized investment of $0.7 billion as stated. In 2024, GM made a direct investment of $0.7 billion, not an increase to $0.9 billion. Thus, the direction and magnitude of the investment change are incorrect. The LLM incorrectly implies growth from $0.7B to $0.9B, whereas the actual evolution was from a $0.8B contingent liability to a $0.7B actual investment—representing a decrease in committed capital and a shift in nature from contingent to actual, not an increase. (2) Quantitative accuracy is severely compromised: both years' figures are wrong, and the comparison is invalid. The correct narrative involves a change in the type of financial commitment, not a simple increase. (3) The reasoning is flawed: the LLM fails to recognize the multi-hop nuance that the relationship evolved from a VIE with contingent commitments (where GM lacked control) to a direct investment, which may imply greater influence. Instead, it incorrectly frames it as a straightforward capital increase while still asserting GM lacks control—missing the strategic realignment indicated in the original answer. (4) Contextual relevance is moderate: the answer addresses GM's capital involvement and strategic positioning in Ultium Cells, but with incorrect data and reasoning, undermining the validity of the conclusion. The mention of supply chain and EV transition is plausible context but does not compensate for factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 433,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: in 2022, Visa released $3.5 billion of as-converted value from its series B and C preferred stock during the sixth anniversary release and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.5 billion released in 2022, 176,655 series A shares issued; $2.7 billion released in 2024, 99,264 series A shares issued. These match the ground truth exactly. The years (2022 = sixth anniversary, 2024 = eighth anniversary) are also accurate. (2) All numbers, dollar amounts, and share counts are factually correct with no calculation errors. Format is consistent and clear. (3) The multi-hop reasoning is sound—information is correctly synthesized across time points (2022 vs 2024) and across metrics (as-converted value and shares issued). However, the LLM adds a detail not present in the ground truth: it mentions release of value 'from series B and C preferred stock', which is not referenced in the original answer. While this may be contextually plausible, it introduces an unverified entity (series B/C) not confirmed in the ground truth, slightly reducing qualitative accuracy. (4) Despite this minor over-specification, the core financial evolution is accurately conveyed, comparisons are valid, and the answer fully addresses the question about changes in value released and shares issued. Semantic equivalence is high, and contextual relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 351,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation and business adjustments. In 2023, 3M deconsolidated the Aearo Entities in Q3 2022 due to their voluntary Chapter 11 bankruptcy, which was aimed at resolving litigation related to Combat Arms Earplugs and respirator mask/asbestos claims. However, the bankruptcy was dismissed in June 2023, leading to the reconsolidation of the Aearo Entities in Q2 2023. This reconsolidation had minimal financial impact on 3M's income statement. In 2024, the CAE Settlement was implemented, under which 3M contributed $6.0 billion between 2023 and 2029 to resolve litigation involving the Combat Arms Earplugs. This settlement significantly affected 3M's financials, with a pre-tax charge of $4.2 billion recorded in Q3 2023. The litigation impact and reconsolidation also influenced the reporting of costs related to Aearo in the Safety and Industrial segment, shifting some costs to Corporate and Unallocated during the bankruptcy period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that 3M deconsolidated the Aearo Entities in Q3 2022 due to bankruptcy, but the ground truth confirms deconsolidation occurred in 2022 (without specifying Q3), and the bankruptcy filing was voluntary by Aearo, not initiated by 3M. More critically, the LLM claims the reconsolidation occurred in Q2 2023, while the original answer states it happened after the June 2023 dismissal—logically post-Q2, likely Q3. The $6.0 billion settlement contribution between 2023–2029 and the $4.2 billion pre-tax charge in Q3 2023 are not present in the ground truth and are therefore unverified/inaccurate. These are major quantitative errors. (2) The ground truth does not mention any pre-tax charge or specific dollar amounts related to the CAE Settlement, nor does it state that the settlement was 'implemented' in 2024—only that the reconsolidation had immaterial income statement impact. The LLM introduces financial figures and impacts not supported by the original answer, failing the quantitative accuracy test. (3) The multi-hop reasoning is partially sound—linking bankruptcy, dismissal, reconsolidation, and segment reporting—but incorrectly frames the timeline and financial consequences. It also misattributes segment-level cost shifts to Safety and Industrial, while the original answer references Transportation and Electronics as the segment where Aearo’s deconsolidation/reconsolidation were reported as divestiture/acquisition effects. This reflects a failure in entity and context mapping. (4) Despite these issues, the LLM captures the general evolution: bankruptcy, dismissal, reconsolidation, and changing strategic treatment. It addresses litigation impact and business adjustments, maintaining contextual relevance. However, due to significant factual and numerical inaccuracies, especially around timing and financials, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 526,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment and structure of Class C Common Stock evolved significantly due to the exchange of Class B-1 common stock for Class C common stock in May 2024. This exchange increased the number of Class C shares outstanding, contributing to higher earnings per share (EPS) for Class C compared to other classes. In 2024, Class C Common Stock had a basic EPS of $38.97 and a diluted EPS of $38.92, significantly outperforming Class A and Class B-1 shares, which had much lower EPS figures. This disparity reflects the reduced number of Class C shares outstanding and the lack of transfer restrictions, making it a more valuable and liquid class compared to others.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, the EPS figures for Class C Common Stock in 2024 are wrong: the LLM reports $38.97 (basic) and $38.92 (diluted), while the ground truth is $33.17 (basic) and $33.13 (diluted). Similarly, the claim that Class A and Class B-1 had 'much lower EPS' is unsupported by specific numbers and misrepresents the comparison. The ground truth specifies Class A EPS as $8.29/$8.28, but the LLM does not provide these. (2) The date of May 2024 for a Class B-1 to Class C exchange is not mentioned in the ground truth and appears to be fabricated. There is no mention of Class B-1 stock in the original answer, nor any structural change due to share exchange. The increase in EPS is attributed to reduced shares outstanding and lack of transfer restrictions, which is speculative and not supported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM invents a causal mechanism (share exchange) not present in the original data and misattributes the reason for higher EPS. While it correctly identifies that Class C outperformed other classes in EPS by 2024, it fails to note that the governance role remained unchanged, which is a key point in the original answer. (4) The contextual relevance is moderate because the answer addresses the evolution of Class C stock and compares EPS across classes, but the incorrect numbers and invented events severely undermine factual correctness. Quantitative accuracy is very low due to incorrect EPS values and unsupported dates. Qualitative accuracy is partially acceptable in framing performance differences but penalized for incorrect entity relationships and reasoning. Correctness score is low due to major factual and numerical errors despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 490,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in ADAS/AD technology evolved significantly from fiscal 2022 to 2024. In 2022, Qualcomm acquired Veoneer's Arriver business to strengthen its ADAS/AD capabilities, and its automotive revenue was $1.5 billion. By 2024, automotive revenue had grown to $2.91 billion, reflecting expanded product offerings in connectivity, digital cockpit, and ADAS/AD solutions. Additionally, strategic investments and R&D efforts were directed toward integrating AI and sensor technologies to advance autonomous driving capabilities, as highlighted in Qualcomm's focus on innovation and expansion into automotive applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies, particularly in quantitative details. The acquisition of Veoneer's Arriver business occurred in fiscal 2021, not 2022, which misaligns the timeline. Additionally, the reported automotive revenues of $1.5 billion in 2022 and $2.91 billion in 2024 are not supported by the ground truth data; the original answer does not mention specific revenue figures, so introducing these numbers without verification introduces false precision. (2) While the general trend of growth in automotive revenue and strategic focus on ADAS/AD is consistent with Qualcomm's trajectory, the absence of such figures in the ground truth means these numbers cannot be confirmed and likely reflect hallucination. The ground truth emphasizes a shift from development (2022) to commercialization (2024) evidenced by ADAS/AD being categorized under automotive revenue streams, not specific dollar amounts. (3) The reasoning partially captures the multi-hop evolution—Qualcomm did move from R&D/investment to commercialization—but the LLM substitutes conceptual progression with unsupported numerical growth, weakening the logical foundation. It correctly identifies strategic R&D and AI integration as part of the evolution, aligning with the original answer’s emphasis on innovation and expansion. (4) Despite incorrect numbers, the answer addresses the core question about evolution in strategic activities and revenue categorization, correctly identifying the transition to commercialization and inclusion in automotive products. Hence, qualitative reasoning and contextual relevance are reasonably strong, but quantitative inaccuracy significantly undermines overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 469,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan has evolved by increasing the U.S. litigation escrow account balance significantly, from $1,449 million in 2022 to $3,089 million in 2024. This mechanism, which includes deposits into the escrow account to address potential liability in covered litigation, reflects Visa's proactive approach to managing litigation risk by setting aside funds to cover settlements or judgments. The evolution suggests a strategic effort to mitigate financial exposure and ensure resources are available to address ongoing and potential legal claims, thereby stabilizing the company's financial position in the face of litigation uncertainties.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies a quantitative increase in the U.S. litigation escrow account from $1,449 million in 2022 to $3,089 million in 2024, which aligns with factual data and demonstrates acceptable quantitative accuracy (minor formatting: 'million' vs 'M' is fine). However, the original answer emphasizes a structural evolution in the plan's mechanisms—not just an increase in escrow funds. The LLM omits critical qualitative developments: the introduction of a U.S. litigation escrow agreement, conversion features for Class B stock, makewhole agreements, indemnification obligations, interchange judgment sharing, loss sharing, and omnibus agreements. These are central to understanding how the plan evolved from a basic escrow mechanism to a complex, layered risk management framework. The LLM incorrectly frames the evolution primarily as a funding increase rather than a systemic expansion of legal and financial structures. While the conclusion about a proactive approach to litigation risk is directionally consistent, it is based on incomplete reasoning. The answer fails to synthesize the multi-hop elements involving multiple interrelated agreements and their implications, resulting in significant qualitative inaccuracy. Contextually, the response is relevant to Visa’s litigation risk management but lacks depth and misses key components of the plan’s evolution as described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 391,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as part of its collaboration with AstraZeneca, showed growth between 2023 and 2024, with alliance revenue related to Lynparza increasing by 9% in 2024. This growth was primarily driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for the adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating its expanding strategic importance and regulatory success in key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in alliance revenue for Lynparza in 2024 and the January 2025 China approval, both of which match the ground truth. It accurately notes the international demand as a driver and correctly specifies the indication (adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer) and the OlympiA trial as the basis—details consistent with the product's strategic expansion. However, the LLM omits the specific $1.5 billion net intangible asset reported by Merck in 2023, which was a key part of the financial stake at the start of the period. This omission slightly reduces completeness but does not distort the overall narrative. (2) All numbers and dates are accurate: 9% revenue growth in 2024 and January 2025 approval are correctly stated. No calculations are required, and all quantitative elements are preserved. (3) The multi-hop reasoning is sound—linking revenue growth, international demand, and regulatory approval to infer increasing strategic importance is logically supported by the data. The collaboration with AstraZeneca is correctly identified, and the entities (Merck, Lynparza, AstraZeneca, China approval) are accurate. (4) The answer is highly contextually relevant, directly addressing the evolution of Merck’s stake and indicators of performance and strategic importance. The omission of the $1.5B asset prevents a perfect score, but the rest of the response is factually aligned and semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 425,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined, as reflected in its reduced shipment volume and retail share. In 2024, Skoal's shipment volume dropped to 147 million units from 163.1 million in 2023, and its retail share fell to 7.6% from 9.3%. This decline was driven by retail share losses and competition from oral nicotine pouches, particularly on! nicotine pouches, which saw increased market share despite a decrease in their own share by 2.6 points. The growth of the oral nicotine pouch category and shifting consumer preferences contributed to the overall challenges faced by traditional moist smokeless tobacco (MST) products like Skoal.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Skoal's declining market position, with accurate retail share figures (9.3% in 2022 and 7.6% in 2024), which matches the ground truth. However, the LLM introduces shipment volume data (163.1 million in 2023 and 147 million in 2024) that is not present in the original answer and cannot be verified against the provided ground truth, raising concerns about factual accuracy. Additionally, the claim that on! 'decreased by 2.6 points' is factually incorrect — the original answer states on! increased from 6.8% to 8.3% (a gain of 1.5 points), so this is a significant quantitative error. (2) While the 9.3% and 7.6% figures are correct and properly attributed to Skoal’s retail share, the inclusion of unverified shipment volumes and the incorrect characterization of on!’s performance undermine quantitative accuracy. The timeline (2022–2024) is handled appropriately. (3) The reasoning correctly identifies that Skoal underperformed due to competition from on! and shifting consumer preferences toward nicotine pouches, which aligns with the original answer’s implication. It also correctly contextualizes Skoal as a traditional MST product facing category-wide headwinds. However, it fails to mention Copenhagen’s performance (23.5% to 19.1%), which is a key comparative point in the original answer, thus missing a critical multi-hop comparison. (4) Despite missing some key comparative data and introducing incorrect metrics, the LLM answer captures the core trend — Skoal’s weakening position relative to newer products — and remains focused on the question. The answer is relevant and mostly logically sound, but the factual errors in numbers and omission of key competitor data prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 476,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased significantly between fiscal years 2022 and 2023. In fiscal year 2022, Dynamics products and cloud services revenue was $4,687 million, and it grew to $5,437 million in fiscal year 2023, representing an increase of $750 million or approximately 16%. This growth was driven by the strong performance of Dynamics 365, which saw 39% growth in fiscal year 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific dollar amounts for Dynamics 365 revenue in fiscal years 2022 or 2023—only that Dynamics 365 was part of the $91.2B (FY2022) and $111.6B (FY2023) Microsoft Cloud revenue and that it grew 39% in FY2022. The LLM invents precise figures ($4,687M and $5,437M) and claims a 16% increase, which are not supported by the original data. (2) Calculations such as '$750 million or approximately 16%' are incorrect because they are based on fabricated inputs. There is no mention in the ground truth of Dynamics 365's absolute revenue, so any specific dollar amount is a hallucination. (3) The reasoning partially captures the multi-hop aspect by recognizing Dynamics 365's growth in FY2022 (39%) and its continued role in Microsoft Cloud, but fails to acknowledge that FY2023 growth specifics are not disclosed. Instead, it fabricates data to fill the gap, breaking factual integrity. (4) While the answer is contextually relevant—addressing the evolution of Dynamics 365 revenue—and correctly references the 39% FY2022 growth, the invention of numerical data severely undermines correctness. Quantitative accuracy is very low due to false precision; qualitative accuracy is moderate due to correct entity and year identification but flawed synthesis; contextual relevance is high as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 398,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "From 2023 to 2024, Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program remained largely consistent in terms of instruments used, primarily relying on forward exchange contracts to hedge monetary assets and liabilities. However, a notable evolution was the increased use of euro-denominated notes as economic hedges of the net investment in foreign operations, as evidenced by the $192 million pretax loss recognized in 2024 compared to a $105 million gain in 2023. This shift suggests a broader scope of hedging activities, incorporating more long-term debt instruments to manage net investment exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the evolution of Merck's Balance Sheet Risk Management Program from 2023 to 2024 as described in the ground truth. (1) The instruments cited in the LLM response—euro-denominated notes used as economic hedges of net investment—are not mentioned in the original answer and pertain more to cash flow or net investment hedging, not balance sheet risk management. The ground truth specifies forward exchange contracts in 2023 and an expansion in 2024 to include purchased local currency put options and collar options, which the LLM completely omits. (2) The quantitative figures referenced—$192 million pretax loss in 2024 vs. $105 million gain in 2023—are not present in the original answer and appear to be fabricated or misattributed; these numbers do not relate to the balance sheet hedging program described. (3) The reasoning is flawed: the LLM incorrectly infers that using euro-denominated debt instruments indicates an evolution in the balance sheet risk management program, but this is a different hedging strategy (net investment hedge) and not part of the forward/collar/option-based balance sheet program described in the ground truth. (4) The LLM fails to capture the key multi-hop evolution: shift from simple forward contracts (2023) to a more structured, layered program with options and dynamic hedging timing (2024). While the mention of forward contracts in 2023 is correct, the rest of the answer misrepresents the scope and instruments. Contextual relevance is moderate because it discusses foreign exchange risk and Merck, but the focus on debt instruments misaligns with the actual program. Thus, the answer is factually inaccurate and misses the core developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables between 2022 and 2024 has shown growth, with the total outstanding balance increasing from $1.2 billion in 2022 to $1.5 billion in 2024. Credit loss provisions for merchant receivables decreased from $380 million in 2023 to $348 million in 2024, primarily due to improved credit quality in U.S. interest-bearing installment loans, despite growth in other loan categories. Additionally, PayPal's direct investment in merchant financing products, through its PPWC and PPBL offerings, increased, with $1.8 billion in merchant receivables purchased in 2024 compared to $1.7 billion in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, the original answer states that the $1.2 billion outstanding balance was as of 2023, not 2022, and does not provide a 2022 balance—so claiming an increase from $1.2B in 2022 to $1.5B in 2024 is incorrect. Second, the original answer does not mention credit loss provisions of $380M in 2023 or $348M in 2024; these figures are entirely fabricated and not present in the ground truth. Third, the $1.7 billion in receivables purchased in 2023 is not supported by the original answer, which only provides data for 2024 ($1.8B purchased) and outstanding balances for 2023 and 2024. (2) The only correct quantitative data is the $1.8 billion in merchant receivables purchased in 2024 and the $1.5 billion outstanding as of December 31, 2024, and the $1.2 billion outstanding in 2023. All other numbers (credit loss provisions, 2022 balance, 2023 purchases) are incorrect or unsupported. (3) The reasoning partially captures the shift toward direct investment via PPWC and PPBL, which is mentioned in both answers, and the expansion of involvement is correctly inferred. However, the model fails to reference the 2022 focus on credit loss methodology using macroeconomic forecasts and historical data, a key part of the evolution. The synthesis is incomplete and introduces false data, undermining the multi-hop logic. (4) The contextual relevance is high because the answer addresses the core themes: evolution of involvement, credit loss provisions, and direct investment. However, due to significant quantitative errors and omission of key 2022 context (methodology disclosure vs. active investment), the correctness and quantitative accuracy scores are low. The answer creates a plausible but factually incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 487,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) has shown a slight decline in operating income performance, with operating income for smokeable products decreasing from $10,670 million in 2023 to $10,821 million in 2024, despite a marginal increase in net revenues from $21,756 million to $21,204 million. Additionally, goodwill allocated to smokeable products has remained stable at $99 million over the period, indicating no significant changes in the valuation of this segment's intangible assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that operating income for smokeable products decreased from $10,670 million in 2023 to $10,821 million in 2024, which is false—the numbers show an increase, not a decrease. The original answer correctly identifies that operating income rose from $10,670M in 2023 to $10,821M in 2024. Additionally, the LLM reverses the net revenue trend, claiming an increase from $21,756M to $21,204M, which is mathematically a decrease, and these revenue figures are not even present in the ground truth, making them fabricated. (2) The only correct number is the $99 million goodwill allocation in 2022; however, the LLM falsely claims this remained stable through 2024, while the original answer explicitly states that no updated goodwill figure is disclosed for 2024. Thus, asserting stability is incorrect. (3) The multi-hop reasoning fails: the LLM misinterprets the direction of operating income change and invents revenue data not present in the source, indicating a failure to synthesize correctly across years and metrics. It also mischaracterizes the trend as a decline when it is actually a slight increase. (4) The contextual relevance is moderate because the answer addresses goodwill and operating income over time, which are relevant, but due to severe quantitative and qualitative inaccuracies, the conclusion is fundamentally wrong. Hence, correctness and quantitative accuracy are very low, qualitative accuracy is poor due to flawed logic, and contextual relevance is acceptable but undermined by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 440,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $10,289 million in fiscal year 2022 to $13,631 million in fiscal year 2023, representing a growth of $3,342 million or approximately 32.5%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. The original answer states that Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was $91.2 billion in FY2022 and $111.6 billion in FY2023. The LLM incorrectly reports the LinkedIn commercial portion alone as $10,289 million ($10.289 billion) and $13,631 million ($13.631 billion), implying that this is the revenue contribution specifically from LinkedIn within Microsoft Cloud. However, no such breakdown of LinkedIn's standalone commercial revenue is provided in the ground truth, and the figures cited by the LLM do not appear in the original answer. The $20.4 billion increase in Microsoft Cloud revenue (from $91.2B to $111.6B) is attributed broadly to the commercial cloud segment including LinkedIn, but the LLM falsely isolates and quantifies LinkedIn’s contribution with precise numbers unsupported by the source. The 32.5% growth calculation may be mathematically correct based on the LLM's numbers (3,342 / 10,289 ≈ 32.5%), but since the underlying data is fabricated or misattributed, the entire quantitative analysis is invalid. There is no evidence in the ground truth that LinkedIn’s commercial revenue was reported at these levels or growth rates. The reasoning fails the multi-hop requirement: it should have recognized that LinkedIn's revenue is embedded in Microsoft Cloud but not extractable as a separate line item from the given data. While the answer addresses the question's topic and direction of growth (increasing contribution), it invents specific figures not present in the original, leading to a very low correctness score. Contextual relevance is moderate because it attempts the right question, but factual accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 477,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization and market expansion showed growth, particularly in international markets. Alliance revenue related to Lynparza increased by 9% in 2024, driven by higher demand globally. Notably, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, marking a key geographic expansion. This approval, along with ongoing international demand, contributed to the revenue growth during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% alliance revenue growth in 2024 and the January 2025 China NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. These key facts match the ground truth. However, the LLM omits the 2023 FDA and Japan MHLW approvals for BRCA-mutated mCRPC, which were part of the commercialization evolution between 2023 and 2024. This is a minor omission affecting completeness but does not undermine the core accuracy. (2) All quantitative elements are correct: the 9% revenue growth and the January 2025 approval date are accurately reported. No calculations are required, and all numbers align with the original answer. (3) The multi-hop reasoning is sound—linking the China approval to geographic expansion and connecting increased international demand to revenue growth shows appropriate synthesis. The only gap is the missing 2023 approvals, which would have strengthened the timeline of market expansion. (4) The answer is contextually highly relevant, directly addressing both geographic approvals and revenue growth. The omission of the 2023 approvals prevents a perfect score, but the response remains factually accurate and well-reasoned overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 358,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "The Powder Metal Matter's future income tax benefits decreased from $644 million in 2023 to $455 million in 2024, indicating a reduction in the associated tax asset, likely due to adjustments in the valuation or resolution of related uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative figures — future income tax benefits decreased from $644 million in 2023 to $455 million in 2024 — which matches the ground truth exactly. The calculation of a $189 million decrease is implied and accurate, though not explicitly stated. However, the LLM omits a critical part of the evolution: in 2023, the Powder Metal Matter was treated as a reduction in sales, not as a tax benefit. This shift in accounting treatment (from sales reduction to tax benefit recognition) is a core part of the question and is entirely missing from the LLM response. (2) All numbers and years are correct and precisely match the ground truth. The dollar amounts ($644M and $455M) and years (2023, 2024) are accurate. (3) The reasoning is partially sound — the LLM correctly notes a decrease in future tax benefits and plausibly suggests a reason (valuation adjustments or resolution of uncertainties), but it fails to perform the necessary multi-hop synthesis between the 2023 and 2024 treatments across different financial statement categories. The evolution in *treatment* (from sales impact to tax benefit) is not addressed, which is central to the question. (4) The contextual relevance is high because the answer focuses on the correct topic and timeframe, and provides a reasonable interpretation of the tax benefit trend. However, due to the omission of the shift in financial treatment, the qualitative accuracy is reduced. The answer is factually correct where it speaks, but incomplete in covering the full evolution, warranting a 7 in correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 440,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity of the Paidy Credit Agreement increased from approximately $198 million in 2021 to $574 million by December 31, 2024, following a modification in September 2022 that raised the total borrowing capacity from ¥60.0 billion to ¥90.0 billion. The terms of the agreement remained largely similar, with interest rates based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%, and a maturity date extended to February 2027. The financial covenant under the agreement requires the company to maintain a maximum consolidated leverage ratio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in borrowing capacity from approximately $198 million to $574 million and the conversion to ¥90.0 billion, as well as the interest rate based on TIBOR plus 0.40%-0.60%, the February 2027 maturity, and the inclusion of a consolidated leverage ratio covenant. However, it incorrectly states that the modification occurred in September 2022, which is not mentioned in the ground truth, and uses 2021 data ($198 million) while the question asks about evolution from 2022 to 2024. The original answer clarifies that the $198 million facility was in place in 2022, with $98 million outstanding as of December 31, 2021 — a nuance the LLM misrepresents by attributing the $198M figure to 2021 rather than 2022. (2) The quantitative values (dollar amounts, yen amount, interest rate range, maturity date) are mostly accurate, but the erroneous citation of a September 2022 modification introduces a false event not supported by the ground truth, reducing quantitative accuracy. The conversion of ¥90.0 billion to $574 million is contextually acceptable if based on 2024 exchange rates. (3) The reasoning is generally sound in tracking the evolution of terms, but the unsupported claim about a September 2022 amendment reflects a failure in multi-hop synthesis — no such detail exists in the ground truth, suggesting fabrication or misattribution. (4) Despite the error, the answer captures the core evolution of capacity, security status (implied by lack of mention of secured), interest rate, maturity, and covenants, making it contextually relevant and largely complete. The qualitative accuracy is high due to correct identification of key terms and logical flow, but docked slightly for the unsupported modification date.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 484,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long-term senior unsecured notes as part of its capital resources remained significant between 2022 and 2024, with total long-term debt at $24.9 billion in 2024 and $28.0 billion in 2022. In 2024, Altria issued $1.0 billion in new senior unsecured notes and repaid $1.121 billion in maturing notes, while in 2022, it repaid $1.5 billion in maturing notes and issued $5.5 billion in new senior unsecured notes. This indicates a continued use of long-term senior unsecured notes for liquidity and debt management, though with a reduction in total long-term debt over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical data. The ground truth does not mention total long-term debt figures of $24.9 billion in 2024 or $28.0 billion in 2022, nor does it specify issuance of $5.5 billion in 2022 or $1.0 billion in 2024. These figures are not supported by the original answer and appear to be fabricated or misattributed. The original answer focuses on Altria's continued reliance on long-term senior unsecured notes as a capital resource and highlights a decline in cash and cash equivalents from $4.5 billion in 2022 to $3.1 billion in 2024, which the LLM answer omits entirely. (2) The quantitative inaccuracies are severe: the LLM introduces specific debt issuance and repayment amounts not present in the ground truth, and the total long-term debt numbers are not corroborated. The original answer does not provide total debt balances for those years, so the LLM's inclusion of such precise figures undermines its credibility. (3) While the LLM correctly identifies that Altria continues to rely on long-term senior unsecured notes, it fails to synthesize the key multi-hop insight from the original answer: that decreasing cash reserves suggest increased reliance on external financing. This is a critical analytical point that the LLM misses despite having the right general direction. (4) The contextual relevance is high because the answer addresses the evolution of Altria's use of senior unsecured notes over time and attempts to compare issuance and repayment activity. However, due to major factual errors and omission of the cash reserve trend—which is central to the original reasoning—the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning structure is sound, but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 500,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter evolved from a net sales charge of $5.4 billion in 2023 to a reduction in cost of sales of $2.5 billion in 2024, indicating a shift from a direct sales impact to a cost-related adjustment. This evolution suggests that the Powder Metal Matter's impact on future income tax benefits is reflected in a decrease in deferred tax assets from $644 million in 2023 to $455 million in 2024, implying a reduced tax benefit as the matter is being resolved.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. The key correct element is the decrease in deferred tax assets (future income tax benefits) from $644 million in 2023 to $455 million in 2024, which matches the ground truth and correctly reflects the diminishing impact on RTX's tax position. However, the LLM introduces incorrect financial figures — claiming a 'net sales charge of $5.4 billion' in 2023 and a 'reduction in cost of sales of $2.5 billion' in 2024 — which are not present in the ground truth and appear to be hallucinated. These figures are not supported by the original answer and contradict the focus on tax benefits. (2) Quantitative accuracy is partially correct: the $644M to $455M decrease in deferred tax assets is accurate and correctly interpreted. However, the inclusion of the $5.4B and $2.5B figures, which are not in the original answer, significantly undermines numerical accuracy. (3) The multi-hop reasoning is flawed: while the model correctly infers that a decrease in deferred tax assets implies reduced future tax benefits, it fabricates an evolution in 'financial treatment' involving sales and cost of sales that is not in the source data. The original answer does not mention any shift in accounting treatment beyond the change in tax benefit amount. (4) Contextual relevance is high because the answer addresses the core question about evolution and future tax implications, and correctly interprets the trend in tax benefits. However, the hallucinated financial metrics reduce qualitative accuracy and overall correctness. The answer would be stronger if it focused solely on the confirmed change in deferred tax assets without introducing unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 471,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the agreement had a borrowing capacity of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the borrowing capacity was increased to ¥90.0 billion (approximately $574 million as of December 31, 2024), and the full amount was drawn down during the year, leaving no available borrowing capacity under the Paidy Credit Agreement as of December 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key numbers are correct: $198 million borrowing capacity in 2022, $98 million outstanding as of December 31, 2021 (which implies ~$100 million available at start of 2022), and by 2024, capacity increased to ¥90.0 billion (~$574 million) with full drawdown. The conversion from yen to dollars is appropriately noted and matches the time-specific exchange rate context. (2) Quantitative accuracy is perfect: values match exactly, with acceptable formatting variations (e.g., 'approximately $574 million' = '$574 million'). The statement that the full amount was drawn down, leaving no capacity, is consistent with the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes data across years and entities (PayPal, Paidy Credit Agreement), tracking changes in capacity and utilization over time. (4) The answer addresses both parts of the question: evolution of borrowing capacity and actual drawdown. Wording differs slightly but maintains semantic equivalence. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 314,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. remained largely consistent, with noncontrolling interests held by current and former members of Accenture Leadership being less than 1% as of August 31, 2024. Exchangeable shares issued to pre-incorporation partners in Canada and New Zealand remained redeemable or exchangeable for Accenture plc Class A ordinary shares on a one-for-one basis, with no significant changes in redemption or exchange policies during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that noncontrolling interests were less than 1% as of August 31, 2024, which aligns with the ground truth. It also accurately describes the exchangeable shares' one-for-one exchange feature with Accenture plc Class A ordinary shares. However, it fails to mention the key evolution in 2024 regarding Accenture plc Class X ordinary shares and the structural restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held—a critical addition in the equity framework. Instead, the LLM claims there were 'no significant changes' in redemption or exchange policies, which contradicts the ground truth indicating a more formalized and structured relationship in 2024. (2) Quantitatively, all dates and percentages are accurate: 'less than 1%' and 'August 31, 2024' match the original. No calculations are required, and number formats are consistent. (3) The multi-hop reasoning is partially sound—the model correctly identifies the continuity in ownership percentage and exchange mechanism but misses the synthesis between the 2023 disclosure (simple noncontrolling interest) and the 2024 structural enhancement involving Class X shares. This omission reflects a failure to fully capture the evolution in equity structure. (4) The answer is contextually relevant and addresses ownership, noncontrolling interests, and exchangeable shares, but the conclusion that the structure 'remained largely consistent' with 'no significant changes' is factually incorrect per the ground truth, which emphasizes formalization and new structural provisions in 2024. This major qualitative inaccuracy reduces correctness despite numerical precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 468,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck expanded its use of forward exchange contracts to manage balance sheet risk by hedging exposures in a broader range of currencies, including the euro, Japanese yen, British pound, Canadian dollar, Swiss franc, and Chinese renminbi. The company conducts cost-benefit analyses to determine when hedging is economical, factoring in exposure magnitude, exchange rate volatility, and hedging instrument costs. In 2024, Merck emphasized short-term forward contracts (typically with average maturities of less than six months) to mitigate spot-forward differences, reflecting a more dynamic and responsive approach to currency risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly mentions the use of forward exchange contracts and cost-benefit analysis in 2022, including the Chinese renminbi, it incorrectly states that Merck 'expanded' its hedging to include multiple currencies like the euro, yen, pound, etc., which is not supported by the original answer. The original does not mention such an expansion or list those specific developed market currencies. Instead, the key evolution noted is the omission in 2024 of the detailed cost-benefit discussion and the specific reference to the Chinese renminbi — suggesting a simplification or shift in focus, not broadening. The LLM instead portrays a more active and expanded strategy in 2024, which contradicts the ground truth. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, maturities) in the original answer, so quantitative accuracy is partially satisfied where the LLM introduces 'less than six months' maturity — a detail not present in the ground truth. This addition lacks support and introduces potentially misleading specificity. (3) The multi-hop reasoning is flawed: the question asks about evolution in approach, particularly regarding currencies and cost-benefit considerations. The correct inference requires recognizing what was present in 2022 (explicit cost-benefit analysis, mention of renminbi) and absent in 2024 (those details), implying a change in emphasis. The LLM fails this synthesis, instead asserting expansion and increased dynamism not present in the source. (4) Scores reflect partial factual accuracy (some correct elements in 2022 description), but major errors in characterizing the evolution, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate as the answer stays on topic but misrepresents the trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 511,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024, as reflected in the deferred tax assets related to the matter (from $644 million in 2023 to $455 million in 2024), suggests a reduction in the anticipated future income tax benefits associated with this matter. This decrease likely indicates either a reassessment of the tax attributes or a resolution of some portion of the issue, leading to a lower expected tax benefit in future periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the deferred tax benefit decreased from $644 million in 2023 to $455 million in 2024, and the LLM correctly reports these values. (2) The answer correctly identifies the shift in disclosure treatment—moving from an operational loss (implied in 2023) to a deferred tax asset in 2024—and interprets the decline in value as a reduction in anticipated future income tax benefits. (3) The reasoning is sound: the decrease suggests either partial resolution or reassessment of tax attributes, which is consistent with the ground truth’s implication of a move toward long-term recovery. (4) The only minor shortcoming is that the LLM does not explicitly mention the $5.3 billion net sales charge in 2023, which provides important context for the initial operational impact. While this omission slightly reduces completeness, the core of the multi-hop reasoning—linking the change in disclosure and value to evolving financial impact on future tax benefits—is correctly synthesized and conveyed. Thus, the answer is factually correct, contextually relevant, and semantically equivalent in meaning, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 344,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space between 2022 and 2024 has expanded in scale and complexity. By 2024, the total outstanding balance in its merchant loans, advances, and interest and fees receivable reached $1.5 billion, up from $1.2 billion in 2023. This growth reflects increased adoption of its PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products. In the U.S., PayPal partners with WebBank to originate and purchase merchant receivables, while internationally, it extends financing through its Luxembourg and Australian subsidiaries. Additionally, PayPal has refined its risk assessment models and credit monitoring practices to manage the growing portfolio, incorporating data on merchant payment history, credit bureau reports, and delinquency trends.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the growth in the total outstanding balance of merchant loans, advances, and interest and fees receivable from $1.2 billion in 2023 to $1.5 billion as of December 31, 2024, which matches the ground truth. However, it omits key quantitative details about the scale of receivables purchased by PayPal—$1.8 billion in 2024 (up from $1.7 billion in 2023)—and the increase in participation interest sold to the partner institution from $44 million in 2023 to $53 million in 2024. These are central to the evolution of PayPal’s relationship with partner institutions and are missing, reducing completeness. (2) The numbers that are present ($1.5B and $1.2B) are accurate and correctly attributed to the right years. No calculation errors are present, but the absence of the $1.8B and $53M figures limits quantitative completeness. (3) The LLM correctly identifies WebBank as the U.S. partner and notes the program structure involving purchase and sale of receivables, though it does not explicitly describe the accounting treatment (derecognition of participation interests) or the program agreement dynamics mentioned in the original. It adds information about international operations via Luxembourg and Australia, which is not in the ground truth and may be plausible but unverified, slightly weakening qualitative accuracy. The mention of refined risk models and credit monitoring is not supported in the original answer and introduces unsupported detail. (4) The answer is contextually relevant and addresses the evolution in scale and partner relationships, but lacks full multi-hop synthesis—specifically, the quantitative growth in both receivables purchased and participation interests sold, which together demonstrate deepening collaboration with partner institutions. The core facts on portfolio growth are correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 516,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to the previous year, primarily due to higher demand in most international markets. This growth was further supported by the approval of Lynparza in China in January 2025 for the adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, which likely contributed to the upward trend in revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in alliance revenue for Lynparza by 2024 and attributes it to increased international demand and the China approval in January 2025 based on the OlympiA trial, which aligns with the ground truth. However, the LLM omits the specific 2022 revenue figure of $989 million, which is a key part of the original answer and directly addresses the first part of the question about revenue evolution between 2022 and 2024. (2) The percentage increase (9%) is accurate, and the January 2025 China approval date is correctly stated. The only quantitative shortcoming is the missing $989 million baseline for 2022, which reduces completeness and quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects Lynparza’s approval in China to revenue growth and correctly links it to international demand, demonstrating proper synthesis across time and geography. (4) Despite the omission of the 2022 dollar amount, the answer captures the core trend and drivers accurately, with strong qualitative and contextual alignment. The missing baseline revenue prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 333,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables between 2022 and 2024 has shown growth in both financial exposure and operational role. The total outstanding balance in the merchant loans and advances pool increased from $1.2 billion in 2023 to $1.5 billion in 2024, reflecting higher financial exposure. Operationally, PayPal continues to purchase receivables from a partner institution and manages servicing functions, with purchases rising from $1.7 billion in 2023 to $1.8 billion in 2024. Delinquency rates remained low, with 90.4% of receivables current as of December 31, 2024, indicating strong credit quality and effective risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative figures from the ground truth: the increase in outstanding balance from $1.2 billion to $1.5 billion, and receivables purchases rising from $1.7 billion in 2023 to $1.8 billion in 2024. These numbers are accurate and properly attributed to the correct years. The mention of 90.4% of receivables being current as of December 31, 2024, while not in the original answer, does not contradict it and may reflect additional but unverified data; however, since it doesn't affect core claims, it doesn't reduce correctness. (2) Quantitative accuracy is perfect—dollar amounts and year-over-year trends match the ground truth exactly, with appropriate formatting. (3) The multi-hop reasoning is sound: the model correctly synthesizes financial exposure (via growing balances and purchases) and operational role (servicing functions), capturing the evolution from 2022 to 2024. However, the LLM slightly underrepresents the shift in 2022, which emphasized CECL and credit loss accounting, whereas the answer focuses only on 2023–2024 trends. This omits part of the temporal evolution but retains the core progression. (4) The answer is contextually relevant and conveys the same essential conclusion: PayPal deepened its involvement in merchant receivables through increased financial exposure and operational control. The only minor gap is the lack of explicit reference to 2022 risk management framing, but the overall trajectory is accurately captured. Thus, the answer is highly accurate with only a small omission in historical context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 439,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "From 2022 to 2024, Merck's involvement in the development and commercialization of Lynparza showed notable regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review for adjuvant treatment of early-stage breast cancer based on the OlympiA trial, with a PDUFA date in early 2022. By 2024, Lynparza achieved regulatory milestones, including approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer in January 2025. Additionally, alliance revenue related to Lynparza grew by 9% in 2024, driven by higher demand in most international markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Merck's involvement in Lynparza from 2022 to 2024, including regulatory progress and revenue growth. It accurately notes the 2022 regulatory review for adjuvant treatment of early-stage breast cancer based on the OlympiA trial with a PDUFA date in early 2022, which aligns with the ground truth. The mention of the January 2025 China approval is factually consistent with the original answer’s statement about continued global regulatory momentum, even though the approval occurs in 2025 — this is acceptable as it reflects forward-looking progress stemming from earlier development efforts. The 9% alliance revenue growth in 2024 is correctly reported and attributed to increased international demand. (2) Quantitatively, all numbers are accurate: the 9% revenue growth and the timeline (PDUFA in early 2022, approval in January 2025) match the ground truth. The only minor issue is that the approval date (January 2025) slightly extends beyond the 2024 timeframe in the question, but it is presented as a milestone reflecting ongoing commercialization momentum, which is contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 regulatory status → 2024 outcomes), geography (U.S. and China approvals), and financial performance (revenue growth). It correctly identifies Merck’s role, the drug (Lynparza), the indication, and the trial basis (OlympiA). (4) The answer is semantically equivalent to the original, with only slight rewording (e.g., 'germline BRCA-mutated' adds specificity not in the original but is medically accurate and consistent). No critical facts are omitted, and the core narrative of regulatory expansion and commercial growth is fully preserved. Minor deduction in quantitative accuracy due to the 2025 date being slightly out-of-scope but still contextually justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 518,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, using them to hedge against price fluctuations for items used in production through 2031, as noted in the 2024 filing. In 2022, the financial exposure from commodity price risk was estimated at $46 million for a 10% market price change, while the 2024 filing does not provide an updated exposure figure but emphasizes continued use of commodity swaps and purchase contracts to mitigate market price fluctuations. This indicates a strategic shift toward longer-term hedging and ongoing commitment to managing financial exposure through derivative instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: in 2022, Boeing's exposure was $46 million for a 10% change in commodity prices, and it used swaps and purchase contracts to hedge risk. In 2024, Boeing extended its hedging horizon to 2031 using commodity purchase contracts and derivatives. These points match the ground truth exactly. (2) Quantitative accuracy is perfect: the $46 million figure and 10% price change are correctly cited, and the extension to 2031 is accurately reported. No calculations are required, and all numbers are presented correctly. (3) The multi-hop reasoning is sound—information is synthesized across 2022 and 2024 filings, showing evolution in strategy. The LLM correctly infers a strategic shift toward longer-term hedging, though it does not explicitly state the connection to 'extended production planning cycles' or 'proactive cost predictability for strategic stability' as in the original answer. This minor omission in depth of interpretation prevents a perfect qualitative score. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution in risk management horizon and financial exposure. It clearly contrasts the two years and highlights the strategic shift. The only minor gap is the lack of explicit mention that the 2024 strategy reflects alignment with long-term production cycles, but the core factual and inferential content is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 402,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to Pledged Asset Lines (PALs) and the associated credit risk evolved with improved credit quality and reduced allowance for credit losses. In 2021, the allowance for credit losses on total bank loans was 0.09%, decreasing to 0.05% by 2024. Additionally, the ratio of the allowance for credit losses to total nonaccrual loans dropped significantly from 253% in 2023 to 60% in 2024. This decline reflects lower projected loss rates and stronger credit quality metrics in Schwab's bank loans portfolio. Furthermore, all PALs remained fully collateralized by securities with fair values exceeding borrowings in both 2021 and 2024, eliminating the need for an allowance for credit losses on PALs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that no allowance for credit losses was required for PALs in 2021 because they were fully collateralized, and this remained true in 2024. However, the LLM introduces specific percentages (0.09% in 2021 and 0.05% in 2024) for the 'allowance for credit losses on total bank loans,' which are not mentioned in the original answer and are irrelevant to PALs specifically. Additionally, the claim about the ratio of allowance to nonaccrual loans dropping from 253% in 2023 to 60% in 2024 is not supported by the ground truth and introduces data points outside the scope of the question. (2) These numbers are not present in the original answer and appear to conflate PALs with Schwab's broader bank loan portfolio. The original answer emphasizes that PALs did not require an allowance due to full collateralization in both years, while the LLM incorrectly implies that there was an allowance and that it decreased. This misrepresents the core financial treatment of PALs. (3) The multi-hop reasoning is flawed: the model fails to correctly isolate PALs from other loan types. While it correctly notes that PALs were fully collateralized in both years, it undermines this with incorrect assertions about allowances on bank loans, suggesting a failure to synthesize the specific risk treatment of PALs versus general credit loss trends. (4) Despite these issues, the answer is contextually relevant and captures the directional trend of improved credit quality. It also correctly states that PALs remained fully collateralized, aligning with the ground truth. However, the introduction of unsupported numerical data severely compromises factual accuracy, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 500,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved significantly due to cost impacts and R&D investments. In 2022, the 777X program was noted as a contributor to higher development charges and cost overruns, with initial delays in its entry into service pushed to late 2023. By 2024, the 777X program continued to impact financials through \"reach-forward losses,\" which increased cost of sales as a percentage of revenue and contributed to higher R&D expenses, particularly at the Commercial Airplanes segment. This reflects ongoing financial strain and a strategic focus on managing costs while advancing the program toward delivery.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of Boeing's financial treatment and strategic positioning of the 777X program. While it correctly identifies that the 777X caused financial strain in 2022 due to cost overruns and delays, it fails to capture the key shift in strategic positioning by 2024. Instead of recognizing the program as transitioning into a strategic investment priority, the LLM implies ongoing financial strain without acknowledging the proactive R&D increases as strategic investments. (2) Quantitatively, the LLM omits all specific R&D investment figures cited in the ground truth: a $525 million increase in 2023 over 2022 and a $435 million increase in 2024 over 2023. These are critical data points that demonstrate the strategic shift and are entirely missing from the LLM response, resulting in a low quantitative accuracy score. (3) The multi-hop reasoning is flawed. The ground truth requires synthesizing information across years and interpreting increased R&D spending as a sign of strategic prioritization, not continued financial burden. The LLM misinterprets 'reach-forward losses' in 2024 as evidence of ongoing strain without balancing it with the strategic investment narrative supported by rising R&D. It fails to connect the increased spending to a deliberate shift in positioning. (4) Contextual relevance is high because the answer addresses the 777X program, financial treatment, cost impacts, and R&D—core elements of the question—but the qualitative and quantitative inaccuracies severely undermine correctness. The answer captures the early-stage challenges but misrepresents the 2024 outlook, leading to a correctness score of 4 due to partial accuracy with major omissions and misinterpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved with a decrease in the allowance for credit losses as a percentage of total year-end loans, from 0.09% in 2023 to 0.05% in 2024, reflecting improved credit quality and reduced projected loss rates. Additionally, the credit loss allowance methodology for PALs remained focused on collateral maintenance, leveraging over-collateralization and daily monitoring of collateral values to limit credit risk. Portfolio growth in PALs contributed to the overall increase in average loans, driven by Schwab's expanding client base and assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Schwab's risk management for PALs, noting continued reliance on collateral maintenance, over-collateralization, and daily monitoring, which aligns with the 2022 methodology. It also correctly identifies that PALs contributed to portfolio growth and that the allowance ratio decreased due to improved credit quality and lower projected loss rates. However, the LLM introduces specific percentages—0.09% in 2023 and 0.05% in 2024—that are not present in the original answer (ground truth), making them factually unsupported. The ground truth mentions a general decrease in the allowance ratio in 2024 but does not provide exact figures for 2023 or 2024. (2) These introduced numbers represent a significant quantitative inaccuracy, as they imply precision not present in the source and cannot be verified from the ground truth. There is no mention of 0.09% or 0.05% in the original, so their inclusion reduces quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes information about methodology continuity, portfolio growth, and declining risk profile. It connects collateral practices (from 2022) with later trends in allowance and credit quality (by 2024), showing appropriate cross-year synthesis. (4) Despite the invented percentages, the core qualitative narrative—methodology stability, portfolio growth, and reduced risk due to better credit metrics—is consistent with the ground truth. Contextual relevance is perfect, as all parts of the question are addressed directly and coherently.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 440,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes decreased from $356 million in 2022 to $- in 2023, as shown in the provided data. This shift suggests that the company either fully settled its pound sterling-denominated debt or restructured its foreign currency exposure during the period. The change reflects an active approach to managing foreign exchange risk, potentially reducing exposure to currency fluctuations in the British pound and aligning its debt portfolio with strategic or financial goals.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change. According to the ground truth, MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. The LLM incorrectly states a value of $356 million in 2022 and claims it decreased to '$-' (undefined) in 2023, which contradicts the ground truth. These numbers are not close in any format variation (e.g., $356M vs $3M is a 100x+ error). (2) Quantitative accuracy is extremely low: both the starting value ($356M vs $3M) and ending value (missing vs $45M) are wrong, and the implied trend (decrease vs actual large increase) is opposite. No valid calculation or comparison can be made from incorrect inputs. (3) The multi-hop reasoning is flawed because it is based on false data. The conclusion about reducing exposure or settling debt contradicts the ground truth, which indicates increased exposure and a strategic shift toward greater GBP involvement. The reasoning about active FX risk management has some plausibility but is applied in the wrong direction. (4) Contextual relevance is moderate because the answer addresses foreign exchange risk management strategy as asked, but the analysis is based on fabricated data. Correctness and quantitative accuracy are near zero due to complete factual mismatch. Qualitative accuracy is low because entity (MDLZ, GBP notes) and time period (2022–2023) identification is correct, but synthesis and logic fail due to incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 417,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 filing, the 3.125% 2025 Notes are disclosed with a coupon rate of 3.125%, and there is no mention of an effective interest rate different from the coupon rate. In the 2024 filing, the 3.125% 2025 Notes are hedged using an interest rate swap, effectively converting the fixed coupon rate to a floating rate of SOFR + 2.1%. This indicates that Amgen has adopted a hedging strategy to manage interest rate risk for this debt instrument, aiming to align its debt cost with market conditions and reduce exposure to fixed-rate obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.125% coupon rate in the 2022 filing and the SOFR + 2.1% floating rate in the 2024 filing, which aligns with the ground truth. The dates (2022 and 2024 filings) and the instrument (3.125% 2025 Notes) are accurately referenced. However, the LLM attributes the floating-rate exposure to an interest rate swap (a hedging mechanism), whereas the ground truth states that the interest rate itself was disclosed as tied to SOFR, implying a structural change in the debt terms, not a derivative hedge. This is a significant qualitative difference in interpretation. (2) Quantitatively, all numbers—3.125%, SOFR + 2.1%, and the years—are correct. There are no calculation errors. Format variations are acceptable and not an issue. (3) The multi-hop reasoning is partially sound: the model correctly compares disclosures across two filings and infers a strategic shift. However, it misattributes the mechanism (hedging via swap vs. actual repricing of the note), leading to an incorrect explanation of *how* the rate became floating. This affects the validity of the conclusion about Amgen’s debt financing approach. (4) The contextual relevance is perfect—the answer directly addresses the comparison and its implications. Due to the factual error in the mechanism (swap vs. direct rate reset), the correctness score is reduced to 7, as the core numbers are right but the explanation of the financial engineering is not aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 411,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program decreased between 2022 and 2024 as the company increasingly turned to higher-cost funding sources like Federal Home Loan Bank (FHLB) secured credit facilities and repurchase agreements due to market disruptions and rising interest rates. In 2022, Schwab mentioned maintaining a commercial paper issuance program as part of its external financing options, but by 2024, the company emphasized using secured credit facilities and other funding mechanisms to address liquidity needs amid higher borrowing costs and client outflows of cash balances into higher-yielding alternatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim: it states that Schwab's reliance on the Commercial Paper Issuance Program *decreased* between 2022 and 2024, while the ground truth explicitly states that reliance *increased* by 2024 as a complement to other funding mechanisms. This is a critical reversal of the actual trend and undermines the entire response. (2) There are no specific numeric values (e.g., dollar amounts, percentages, interest rate figures) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct, and references to rising interest rates and client outflows are consistent. Thus, quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the LLM correctly identifies Schwab’s use of external financing tools and mentions FHLB advances and repurchase agreements, but fails to synthesize the correct evolution of the commercial paper program’s role. Instead, it incorrectly positions secured facilities as replacements that reduced reliance on commercial paper, whereas the ground truth describes them as complementary, with commercial paper use increasing under more constrained conditions. (4) Contextual relevance is moderate—the answer addresses the general topic of funding sources and market conditions, but the incorrect directional claim about reliance severely limits its usefulness. The explanation of rising rates and client outflows is relevant, but the conclusion drawn is unsupported. Therefore, correctness and qualitative accuracy are low due to the fundamental factual error in synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 442,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes matured in 2022, with a notional amount of $1,400 million as of December 31, 2023, and were fully repaid by December 31, 2024, as indicated by the $- notional amount in 2024. These notes were previously hedged with interest rate swaps at SOFR + 3.4%, but the swaps matured in 2024 alongside the notes. This indicates that the company effectively managed its debt by repaying the 2022 notes on schedule and utilizing hedging instruments to mitigate interest rate risk, aligning with a strategy of maintaining disciplined debt management and optimizing interest costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 3.625% Notes matured in 2022, while the ground truth indicates they were 2024 Notes, meaning they matured in 2024, not 2022. Second, it claims the notional amount was $1,400 million as of December 31, 2023, which may be plausible, but the ground truth specifies the carrying value in 2022 was $1,400 million, not 2023. The $0 notional in 2024 is correct. However, the LLM introduces unverified details: it mentions interest rate swaps hedging the notes at SOFR + 3.4%, which is not present in the ground truth and cannot be confirmed. The ground truth states the new debt issued in place of the 3.625% Notes carries floating rates tied to SOFR, but the LLM does not clearly convey this strategic replacement; instead, it focuses on hedging, which distorts the core insight. (2) Quantitative accuracy is partially correct: $1,400 million and $0 notional in 2024 align with the truth (allowing for format flexibility), but the timing of maturity and the introduction of swap rates (SOFR + 3.4%) are unsupported and incorrect. The interest rate of 3.625% is correctly referenced. (3) Multi-hop reasoning is flawed: the LLM fails to correctly track the evolution of the debt instrument over time (misplacing maturity to 2022) and misattributes the use of SOFR to hedging rather than to new floating-rate debt issuance. This breaks the logical chain required to infer Amgen’s strategic shift in debt management. (4) Contextual relevance is moderate—the answer discusses debt repayment and interest rate management, which are relevant, but the emphasis on hedging and incorrect timeline undermines the accuracy. The conclusion about disciplined debt management is plausible but misaligned with the actual strategy of shifting from fixed to floating rates. Overall, the answer is partially correct on numbers but significantly flawed in reasoning and factual synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 531,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has remained consistent in terms of intent and conditions for funding commitments. According to the 2022 and 2024 disclosures, Schwab has not provided, and does not intend to provide, financial or other support to VIEs beyond what is contractually required. The funding of remaining commitments to these VIEs, primarily related to Community Reinvestment Act (CRA) investments such as Low-Income Housing Tax Credit (LIHTC) investments, is contingent upon specific conditions, with Schwab expecting to fulfill these commitments between 2022 and 2025. There has been no indication of a shift in Schwab's intent or conditions for such funding during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Schwab's approach remained consistent between 2022 and 2024. The ground truth states there was a clear shift: in 2022, Schwab explicitly stated it did not provide and did not intend to provide support beyond contractual obligations. By 2024, Schwab acknowledged it may choose to provide support (e.g., credit or liquidity) to its proprietary funds under stress conditions like significant valuation declines or redemptions, even without contractual obligation. This represents a meaningful evolution in intent and policy, which the LLM answer completely misses. (2) Quantitatively, the LLM correctly references the 2022–2025 timeline for fulfilling CRA-related commitments (e.g., LIHTC investments), which aligns with typical disclosure patterns and does not contradict the ground truth. However, this information, while accurate, is not directly responsive to the question about intent and conditions regarding VIE support more broadly. (3) The multi-hop reasoning fails because the LLM does not synthesize the change in language and policy stance between the two years. Instead, it incorrectly asserts consistency, ignoring the key 2024 disclosure about discretionary support. This reflects a failure to identify and interpret evolving qualitative disclosures across filings. (4) The contextual relevance is moderate because the answer discusses VIEs and funding commitments, but it mischaracterizes the evolution in Schwab’s intent, rendering the response misleading despite some accurate background details. The qualitative accuracy is very low due to the incorrect conclusion about no shift in policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 459,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's evolved as the company realized proceeds from the sale of JDEP shares, positively impacting liquidity. In 2023, net cash from investing activities improved partly due to higher proceeds from JDEP share sales compared to the prior year. The investment in JDE Peet's provided MDLZ with additional financial flexibility, though it did not significantly alter the company's overall capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) It incorrectly frames the evolution of MDLZ's relationship with JDE Peet's as primarily driven by the sale of shares and resulting proceeds, which is not supported by the original answer. The ground truth emphasizes a reclassification of the relationship from 'Has_Stake_In' to 'Invests_In', reflecting a strategic shift in how MDLZ accounts for and views the investment—not a divestment or sale of shares. (2) There are no specific numeric values (e.g., dollar amounts, percentages, or exact figures) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the mention of 'higher proceeds from JDEP share sales' introduces unverified financial activity not present in the ground truth, reducing confidence in factual accuracy. (3) The multi-hop reasoning is flawed: the LLM infers liquidity impact from share sales, while the original answer attributes improved financial flexibility to the strategic reclassification of the investment within MDLZ’s capital framework—without mentioning disposals. (4) While the LLM correctly identifies that the investment contributes to financial flexibility, it misses the core conceptual shift in the nature of the relationship and misrepresents the mechanism (i.e., sale of shares vs. reclassification). This leads to a low qualitative accuracy score. Contextual relevance is moderate because the answer addresses liquidity and capital structure, but with incorrect supporting logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 431,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate applied under the swap agreements for the 3.125% 2025 Notes remained consistent at SOFR + 2.1% in both 2022 and 2024, as reflected in the provided data. There was no change in the hedged interest rate during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the interest rate under the swap agreements remained consistent at SOFR + 2.1% in both 2022 and 2024. According to the ground truth, in 2022, the company terminated existing swaps and entered into new agreements, but the specific rate for the 3.125% 2025 Notes was not disclosed. The SOFR + 2.1% rate was only explicitly stated in 2024. Therefore, claiming the rate was the same in both years is a significant factual error. (2) The notional amount of $1,000 million is correctly implied in context (as it remained consistent), but the LLM does not mention this figure at all, omitting a key quantitative detail. More critically, the interest rate for 2022 is misrepresented—no such rate was disclosed, so asserting SOFR + 2.1% applies retroactively is incorrect. (3) The multi-hop reasoning fails because the model did not properly synthesize the evolution over time: it ignored the termination and re-issuance of swaps in 2022 and the lack of disclosed rate that year, leading to an erroneous conclusion of stability. The ground truth indicates a change in strategy (termination and reentry), which the LLM overlooks. (4) While the answer is contextually relevant—focusing on the right instrument and time frame—the core factual inaccuracy regarding the interest rate in 2022 severely undermines correctness. Hence, low scores for correctness, quantitative, and qualitative accuracy; contextual relevance is higher as the topic and entities are appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 420,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,570 million in fiscal year 2022 to $4,414 million in fiscal year 2023. The magnitude of this change was a $1,156 million decrease.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both the reported values and the calculated change. According to the ground truth, Walmart's fair value of equity investments using Level 2 inputs was $5,819 million in fiscal year 2022 and decreased to $5,570 million in fiscal year 2023, resulting in a $249 million decline. The LLM incorrectly states the 2022 value as $5,570 million and the 2023 value as $4,414 million, which reverses the correct figures and introduces a significantly larger drop. (2) The magnitude of change is miscalculated: the LLM reports a $1,156 million decrease, whereas the correct difference is $5,819M - $5,570M = $249M. This represents a severe quantitative inaccuracy. (3) While the LLM correctly identifies the metric (fair value of equity investments, Level 2 inputs) and the company (Walmart), and attempts to describe a year-over-year change (multi-hop reasoning across fiscal years), the synthesis is based on incorrect data, undermining the reasoning. (4) The contextual relevance is high because the answer addresses the right company, metric, time frame, and type of change (decrease), but the severe numerical inaccuracies result in a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly above minimum due to correct entity and metric identification, but flawed data invalidates the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 385,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Between 2023 and 2024, Apple's characterization of its reliance on marketing abilities remained consistent, emphasizing the importance of marketing as a key competitive factor. In both filings, marketing is listed among critical elements such as product innovation, design, and distribution capability. However, the 2024 filing places slightly more emphasis on the challenges of competitors imitating Apple's product features and marketing strategies, highlighting the need for continued differentiation through innovation and strong brand reputation.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its core claim. The original answer states that Apple changed its language from 'relies primarily' in 2023 to 'depends heavily' in 2024, indicating a shift in emphasis and framing. However, the LLM incorrectly asserts that Apple's characterization 'remained consistent' between the two years, which contradicts the ground truth. This misrepresents the evolution in Apple's stated reliance, undermining the multi-hop reasoning required to compare the two filings. While the LLM correctly identifies marketing as a key factor and notes increased competitive pressure in the 2024 filing, it fails to capture the nuanced shift in language and strategic emphasis—particularly the stronger linkage in 2024 between marketing abilities and the timely delivery of competitive offerings. There are no numerical errors (hence full quantitative accuracy), and the response is contextually relevant, but the qualitative inaccuracy in interpreting the change in wording significantly reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 307,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes remained at $1,400 million between 2022 and 2024; however, the interest rate structure changed from LIBOR + 3.2% in 2022 to SOFR + 3.4% in 2024. This change reflects Amgen's shift from LIBOR-based to SOFR-based hedging instruments, aligning with market transitions away from LIBOR. The consistent notional amount and updated interest rate structure indicate that Amgen maintained its hedging strategy for this debt, adjusting only to reflect current market benchmarks while managing interest rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims the notional amount remained constant at $1,400 million between 2022 and 2024, but the ground truth states that in 2022, Amgen terminated $5.2 billion in swaps (including those for the 3.625% 2024 Notes) and reentered new swaps at then-current rates. By 2024, the notional amount for the 3.625% 2024 Notes dropped to $0 as of December 31, 2024, down from $1,400 million in December 2023. The LLM incorrectly implies continuity in hedging, while the truth is that Amgen fully unwound its position by 2024. (2) The interest rate structure is also wrong: the LLM claims it was LIBOR + 3.2% in 2022, but the ground truth does not specify the 2022 rate for this specific note—only that swaps were terminated and reentered. The SOFR + 3.4% rate applied in 2023, not 2024 as implied. The LLM fabricates a 2022 rate not in the original data. (3) The multi-hop reasoning fails: the question requires synthesizing changes over time across filings, but the LLM misses the key event in 2022 (termination and re-issuance of swaps) and the full unwind by 2024. Instead, it assumes a static notional and a simple benchmark transition, misrepresenting Amgen’s strategy as consistent rather than actively unwound. (4) The contextual relevance is moderate because it addresses hedging strategy and benchmark transition (SOFR vs LIBOR), which is relevant, but the factual foundation is flawed. Scores reflect major factual errors in numbers, dates, and interpretation of corporate actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 433,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab completed the integration of TD Ameritrade's customizable portfolio rebalancing solution, iRebal, into its offerings for independent advisor clients following the 2020 acquisition. By 2023, Schwab had transitioned approximately $1.6 trillion in client assets, including 7,000 RIAs, from TD Ameritrade to the Schwab platform, retaining iRebal as part of its advisor services. This integration demonstrates Schwab's strategic focus on enhancing its RIA offerings through advanced tools, strengthening its competitive positioning in the RIA market by providing robust, customizable solutions that meet the evolving needs of independent advisors.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Schwab integrated iRebal as part of its offering for independent advisors and references the $1.6 trillion in client assets moved from TD Ameritrade, which aligns with the ground truth. However, it incorrectly states that the integration was completed 'following the 2020 acquisition' and implies full integration by 2023 without capturing the evolution between 2022 and 2023. The original answer emphasizes a progression: in 2022, Schwab was retaining iRebal but had not yet fully emphasized it; by 2023, it became a core offering. This nuance is missing, weakening the multi-hop reasoning. Additionally, the LLM introduces '7,000 RIAs' as a specific figure not present in the ground truth, which lacks support and appears to be fabricated or misattributed. (2) Quantitative accuracy is partially compromised: while $1.6 trillion is correct, the '7,000 RIAs' figure is unsupported and likely incorrect, as the original answer mentions 'more than 15 million client accounts' but does not specify the number of RIAs. This is a significant factual overreach. (3) The reasoning is generally sound—Schwab enhancing RIA offerings via iRebal integration reflects strategic positioning—but fails to fully synthesize the temporal evolution from 2022 to 2023. The answer skips the intermediate state (retaining but not emphasizing iRebal) and jumps to full integration, missing a key analytical point about the progression. (4) Contextual relevance is high—the answer addresses Schwab’s competitive positioning in the RIA market and ties iRebal to enhanced service offerings. Qualitative accuracy is good but docked slightly for missing the phased integration narrative. Correctness score is 7 due to accurate core facts (iRebal retention, $1.6T assets) but penalized for missing the 2022–2023 evolution and introducing an unsupported number.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 511,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple introduced a new iMac in the first quarter of 2024, indicating a continued focus on updating its desktop product line. However, the 2023 10-K does not specifically mention iMac-related product announcements, suggesting that the iMac was not a major focus of new releases in 2023 compared to 2024. This implies that Apple's approach to the iMac product line became more active in 2024 with a new iteration being launched.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the shift in Apple's approach to the iMac between 2023 and 2024 based on 10-K disclosures: in 2023, the iMac was not highlighted as a major product announcement, while in 2024 it was noted as a new launch, indicating increased strategic focus. The claim about a 'new iMac in Q1 2024' is consistent with Apple's actual product refresh and is reasonably inferred from the 2024 10-K's mention of iMac among key product launches. The 2023 10-K indeed does not single out iMac in major announcements, supporting the contrast. However, the original answer provides deeper qualitative insight—framing the change as an elevation in strategic importance within the innovation cycle and linking it to the MD&A section's treatment of iMac alongside flagship products. The LLM answer misses this nuance about disclosure language and positioning in the report, slightly reducing completeness and reasoning depth. There are no numerical inaccuracies; dates and events are correctly represented. The reasoning is sound but less detailed in connecting disclosure patterns to strategic implications. Semantic equivalence is strong, though not perfect. Contextual relevance is excellent—directly addresses the evolution in Apple's approach as reflected in filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 371,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX's 2.820% Notes Due 2051 have remained a consistent part of its long-term debt structure, with a principal balance of $1,000 million reported in both 2024 and 2022. This indicates that the company has not repaid or significantly altered the terms of this debt obligation during the period. The continued presence of these notes reflects RTX's strategy of maintaining a diversified and long-duration debt portfolio, which helps manage interest rate risk and provides stable financing over an extended period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that RTX's 2.820% Notes Due 2051 had a principal balance of $1,000 million in both 2022 and 2024, which matches the ground truth. This demonstrates full quantitative accuracy. (2) All numbers, dates, and percentages are correct: the interest rate (2.820%), maturity year (2051), principal amount ($1,000 million), and time frame (2022–2024) are accurately reported. There are no calculation errors. (3) However, the LLM answer is incomplete in its qualitative reasoning and multi-hop synthesis. While it correctly notes the stability of the 2051 notes, it fails to mention the broader context that RTX's total long-term debt increased from $40,078 million (implied 2022 total) to $41,146 million in 2024, indicating new debt issuances outside the 2051 notes. This omission weakens the analysis of what the stability of the 2051 notes indicates about the overall debt structure. The ground truth emphasizes that the 2051 notes remained unchanged *while* overall debt grew—highlighting a key nuance about debt diversification and expansion that the LLM answer does not capture. (4) The contextual relevance is high because the response directly addresses the evolution of the specific debt instrument and draws reasonable inferences about long-term financing strategy. However, the qualitative accuracy is reduced due to the missing comparative analysis of total long-term debt, which is essential for fully answering the second part of the question about implications for the company's long-term debt structure. Thus, while factually correct on the specific instrument, the answer lacks completeness in multi-hop reasoning across the full debt portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 465,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab's IDA agreement transitioned from referencing LIBOR to alternative benchmark rates, as noted in the 2023 10-K. Additionally, the service fees associated with the IDA agreement were adjusted, with a specific mention in the 2022 10-K that the amended IDA agreement reduced the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from the previous 25 basis points under the prior agreement. No further changes to the service fee were explicitly mentioned for 2023, indicating that the 15 basis point rate remained in effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the reduction in service fee from 25 to 15 basis points in 2022 is accurately reported, and the 2023 transition from LIBOR to alternative benchmarks is correctly attributed to the 2023 10-K. No calculation errors are present. (2) The answer is complete, addressing both parts of the question: changes in service fees (2022) and reference rate adjustments (2023). It correctly identifies that no further fee changes were disclosed in 2023, implying continuity of the 15 bps rate. (3) Entity accuracy is strong: 'Schwab', 'IDA agreement', 'TD Depository Institutions', and correct fiscal years (2022, 2023) are all properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis—linking the 2022 fee change and the 2023 benchmark transition as evolutionary steps in the agreement. The only minor shortcoming is that the LLM does not explicitly characterize the evolution as a 'shift from fee adjustments to reference rate mechanisms' as in the original answer, slightly reducing qualitative depth. However, the factual content and implications are equivalent. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 352,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024 suggests a reassessment of its strategic importance and valuation. This shift likely reflects a decision by the company to integrate Filorga into a broader portfolio of trademarks, potentially due to a decline in its standalone significance or a strategic realignment. It may also indicate a more conservative valuation approach, consolidating intangible assets under a unified framework rather than treating Filorga separately.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Filorga had $221 million in goodwill in 2023 as a standalone reporting unit, and in 2024 it was grouped with other trademarks without separate disclosure—this matches the original answer exactly. Number formatting is consistent and accurate. (2) The answer addresses the strategic and valuation implications of the change in reporting, correctly interpreting the integration into broader segments as a potential sign of reduced standalone significance or strategic realignment. (3) The reasoning is sound: the shift from standalone to consolidated treatment implies a change in how the company assesses Filorga’s performance and value, which affects strategic decisions. The LLM infers a 'more conservative valuation approach' and 'integration into a broader portfolio,' which are reasonable interpretations, though the original answer adds nuance about implications for impairment analysis and future decisions like divestiture or investment. (4) The only minor gap is the omission of the specific mention of 'impairment analysis' and the potential impact on future strategic actions, which slightly reduces completeness in qualitative depth. However, the core multi-hop synthesis—linking financial treatment change to strategic and valuation implications—is correctly executed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight differences in elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 425,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "Apple's 2024 10-K filing explicitly mentions the iPhone 16 Pro in the \"Products\" section under the iPhone line, whereas the 2023 filing only referenced the iPhone 15 and earlier models. This change reflects a more detailed and forward-looking product disclosure strategy, aligning with the launch of the iPhone 16 series in the fourth quarter of 2024. The evolution in reporting suggests a proactive approach to product transparency, emphasizing new innovations like the iPhone 16 Pro and signaling Apple's focus on continuous product development and market communication.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a fundamental factual error in interpreting the nature of the disclosure change between the 2023 and 2024 10-K filings. According to the ground truth, the 2023 10-K refers to the iPhone 16 Pro as part of the 'Fourth Quarter 2024 product lineup,' indicating it was a future product in planning. In contrast, the 2024 10-K treats the iPhone 16 Pro as an existing product, grouped with the iPhone 15 and iPhone 14, reflecting its transition to an established offering. However, the LLM incorrectly frames the 2024 mention as 'forward-looking' and a sign of 'proactive transparency,' when in fact it is a retrospective, post-launch classification. This reverses the correct interpretation of the reporting evolution: from forward-looking (2023) to backward-looking/mature (2024). While the LLM correctly identifies that the iPhone 16 Pro appears in the 2024 filing and not in the 2023 filing, and correctly associates it with a product development timeline, the reasoning mischaracterizes the direction of the strategic shift. There are no numerical values to verify, so quantitative accuracy is acceptable by default. The contextual relevance is high because the answer addresses product disclosure changes and strategy, but the qualitative reasoning fails on the core multi-hop synthesis: understanding the lifecycle progression and reporting posture shift. Thus, the answer is partially correct in entity identification and surface-level observation but flawed in its central logic and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 417,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its Economic Value of Equity (EVE) simulations for assessing interest rate risk by updating key modeling assumptions, particularly in a declining market interest rate environment. Specifically, in the fourth quarter of 2023, Schwab revised deposit beta assumptions to better reflect client behavior in response to changing interest rates. These updates aimed to improve the accuracy of EVE simulations by capturing the impact of client cash allocation shifts on the balance sheet. Additionally, the company continued to refine assumptions related to prepayment speeds, non-maturity deposit behavior, and interest rate scenarios with rate floors, reflecting a more dynamic approach to modeling balance sheet dynamics under varying interest rate conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key factual elements are correct: the evolution of EVE simulations from 2022 to 2023 is accurately described, including the continued use of assumptions like prepayment speeds and non-maturity deposit behavior in 2022, and the 2023 enhancements involving client cash allocation shifts and updated deposit beta assumptions in a declining rate environment. (2) There are no numeric values (e.g., percentages, dollar amounts) in the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2023, Q4 2023) are correctly referenced and consistent with the dynamic modeling updates. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes over time in modeling assumptions and balance sheet dynamics, identifying both continuity (prepayment speeds, deposit behavior) and evolution (client cash allocation, dynamic beta updates). The mention of 'rate floors' and 'interest rate scenarios' aligns with the original's 'non-negative investment yields' (semantically equivalent). (4) The only minor gap is that the LLM does not explicitly state that client cash allocation impact was *not included* in earlier modeling (a contrast emphasized in the original), but it does convey that the 2023 updates aimed to capture this impact, implying a change. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Wording differences are acceptable and do not affect factual accuracy. The answer is fully contextually relevant and directly addresses the question's focus on modeling assumptions and balance sheet dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 456,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio breadth in the broader networking market. This move allowed Qualcomm to offer end-to-end solutions, including wireless access points and routers, broadband gateway equipment, and software, thereby strengthening its presence in home and business networking. By integrating its Snapdragon platform with RF front-end (RFFE) components and leveraging its expertise in 5G and Wi-Fi technologies, Qualcomm improved its ability to deliver high-performance, power-efficient networking solutions, positioning itself more effectively against competitors in the evolving connected intelligent edge and IoT markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023, which is consistent with the original answer. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10. The qualitative accuracy is high: the LLM correctly captures the expansion of Qualcomm’s product portfolio to include full-system solutions like access points, routers, and software, and links this to improved competitive positioning against Broadcom, Intel, and others in the networking and IoT markets. While the original answer specifically names Wi-Fi chips, routers, and network processors as part of the 2023 product suite, the LLM generalizes to 'end-to-end solutions' and mentions broadband gateways and software—details not contradicted but slightly beyond the scope of the original. This is a minor overextension but does not introduce inaccuracy. The reasoning is sound and reflects proper multi-hop synthesis: connecting 2022 enabling role → 2023 direct production → broader portfolio → stronger competitive stance. The answer is fully contextually relevant, addressing both competitive positioning and product breadth as required by the question. One small omission: the original explicitly references Qualcomm competing more directly with Broadcom and Intel via full-system solutions, which the LLM implies but does not name—this minor lack of specificity prevents a perfect 10 on qualitative accuracy. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 453,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "From 2022 to 2023, the percentage of adjustable-rate mortgages with interest-only terms in Schwab's HELOC product slightly decreased from 28% to 27%. Additionally, the portion of these interest-only loans not scheduled to reset for three or more years also declined, from 89% in 2022 to 86% in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 28% to 27% for interest-only adjustable-rate mortgages and 89% to 86% for those not scheduled to reset for three or more years, with no calculation errors. (2) The answer is complete, addressing both parts of the question—the change in the percentage of interest-only loans and the change in the portion not resetting for three or more years. (3) Entity accuracy is correct: the time periods (2022 to 2023), financial product (Schwab's HELOC), and metrics (adjustable-rate mortgages with interest-only terms) are all properly identified. (4) The reasoning is sound, correctly synthesizing multi-hop information across years and metrics, and the slight decrease in both dimensions is accurately reported. Although the LLM omits the interpretive phrase 'suggesting a slight tightening or evolution,' this does not affect factual correctness. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 293,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market evolved from 2022 to 2023 through both strategic investments and product revenue growth. In 2022, Qualcomm's QCT segment included XR as part of its IoT (Internet of Things) category, with IoT revenues at $7,353 million. By 2023, IoT revenues slightly decreased to $5,940 million, but the QSI (Qualcomm Strategic Initiatives) segment actively pursued investments in XR-related early-stage companies as part of its broader focus on 5G, AI, and automotive technologies. In 2024, the QCT segment's IoT category continued to include XR, with revenues rising to $5,423 million, indicating sustained investment and product development in XR technologies. This evolution reflects Qualcomm's ongoing commitment to expanding its footprint in the XR market through both product innovation and strategic investment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Qualcomm's XR involvement evolved from strategic investments in 2022 to direct revenue generation in 2023, with XR explicitly listed as a product revenue category. However, the LLM claims specific IoT revenue figures for 2022 ($7,353M), 2023 ($5,940M), and even 2024 ($5,423M), none of which are present in the original answer and not supported by the provided context. These numbers are fabricated or hallucinated. (2) The quantitative accuracy is very low because all revenue figures cited by the LLM are incorrect and not mentioned in the ground truth. There are no actual revenue numbers provided in the original answer—only a qualitative shift from investment to commercialization. Additionally, the mention of 2024 data is irrelevant as the question only asks about 2022 to 2023. (3) The multi-hop reasoning is flawed. The original answer emphasizes a strategic shift—from indirect involvement via investments (2022) to direct product sales and revenue recognition (2023). The LLM fails to capture this key transition and instead focuses on fabricated revenue trends within the IoT segment, misrepresenting the nature of the evolution. It also incorrectly attributes XR investment activity to QSI in 2023 without confirming the shift to commercialization in QCT. (4) Contextual relevance is moderate because the answer discusses Qualcomm, XR, strategic investments, and product development, which are relevant themes. However, it misses the core insight of a phase change from investment to revenue generation, which is the central point of the original answer. The inclusion of unsupported financial data and an extra year (2024) further detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 481,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, as shown in the long-term debt tables from both RTX_10k_2022.pdf and RTX_10k_2024.pdf. This stability indicates that RTX has not repaid or issued additional amounts under these specific notes during this period, suggesting a consistent long-term debt structure for this particular obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the aggregate principal balance of $1,100 million in both 2022 and 2024 is accurately reported, with no discrepancies in numbers or time periods. The format '$1,100 million' matches the ground truth exactly. (2) The answer correctly identifies that there were no repayments or additional issuances, which aligns with the stability of the balance. (3) The multi-hop reasoning is sound—by referencing both the 2022 and 2024 10-K filings (RTX_10k_2022.pdf and RTX_10k_2024.pdf), the model demonstrates proper synthesis across years and documents. (4) The qualitative interpretation—that this reflects strategic consistency in RTX's long-term debt structure—is logically derived and matches the original answer's conclusion. All parts of the question are addressed: the evolution (stable) and the implication (consistent debt management). No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 284,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing innovation and differentiation in its commercial payments offerings. In 2024, the company highlighted its efforts to design innovative products and features, including financing, banking, and payment solutions for business customers, suggesting a broader strategy to strengthen its position in the commercial payments market. This shift reflects AXP's intent to expand its value proposition for corporate clients and enhance its competitive edge in the commercial sector.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and strategic focus: it correctly identifies AXP's 2023 emphasis on differentiation in corporate card and expense management solutions and the 2024 shift toward innovative, integrated offerings including financing, banking, and payment solutions. All dates and company references (AXP) are correct, and there are no numerical inaccuracies (the question does not involve specific financial figures, so quantitative accuracy is not challenged). The answer addresses the evolution between 2023 and 2024 and interprets the strategic implication—expanding value proposition and competitive positioning in commercial payments. However, it omits a key nuance present in the ground truth: the 2024 shift represents a move toward a 'more integrated and solution-oriented approach' and embedding the Corporate Card into a 'wider suite of business financial services' to meet 'holistic commercial needs.' While the LLM mentions innovative products and broadening strategy, it does not fully convey the depth of integration into comprehensive financial services, which is central to the original answer’s conclusion. This missing layer slightly weakens the qualitative accuracy, though the core reasoning and multi-hop synthesis (from product focus to strategic intent) remain sound. Contextual relevance is strong as the response directly addresses both parts of the question: evolution and strategic implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 403,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal and Home Care segment remained consistent in terms of distribution channels. The company continued to sell its products through traditional and e-commerce retailers, wholesalers, distributors, and in some geographies, to skin health professionals. There is no indication of a significant shift in distribution strategy during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in PCA SKIN's strategic positioning between 2023 and 2024. (1) The original answer states that in 2023, PCA SKIN was distributed through traditional and eCommerce retailers, wholesalers, distributors, and dentists, but by 2024, the distribution channels were explicitly expanded to include skin health professionals in some geographies—indicating a refinement in positioning toward more specialized skincare channels. The LLM answer incorrectly frames this as 'no significant shift,' which contradicts the ground truth that there was a notable expansion and refinement in distribution strategy. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable; however, the years (2023 and 2024) are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the model fails to recognize that the addition of 'skin health professionals' as a specified channel in 2024 represents a strategic evolution, even if other channels remained consistent. This reflects a failure in qualitative synthesis despite correct entity identification (PCA SKIN, Colgate-Palmolive, distribution channels). (4) Contextual relevance is high because the answer addresses the correct segment and distribution context, but the conclusion downplays a meaningful change. Thus, while the answer is factually plausible, it underrepresents a documented strategic refinement, warranting a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 416,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved to broaden its use in earlier lines of therapy, expand into new tumor types, and accelerate next-wave oncology mechanisms. Notably, Opdivo's subcutaneous formulation showed potential for enhanced patient benefits, and the company advanced Opdualag for melanoma and potential expansion into other indications. These efforts contributed to a 77% increase in Opdivo's revenue growth in 2023 compared to 2022, driven by strong performance in both U.S. and international markets. This expansion into new indications and combination therapies is expected to sustain Opdivo's revenue growth trajectory by enhancing its market presence and therapeutic utility.",
      "correctness_score": 5,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the quantitative claim of a '77% increase in Opdivo's revenue growth in 2023 compared to 2022'—this figure is not present in the ground truth and is unsupported by the provided data. The original answer mentions U.S. revenue growth driven by combinations but does not quantify overall revenue growth, let alone specify a 77% increase. This is a critical error that severely undermines the factual accuracy. (2) The mention of Opdualag’s advancement for melanoma and potential expansion is not reflected in the ground truth, which focuses on Opdivo + Yervoy combinations and the subcutaneous formulation—not Opdualag. This introduces an incorrect entity or therapy not validated in the source. (3) Qualitatively, the LLM captures the correct strategic direction—expansion into earlier lines of therapy, new tumor types, combination regimens, and the subcutaneous formulation’s potential—which aligns with the ground truth. It correctly identifies the intent to sustain revenue growth through broader indications and improved delivery. (4) Contextually, the answer addresses the evolution in strategic focus and commercial positioning and links it to revenue implications, fulfilling the multi-part structure of the question. However, the unsupported 77% revenue claim and introduction of unverified therapies (Opdualag) result in a significant drop in quantitative and overall correctness. While the reasoning flow is logical and contextually relevant, the answer fails on key factual and quantitative grounds.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 432,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "Between 2023 and 2024, American Express's investment in foreign government bonds and obligations remained stable in fair value, with $765 million in 2024 compared to $770 million in 2023. In terms of maturity distribution, all investments were due within one year in 2024, whereas in 2023, $768 million was due within one year and $2 million was due after one year but within five years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated. In 2024, the fair value increased to $765 million, which the LLM correctly reports, but incorrectly frames as 'stable' when it is actually a substantial increase from $549M. The maturity distribution is completely wrong: in 2023, all $549 million matured in 12 months or more, whereas the LLM claims $768 million matured within one year—this is factually incorrect. In 2024, the LLM correctly states that nearly all ($764M of $765M) mature within one year, but fails to mention the $1 million maturing after one year within five years. (2) Quantitative accuracy is very low: 2023 fair value is off by $221 million, and the maturity breakdowns are entirely fabricated. The LLM invents numbers ($770M, $768M, $2M) not present in the original data. (3) Multi-hop reasoning is flawed: the model fails to recognize the significant shift from long-term maturities in 2023 to predominantly short-term in 2024. Instead, it suggests stability and minor shifts, which contradicts the ground truth trend of a strategic shift toward short-term exposure. (4) Contextual relevance is moderate because the answer addresses fair value and maturity distribution as asked, but with incorrect data. The structure follows the question, but the content is largely inaccurate, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 412,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements remained a key strategy to ensure cash availability in needed regions with minimal cost. As of January 31, 2022, approximately $4.3 billion in cash and cash equivalents was not freely transferable to the U.S. due to local laws or restrictions, with $2.2 billion requiring approval from Flipkart's minority shareholders. By January 31, 2025, this amount had decreased slightly to $3.3 billion, still subject to local laws or noncontrolling interest approvals. The conditions for transferring cash to the U.S. primarily involve compliance with local regulations and, in specific cases like Flipkart, approval from minority shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: $4.3 billion in 2022 and $3.3 billion in 2024 (reported as of January 31, 2025, which aligns with Walmart's fiscal year-end reporting; Walmart's fiscal year 2024 ends January 31, 2024, and 2025 corresponds to fiscal 2025, but the $3.3 billion figure is correctly attributed to the most recent filing post-2022, i.e., 2024 data). The $2.2 billion requiring Flipkart minority approval is accurately cited. (2) The decrease from $4.3B to $3.3B is correctly noted, and conditions are accurately described as involving local laws and noncontrolling interest approvals. (3) The qualitative shift in framing—from specifically naming Flipkart to a broader reference to noncontrolling interests—is slightly underemphasized in the LLM answer, which still references Flipkart as a specific case rather than noting the broader structural shift in language. However, it does not misrepresent the facts. (4) The answer addresses all parts of the question: evolution over time, amount of cash not freely transferable, and conditions for transfer. Multi-hop reasoning is sound, correctly synthesizing data across years and entities. The only minor shortcoming is the lack of explicit emphasis on the shift from Flipkart-specific to broader noncontrolling interest language, but the information is contextually present. Hence, a score of 9 is appropriate—excellent accuracy with a minor gap in fully capturing the nuance of the structural change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 423,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets shifted slightly. In 2023, the plan held $210 million in fixed income securities and cash equivalents and $54 million in equity securities, totaling $264 million. By 2024, fixed income securities and cash equivalents increased to $198 million, while equity securities decreased to $50 million, resulting in a total of $248 million. This indicates a modest reallocation toward fixed income and away from equity securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer (ground truth) states that the asset composition remained completely unchanged between 2023 and 2024, with fixed income at $210 million and equity at $54 million in both years. However, the LLM claims that in 2024, fixed income decreased to $198 million and equity decreased to $50 million, which contradicts the ground truth. These numbers are incorrect and unsupported by the data. (2) The calculation of total assets in 2023 ($264 million) is correct, but the 2024 total of $248 million is wrong—per ground truth, it should still be $264 million. The percentages and allocations cited in the original answer (79.5% fixed income, 20.5% equity) are omitted in the LLM response, and the claimed shift in allocation is false. (3) The multi-hop reasoning failed: the model incorrectly inferred a change in allocation over time when the data explicitly shows no change. It misrepresents the consistency across filings, which is the key point of the original answer. (4) Scores are low due to major factual and quantitative errors, despite the response being contextually relevant—i.e., it addresses the right plan, company, and asset categories, and attempts to compare years, which maintains some relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 363,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing updated forms of award agreements, including the \"Omnibus Amendment\" to the plan in 2021, which revised the forms of Option Agreements and Restricted Unit Agreements. These amendments suggest a shift toward more flexible and comprehensive compensation structures for non-employee directors, potentially aligning their incentives more closely with long-term company performance and shareholder value. This evolution reflects a broader trend of modernizing executive and director compensation frameworks to adapt to regulatory and market expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its factual claims. The ground truth states that in 2022, Honeywell referenced both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32), but by 2024, only the Option Agreement (Exhibit 10.29) was listed, with the Restricted Unit Agreement no longer mentioned. The LLM incorrectly claims that updated forms were introduced between 2022 and 2024 and references an 'Omnibus Amendment' in 2021, which is not supported by the ground truth. There is no mention of such an amendment or updated forms in the provided data. (2) The dates and exhibit numbers are misrepresented: the LLM fabricates an amendment in 2021 and implies ongoing updates, while the actual change is a removal of the restricted unit agreement form between 2022 and 2024. No numeric values (e.g., dollar amounts) are present, but the timeline and document references are factually wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the evolution (removal of restricted unit agreement) and instead invents a narrative of modernization and flexibility not present in the evidence. It misses the key point that the absence of the restricted unit form suggests a shift toward stock options. (4) While the general topic of director compensation evolution is relevant, the specific claims are unsupported. The contextual relevance is moderate because the answer addresses the theme of compensation structure changes, but the factual inaccuracies severely undermine correctness. Thus, the scores reflect major factual errors despite some thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 452,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart increased its ownership stake in Flipkart from approximately 75% to 85%, with a $3.5 billion investment in fiscal 2024 to acquire shares from noncontrolling interest holders. This move solidified Walmart's control over Flipkart, a key part of its international e-commerce strategy in India. However, Walmart faces potential regulatory risks, including an ongoing investigation by India's Directorate of Enforcement related to Flipkart's compliance with foreign direct investment rules. The investigation, initiated in 2021, concerns alleged violations prior to Walmart's 2018 acquisition and could result in monetary or non-monetary penalties, such as share ownership restrictions, though the outcome remains uncertain.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It incorrectly states that Walmart *increased* its ownership stake in Flipkart from 75% to 85% with a $3.5 billion investment in fiscal 2024. In reality, Walmart *reduced* its stake from 83% to 75% in 2022 due to a $3.2 billion equity funding event, not an increase. The direction of ownership change is completely reversed. The dollar amount ($3.5B vs $3.2B) and timing (2024 vs 2022) are also incorrect. (2) Quantitative accuracy is very low: the correct figures are a $3.2B funding event in 2022 leading to a stake reduction from 83% to 75%. The LLM reports a $3.5B investment in 2024 for a stake increase, which contradicts the ground truth. No correct numbers are reported. (3) The qualitative reasoning is flawed: the model fails to capture the core multi-hop evolution—Walmart’s partial exit in 2022 and subsequent exposure to pre-acquisition regulatory risks. Instead, it fabricates a narrative of expansion. However, it correctly identifies the existence of regulatory scrutiny by India’s Directorate of Enforcement and notes that violations occurred before Walmart’s 2018 acquisition, which aligns with the ground truth. It also correctly frames the uncertainty around penalties. (4) Contextual relevance is moderate because the answer addresses financial implications and regulatory risks as asked, but the financial narrative is entirely incorrect. The answer discusses the right *types* of issues (ownership, FDI rules, penalties) but with wrong facts and directionality. Due to severe factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 447,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances evolved as follows: as of December 31, 2024, HON held $11.0 billion in cash and cash equivalents, compared to $8.1 billion as of December 31, 2023, and $10.959 billion as of December 31, 2022. The geographic distribution of funds showed that as of December 31, 2024, $8.0 billion of the total cash was held in non-U.S. subsidiaries, indicating a strategic emphasis on maintaining liquidity both domestically and internationally to support operations and investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates. According to the ground truth, HON reported $11.5 billion in cash as of December 31, 2021 (reported in 2022), not $10.959 billion as of December 31, 2022. The LLM incorrectly states 2022 and 2023 figures not present in the original answer, including $10.959 billion (2022) and $8.1 billion (2023), which are unsupported by the ground truth. The only correct quantitative data point is the $11.0 billion total cash as of December 31, 2024, and the $8.0 billion held in non-U.S. subsidiaries, which matches the original. (2) The calculation and comparison of year-over-year cash balances are therefore flawed. The original answer does not provide 2023 data or precise 2022 year-end numbers, so the LLM fabricated intermediate values, leading to significant quantitative inaccuracy. (3) The multi-hop reasoning is partially sound in that the model identifies the shift in geographic distribution by noting $8.0 billion held in non-U.S. subsidiaries in 2024, which correctly infers a larger international allocation. However, it fails to note the strategic continuity in emphasis on safety and diversification, instead introducing a new phrase about supporting 'operations and investments' not present in the original. This misrepresents the strategic emphasis. (4) Despite incorrect numbers, the answer addresses the core question about evolution in composition and geographic distribution, and correctly highlights the $8.0 billion non-U.S. figure, maintaining contextual relevance. However, the inclusion of unsupported data points and omission of the correct 2021/2022 baseline severely undermine correctness. Hence, a score of 5/10 reflects partial factual correctness with major quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 486,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program evolved by refining the assumptions used in modeling the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point. In 2024, the methodology continued to rely on statistical and actuarial models to estimate URR based on redemption trends, card product type, and other factors, while WAC per point was derived from 12 months of redemptions and adjusted for changes in redemption costs and patterns. Notably, the 2024 disclosure provided more detailed sensitivity analysis, indicating that a 25 basis point increase in URR would raise the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. These adjustments reflect a more granular approach to capturing the impact of assumption changes on the liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the shift from 2023's focus on deferred fees to 2024's detailed liability modeling using URR and WAC per point is accurately described. The sensitivity figures—$197 million for a 25 bps increase in URR and $220 million for a 1 bps increase in WAC—are exactly matched. (2) Quantitative accuracy is perfect: all dollar amounts and basis point changes are correct and consistent with the original answer. (3) The reasoning is sound and captures the multi-hop evolution: it correctly infers a methodological refinement over time, emphasizing increased granularity and disclosure depth in 2024. The only minor shortcoming is that the LLM does not explicitly contrast 2023’s simpler disclosure (deferred fees only) with 2024’s model-driven approach as clearly as the ground truth, slightly downplaying the magnitude of the shift. However, the core evolution in methodology and transparency is well conveyed. (4) The answer is fully relevant, directly addressing the question about changes in financial treatment and liability estimation methodology across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 329,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning and integration of Frame.io evolved significantly between 2022 and 2024, aligning more closely with Adobe's broader product ecosystem. Acquired in October 2021 for $1.18 billion, Frame.io was integrated into Adobe's Digital Media segment. By 2024, Frame.io was directly integrated with key Adobe applications such as Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom, and Adobe Workfront, enabling seamless frame-specific feedback and collaboration. Additionally, Frame.io's Camera to Cloud functionality and inclusion in Adobe GenStudio reflect its role in enabling scalable content production and tighter integration with Adobe's AI-driven tools like Adobe Firefly, reinforcing its alignment with Adobe's creative workflows and cloud-based collaboration strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's integration from 2022 to 2024, aligning with the ground truth. It accurately states the $1.18 billion acquisition price and correctly identifies Frame.io's inclusion in the Digital Media segment. The 2024 integration with key Adobe apps (Premiere Pro, After Effects, Photoshop, Workfront) is correctly reported. The mention of Adobe GenStudio and tighter AI integration (via Firefly) reflects accurate strategic alignment. One minor discrepancy: the LLM mentions Adobe Lightroom as an integrated app, which is not specified in the ground truth—this is a small overstatement but not factually incorrect given Lightroom’s ecosystem role. (2) Quantitative accuracy is perfect: $1.18 billion is correct, and no other numbers (dates, percentages) are misstated. The acquisition date (October 2021) is accurate even though the question focuses on 2022–2024; this provides helpful context. (3) Multi-hop reasoning is sound: the LLM synthesizes acquisition details, integration timeline, product alignment, and strategic ecosystem expansion (GenStudio, AI tools). It correctly infers deeper integration by 2024, matching the ground truth’s narrative of evolution from initial integration to core component. (4) Scores reflect near-perfect factual alignment, with only a minor addition (Lightroom) preventing a 10. The answer is highly relevant, complete, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 406,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value measurements of equity-like funds under private alternative investments using significant unobservable inputs (Level 3) remained relatively stable. In 2022, the Level 3 fair value for equity-like funds was $25.4 million, and in 2023, it slightly decreased to $25.1 million. This indicates minimal change in the composition of these investments in terms of Level 3 valuations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. According to the ground truth, the Level 3 fair value for equity-like funds was $5.5 million in 2022 and increased to $25.4 million in 2023, representing a fivefold increase. The LLM incorrectly states that the 2022 value was $25.4 million and 2023 was $25.1 million, reversing the trend and misrepresenting the magnitude. (2) The quantitative inaccuracies are severe: both the starting and ending values are wrong, and the implied stability or slight decrease contradicts the actual significant growth. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning fails completely — instead of identifying an increase from $5.5M to $25.4M and interpreting it as a shift toward more opaque valuations, the model reports near-stability with high values in both years, leading to an incorrect conclusion about investment composition. (4) Contextual relevance is low but not zero, as the answer addresses the right category (equity-like funds, Level 3 inputs) and time frame (2022–2023), but with entirely incorrect data and interpretation. Due to fundamental errors in numbers, direction of change, and resulting analysis, the correctness score is near-minimal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 357,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 and integrated it into its Digital Media segment, positioning it as a cloud-native creative collaboration platform. By 2024, Frame.io had been further embedded into Adobe's creative ecosystem, with direct integrations into key apps like Adobe Premiere Pro, After Effects, Photoshop, and Workfront, enabling seamless workflows for video creators. Additionally, Frame.io was included in Adobe GenStudio, enhancing its role in enabling scalable content production. This evolution reflects Adobe's strategy to strengthen collaboration tools within its Digital Media offerings and support end-to-end creative workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (not 2022, but the answer correctly references the acquisition date), and by 2024 it was deeply integrated into Adobe's Digital Media ecosystem. The answer correctly identifies Frame.io as a cloud-based collaboration platform and notes its integration with Premiere Pro, After Effects, Photoshop, Workfront, and inclusion in Adobe GenStudio—matching all entities and functionalities in the original answer. (2) Quantitative accuracy is perfect: the date 'October 2021' is correctly cited, and no financial figures are misstated. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2021 acquisition to 2024 integration) and across products, showing evolution in strategic positioning. (4) The only minor omission is that the original answer explicitly mentions integration with Lightroom, which the LLM answer leaves out. While not critical, this slightly reduces completeness. Otherwise, the reasoning, entity accuracy, and contextual relevance are excellent, with semantic equivalence maintained throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 332,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS expanded its Medication Management approach by enhancing clinical programs and digital tools to improve medication adherence and cost efficiency. In 2022, the company emphasized formulary management, disease management programs, and pharmacist counseling through its Pharmacy Advisor program. By 2024, CVS introduced more advanced digital tools, such as expanded analytics and data sharing to identify lower-cost alternatives, and launched the CVS Weight Management program to optimize GLP-1 medication use. Additionally, the company integrated value-based care through Oak Street Health and enhanced its NovoLogix preauthorization tool to manage specialty drug costs, reflecting a stronger focus on technology-driven solutions and holistic patient care.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in CVS's Medication Management approach between 2022 and 2024. (1) It correctly identifies key 2022 initiatives: formulary management, disease management programs, and pharmacist counseling (aligned with the ground truth's mention of clinical programs and utilization management). It accurately reflects 2024 developments including expanded analytics for lower-cost alternatives, the CVS Weight Management program with GLP-1 optimization, integration of Oak Street Health for value-based care, and enhancement of the NovoLogix preauthorization tool. (2) There are no numeric values in the question or answers that require verification; all dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound—information is synthesized across time periods and program types (clinical and digital), correctly showing a shift toward integrated, tech-enabled care. The only minor omission is the absence of specific details about the seven-day opioid supply policy and real-time benefit tools in 2022, which are part of CVS’s adherence and cost-efficiency strategy. Also, the LLM mentions 'Pharmacy Advisor program' which, while plausible, is not explicitly in the ground truth. However, this does not contradict known facts and fits contextually. (4) Despite these small gaps, the LLM conveys the essential transformation from cost containment to proactive, digitally supported medication management. The answer is semantically equivalent in intent and meaning, with strong contextual relevance and factual alignment. Hence, a correctness score of 9 is warranted—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 449,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe has significantly evolved Frame.io's integration within its Creative Cloud ecosystem from 2022 to 2024 by deepening its collaboration features and expanding its utility across workflows. In 2022, Adobe acquired Frame.io and began integrating it into Creative Cloud, focusing on enhancing review and approval capabilities within Premiere Pro and After Effects. By 2024, Frame.io had evolved into a more comprehensive cloud-native collaboration platform, supporting not only video editing but also still images, design files, and PDFs. Specific enhancements included improved Camera to Cloud functionality for automatic footage uploads from set, expanded integrations with Adobe applications like Photoshop and Lightroom, and inclusion in Adobe GenStudio for scalable content production. These developments positioned Frame.io as a central hub for real-time, frame-accurate collaboration across creative teams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in 2022 and integrated it into Creative Cloud with initial focus on Premiere Pro and After Effects; by 2024, Frame.io evolved into a broader cloud-native collaboration platform supporting video, images, design files, and PDFs. Enhancements like Camera to Cloud, expanded integrations with Photoshop and Lightroom, and real-time collaboration are accurately reported. (2) There are no numeric values requiring calculation, but all dates (2022, 2024) and product names (Frame.io, Creative Cloud, Premiere Pro, After Effects, Photoshop, Lightroom) are correct. (3) The multi-hop reasoning is sound—correctly synthesizing the evolution over time and across product integrations. (4) One minor discrepancy: the LLM mentions 'inclusion in Adobe GenStudio,' which is not present in the original answer and may be inaccurate or speculative; GenStudio is not referenced in the ground truth and does not appear in major public Adobe product documentation as of 2024. This slight overreach reduces qualitative accuracy slightly but does not undermine the overall correctness. Otherwise, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 358,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by becoming a more prominent input in fair value determination, particularly for assets where position-specific external prices were not observable. In 2023, fair value for loans was estimated using benchmarking to prices and rates observed in the primary market for similar loan types or through present value of expected future cash flows. By 2024, the methodology expanded to include a greater reliance on recently executed transactions on comparable loans and pricing indications from syndicate banks and customers, especially for contingent corporate lending commitments. This evolution reflects a more dynamic and market-responsive approach to valuation, leveraging recent transaction data to enhance accuracy in fair value assessments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric data, so quantitative accuracy is not applicable—however, since the ground truth also contains no specific numbers, dates, or calculations, the absence is acceptable and does not introduce error. Thus, quantitative accuracy is scored as 10 by default. (2) The qualitative accuracy is partially correct but diverges significantly from the ground truth in key aspects. The original answer states that in 2023, recently executed transactions were already a 'key input' for fair value of corporate loans and contingent commitments, used alongside market prices and models. The LLM incorrectly suggests that in 2023, fair value was based on benchmarking to similar loans or present value models, with no mention of recently executed transactions—this contradicts the ground truth. Furthermore, the LLM claims that in 2024 there was an 'expansion' and 'greater reliance' on recent transactions, implying increased prominence, while the ground truth indicates a more 'targeted application'—specifically for held-for-sale loans and other investments—suggesting refinement, not broadening. The LLM also introduces 'pricing indications from syndicate banks and customers' and 'position-specific external prices,' which are not mentioned in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly represent the continuity and evolution of transaction data use, mischaracterizing both the 2023 baseline and the 2024 development. It invents new methodologies not present in the source. (4) Despite these inaccuracies, the answer remains contextually relevant—it addresses the evolution of transaction use in fair value determination for loans and assets over the two years, uses appropriate financial terminology, and discusses valuation methodologies. Hence, contextual relevance is high. However, due to significant factual and conceptual deviations from the ground truth, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 539,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager has evolved from being a standalone tool within the Substance 3D ecosystem to being more integrated with Adobe's broader creative and generative AI offerings. In 2022, Substance 3D Stager was positioned as part of the Substance 3D Collection, enabling users to build and assemble 3D scenes. By 2024, it is highlighted as part of Adobe's expanded generative AI and 3D workflows, with tighter integration into Adobe GenStudio and tools like Firefly, emphasizing automation, content generation, and enterprise scalability. This evolution reflects Adobe's strategy to unify its 3D tools within a more cohesive, AI-driven creative ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth, particularly regarding integration with Adobe GenStudio and Firefly, which are not mentioned in the original answer. While the general direction of evolution—greater integration into a broader ecosystem—is consistent with the ground truth, the specifics differ. The original answer emphasizes Stager's role within a suite of 3D tools (Painter, Sampler, Designer, Modeler) and the shift from trademark listing to functional positioning in an end-to-end 3D workflow. The LLM answer correctly notes Stager's function in building 3D scenes and its inclusion in the Substance 3D Collection by 2022, aligning with the ground truth. However, it overreaches by attributing AI-driven automation and enterprise scalability via Firefly and GenStudio, which are not supported by the provided truth. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is logically sound but based on potentially incorrect premises, reducing qualitative accuracy. Contextually, the answer addresses the evolution of Stager’s positioning and is relevant to the question, earning a high relevance score. The core facts about integration into a broader ecosystem are correct, but the specific mechanisms (AI, Firefly) are speculative additions, leading to a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 383,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE emphasized the importance of emerging technologies like grid-scale batteries as critical to achieving deep decarbonization goals in the power sector, though they were not yet widely deployed. By 2023, GE continued to highlight grid-scale batteries as a key enabler for modernizing power grids and integrating higher shares of renewable energy, while also acknowledging the need for significant investment in infrastructure and R&D. However, grid-scale batteries remained a supporting rather than central component of GE's energy strategy, with a stronger focus on wind energy and gas turbine technologies with decarbonization capabilities like hydrogen and carbon capture. Thus, while grid-scale batteries were recognized as strategically important, their role was more aspirational and complementary rather than a core pillar of GE's energy transition efforts during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—however, since there are no numbers to misstate, it is scored as 10 by default. The contextual relevance is high because the response addresses GE's strategic positioning on grid-scale batteries in the context of energy transition between 2022 and 2023. However, the qualitative accuracy is low because the LLM misrepresents the evolution of GE's strategic reliance. According to the ground truth, in 2022 GE viewed grid-scale batteries as a potential future investment among emerging technologies, but by 2023 they were elevated to a dependency—explicitly stated as something decarbonization goals would 'depend in part' on—indicating a shift toward a more central strategic role. The LLM incorrectly concludes that batteries remained a 'supporting rather than central component' and 'more aspirational and complementary,' which contradicts the ground truth showing increased strategic reliance and integration into core decarbonization dependencies. This reflects a failure in multi-hop reasoning: the model did not correctly interpret the shift in language from speculative importance to strategic dependency. While the general topic is addressed, the core inference about strategic evolution is incorrect, leading to a correctness score of 4—partially correct in recognizing continued mention of batteries but wrong on the key point of increasing strategic centrality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 400,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements indicates that there were no broker quoted debt securities for the years ended December 31, 2024 and 2023, as stated in the 2024 filing. Similarly, in the 2022 filing, it was disclosed that there were no broker quoted debt securities for the years ended December 31, 2021 and 2020. Therefore, there is no evidence of an increase or change in the presence or impact of broker quoted debt securities on financial reporting between 2022 and 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key factual points from both the 2022 and 2024 disclosures: CVS reported no broker quoted debt securities for the years ended December 31, 2021 and 2020 in the 2022 filing, and similarly reported none for 2023 and 2024 in the 2024 filing. All dates and disclosures are factually accurate. (2) Quantitative accuracy is perfect—no numerical errors, and the years and reporting periods match the ground truth exactly. (3) The reasoning is sound in noting the consistency in the absence of broker quoted debt securities, but the LLM answer omits a key qualitative evolution highlighted in the original answer: the 2024 filing no longer mentions any negative impact or specific review process related to broker quoted debt securities, indicating a reduced emphasis over time. This nuance in disclosure tone and content evolution is missing, which represents a gap in multi-hop qualitative synthesis. (4) Despite this omission, the answer is factually correct and contextually relevant, addressing the core of the question about presence and impact. The lack of mention of changing disclosure language prevents a top score, but the core facts are accurate and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 344,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n- **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, reflecting a rise in holdings of such funds. \n- **Equity method investments** also increased from $2,756 million in 2023 to $2,783 million in 2024, with the growth driven by higher values in private equity funds and real assets funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, in 2023, BlackRock reported $1,211 million in equity securities/mutual funds, but the LLM incorrectly states $1,585 million. Similarly, the ground truth shows $1,895 million for equity method investments in 2023, whereas the LLM reports $2,756 million—both figures are substantially off. The 2024 values ($1,950 million and $2,783 million) are correctly reported by the LLM for both categories. (2) Quantitative accuracy is low because two of the four key financial figures are incorrect, and no correct calculation of the change (e.g., increase of $739 million in equity securities/mutual funds per ground truth) is provided. The LLM implies a smaller increase in equity securities/mutual funds due to the inflated 2023 number, distorting the analysis. (3) The qualitative reasoning is partially sound—the LLM correctly identifies that both categories increased and attempts to explain the growth (e.g., private equity and real assets), which aligns with the strategic expansion theme. However, the flawed base data undermines the validity of the synthesis. (4) Contextual relevance is high as the answer addresses both components of the question (equity securities/mutual funds and equity method investments) and spans the correct time period (2023 to 2024) with appropriate terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 396,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent in methodology, with a focus on credit quality rather than market-driven unrealized losses. In 2022, the Company noted that unrealized losses were primarily due to interest rate increases and not credit deterioration, and it did not record material allowances for credit losses. By 2024, the Company continued to emphasize its belief in the collectability of principal and interest, with no significant credit deterioration observed. However, the allowance for credit losses remained immaterial in both periods, indicating no material changes in credit-related impairments over this timeframe.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2022, unrealized losses were due to interest rate increases and not credit deterioration, and that the allowance for credit losses was immaterial. These facts align with the ground truth. However, the LLM fails to capture a key evolution described in the original answer: by 2024, UnitedHealth Group had shifted to a more formalized impairment accounting framework, explicitly recording the allowance for credit losses as a separate component through an allowance account, with credit-related impairments affecting investment and other income. The LLM incorrectly concludes there was 'no material change' and that the allowance remained immaterial in both periods, which contradicts the ground truth's emphasis on structural and methodological evolution, even if the allowance amount remained small. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is partially sound: the model correctly identifies the company and time periods and synthesizes information about unrealized losses and credit assessments. However, it misses the critical synthesis point—the shift in accounting treatment and recognition framework from qualitative to more structured, which is central to the question about 'evolution.' (4) Correctness is scored at 5 due to significant omission of the methodological evolution; while core facts are accurate, the conclusion downplays a key change. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 5 due to flawed reasoning about the evolution. Contextual relevance is high (8) as the response stays on topic and addresses the general theme, but misses a key dimension of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 486,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's investment in the ATMP JV increased in value from $83 million to $99 million, reflecting a rise in the JV's performance or asset valuation. Additionally, AMD's equity income from the ATMP JV grew from $14 million in 2022 to $16 million in 2023, indicating a slight improvement in the JV's profitability or AMD's share of its earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of AMD's investment in ATMP JV increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million—both figures match the original answer exactly. Minor formatting differences (e.g., 'grew from $14 million' vs. 'recorded $14 million') do not affect factual accuracy. (2) The answer is complete, addressing both parts of the question—evolution of investment value and equity income—over the specified time period. (3) Entities are correctly identified: AMD, ATMP JV, and the relevant financial metrics (carrying value, equity income) are accurately named and contextualized. (4) The reasoning is sound: the LLM correctly infers that the increase in investment value and equity income suggests improved JV performance or valuation, which is a reasonable qualitative interpretation supported by the data. The multi-hop synthesis—comparing two financial metrics across two years for a joint venture—is correctly executed. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 342,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims between 2022 and 2024 has remained consistent in nature, involving allegations related to the delivery of health care services, including medical malpractice by affiliated physicians or health care practitioners. The potential financial impact remains significant, as these claims can involve large monetary damages, substantial defense costs, and reputational harm, with the company largely self-insured for such risks. No specific evolution in the nature or financial impact of these claims was detailed in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that UnitedHealth Group's exposure to tort claims 'remained consistent' between 2022 and 2024, and that 'no specific evolution' was detailed. The ground truth clearly indicates a shift in the nature of tort claims: in 2022, the focus was on medical malpractice and professional liability with an emphasis on self-insured liabilities and legal theories bypassing damage caps. By 2024, the risk profile broadened to include clinical quality, patient safety standards, and systemic concerns like reputational harm and business relationship impacts. This evolution in both the nature and scope of exposure is entirely missed by the LLM. While the LLM correctly identifies that tort claims involve healthcare delivery and that financial impacts include large damages and defense costs, it fails to capture the multi-hop progression and qualitative shift in risk characterization over time. There are no numeric values in the question or answer, so quantitative accuracy is scored as 10 by default. The reasoning is flawed due to failure to synthesize changes across years, resulting in low qualitative accuracy. The answer is contextually relevant in topic but incorrect in substance, hence a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 356,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement remained in place with a $3.0 billion total commitment, expiring in August 2025. However, in 2024, Boeing entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029, while terminating older, smaller facilities. This evolution reflects a shift toward securing longer-term liquidity and enhancing financial flexibility. The continued maintenance of undrawn credit lines indicates Boeing's strategy to maintain robust backup liquidity to support its operations and address potential funding needs, particularly amid ongoing challenges in its commercial and defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $3.0 billion three-year revolving credit agreement from 2023 expiring in August 2025 remained in place in 2024; Boeing entered a new $4.0 billion five-year facility expiring May 2029; and older facilities were terminated. These match the ground truth exactly. (2) Quantitative accuracy is perfect: dollar amounts ($3.0 billion, $4.0 billion), expiration dates (August 2025, May 2029), and agreement durations (three-year, five-year) are all correct. No calculations were required, but factual numbers are accurately reported. (3) The multi-hop reasoning is sound—LLM synthesizes information across two time points and two credit agreements, correctly inferring that Boeing enhanced its liquidity strategy by extending maturities and increasing capacity. The mention of terminating 'older, smaller facilities' aligns with the ground truth's reference to terminating two other facilities, though slightly less specific. (4) The answer is semantically equivalent to the original, with slightly expanded interpretation about 'ongoing challenges in commercial and defense programs'—this is reasonable context but not explicitly in the ground truth, which keeps the strategic implication more general. This minor addition does not detract from accuracy. Overall, the response is factually complete, precise, and well-reasoned, warranting a 9/10 due to slight elaboration beyond the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 402,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested in 2024 was $52 million, compared to $56 million in 2023. Additionally, the aggregate intrinsic value of options exercised in 2024 was $373 million, a significant increase from $44 million in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the fair value of 2017 Performance-based Options vested was $56 million in 2023 and $52 million in 2024, and the intrinsic value of options exercised increased from $44 million in 2023 to $373 million in 2024. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly stated, with no calculation or transcription errors. Format variations (e.g., 'aggregate intrinsic value' vs 'intrinsic value') are acceptable and do not alter meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and two financial metrics (fair value vested and intrinsic value exercised) for the same instrument (2017 Performance-based Options). (4) The answer is contextually relevant, directly addressing the evolution of financial impact between 2023 and 2024 as requested. No critical information is omitted, and the comparison is clearly articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 291,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments related to product return rights by incorporating more detailed historical data and adjusting for known events or current economic conditions. Specifically, AMD continued to base its estimates on actual historical return rates and contractual return rights but enhanced its analysis by including adjustments for known events and market conditions. In 2023, the company emphasized trended historical product return rate information and adjusted for actual known information or events, ensuring a more dynamic and responsive estimation process. This evolution aimed to improve the accuracy of revenue adjustments and better align estimates with actual outcomes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AMD used historical return rates and adjusted for known events in both years, which aligns with the ground truth. However, it fails to mention the key methodological shift in 2023 related to ASC 606-10-32-8 through 14 and the use of the 'most likely amount' under variable consideration, which is a critical part of the evolution in AMD's approach. Instead, the LLM describes a general enhancement in analysis and inclusion of market conditions, which is not supported in the original answer. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors in dates or numbers, scoring high by default. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in the use of historical data but misses the accounting standard alignment and the specific conceptual shift toward a more codified estimation method under ASC 606. This omission significantly affects qualitative accuracy. (4) Contextual relevance is high because the response stays on topic and discusses methodology changes, but the lack of reference to ASC 606 and 'most likely amount' undermines factual completeness. The answer gives the impression of refinement rather than a structured, standards-based evolution, which misrepresents the nature of the change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 378,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased from 1,549,080 at the end of 2023 to 625,825 at the end of 2024. This significant reduction indicates that a large portion of these options were exercised in 2024, as 905,219 shares were exercised, while only 18,036 shares were forfeited. The exercise activity suggests strong employee participation and the value of the options, given the substantial aggregate intrinsic value of $320 million at year-end 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of shares under option at the end of 2023 (1,549,080) and 2024 (625,825), matching the ground truth. It accurately calculates the number of shares exercised (1,549,080 - 625,825 = 923,255; however, the stated 905,219 exercised and 18,036 forfeited sum to 923,255, confirming internal consistency and alignment with the ground truth). These numbers are factually correct and match the original answer. (2) All numeric values—1,549,080, 625,825, 905,219, and 18,036—are accurate and consistent with the ground truth. The implied calculation (1,549,080 - 625,825 = 923,255 = 905,219 + 18,036) is correct, confirming quantitative accuracy. (3) The reasoning correctly infers that the decline indicates exercise and forfeiture trends, and that this reflects progression toward the end of the options' lifecycle. The addition of context about 'strong employee participation' and 'aggregate intrinsic value of $320 million' is plausible and adds value, though this specific dollar figure is not in the ground truth and was not requested in the question. While this extra detail doesn't contradict the truth, it slightly extends beyond the provided information, slightly reducing qualitative precision. (4) The answer fully addresses both parts of the question: the evolution of shares (quantitative change) and what it indicates (exercise and forfeiture trends). The multi-hop synthesis—linking the change in outstanding shares to exercise and forfeiture behavior—is sound and well-reasoned. The added intrinsic value context is relevant but not required, not detracting from relevance. Final scores: Correctness 9 (all key facts correct, minor addition of unverified value), Quantitative 10 (all numbers and calculations correct), Qualitative 9 (excellent reasoning, slight over-enrichment), Contextual Relevance 10 (directly responsive and on-topic).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 515,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services expanded its role and strategic positioning within UnitedHealth Group by enhancing its service offerings and integrating more deeply into the broader health care ecosystem. The evolution is marked by increased script volumes due to growth in both new and existing clients, as well as expansion in pharmacy services. Optum Rx also focused on operating cost efficiencies and supply chain initiatives, fulfilling over 1.6 billion adjusted scripts in 2024. Its strategic positioning was further solidified by leveraging data and analytics to support integrated medical and pharmaceutical care, aligning with UnitedHealth Group's mission to improve health outcomes and affordability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct qualitative elements, such as Optum Rx's deeper integration into UnitedHealth Group's ecosystem, use of data and analytics, and focus on affordability and health outcomes. However, it introduces a quantitative claim—'fulfilling over 1.6 billion adjusted scripts in 2024'—that is not present in the original answer or supported by the ground truth. The original answer cites $112 billion in pharmaceutical spending (including $45 billion in specialty drugs) in 2022, but no such figures are provided for 2024. The LLM invents a specific script volume metric not found in the source, which undermines factual accuracy. (2) There are no calculations in the original answer, but the introduction of a new, unsupported number (1.6 billion scripts) constitutes a significant quantitative error. The original emphasizes spending amounts and network scale (67,000 pharmacies), not script volume. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that Optum Rx became more integrated into Optum’s broader strategy around data, analytics, and care integration. It captures the shift toward a more connected, value-oriented model. However, it fails to mention the 67,000+ retail pharmacy network, home delivery, specialty pharmacies, and infusion services described in 2022, and omits the explicit mention of clinical programs and digital tools for medication management. (4) The contextual relevance is high because the answer addresses the evolution of service offerings and strategic positioning. The qualitative accuracy is moderate due to correct thematic progression but missing key details. The correctness score is reduced primarily due to the fabrication of a major quantitative metric not present in the ground truth, which violates factual integrity despite otherwise reasonable synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 504,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Between 2023 and 2024, the composition and valuation of BlackRock's Equity Securities at FVTNI increased from $1,585 million to $1,950 million. Specifically, investments held for deferred cash compensation plans were included within Equity Securities at FVTNI in 2023 at $14 million, but these were reclassified under \"Investments related to deferred cash compensation plans\" in 2024, valued at $173 million, indicating a significant increase in the valuation of these specific investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2023, BlackRock reported $9 million (not $14 million) in Equity Securities at FVTNI for deferred cash compensation plans. The LLM also incorrectly states the total Equity Securities at FVTNI values as $1,585 million in 2023 and $1,950 million in 2024—these totals are not present in the ground truth and appear to be fabricated or misattributed. The only correct quantitative element is the 2024 reclassified amount of $173 million under 'Investments related to deferred cash compensation plans'. (2) The calculation of an increase from $14M to $173M is based on incorrect initial data, rendering the comparison misleading. The ground truth emphasizes a reclassification, not a growth in investment value per se. (3) The reasoning partially captures the multi-hop aspect by identifying a reclassification from FVTNI to the Equity Method section, which aligns with the ground truth’s conclusion about reporting changes. However, it fails to mention the Equity Method context explicitly and instead implies the change was merely a label shift without clarifying the accounting implications. (4) Despite incorrect numbers, the answer addresses the core theme—reclassification of deferred compensation investments—and remains contextually relevant. Hence, moderate scores for qualitative accuracy and contextual relevance, but low quantitative accuracy drags down overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 414,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program increased from $3,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024. This increase indicates a continued commitment to returning value to shareholders through share repurchases, reflecting confidence in the company's financial position and a strategic focus on optimizing capital allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the aggregate available authorization increased from $3,129,296 in 2022 to $2,694,281 in 2024, when in fact it decreased. This reverses the direction of change and misrepresents the core fact. The numbers themselves are numerically accurate (matching the ground truth values), but their interpretation as an 'increase' is false—$2,694,281 is less than $3,129,296. (2) Quantitative accuracy is partially correct because the dollar amounts and dates (August 31, 2022 and August 31, 2024) match the ground truth, but the comparison (increase vs. decrease) is wrong, leading to a flawed conclusion. No calculation is required beyond comparison, which is incorrect. (3) The multi-hop reasoning fails because the model draws the opposite conclusion based on the same data. Instead of recognizing a reduction in authorization indicating a more conservative capital strategy, it claims an increase and infers greater shareholder return commitment—this is logically inconsistent with the actual figures. (4) Contextual relevance is moderate because the answer addresses the right company (Accenture), the right program (open-market share purchase), and the right time frame, and attempts to interpret capital allocation strategy. However, due to the fundamental error in interpreting the trend, the qualitative and overall correctness scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 388,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares remained largely consistent, but there were notable developments in share repurchase activity and shareholder rights. In 2022, the company disclosed its intention to use a significant portion of cash from operations for share repurchases in fiscal 2023, with the number of shares repurchased subject to market conditions and other factors. By 2024, the share repurchase activity had progressed, with the Board of Directors authorizing funding for open-market share purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares, with an aggregate available authorization of $2,694,281 as of August 31, 2024. Shareholder rights remained unchanged, with exchangeable shares still allowing holders to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, and Accenture retaining the option to satisfy exchanges with cash.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key aspects. (1) Quantitative accuracy is perfect: the $2,694,281 share repurchase authorization as of August 31, 2024, is correctly reported, and the timeline (2022 intentions vs. 2024 authorization) aligns with the original. (2) The answer addresses both share repurchase activity and shareholder rights, covering the evolution from general intent in 2022 to a specific, quantified authorization in 2024. (3) However, there is a subtle but important discrepancy in the description of shareholder rights: the ground truth emphasizes Accenture's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares, which is a structural governance update not mentioned in the LLM response. Additionally, while the LLM correctly notes the one-for-one exchange right and cash settlement option, it states that 'shareholder rights remained unchanged,' which understates the evolution in disclosure depth and structural alignment described in the original answer. This omission affects qualitative accuracy, as it misses a key aspect of how disclosures evolved. (4) Despite this, the answer is contextually relevant, factually sound on all reported details, and correctly synthesizes information across years and disclosures, warranting a high correctness score with a minor deduction for incomplete qualitative nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 388,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2023 ($2,195 million) and 2024 ($2,467 million) are accurate, and the stated percentage change excluding foreign exchange fluctuations (14.4%) is correct. The total percentage change (12.3%) is not required in the answer since the question specifically asks for the percentage change excluding FX impact, which is correctly provided. (2) The calculations are sound: the actual growth rate can be verified as (2,467 - 2,195) / 2,195 ≈ 12.39%, which rounds to 12.3%, and the FX-neutral growth of 14.4% is explicitly confirmed in the ground truth. (3) The reasoning is logically sound and synthesizes the correct multi-hop data points: revenue values across two years and the adjusted growth rate. (4) All entities—'Electrophysiology Devices', '2023', '2024', and the financial metric 'revenue excluding foreign exchange fluctuations'—are accurately identified and correctly used. The answer is semantically equivalent to the original, with no omissions or distortions. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 317,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Accenture's investment in Duck Creek Technologies has shown significant valuation growth, impacting its financial performance. As of August 31, 2022, Accenture's investment in Duck Creek, accounted for under the equity method, had a carrying amount of $138,902 and an estimated fair value of $223,166. By fiscal 2024, this investment generated a $253 million gain, which positively affected adjusted earnings per share and operating performance. The increase in valuation reflects Accenture's confidence in Duck Creek's growth and strategic alignment, contributing to Accenture's broader technology and consulting offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $253 million gain in fiscal 2024 and the $223,166 fair value in fiscal 2022, which matches the ground truth. However, it introduces a new figure—'carrying amount of $138,902'—that is not present in the original answer and may be factually accurate but is unverifiable against the provided ground truth, thus introducing a potential inaccuracy. The 16% ownership stake mentioned in the ground truth is omitted, which is a minor but relevant detail regarding the nature of the investment. (2) The key financial figures—the $223,166 fair value and $253 million gain—are correctly reported, though the additional carrying amount figure lacks corroboration. No calculation errors are present, but completeness of numeric data is slightly compromised. (3) The multi-hop reasoning is sound: the LLM connects the valuation in 2022 to the financial impact in 2024 and infers strategic significance, correctly synthesizing evolution over time. The shift from equity-method accounting to a realized gain is implied through the mention of a $253 million gain affecting earnings, indicating a qualitative change in financial impact. (4) The answer is highly contextually relevant, directly addressing the evolution of the financial relationship, valuation changes, and performance impact. The qualitative interpretation about strategic alignment is reasonable and adds value without overreaching. The correctness score is 8 due to the introduction of an unverified number and omission of the ownership percentage, but core facts and reasoning remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 438,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, the composition and scale of Union Pacific's retention share and unit awards shifted, with a notable increase in the number of retention units and a decrease in the number of outstanding stock options. In 2022, the 2021 Plan had 389,207 retention shares outstanding, while in 2023, the 2021 Plan and subsequent awards under new agreements (e.g., performance stock units for executives like V. James Vena) indicate a stronger focus on long-term equity incentives. This shift suggests a strategic move by Union Pacific to align executive compensation more closely with long-term performance and shareholder value, emphasizing retention and performance-based rewards over traditional stock options.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual accuracy but introduces significant errors. It correctly states the 2022 figure of 389,207 retention shares outstanding as of December 31, 2021 (disclosed in 2022), but misrepresents the 2023 data. The ground truth states that in 2023, Union Pacific disclosed 954,405 retention shares *issued and outstanding* and *additionally* 366,046 retention units. The LLM incorrectly implies a shift from shares to units and suggests a decrease in stock options, which is not supported by the original answer—no mention of stock options decreasing was made in the ground truth. (2) The quantitative accuracy is partially correct: the 389,207 figure is accurate, and the general direction of increase is correct, but the LLM fails to report the exact 2023 figures (954,405 retention shares and 366,046 retention units), instead vaguely referencing 'performance stock units' and executive names (e.g., V. James Vena) not mentioned in the ground truth. The introduction of retention units is correctly interpreted as a strategic shift, but the absence of specific numbers reduces precision. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic emphasis on long-term incentives and retention. However, it conflates retention shares/units with performance stock units and stock options, which are distinct instruments not mentioned in the original answer. This indicates a failure to accurately synthesize the specific composition change. (4) The contextual relevance is high, as the answer addresses both the change in scale/composition and the implication for executive compensation strategy. However, due to factual inaccuracies in the quantitative details and incorrect references to stock options and other award types, the correctness score is limited to 5. The qualitative reasoning is reasonable but based on flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 514,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in its approach to excluding the impact of market volatility and asymmetrical accounting adjustments. Specifically, adjusted earnings continues to exclude net investment gains (losses), net derivative gains (losses), MRB remeasurement gains (losses), and goodwill impairments, as well as asymmetrical accounting adjustments related to in-force reinsurance and non-economic losses at contract inception for certain single premium annuity business. However, the 2024 filings reflect updated calculations under the Long-Duration Targeted Improvements (LDTI) guidance, which simplified the measurement model for DAC and VOBA and reclassified most embedded derivatives as MRBs. This resulted in the exclusion of changes in fair value associated with MRBs and changes in discount rates on certain annuitization guarantees from adjusted earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the continuity in MetLife's approach to adjusted earnings exclusions between 2023 and 2024 and accurately references key exclusions such as MRB remeasurement gains (losses), discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. It also correctly notes the impact of LDTI adoption, including the reclassification of embedded derivatives as MRBs and the simplification of DAC/VOBA measurement—elements aligned with the 2023 changes in the ground truth. However, the LLM fails to capture the *evolution* in 2024 as required by the question. Specifically, it omits the 2024 expansion of exclusions to include policyholder liability remeasurement gains (losses) tied to asymmetrical accounting from in-force reinsurance and the new exclusion of equity method adjustments in joint ventures from net investment income—both key developments noted in the original answer. While the LLM mentions 'updated calculations' under LDTI in 2024, it does not specify these new exclusions, suggesting continuity rather than refinement. This represents a significant gap in qualitative accuracy and completeness, particularly for a multi-hop question focused on *how the application evolved*. The answer is factually sound where it goes, but misses critical 2024-specific developments, leading to a partial correctness score. Quantitative accuracy is high as no incorrect numbers are presented (and none are contradicted), and contextual relevance is strong since the response stays focused on GAAP guidance, adjusted earnings, and market volatility exclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 443,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "Accenture's approach to achieving compressed transformations from 2022 to 2024 has evolved with a stronger emphasis on advanced technologies and expanded service scope. In 2022, the focus was on foundational digital transformation, leveraging cloud, data, AI, and automation to help clients build digital cores, optimize operations, and accelerate revenue growth. By 2024, the approach has expanded to include transformative technologies such as generative AI, digital twins, IoT, advanced robotics, and the metaverse, enabling clients to reimagine products, processes, and customer experiences. Additionally, the scope of services now includes deeper integration of intelligent operations through platforms like SynOps, as well as end-to-end solutions for capital projects and sustainable, intelligent product design, reflecting a broader and more integrated transformation strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Accenture's approach from 2022 to 2024 with a focus on advanced technologies and expanded scope. It accurately notes the inclusion of generative AI, digital twins, IoT, robotics, and metaverse by 2024, which aligns with the ground truth. However, it misrepresents the 2022 technological focus by omitting specific mention of 5G and Edge computing, and incorrectly frames 2022 as centered on 'foundational digital transformation' and 'building digital cores,' which is not in the original answer. The original specifies that in 2022, Accenture was already using digital twins, AI, IoT, cloud/Edge, 5G, robotics, and metaverse for redefining product lifecycle functions—not just foundational digital core building. Additionally, the LLM answer does not mention Accenture’s own development of automation equipment and commercial hardware, a key 2024 enhancement. The expansion into capital projects (plant construction, infrastructure, etc.) is correctly noted, though phrased more generally as 'end-to-end solutions for capital projects.' (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a technological evolution and broadening scope, but misattributes the starting point (2022 focus) and misses a key aspect of Accenture’s vertical integration in hardware development by 2024. (4) The answer is contextually relevant and well-structured, conveying a plausible narrative of evolution. Due to accurate mention of generative AI, digital twins, and capital projects, and mostly correct synthesis, the correctness score is 7—core facts are present but with notable omissions and slight misrepresentation of 2022 focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 503,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott maintained interest rate hedge contracts with notional values of $2.2 billion in both years to manage exposure to changes in the fair value of fixed-rate debt. These contracts are designated as fair value hedges, converting fixed-rate obligations to variable rates. In 2023, Abbott had $2.2 billion in such contracts, a decrease from $2.9 billion in 2022 due to maturities. By 2024, the notional value remained stable at $2.2 billion, indicating consistent use of these hedges to mitigate interest rate risk on its fixed-rate debt portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Abbott maintained $2.2 billion in interest rate hedge contracts in both 2023 and 2024, accurately reflecting the stable notional amount and the designation of these as fair value hedges that convert fixed-rate debt to variable-rate debt. This aligns with the ground truth. However, the LLM introduces information about a decrease from $2.9 billion in 2022 due to maturities, which is not present in the original answer and cannot be verified from the provided ground truth, making it an unsupported addition. (2) All numeric values directly related to 2023 and 2024 ($2.2 billion notional amount) are correct. The average interest rate increase from 3.6% to 3.8% is a key factual point in the ground truth that explains the context of the stable hedge amount amid changing debt conditions, but this detail is entirely missing in the LLM answer. This omission affects completeness and qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes that consistent notional value implies a stable hedging strategy. However, it fails to incorporate the evolution context fully by omitting the shift in average interest rates, which is central to understanding how the use of hedges evolved (or didn't evolve) in response to changing debt economics. (4) The correctness score is 8 because core facts about hedge usage are accurate and the main quantitative data is correct, but the missing interest rate trend weakens the completeness and depth of the evolution analysis. Quantitative accuracy is 9 because all stated numbers are correct, though not all relevant numbers are included. Qualitative accuracy is 8 due to sound reasoning but incomplete synthesis. Contextual relevance is 10 as the response directly addresses the question's focus on Abbott's hedge contract evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 505,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's treatment and definition of Adjusted Earnings remained consistent between 2023 and 2024 in terms of its role as the GAAP measure of segment performance and its use for evaluating management compensation and business performance. However, the 2024 filing explicitly highlights that the adoption of the Long-Duration Targeted Improvements (LDTI) impacted the calculation of Adjusted Earnings. Specifically, Adjusted Earnings in 2024 excludes changes in fair value associated with Market Risk Benefits (MRBs), changes in discount rates on certain annuitization guarantees, losses at contract inception for single premium business, and asymmetrical accounting from in-force reinsurance, reflecting the updated accounting model under LDTI. This update aligns Adjusted Earnings with the revised amortization and measurement models for Deferred Policy Acquisition Costs (DAC) and Value of Business Acquired (VOBA).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the impact of LDTI on Adjusted Earnings and correctly identifies key exclusions introduced in 2023 that carried into 2024, such as MRB fair value changes, discount rate adjustments on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. It correctly notes that Adjusted Earnings remains the GAAP measure of segment performance. However, it omits a critical aspect of the evolution: the 2024 refinements expanded and more clearly structured the exclusions beyond LDTI-related items to include non-economic losses from single premium annuity contracts, inflation-indexed benefit adjustments, and clearer exclusion of divested business results and discontinued operations. While the LLM mentions 'losses at contract inception for single premium business,' this is not equivalent to the more specific 'non-economic losses from single premium annuity contracts' emphasized in the ground truth. Additionally, the answer implies consistency between 2023 and 2024 in treatment, but the ground truth indicates a refinement and expansion in 2024, which the LLM underemphasizes. There are no numerical inaccuracies (hence quantitative accuracy is high), and the entities (LDTI, MRB, DAC, VOBA) are correctly identified. The reasoning is sound but incomplete in capturing the full scope of 2024 changes, leading to a moderate deduction in qualitative accuracy. Contextual relevance is high as the response directly addresses the evolution of Adjusted Earnings in relation to GAAP and segment performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 431,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's share purchase program saw an increase in available authorization, with $3,129,296 in 2022 rising to $6,694,281 in 2024. In terms of share acquisition methods, open-market purchases remained the primary method, with 9,635,751 shares repurchased in 2022 and 11,753,807 in 2024. Additionally, shares were acquired via employee equity plans, primarily through share withholding for payroll tax obligations, with minimal impact on available authorization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Accenture had an aggregate available authorization of $3,129,296 in 2022, but the LLM claims it increased to $6,694,281 in 2024 — this figure is not present in the original answer and is therefore incorrect. Additionally, the LLM introduces specific share repurchase volumes (9,635,751 in 2022 and 11,753,807 in 2024), which are not mentioned in the ground truth and appear fabricated. (2) The only correct quantitative element is the 2022 authorization amount ($3,129,296), which matches the original. All other numbers — including the 2024 authorization and share counts — are unsupported and false. There are no calculations in the ground truth to verify, but the LLM invents numerical trends (increase in authorization, share counts) that cannot be substantiated. (3) The qualitative reasoning is partially sound in identifying share withholding for payroll tax obligations as a method of acquisition in 2024 and noting that such purchases do not impact public program authorization. However, it misrepresents the evolution by suggesting open-market purchases remained the 'primary' method, while the original answer emphasizes a shift toward non-open-market methods like withholding. The LLM also fails to mention the inclusion of Accenture Canada Holdings Inc. exchangeable shares in 2022 or the clarification in 2024 that only Accenture plc Class A shares were covered under the open-market program. (4) The contextual relevance is moderate because the answer addresses funding levels and acquisition methods, aligning with the question’s focus, but the severe quantitative errors and omission of key qualitative details (e.g., treasury use for employee benefits, entity-specific share types) undermine overall correctness. The answer creates a misleading narrative of growth and volume-based repurchases not supported by the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 524,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities remained consistent in terms of cost basis, as these securities are primarily valued using amortized cost for fixed maturity components and original cost for equity components. However, the fair value sensitivity for Unit-linked Securities in 2024 appears to reflect broader market conditions, as the fair value increased from $10,331 million in 2023 to $12,150 million in 2024 (based on context from 2024 disclosures). Sensitivity to inputs such as equity volatility, interest rates, and credit spreads remained a factor, with methodologies emphasizing the use of observable and unobservable inputs depending on the level of market data availability.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The core claim that MetLife's valuation methodology 'remained consistent' from 2023 to 2024 is directly contradicted by the ground truth, which states a clear shift from a cost-based approach in 2023 to a Level 3 fair value methodology with significant unobservable inputs in 2024. The LLM incorrectly implies continuity in treatment, missing the key evolution in methodology. (2) The quantitative values cited ($10,331 million in 2023 and $12,150 million in 2024) are not present in the original answer and appear to be fabricated or misattributed; the ground truth does not provide any dollar amounts for Unit-linked Securities' fair value in either year. This is a critical error in quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks about changes in treatment and valuation methodology, particularly cost basis and fair value sensitivity. The ground truth highlights a shift from static cost-based valuation (amortized/original cost) to a dynamic, assumption-driven Level 3 model. The LLM fails to identify this shift and instead incorrectly asserts consistency in cost basis while vaguely referencing sensitivity inputs. It also introduces market-condition-driven fair value changes not mentioned in the original. (4) While the LLM mentions some correct concepts (e.g., amortized cost, equity volatility, unobservable inputs), it misrepresents their timing and significance. The contextual relevance is moderate because it discusses related topics, but the failure to capture the fundamental methodological shift severely undermines correctness. The answer is partially informed but ultimately misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 466,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "The structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023 as follows: in 2022, market-based RSUs generally vested over four years, with grantees potentially receiving 0% to 300% of the original grant based on total stockholder return (TSR) performance. In 2023, in addition to the four-year vesting RSUs, Broadcom also granted market-based RSUs that vested over five years, subject to satisfaction of stock price performance milestones.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, market-based RSUs vested over four years with payout between 0% and 300% based on TSR performance; in 2023, the company maintained four-year vesting RSUs and introduced five-year market-based RSUs tied to stock price performance milestones. (2) There are no numeric or date inaccuracies—percentages, timeframes, and performance ranges match the original answer exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across fiscal years, identifying both continuity (four-year vesting) and evolution (addition of five-year vesting with different performance criteria). (4) The answer is fully relevant and addresses both the structural and timeline aspects of the question, capturing the expansion in RSU design. Minor wording differences (e.g., 'satisfaction of stock price performance milestones' vs 'contingent on achieving stock price performance milestones') do not affect meaning and are semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 305,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital continued under the CECL Transition Rule. In 2023, 50% of the cumulative \"day 2\" ongoing impact had been phased in, with the remaining 50% to be phased in over 2024 and 2025. By 2024, 75% of this impact had been phased in, with the final 25% scheduled for full implementation by January 1, 2025. During the phase-in period, the impact of CECL was phased in at 25% per year starting from January 1, 2022, with the \"day 1\" CECL adoption impact and cumulative \"day 2\" ongoing impact being added back to regulatory capital incrementally.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative timeline and phase-in schedule. According to the ground truth, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased in at 25% per year from January 1, 2022, through December 31, 2024—meaning the phase-in period ended in 2024, not 2025. The correct progression is: 25% by 2022, 50% by 2023, and 75% by 2024, with full implementation by January 1, 2025. However, the LLM incorrectly states that in 2023 only 50% had been phased in (correct), but then claims the remaining 50% would be phased in over 2024 and 2025—this contradicts the ground truth that the annual 25% phase-in ends in 2024, not extending into 2025. This introduces a critical error in the phase-in duration. Additionally, the original answer confirms the treatment was consistent between 2023 and 2024, which the LLM acknowledges, but the incorrect extension into 2025 undermines the accuracy. The mention of 'day 1' impact being added back is not in the ground truth and introduces unsupported detail. While the core concept of 25% annual phase-in is correct, and the general regulatory framework (CECL Transition Rule) is properly identified, the miscalculation of the phase-in timeline and erroneous extension to 2025 result in major quantitative and qualitative flaws. The answer is contextually relevant and attempts correct multi-hop synthesis, but fails in precise factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 403,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association evolved in terms of the types and terms of senior notes issued under their indentures. In 2022, Broadcom issued several senior notes, including the 4.926% Senior Notes due 2037 under an indenture dated April 18, 2022. In 2023, the company continued this trend, issuing new senior notes such as the 5.050% Senior Notes due 2027, 5.050% Senior Notes due 2029, and 5.150% Senior Notes due 2031 under an indenture dated July 12, 2024. Additionally, in October 2024, Broadcom issued further senior notes, including the 4.150% Senior Notes due 2028, 4.350% Senior Notes due 2030, 4.550% Senior Notes due 2032, and 4.800% Senior Notes due 2034 under a supplemental indenture dated October 2, 2024. These developments indicate an expansion in the variety and maturity terms of senior notes issued under the indentures with Wilmington Trust, National Association.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in dates and interest rates. The original answer states that in 2022, Broadcom issued notes under indentures from January 2021 and April 18, 2022, including a 4.926% note due 2037. This part is partially correct. However, the LLM claims that in 2023, Broadcom issued 5.050% and 5.150% notes under an indenture dated July 12, 2024 — which is a future date and not supported by the ground truth. The original answer only mentions notes issued in October 2024 with rates from 4.150% to 4.800%, not the 5.050% or 5.150% rates cited by the LLM. Additionally, the LLM fabricates a supplemental indenture dated October 2, 2024, which is not mentioned in the original. (2) Quantitative accuracy is low: multiple incorrect interest rates (e.g., 5.050%, 5.150%) and maturities (e.g., due 2027, 2029, 2031) are introduced without basis. The October 2024 issuance is misrepresented with finer breakdowns not in the original. Also, citing a July 12, 2024 indenture in a 2023 context is chronologically inconsistent. (3) The multi-hop reasoning is partially sound — the model recognizes that the relationship evolved with new indentures and higher-yielding notes — but fails to accurately represent the timeline and specific terms. It incorrectly implies activity in 2023 when the new indentures were actually executed in 2022 and 2024. (4) Despite inaccuracies, the answer is contextually relevant, addressing the evolution of the relationship and attempting to describe changes in note types and terms. The core idea of increasing yields and expanding maturities aligns with the original, but the factual foundation is flawed, warranting a moderate score for qualitative accuracy and low for quantitative correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 486,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 by following a phased-in progression as outlined in the CECL Transition Rule. In 2023, 50% of the cumulative \"day 2\" ongoing impact of CECL was phased in, and by January 1, 2024, 75% of the total add-back amount had been phased in. This reflects the annual 25% phase-in increment mandated by the rule from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the phase-in progression from 50% in 2023 to 75% by January 1, 2024, which matches the ground truth. It accurately reflects the 25 percentage point annual increase under the CECL Transition Rule. However, it omits the specific dollar amount of $2.4 billion that Capital One added back in 2023, which is a key quantitative detail present in the original answer. (2) All percentages and dates are correct: 50% as of 2023 and 75% by January 1, 2024, with a 25% annual phase-in increment. The timeline aligns with the five-year phase-in process starting from 2021, though the LLM incorrectly states the annual increments apply from 2022 through 2024, while the rule began phasing in from 2021 onward (with 25% increments starting after 2021). This is a minor error in framing but does not invalidate the core correctness. (3) The multi-hop reasoning is sound—linking the phase-in percentages across years and referencing the regulatory framework—but the omission of the $2.4 billion figure reduces completeness. The model correctly synthesizes the progression logic but misses a concrete financial metric. (4) The answer is highly accurate in reasoning and context, with only minor omissions and a slight misstatement on the phase-in period. Hence, a 9/10 for correctness and qualitative accuracy, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 391,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition in November 2023, all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts. This marked a shift from the prior year (2022), when the VMware merger was pending, and similar accelerated treatment was outlined but not yet executed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that in 2022, the accelerated treatment of VMware stock options and RSUs for non-employee directors was planned but not yet executed due to the pending Broadcom acquisition, and that in 2023, following the November 2023 completion, these awards were accelerated and converted into equal parts cash and Broadcom shares. (2) There are no numeric values requiring calculation, but the key date—November 2023—is correctly stated and aligns with the acquisition's completion. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution from a planned event in 2022 to an actualized outcome in 2023, drawing appropriate contrast between the two years. (4) The only minor shortcoming is that the LLM does not explicitly mention that the 2022 plan was documented in the 10-K filing, which slightly reduces qualitative accuracy, but this omission does not affect the factual correctness of the response. Overall, the answer is semantically equivalent, contextually relevant, and accurately reflects the transition from plan to execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 330,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar (cariprazine) evolved from 2022 to 2024 to include its evaluation as an adjunctive treatment for major depressive disorder (MDD). In 2021, AbbVie reported top-line results from two Phase 3 trials, where Vraylar met the primary endpoint in one study and showed numerical improvement in the other. By 2024, while no new approvals for MDD were disclosed, Vraylar continued to be indicated for schizophrenia, bipolar disorder, and manic or mixed episodes, with its expanded data supporting its potential broader use in psychiatric conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key aspects of the evolution in therapeutic positioning. It correctly notes that in 2022 (and referencing 2021 data), Vraylar was evaluated in Phase 3 trials for adjunctive treatment of MDD, with one trial meeting the primary endpoint and the other showing numerical but not statistically significant improvement. However, it inaccurately states that 'by 2024, while no new approvals for MDD were disclosed,' which contradicts the ground truth: by 2024, AbbVie explicitly disclosed that Vraylar was *indicated* for adjunctive treatment in MDD, reflecting regulatory progress. (2) Quantitatively, the dates and trial outcomes are mostly accurate—referring to two Phase 3 trials with mixed results—but incorrectly shifts focus to 2021 instead of 2022 as the reference year in the original answer. This is a minor timing discrepancy but does not severely impact accuracy. No numerical values (e.g., p-values, patient counts) are misstated because none were provided. (3) The multi-hop reasoning is partially sound: the model connects clinical trial data to therapeutic positioning, but fails to fully synthesize the expansion of approved indications by 2024. The ground truth emphasizes a broadening to include acute and maintenance treatment of schizophrenia, bipolar mania/mixed episodes, bipolar depression, and adjunctive MDD—this comprehensive expansion is not reflected in the LLM answer, which only mentions continuation of existing indications without highlighting the *broadened* scope. (4) Contextual relevance is high—the response stays on topic and discusses therapeutic positioning over time. However, due to omission of the full range of 2024 indications and incorrect implication that MDD approval did not occur, the qualitative and overall correctness scores are reduced. The answer captures part of the evolution but lacks completeness and precision in reflecting the approved expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 534,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "GE's accounting policy for long-term service agreements has remained consistent in using the percentage of completion method for revenue recognition, based on costs incurred to date relative to total expected costs, from 2022 to 2024. However, there have been refinements in estimating contract billing and costs. In 2024, the company emphasized the use of historical utilization trends and forward-looking information such as market conditions and asset retirements to estimate customer payments and future costs. Additionally, cost estimates now incorporate observed cost improvements or those proven through regulatory or engineering approvals, ensuring more accurate and reliable projections. These adjustments reflect a continued focus on enhancing the precision of revenue and cost estimates to align with actual performance and market dynamics.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that GE used the percentage of completion method from 2022 to 2024. According to the ground truth, in 2022, GE used the straight-line basis for revenue recognition in long-term services agreements, particularly in Healthcare and Renewable Energy. The shift to percentage of completion occurred by 2024, primarily in the CES segment. This fundamental misrepresentation of the revenue recognition method timeline severely undermines the answer's correctness. Additionally, the LLM claims the policy 'remained consistent,' which directly contradicts the evolution described in the original answer. (2) Quantitatively, the LLM fails to mention any of the key figures from the ground truth: the $6.6 billion net liability balance in 2024, the $162 billion total estimated life of contract billings, or the 4.1% ratio. These specific numbers are central to demonstrating the enhanced estimation process in 2024 and their absence indicates a major omission. No calculations are attempted, but the missing data points are critical. (3) The multi-hop reasoning is flawed. The question asks for an evolution from 2022 to 2024, requiring comparison across years and synthesis of changes in both revenue recognition method and billing estimates. The LLM incorrectly asserts consistency rather than change, failing to recognize the shift from straight-line to percentage of completion. While it does mention refinements in 2024 regarding utilization trends and cost improvements, this is only partial and presented as an incremental update rather than part of a broader policy shift. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right topic (accounting policy for long-term service agreements), discusses revenue recognition and cost estimation, and references forward-looking adjustments. However, the core factual inaccuracy regarding the revenue recognition method timeline results in a low correctness score. Minor positive credit is given for correctly identifying the use of cost-based percentage of completion in 2024 and mentioning improved estimation techniques, but these do not compensate for the major error in historical policy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 596,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing, IBM's 1.250% Notes due 2027 are referenced as being incorporated by reference from Form 8-K filed January 30, 2019. In the 2023 10-K filing, the 1.250% Notes due 2027 are explicitly listed under the company's registered securities on page 1, indicating a more direct and prominent disclosure in the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 1.250% interest rate, 2027 maturity, and the reference to the Form 8-K filed on January 30, 2019, are all correctly stated. The evolution between the 2022 and 2023 10-K filings is accurately captured—specifically, the shift from incorporation by reference in 2022 to explicit listing as a registered security in 2023. The mention of 'page 1' in the 2023 10-K is not in the ground truth but does not contradict it and may reflect actual placement; thus, it doesn't reduce accuracy. The core evolution—increased prominence and direct disclosure—is correctly interpreted. The only minor gap is that the LLM does not mention the trading symbol 'IBM 27B' or the New York Stock Exchange listing detail present in the original answer, which adds specificity about registration. This omission reduces completeness slightly but does not affect the central correctness. The reasoning is sound, demonstrating proper multi-hop synthesis across two filings. The answer is contextually relevant and conveys semantically equivalent information with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 316,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure and performance criteria of AbbVie's performance-vested RSUs evolved in terms of vesting increments and performance metrics. In 2022, performance-vested RSUs were tied to AbbVie's return on invested capital (ROIC) relative to a defined peer group. By 2024, the performance metrics shifted to focus on AbbVie's return on invested capital (ROIC) and total stockholder return (TSR) relative to the same peer group. Additionally, vesting remained in one-third increments over a three-year performance period in both years, but the 2024 structure emphasized a broader set of financial and market performance indicators.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the performance metrics in 2024. The ground truth states that by 2024, the performance criteria were streamlined and focused primarily on ROIC relative to the peer group, without introducing new metrics. However, the LLM incorrectly claims that total stockholder return (TSR) was added as a performance metric in 2024, which contradicts the original answer. This is a major qualitative inaccuracy. (2) Quantitatively, the answer correctly identifies the vesting structure (one-third increments over a three-year period) for both years, which aligns with the ground truth. There are no numerical values to verify beyond this structural description, and the timeline (2022 to 2024) is correctly framed. (3) The multi-hop reasoning is partially sound— the model correctly identifies the continuity in vesting increments and attempts to compare changes in performance metrics. However, it fails in synthesizing the correct evolution of metrics, incorrectly suggesting an expansion (adding TSR) rather than a simplification or standardization of criteria as stated in the ground truth. (4) Contextual relevance is high because the response addresses both vesting structure and performance metrics over time, directly engaging with the question's focus. However, due to the critical error in describing the 2024 performance metrics, the correctness and qualitative accuracy scores are significantly reduced. The answer is partially correct but contains a key factual misstatement that alters the interpretation of how the RSU criteria evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 442,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains or losses on its investment, showed a significant shift. In 2022, GE reported a realized and unrealized loss of $865 million, indicating a substantial decline in the value of its investment in AerCap. However, by 2023, this loss had reduced to $129 million, suggesting some recovery in the investment's value. In 2024, GE recorded a gain of $38 million, indicating an improvement in the financial position of its investment in AerCap. This evolution reflects a gradual recovery in the value of GE's investment in AerCap over the three-year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, GE reported an *unrealized loss* of $865 million, but the LLM incorrectly describes it as a 'realized and unrealized loss,' conflating the nature of the loss. More critically, the LLM introduces a figure for 2023—$129 million loss—which is not present in the original answer or ground truth. There is no mention of 2023 in the ground truth, making this an unsupported addition. The 2024 gain of $38 million is correctly cited as a 'realized and unrealized gain' in the original, but the LLM simplifies it to just 'gain,' losing precision. (2) Quantitative accuracy is low because the model fabricates a data point for 2023 and mischaracterizes the 2022 loss. While $865M and $38M are correctly used, their classification and context are flawed. (3) The multi-hop reasoning is partially sound in identifying a trend from loss to gain, but the introduction of an unverified intermediate year (2023) undermines the logical synthesis. The conclusion of a 'gradual recovery' over three years is speculative and not fully supported by the two data points provided in the ground truth. (4) Contextual relevance is high because the answer addresses the evolution of GE's financial relationship with AerCap through gains/losses. However, correctness is severely impacted by hallucinated data and misclassification of financial terms, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 405,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2022 SEC filing, the 0.300% Notes due 2026 are explicitly listed on page 33 as an exhibit incorporated by reference, with the instrument filed as Exhibit 4 to Form 8-K on November 1, 2016. In the 2023 SEC filing, the 0.300% Notes due 2026 are directly disclosed on page 1 under the list of securities registered pursuant to Section 12(b) of the Exchange Act, with the trading symbol \"IBM 26B\" and listed on the New York Stock Exchange. This indicates an increased visibility in the 2023 filing, where the notes are explicitly named and categorized, compared to the 2022 filing, where they were referenced only in the exhibit list without direct mention in the main body of the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution in disclosure status of the 0.300% Notes due 2026 from 2022 to 2023: in 2022, the notes were referenced as Exhibit 4 to Form 8-K filed on November 1, 2016, incorporated by reference, which aligns with the ground truth. In 2023, the notes are explicitly listed under Section 12(b) of the Exchange Act with the trading symbol 'IBM 26B' on the New York Stock Exchange, indicating increased visibility and formal recognition—this is correctly captured. (2) All dates (November 1, 2016), percentages (0.300%), maturity year (2026), and trading symbol (IBM 26B) are factually accurate. Page references (page 33 in 2022, page 1 in 2023) add precision and are consistent with typical SEC filing structures, though not contradicted by the ground truth. (3) The multi-hop reasoning—comparing the treatment of the same financial instrument across two years and interpreting the shift from exhibit-level reference to direct registration—is sound and well-articulated. (4) The answer conveys semantic equivalence to the original answer, with enhanced detail (e.g., specific filing sections and page numbers) that improve clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 367,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved by increasing its strategic emphasis on sustainable aviation technologies and accelerating investment in innovation to reduce fuel consumption and CO2 emissions. In 2022, the RISE program was introduced as a technology development initiative targeting over 20% lower fuel consumption and CO2 emissions compared to existing engines. By 2024, GE's R&D funding had increased significantly, with a stronger focus on programs like RISE to enable a more sustainable future of flight, reflecting a deeper commitment to advancing clean propulsion solutions and meeting evolving regulatory and market demands for environmental performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2022 announcement of the RISE Program targeting over 20% reduction in fuel consumption and CO2 emissions is accurately reported, and the 2024 shift to 'significant investments' in R&D for sustainable flight is correctly conveyed. (2) Quantitative accuracy is perfect: the 20% reduction figure is correctly cited, and no erroneous numbers are introduced. (3) The multi-hop reasoning is sound—information from 2022 (program announcement) and 2024 (investment escalation) is properly synthesized to show evolution in strategy. The LLM captures the shift from conceptual to active R&D, though it does not explicitly mention Safran as the collaborator in 2022, which is a minor omission affecting completeness but not the core strategic narrative. (4) The answer is contextually relevant, directly addressing both strategic emphasis and investment focus as asked. Wording differs slightly but maintains semantic equivalence. The absence of Safran slightly reduces qualitative accuracy, but the overall reasoning and factual correctness remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 324,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, the role and emphasis on asset securitizations within American Express's funding strategy remained a key component but with evolving considerations. In 2022, the company highlighted asset securitizations as part of its diverse funding sources, including deposits, unsecured debt, and secured borrowings, with a focus on maintaining a balanced debt maturity profile. By 2023, while still emphasizing securitizations as a core funding tool, the company noted increased sensitivity to external factors such as market capacity, regulatory changes, and the performance of previously securitized loans and receivables. This shift reflects a more cautious and adaptive approach to securitization within a broader, diversified funding strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of American Express's treatment of asset securitizations from 2022 to 2023. According to the ground truth, in 2022, asset securitizations were only mentioned in a glossary entry as a defined term, with no strategic emphasis — they were not described as part of a diverse funding strategy or discussed alongside deposits and unsecured debt. The LLM incorrectly claims that in 2022, securitizations were already highlighted as a funding source among others, which contradicts the original answer. In reality, the strategic positioning of securitizations as a core funding component began in 2023, which the LLM correctly notes, but it misrepresents the 2022 context. Additionally, the LLM introduces new details not present in the ground truth — such as 'increased sensitivity to external factors' and 'performance of previously securitized loans' — which are unsupported by the provided disclosures. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years 2022 and 2023 are used correctly in context, hence a score of 10. (3) The multi-hop reasoning is flawed because the LLM fails to accurately distinguish the nature of the disclosures between the two years — it incorrectly assumes strategic discussion in 2022 when only a definitional glossary entry existed. This undermines the synthesis required to show evolution. (4) While the LLM answer is relevant to the question and addresses the general theme of funding strategy evolution, its core factual misrepresentation of the 2022 disclosure significantly reduces correctness and qualitative accuracy. The contextual relevance remains high because the response attempts the right comparison across years and focuses on funding strategy, even if the details are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 518,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial and strategic relationship with AspenTech evolved significantly. In May 2022, Emerson contributed two industrial software businesses and $6.0 billion in cash to Heritage AspenTech, acquiring 55% of the newly formed AspenTech. This integration positively impacted Emerson's 2023 financials, contributing to a 20% increase in Software and Control sales and a 0.6 percentage point improvement in gross margin. By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech for $240 per share, signaling a move toward full ownership and further operational integration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson held a minority investment in AspenTech with $656 in sales and $12 earnings gain, and total assets of $14,484. However, the LLM claims Emerson acquired a 55% stake in May 2022 through a $6.0 billion cash contribution and asset transfer — this is incorrect and contradicts the ground truth that the controlling interest was established in 2023, not 2022. The 0.6 percentage point improvement in gross margin in 2023 is correctly mentioned, but the 20% increase in Software and Control sales is not supported by the original answer and appears fabricated. The mention of a November 2024 proposal to acquire the remaining 43% at $240 per share is not present in the ground truth and introduces future events and details not in the original data. (2) Quantitative inaccuracies include: wrong year for the 55% acquisition (2022 vs actual 2023), incorrect cash amount ($6.0 billion not in original), incorrect ownership percentage remaining (43% vs original implication of 45%), and unsupported metrics like 20% sales increase. The only correct number is the 0.6 percentage point gross margin improvement in 2023. (3) The multi-hop reasoning is partially sound in recognizing a strategic evolution from investment to control and linking operational integration to financial impact, but the timeline and supporting data are incorrect. The model fails to accurately synthesize the progression from minority stake in 2022 to majority control in 2023 based on actual financials. (4) Contextual relevance is high as the answer addresses investment returns and operational integration, but correctness is severely undermined by false specifics. The qualitative accuracy is moderate due to correct directional logic but flawed factual grounding. Quantitative accuracy is low due to multiple incorrect figures and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 520,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly due to the 2022 business combination with Heritage AspenTech. Emerson became the accounting acquirer and owned 55% of AspenTech's outstanding shares, with a noncontrolling interest of $5.9 billion for the 45% owned by former Heritage AspenTech stockholders. The Heritage AspenTech acquisition positively impacted Emerson's 2023 financials, contributing to higher sales and margin benefits, while also increasing SG&A expenses due to higher stock compensation costs. Additionally, the acquisition led to higher intangible amortization expenses in 2023, which affected gross margins and operating expenses.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Emerson's 55% ownership and the $5.9 billion noncontrolling interest in 2022, which aligns with the ground truth. However, it omits the $6.0 billion cash contribution and the $550 million decrease to additional paid-in capital—key quantitative details from the 2022 transaction. In 2023, the LLM mentions increased SG&A expenses due to stock compensation, which is correct, but incorrectly attributes higher intangible amortization to gross margin impacts, whereas the ground truth states the AspenTech acquisition *improved* gross margins by 0.6 percentage points. This is a significant factual error affecting quantitative and qualitative accuracy. (2) The ground truth specifies SG&A rose by $572 million, a precise figure missing in the LLM response. The LLM does not quantify any financial impacts, reducing its numerical precision. (3) The multi-hop reasoning is generally sound—linking the 2022 ownership structure to 2023 financial effects—but fails in accurately representing the direction of gross margin impact. It correctly identifies the shift from accounting to operational integration but misrepresents the financial effect. (4) Despite missing key numbers and containing a directional error on gross margins, the LLM captures the core evolution: initial noncontrolling interest accounting in 2022 and operational expense impacts in 2023. Hence, correctness is reduced to 7 due to material omissions and one major financial misstatement, though the overall narrative remains relevant and partially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 432,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In the 2022 SEC filing (IBM_10k_2022.pdf, page 31), the 6.22% Debentures due 2027 are referenced as an exhibit (Exhibit 3 to Form 8-K, filed August 1, 1997). In the 2023 SEC filing (IBM_10k_2023.pdf, page 1), the 6.22% Debentures due 2027 are listed among IBM's registered securities under Section 12(b) of the Exchange Act, indicating ongoing disclosure as part of the company's publicly traded debt instruments. There is no substantive change in the treatment of the debentures, but their inclusion in the 2023 filing reflects continued recognition in the company's financial disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts from both the 2022 and 2023 filings: in 2022, the 6.22% Debentures due 2027 were referenced via Exhibit 3 to Form 8-K filed on August 1, 1997 (page 31 of the 2022 10-K), and in 2023, they are listed under Section 12(b) of the Exchange Act as registered securities (page 1 of the 2023 10-K). All dates, percentages, and document references are accurate. (2) Quantitative accuracy is perfect: the interest rate (6.22%), maturity year (2027), exhibit number (3), and filing date (August 1, 1997) are all correctly reported with no calculation errors. (3) However, the LLM understates the evolution in disclosure. While it notes the 2023 inclusion under Section 12(b), it claims 'no substantive change in the treatment,' which contradicts the ground truth that highlights a shift toward a more structured, transparent, and market-oriented presentation — including the addition of the trading symbol (IBM 27) and explicit listing among NYSE-registered securities. This omission of the enhanced transparency and market integration weakens the qualitative accuracy. (4) The answer remains contextually relevant and factually grounded, but fails to fully capture the significance of the disclosure evolution, particularly the move from a passive historical reference to an active, current market listing. Hence, correctness is reduced to 7 for missing this key interpretive point despite factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 403,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased from 2023 to 2024, as evidenced by the growth in its Medicare Advantage and Medicare Part D premium revenues, which accounted for 40% of total consolidated revenues in 2024. This expansion of risk-based arrangements enhances the Company's financial exposure to the health status and medical cost trends of enrolled members. As a result, the Company faces greater challenges in accurately estimating medical costs and ensuring adequate financial and medical care resources from its provider partners. If these providers face financial difficulties or fail to manage costs effectively, UnitedHealth Group could incur higher-than-expected claims liabilities, which could negatively impact its service delivery and profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UnitedHealth Group's financial risk exposure increased from 2023 to 2024 due to expanded risk-based arrangements and greater provider-related financial and operational risks. It also correctly notes implications for cost estimation and service delivery. However, it introduces a specific quantitative claim—'Medicare Advantage and Medicare Part D premium revenues accounted for 40% of total consolidated revenues in 2024'—that is not present in the original answer and cannot be verified from the provided ground truth. This number is likely fabricated or misattributed, significantly undermining quantitative accuracy. (2) There are no calculations in the LLM answer, but the introduction of an unsupported percentage (40%) is a critical factual error. The original answer does not mention revenue breakdowns by segment or percentages, so this detail is extraneous and incorrect. (3) The multi-hop reasoning is partially sound: the model infers increased risk exposure and links it to provider solvency and cost estimation challenges, aligning with the original answer’s emphasis on heightened responsibility for unpaid claims and provider performance. However, it misses key nuances from 2023—such as the recognition of premium revenues based on estimated earnings and rebates, and per-member-per-month value-based arrangements—which would have demonstrated fuller synthesis across years. (4) The contextual relevance is high because the answer addresses the evolution of risk exposure and its implications on cost estimation and service delivery. Qualitative accuracy is moderate due to correct conceptual understanding but incomplete representation of the original disclosures. Correctness score is 6 due to a mix of accurate reasoning and significant factual overreach with the unverified 40% figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 504,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Emerson's financial relationship with AspenTech evolved significantly between 2022 and 2023, both in terms of investment magnitude and strategic involvement. In 2022, Emerson contributed two of its industrial software businesses to Heritage AspenTech in exchange for equity, increasing its ownership stake. By 2023, Emerson owned 55% of AspenTech, and the company's financial involvement expanded, with AspenTech's sales rising from $656 million in 2022 to $656 million in 2023, reflecting strategic integration and growth. Additionally, Emerson recognized gains from AspenTech's equity investments and foreign currency contracts, highlighting its deepening strategic and financial commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that in 2022, Emerson contributed industrial software businesses to Heritage AspenTech, when in fact in 2022 Emerson only had a financial investment of $362 million in AspenTech, not a strategic contribution. The major transaction—where Emerson contributed its Industrial Software Business and ~$6.0 billion in cash—occurred in 2023, not 2022. The LLM reverses the timeline of the strategic shift. Additionally, the claim that AspenTech's sales were $656 million in both 2022 and 2023 is irrelevant and unsupported by the ground truth, which does not mention AspenTech's sales figures. The 55% ownership stake is correctly identified, but it is misattributed to 2023 without clarifying that this resulted from the 2023 transaction, not a gradual increase. (2) Quantitative inaccuracies include the missing $362 million investment figure for 2022 and the erroneous $656 million sales data. The $6.0 billion cash contribution is omitted entirely, a major quantitative error. The LLM mentions 'gains from equity investments and foreign currency contracts,' which are not in the ground truth and appear fabricated. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence the evolution from financial (2022) to strategic (2023) and misattributes actions to the wrong year. It conflates Emerson’s actions with AspenTech’s financials without proper sourcing. (4) Despite these issues, the answer is contextually relevant—addressing the evolution of the relationship, investment magnitude, and strategic involvement—and correctly identifies the 55% ownership outcome. However, due to significant factual and chronological errors, especially in key financial figures and transaction timing, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 494,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Adobe Target's role within Adobe's customer journey solutions evolved from being a core personalization and optimization tool to a more integrated and strategic component of Adobe's AI-driven personalization ecosystem. In fiscal 2022, Adobe Target was highlighted as a personalization engine enabling A/B and multivariate tests, while in fiscal 2023, it was emphasized as a key player in delivering AI-powered, omnichannel experiences across customer journeys, working closely with Adobe Journey Optimizer and Adobe Sensei. This evolution indicates Adobe's strategic direction to deepen AI integration across its solutions, enhancing real-time personalization capabilities to help businesses deliver dynamic, data-driven customer experiences at scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Adobe Target from fiscal 2022 to 2023, accurately reflecting its enhanced role as an AI-driven personalization engine. While the original answer specifies Adobe Target was grouped with Marketo Engage, Adobe Campaign, and Journey Optimizer in 2022, the LLM mentions integration with Journey Optimizer and Adobe Sensei—slightly different emphasis but still factually aligned, as Sensei is Adobe’s AI/ML framework. The core transformation—from a personalization tool to an AI-powered engine—is correctly conveyed. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations; however, the fiscal years 2022 and 2023 are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two fiscal years and infers strategic direction from product evolution. The mention of 'AI-powered, omnichannel experiences' and 'real-time personalization at scale' aligns with the ground truth’s emphasis on AI/ML-driven automation and omnichannel capabilities. The only minor gap is that the LLM does not explicitly name all peer tools (e.g., Marketo, Campaign) from 2022, but this does not detract from the central thesis. (4) The answer is contextually highly relevant, directly addressing both parts of the question: the evolution of Adobe Target and what it indicates about Adobe’s AI strategy. The conclusion about Adobe deepening AI integration is semantically equivalent to the original answer’s claim about strategic emphasis on AI-driven personalization. Minor deduction in qualitative accuracy due to slight shift in supporting details, but overall highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 483,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed the acquisition of AspenTech in May 2022 for $11.2 billion, significantly increasing its financial stake through the inclusion of $2.3 billion in customer relationship intangible assets and $1.35 billion in developed technology intangible assets. By 2023, post-acquisition integration activities included the conversion of Heritage AspenTech stock-based compensation awards into AspenTech awards, aligning terms and conditions, and the continued vesting of restricted stock units and performance-based stock units under AspenTech's equity plans. These actions reflect Emerson's integration of AspenTech's operations and employee incentives following the acquisition.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that Emerson reported a balance of $8,326 million related to AspenTech in 2022 as part of its acquisitions, but the LLM claims the acquisition was for $11.2 billion and breaks down intangible assets ($2.3B and $1.35B), which are not mentioned in the original answer and contradict the reported balance. These figures may be from external knowledge but are not supported by the provided ground truth, making them incorrect in this evaluation context. (2) The date of acquisition (May 2022) is plausible but not confirmed in the original answer, which only references a 2022 balance. The original does not mention the $11.2B figure or asset breakdown, so including them reduces quantitative accuracy. (3) Qualitatively, the LLM correctly identifies post-acquisition integration activities in 2023, such as conversion of stock-based compensation awards and continuation of vesting under AspenTech's equity plans, which aligns with the original answer’s mention of aligned stock options, RSUs, and performance stock units. This shows sound reasoning in understanding integration of employee incentives. However, it misses the key point that AspenTech became a separate publicly traded company under Emerson's acquisition framework—a critical structural evolution. (4) Contextually, the answer is relevant and addresses both financial stake and integration activities. While it captures some correct elements of post-acquisition integration, the incorrect financial figures and absence of the public company structure significantly reduce factual correctness. The answer reflects partial understanding but fails on key multi-hop facts from the knowledge graph, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 492,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions evolved significantly, particularly in integration with AI-powered tools and cross-channel campaign orchestration. In 2022, Adobe Experience Platform was highlighted as a foundational infrastructure for unifying customer data and enabling AI-driven insights across Adobe Experience Cloud solutions. By 2023, the platform had advanced further, with Adobe Journey Optimizer being emphasized as a scalable app built on the Experience Platform to orchestrate and deliver personalized, connected customer journeys across any channel. Additionally, AI-powered tools like Adobe Target and Adobe Mix Modeler were more deeply integrated, enhancing real-time decision-making and campaign optimization. This evolution reflects Adobe's focus on leveraging AI and machine learning to deliver more dynamic, data-driven customer experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Adobe Experience Platform's role as foundational infrastructure in 2022, its integration with AI via Adobe Sensei, and its evolution in 2023 to support cross-channel orchestration via Adobe Journey Optimizer are accurately described. The mention of Adobe Mix Modeler being introduced in 2023 and powered by Adobe Sensei is correct and matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time (2022 vs 2023), platforms (Experience Platform), applications (Journey Optimizer, Mix Modeler), and AI integration. One minor omission: the original answer specifies that in 2022, AI capabilities included automated insights, sentiment analysis, and anomaly detection—this level of detail is missing in the LLM response. Also, the LLM mentions Adobe Target’s deeper integration, which is not present in the ground truth and could be considered a slight overreach, though not factually incorrect per se. (4) Despite these small gaps, the LLM captures the core evolution—shift from data foundation to active orchestration engine—and maintains semantic equivalence. Contextual relevance is perfect, directly addressing the question’s focus on AI integration and cross-channel orchestration. Thus, correctness is 9 due to minor completeness and specificity issues, but not enough to drop below 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 442,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group accelerated its transition from fee-for-service to fully accountable value-based care delivery models. The company intensified efforts to innovate and integrate care delivery models, including in-clinic, in-home, behavioral, and virtual care, while leveraging data and analytics to improve care efficiency and outcomes. Additionally, UnitedHealth Group focused on enhancing clinical engagement and investing in care coordination technology to manage costs and improve health outcomes over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies UnitedHealth Group's focus on value-based care, clinical engagement, care coordination technology, and multi-channel care delivery (in-home, virtual, etc.) as part of its strategy from 2023 to 2024, which aligns with the ground truth. However, it omits a critical component of the evolution: the shift in 2024 from expansion-focused investment to cost containment and strategic retrenchment due to Medicare Advantage funding pressures. The original answer highlights specific operational adjustments such as changes to provider networks, benefit structures, and county-level plan offerings in response to reduced benchmarks and risk adjustment changes—details entirely missing in the LLM response. While the LLM accurately reflects the continuity of innovation and integration efforts, it fails to capture the qualitative shift in strategy driven by financial constraints, thus presenting an incomplete and potentially misleading picture of the company's evolving approach. There are no numerical inaccuracies (hence a perfect quantitative score), but the lack of synthesis around the 2024 strategic pivot significantly undermines the qualitative accuracy. The answer remains contextually relevant and factually sound on the elements it includes, but misses key multi-hop reasoning linking funding pressures to strategic retrenchment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 378,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The 1.950% Notes due 2029 were issued by TMO and are listed as one of its debt instruments on the New York Stock Exchange, as noted in both the 2022 and 2023 10-K filings. There is no specific information provided in the given pages about changes in the composition of TMO's debt instruments between 2022 and 2023 or about the issuance, redemption, or material changes to the 1.950% Notes due 2029 during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.950% Notes due 2029 were present in both 2022 and 2023, and that they are listed in TMO's 10-K filings, which aligns with the ground truth. The percentage (1.950%) and maturity year (2029) are accurate, satisfying quantitative accuracy for those elements. However, the LLM incorrectly claims there is 'no specific information provided' about changes in debt composition, which contradicts the ground truth that explicitly notes the introduction of new debt instruments in 2023 (3.200% Notes due 2026 and 3.650% Notes due 2034). This omission represents a major failure in completeness and reasoning. (2) No calculations were required, but the dates and percentages mentioned are factually correct where stated. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolution of TMO's debt portfolio by recognizing the addition of new notes in 2023 while the 1.950% Notes remained unchanged. Instead, it defaults to a 'no information' stance despite the ground truth being derived from structured data likely extracted from the same 10-Ks. (4) The contextual relevance is moderate because the answer addresses the 1.950% Notes but fails to report the broader debt composition changes, which is a central part of the question. Thus, while some facts are correct, the overall answer misrepresents the availability of information and misses key insights, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 403,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instrument composition saw the continued inclusion of the 0.500% Notes due 2028, which remained listed on the New York Stock Exchange. Additionally, new note categories were introduced, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034 in 2023, indicating a diversification of debt maturities and coupon rates compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued presence of the 0.500% Notes due 2028 and accurately reports the introduction of the 3.200% Notes due 2026 and 3.650% Notes due 2034 in 2023. All numeric values—interest rates and maturity years—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: percentages (0.500%, 3.200%, 3.650%) and years (2026, 2028, 2034) are all correct with no calculation errors. (3) The multi-hop reasoning is sound—comparing TMO's debt composition across 2022 and 2023, identifying continuity and change in debt instruments. The LLM correctly infers a diversification strategy, aligning with the ground truth’s interpretation. (4) The only minor omission is that the original answer also notes the continued presence of the 1.375% Notes due 2028 in both years, which the LLM omits. While not critical to the core question about the 0.500% Notes and new categories, this detail adds completeness. Despite this, the LLM captures the key evolution and strategic implication, making the answer largely equivalent in meaning and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 319,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units narrowed between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical ranges for both 2023 (140% to 495%) and 2024 (70% to 450%), matching the ground truth exactly. These percentages are critical and accurately presented. (2) All numbers, dates, and percentages are factually correct with no calculation errors. The format is consistent and clear. (3) The reasoning is sound: the LLM correctly identifies that the range narrowed year-over-year, which requires multi-hop comparison across the two annual analyses. It captures the key change—particularly the decrease in the lower bound from 140% to 70%—though it omits the explicit interpretation that this reflects a reduced cushion before potential impairment. (4) While the core facts and quantitative data are fully accurate, the answer slightly lacks the qualitative nuance in the original about the implication of the reduced range (i.e., decline in overall cushion). However, the omission does not detract from factual correctness, only from completeness of interpretation. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 327,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In 2022, under the 2022 Employee Stock Plan, RSUs canceled and shares withheld to satisfy tax withholding obligations increased the number of shares available for grant by a factor of two times the number of RSUs canceled or shares withheld. By 2023, this mechanism remained unchanged, as the treatment of canceled RSUs and tax-withheld shares continued to add shares back to the available share pool at twice the number of RSUs canceled or withheld, maintaining the same impact on the available share pool as in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the mechanism remained unchanged in 2023. The ground truth explicitly states that the 'factor of two times' language was omitted in 2023, indicating a change in treatment. The LLM incorrectly asserts continuity, which contradicts the original answer. (2) While the description of the 2022 policy is quantitatively accurate (factor of two applied), the 2023 characterization is wrong—there is no evidence in the ground truth that the doubling mechanism continued. Thus, the quantitative accuracy is partially correct for 2022 but fails for 2023. (3) The multi-hop reasoning is flawed: the question requires comparing plan provisions across two years, and the LLM failed to detect the critical omission in the 2023 plan language. This undermines the qualitative accuracy, as the core of the question hinges on identifying a change in policy. (4) Contextual relevance is high because the answer addresses the right topic (treatment of canceled RSUs and tax-withheld shares) and the correct plan and years, but the conclusion is factually inverted. The answer should have highlighted a reduction in share pool replenishment due to the removal of the 2x factor, not maintained status quo.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 351,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Danaher's strategic relationship with Aldevron remained integrated within its Life Sciences segment, as Aldevron had been acquired in 2021. There is no indication of a change in Danaher's financial stake in Aldevron during this period, and Aldevron continued to contribute to the Life Sciences segment's offerings, particularly in bioprocessing and nucleic acid-based therapies. No new acquisitions or divestitures involving Aldevron are mentioned in the 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. It claims that Aldevron was acquired in 2021 and remained integrated without change between 2023 and 2024, which contradicts the ground truth that shows a clear evolution in Danaher's relationship with Aldevron during this period. The key financial figure of $9,561 million in net cash consideration allocated to Aldevron in 2023 is completely omitted, representing a major quantitative inaccuracy. (2) The LLM fails to report any numeric data from the ground truth, particularly the $9,561 million acquisition cost, which is central to assessing Danaher's financial stake. This results in a very low quantitative accuracy score. (3) The multi-hop reasoning is flawed: the question asks about the evolution between 2023 and 2024, but the LLM asserts no change occurred, missing the critical shift from a separately accounted stake in 2023 to full integration into the Life Sciences segment by 2024. The model incorrectly implies continuity rather than transformation. (4) Contextually, the answer is relevant in that it discusses Aldevron’s role in the Life Sciences segment and mentions bioprocessing contributions, but it fails to address the core of the question—how the financial stake and integration evolved. The omission of the acquisition accounting detail and the misrepresentation of timeline and strategic shift severely undermine accuracy. Overall, the answer misses key facts, omits critical data, and presents an incorrect narrative of stasis instead of evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 430,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft has further solidified Microsoft 365's role as an AI-first platform, enhancing its integration with AI technologies such as Copilot for Microsoft 365 and role-specific Copilot extensions (e.g., Copilot for Sales, Service, and Finance). This evolution is reflected in the 2024 10-K, which emphasizes how Microsoft 365, alongside Dynamics 365 and the Microsoft Cloud, delivers AI-driven insights and automation to streamline business processes. In terms of commercial business metrics, Microsoft 365 contributes significantly to the Productivity and Business Processes segment, with key metrics including Office Commercial revenue growth, Office 365 Commercial seat growth, and Microsoft 365 Consumer subscribers, all underscoring its central role in Microsoft's commercial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft 365's evolution as an AI-first platform with integration of Copilot and AI-driven productivity tools, which aligns with the ground truth. It accurately references the commercial importance of Microsoft 365 and its role in the Productivity and Business Processes segment. However, it misses a key factual update from the ground truth: the 2024 change in the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, which was a notable shift in reporting aligned with internal business practices. This omission affects completeness and qualitative accuracy. (2) There are no numeric values, percentages, or financial figures in either the question or ground truth that require verification; thus, quantitative accuracy is not compromised—any mention of metrics (e.g., seat growth, revenue growth) is general but consistent with plausible reporting and does not contradict the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly links Microsoft 365, AI integration (Copilot), and commercial metrics, but fails to synthesize the specific 2024 change in subscriber definition, which is a critical detail in the evolution of strategic positioning. (4) The answer is contextually relevant and well-structured, but the absence of the subscriber metric change reduces its factual completeness, warranting a correctness score of 7 rather than higher. Qualitative accuracy is docked for missing this strategic signal, though core AI integration points are valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 431,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has elevated Copilot Pro's role within its ecosystem, emphasizing it as a consumer subscription service that offers enhanced AI assistance in Microsoft 365 apps and on the web. In 2023, Copilot Pro was introduced as part of Microsoft's broader AI strategy, while in 2024, it was highlighted more prominently as part of the Copilot stack, underscoring its integration with Microsoft 365 and web-based AI assistance to deliver faster and more powerful capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Copilot Pro was introduced in 2023 as a consumer subscription offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, and that by 2024, its positioning became more prominent within the broader Copilot stack and Microsoft's AI strategy. The answer captures the evolution in emphasis—increased integration and strategic importance—without misrepresenting the timeline or features. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9) because the LLM does not fully convey the 'broader narrative of AI-driven transformation across Microsoft's ecosystem' mentioned in the original answer, which provides deeper strategic context. However, the core multi-hop reasoning—linking Copilot Pro’s evolution from a standalone service to a more integrated component of Microsoft 365 and web-based AI—is sound and correctly synthesized. Contextual relevance is perfect, as the response directly addresses the question about positioning and emphasis changes between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 330,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "As of December 31, 2023, approximately 48 million shares remained available for issuance under the 2007 Omnibus Incentive Plan. By December 31, 2024, this number had decreased to approximately 47 million shares, indicating a reduction of 1 million shares during this period. This decline reflects the issuance of shares related to stock-based compensation awards during 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative details. The original answer states that no specific figure was provided for remaining shares available for issuance under the 2007 Omnibus Incentive Plan in 2023. However, the LLM claims that approximately 48 million shares remained available as of December 31, 2023, which is not supported by the ground truth. The only confirmed number in the ground truth is the 47 million shares available as of December 31, 2024. The LLM fabricates the 2023 number and incorrectly implies a year-over-year comparison with precise figures. (2) The calculation of a 1 million share reduction is therefore invalid, as the starting point (48 million in 2023) is not present in the original data. While the 47 million figure for 2024 matches the ground truth, the 2023 number does not, making the quantitative accuracy very low. (3) The reasoning is flawed in terms of multi-hop synthesis: the model fails to recognize that the 2023 disclosure lacked a specific share availability number, and instead invents one to create a narrative of decline. The original answer emphasizes a shift in disclosure transparency, not a quantifiable reduction. The LLM misses this qualitative evolution and replaces it with a false quantitative trend. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right plan, the correct company (implied), and the topic of share availability over time. It also correctly identifies that share usage occurred in 2024, which aligns with the idea of awards being issued. However, the core factual inaccuracy in numbers and reasoning severely undermines correctness, warranting a low score of 3. The qualitative accuracy is partially preserved due to correct framing, and contextual relevance is maintained, but quantitative accuracy is critically flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 506,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft maintained its accounting policy regarding the estimated useful lives of server and network equipment, which was changed in July 2022. The company increased the estimated useful lives from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. No further modifications to this policy were disclosed for fiscal year 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Microsoft increased the estimated useful lives of server and network equipment from four to six years, effective at the beginning of fiscal year 2023, and that the policy remained unchanged in fiscal year 2024. The drivers—investments in software improving operational efficiencies and advances in technology—are accurately reported. The only minor discrepancy is the mention of July 2022 as the announcement date, which is not present in the ground truth; however, this does not contradict the effective start in fiscal year 2023 and may reflect the actual timing of the change disclosed in filings. (2) All numeric values (4 years, 6 years, fiscal years 2023 and 2024) are correct and consistent with the ground truth. No calculations are required, and all dates align contextually. (3) The multi-hop reasoning is sound: the model correctly identifies a policy change in 2023, its continuation in 2024, and the rationale behind it, synthesizing information across time periods and causal factors. (4) The answer is factually accurate, complete, and semantically equivalent to the ground truth, with only a slight addition (July 2022) that does not impair correctness. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 371,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value from 2022 to 2023, at $33 million. In both years, these securities were classified within \"Other Assets\" on the balance sheet, with no changes in their valuation or classification observed during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDT's auction rate securities had a fair value of $33 million in both 2022 and 2023, which matches the ground truth. However, it incorrectly claims that the securities were classified under 'Other Assets' in both years. According to the original answer, in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly reclassified into 'Other Assets'. This is a critical factual error in the qualitative reasoning and classification timeline. (2) Quantitative accuracy is perfect—$33 million in both years is correctly reported with no calculation issues. (3) The multi-hop reasoning fails because the model does not recognize the change in balance sheet classification over time, which is central to the question about how exposure 'evolved'. Instead, it asserts no change occurred, contradicting the ground truth. (4) Contextual relevance is high because the answer addresses fair value and classification as asked, but the incorrect assertion about consistent classification undermines the core of the response. Thus, while numbers are right, the key evolution in accounting treatment is misrepresented, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 355,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million in fiscal 2023 to a loss of $67 million in fiscal 2024. This indicates a deterioration in the performance of this investment category, likely due to market interest rate fluctuations and other market conditions affecting the fair value of these investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net losses for both fiscal years—$21 million in 2023 and $67 million in 2024—matching the ground truth exactly. The increase in losses is accurately portrayed. (2) All numeric values are correct and properly attributed to the right fiscal years. No calculation errors; the comparison between years is factually sound. Format variations are acceptable and consistent. (3) The multi-hop reasoning is solid: the model correctly synthesizes data across two fiscal periods and draws a valid conclusion about deteriorating performance. The added context about market interest rate fluctuations and market conditions is reasonable and does not contradict the ground truth; it provides plausible explanation without overreaching. (4) The answer is fully relevant and addresses both parts of the question: the change in net gains/losses and what it indicates. The only reason for not giving a perfect 10 is that the original answer emphasizes 'significant worsening' while the LLM uses 'deterioration'—semantically equivalent but slightly less precise in tone. However, this does not affect factual correctness. Overall, the response is factually accurate, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 347,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco shifted its approach to the APJC region by streamlining its operational structure, as evidenced by a reduction in the percentage of total revenue from APJC (from 14.8% in 2023 to 14.3% in 2024), while maintaining a focus on high-value offerings like Networking and Security. Financial investment appears to have remained stable, but the decline in product revenue (particularly in Networking and Collaboration) and the shift toward subscription-based services suggest a strategic pivot toward recurring revenue models in the region. This evolution implies a move toward long-term customer relationships and service-driven revenue, which could provide more predictable income but may require continued investment in digital transformation and localized support to sustain growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Cisco evolved from direct operational presence in APJC in 2023 to include financial investments (marketable and non-marketable equity securities, equity method investments) in 2024. However, the LLM answer incorrectly claims a 'streamlining of operational structure' based on a 0.5% drop in APJC revenue share (14.8% to 14.3%), which is not mentioned or supported in the original answer. There is no mention in the ground truth about changes in revenue percentages, product revenue declines, or shifts to subscription models in APJC. (2) The quantitative claims (14.8% to 14.3%) are fabricated; the original answer does not provide any revenue percentages or financial metrics related to APJC revenue share. The LLM invents specific numbers and interprets them as evidence of structural change, which is unsupported. (3) The multi-hop reasoning is flawed: the original answer requires synthesis of Cisco’s operational model in 2023 (direct operations) with its 2024 financial investment strategy (equity instruments), but the LLM instead fabricates a narrative around revenue mix and subscription shifts not present in the source. It fails to mention any of the key investment categories (marketable/non-marketable securities, equity method) that define the 2024 shift. (4) While the LLM attempts to address the question’s theme—evolution in Cisco’s APJC strategy—it does so with incorrect data and reasoning. The contextual relevance is moderate because it discusses Cisco and APJC over 2023–2024 and touches on operational and financial aspects, but the substance is factually wrong. Correctness is severely compromised by hallucinated data and absence of key facts from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 491,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adapted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, the Company acknowledged potential risks from litigation, competition, and regulatory requirements, including the possibility of reduced App Store sales and commission rates. By 2024, Apple had implemented specific changes, such as modifying how developers communicate with consumers in the U.S. regarding alternative purchasing mechanisms and adapting to the EU’s Digital Markets Act (DMA). These changes included new fee structures, alternative app distribution methods, and additional developer tools, reflecting a more proactive approach to compliance and addressing external pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple acknowledged regulatory and legal risks in 2022 related to App Store commissions, and by 2024 had implemented concrete changes in response, particularly in the U.S. and EU. The mention of the Digital Markets Act (DMA) is accurate and contextually appropriate. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no figures were introduced or misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes Apple’s evolving stance from a general risk disclosure in 2022 to specific compliance actions by 2024, linking legal pressures to operational changes like alternative distribution, fee structures, and developer tools. (4) The LLM omits the explicit mention of 'new business terms' included in the original answer but captures the equivalent concepts through 'modifying how developers communicate' and 'alternative purchasing mechanisms.' Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, directly addressing the evolution of Apple’s approach in response to legal and market pressures. Minor deduction in qualitative accuracy due to slightly less comprehensive detail on the scope of 2024 changes, but core facts and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 388,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments' U.S. Retiree Health Care Plan maintained a conservative allocation strategy, with fixed income securities and cash equivalents consistently making up the majority of the portfolio. In 2022, the allocation was 75%-85% in fixed income and 15%-25% in equity securities, and by 2024, the allocation remained within the same target range, with fixed income at 80% and equity securities at 20%. This indicates a stable approach with no significant shift in the allocation strategy between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, fixed income and cash equivalents totaled $248 million and equity securities were $137 million, which corresponds to approximately 64.4% fixed income and 35.6% equities (total portfolio ~$385M). However, the LLM claims the 2022 allocation was 75%-85% fixed income and 15%-25% equities, which is incorrect and not supported by the dollar amounts. The 80%/20% split mentioned for 2024 aligns with the ground truth, but the claim that the allocation 'remained within the same target range' from 2022 to 2024 is false, as the actual allocation shifted from ~64.4% to 80% in fixed income—a significant change. (2) The quantitative accuracy is partially correct for 2024 (80%/20%) but incorrect for 2022. The LLM invents a range (75%-85%) not present in the original data and ignores the actual dollar values provided. There is no mention of the $248M and $137M figures, which undermines completeness and accuracy. (3) The multi-hop reasoning is flawed: the model fails to calculate the actual 2022 percentages from the dollar amounts and incorrectly asserts stability in strategy, directly contradicting the ground truth's conclusion of a 'significant shift toward a more conservative posture.' The synthesis across years is therefore invalid. (4) Despite these issues, the answer is contextually relevant—it addresses the right plan, company, and time frame, and correctly identifies the general trend toward conservatism in 2024. However, due to major factual and reasoning errors, especially in quantitative details and interpretation of change over time, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 462,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments has maintained a strategic emphasis on Embedded Processing Products as a core component of its business model, contributing to its competitive advantages and segment reporting structure from 2022 to 2024. In both years, Embedded Processing is one of the two reportable segments, alongside Analog, with consistent definitions and operational focus. However, from 2022 to 2024, Embedded Processing's contribution to revenue and operating profit declined significantly, with revenue dropping by 25% and operating profit by 65% in 2024 compared to 2023. Despite this, the segment continues to support TI's competitive advantages, particularly through its role in the company's broad portfolio of analog and embedded processing products, which enhances customer value and market reach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that Embedded Processing was a reportable segment in 2022, when the ground truth confirms it was not elevated to a reportable segment until 2024. This misrepresents a key strategic evolution. Additionally, the LLM introduces quantitative data (25% revenue drop, 65% operating profit decline in 2024 vs 2023) that are not present in the original answer and contradict the focus of the question, which is about strategic emphasis and structural changes, not financial performance declines. (2) The numbers cited (25%, 65%) are unsupported by the ground truth and appear fabricated; there is no mention of financial trends in the original answer, so these figures are incorrect. The years referenced (2023, 2024 comparisons) also misalign with the 2022–2024 evolution asked about. (3) The multi-hop reasoning fails: the model does not correctly synthesize the evolution in segment reporting structure—specifically, the shift from Embedded Processing being a product line within a broader strategy in 2022 to becoming a standalone reportable segment in 2024. Instead, it assumes consistency across years, missing the strategic shift entirely. (4) Contextual relevance is moderate because the answer discusses the right company and topic, but it introduces irrelevant financial declines and misses the core strategic evolution. The qualitative reasoning is flawed due to incorrect entity-state mapping over time. Correctness is severely compromised by the false claim about segment status in 2022 and the invented financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 447,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "Between 2022 and 2024, TMO issued and maintained a 2.00% 10-Year Senior Notes, which were euro-denominated and part of a series of debt instruments managed through its wholly-owned finance subsidiary, Thermo Fisher International. As of December 31, 2024, the 2.00% Senior Notes due 2051 had a carrying value of $777 million. In 2022, TMO redeemed its 3.650% Senior Notes due 2025, incurring $26 million in losses on the early extinguishment of debt. The 2.00% Senior Notes due 2051 were issued in public offerings and are fully guaranteed by TMO. The valuation of these notes reflects their effective interest rate of 2.06% as of December 31, 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that TMO's 2.00% 10-Year Senior Notes due 2031 had a principal amount of $1,200 million in both 2022 and 2024, with an effective interest rate of 2.23%. However, the LLM answer incorrectly refers to '2.00% Senior Notes due 2051' with a carrying value of $777 million and an effective interest rate of 2.06% as of 2024—none of which matches the ground truth. Additionally, the LLM introduces euro-denominated notes and a finance subsidiary, Thermo Fisher International, which are not mentioned in the original answer and appear to be hallucinated. (2) Quantitative accuracy is very low: the principal amount ($777M vs $1,200M), maturity year (2051 vs 2031), interest rate (2.06% vs 2.23%), and even the nature of the instrument (10-year note) are all incorrect. The mention of redeeming 3.650% notes in 2022, while possibly true, is irrelevant to the specific question about the 2.00% 10-Year Senior Notes. (3) The multi-hop reasoning is flawed—the question asks for the evolution of a specific debt instrument (2.00% 10-Year Senior Notes) between 2022 and 2024, but the LLM fails to track the same instrument across years, instead conflating it with a different maturity (2051) and introducing unrelated details. (4) Contextual relevance is moderate because the answer discusses TMO's debt instruments, but it fails to address the correct note series, timeline, or valuation evolution. The core facts are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 425,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE's sales declined from $1,839 million in 2022 to $1,605 million in 2024, representing a 12.8% decrease. This decline indicates that REMICADE's contribution to Johnson & Johnson's Pharmaceutical segment has weakened over the period, likely due to market competition and the launch of newer therapies within the Immunology therapeutic area.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sales figures of $1,839 million and $1,605 million and the 12.8% decline, which matches the ground truth in magnitude and calculation. However, it incorrectly states that $1,839 million was the 2022 sales figure, while the ground truth specifies this as the 2023 value. This misattribution of the year affects the temporal accuracy of the trend description. (2) The calculation of the percentage decrease (~12.8%) is accurate: (1,839 - 1,605) / 1,839 ≈ 0.127, which rounds to 12.7%–12.8%, so this is correct. However, the use of 2022 instead of 2023 for the $1,839 million figure is a factual error in dating, reducing quantitative accuracy. (3) The reasoning about REMICADE's weakening role due to competition and newer therapies aligns with the ground truth’s suggestion of declining relevance in the Immunology segment. The LLM correctly synthesizes the implication of declining sales on strategic importance, showing sound qualitative reasoning. (4) The answer is contextually relevant and addresses both parts of the question—evolution of financial performance and implications for J&J’s Pharmaceutical segment—though with a minor but notable error in the timeline. The core facts (sales drop, percentage decline, competitive dynamics) are correct, but the incorrect year assignment prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 380,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE's sales declined from $3.19 billion in 2022 to $1.605 billion in 2024, representing a significant decrease of 12.8% in 2024 compared to 2023 and a cumulative drop of 48.3% over the two-year period. This decline indicates that REMICADE is losing market share within JNJ's Immunology portfolio, as newer products like STELARA and TREMFYA are experiencing growth, highlighting a shift in the portfolio's focus toward more competitive and innovative therapies.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports REMICADE's sales of $3.19 billion in 2022 and $1.605 billion in 2024, aligning with the ground truth ($3,190 million and $1,605 million). The 12.8% decline in 2024 compared to 2023 is accurately stated per the original answer. However, the LLM introduces a 'cumulative drop of 48.3%' from 2022 to 2024, which, while mathematically correct ((3190 - 1605) / 3190 ≈ 49.7%, not 48.3%), contains a minor calculation inaccuracy. The ground truth does not mention this two-year cumulative decline, so while the direction is correct, the specific figure is slightly off and not part of the verified data. (2) The LLM omits the 2022 vs 2020 decline of 14.9% mentioned in the original answer, which is relevant to the 'evolution from 2022 to 2024' timeline context. (3) The reasoning about REMICADE losing market position is sound and logically inferred from the declining sales. The mention of STELARA and TREMFYA as growing competitors adds contextual insight not in the original answer but is plausible and enhances qualitative reasoning, though it is not verifiable from the provided ground truth. This represents an acceptable inference but slightly extends beyond the given data. (4) The answer is highly relevant, addresses the sales evolution and market position, and synthesizes the trend effectively. The minor quantitative discrepancy and omission of the 2020 comparison prevent a top score, but core facts and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 406,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE's sales declined significantly, from $3.19 billion in 2021 to $1.605 billion in 2024. This decline was primarily driven by biosimilar competition in the United States and other markets, which led to a reduction in market share and sales. The impact of biosimilars continued to intensify over the period, contributing to the sustained sales decrease.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2021 sales figure. The ground truth states REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, while the LLM incorrectly reports $3.19 billion. This is a major quantitative discrepancy. The 2024 sales figure ($1.605 billion) is correct and matches the ground truth of $1,605 million. However, the LLM omits the specific 12.8% year-on-year decline from 2023 to 2024, which is a key detail in the original answer. (2) The calculation of decline implied by the LLM (from $3.19B to $1.605B) suggests roughly a 50% drop, which is inconsistent with the actual trajectory implied by the ground truth (a continued decline culminating in a 12.8% drop in the final year). The ground truth suggests a more gradual, sustained decline due to biosimilars, not a halving of sales between 2021 and 2024. (3) The qualitative reasoning about biosimilar competition in the U.S. and global markets is accurate and aligns with the original answer. The LLM correctly identifies the primary cause of the decline and notes its intensification over time, demonstrating sound multi-hop reasoning regarding market dynamics. (4) Contextual relevance is high—the answer addresses both parts of the question: sales evolution and contributing factors. While the narrative structure and causal explanation are well-formed and semantically aligned, the major error in the 2021 sales figure undermines the quantitative foundation of the response, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 427,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales, reflecting a 4.6% total decrease in 2024 compared to 2023, with a 3.4% operational decline and a 1.2% negative currency impact. This decline followed strong growth in 2021, where STELARA sales reached $5.9 billion in the U.S. due to its expansion into Crohn's disease and Ulcerative Colitis. However, the expiration of STELARA's U.S. patent in September 2023 likely contributed to the subsequent sales reduction as competition increased.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it misstates STELARA's 2024 sales as being compared to an incorrect 2023 baseline: the ground truth reports $10,361 million in 2024 and $10,858 million in 2023, a 4.6% decline. The LLM correctly identifies the 4.6% decline but fabricates a $5.9 billion U.S.-only figure for 2021, which is not supported by the ground truth and conflates regional and global figures. Additionally, the claim about the U.S. patent expiring in September 2023 is not present in the original answer and cannot be verified from the provided data, making it an unsupported assertion. (2) The quantitative inaccuracies are significant: the $5.9 billion figure is presented without context or correct year (attributed to 2021 but not mentioned in the ground truth), and the breakdown into 3.4% operational decline and 1.2% currency impact is extraneous and unverified. The only correct quantitative point is the 4.6% total sales decline. (3) The multi-hop reasoning is partially sound in linking declining sales to potential competition, but it fails to incorporate the key evolution from regulatory filing status in 2022 (pediatric psoriatic arthritis indication under review) to mature commercial product in 2024. This critical developmental transition is entirely omitted, weakening the qualitative assessment of the drug's lifecycle progression. (4) The contextual relevance is moderate because the answer addresses sales trends and possible drivers, but it introduces unverified details (patent expiration, regional sales figures) and omits the regulatory status change that was central to the original answer. Thus, while the direction of sales decline is correct, the supporting data and reasoning are flawed, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 492,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease in 2024. In 2023, the decrease from $621 million in 2022 to $382 million was a 38.5% decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Restasis net revenue in the U.S. was $382 million in 2023 and $172 million in 2024. It accurately states the 55.2% decrease in 2024 compared to 2023. It also correctly references the 38.5% decrease in 2023 compared to 2022, using the correct prior-year figure of $621 million (implied in the calculation: (621 - 382)/621 ≈ 38.5%). (2) All numeric values match the ground truth: $382M (2023), $172M (2024), 38.5% (2023 decline), and 55.2% (2024 decline) are accurate. Calculations are correct and consistent with the data. (3) The multi-hop reasoning is sound: the model synthesizes data across three years (2022, 2023, 2024), correctly computes year-over-year percentage changes, and attributes them to the right years. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (explicit mention of 2022 revenue), enhancing clarity without introducing error. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 290,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of Master Lease Agreements (MLAs) for AMT evolved to become a more integral component of its international growth and tenant relationship strategy. These agreements provide consistent, long-term revenue and reduce the likelihood of non-contractual churn, thereby strengthening AMT's position in international markets. By streamlining colocation processes and enabling rapid deployment of tenant equipment, MLAs have supported AMT's ability to meet the growing demand for network densification and 5G infrastructure, particularly in emerging and rapidly evolving markets. This strategic use of MLAs has reinforced AMT's relationships with large multinational carriers, enhancing its long-term revenue growth potential.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic importance of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, including their role in generating long-term revenue, reducing churn, and enabling rapid deployment. However, it omits specific quantitative details from the ground truth: the international portfolio size of approximately 177,000 sites in 2022 and 182,000 in 2023. These numbers are key to demonstrating the evolution of MLAs in the context of portfolio growth. (2) Quantitative accuracy is high because the LLM does not introduce any incorrect numbers or misstate figures—it simply fails to include the site counts. No calculations are required, and no erroneous data is presented. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the functional benefits of MLAs (e.g., streamlining colocation, supporting 5G) and their strategic value in tenant retention and international expansion. However, it misses the explicit evolution from 2022 to 2023 as framed in the original answer—specifically, the shift from emphasizing operational efficiency (2022) to reinforcing revenue stability and risk mitigation (2023). (4) The contextual relevance is strong, as the response directly addresses the question’s focus on strategic evolution and tenant relationships. The qualitative accuracy is reduced due to the omission of key metrics and the nuanced shift in strategic emphasis over the two years. While the overall meaning aligns, the lack of specific portfolio sizes and risk mitigation context (e.g., customer consolidation, regulatory changes) limits completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 459,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, with revenues recognized on a gross basis for ads placed on Google Network properties. This means that the amounts billed to customers are recorded as revenues, while payments to Google Network partners are classified as cost of revenues. There is no indication of a material change in the recognition or management of advertising revenues across Google Network properties during this period, suggesting consistent practices in how advertising revenues are accounted for and managed.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that advertising revenues on Google Network properties were recognized on a gross basis in both 2023 and 2024, which aligns with the ground truth. However, it incorrectly claims there was 'no material change' in revenue recognition or management practices, which directly contradicts the original answer stating that the platform's role evolved in 2024 to include a more nuanced evaluation of principal versus agent status and greater emphasis on control over inventory. This evolution is a key factual point that the LLM answer misses. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or financial terms used. (3) The multi-hop reasoning is flawed: the question asks how the role evolved, requiring comparison across years and synthesis of changes in accounting rationale and platform function. The LLM fails to identify the shift in 2024 toward enhanced justification for gross reporting and the expanded description of the platform’s central role in ad delivery. Instead, it asserts consistency, missing the core development. (4) While the answer is contextually relevant and uses correct terminology (e.g., gross revenue recognition, cost of revenues), it lacks the critical qualitative insight about the evolution in 2024, resulting in a partially correct but ultimately misleading response. Hence, correctness and qualitative accuracy are significantly penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 407,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Based on the data from the provided pages:\n\nIn 2023, the volume of Federal Funds Purchased & Securities Loaned was $481,896 million, while in 2024, it increased to $570,236 million. The fair value of these instruments also rose from $178,609 million in 2023 to $192,859 million in 2024. This increase in both volume and fair value indicates that Bank of America (BAC) has expanded its short-term funding activities, likely to manage liquidity needs or take advantage of favorable short-term interest rates. The growth in these funding strategies suggests a proactive approach to maintaining short-term liquidity and potentially optimizing the cost of funds.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements but contains significant quantitative inaccuracies. The ground truth states that in 2023, the *net change* in volume was $16,466 million, not that the total volume was $481,896 million. The LLM incorrectly interprets absolute volume values for 2023 and 2024 ($481,896M and $570,236M), which are not present in the original answer and cannot be verified from the provided context. However, the fair value figures are partially correct: the 2024 fair value of $192,859 million matches the ground truth, but the 2023 fair value is stated as $178,609 million in the LLM answer, which is not confirmed in the original answer (the original only implies an increase without specifying the prior year's value). (2) Calculations: The LLM implies a year-over-year increase in both volume and fair value, which aligns with the direction of change, but the specific volume numbers and net change are not supported by the ground truth. The original emphasizes a *net change* of $16,466M in volume in 2023, not absolute levels. (3) Multi-hop reasoning: The LLM correctly infers that increased Federal Funds Purchased & Sec Loaned indicate expanded short-term funding strategies, which is consistent with the original interpretation regarding BAC's liquidity and funding activities. The reasoning about managing liquidity needs and optimizing funding costs is plausible and contextually sound. (4) The qualitative and contextual accuracy are high because the overall trend and strategic implication are correctly interpreted. However, the quantitative accuracy is reduced due to unsupported absolute volume figures and a potentially incorrect 2023 fair value. The answer is relevant and addresses all parts of the question, but the factual foundation for the numbers is weak, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 505,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations became more detailed and integrated into broader market risk discussions. In 2022, the sensitivity was mentioned in the context of critical accounting estimates, without specific quantitative details. By 2024, the disclosure explicitly linked pension and retiree medical plan liabilities to market risks such as interest rates, inflation, and economic conditions, reflecting a more comprehensive risk management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, PepsiCo discussed the sensitivity of pension and retiree medical plan liabilities within its critical accounting policies without detailed quantitative disclosures. This matches the original answer's reference to 'Our Critical Accounting Policies and Estimates.' (2) For 2024, the LLM correctly notes an expansion in disclosure to include not only market fluctuations but also inflation and broader economic conditions—consistent with the ground truth's mention of inflationary, deflationary, and recessionary conditions. The only minor omission is that the LLM does not explicitly mention 'deflationary' conditions, instead generalizing under 'economic conditions,' which slightly reduces completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across years and entities (PepsiCo, pension/retiree medical plans, risk disclosures), demonstrating proper cross-temporal analysis. (4) All dates (2022, 2024) and entities (PepsiCo, pension and retiree medical plans) are accurate. There are no numerical inaccuracies, and while no specific numbers are involved, the qualitative descriptors are factually correct. The answer is contextually fully relevant, directly addressing the evolution of risk disclosures. The slight deduction from 10 to 9 on correctness and qualitative accuracy reflects the minor lack of specificity around 'deflationary' conditions, but overall, the semantic meaning and factual content are substantially equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 433,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan has evolved from being a standalone mobile scanning tool in 2023, focused on converting paper documents into searchable PDFs, to being more deeply integrated into Adobe's broader Document Cloud ecosystem in 2024. In 2024, Adobe Scan is positioned as a key component of Adobe Document Cloud, working alongside Acrobat, Acrobat Sign, and other services to enable seamless, automated digital document workflows across desktop, mobile, and third-party platforms. This integration enhances productivity by allowing instant sharing, editing, and collaboration within Adobe's unified cloud environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Scan between 2023 and 2024. It accurately captures the shift from a standalone mobile scanning tool in 2023 to a more integrated component of Adobe Document Cloud in 2024, emphasizing enhanced integration with broader document workflows. The entities (Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign) and timeframes (2023 to 2024) are correctly identified, and there are no numerical inaccuracies (non-applicable here as no numbers are involved). The reasoning is sound and reflects multi-hop synthesis across positioning changes over time. However, the LLM answer omits specific 2024 advancements mentioned in the ground truth, such as AI-driven features like Content Credentials and Firefly-powered generative AI workflows, which are key indicators of Adobe's strategic shift toward digital trust and enterprise integration. While the emphasis on integration and productivity is correct, the absence of these AI and trust-related elements reduces completeness and nuance. This results in a high but not perfect qualitative and overall correctness score. The answer remains contextually highly relevant and semantically aligned with the core evolution described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 356,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in December 2023 to 2024. In 2024, Google launched Gemini 2.0, an enhanced version of the model, which is now powering AI features across all seven of Google's two billion-user products, including Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities include the ability to generalize and seamlessly understand, operate across, and combine different types of information, such as text, code, audio, images, and video. These enhancements have enabled Gemini to support new experimental features like Dream Screen in YouTube and Project Astra, which explores the future of a universal AI assistant.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini launched in 2023 as a multimodal model; in 2024, Gemini 2.0 was introduced and integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. The mention of Project Astra is accurate. (2) Quantitative elements—'2023', '2024', and 'seven' products—are correct and match the ground truth. No calculations were required. (3) The multi-hop reasoning is sound: the answer synthesizes the evolution over time, product integration, and advancements in multimodal capabilities. (4) Minor deduction in qualitative accuracy because the LLM mentions 'Dream Screen in YouTube', which is not present in the ground truth and could be speculative or unverified; otherwise, the core advancements in multimodal capabilities (text, code, audio, images, video) are correctly described. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 292,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale business experienced a decline in sales and operating profit. In 2024, sales for the \"Other\" segment, which includes global helium wholesale, decreased by 2% compared to 2023, primarily due to lower volumes in global helium. Operating profit, however, increased by 44% in 2024 versus 2023, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs related to helium. This suggests that while helium volumes declined, cost management and insurance recoveries helped improve profitability in the segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2% sales decrease in the 'Other' segment due to lower global helium volumes in 2024 and the 44% operating profit increase driven by insurance recovery in LAMT, partially offset by higher helium costs. These key quantitative figures match the ground truth. However, the LLM incorrectly frames the operating profit context by stating the 44% increase was 'driven by insurance recovery' without clarifying that helium-related costs limited further growth—this nuance is present in the original answer but underemphasized. (2) All numbers—2% sales decline, 44% operating profit increase—are accurate and correctly attributed to 2024 vs. 2023. The time frame is slightly misaligned with the question, which asks about evolution between 2022 and 2024, but the LLM focuses on 2023–2024 changes. The shift from neutral/positive in 2022 to negative impact in 2024 is mentioned in the original but omitted in the LLM response, representing a minor completeness gap. (3) The multi-hop reasoning is mostly sound: the model correctly links helium volumes to sales impact and helium costs to profit constraints within the 'Other' segment and LAMT. However, it fails to explicitly note the evolution from 2022 (helium as a supply/input) to 2024 (helium as a cost pressure), which is central to the question. (4) Despite missing the 2022 baseline characterization, the answer remains highly relevant and factually accurate on the core financial impacts. Wording differences are acceptable under semantic equivalence, but the omission of the relationship shift from neutral to negative slightly reduces qualitative and correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 458,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $789 million in 2022 to $598 million in 2024, representing a decline of $191 million over the two-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for 2022 ($789 million) and 2024 ($598 million) are accurate, and the calculated decline of $191 million (789 - 598 = 191) is correct. (2) The answer addresses both parts of the question: the evolution of the net value (decrease from 2022 to 2024) and the magnitude of the change ($191 million). (3) Entities—'acquired franchise rights', '2022', '2024', and the financial metric—are correctly identified and used. (4) The reasoning is sound: the model correctly synthesized the two data points across time and computed the difference, demonstrating proper multi-hop logic. The answer is semantically equivalent to the ground truth, with slightly more detail by explicitly stating the magnitude of change, which enhances completeness. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 256,
        "total_tokens": 1338
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments related to Tengizchevroil (TCO) in Kazakhstan increased slightly from 2023 to 2024, with the company committed to delivering 3.2 trillion cubic feet (tcf) of natural gas from 2025 through 2027 in 2024, compared to 2.9 tcf from 2024 through 2026 in 2023. Production volumes from TCO remained stable, with 45 million barrels of oil-equivalent (MMBOE) in 2024 and 45 MMBOE in 2023. Additionally, TCO's proved undeveloped reserves increased to 197 million BOE in 2024, up from previous years, reflecting ongoing development efforts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and does not align with the ground truth. The original answer states that Chevron's natural gas volumes—both consumed and sold—increased from 2023 to 2024, with specific figures: 596 to 609 MMcf/d consumed and 7,148 to 7,569 MMcf/d sold, all inclusive of Tengizchevroil (TCO) contributions. However, the LLM answer introduces unrelated data: delivery commitments of 2.9 tcf and 3.2 tcf over future periods (2024–2026 and 2025–2027), which are not mentioned in the ground truth and appear fabricated or misattributed. Additionally, the LLM cites production in MMBOE (45 in both years), which is not the focus of the question—natural gas volumes in cubic feet per day are the key metric. (2) The numbers provided in the LLM answer (3.2 tcf, 2.9 tcf, 45 MMBOE) are not present in the ground truth and contradict the actual data. The correct figures are daily volumes (millions of cubic feet per day), not multi-year cumulative commitments. There is no mention of 3.2 tcf or 2.9 tcf in the original answer, nor is there any reference to future delivery commitments. The stability in MMBOE production is irrelevant because the question specifically asks about natural gas delivery and production volumes, not oil-equivalent totals. (3) The multi-hop reasoning is flawed. The LLM fails to extract and compare the actual natural gas volumes (sold and consumed) from 2023 to 2024 as reported in the filings. Instead, it invents or misattributes forward-looking delivery commitments and shifts focus to oil-equivalent production, which is not responsive. The correct reasoning would involve identifying Chevron’s reported gas volumes inclusive of TCO share and noting the year-over-year increase. (4) The contextual relevance is moderate because the answer discusses Tengizchevroil and Chevron’s natural gas activities, but it misses the core data and trend described in the ground truth. Due to major factual inaccuracies, incorrect metrics, and failure to report the actual evolution of gas volumes, the correctness score is low at 2. Quantitative accuracy is 2 due to almost entirely incorrect numbers. Qualitative accuracy is 3 due to correct entity identification (Chevron, TCO) but flawed reasoning. Contextual relevance is 5 because the topic is related but the substance is off-target.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 622,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "Between 2023 and 2024, the description of payments to Google Network partners in the 10-K filings shows a consistent structure, with no significant changes in the way these payments are characterized. In both years, payments to Google Network partners are included in \"TAC\" (Traffic Acquisition Costs) under cost of revenues, and they are described as amounts paid primarily for ads displayed on partners' properties. The 2024 filing maintains the same accounting treatment and explanation as the 2023 filing, indicating that the role of Google Network partners in the advertising revenue model has not fundamentally changed in terms of how their compensation is reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no change in the description of payments to Google Network partners between 2023 and 2024. The ground truth states that in 2023, these payments were described as a general operating expense under cash flows from operating activities, while in 2024 they were re-categorized under Traffic Acquisition Costs (TAC) with explicit linkage to ad revenue generation—indicating a strategic shift. The LLM incorrectly asserts that the treatment and description remained consistent across both years, directly contradicting the ground truth. While the LLM correctly identifies that TAC is related to payments for ads on partner properties (qualitatively accurate terminology), it fails to detect the material change in classification and strategic framing, which is the central point of the question. This represents a failure in multi-hop reasoning and synthesis across the two years’ filings. There are no numerical values to verify, so quantitative accuracy is not heavily penalized. Contextual relevance is moderate because the answer discusses the right topic (Google Network partners, TAC, advertising model), but it draws an incorrect conclusion about evolution in reporting. The answer lacks semantic equivalence with the ground truth due to this fundamental disagreement in interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 375,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America's climate-related regulatory requirements has shown an increasing trend in jurisdictional divergence and compliance risks. In 2023, the Corporation noted a global regulatory focus on climate change, with new or heightened requirements across state, federal, and non-U.S. jurisdictions, leading to potential legal, compliance, and disclosure risks. By 2024, the evolution of these policies is marked by a more pronounced emphasis on regulatory divergence, which is expected to increase the Corporation's legal, compliance, and public disclosure risks and costs in both the U.S. and globally. This divergence complicates the Corporation's ability to maintain consistent compliance strategies across different jurisdictions, amplifying the challenges in managing climate-related risks effectively.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of factual content, entities, and timeframes. It accurately identifies the increasing regulatory focus on climate change in 2023 and the growing concern over jurisdictional divergence impacting compliance risks. The entities (Bank of America, state/federal/non-U.S. jurisdictions), years (2023 to 2024), and key risks (legal, compliance, disclosure) are correctly identified. Quantitative accuracy is perfect—no numerical data is misstated, and no incorrect figures are introduced. The reasoning is sound in capturing the trend of escalating regulatory pressure. However, there is a subtle but important difference in the characterization of the 2024 situation: the original answer states that jurisdictional divergence is *now actively impacting* risks and costs, indicating a shift from anticipation to actual impact. The LLM answer says these risks are *expected to increase*, which retains a forward-looking tone and slightly underrepresents the shift from anticipated to realized impacts. This minor omission in nuance affects the qualitative accuracy but does not undermine the overall correctness. Contextual relevance is excellent, as all parts of the question are addressed with appropriate detail and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 361,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by stronger performance in 2024. In the year ended December 31, 2024, GM North America's Total Net Sales and Revenue increased by 11.4%, driven primarily by increased sales of full-size pickup trucks, mid-size pickup trucks, and other vehicles. Additionally, EBIT-adjusted for GM North America rose by 18.1%, with favorable cost adjustments and increased wholesale volumes, particularly in full-size pickup trucks and full-size SUVs, contributing to improved profitability and market positioning for this product line.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of GM's focus on full-size pickup trucks from 2022 to 2024 and links it to improved performance and market positioning. However, it introduces mid-size pickup trucks and 'other vehicles' as contributors to revenue growth, which are not mentioned in the ground truth and dilute the specific emphasis on full-size trucks. The ground truth highlights a key shift from 'risk factor' in 2022 to 'demonstrated strength' in 2024 due to net wholesale volume increases and a specific variable profit of ~160% for full-size trucks. The LLM answer omits this critical 160% profitability metric, which is a major quantitative indicator of performance. Instead, it cites overall GM North America revenue growth of 11.4% and EBIT-adjusted growth of 18.1%, which, while potentially accurate, are broader metrics not specifically tied to full-size pickup trucks alone. (2) The numbers (11.4%, 18.1%) may be factually correct in context but are not the key quantitative indicators specified in the ground truth. The absence of the 160% variable profit figure—a core data point—represents a significant omission in quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects increased sales to revenue and profitability, and correctly infers stronger market positioning. However, it fails to fully synthesize the specific evolution from risk to strength centered on full-size trucks, instead generalizing across vehicle types. (4) The contextual relevance is high because the answer addresses the strategic shift and supports it with financial performance data. Qualitative accuracy is good due to correct entity identification (GM, full-size pickup trucks, EBIT-adjusted) and logical flow, but the lack of the key 160% profitability metric and overgeneralization of sales drivers reduce correctness. Quantitative accuracy is moderate because the numbers presented are plausible but not the precise indicators from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 543,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "The allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased from $21 million in 2022 to $20 million in 2023 and further to $349 million in 2024. This significant shift indicates a strategic move by the company to prioritize safer, more liquid investments, likely reflecting a cautious approach to managing funds designated for future nuclear decommissioning obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states a single allocation that increases from $21M in 2022 to $20M in 2023 and then to $349M in 2024, which misrepresents the ground truth. The original answer distinguishes between two companies—Alabama Power and Georgia Power—with different allocations across years. In 2022, Alabama Power had $21M and Georgia Power had $293M; by 2024, Alabama Power decreased to $20M while Georgia Power increased to $349M. The LLM incorrectly aggregates or conflates these figures into a single time series, omitting Alabama Power’s data entirely in 2024 and misrepresenting the trend. (2) The quantitative inaccuracies are severe: the $20M figure is from 2024 (not 2023), and there is no support for a $20M value in 2023. Additionally, the LLM implies a continuous increase, but the actual data shows a slight decrease for Alabama Power and a large increase for Georgia Power. (3) The reasoning is partially sound in interpreting the shift toward safer investments, but it fails the multi-hop synthesis requirement by not recognizing the subsidiary-level allocation changes. The conclusion about a company-wide shift to safer assets oversimplifies what is actually a strategic reallocation between subsidiaries, with emphasis shifting to Georgia Power. (4) While the general direction of interpretation (safer investments) has some plausibility, the factual foundation is flawed, leading to a low correctness score. Quantitative accuracy is particularly poor due to incorrect numbers and timelines. Qualitative accuracy is moderate because the logic would follow if the numbers were right. Contextual relevance is acceptable since the answer addresses investment strategy in response to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 480,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved in terms of financial incentives and strategic dependency by continuing to provide annual bottler funding to support various programs, including advertising, new product initiatives, and equipment placement. The financial incentives remain a key component of PepsiCo's strategy to maintain strong relationships with its bottlers, ensuring effective distribution and promotion of its products. Additionally, PepsiCo's strategic dependency on independent bottlers remains significant, as these bottlers hold exclusive rights to manufacture and distribute PepsiCo's beverage products in specific geographic areas, highlighting their continued importance in PepsiCo's overall business model.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of PepsiCo's relationship with independent bottlers in terms of financial incentives and strategic dependency, noting continued annual funding and support for advertising, new product initiatives, and equipment placement. However, it omits a key quantitative fact from the ground truth: in 2024, Walmart alone accounted for approximately 14% of PepsiCo’s consolidated net revenue, which is critical to demonstrating the increased strategic dependency on bottlers. This missing data point significantly undermines the completeness and factual accuracy of the response. (2) No numeric values are mentioned in the LLM answer, despite the original answer including a specific percentage (14%) tied to Walmart’s contribution. This results in a low quantitative accuracy score, as the model fails to report a key metric that illustrates the extent of strategic dependency. While no incorrect numbers are stated (avoiding negative impact), the absence of this figure limits the answer’s precision. (3) The qualitative reasoning is sound in describing the shift toward more structured, annually negotiated funding and the ongoing importance of bottlers in distribution. The answer correctly identifies the exclusive rights of bottlers and the focus on marketing and distribution support, showing adequate multi-hop synthesis across time (2022 to 2024) and incentive types. However, it does not explicitly contrast the 2022 ‘accruals based on targets and experience’ with the 2024 ‘specific allocation across trade and consumer programs,’ missing a nuanced evolution in incentive structure. (4) Contextual relevance is high, as the response directly addresses the question’s focus on financial incentives and strategic dependency, using appropriate terminology and logical flow. The main shortcoming is the omission of a critical data point that would have strengthened both quantitative and qualitative accuracy, leading to a correctness score of 6—partially correct but with significant missing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 554,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role evolved from being a newly introduced generative AI product in 2023 to a more central and strategic component of Adobe's innovation efforts in 2024. In 2023, Firefly was positioned as part of Adobe's broader AI initiatives, such as Adobe Sensei, with an emphasis on enabling content creation and marketing. By 2024, Firefly is highlighted as a key example of Adobe's responsible AI development and is explicitly tied to the company's risk management and regulatory compliance strategies, particularly in response to emerging global AI regulations like the EU AI Act. This shift reflects Firefly's growing importance in Adobe's product innovation and its alignment with both customer needs and regulatory expectations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric values, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is partially incorrect due to factual misrepresentation of Adobe Firefly's evolution based on trademark listings and risk disclosures. The original answer states that in 2023, Firefly was listed among trademarks (indicating established status), while in 2024 it appeared in risk factors as a newly released generative AI product, signaling strategic importance. The LLM incorrectly claims Firefly was 'newly introduced' in 2023 and already part of broader AI initiatives like Adobe Sensei, which is not supported by the ground truth. It also introduces details not in the original—such as the EU AI Act and responsible AI development—which, while plausible, are not mentioned in the ground truth and represent unsupported extrapolation. The multi-hop reasoning is partially sound in identifying a strategic shift, but the evidence cited (trademark vs. risk factor positioning) is misrepresented. The answer is contextually relevant and addresses the evolution question, but with incorrect sourcing and added details, reducing factual accuracy. Thus, correctness is partially accurate but contains significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 363,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth declined in 2023 compared to 2022, particularly in the U.S. & Canada segment. In 2023, contractual escalations contributed $12.5 million to tenant billing growth, down from $229.9 million attributed to colocations and amendments. This shift reflects increased churn and lease cancellations, notably from T-Mobile, which led to a higher churn rate of approximately 3% in 2023. As a result, contractual escalations became a smaller driver of growth compared to previous years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific dollar amounts such as $12.5 million from contractual escalations or $229.9 million from colocations and amendments—these figures are entirely fabricated or misattributed. There is no support in the original answer for any numerical breakdown of growth contributions by source, making the core quantitative claim false. (2) The churn rate of approximately 3% in the U.S. & Canada segment is correctly identified and contextually relevant, as is the reference to T-Mobile's lease cancellations. However, the assertion that contractual escalations 'declined' in contribution from 2022 to 2023 is not supported by the original answer, which states that escalations remained a stated driver of growth, albeit in a more challenging environment due to churn. The original does not claim a decline in dollar terms or relative importance, only a contextual shift. (3) The multi-hop reasoning is partially sound—linking increased churn and T-Mobile cancellations to a more difficult environment for rent escalations aligns with the original's logic. However, the model incorrectly infers a quantitative decline and introduces unsupported figures, breaking the chain of accurate synthesis. (4) The contextual relevance is moderate because the answer addresses the core elements: rent escalations, churn, T-Mobile, and the U.S. & Canada segment. However, the introduction of false numbers severely undermines factual correctness. Correctness score is low due to major quantitative errors and misleading conclusions not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 463,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil (TCO) in 2024 shows an increase in capital expenditure commitments, with approximately $1.3 billion of equity affiliate investments allocated to TCO's development projects in Kazakhstan. This reflects a continued focus on advancing proved undeveloped reserves at TCO, where around 197 million BOE of reserves have remained undeveloped for five years or more due to facility constraints and reservoir depletion considerations. Chevron's production involvement with TCO is also evident, as TCO contributes to Chevron's affiliate production volumes, particularly in Kazakhstan.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. The ground truth states that nearly half of Chevron's $3 billion Affiliate Capex in 2024 (i.e., ~$1.5 billion) was allocated to Tengizchevroil's FGP/WPMP project. The LLM claims $1.3 billion was allocated, which is close but not exact and lacks reference to the $3 billion total or 'nearly half' framing. More critically, the LLM introduces a figure of '197 million BOE of reserves' that is not present in the original answer and cannot be verified from the provided ground truth, making it factually unsupported. (2) The year references are partially correct—2024 is appropriately discussed—but the 2023 context is missing entirely in the LLM answer. The original answer highlights a shift from capital commitments in 2023 to production focus in 2024; the LLM fails to capture this evolution and instead focuses only on 2024, missing the comparative timeline. (3) The multi-hop reasoning is incomplete. While the LLM correctly identifies Chevron’s ongoing production involvement with TCO and its contribution to affiliate production, it does not synthesize the transition from investment (2023 capex planning) to operational phase (2024 production), which is the core of the question. (4) Contextual relevance is strong—the answer addresses capital expenditures and production involvement with TCO—but the absence of 2023 data and introduction of unverified reserve numbers reduce factual reliability. Overall, the answer is directionally correct but lacks precision and completeness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 442,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent in methodology but showed changes in the resulting discount rates. The bond matching approach involves selecting specific bonds that align with projected benefit payments, reflecting the process UPS would use to settle obligations. In 2024, the U.S. pension discount rate was 5.88%, down from 5.42% in 2023, while the U.S. postretirement medical discount rate decreased slightly to 6.18% from 5.80%. These adjustments reflect updated bond yields and market conditions, but the core methodology of the bond matching approach did not change significantly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reports the discount rate changes, stating that the 2024 U.S. pension discount rate was 5.88%, down from 5.42% in 2023, and the postretirement rate decreased to 6.18% from 5.80%. This is factually wrong — the rates increased from 2023 to 2024, not decreased, and the numbers themselves do not match the ground truth. There is no mention in the original answer about specific rate values, so fabricating these numbers is a serious error. (2) The quantitative inaccuracies are severe: not only are the percentages incorrect, but the direction of change (increase vs decrease) is reversed, which distorts the financial interpretation. The original answer does not provide specific rates, so the LLM hallucinated data. (3) The qualitative reasoning partially captures the continuity of the bond matching methodology, correctly noting that the core approach remained consistent. However, it fails to address the key evolution in language and framing emphasized in the ground truth — specifically, the shift in 2024 to describing the approach as a 'guide' for bond selection, which reflects a more precise operational framing. This nuance is entirely missing. (4) The contextual relevance is moderate because the answer discusses the right topic (bond matching approach for discount rates) and correctly identifies UPS and the relevant benefit plans, but it introduces false quantitative data and misses the central qualitative evolution in disclosure language. The multi-hop synthesis is weak because it does not connect the change in narrative tone across years as required by the question. Correctness is low due to hallucinated numbers and omission of the actual evolution in specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 470,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's relationship with helium has shifted from 2022 to 2024, with the global helium wholesale business being included in the \"Other\" segment in 2024, indicating a strategic reorganization. This change led to a 2% decrease in sales for the \"Other\" segment in 2024 compared to 2023, primarily due to lower helium volumes. Despite this, operating profit in the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift in Linde's relationship with helium from 2022 to 2024 and notes the negative impact on sales due to lower helium volumes in the 'Other' segment. It accurately states a 2% decrease in sales, aligning with the ground truth. However, it omits the specific $32 million figure cited in the original answer, which reduces quantitative precision. The LLM also correctly mentions the 44% increase in operating profit in the 'Other' segment due to insurance recovery for LAMT and higher helium-related costs, but this detail is not in the ground truth, which only states that helium had downward pressure on operating profit, partially offset by insurance recovery—without citing a 44% increase. This addition introduces unverified data. (2) The time frame comparison is mostly accurate, though the LLM compares 2024 to 2023 instead of tracking the evolution from 2022 to 2024 as required. The ground truth explicitly references 2022 as a baseline where helium was a supply input, but the LLM does not mention helium’s role in 2022, missing a key part of the multi-hop evolution. (3) The reasoning is logically sound in connecting helium volumes to sales decline and insurance recovery to profit improvement, but fails to fully synthesize the change from 2022 to 2024, focusing instead on 2023–2024. The entity identification (Linde, LAMT, 'Other' segment) is correct. (4) The answer is contextually relevant and well-structured, but lacks full completeness on the temporal evolution and exact financial figures. The correctness score is 7 due to accurate core facts but missing/misstated numbers and incomplete multi-year synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 458,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. During the same period, the recognized tax credits related to these investments slightly decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. These values exactly match the original answer, with no calculation or reporting errors. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy is correct—Bank of America, the correct years (2023 and 2024), and the proper financial metrics (unfunded capital contributions and recognized tax credits) are all accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across time points and financial metrics. While the LLM answer is more concise than the original and omits the interpretive sentence about reduced near-term commitments, it still conveys the same core factual information with semantic equivalence. No factual or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 311,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "General Motors' approach to fleet sales involving commercial fleet customers from 2022 to 2024 has shown a decline in the proportion of fleet sales relative to total vehicle sales. In 2022, fleet sales accounted for 11.3% of total vehicle sales, decreasing to 11.3% in 2023 and further to 11.3% in 2024, indicating a consistent but lower share compared to previous years. Sales channels for fleet vehicles have primarily remained through the dealer network, with some direct sales to fleet customers. Profitability considerations highlight that certain fleet transactions, particularly with daily rental car companies, are generally less profitable than retail sales, suggesting a strategic focus on balancing fleet sales with higher-margin retail sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that fleet sales were 11.3% of total vehicle sales in 2022, 2023, and 2024. The ground truth does not provide any specific percentage data on fleet sales as a share of total sales, so this repeated figure is unsupported and likely incorrect. This undermines the core of the response. (2) There are no calculations in the answer, but the repeated use of 11.3% across all three years suggests either a data error or a failure to differentiate trends over time, which contradicts the idea of 'evolution' in approach. The ground truth focuses on changes in sales channels and profitability, not volume trends. (3) The qualitative aspects partially align: the LLM correctly notes that fleet sales to daily rental companies are less profitable than retail, and that sales occur through dealers or directly—this matches the ground truth. It also acknowledges a strategic balance with retail sales, which is consistent. However, it fails to highlight the key evolution from 2022 to 2024: in 2022, direct and dealer channels were used without distinction, but by 2024, GM emphasized a more structured approach involving dealers and selective direct engagement, implying optimization. This shift in strategy is underemphasized. (4) Contextual relevance is moderate—the answer addresses fleet sales, channels, and profitability, which are relevant, but introduces unsupported metrics that distract from the actual evolution in strategy. The reasoning is partially sound but based on fabricated data, reducing overall correctness. Quantitative accuracy is very low due to the unsupported percentages; qualitative accuracy is mid-range due to correct general concepts; contextual relevance is fair as it stays on topic but misdirects focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 498,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra remained consistent as a joint venture with the Strauss Group, where PepsiCo's FLNA division made, marketed, distributed, and sold Sabra refrigerated dips and spreads. There were no significant structural changes in this partnership during the period. Financially, there were no material gains or charges directly tied to Sabra during this time, as indicated by the absence of relevant entries in the provided financial tables.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims there were no structural changes in PepsiCo's relationship with Sabra between 2022 and 2024, directly contradicting the ground truth that PepsiCo divested part of its ownership and retained only a 50% equity stake by 2024. (2) The financial implication stated in the ground truth—a $122 million pre-tax gain from remeasuring the remaining 50% stake at fair value—is entirely absent from the LLM response, which incorrectly asserts no material gains were recorded. (3) The multi-hop reasoning required—connecting PepsiCo’s ownership change to the financial impact via fair value remeasurement—is missing; instead, the LLM falsely concludes no changes occurred. (4) Entity accuracy fails: while Sabra and PepsiCo are correctly identified, the timeline (2022 vs 2024 ownership status) and financial metric ($122M gain) are wrong. The answer is contextually relevant to the question’s topic but factually opposite to the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 300,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe Scan has been increasingly integrated into Adobe's broader product ecosystem between 2023 and 2024. In 2023, Adobe Scan was listed as part of Adobe Document Cloud in the trademarks section, indicating its role within that suite. By 2024, Adobe Scan is explicitly included in the Adobe Document Cloud offering, which emphasizes digital document workflows and integrates with other Adobe products like Adobe Acrobat and Adobe Acrobat Sign. This evolution highlights Adobe's strategy to position Adobe Scan as a core component of its end-to-end document management and productivity solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities—Adobe Scan, Adobe Document Cloud, Adobe Acrobat, Adobe Acrobat Sign—are correctly identified, and the years 2023 and 2024 are accurately used. (2) There are no numeric values requiring verification, so quantitative accuracy is not applicable but assumed perfect. (3) The multi-hop reasoning is sound: the model correctly infers an evolution in positioning from trademark listing in 2023 to explicit inclusion in Document Cloud in 2024, reflecting deeper integration. (4) The only minor discrepancy is that the LLM states Adobe Scan was 'listed as part of Adobe Document Cloud in the trademarks section' in 2023, while the ground truth only confirms it was listed among trademarks without specifying Document Cloud at that time. This is a slight overinterpretation but does not materially misrepresent the strategic shift. Overall, the answer captures the essence of increased strategic emphasis and integration, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 309,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024 regarding indemnifications and historical liabilities have remained largely consistent, with no significant changes noted. In both periods, GM indemnifies Stellantis for certain losses arising from inaccuracies in representations and warranties, breaches of covenants, and specific liabilities such as emissions claims, product liabilities, and recalls related to the 2017 Opel/Vauxhall sale. As of 2024, GM states it is unable to estimate any reasonably possible material loss or range of loss from these obligations, either directly or through indemnification claims. Additionally, GM has indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, with such further indemnifications considered remote.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements regarding GM's indemnification obligations to Stellantis, including emissions claims, product liabilities, recalls (e.g., Takata), and the immaterial nature of accrued amounts. It correctly identifies the ongoing nature of indemnifications stemming from the 2017 Opel/Vauxhall sale. However, it fails to accurately reflect the evolution in the *nature* of the relationship from 2022 to 2024 as described in the ground truth. The original answer emphasizes a shift from active supply-related transactions in 2022 to a more passive, indemnification-based financial relationship by 2024. The LLM answer incorrectly states that there has been 'no significant changes noted,' which contradicts the transformation highlighted in the ground truth. This misrepresents the core multi-hop insight: the evolution from operational to financial exposure. Additionally, while the LLM mentions GM's inability to estimate possible losses, this detail is not present in the ground truth and may reflect overgeneralization or hallucination. The mention of 'inaccuracies in representations and warranties' and 'breaches of covenants' lacks specificity to the emissions, Takata, and end-of-life vehicle regulatory issues emphasized in the original. Quantitatively, the use of 'immaterial amount' aligns with the ground truth's 'accrued an immaterial amount,' so numerical accuracy is acceptable. Contextually, the answer stays on topic and addresses indemnifications and historical liabilities, but misses the dynamic change over time, which is central to the question. Thus, while factually plausible in parts, the LLM answer lacks the correct qualitative synthesis and evolution narrative, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 475,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo's relationship with co-packers between 2022 and 2024 has remained relatively stable in terms of operational dependency, as the company continues to utilize a network of co-packers, contract manufacturers, and joint ventures to support its production and distribution activities. However, strategic involvement appears to have increased, particularly in regions like Latin America and through joint ventures, such as the distribution agreement for the Tropicana and Naked brands post-Juice Transaction. This reflects a more integrated approach to managing supply chains and leveraging partnerships for market expansion and operational efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies a shift toward greater strategic involvement with co-packers between 2022 and 2024, particularly through joint ventures and regional expansions, which aligns with the ground truth. It accurately reflects that PepsiCo continues to rely on co-packers operationally, maintaining consistency in operational dependency. However, it misses the key evolution in language from 'highly distributed network of plants, warehouses and distribution centers' in 2022 (indicating third-party operational dependency) to 'strategic alliances or joint ventures in which we have an equity interest' in 2024 (indicating ownership-based integration), which is central to the original answer. While the LLM references the Tropicana and Naked brands post-Juice Transaction as an example, this specific detail is not in the ground truth and may introduce unsupported specificity. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is generally sound, though the multi-hop synthesis between the two years’ strategic framing is incomplete. The answer remains contextually relevant and captures the directional shift, but lacks precise textual support from the knowledge graph on how the relationship was characterized in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 356,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG sold a portion of its interest in ABG, resulting in a pre-tax gain of $157.1 million, and ABG's capital transactions further diluted SPG's ownership to approximately 9.6%. By 2024, SPG sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, generating a substantial pretax gain of $414.8 million. These transactions reflect a strategic divestment from ABG, with SPG recognizing significant gains in both years as it reduced its equity stake.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, SPG recognized a $157.1 million gain from selling a portion of its ABG interests and a $59.1 million gain from deemed disposals due to ABG's capital transactions, plus a $145.8 million gain from dilution in SPARC Group. However, the LLM incorrectly states that SPG sold *all* remaining interest in ABG in 2024 for $1.2 billion and recorded a $414.8 million gain, which is not supported by the original answer. The original answer mentions only an $18.8 million gain in 2024 from the sale of a portion of its ABG interest in *December 2021*, not 2024, indicating a misattribution of timing and amount. (2) Quantitatively, the $157.1 million gain in 2023 is correctly cited, but the $414.8 million gain and $1.2 billion cash proceeds are entirely fabricated and not present in the ground truth. The 9.6% ownership figure is plausible but not verifiable from the provided truth. (3) The multi-hop reasoning is flawed: instead of identifying a shift from financial gains to strategic operational collaboration (e.g., Reebok partnership), the LLM concludes a full divestment, contradicting the original narrative of deepening collaboration. It fails to mention the strategic partnership with ABG for Reebok, a key qualitative shift. (4) The contextual relevance is moderate because it addresses SPG’s financial relationship with ABG and gains, but the core evolution—moving from financial transactions to strategic collaboration—is misrepresented as complete divestiture, fundamentally undermining the accuracy. Thus, the correctness score is low due to major factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 463,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs, under its Rotary and Mission Systems (RMS) segment, saw an increase in production volume from 2022 to 2024. In 2022, higher production volume on Sikorsky helicopter programs contributed to increased product costs at RMS. By 2024, Sikorsky programs remained a key part of RMS's major programs, indicating continued emphasis on these initiatives, though specific production volume figures for 2024 were not provided. The scope of these programs includes military and commercial helicopters such as the Black Hawk, Seahawk, and CH-53K King Stallion, as well as the Combat Rescue Helicopter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly identifies the 2022 increase in product costs due to higher production volume on Sikorsky programs, matching the $560 million increase in costs (though the exact dollar amount is not repeated in the LLM answer, it correctly infers the cause-effect relationship). The LLM does not fabricate any numbers and acknowledges that specific 2024 production figures were not provided, which is accurate. (2) The entities—Lockheed Martin, RMS segment, Sikorsky programs (Black Hawk, Seahawk, CH-53K King Stallion, and Combat Rescue Helicopter)—are all correctly named and contextualized within the correct time frame (2022–2024). (3) The reasoning is sound: it traces the evolution from increased production volume in 2022 as a cost driver to continued strategic emphasis in 2024, reflecting the shift toward a defined product line. The only minor gap is that the LLM does not explicitly state the strategic evolution from 'cost driver' to 'strategic product line' as emphasized in the original answer, slightly weakening the qualitative synthesis. (4) The answer is fully relevant, directly addressing both production volume trends and program scope expansion. Overall, the response is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for missing the full strategic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 402,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart's ownership stake in Alert Innovation increased from approximately 100% to full ownership, as the company completed a $0.4 billion acquisition of the remaining stake in fiscal 2023. However, Alert Innovation was subsequently sold and deconsolidated in fiscal 2025. There were no further financial investments or changes in ownership mentioned for Alert Innovation in fiscal 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart completed a $0.4 billion acquisition in fiscal 2023, aligning with the ground truth that Walmart increased its ownership to approximately 100%. This numeric and event accuracy supports a high quantitative accuracy score. However, the LLM incorrectly states that Alert Innovation was sold and deconsolidated in fiscal 2025, while the ground truth indicates there was no mention of ownership in fiscal 2024, implying the exit occurred by or during that period. This misplacement of the divestiture timeline introduces a significant factual error. (2) The $0.4 billion figure is accurate and correctly formatted. There are no calculation errors, but the temporal misalignment of the divestiture (fiscal 2025 vs. implied exit by fiscal 2024) undermines the factual correctness. (3) The multi-hop reasoning is partially sound—Walmart’s full acquisition in 2023 is correctly inferred and linked to ownership. However, the synthesis fails in the second hop: instead of concluding that Walmart likely exited its stake by fiscal 2024 due to absence of mention (as per ground truth), the model introduces an unsupported claim about a fiscal 2025 deconsolidation, which is not in the original data. This reflects flawed reasoning based on external assumptions. (4) The answer is contextually relevant and addresses both ownership and investment changes, but the incorrect timing of the divestiture and the introduction of a future event (fiscal 2025) not present in the source data reduce the correctness and qualitative accuracy scores. The core financial investment detail is correct, but the evolution of ownership is misrepresented in the second year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 463,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility remained relatively low, with only $323.7 million outstanding under the Credit Facility as of December 31, 2024. The Supplemental Facility had a borrowing capacity of $3.5 to $4.5 billion during its term, and SPG had an aggregate available borrowing capacity of $8.2 billion under the Credit Facilities as of December 31, 2024. In terms of repayment strategy, SPG repaid $750.0 million in Euro-denominated borrowings under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. Additionally, SPG redeemed several debt instruments in 2024, including $1.0 billion in 2.00% senior unsecured notes at maturity on September 13, 2024, and $900.0 million in 3.38% senior unsecured notes at maturity on October 1, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include the repayment of €750.0 million under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. This aligns with the ground truth. However, the LLM incorrectly states that $323.7 million was outstanding under the Credit Facility as of December 31, 2024, which contradicts the ground truth that there was *no outstanding balance* under the Supplemental Facility in 2024. This is a major factual error. Additionally, the LLM introduces unrelated redemptions in 2024—$1.0 billion in 2.00% notes and $900.0 million in 3.38% notes—that are not tied to the Supplemental Facility and were not part of the original answer, creating confusion. (2) Quantitative accuracy is partially correct: the €750.0 million borrowing and repayment date (Nov 17, 2023) are accurate, but the $323.7 million outstanding balance is factually wrong in the context of the Supplemental Facility. The $1.0 billion bond issuance in September 2024 mentioned in the ground truth was for refinancing and reducing reliance on the facility, but the LLM mischaracterizes it as a redemption at maturity, which is a different financial action. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of the Supplemental Facility usage—specifically, the full repayment and strategic shift away from it. Instead, it implies continued use by citing an outstanding amount under broader Credit Facilities, conflating different facilities. The strategic shift to long-term unsecured notes is mentioned but inaccurately framed. (4) Contextual relevance is moderate—the answer discusses SPG’s debt activity and facilities, but misdirects focus to unrelated repayments and incorrect balances, reducing its accuracy. The core narrative of reduced reliance is partially present but undermined by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 530,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has elevated helium's positioning in its industrial gases business between 2023 and 2024, emphasizing it as a key product within its merchant and packaged gas distribution methods. Helium, categorized as a process gas, is highlighted for its ability to be shipped over long distances, aligning with Linde's broader strategy to serve diverse customer needs. Supply strategies reflect helium's inclusion in multi-year supply agreements, with contracts typically lacking minimum purchase requirements but allowing flexibility to meet fluctuating customer demands. This evolution underscores helium's growing strategic importance in Linde's portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about Linde's treatment of helium between 2023 and 2024. According to the ground truth, helium was explicitly listed as a primary product in 2023 but was no longer specifically named in 2024, indicating a downgraded or subsumed status within the product portfolio. However, the LLM claims helium's positioning was 'elevated' and 'emphasized as a key product,' which directly contradicts the original answer. This misrepresents the strategic shift, turning a reduction in emphasis into an increase. While the LLM correctly references multi-year contracts without minimum purchase requirements (a detail present in the 2023 filing), it incorrectly projects this as evidence of growing strategic importance, when the ground truth suggests the opposite trend—helium being grouped more generically with other gases. There are no numerical values in the question or answers requiring calculation, so quantitative accuracy is high by default (dates 2023–2024 are correct). Entity accuracy is acceptable—Linde, helium, industrial gases, and contract terms are correctly identified. However, the reasoning is flawed: the model fails to recognize the significance of helium being omitted as a named product in 2024, which is a critical multi-hop signal indicating strategic repositioning. Instead, it infers increased importance without evidence, leading to a qualitatively inaccurate conclusion. Contextually, the answer addresses the right topic and some relevant aspects (distribution methods, contracts), but draws the wrong inference about evolution, making it partially relevant but factually misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 451,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the allocation of assets in the U.S. Retiree Health Care Plan remained relatively stable, with slight shifts in fixed income securities and equity securities. In 2023, the plan held $210 million in fixed income securities and cash equivalents and $54 million in equity securities, compared to $182 million in fixed income and $98 million in equity in 2022. This indicates a modest increase in fixed income and a decrease in equity securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the 2022 asset allocations. According to the ground truth, in 2022, the plan had $248 in fixed income securities and cash equivalents and $137 in equity securities. However, the LLM incorrectly states $182 for fixed income and $98 for equity in 2022, which are both factually wrong. The 2023 figures ($210 in fixed income and $54 in equity) are correct. (2) Calculations: The ground truth shows total assets decreasing from $385 in 2022 to $264 in 2023, with both categories declining. The LLM misrepresents the trend by claiming a 'modest increase in fixed income' when in fact fixed income decreased from $248 to $210. Equity also decreased more significantly than reported. The LLM’s comparison is therefore invalid due to incorrect baseline numbers. (3) Multi-hop reasoning: The model fails to correctly synthesize the data across years. It incorrectly infers stability and a shift toward fixed income, when the actual data shows a substantial reduction in both asset classes, especially equities (from $137 to $54). The conclusion about 'modest increase in fixed income' is false and stems from incorrect input data. (4) Scores justified: Correctness is low (2/10) due to major factual inaccuracies in core numbers and resulting flawed analysis. Quantitative accuracy is poor (2/10) because only half the numbers are correct (2023 values only). Qualitative accuracy is slightly higher (3/10) because the structure of the response and intent to compare is valid, but reasoning is based on wrong data. Contextual relevance is acceptable (7/10) as the answer addresses the right plan and asset classes over time, just with incorrect values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 466,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's financial performance and strategic positioning showed significant growth and regulatory progress. Revenue from Trodelvy increased by 56% in 2023 compared to 2022, reflecting strong sales growth across all regions. Strategically, Trodelvy received key regulatory approvals, including FDA and European Commission (EC) approvals for expanded indications, such as for HR+/HER2- breast cancer, enhancing its market reach and therapeutic utility. These developments underscored Trodelvy's growing importance in Gilead's oncology portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic positioning improvements in 2023 with FDA and EC approvals for HR+/HER2- metastatic breast cancer, which aligns with the ground truth. However, it introduces a specific quantitative claim—'revenue increased by 56% in 2023 compared to 2022'—that is not supported by the original answer, which only provides the 2022 revenue figure ($380 million) and explicitly states that 'specific revenue figures for 2023 are not provided.' Therefore, the 56% growth figure is fabricated or inferred without basis. (2) The calculation of a 56% increase cannot be verified and is inconsistent with the ground truth's omission of 2023 revenue data. This represents a major quantitative inaccuracy. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes regulatory milestones across FDA and EC approvals and links them to expanded market potential. However, it fails in financial synthesis by asserting a precise growth rate absent from the source data. (4) While the qualitative and contextual aspects are strong—correct entities (Trodelvy, FDA, EC, HR+/HER2- indication), correct years (2022–2023), and relevant strategic implications—the inclusion of an unsupported numerical claim significantly undermines factual correctness, warranting a mid-range score of 5 for overall correctness. Quantitative accuracy is low (3) due to the invented percentage; qualitative accuracy is solid (7) for correct reasoning and entities; contextual relevance is high (9) as the response directly addresses the question's focus on performance and positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 443,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex decreased from $13 million in 2019 to $85 million in 2022, then further declined to a loss of $185 million in 2024, indicating a weakening financial performance in the joint venture. Despite this, Chevron maintains a 50% ownership stake in GS Caltex, highlighting its strategic importance in the South Korean market for refining, marketing, and petrochemicals. The continued investment suggests Chevron values the joint venture's regional presence and long-term potential despite short-term earnings challenges.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It claims Chevron's downstream-related earnings from GS Caltex were $13 million in 2019 (not mentioned in the question or ground truth), $85 million in 2022, and a loss of $185 million in 2024—none of which appear in the original answer and contradict the ground truth, which states that Chevron reported higher downstream earnings in 2022 and does not mention losses in 2024. The only correct entity relationship is Chevron’s 50% ownership in GS Caltex, maintained through 2024. (2) The ground truth reports $16,286 million in sales and other operating revenues with affiliated companies in 2022 and $13,850 million in 2024—this is a decrease, but these figures represent total revenues with affiliates, not downstream earnings specifically from GS Caltex, and certainly not losses. The LLM misrepresents both the metric and the values. There are no calculations in the LLM answer, but the numbers cited are entirely fabricated or misattributed. (3) The multi-hop reasoning fails: the LLM incorrectly infers declining performance and losses without evidence, and incorrectly ties this to strategic importance. While it correctly identifies the joint venture's activities and Chevron’s continued stake, it draws the opposite conclusion about financial performance compared to the ground truth, which indicates stable strategic importance with slightly reduced affiliated revenues—not deteriorating earnings. (4) The contextual relevance is moderate because the answer addresses the right companies and the general idea of strategic importance, but the factual foundation is so flawed that the conclusion is misleading. Correctness and quantitative accuracy are very low due to invented numbers and incorrect trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 484,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program's production volume increased, contributing to higher product sales in RMS, particularly in 2024. In 2022, RMS reported increased net sales due to higher production volume on the CH-53K program. By 2024, the production ramp-up continued, with RMS noting higher production volume on the CH-53K as a key driver of increased product sales. Additionally, risk retirements, which reflect improved cost estimates and reduced uncertainties, contributed to operating profit growth in earlier years, though specific figures for the CH-53K were not detailed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies increasing production volume on the CH-53K program from 2022 to 2024 and acknowledges the role of risk retirements in earlier years in boosting profits. However, it omits the key quantitative detail from 2022—$140 million in increased profit driven by risk retirements and production volume—which is central to the original answer. Additionally, while the LLM notes continued production ramp-up in 2024, it fails to mention the 73% decline in RMS operating profit, a critical context that suggests diminished gains from risk retirements despite higher volume. (2) No specific numbers are provided in the LLM answer, and while it avoids inventing false figures, the absence of the $140 million profit impact in 2022 and the 73% profit decline in 2024 constitutes a significant quantitative omission. The answer does not contradict these numbers but does not include them, reducing quantitative accuracy. (3) The reasoning is partially sound: the model correctly infers that higher production volume contributed to sales and that risk retirements improved profitability in earlier years. However, it fails to synthesize the multi-hop insight that while production increased, overall profitability at RMS declined sharply by 2024, implying a reduction in risk retirement benefits as the program matured. This weakens the qualitative reasoning. (4) The answer remains contextually relevant, addressing both production volume and risk retirements over the specified time frame, and uses appropriate terminology (e.g., 'risk retirements', 'production ramp-up'). Despite missing key financial data and the broader profit trend, it stays focused on the question's core themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 468,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs has evolved with a stronger strategic emphasis on enhancing trust and security for both merchants and consumers. In 2022, the focus was on maintaining and supporting existing protection programs to mitigate financial loss risks, particularly in the context of counterparty nonperformance. By 2023, PayPal explicitly highlighted the integration of these programs into its broader strategy to differentiate itself in a competitive market, emphasizing innovation, risk management, and the promotion of confidence in its payments platform. Additionally, the 2023 documents reflect a heightened awareness of regulatory and operational risks, suggesting a more proactive approach to managing exposure through compliance and program refinement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of PayPal's seller protection programs from 2022 to 2023. (1) It accurately captures the shift from risk mitigation in 2022 to strategic differentiation in 2023, emphasizing trust, merchant confidence, and competitive positioning. The mention of integration with broader risk management and compliance efforts in 2023 is consistent with the original answer. (2) Quantitative accuracy is perfect: while no specific numbers are repeated (e.g., 0.09%–0.15% loss rates), the LLM does not introduce any incorrect figures, and the absence of these percentages does not constitute an error—though their inclusion would have strengthened completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes a shift in strategic emphasis across years, linking seller protection to platform growth and merchant trust, even if it frames the 2022 focus slightly more broadly as 'counterparty nonperformance' rather than regional and regulatory risk exposure. (4) The answer is contextually relevant and addresses both parts of the question—risk exposure and strategic emphasis—though it could have more explicitly contrasted 2022's focus on quantified risk exposure (with TPV-linked loss rates) versus 2023's value proposition framing. The omission of the specific TPV loss range is the primary reason for not awarding a 9 or 10 in correctness and qualitative accuracy. Overall, the semantic meaning is equivalent and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 419,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages evolved in terms of revenue recognition and supplier dependency. In 2024, the company continued to sell a variety of ready-to-drink beverages through its Global Coffee Alliance with Nestlé, with product sales generally recognized upon shipment. However, the 2024 10-K noted a decline in \"Other\" revenues, which includes these ready-to-drink beverages, by $95 million compared to 2023, primarily due to a decline in the Global Coffee Alliance revenue following the sale of the Seattle's Best Coffee brand to Nestlé in 2023 and product SKU optimization. Supplier dependency remained significant, with Starbucks relying on several specialty suppliers for ready-to-drink beverages under long-term contracts, though the 2024 report highlighted increased risks related to supply chain challenges and supplier performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements but introduces significant factual inaccuracies. The claim that 'Other' revenues declined by $95 million in 2024 due to the sale of Seattle's Best Coffee to Nestlé is not supported by the ground truth, which does not mention this sale or a specific $95M decline. The ground truth emphasizes a shift in reporting focus from revenue recognition to supply chain resilience, not a quantified revenue drop. This major addition of unverified financial data undermines factual correctness. (2) The $95 million figure and the causal link to SKU optimization and brand sale are not present in the original answer and cannot be verified from the provided context, making the quantitative claim incorrect. The ground truth does not provide specific revenue figures for ready-to-drink beverages in either year. (3) The LLM correctly identifies that revenue was recognized upon shipment in both years and notes continued reliance on specialty suppliers under long-term contracts, showing accurate multi-hop synthesis of revenue recognition and supplier dependency trends. It also correctly references the Global Coffee Alliance with Nestlé, adding contextual detail not in the ground truth but plausibly aligned. (4) Despite strong contextual relevance and partial qualitative accuracy in identifying strategic themes, the inclusion of unsupported quantitative claims significantly reduces correctness. The answer shifts focus to a revenue decline not mentioned in the ground truth, misrepresenting the nature of the evolution. Thus, while reasoning is partially sound and entities are accurate, the fabrication of a $95M decline and its explanation results in a score of 6—partially correct but with significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 480,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was approved in several countries, including Canada for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who had received two or more therapies. In 2023, Trodelvy received additional regulatory approvals, including from the European Commission for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the FDA approved Trodelvy for the same HR+/HER2- breast cancer indication. These approvals expanded Trodelvy's availability to more patient populations and geographic regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory approvals for Trodelvy in 2023 by both the FDA and the European Commission for HR+/HER2- metastatic breast cancer, which aligns with the ground truth and indicates expanded therapeutic use and likely geographic reach. However, the LLM introduces information not present in the original answer—specifically, approval in Canada in 2022 for TNBC—which is not mentioned in the ground truth and cannot be verified from the provided data. While this detail may be factually correct in reality, it is not supported by the original answer and thus represents an unsupported addition. (2) The original answer includes quantitative sales data: $370M in U.S. sales and $10M in Europe in 2022, with no international sales reported. The LLM answer omits all quantitative sales figures entirely, which is a notable omission in terms of geographic reach assessment. This lack of numeric data reduces quantitative accuracy despite no incorrect numbers being stated. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that new approvals in 2023 imply broader market access and expanded reach. However, it fails to contrast the limited 2022 geographic footprint (U.S. and minimal Europe) with the 2023 developments, weakening the comparative analysis. The synthesis is logical but incomplete. (4) The answer is contextually relevant and well-structured, addressing both regulatory and geographic evolution. Due to correct core facts about 2023 approvals and reasonable inference about expanded reach, but with missing sales data and an unverified claim about Canada, the correctness score is 7. Quantitative accuracy is 8 because no numbers are wrong—just omitted. Qualitative accuracy is 7 due to correct reasoning but unsupported 2022 claim. Contextual relevance is high at 9 because the response directly addresses the question's focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 516,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. In 2023, Simon recognized multiple non-cash gains from deemed disposals due to dilutions in its ownership stake, including a 9.6% stake by year-end. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, resulting in a pretax gain of $414.8 million. This marked the complete divestiture of Simon's ownership in ABG, with substantial financial gains realized over the two-year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG in 2023, reducing from 12.3% to 11.8%, then 11.7%, and finally to 9.6%, with corresponding non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M. However, the LLM incorrectly claims that in 2024, SPG sold all of its remaining interest in ABG for $1.2 billion and recognized a pretax gain of $414.8 million. This is entirely false—no such transaction occurred in 2024. Instead, the ground truth states that SPG did not report any new transactions in 2024 and only referenced a prior 2021 transaction involving an $18.8M gain and a $100M acquisition. (2) Quantitative accuracy is very low: the claimed $1.2 billion in proceeds and $414.8 million gain in 2024 are fabricated. The only correct numeric element is the mention of a 9.6% stake at year-end 2023, which aligns with the ground truth. All other numbers are incorrect. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution of SPG’s stake and gains over time. It incorrectly infers a complete divestiture in 2024, contradicting the ground truth that SPG took a passive disclosure stance in 2024 with no new transactions. The model also ignores the non-cash, dilution-driven nature of the 2023 gains and falsely presents the 2024 gain as a cash transaction. (4) Scores are justified as follows: Correctness is low (2/10) due to major factual errors in both ownership changes and financial gains. Quantitative accuracy is poor (2/10) because most numbers are incorrect. Qualitative accuracy is slightly higher (3/10) as the model recognizes the concept of dilution gains in 2023 but misrepresents the 2024 situation. Contextual relevance is moderate (6/10) because the answer addresses the general topic of SPG’s stake and gains in ABG, but with serious factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 527,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between the 2023 and 2024 filings, the 2012 Equity Incentive Plan underwent an amendment in the form of a \"Fourth Amendment,\" disclosed in the 2024 filing (page 127). Additionally, the 2024 filing includes updated forms of award agreements under the 2012 Equity Incentive Plan, with additional forms disclosed in filings dated April 25, 2024. The 2023 filing did not mention a fourth amendment or award agreements from 2024, indicating the evolution of the plan through new amendments and updated award forms in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Fourth Amendment dated August 1, 2024 (implied by the 2024 filing), which matches the original answer's 'Fourth Amendment dated August 1, 2024'. The mention of updated award agreements from April 2024 (specifically April 25, 2024) is consistent with the ground truth's reference to 'additional forms of award agreements from April 2024'. (2) All dates and amendment numbers are factually correct; no calculations are required. (3) The multi-hop reasoning is sound: the model contrasts the 2023 and 2024 filings appropriately, noting that the 2023 filing included the Third Amendment and referenced 2012/2017 award forms, while the 2024 filing introduced the Fourth Amendment and new 2024 forms—this synthesis across years is accurate even if the 2023 details were not explicitly restated in the LLM answer, as they were contextually implied. (4) The answer is contextually complete and relevant, focusing precisely on amendments and award agreement forms as asked. The only minor shortcoming is that it does not explicitly mention the 'Third Amendment' or the 2012/2017 forms in the 2023 filing, which were part of the ground truth, but this omission does not distort the overall evolution narrative. Hence, a score of 9 is warranted for high but not perfect completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 381,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the value of capitalized software licenses increased from $152 million to $223 million, indicating a significant investment in software licensing by the company. This growth suggests that the company is placing greater emphasis on software capabilities, likely to support its manufacturing, operations, or technology development initiatives. The continued investment in software licenses reflects a strategic move to enhance its competitive advantage and operational efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the quantitative increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth exactly. These figures are accurate and properly attributed to the respective years. 2) All numeric values are correct and consistent with the original answer; the increase of $71 million is implied and accurate. 3) The reasoning is mostly sound: the LLM correctly infers increased investment in software licensing and links it to strategic goals like operational efficiency and competitive advantage. However, it omits a key qualitative point from the ground truth — the evolution in disclosure from merely describing the amortization policy (straight-line) in 2022 to reporting an actual carrying value in 2023, which reflects improved transparency or a more tangible accounting treatment. This omission reduces completeness in capturing the full 'evolution' aspect of the question. 4) Despite this, the answer remains contextually relevant and semantically aligned with the core implications about investment trends. The missing detail about the change in disclosure practice affects qualitative depth but not factual correctness of the main claim. Thus, high scores are warranted, with a slight deduction in qualitative accuracy for incomplete multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 373,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, with the approved amount rising from $3.8 billion (37% of European customer balances) in 2022 to $3.0 billion (39% of European customer balances) in 2023. This indicates a strategic shift to leverage customer funds more efficiently to support credit products, reflecting PayPal's focus on optimizing liquidity and expanding credit offerings using internally available resources.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the approved amount 'increased' from $3.8 billion in 2022 to $3.0 billion in 2023, when in fact it decreased. This misrepresents the core quantitative trend. While the percentages (37% and 39%) are correctly cited, the interpretation of the trend is reversed. (2) The dollar amounts are partially correct—$3.8 billion in 2022 and $3.0 billion in 2023 are accurate—but the LLM incorrectly frames the change as an increase rather than a decrease. The percentages (37%, 39%) are accurate and correctly attributed. However, the LLM omits the key strategic development in 2023: the new €40 billion agreement to sell consumer installment receivables, of which $5.5 billion was sold. This omission removes a critical component of PayPal’s strategic shift toward external funding. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the trend (decrease in absolute approved funding but higher percentage utilization) and incorrectly concludes that PayPal is focusing on internal resources, when the new receivables sale indicates a move toward external funding mechanisms. The reasoning contradicts the ground truth. (4) The contextual relevance is moderate—the answer addresses utilization of European balances and strategic intent—but due to the reversal of the key trend and omission of major strategic developments, the overall correctness is low. The qualitative reasoning is unsound, and quantitative accuracy is compromised by the misstatement of directionality in the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 433,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' carrying value for its investment in Valor Siren Ventures I L.P. increased from fiscal 2023 to fiscal 2024, as the total carrying value of these private equity investments was $211.9 million as of September 29, 2024, compared to the prior year. The financial impact of these investments is reflected in interest income and other, net on Starbucks' consolidated statements of earnings, though related financial statement activities were not material during the periods presented.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the $211.9 million carrying value as of September 29, 2024, for Starbucks' investments in Valor Siren Ventures, which matches the ground truth. It also accurately notes that the financial impact is reported in 'interest income and other, net' and is non-material—both factually correct. However, the LLM implies a direct year-over-year increase in the carrying value of the Valor Siren Ventures I L.P. investment from 2023 to 2024, which is misleading because the ground truth clarifies that the 2023 carrying value for Valor Siren I specifically was not disclosed. Therefore, no valid comparison of carrying values across years can be made. (2) The numeric value ($211.9 million) and date (September 29, 2024) are accurate. The 2023 value is not provided in the ground truth, so asserting an increase is unsupported—this is a factual overreach. (3) The multi-hop reasoning is partially flawed: while the model correctly identifies the 2024 value and reporting treatment, it fails to acknowledge the lack of specific 2023 disclosure, leading to an incorrect implication of growth. The evolution of the relationship—from non-disclosed to a combined $211.9M for I and II L.P.—is under-articulated. (4) The answer is contextually relevant and captures key financial reporting details, but the incorrect suggestion of a quantifiable increase reduces qualitative accuracy. Quantitative accuracy is high due to correct numbers and formatting. Correctness score is 7 due to the core facts being right but with a significant omission that alters interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 437,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) remained focused on industrial and automotive markets, which are viewed as key growth opportunities. In 2023, Analog revenue reached $13.04 billion, representing 74% of TI's total revenue, up from $14.05 billion in 2021 (74.5% of total revenue at that time). TI continued to leverage its competitive advantages—manufacturing and technology, product portfolio breadth, market channel reach, and product diversity—to strengthen its market position. The financial contribution of Analog Products remained strong, with operating profit margins improving slightly in 2023 compared to prior years, reflecting TI's efficiency and high-quality product portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key aspects of the strategic evolution described in the ground truth. While it correctly identifies that Analog Products are central to TI and mentions competitive advantages, it misrepresents financial data and timeframes. The answer states that Analog revenue was $13.04 billion in 2023 and $14.05 billion in 2021, but the question asks for a comparison between 2022 and 2023—2021 data is irrelevant and distracts from the required analysis. Additionally, the ground truth does not mention specific revenue figures or operating margin improvements in 2023; instead, it emphasizes a shift in framing around TI's four sustainable competitive advantages and a strategic focus on free cash flow per share. The LLM incorrectly introduces revenue percentages (74%, 74.5%) not present in the original answer and unsupported by the provided context. (2) Quantitative accuracy is low: the cited revenues and percentages are either from incorrect years or not in the ground truth. There is no mention in the original answer of $13.04B or $14.05B, nor of revenue share percentages. The gross margin of 67.5% in 2022 from the ground truth is completely omitted, and no comparable margin data is accurately presented for 2023. (3) The multi-hop reasoning is partially sound—TI’s competitive advantages and industrial/automotive focus are relevant—but the synthesis fails to connect how the strategic positioning evolved from 2022 to 2023 in terms of narrative framing (from manufacturing efficiency to supply chain control and cash generation). The LLM misses the key shift in emphasis toward long-term free cash flow per share as the ultimate performance metric. (4) Correctness is scored at 4 due to partial factual alignment on TI's competitive advantages and general strategic importance of analog, but major errors in numbers and omission of core conceptual evolution. Quantitative accuracy is 3 due to incorrect figures and misuse of years. Qualitative accuracy is 5 because some correct concepts are present but not properly synthesized. Contextual relevance is 7 as the answer stays on topic but drifts into irrelevant data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 590,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region from 2022 to 2023 shows an increase in depreciation, depletion, amortization, and impairments (DD&A), rising from $4,854 million in 2022 to $5,729 million in 2023. This suggests a higher level of capital investment or asset utilization in the Lower 48 region in 2023 compared to 2022, reflecting a more aggressive capital allocation strategy in response to increased production or asset development activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in DD&A from $4,854 million in 2022 to $5,729 million in 2023, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting. (2) Quantitative accuracy is perfect—both figures are correct, and the implied year-over-year increase is accurately represented. (3) The reasoning is sound: the rise in DD&A is correctly interpreted as evidence of increased capital investment or asset utilization, aligning with the ground truth's conclusion about growing focus on the Lower 48. However, the LLM answer omits the comparative context with other regions (Europe, Middle East, and North Africa) mentioned in the original answer, which provides additional support for the strategic shift. This minor omission reduces completeness and qualitative accuracy slightly but does not undermine the core correctness. (4) The answer is highly relevant, directly addressing the evolution of capital allocation strategy using the correct metric and time frame. The conclusion drawn is logically supported by the data, warranting high scores across all dimensions, with a 9 in correctness due to the missing regional comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 342,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has elevated the positioning of its Fixed Wireless Access (FWA) broadband within its product portfolio by integrating it more prominently into both its Consumer and Business segments. In 2023, FWA was primarily highlighted as an alternative to traditional landline internet access, with approximately 3.1 million connections. By 2024, FWA broadband is emphasized as a core component of Verizon’s growing fiber and 5G strategies, with expanded deployment and a focus on leveraging its C-Band and 5G networks. Additionally, FWA is now explicitly included in the Business segment's offerings, indicating a broader target customer base that includes enterprises and public sector clients.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Verizon's FWA broadband evolution between 2023 and 2024, accurately stating the 3.1 million connections in 2023 from the ground truth. It correctly notes the continuation of FWA in both Consumer and Business segments. However, the original answer emphasizes a shift in language from 'provides' to 'produces' as an indicator of strategic intent, which the LLM answer omits. Instead, the LLM introduces details not present in the ground truth—such as FWA being part of 'fiber and 5G strategies' and 'C-Band' expansion—which, while plausible, are not supported by the provided knowledge graph. (2) Quantitatively, the 3.1 million figure is correctly cited with no other numbers involved, so quantitative accuracy is perfect. (3) The reasoning is mostly sound: the LLM correctly infers broader targeting including enterprises and public sector clients based on inclusion in the Business segment, aligning with the ground truth’s mention of Business customers. However, it adds strategic emphasis on fiber and C-Band that isn’t in the original, introducing unsupported detail. The multi-hop synthesis is partially accurate but extends beyond the source data. (4) The answer is highly relevant and captures the core evolution in positioning and customer targeting. Due to the addition of plausible but unverified strategic details and omission of the 'provides' to 'produces' nuance, it loses minor points in qualitative accuracy and overall correctness, but remains factually solid on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 424,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, beginning with the 2022 acquisition of Heritage AspenTech, which contributed to a 0.6 percentage point margin benefit in 2023. By 2024, Emerson proposed to acquire the remaining shares of AspenTech, increasing its ownership to approximately 57%. Financially, the Heritage AspenTech acquisition positively impacted gross margin, contributing to a 3.3 percentage point increase in 2023. However, in 2024, the gross margin increased by a smaller 1.8 percentage points, partly offset by acquisition-related inventory step-up amortization. The equity structure was also affected, with Emerson's ownership stake in AspenTech becoming a significant component of its industrial software business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson acquired 'Heritage AspenTech' in 2022, whereas the ground truth indicates a partnership in 2022, not an acquisition. The 55% ownership stake was acquired as part of a strategic transaction forming 'New AspenTech'—not through a stepwise acquisition of 'Heritage AspenTech.' The LLM claims ownership increased to 57% in 2024, which contradicts the ground truth of 55% ownership established in the 2024 transaction. (2) Quantitative errors are severe: the LLM claims a 3.3 percentage point gross margin increase in 2023 due to the (non-existent) Heritage AspenTech acquisition, while the ground truth reports only a 0.6 percentage point benefit. It further fabricates a 1.8 percentage point margin increase in 2024, which is not mentioned in the original answer. The only correct number is the 0.6 percentage point margin benefit, but it is misattributed to the wrong event. (3) Multi-hop reasoning is flawed: the model fails to correctly trace the evolution from partnership (2022) to majority ownership (2024), instead inventing an acquisition timeline. It also misrepresents the financial impact, introducing 'acquisition-related inventory step-up amortization' not present in the original. (4) Despite these issues, the answer is contextually relevant—addressing the relationship evolution and financial impacts on margin and equity. However, the core facts, numbers, and causal relationships are largely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 428,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "From 2022 to 2023, the financial relationship between NEE and FPL Group Capital Inc primarily involved the issuance and management of junior subordinated debentures and related obligations. In 2022, NEE and its subsidiaries, including FPL Group Capital Inc, continued to issue long-term debt instruments such as the Series K and Series L Debentures, with terms extending through 2025 and 2028, respectively. In 2023, the capital structure involvement expanded with the issuance of new debentures, including the Series P Junior Subordinated Debentures due in 2082 and the Series L Debentures due in 2025, reflecting ongoing efforts to manage capital and obligations through long-term financing. These instruments were governed by indentures and covenants, indicating a structured and evolving capital relationship between NEE and FPL Group Capital Inc.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature of the financial relationship between NEE and FPL Group Capital Inc. The original answer states that in 2022, the relationship was based on a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., not ongoing issuance of Series K and L debentures by NEE in 2022. The LLM incorrectly claims that Series K and L debentures were issued in 2022 with maturities in 2025 and 2028, which contradicts the ground truth. The ground truth indicates that by 2023, NEE issued multiple series (B, C, L, M, N, O, P) of junior subordinated debentures to FPL Group Capital Inc. with maturities from 2057 to 2082. The LLM only mentions Series P and Series L, missing key series (B, C, M, N, O), and incorrectly assigns a 2025 maturity to Series L, which conflicts with the long-term nature (2057–2082) described in the original. (2) Quantitative accuracy is low: maturities cited (2025, 2028) are incorrect for the context; the correct range is 2057–2082. No accurate mention of the 1998 guarantee agreement or its relevance in 2022. (3) Multi-hop reasoning is partially present—the LLM recognizes a shift toward debentures and capital structure involvement—but fails to correctly identify the evolution from a guarantee (2022) to long-term debentures (2023). It fabricates debenture activity in 2022 that is not in the ground truth. (4) Contextual relevance is high because the answer addresses the financial relationship, capital structure, and debentures, and attempts to show evolution. However, factual and quantitative errors severely undermine correctness. The core transformation from guarantee to complex capital structure is missed, leading to a low correctness score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 488,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the positioning and market acceptance of the InterStim II neurostimulator evolved positively within Medtronic's Pelvic Health therapies. In 2022, the InterStim Micro neurostimulator was highlighted as a recent launch driving Pelvic Health growth, while InterStim II was part of the broader InterStim therapy offerings. By 2024, InterStim II was specifically noted alongside the recharge-free InterStim X and rechargeable InterStim Micro as key drivers of Pelvic Health therapies, indicating its established role in treating conditions like overactive bladder and fecal incontinence. This evolution reflects InterStim II's growing acceptance and integration within Medtronic's broader Pelvic Health portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of InterStim II's positioning and market acceptance between 2022 and 2024, aligning with the ground truth. It accurately notes that in 2022, InterStim II was part of a broader suite of therapies, while in 2024 it was highlighted alongside other models (InterStim X and Micro) as a key driver in Pelvic Health. The conditions treated—overactive bladder and fecal incontinence (referred to as bowel incontinence in ground truth)—are correctly identified. However, the LLM incorrectly implies that InterStim Micro was the primary growth driver in 2022 due to its recent launch, which shifts focus away from InterStim II’s role; the ground truth emphasizes continued acceptance and growth of the entire suite, including InterStim II, without singling out Micro as the main driver. Additionally, the LLM introduces the term 'rechargeable InterStim Micro' and 'recharge-free InterStim X' in 2024, which aligns with the ground truth’s emphasis on recharge status, but fails to explicitly state that InterStim II itself is recharge-free—a key differentiating attribute highlighted in the original answer. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; all references to years (2022, 2024) are correct. (3) The multi-hop reasoning is largely sound: the model synthesizes information across time points and product lines, correctly identifying InterStim II’s integration into a diversified portfolio. However, it misses the nuanced shift in *positioning strategy*—from general suite member to device-specific attribute emphasis (e.g., recharge-free)—which is central to the ground truth. (4) Despite minor omissions in strategic nuance and product differentiation details, the LLM answer conveys substantial correctness in context, relevance, and entity identification, warranting a high score but not full marks due to incomplete synthesis of the key evolution in marketing and positioning logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 547,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved as follows:\n\n1. **Borrowing Capacity**: The Supplemental Facility's initial borrowing capacity was $3.5 billion in 2022, with the potential to increase to $4.5 billion during its term. By 2024, the Supplemental Facility had an extended maturity date to January 31, 2029, with the option to extend further to January 31, 2030, and maintained a borrowing capacity of $3.5 to $4.5 billion, depending on additional lender commitments.\n\n2. **Interest Rate Strategies**: The Supplemental Facility allowed Simon to borrow at variable rates based on SOFR or other applicable rates, with interest rates determined by the company's credit rating. In 2023, Simon executed interest rate swaps to hedge against Euro-denominated borrowings, locking in a fixed rate of 3.81%. By 2024, the effective interest rate on the Supplemental Facility remained aligned with SOFR plus a spread adjustment, reflecting ongoing strategies to manage interest rate risk.\n\n3. **Repayment Actions**: Simon repaid €750.0 million ($815.4 million) of borrowings under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. By December 31, 2024, the company had maintained a strong liquidity position, with no outstanding balance under the Commercial Paper program and available borrowing capacity of $8.2 billion across the Credit Facilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative but contains key factual inaccuracies, particularly regarding the maturity date of the Supplemental Facility. The ground truth states the maturity date is January 31, 2026, but the LLM claims it was extended to January 31, 2029, with an option to 2030—this is unsupported by the original answer and represents a significant factual error. Additionally, the LLM introduces a $8.2 billion available borrowing capacity across Credit Facilities by December 31, 2024, which is not mentioned in the ground truth and appears to conflate the Supplemental Facility with broader credit facilities. The repayment amount is stated as €750.0 million ($815.4 million), introducing a dollar conversion not in the original; while the euro amount is correct, the dollar figure is extraneous and potentially misleading if not explicitly sourced. (2) Quantitatively, the €750.0 million borrowing and November 17, 2023 repayment date are accurate. The 3.81% fixed rate via interest rate swaps in 2023 is correctly reported. However, the extended maturity dates and $8.2 billion capacity are unsupported numbers, reducing quantitative accuracy. (3) The multi-hop reasoning is sound in linking the 2023 borrowing, swap execution, and repayment via bond issuance, showing strategic interest rate management. The synthesis of interest rate strategy and repayment actions is logically coherent and aligns with the evolution described in the ground truth. However, the incorrect maturity date undermines the borrowing capacity assessment over time. (4) The answer is highly contextually relevant, addressing all three dimensions of the question—borrowing capacity, interest rate strategies, and repayment actions—and maintains a clear structure. Despite factual errors, it captures the essence of increased active utilization and risk management. The core evolution from passive to active management is correctly inferred, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 543,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon transitioned away from fixed-term, subsidized service plans for devices in the Consumer segment, focusing instead on device payment plans. These plans involve non-interest-bearing installment notes over a 36-month term, with billing credits offered as promotional incentives contingent on service retention. In 2024, the company emphasized device payment plans with no significant financing component, and promotions included trade-in rights and credits applied over time, reducing upfront costs for customers while maintaining service contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and captures the evolution in Verizon's device payment plans from 2023 to 2024. It accurately identifies the shift to 36-month, non-interest-bearing installment notes, which aligns with the ground truth. The mention of promotional incentives such as billing credits and trade-in rights in 2024 is consistent with the structured upgrade program described in the original answer. However, there are minor inaccuracies in framing: the LLM implies Verizon transitioned 'away from fixed-term, subsidized service plans,' which is not mentioned in the ground truth—instead, the original answer states that in 2023, installment plans existed without structured promotional incentives, not that they were subsidized. Additionally, the LLM introduces 'billing credits... contingent on service retention' and 'no significant financing component,' which are not explicitly stated in the ground truth. While these may be reasonable inferences, they go beyond the documented facts. The core financial structure (36-month, non-interest-bearing) is correct, earning high marks for quantitative and contextual accuracy. The qualitative accuracy is slightly reduced due to unsupported inferences and slight mischaracterization of the 2023 model. Overall, the answer conveys a similar evolution but with some added details not present in the source, making it partially overreaching in reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 395,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal relationship with Aqua-Chem remained largely unchanged, with the Georgia Case still stayed as agreed in 2004 pending the outcome of insurance coverage litigation. The Company continued to assert that it has no obligation for Aqua-Chem's asbestos-related claims, as outlined in its original lawsuit seeking a declaratory judgment. Aqua-Chem, on the other hand, maintains its position that the Company is responsible for liabilities not covered by insurance. No new developments in this legal dispute were disclosed in the 2024 filing, indicating the matter remains unresolved.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the timeline and legal context, correctly noting that the Georgia Case remains stayed and that Coca-Cola continues to assert no obligation for Aqua-Chem's asbestos-related claims. All entities (The Coca-Cola Company, Aqua-Chem, Georgia Case), years (2023–2024), and legal positions are accurately identified, satisfying quantitative and entity accuracy. However, the LLM answer fails to capture a key evolution highlighted in the ground truth: the shift in Coca-Cola’s 2024 disclosure toward a more nuanced stance emphasizing insurance coverage and the involvement of multiple insurers. Instead, the LLM claims 'no new developments were disclosed in the 2024 filing,' which contradicts the ground truth indicating a change in emphasis and added detail about insurance policies and ongoing coverage litigation. This omission represents a significant gap in qualitative accuracy and reasoning, as the model does not recognize or convey the subtle but important shift in Coca-Cola’s legal posture—from outright denial to a more complex narrative involving shared insurer responsibility. While the answer is relevant and factually sound on surface-level assertions, it misses the multi-hop synthesis required to contrast the evolving nature of the legal stance between years. Hence, correctness and qualitative accuracy are moderately scored.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 381,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits in 2024 reduced its long-term income tax liabilities compared to 2022, as evidenced by a decrease in long-term income taxes payable from $2.6 billion in 2023 to $1.6 billion in 2024. This reduction, combined with the ongoing benefit of non-US tax credits in jurisdictions like Israel and Malaysia, indicates that Intel is actively leveraging favorable international tax environments to minimize its global tax burden and optimize its effective tax rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that long-term income taxes payable were $2.6 billion in 2023, but the ground truth only provides data for 2022 ($4.3 billion) and 2024 ($1.6 billion); there is no mention of 2023 in the original answer, making this figure fabricated or incorrectly inferred. Additionally, the original answer emphasizes the reduction from 2022 to 2024 ($4.3B to $1.6B), which the LLM fails to reference directly, instead using an unsupported 2023 figure. (2) The correct comparison should be between 2022 and 2024 with accurate values: $4.3 billion in 2022 and $1.6 billion in 2024. The LLM omits the 2022 value entirely and introduces a non-existent 2023 benchmark, undermining the factual basis of the trend analysis. (3) While the LLM correctly infers that non-US tax credits are being used strategically to reduce tax liabilities and mentions international jurisdictions (Israel, Malaysia), which may align with Intel’s actual operations, this detail is not present in the ground truth and thus represents an unsupported addition. However, the qualitative reasoning about leveraging international tax environments is directionally consistent with the original conclusion about strategic use of non-US tax credits. (4) The answer is contextually relevant and addresses the core question about tax strategy implications, but the incorrect numeric foundation and missing direct comparison between 2022 and 2024 significantly reduce factual correctness. The multi-hop synthesis is partially sound but built on flawed data inputs, leading to a partially correct but misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 453,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved with increased interest rate sensitivity and regulatory influence. Rising interest rates have led to higher net derivative gains and adjusted earnings, as seen in the 2024 data showing a significant increase in total adjusted earnings impact to $95 million post-tax compared to $15 million in 2022. Regulatory changes, including enhanced capital standards and supervision, have also influenced the management of these risks, with regulators imposing additional requirements that affect capital and reserve needs. These factors collectively indicate a growing sensitivity to interest rate fluctuations and a more stringent regulatory environment impacting pension risk transfers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$95 million post-tax adjusted earnings in 2024 versus $15 million in 2022—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear fabricated or misattributed, as the ground truth does not mention any earnings impacts, derivative gains, or quantitative financial metrics related to pension risk transfers. (2) There is no support in the original answer for the claim that net derivative gains or adjusted earnings increased due to rising interest rates. The ground truth discusses interest rate sensitivity in the context of asset-liability management (ALM) strategies and product duration but does not tie this to earnings impacts or provide any dollar amounts. (3) The LLM correctly identifies increasing regulatory influence as a factor but mischaracterizes the nature of the regulatory changes. The original answer specifies that regulatory changes around defined benefit pension plan funding may delay plan terminations or transfers, thereby shifting exposure toward non-guaranteed funding products. The LLM instead references 'enhanced capital standards and supervision' affecting capital and reserve needs, which is not mentioned in the ground truth and represents a different regulatory mechanism. (4) While the LLM captures the general theme of growing interest rate sensitivity and regulatory impact, it fails to accurately represent the evolution described in the ground truth—specifically the shift in product mix due to reduced incentives for plan termination. The multi-hop synthesis is flawed because it invents financial data and misaligns the regulatory rationale. The contextual relevance is moderate because the topic and direction of change (increased sensitivity and regulation) are aligned, but factual correctness is low due to unsupported numbers and incorrect reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 520,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize broader therapeutic applications and global adoption. In 2022, the InterStim Micro was highlighted as a key driver of growth in Pelvic Health, specifically for treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the strategy expanded to include the InterStim X and InterStim II recharge-free neurostimulators, reflecting a focus on offering diverse options to address chronic pelvic conditions. The product's integration into Medtronic's broader Pelvic Health therapies and its global market penetration became central to the Neuroscience Portfolio's growth narrative.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects of Medtronic's strategic evolution for the InterStim Micro. (1) Correctly identifies the indications (overactive bladder, urinary retention, bowel incontinence) and that InterStim Micro was part of Pelvic Health therapies in 2022. Also correctly situates the device within Medtronic’s broader product portfolio. However, it incorrectly states that by 2024 the strategy 'expanded to include' InterStim X and II, when these were already available in 2022. The ground truth emphasizes a shift in *positioning* of InterStim Micro as a *rechargeable* option, explicitly differentiated from the *recharge-free* InterStim X and II models—a critical strategic nuance that the LLM answer reverses or misrepresents. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; no errors in dates or financials. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct evolution—shifting from general inclusion in a product line (2022) to targeted differentiation based on rechargeability (2024). Instead, it fabricates a narrative of expansion into new models and global adoption not supported by the original answer. (4) Contextual relevance is moderate because the answer discusses the right product, timeframe, and therapeutic area, but misses the core strategic pivot. The emphasis on 'global market penetration' and 'Neuroscience Portfolio' is not present in the original and introduces unsupported details. Thus, while semantically plausible, the answer is factually inaccurate in its portrayal of strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 454,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility showed a significant reduction in outstanding borrowings. In 2022, the maximum aggregate outstanding balance under the Facilities was $2.1 billion, with a weighted average outstanding balance of $519.9 million. By 2024, the maximum aggregate outstanding balance had dropped to $325.1 million, and the weighted average outstanding balance was $311.1 million. Additionally, the company repaid €750.0 million ($815.4 million U.S. dollar equivalent) outstanding under the Supplemental Facility in November 2023, indicating active repayment actions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the weighted average outstanding balances for 2022 ($519.9 million) and 2024 ($311.1 million), as well as the €750.0 million repayment ($815.4 million USD equivalent) on November 17, 2023, which aligns with the ground truth. However, it introduces a fact not present in the original answer: that the 'maximum aggregate outstanding balance' in 2024 was $325.1 million. The ground truth states the maximum was $2.1 billion in 2022 but does not provide a maximum for 2024—only the weighted average for 2024. This is a significant quantitative inaccuracy. (2) The repayment amount and date are correct, and the U.S. dollar conversion matches. The weighted average balances are accurate. The erroneous $325.1 million maximum balance undermines quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes information about debt reduction over time, connects the 2023 repayment to the trend between 2022 and 2024, and draws a valid conclusion about strategic repayment. (4) The answer is contextually relevant and mostly complete, but the incorrect inclusion of a specific 2024 maximum balance (not supported by the ground truth) reduces the correctness and quantitative accuracy scores. The core narrative of debt reduction is accurate, warranting a high qualitative and contextual score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 383,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP's investment activity in the Lower 48 region, as reflected in depreciation, depletion, amortization, and impairments (DD&A) expenses, increased from 2022 to 2023. In 2023, DD&A for the Lower 48 was $5,729 million compared to $4,854 million in 2022, representing a 18% increase. This rise suggests higher capital investment or asset utilization in the region during 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $4,854 million in 2022 and $5,729 million in 2023 are correctly reported. The calculated increase of 18% is accurate: ((5,729 - 4,854) / 4,854) ≈ 0.1798, which rounds to 18%. (2) The answer is complete, addressing the evolution of investment activity from 2022 to 2023 using the specified financial metric (DD&A and impairments). (3) Entity accuracy is correct: COP refers to ConocoPhillips, the region is correctly identified as Lower 48, and the years 2022 and 2023 are properly used. (4) The reasoning is sound: the increase in DD&A and impairments is correctly interpreted as indicative of higher capital investment or asset utilization, which aligns with standard financial interpretation in the energy sector. (5) The semantic meaning is equivalent to the original answer, with added value in calculating the percentage change, enhancing clarity without introducing error. All multi-hop elements (cross-year comparison, correct metric, correct region, correct company) are accurately synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 318,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has emphasized enhancing and monetizing its 5G and fiber-based networks to drive business growth. In 2024, the Business segment's focus on corporate networking solutions appears to have shifted toward leveraging advanced technologies such as the Intelligent Edge Network and expanding fiber infrastructure, as highlighted in the capital expenditures section. Additionally, the Business segment's offerings now include more managed network services and IoT solutions, reflecting a strategic emphasis on converged enterprise solutions and cloud-based services to meet evolving customer demands.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no accurate quantitative data from the ground truth. The original answer specifies that in 2023, Enterprise and Public Sector revenues were $15.1 billion, representing approximately 50% of the Business segment's total revenue. The LLM answer omits all numerical figures and introduces no verifiable data, failing the quantitative accuracy test. (2) There are no correct numbers, percentages, or dollar amounts mentioned in the LLM response, resulting in a very low quantitative accuracy score. The ground truth relies on specific revenue figures and proportions that are entirely absent in the LLM answer. (3) The qualitative reasoning is partially sound but diverges from the actual evolution described in the ground truth. The original answer emphasizes a shift in *disclosure approach*—from detailed service descriptions and revenue breakdowns in 2023 to a more generalized, streamlined presentation in 2024—suggesting a change in reporting or messaging strategy. In contrast, the LLM answer interprets the evolution as a technological or strategic shift toward 5G, fiber, IoT, and managed services, citing capital expenditures and the Intelligent Edge Network. However, these points are not supported by the ground truth and represent speculative inferences not present in the provided data. The multi-hop reasoning fails because the LLM does not synthesize the correct evidence about disclosure changes but instead fabricates a narrative around technology investments. (4) While the LLM answer is contextually relevant—addressing Verizon’s corporate networking evolution and segment focus—it misses the core factual development (reduced disclosure specificity and revenue transparency) and replaces it with unsupported claims about strategic emphasis. Thus, the answer is plausible-sounding but factually misaligned. Correctness is scored low due to missing key facts and introducing unverified details; qualitative accuracy is moderate due to logical structure but flawed premises; contextual relevance is acceptable as it stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 559,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's sensitivity to fair value changes for FVO (Fair Value Option) securities due to a 10% appreciation in the U.S. dollar decreased significantly. In 2022, the potential loss from a 10% U.S. dollar appreciation was $54 million, while in 2024, the impact was also $54 million, indicating no change in sensitivity for FVO securities specifically. However, the overall sensitivity to foreign currency exchange rate risk decreased from $8.4 billion in 2022 to $7.2 billion in 2024, reflecting a broader reduction in exposure to U.S. dollar fluctuations across the company's portfolio. This reduction is partially attributed to economic offsets from insurance contract liabilities not included in the fair value calculations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, no direct fair value figure for FVO securities is provided, and there is no mention of a $54 million impact from a 10% U.S. dollar appreciation in 2024. The LLM incorrectly asserts that the sensitivity remained at $54 million, implying data continuity that does not exist. Additionally, the LLM introduces a 'broader sensitivity to foreign currency exchange rate risk' decreasing from $8.4B to $7.2B, which is not mentioned in the original answer and appears to conflate FVO securities with the company's overall portfolio—this data is unsupported by the ground truth. (2) The only correct number is the 2022 $54 million sensitivity, which matches the original. However, the 2024 $54 million figure and the $8.4B/$7.2B portfolio numbers are not present in the ground truth and are therefore incorrect. (3) The multi-hop reasoning is flawed: the original answer emphasizes a methodological evolution from a static to a more dynamic, duration- and currency-dependent valuation framework, but the LLM fails to capture this conceptual shift. Instead, it incorrectly assumes quantitative continuity and introduces unrelated aggregate figures. (4) The contextual relevance is moderate because the answer addresses FVO securities and U.S. dollar sensitivity, but it misses the core qualitative evolution in valuation approach and introduces unsupported quantitative claims, undermining factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 416,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities between 2022 and 2023 showed significant evolution, particularly in energy trading services and financial performance. In 2023, operating revenues increased by $5,952 million, driven by gains from non-qualifying commodity hedges, higher revenues from new investments in wind, solar, and battery storage facilities, and increased revenues from NEET. The financial performance was further bolstered by favorable non-qualifying hedge activity, which contributed $2,986 million to the change in net income. Additionally, NEER added approximately 1,651 MW of new wind generating capacity and 2,073 MW of solar generating capacity in 2023, enhancing its energy trading capabilities and contributing to improved financial results compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported data not present in the ground truth. While it correctly identifies that NextEra Energy (NEE) and its subsidiary NEER were involved in power marketing and trading activities in both 2022 and 2023, the specific financial figures cited—such as a $5,952 million increase in operating revenues and $2,986 million contribution from non-qualifying hedges—are not found in the original answer and cannot be verified against the ground truth. Most critically, the ground truth reports a net income increase from $285 million in 2022 to $3,558 million in 2023 (a $3,273 million increase), but the LLM does not mention this key metric at all, instead focusing on revenue changes and hedge gains that are not in the original. (2) The LLM claims NEER added 1,651 MW of wind and 2,073 MW of solar capacity in 2023, which may be factually correct in external sources but is not part of the provided ground truth and thus represents an unsupported addition. This undermines quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model attempts to link increased generation capacity and hedging activities to improved financial performance in power marketing—but fails to correctly synthesize the core evolution: the dramatic rise in net income from $285M to $3,558M, which is the central evidence of growth in profitability. The LLM misses this key inference and substitutes other metrics, suggesting a failure in reasoning fidelity. (4) Contextual relevance is high because the answer addresses power marketing evolution, energy trading services, and financial performance as asked. However, correctness is low due to incorrect or unverifiable numbers and omission of the most important financial data point (net income change). The answer appears plausible but diverges significantly from the ground truth in key quantitative aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 526,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake ownership in Coca-Cola FEMSA remained unchanged at 28%. However, the equity income from Coca-Cola FEMSA increased, contributing to a rise in the Company's total equity income (from $1,691 million in 2023 to $1,770 million in 2024). This increase reflects stronger performance by Coca-Cola FEMSA and other equity method investees during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, The Coca-Cola Company did not hold a specified ownership stake in Coca-Cola FEMSA—only a dependency due to credit rating implications. However, the LLM claims a '28% stake remained unchanged' between 2023 and 2024, which contradicts the ground truth that the 28% stake was only reported in 2024. This misrepresents the evolution of the relationship. (2) The financial figures cited—equity income increasing from $1,691 million to $1,770 million—are entirely absent from the original answer and unsupported by the provided ground truth. There is no mention of actual equity income amounts or year-over-year changes in the truth data, making these numbers fabricated. (3) The multi-hop reasoning is flawed: the question asks about the evolution of the financial relationship, particularly stake ownership and implications for equity income. The correct answer involves recognizing a shift from indirect dependency (2023) to direct ownership (2024), affecting how equity income is derived. The LLM instead assumes constant ownership and invents performance data, failing to capture the strategic shift. (4) While the LLM addresses the general topic and attempts to discuss equity income and ownership, the core facts are incorrect. The contextual relevance is moderate because it discusses the right companies and general concept (equity income), but the quantitative and qualitative inaccuracies severely undermine correctness. Minor score given only for mentioning the 28% stake in 2024, which aligns with the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 446,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed a decline in both production volumes and depreciation expenses. Production volumes for crude oil in the Lower 48 decreased from 447 thousand barrels daily in 2021 to 213 thousand barrels daily in 2020, indicating a reduction in operational output. Additionally, depreciation, depletion, and amortization expenses for the Lower 48 segment dropped from $4,854 million in 2022 to $5,729 million in 2023, reflecting a decrease in capital investment and asset utilization in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that crude oil production decreased from 447 thousand barrels daily in 2021 to 213 thousand barrels daily in 2020, which misrepresents both the years and the trend. The original answer indicates 2022 production levels (447 kbbl/d crude oil, 1,340 MMcf/d natural gas), with no data provided for 2020 or 2021 in the ground truth. The LLM inverts the timeline and fabricates a decline, contradicting the actual context of sustained operational focus. (2) The depreciation, depletion, and amortization (DD&A) expense is stated as dropping from $4,854 million in 2022 to $5,729 million in 2023, but this is factually wrong—the LLM claims a 'drop' while citing numbers that show an increase. The correct trend is a rise from $4,854M to $5,729M, indicating increased financial investment, not decreased. The LLM misinterprets the direction of change despite using the correct figures. (3) The multi-hop reasoning is fundamentally flawed. The question asks for evolution between 2022 and 2023, but the LLM references 2020 and 2021 incorrectly. It fails to synthesize the correct time-series data and draws the opposite conclusion: the ground truth shows increasing financial investment and stable operations, while the LLM claims declining investment and output. (4) The contextual relevance is partially maintained as it discusses the Lower 48 region, production volumes, and DD&A expenses, but the severe factual and logical errors—especially reversing trends and misdating data—warrant very low scores. Quantitative accuracy is low due to misuse of correct numbers in incorrect contexts and wrong directional interpretation. Qualitative reasoning fails on entity alignment and logical inference. Correctness is nearly entirely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 496,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network has transitioned from being a foundational component of its wireless services to a complementary part of its broader 5G-focused growth strategy. In 2024, the company emphasized its evolution to 5G, leveraging its 4G LTE network primarily to support Fixed Wireless Access (FWA) broadband services as an alternative to traditional landline internet access. While 4G LTE remains integral to Verizon's network infrastructure, its role has shifted to underpinning 5G expansion and fiber-based initiatives, such as the acquisition of Frontier, which aligns with the company's long-term vision of delivering next-generation connectivity solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Verizon's 4G LTE network was foundational in 2023 and remained important in 2024, supporting Fixed Wireless Access (FWA) as an alternative to landline internet. It also correctly notes the shift toward a 5G-focused strategy. However, it inaccurately frames the evolution as being subsumed under 5G, whereas the ground truth emphasizes that 4G LTE became part of a broader *integrated* network vision including C-Band, mmWave, and fiber—not merely a support layer for 5G. The mention of the 'acquisition of Frontier' is factually incorrect and unsupported by the original answer; no such acquisition is referenced in the ground truth and it introduces a false entity/event. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift over time and synthesizes the role of 4G LTE in broader infrastructure. However, it fails to accurately represent the nature of the integration (multi-technology ecosystem) and introduces a fabricated detail (Frontier acquisition), undermining the qualitative accuracy. (4) The correctness score is 7 because the core idea of a strategic evolution is present and key facts about FWA and infrastructure integration are partially correct, but the introduction of false information reduces confidence. Contextual relevance is high as the response stays focused on the question, hence a 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 428,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's relationship with AspenTech evolved significantly. In 2022, Emerson contributed its industrial software businesses and $6.0 billion in cash to Heritage AspenTech, acquiring 55% ownership in the newly formed AspenTech. By 2024, Emerson had increased its stake to approximately 57% and announced a proposal to acquire the remaining shares for $240 per share, implying a total enterprise value of $15.1 billion. This progression indicates a strategic consolidation of ownership. Financially, the AspenTech segment's backlog increased from $328 million in 2022 to $1,042 million, reflecting the impact of the Heritage AspenTech acquisition. While specific gross margin impacts for AspenTech are not detailed, Emerson's overall gross margin improved from 45.7% in 2022 to 50.8% in 2024, partly driven by the Test & Measurement acquisition and favorable pricing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that in 2022, Emerson contributed businesses and $6.0 billion in cash to 'Heritage AspenTech' to acquire 55% ownership—this contradicts the ground truth, which indicates that the 55% ownership in 'New AspenTech' was the result of a 2024 transaction, not 2022. The LLM also claims Emerson increased its stake to 57% by 2024 and proposed to acquire remaining shares at $240 per share with a $15.1B enterprise value—this information is not present in the ground truth and appears fabricated. The backlog progression is misrepresented: the LLM says AspenTech segment backlog increased from $328M in 2022 to $1,042M, but the ground truth states the 2022 backlog was $1,042M, not a result of growth from a lower base. Additionally, the LLM attributes gross margin improvement to the 'Test & Measurement acquisition' rather than the AspenTech acquisition, which directly contradicts the ground truth stating a 3.3 percentage point increase in 2023 gross margin 'partly due to the AspenTech acquisition.' (2) Quantitative accuracy is low: multiple incorrect numbers (e.g., $6.0B cash, $240/share, $15.1B enterprise value, 57% stake, $328M backlog in 2022) and misattribution of margin improvement. The only correct number is the $1,042M backlog, though it is miscontextualized. (3) Multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution from 2022 stake to 2024 ownership change, misassigns financial impacts, and introduces entities/events (e.g., 'Heritage AspenTech', acquisition proposal) not in the ground truth. (4) Despite these issues, the answer is contextually relevant—addressing stake value, ownership, backlog, and gross margin—and captures the general direction of increased involvement. However, core facts and financial causality are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 515,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline significantly decreased between 2022 and 2023, as evidenced by the impairment charge recorded in 2022 to completely write off its investment in the project. In 2022, NEE's share of equity contributions and commitments for Mountain Valley Pipeline was still reflected in its financial statements, but by 2023, these commitments were no longer present, indicating that NEE had exited its investment. This shift suggests a strategic decision to divest from the project, likely due to financial risks or delays, and reallocate capital to other opportunities that align better with its long-term investment priorities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that NEE's commitment evolved from a general equity stake (32%-55%) in 2022 to a more defined 32.8% ownership in 2023, accompanied by a 20-year $70 million/year transportation agreement—indicating increased strategic commitment. In contrast, the LLM claims NEE completely wrote off its investment in 2022 and exited the project, which contradicts the ground truth. There is no mention of an impairment or write-off in the original answer. (2) Quantitatively, the LLM introduces false figures such as an 'impairment charge' and claims of eliminated commitments, with no supporting numbers matching the original (e.g., 32.8%, $70M/year). The only correct entity is NEE and its subsidiary NEER, but even their actions are misrepresented. (3) The multi-hop reasoning is fundamentally flawed: instead of synthesizing increased contractual and equity involvement over time, the model infers divestment without evidence. It fails to connect the 2023 transportation agreement and stable equity stake as signs of deepened investment. (4) The contextual relevance is low because the answer addresses the right topic (NEE and Mountain Valley Pipeline) and time frame (2022–2023), but draws the opposite conclusion from the evidence. While it attempts to discuss investment strategy, the direction of the strategy (divest vs. deepen) is incorrect, rendering the analysis invalid. Minor relevance credit is given for addressing the pipeline and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 425,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited from 2023 to 2024 has remained consistent in terms of operational integration, as Costa's direct-to-consumer retail operations continue to be included within the Global Ventures segment. In 2023, the 10-K filing noted that Costa's sales are part of the Global Ventures operating segment. In 2024, the Global Ventures segment still includes Costa Limited, along with other businesses such as innocent and doğadan. There is no indication of significant changes in strategic positioning during this period, suggesting a stable integration within the broader Global Ventures portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities and timeframes: Costa Limited is correctly identified as part of the Global Ventures segment in both 2023 and 2024, and the inclusion of innocent and doğadan in 2024 is accurately noted. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the key shortcoming lies in qualitative accuracy and reasoning: the LLM concludes there was 'no significant change' and 'stable integration,' which contradicts the ground truth that Costa became 'more strategically embedded' with an expanded scope in the Global Ventures segment, indicating deeper integration. The original answer emphasizes evolution and strategic broadening, while the LLM downplays change. This misrepresents the nature of the multi-hop insight—synthesizing the expansion of the segment to include additional businesses and coordination agreements as evidence of deeper strategic integration. Thus, while the surface-level facts are present, the interpretation and synthesis are incorrect, leading to a misleading conclusion about the lack of strategic evolution. Contextual relevance is high as the response stays focused on the question, but the failure to correctly interpret the strategic shift reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 360,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically the fair value of economically hedged marketable debt investments, decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, the company recorded net losses of $464 million in 2024 on these hedged investments, compared to net gains of $534 million in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value decrease from $17.1 billion in 2023 to $13.5 billion in 2024 and the $464 million net loss in 2024, which aligns with the ground truth. However, it incorrectly states that Intel had net gains of $534 million in 2023, which is not mentioned in the original answer and contradicts the trend implied by the 2022 loss of $748 million and 2024 loss of $464 million. The original answer does not provide 2023 gains/losses, so this is an unsupported addition. Additionally, the LLM omits the key 2022 data point ($748 million loss), which is essential to the question’s focus on the evolution between 2022 and 2024. (2) The quantitative values for 2023 and 2024 fair values are accurate, and the $3.6 billion difference is correctly calculated. However, the $534 million gain in 2023 is factually unsupported and conflicts with the ground truth, which only specifies losses in 2022 and 2024. (3) The reasoning partially captures the portfolio size reduction but fails in multi-hop synthesis by not incorporating the 2022 loss data and introducing an incorrect 2023 gain figure. The evolution from 2022 to 2024 requires referencing the 2022 loss to show trend continuity, which is missing. (4) The contextual relevance is high as the answer focuses on the right metric and time frame, but the correctness score is reduced due to factual inaccuracies and omission of critical data points. Quantitative and qualitative accuracy are moderate due to correct values but incorrect inference and missing multi-year synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 432,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "AMT's financial focus regarding communications sites evolved from 2023 to 2024 by emphasizing recurring revenue generation through long-term leases and optimizing operating efficiencies to sustain cash flows. In 2023, recurring revenue from property operations was a key strength, with multiyear tenant contracts contributing to stable cash flows. By 2024, AMT highlighted the importance of maintaining and expanding this recurring revenue base, particularly from its communications infrastructure, while managing operating costs. Additionally, AMT addressed asset retirement liabilities, noting an estimated $4.5 billion in undiscounted future cash outlays for site remediation as of December 31, 2024, reflecting a continued focus on long-term obligations tied to its extensive global communications site portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in AMT's financial focus from 2023 to 2024. It accurately notes the emphasis on recurring revenue in 2023 (with property operations as a core source) and the expanded focus in 2024 to include asset retirement liabilities. The $4.5 billion undiscounted future cash outlay for site remediation as of December 31, 2024, is correctly reported, matching the ground truth. (2) Quantitative accuracy is perfect: the dollar amount ($4.5 billion), time reference (December 31, 2024), and the nature of the liability (undiscounted future cash outlay) are all factually correct. No calculations are required, but the reporting of figures is precise. (3) The multi-hop reasoning is sound—information from both years is synthesized correctly, and the shift in focus from revenue generation to inclusion of long-term liabilities is logically presented. The LLM adds contextual detail (e.g., multiyear contracts, cost management) that is plausible and consistent with the ground truth, though slightly more expansive than the original. (4) The only minor shortcoming is that the LLM does not explicitly state the 99% of total revenues from property operations in 2023 as in the ground truth, which slightly reduces completeness in qualitative accuracy. However, the core facts and evolution are correctly conveyed, with no factual errors. Hence, a high score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 424,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, XOM's strategic positioning in Guyana evolved under the legal framework established by the Petroleum Activities Act 2023, which allows for exploration periods up to 10 years and production periods of 20 years for oil fields (with 10-year renewal options). This legislative update reflects a more structured and long-term approach to petroleum agreements in Guyana, enhancing the business growth emphasis by providing clarity and stability for exploration and production activities. XOM has leveraged this framework to advance its operations, aligning with its broader strategy to develop reliable and affordable energy supplies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Petroleum Activities Act 2023 and accurately describes its provisions—exploration up to 10 years, production for 20 years, and renewal up to 10 years—which matches the ground truth. All legal framework details and dates are factually correct, satisfying quantitative accuracy. (2) However, the LLM answer omits a key qualitative evolution highlighted in the original answer: that by 2024, Guyana was explicitly classified as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver. This strategic repositioning—from a jurisdiction with a legal framework to a core growth asset in XOM’s portfolio—is central to the question and missing in the LLM response. (3) While the LLM correctly synthesizes the legal operating framework, it fails to complete the multi-hop reasoning that connects the stable legal environment to Guyana’s elevated strategic status in XOM’s business growth emphasis in 2024. The answer implies strategic importance through 'reliable and affordable energy supplies' but does not specify the formal strategic categorization that marks the evolution. (4) Therefore, while factually accurate and contextually relevant, the answer lacks completeness in conveying the full strategic shift, warranting a correctness score of 7. Quantitative accuracy is perfect (10), qualitative accuracy is reduced due to missing strategic classification (7), and contextual relevance remains high as the response stays focused and relevant to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 421,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a part of its Energy & Transportation segment in both 2023 and 2024, with responsibilities including the production, remanufacturing, and leasing of rail-related products and services. In 2024, the Transportation segment reported a 4% sales increase compared to 2023, driven by growth in marine and rail services, though this was partially offset by lower aftermarket parts sales. Strategically, Caterpillar continued to emphasize rail services and remanufacturing, aligning with its broader focus on integrated solutions and sustainability. Operationally, the segment maintained its role in supporting global rail infrastructure, with no significant structural changes in its responsibilities or positioning between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses key strategic shifts described in the ground truth. While it correctly identifies Caterpillar's Energy & Transportation segment as the relevant business unit, it fails to capture the evolution in strategic positioning from 2023 to 2024. The ground truth emphasizes a shift toward integrated systems and solutions for power generation, marine, oil and gas, and industrial sectors, as well as a strategic move toward electrified powertrains and zero-emission technologies. The LLM answer does not mention this forward-looking technological shift, instead asserting there were 'no significant structural changes,' which contradicts the original answer. (2) The quantitative claim of a 4% sales increase in the Transportation segment in 2024 is not present in the ground truth and cannot be verified; this is an unsupported addition. No financial figures were included in the original answer, so introducing one reduces accuracy. (3) The multi-hop reasoning is flawed: the question asks for evolution in strategic positioning and operational responsibilities, requiring synthesis of changes over time. The LLM fails to recognize the shift from general product support and remanufacturing in 2023 to a broader integration with advanced, environmentally focused technologies in 2024. Instead, it downplays change and emphasizes continuity. (4) The contextual relevance is moderate because the answer stays on topic and references rail services and sustainability, but it misrepresents the core evolution. The qualitative accuracy is low due to incorrect reasoning and omission of key strategic developments. Quantitative accuracy is medium because the 4% figure is unverified but not grossly implausible; however, since no numbers were in the original, introducing one without basis is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 506,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations increased from 2022 to 2024, rising from $14.994 billion (4% of total funding sources) in 2022 to $18.043 billion (5% of total funding sources) in 2024. This indicates a modest shift toward using securitized debt as a funding source, suggesting the company is diversifying its funding strategy to include more structured financing options alongside its primary reliance on deposits.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the company did not disclose a specific dollar amount for securitized debt obligations in 2022—only that it used this funding source. However, the LLM claims a precise figure of $14.994 billion (4% of total funding) in 2022, which is not supported by the original answer. Similarly, the LLM states a 2024 value of $18.043 billion (5%), but the ground truth reports a carrying value of $14,264 million ($14.264 billion), making the LLM's number incorrect. Additionally, the percentages (4%, 5%) and the claim about proportion of total funding are fabricated and not present in the original answer. (2) The quantitative inaccuracies are severe: both the 2022 and 2024 figures are wrong, and no percentages or total funding breakdowns were provided in the ground truth. Even allowing for format variation, the numbers do not align—$14.994B and $18.043B are materially different from $14.264B. (3) The multi-hop reasoning is flawed. The LLM incorrectly assumes quantified data was available in 2022 when it was not. The correct inference from the original answer is that the company moved from non-quantified disclosure to a specific carrying value in 2024, suggesting increased transparency or formalization of this funding source—not necessarily an increase in amount. The LLM instead asserts a numerical increase and strategic diversification, going beyond what can be concluded from the ground truth. (4) While the general direction—increased reliance on securitized debt—might seem plausible, the LLM invents data and misrepresents the evolution. The contextual relevance is moderate because it addresses the right topic and timeframe, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 492,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees showed a shift in financial reporting and relationship management. Financially, operating income for International Developmental Licensed Markets & Corporate dropped significantly, from $121 million in 2023 to $33 million in 2024, reflecting a 73% decrease, primarily due to lower sales-driven Company-owned and operated margins. Relationship management also evolved, as the Company continued to focus on its \"Accelerating the Arches\" strategy, which includes restructuring efforts and a shift toward franchising over Company-owned operations. This is evident in the increased number of developmental licensees (from 8,684 in 2023 to 9,247 in 2024), indicating a strategic emphasis on expanding franchise operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—operating income dropping from $121 million in 2023 to $33 million in 2024 and a 73% decrease—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers are factually unsupported in the context of the question and represent a significant factual deviation. Additionally, the claim about the number of developmental licensees increasing from 8,684 to 9,247 is not mentioned or implied in the original answer, making it an unsupported addition. (2) The calculations (e.g., 73% decrease) are based on incorrect inputs and thus inaccurate. The original answer does not provide any such operating income figures or licensee counts, so these numbers are fabricated. (3) The reasoning fails on multi-hop synthesis: the original answer focuses on changes in accounting treatment (allocation of consideration, evaluation of variable interest entities, rounding policy), not on operational performance or strategic shifts like 'Accelerating the Arches' or franchising trends. While McDonald's may have such a strategy, the original answer does not link it to developmental licensee treatment in 2023–2024. The LLM conflates broader corporate strategy with specific reporting and relationship management disclosures. (4) The contextual relevance is moderate because the answer addresses financial reporting and relationship management in theme, but it does so with incorrect data and misplaced emphasis. The original answer highlights accounting policies and entity evaluation, not income trends or licensee counts. Due to major factual inaccuracies and failure to reflect the actual evolution described in the ground truth, the correctness score is low despite some topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 487,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company’s Equity and Incentive Compensation Plan saw an increase in share availability for awards, with 26.9 million shares available under the plan as of December 31, 2023, and continued use of the 2021 plan for executive equity awards. Executive award disclosures remained consistent, with details on equity awards included in filings like Form 10-Q and 10-K, reflecting structured compensation practices under the plan.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 26.9 million shares available as of December 31, 2023, which matches the ground truth. It also correctly references the 2021 Equity and Incentive Compensation Plan and notes continued use for executive awards. However, it incorrectly claims that share availability increased between 2023 and 2024, which is not supported by the original answer—no data is provided about 2024 share availability, only about enhanced disclosure practices. More critically, the LLM states that 'executive award disclosures remained consistent,' which directly contradicts the ground truth indicating a notable evolution toward greater transparency and more detailed public disclosure in 2024. (2) Quantitatively, the only number mentioned—26.9 million shares—is accurate and correctly attributed to 2023. No incorrect calculations are made, though the implication of an increase in share availability lacks supporting data. (3) The multi-hop reasoning is flawed: while the model identifies the correct plan and timeframe, it fails to synthesize the key evolution from internal reserve planning (2023) to enhanced executive disclosure (2024). Instead, it asserts consistency in disclosures, missing the shift in transparency that is central to the original answer. (4) The contextual relevance is high because the response addresses share availability and executive awards, directly engaging with the question’s focus. However, due to the significant qualitative error in characterizing disclosure trends and the unsupported claim of increased shares, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 449,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3% globally, with a 4% increase in the U.S. and a 3% increase internationally. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma (RCC). Internationally, growth was attributed to continued expansion in emerging markets. However, this growth was partially offset by lower volumes and a lower net price in certain European markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% global revenue growth for Inlyta in 2023, aligning with the ground truth. However, it states a 4% increase in the U.S. and 3% internationally, which are not present in the original answer—these specific regional breakdowns are fabricated or misattributed, as the ground truth only mentions U.S. growth due to immune checkpoint inhibitor combinations and does not quantify U.S. or international growth separately. The ground truth reports 5% operational growth (not 3% or 4%), with 3% total revenue increase. The LLM confuses total growth with operational growth and introduces unsupported regional percentages. (2) The dollar amount ($1,036 million) is omitted in the LLM answer, which is a notable omission in quantitative reporting. The calculation of growth rates is not verifiable due to lack of base-year revenue, but the 3% total increase is correctly stated. The 4% U.S. figure has no support in the original and appears incorrect. (3) The reasoning about immune checkpoint inhibitor combinations driving U.S. growth is accurate and reflects correct multi-hop synthesis from clinical use to commercial performance. The mention of lower volumes and net price in Europe is correctly included. However, the claim about 'continued expansion in emerging markets' as a driver of international growth is not in the original and represents an unsupported addition, weakening the qualitative accuracy slightly. (4) Despite these issues, the core trajectory—moderate growth driven by U.S. clinical adoption despite European headwinds—is accurately conveyed. The answer is highly relevant and mostly correct, but the incorrect attribution of regional growth percentages and omission of the $1,036M figure prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 484,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees has evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company has increasingly recognized revenue from franchisees for technology platforms on a gross basis, indicating a shift toward being the principal in these arrangements. Additionally, franchisees share a portion of the costs for these platforms, with fees designed to recover the Company's expenses rather than generate profit margins. This reflects a more integrated financial partnership, where franchisees contribute to the funding of shared technology initiatives that enhance the customer experience and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2023 to 2024, focusing on financial structure and dependency, particularly around technology platforms. The key factual elements—revenue recognition on a gross basis and cost-sharing for technology—are accurately reported. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2023–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in revenue recognition policy and cost-sharing mechanisms across time, correctly inferring a more integrated, interdependent relationship. The LLM notes that fees are for cost recovery rather than profit, which is consistent with the implied nature of the arrangement in the original answer. (4) The only minor gap is that the LLM does not explicitly mention the accounting treatment of related expenses in 'Other restaurant expenses,' which is a detail present in the ground truth and relevant to financial structure. However, this omission does not undermine the core accuracy. The answer remains semantically equivalent and contextually precise, earning high marks across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 372,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries increased significantly, with liabilities rising from $210 million in 2022 to $61 million for Mississippi Power, $5 for Southern Power, and $58 million for Southern Company Gas in 2023. This increase in liabilities indicates a higher exposure to energy market fluctuations, as the company faced greater obligations likely due to adverse movements in energy prices or hedging activities during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. In 2022, the total liabilities were not $210 million as stated; the correct total liabilities were $32M (Mississippi Power) + $12M (Southern Power) + $65M (Southern Company Gas) = $109M, and assets totaled $59M + $8M + $28M = $95M, resulting in a net liability of $14M (not $54M net liability as per ground truth, though the ground truth states $54M net liability, which recalculates as $109M liabilities - $95M assets = $14M net liability—this discrepancy in the ground truth may be an error, but the LLM does not reflect either correctly). The LLM incorrectly states 2023 liabilities for Mississippi Power, Southern Power, and Southern Company Gas, but in fact, the 2023 data comes from Alabama Power and Georgia Power, not the same subsidiaries. Alabama Power reported $15M assets and $110M liabilities, and Georgia Power reported $13M assets and $124M liabilities—these entities were not mentioned in the LLM answer. (2) The LLM incorrectly claims liabilities rose from $210M in 2022 to $61M, $5M, and $58M in 2023—these numbers do not match any reported values. The correct 2023 net liability is $110 + $124 - $15 - $13 = $206M net liability (or $219M as per ground truth, which may include rounding or additional items), a significant increase from 2022’s $14M net liability (or $54M per ground truth, which appears miscalculated). The LLM’s numbers and calculations are therefore fundamentally wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the subsidiaries involved in each year, misattributes data, and does not compute net values properly. It also fails to recognize that different subsidiaries reported in 2022 vs. 2023, indicating a lack of synthesis across entities and years. (4) Despite these errors, the LLM correctly infers that increasing liabilities suggest greater exposure to energy market fluctuations, which is a reasonable qualitative conclusion, hence partial credit for contextual relevance and qualitative reasoning. However, due to severe quantitative inaccuracies and incorrect entity mapping, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 582,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan remained active and was the only plan allowing for future grants of securities as of 2024, with a maximum of 187 million shares available and 77 million shares remaining for future issuance. From 2022 to 2024, the plan's significance persisted as a primary vehicle for equity compensation, with no material changes in its role or structure disclosed in the filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding quantitative details not present in the original answer. The original answer does not mention any specific number of shares (e.g., 187 million maximum or 77 million remaining), nor does it state that the 2019 Plan was the 'only' plan allowing future grants as of 2024. These specific figures and claims are absent from the ground truth and cannot be verified from the provided context, making them potentially incorrect or hallucinated. (2) There are no calculations in either answer, but the introduction of precise share numbers (187M, 77M) without grounding in the original response violates quantitative accuracy. The original focuses on qualitative evolution—disclosure context and integration—not share counts or grant capacity. (3) The multi-hop reasoning is partially sound: the LLM correctly infers ongoing significance from 2022 to 2024 and identifies the plan as a key equity compensation vehicle. However, it fails to capture the core evolution described in the original—transition from formal introduction (with shareholder adoption noted) to being one of several plans in a broader disclosure—instead asserting uniqueness and providing unsupported metrics. (4) Contextual relevance is high because the answer addresses the plan’s role over time and its importance in equity compensation. However, the addition of unverified quantitative details undermines correctness. While the qualitative trajectory (continued significance) aligns broadly, the lack of evidentiary support for key claims and the omission of the actual disclosed evolution (from new plan to standard offering among others) reduce factual accuracy. Thus, the answer is partially correct but contains critical fabrications, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 492,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets from 2023 to 2024 has remained consistent in its emphasis on diversification and formal rebalancing programs to align asset exposures with target allocations. However, in 2024, there is a more explicit mention of monitoring and managing other aspects of risk beyond diversification, indicating a broader risk management emphasis. Additionally, the 2024 disclosures highlight the use of external investment managers subject to written guidelines to ensure prudent investment practices, reinforcing a structured approach to risk oversight.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of Southern Company's risk management emphasis. The ground truth states that in 2024, the emphasis on external manager oversight was *reduced*, whereas the LLM claims it was *reinforced* through written guidelines, which contradicts the original answer. This misrepresents a key shift in risk management focus. Additionally, the LLM fails to mention the increased linkage of large loss risk to market volatility and interest rate fluctuations in 2024, a critical qualitative shift. However, the LLM correctly identifies the continuity of diversification and rebalancing programs. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes that the core strategy (diversification, rebalancing) remained stable, but it fails to accurately contrast the change in oversight emphasis from 2023 to 2024, leading to flawed conclusions about risk management evolution. (4) Correctness is scored at 5 due to the major error in characterizing external manager oversight, which is central to the question. Qualitative accuracy is 5 because while some elements are right, the reasoning misidentifies a key shift. Contextual relevance is high (8) as the response stays on topic and discusses relevant risk management components, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 421,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "NVIDIA's role in the CUDA platform has evolved from being a foundational programming model to becoming a central pillar of its full-stack computing infrastructure. In 2022, CUDA was highlighted as a key enabler for parallel processing and AI applications, while by 2023, the company emphasized its integration with new hardware like CPUs and DPUs, as well as expanded software offerings such as NVIDIA AI Enterprise and DGX Cloud. This shift indicates a strategic focus on strengthening its ecosystem and providing end-to-end solutions across data centers, AI, and enterprise applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA's role in CUDA between 2022 and 2023: from a foundational/enablement role in 2022 to a more integrated, full-stack infrastructure focus in 2023. While the original answer specifies 'supplier' in 2022 and 'developer' in 2023, the LLM captures the semantic equivalent by describing a shift from 'foundational programming model' to 'central pillar of full-stack computing infrastructure.' (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the platform’s evolution with strategic implications, referencing integration with CPUs, DPUs, and software like NVIDIA AI Enterprise and DGX Cloud—details consistent with a broader ecosystem strategy. These specifics are not in the ground truth but are factually plausible and contextually supportive. (4) The LLM slightly expands beyond the original answer with examples not in the ground truth (e.g., DGX Cloud, AI Enterprise), but these do not contradict and instead enrich the explanation without introducing errors. The core strategic conclusion—that NVIDIA is moving toward end-to-end, full-stack data center and AI solutions—matches the original answer’s emphasis on comprehensive data center-scale solutions. Minor deduction in qualitative accuracy due to rephrasing of 'supplier' and 'developer' roles into a slightly different conceptual framework, though the meaning remains aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 451,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris, formed after the Upjohn separation and combination with Mylan, remained largely non-material in terms of operational impact. As of December 31, 2023, net amounts due to Viatris under various agreements were $33 million, compared to $94 million as of December 31, 2022. These agreements included manufacturing, supply, transition services, and agency arrangements, though the amounts recorded under these agreements were not material to Pfizer's operations in either year. Additionally, services under transition service agreements were largely completed by the end of 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the decrease in net amounts due to Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth exactly. It also accurately notes that transition service agreements (TSAs) were largely completed by the end of 2023, indicating reduced interdependence. However, the LLM omits the specific $780 million revenue growth from PC1 in 2022 related to manufacturing legacy Upjohn products for Viatris, which is a key part of the financial relationship evolution mentioned in the original answer. This omission slightly reduces completeness and qualitative accuracy. (2) All numeric values—$94 million and $33 million—are correct in amount and date attribution. No calculations are required beyond comparison, and the directional change (decrease) is correctly interpreted. (3) The multi-hop reasoning is sound: the model connects Pfizer’s ongoing agreements with Viatris (post-Upjohn separation) and tracks the financial and operational evolution across two years. It correctly identifies the nature of the agreements (manufacturing, supply, transition services) and infers reduced interdependence, aligning with the ground truth. The only gap is the missing reference to the $780M revenue component in 2022, which weakens full synthesis. (4) Despite the omission, the answer remains highly accurate, relevant, and semantically close to the original, especially on the key metric of outstanding balances and TSA completion. The statement about non-materiality is consistent with Pfizer's disclosures but not present in the ground truth; however, it does not contradict it. Hence, correctness is high but not perfect due to missing detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 473,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations remained consistent in terms of structural and financial reporting, but there were notable changes in accounting estimates. In 2024, the company revised the estimated useful life of tower assets from 20 to 30 years, which affected depreciation and amortization expenses and related lease liabilities. This change was applied prospectively and led to a $515 million increase in right-of-use assets and lease liabilities as of January 1, 2024. The disclosure of debt obligations, including securitizations and long-term obligations, remained detailed, with similar categorization and reporting of cash flow commitments. However, the updated useful life assumptions in 2024 reflect a more long-term approach to asset valuation and debt servicing related to communications sites.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the evolution of how communications sites are treated in relation to debt obligations between 2023 and 2024. The ground truth highlights a shift from explicit site-specific collateral disclosures in 2023 (e.g., 3,343 sites securing specific notes, $1.3B repayment via securitization) to broader financial obligations in 2024 (e.g., $4.5B in estimated future cash outlay for asset retirement obligations). In contrast, the LLM focuses on a change in estimated useful life of tower assets (from 20 to 30 years), which affects depreciation and lease liabilities but is unrelated to debt secured by communications sites. This misrepresents the core issue. (2) Quantitatively, the $515 million increase in right-of-use assets and lease liabilities is not supported by the ground truth, which does not mention this figure or any such accounting change. The ground truth cites $1.3B repayment and $4.5B in future cash outlay—neither of which appears in the LLM answer. Thus, key numbers are either fabricated or misaligned. (3) The multi-hop reasoning is flawed: the LLM fails to connect communications sites as collateral for debt in 2023 and the absence of such specificity in 2024. Instead, it introduces an unrelated accounting policy change about asset lives, which does not pertain to debt collateral or securitization disclosures. There is no synthesis of the actual evolution in disclosure practices. (4) While the LLM discusses financial reporting related to communications infrastructure, it misses the central theme—collateralization and disclosure of sites in debt obligations—leading to low correctness and qualitative accuracy. Contextual relevance is moderate because it discusses related topics (tower assets, financial reporting) but not the actual evolution in disclosure treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 503,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained largely consistent, with the company continuing to pay local broadcast television stations for retransmission consent to carry their programming on its video services. In 2023, all of its owned NBC and Telemundo stations elected retransmission consent for the 2021–2023 period, and the company expects to continue facing demands for increased payments or concessions from broadcasters. There was no significant evolution in revenue recognition related to these agreements, as revenue from retransmission consent is included in distribution revenue, which is recognized as programming is provided, typically on a monthly basis under multiyear agreements.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but fundamentally misrepresents the evolution of Comcast's retransmission consent approach between 2022 and 2023. (1) Correctly notes that retransmission consent involves payments to broadcasters and that revenue is recognized monthly as programming is provided, which aligns with the 2022 ground truth. However, it incorrectly states there was 'no significant evolution' in revenue recognition or distribution models, directly contradicting the ground truth, which identifies a clear strategic shift in 2023 toward hybrid distribution models integrating both traditional and virtual MVPDs and explicitly including Peacock. (2) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so no numerical inaccuracies are present—this aspect is neutral. The mention of the '2021–2023 period' is factually plausible but slightly off-focus given the question’s emphasis on 2022–2023 evolution. (3) The multi-hop reasoning fails: the LLM does not synthesize the shift in distribution models or the inclusion of streaming providers in retransmission fees, nor does it recognize the strategic integration of Peacock, which is central to the 2023 update. (4) Contextually, the answer addresses retransmission consent but misses the core of the question—how Comcast’s *approach* evolved in terms of revenue recognition and distribution models. Instead, it focuses on broadcaster demands and payment trends, which were not the focus of the original question. Thus, while factually coherent, it lacks the necessary depth and directional insight, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 453,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives from 2023 to 2024 remained a core part of its Energy & Transportation segment, with continued focus on rail-related products and services, including remanufacturing and leasing. In 2024, Transportation sales increased by 4%, driven by growth in marine and rail services, indicating a strategic emphasis on expanding rail-related offerings. The company also highlighted ongoing investments in compliance with evolving emissions regulations, which impact product development and positioning in the rail sector.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses key aspects of Caterpillar's evolution in diesel-electric locomotive involvement from 2023 to 2024. While it correctly identifies the Energy & Transportation segment and mentions rail-related services, it inaccurately states that this involvement 'remained a core part' of the segment, implying continuity rather than the documented shift in strategic emphasis. The original answer highlights a structural and semantic evolution—from general inclusion in ME&T in 2023 to explicit 'production' language in 2024—indicating a more direct strategic role, which the LLM fails to capture. Additionally, the LLM introduces a 4% increase in Transportation sales without specifying that this figure is not directly tied to diesel-electric locomotives in the source data, risking misattribution. (2) The 4% sales increase is a correct figure from Caterpillar’s 2024 report, but it refers broadly to Transportation sales driven by marine and rail services—not specifically to diesel-electric locomotive production. There are no calculation errors, but the use of this number lacks proper contextual anchoring to the specific product line. (3) The multi-hop reasoning is weak: the LLM does not synthesize the change in segment naming (ME&T to Energy & Transportation), fails to note the shift from remanufacturing and support to explicit 'production' language, and omits the new mention of competitors like Wabtec and Siemens Mobility in 2024—key indicators of strategic repositioning. This omission reflects a failure to connect the evolution in narrative tone and competitive framing across years. (4) The contextual relevance is moderate because the answer discusses related topics (rail services, emissions, segment focus), but it does not accurately reflect the core transformation in Caterpillar’s strategic positioning. The qualitative accuracy is low due to incorrect synthesis and missing key differentiators between 2023 and 2024. Quantitative accuracy is acceptable due to correct use of the 4% figure, though its application is imprecise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 567,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent. Revenues from franchisees continued to include royalties based on a percentage of sales, minimum rent payments, and initial fees. The Company also continued to recover a portion of costs incurred for technology platforms through fees paid by franchisees. There were no significant changes in the structure of these arrangements, and the Company maintained its role as the principal in these transactions, recognizing revenue on a gross basis. Cost-sharing with franchisees for restaurant improvements was also unchanged, with McDonald's generally managing and funding projects upfront before reallocating costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of the structure of revenue recognition (royalties, rent, initial fees) and acknowledges cost-sharing for restaurant improvements, which aligns with the ground truth. There are no numeric inaccuracies, as the response avoids specific figures that could be incorrect, and correctly references consistent revenue components across years—thus earning full marks for quantitative accuracy. However, the answer incorrectly states that there were 'no significant changes' and that arrangements 'remained unchanged,' which contradicts the ground truth: in 2024, McDonald's made notable enhancements in transparency and accounting treatment, particularly by presenting technology platform fees on a gross basis and providing new disclosures on cost-sharing allocations between Property and Equipment and Accounts Receivable during and after improvement projects. The LLM fails to capture these 2024-specific developments, missing the key evolution in disclosure granularity and accounting nuance. This omission represents a significant gap in qualitative accuracy, as it overlooks the multi-hop insight that while core models remained similar, the depth of reporting and specificity in cost allocation processes increased meaningfully in 2024. The answer remains contextually relevant and well-structured, but lacks the critical comparative analysis of disclosure evolution, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 398,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by revising plan documentation and award terms. Specifically, the company issued the Ninth Amendment to the Southern Company Employee Savings Plan in December 2024, and the terms for Named Executive Officer Equity Awards under the 2021 Equity and Incentive Compensation Plan were formalized, indicating a focus on refining and clarifying the structure and administration of executive compensation programs.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures part of the evolution in Southern Company's executive equity compensation approach but contains inaccuracies and omits key details from the ground truth. (1) Correct elements: The formalization of Named Executive Officer (NEO) equity award terms under the 2021 Equity and Incentive Compensation Plan in 2024 is accurately noted, reflecting a more structured approach. However, the mention of the 'Ninth Amendment to the Southern Company Employee Savings Plan' in December 2024 is irrelevant to executive equity compensation and not mentioned in the original answer—this plan pertains to employee savings, not equity awards, indicating a confusion of plans. (2) Quantitative accuracy: The date 'December 2024' is problematic because 2024 filings would not include post-filing amendments made in December 2024 unless explicitly disclosed as future events; the ground truth does not reference any amendment or date beyond the 2024 filing year. This introduces a factual inaccuracy. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the comparative documentation practices between 2023 and 2024. While it notes formalization of terms, it omits the critical point that 2024 introduced specific exhibit designations for equity award terms—a key indicator of improved documentation and transparency absent in 2023. It also fails to mention that PSUs and RSUs were granted under the same plan in both years, with only the level of detail and structure evolving. (4) The answer is contextually relevant and addresses the general theme of increased structure in executive compensation, but due to the inclusion of an irrelevant plan amendment and omission of key documentation practices (exhibits, comparative lack of detail in 2023), the qualitative and overall correctness scores are reduced. Semantic equivalence is partially achieved but undermined by factual misalignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 512,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has increased from 2022 to 2024, reflecting a broader shift toward optimizing its retail channel strategy to align with evolving consumer preferences and competitive dynamics. This shift indicates that P&G is prioritizing high-growth and high-efficiency retail channels, such as membership clubs, to enhance market share and profitability while adapting to the rise of e-commerce and alternative retail formats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Procter & Gamble's strategic reliance on membership club stores from 2022 to 2024, noting an increased focus and alignment with high-growth channels. It accurately reflects the shift from identifying membership clubs as one of many channels in 2022 to a more emphasized, strategic dependency by 2024, which aligns with the ground truth. There are no numeric figures in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022 and 2024) are correctly referenced, earning full marks. The qualitative accuracy is high: the reasoning about evolving consumer preferences and competitive dynamics is logically sound and consistent with the inference in the original answer. The model infers strategic prioritization and links it to market trends like e-commerce, which is contextually appropriate, though the original answer does not explicitly mention 'optimizing for profitability' or 'high-efficiency channels'—these are reasonable extrapolations but slightly extend beyond the documented shift in language. The answer is fully contextually relevant, addressing both parts of the question: the evolution over time and what it indicates about broader strategy. While the core facts and synthesis are correct, the LLM adds slight interpretive emphasis (e.g., 'optimizing profitability') not directly stated in the ground truth, preventing a perfect 10. Overall, the answer is factually aligned, logically coherent, and semantically equivalent in intent and meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 434,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit decreased between 2023 and 2024, as evidenced by the $3.4 million in outstanding letters of credit in 2023, which dropped to zero by 2024. This indicates that AMT fulfilled or settled its financial obligations related to these instruments by the end of 2024. The terms specify that drawn amounts bear interest at SOFR plus a spread and are due 270 days from the drawing date, suggesting that the obligations were time-bound and likely short-term in nature.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.4 million obligation in 2023 and its reduction to $0 in 2024, accurately reflecting the quantitative change in AMT's financial obligation. The conclusion that AMT fulfilled or settled its obligations is consistent with the ground truth. (2) All numeric values are correct: $3.4 million in 2023 and $0 in 2024 match the original answer. No calculations were required beyond comparison, which was handled correctly. Format variations are not an issue here as exact figures are used. (3) The multi-hop reasoning is sound—connecting the drop from $3.4M to $0 and inferring settlement of obligations is valid. The addition of contextual detail about interest terms (SOFR plus spread) and 270-day maturity is accurate and enriches the answer, though not present in the ground truth; however, it does not contradict it and supports the interpretation of short-term, time-bound obligations. (4) The answer is semantically equivalent to the original and adds minor but relevant context without introducing errors. The only reason for not scoring a 10 is that the original answer emphasizes the instrument's removal from the variable rate debt portfolio and carrying value reporting, which the LLM omits—this is a minor completeness gap. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 378,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology for GD's Retirement Annuity Contracts remained consistent, as both years classified these contracts under Level 3 of the fair value hierarchy, indicating the use of significant unobservable inputs. However, the composition of these assets decreased from $25 in 2023 to $22 in 2024. This reduction suggests a decline in the value or quantity of retirement annuity contracts held, potentially reflecting strategic asset reallocation or market adjustments. The consistent Level 3 classification highlights the company's transparent approach to reporting these less liquid and less observable assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, GD reported Retirement Annuity Contracts with a fair value of $35 million as of December 31, 2021, and $38 million as of December 31, 2020 — not $25 million in 2023 or $22 million in 2024 as claimed by the LLM. These numbers are entirely incorrect and not present in the ground truth. (2) The quantitative inaccuracies are severe: the LLM invents values for 2023 and 2024 that do not appear in the original data, and the time frame referenced (2023–2024) does not align with the ground truth, which compares disclosures from 2022 (referring to 2021 and 2020 values) to 2024. There are no calculations in the answer, but the reported figures are false. (3) The reasoning is flawed: the LLM claims the valuation methodology 'remained consistent' under Level 3, but the ground truth explicitly states a shift — by 2024, the contracts were valued using NAV as a practical expedient and were excluded from the formal fair value hierarchy, which is a material change. This misrepresents the core of the question. The LLM fails the multi-hop synthesis by missing the methodological shift and misreporting the financial data. (4) Contextual relevance is moderate because the answer addresses the right topic (valuation of Retirement Annuity Contracts) and the right company (GD), and attempts to discuss Level 3 classification and trends. However, due to major factual and reasoning errors, the answer is mostly incorrect. Correctness score is low due to complete failure on numbers and key methodology change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 442,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Based on the information provided in the document pages:\n\nIn 2024, the restricted cash for securitization investors is reported at $441 million and is classified entirely under Level 1 of the fair value hierarchy, indicating it is valued based on quoted prices in active markets. In 2023, the restricted cash for securitization investors was $458 million, also classified entirely under Level 1. Therefore, there is no change in the fair value hierarchy classification between 2022 and 2024, as both years show Level 1 classification. The value has slightly decreased from $458 million in 2023 to $441 million in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the fair value hierarchy classification in 2022. The ground truth states that in 2022, the fair value hierarchy was not explicitly detailed for restricted cash for securitization investors, whereas the LLM incorrectly claims it was classified as Level 1, based on 2023 data. This misrepresents the evolution of the classification over time. The 2024 value of $441 million and its Level 1 classification are correct. However, the mention of $458 million in 2023 is not part of the original question or ground truth, which focused on 2022 and 2024, making this detail extraneous and potentially misleading. (2) Quantitatively, the $441 million figure for 2024 is accurate, and the Level 1 classification is correctly reported for that year. However, the inference that 2022 also had Level 1 classification is unsupported by the ground truth, which explicitly states that the hierarchy was not detailed in 2022. The use of 2023 data to infer 2022 status is invalid without explicit confirmation. (3) The multi-hop reasoning is flawed because the model fails to recognize that the absence of fair value hierarchy detail in 2022 constitutes a qualitative difference from 2024’s explicit Level 1 classification. The ground truth emphasizes a shift toward more transparent valuation methods by 2024, which the LLM overlooks by asserting no change. This undermines the core of the question about changes in composition and valuation approach. (4) Contextual relevance is high as the answer addresses restricted cash, securitization investors, fair value hierarchy, and provides values across years. However, the incorrect synthesis of 2022 classification and introduction of unrequested 2023 data reduce qualitative accuracy. The correctness score is lowered due to the critical error in reasoning about the evolution of fair value disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 516,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's financial recognition and asset management related to franchisees showed notable changes. In 2023, the Company recognized $290 million in pre-tax charges tied to its \"Accelerating the Arches\" growth strategy, including restructuring costs and asset write-offs. By 2024, these charges decreased to $221 million, primarily from restructuring efforts and transaction costs related to the sale of its business in South Korea and the acquisition in Israel. Additionally, asset dispositions and other expenses increased in 2024 due to higher asset write-offs, contrasting with 2023's gains from property sales. These shifts reflect evolving strategic priorities and asset management practices in McDonald's relationship with franchisees.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the core of the question. The original answer describes a strategic shift in McDonald's relationship with franchisees—from asset acquisition and goodwill management in 2023 to a service-based model involving technology platforms in 2024. The LLM answer instead focuses on pre-tax charges, restructuring costs, and asset write-offs related to geographic transactions (South Korea, Israel), which are not mentioned in the ground truth and do not reflect the evolution in franchisee relationship dynamics. (2) Quantitatively, the LLM introduces specific figures—$290 million in 2023 and $221 million in 2024—but these relate to restructuring and transaction costs under 'Accelerating the Arches,' which are not part of the ground truth narrative about franchisee financial recognition or asset management. These numbers may be factually accurate in another context but are irrelevant here, leading to a partial score for quantitative accuracy due to presence of numbers but misalignment with the topic. (3) The multi-hop reasoning is flawed: the LLM fails to identify the key shift from asset acquisition (with goodwill write-offs) to service-based revenue recognition (gross basis for tech services). It does not mention the use of discounted cash flow for valuing acquired restaurants in 2023 or the recognition of technology service revenue and corresponding expenses in 'Other restaurant expenses' in 2024—both central to the original answer. (4) Contextual relevance is moderate because the answer discusses financial aspects of asset management and changes over time, but it misdirects focus to corporate restructuring and regional divestitures/acquisitions rather than the evolving financial and operational relationship with franchisees. Thus, while it remains within the broad theme of financial strategy, it misses the specific franchisee-centric transformation described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 529,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan remains the primary vehicle for equity compensation at Procter & Gamble as of 2024, with 77 million shares available for future issuance. It allows for the granting of stock options, stock appreciation rights, and full-value awards like RSUs and PSUs, with the latter counted at a five-to-one ratio. The plan is distinct from older plans, which are no longer active for future grants, and it continues to be the sole active plan for new equity compensation awards, reflecting its central role in the Company's executive and director compensation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements, such as the continued relevance of the 2019 Stock and Incentive Compensation Plan in 2024 and its role in equity compensation. However, it introduces specific quantitative details—like '77 million shares available for future issuance'—that are not present in the original answer and cannot be verified from the provided ground truth. This number may be accurate in reality, but since it's absent from the ground truth, it represents an unsupported claim, reducing factual accuracy. (2) The original answer does not mention any numerical figures (e.g., number of shares), so the inclusion of '77 million shares' and the 'five-to-one ratio' for PSUs constitutes a failure in quantitative fidelity. These specifics suggest overprecision and potential hallucination, as the ground truth focuses on qualitative shifts in disclosure emphasis rather than granular plan mechanics. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the 2019 Plan is central and supersedes older plans—but it misses the core evolution highlighted in the original answer: the shift in disclosure tone from governance and adoption (in 2022) to strategic ownership and share availability (by 2024). Instead of tracking how the *disclosure treatment* evolved, the LLM focuses on static plan features, thus failing to capture the longitudinal, narrative shift across years. (4) While the LLM answer is contextually relevant and addresses equity compensation structure and plan hierarchy, it substitutes descriptive detail for analytical evolution, resulting in a partially correct but misaligned response. The correctness score is moderate due to accurate identification of the plan’s ongoing role but docked for hallucinated numbers and failure to reflect the true nature of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 503,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations remained consistent between 2022 and 2023. The brand was listed as a tenant in multiple international premium outlet centers in both years, including locations in Japan (Gotemba, Kobe-Sanda, Rinku, Sano, Shisui, and Toki Premium Outlets), South Korea (Yeoju, Paju, Busan, Siehung), Malaysia (Johor), and Canada (Montreal). No new international outlet locations added Salvatore Ferragamo as a tenant in 2023, nor were any existing listings removed, indicating stable representation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the answer falsely claims Salvatore Ferragamo was present in multiple international locations in both 2022 and 2023, listing outlets in Japan, South Korea, Malaysia, and Canada. However, the ground truth states that in 2022, Ferragamo was only in three Japanese outlets (Gotemba, Kobe-Sanda, Sano), and by 2023, it was only present in one U.S. location (Las Vegas Outlets North), not any international ones. The claim of 'stable representation' is false—there was a significant reduction and geographic shift. (2) The LLM invents outlets (e.g., Rinku, Shisui, Toki, Yeoju, Paju, etc.) and countries (South Korea, Malaysia, Canada) where Ferragamo was supposedly present, with no supporting evidence in the ground truth. (3) The multi-hop reasoning is completely flawed: the question asks about evolution between 2022 and 2023, requiring comparison across years and locations. The LLM fails to detect the reduction from three Japan-based outlets to zero international outlets (and only one domestic U.S. outlet), misrepresenting both the direction and magnitude of change. (4) Contextual relevance is low because the answer discusses international presence remaining stable when in fact it declined to zero internationally. The only minor relevance is that it addresses the topic of Ferragamo’s outlet presence, but all specific claims are factually wrong. Thus, the correctness score is 1 due to complete factual inaccuracy and failure in multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 425,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "From 2023 to 2024, COP's natural gas position in the Asia Pacific/Middle East region showed a slight decline in proved reserves, from 312 BCF at the end of 2023 to 296 BCF at the end of 2024. However, the region's undeveloped reserves remained relatively stable, with 7 BCF in 2024 compared to 7 BCF in 2023. This suggests that while COP is maintaining a presence in the region, its operational focus appears to be more on sustaining existing reserves rather than aggressively expanding new developments in Asia Pacific/Middle East.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the proved natural gas reserves for COP in the Asia Pacific/Middle East region: 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. The mention of undeveloped reserves (7 BCF in both years) is an additional detail not present in the original answer but does not contradict it and is consistent with plausible data. (2) All numeric values are accurate—312 BCF and 296 BCF—and the slight decline is correctly characterized. No calculations are required beyond comparison, which is sound. (3) The multi-hop reasoning is appropriate: the model infers from the slight decline in proved reserves and stable undeveloped reserves that COP is focusing on sustaining rather than expanding, which aligns with and slightly expands upon the original answer’s conclusion about a potential shift or stabilization in operational focus. (4) The LLM answer is semantically equivalent and adds minor contextual detail (undeveloped reserves) that enhances the analysis without introducing error. The core facts, numbers, and interpretation are correct, warranting a high score. Deducted 1 point from correctness due to the introduction of an unverified detail (undeveloped reserves) not present in the ground truth, though it does not appear inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 364,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways from 2022 to 2024 has shown a strategic emphasis on enhancing customer experience and expanding network capabilities. In 2022, wireless gateways were highlighted as part of broadband offerings, combining internet modems with Wi-Fi routers to deliver reliable coverage and advanced features like xFi. By 2024, the focus evolved to include deploying wireless gateways as part of broader network upgrades, aiming to deliver multigigabit symmetrical speeds and improve in-and-out-of-home connectivity. Investment in wireless gateways remained consistent, with capital expenditures in 2024 reflecting continued deployment efforts alongside scalable infrastructure and line extensions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, Comcast offered wireless gateways as part of broadband services with xFi features; by 2024, the strategic emphasis shifted toward integrating gateways into broader network infrastructure upgrades aimed at multigigabit symmetrical speeds. The description of investment continuity is consistent with the original answer’s implication of increased strategic importance and capital deployment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10 due to absence of errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), identifies the evolution in strategic emphasis (from customer-facing features to infrastructure integration), and captures the increased role of gateways in network capacity. The only minor gap is that the LLM says 'investment remained consistent,' while the original emphasizes an 'elevated strategic emphasis' and 'active investment,' suggesting a ramp-up rather than mere consistency. This slight underrepresentation of the increased investment intensity prevents a perfect 10. (4) The answer is fully contextually relevant, directly addressing both strategic emphasis and investment aspects of the question across the specified time frame. Overall, the LLM conveys semantically equivalent information with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 419,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolution showed steady growth, with cumulative deliveries surpassing 300 units by year-end 2024. As part of Gulfstream's modernized product lineup, the G600 replaced the G450 and G550 models and contributed to the segment's technological leadership in speed, range, and cabin efficiency. The G600 solidified its role as a key mid-range offering within Gulfstream's expanded aircraft family, complementing newer models like the G500, G700, and upcoming G800 and G400.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that cumulative deliveries of the G500 and G600 surpassed 300 by year-end 2024, aligning with the ground truth that deliveries more than doubled to over 300 by year-end 2024. However, the LLM omits the 2021 baseline of almost 150 cumulative deliveries, which is critical context for the comparison between 2022 and 2024. While the doubling trend is implied, the specific reference point is missing. (2) The numeric value of 'over 300' by 2024 is accurate and matches the ground truth. The LLM does not misstate any financial figures, dates, or delivery numbers, though it fails to mention that the 150-unit milestone was reached by end of 2021 (referenced in the 2022 context). (3) The reasoning is partially sound: the LLM correctly identifies the G600 as a replacement for the G450 and G550 and notes improvements in performance. However, it incorrectly implies that the G500 is a newer model than the G600 by listing them together as complementary, whereas the ground truth indicates the G500 and G600 were introduced together as a pair and that by 2024, the G600 was no longer considered a 'new' product. Additionally, the LLM incorrectly lists the G700 as a newer model in the lineup, which is not mentioned in the original answer and introduces a fact not supported by the ground truth. The shift in focus to G800 and G400 is correctly noted. (4) The answer is contextually relevant and addresses market presence, production evolution, and role in the product lineup. However, due to the omission of the 2021 delivery baseline, the misrepresentation of the G500 as a newer model, and the introduction of the unsupported G700 reference, the qualitative and correctness scores are reduced. Overall, core facts are correct but with notable omissions and one extraneous inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 494,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of equity ownership and income recognition. As of December 31, 2023, AIG held a 52.2% ownership stake in Corebridge, and in 2024, AIG recognized a $601 million equity method income related to Corebridge, based on changes in its stock price and dividends received. Additionally, AIG recorded a $4.754 billion after-tax loss on the deconsolidation of Corebridge in 2024, which included the retained investment in Corebridge valued at $8.5 billion and other adjustments. This reflects a substantial reduction in AIG's ownership and financial stake in Corebridge during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies that significantly affect correctness. While it correctly states AIG's 52.2% ownership stake in Corebridge as of 2023 (aligned with ground truth), it introduces specific financial figures—$601 million equity method income and a $4.754 billion after-tax loss on deconsolidation—that are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually incorrect or misattributed, as the ground truth does not mention them. Additionally, the $8.5 billion valuation of the retained investment is absent from the original answer, indicating fabrication or incorrect inference. (2) The quantitative accuracy is compromised due to these unverified figures. Although the 52.2% ownership is correct, the other dollar amounts (e.g., $601M, $4.754B, $8.5B) lack support in the ground truth and appear to be either hallucinated or derived from external data not in the knowledge graph. There is no indication in the original answer that AIG recognized $601M in equity income or recorded a $4.754B loss, so these undermine factual reliability. (3) The qualitative reasoning is partially sound: the LLM correctly infers a shift in accounting method and reduced control, aligning with the equity method transition described in the original answer. It captures the essence of a move from control to passive investment, which shows good multi-hop synthesis of the evolving relationship. However, the addition of unsupported financials weakens the reasoning chain. (4) Contextual relevance is high—the response directly addresses the evolution of equity ownership and income recognition between 2023 and 2024, focusing on the right entities and time frame. Despite incorrect numbers, the narrative direction matches the question's intent. Overall, the answer contains key correct elements but fails on critical quantitative accuracy, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 532,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved to focus on localized manufacturing and addressing operational challenges. In 2022, the Solar Roof was produced at Gigafactory New York, with dependencies on state incentives and compliance with hiring and investment targets. By 2024, Tesla continued to emphasize localized production and supply chain efficiency, though challenges such as supplier dependencies, production ramp delays, and scaling installation capabilities remained. Additionally, Tesla faced ongoing operational hurdles, including supply chain constraints and the need to expand its workforce and infrastructure to meet growing demand for its energy products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Gigafactory New York as the production site in 2022 and notes ongoing production challenges in 2024, including supplier dependencies, ramp delays, and scaling issues. It also correctly captures the evolution toward localized production and supply chain efficiency. However, it introduces unverified details not present in the ground truth, such as 'state incentives and compliance with hiring and investment targets' in 2022, which are not mentioned in the original answer. Additionally, while the ground truth emphasizes a shift in tone from active production to increased risk and complexity in 2024—specifically citing 'delays in launching and/or ramping production' and challenges in 'design tolerances, high quality and output rates'—the LLM answer generalizes these as 'operational hurdles' without capturing the specific manufacturing quality and output rate targets. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; all time references (2022, 2024) are correct. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in production location and increasing challenges over time, but fails to fully synthesize the nuanced shift in Tesla’s disclosures—from a confident, integrated strategy in 2022 to a risk-focused, cautionary tone in 2024 filings regarding Solar Roof ramp-up. The mention of 'localized procurement challenges' in the ground truth is partially reflected in 'localized production,' but the LLM does not explicitly link this to procurement risks. (4) The correctness score is 7 because core facts are accurate and the overall trajectory is correctly described, but key qualitative details about design tolerances, output rates, and specific risk language in 2024 are missing or underdeveloped. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to partial omission of critical reasoning points and introduction of unsupported details. Contextual relevance is 9 as the answer stays focused on the question and addresses both manufacturing dependencies and operational challenges across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 592,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm's strategic involvement with on-device AI has evolved by expanding its focus on integrating AI capabilities into a broader range of products and applications beyond mobile handsets. In 2023, Qualcomm emphasized the role of on-device AI in mobile and IoT devices, highlighting its Qualcomm AI Engine and Hexagon NPU for high-performance, low-power AI inference. By 2024, the company expanded its vision to include AI in emerging industries such as automotive, XR, and IoT, with a focus on generative AI models running on edge devices. Additionally, Qualcomm increased its investment in advancing AI technologies through its Snapdragon platforms and the Qualcomm AI Stack, aiming to enable more sophisticated, context-aware AI applications while maintaining a focus on privacy, security, and efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's continued focus on on-device AI from 2023 to 2024 and accurately describes its expansion into automotive, IoT, and XR, which aligns with the ground truth. It also correctly references key technologies like the Qualcomm AI Engine, Hexagon NPU, Snapdragon platforms, and the Qualcomm AI Stack. However, it misses a critical evolution highlighted in the original answer: the strategic shift from on-device AI as a core product offering in 2023 to a more investment-centric, ecosystem-driven approach in 2024 focused on R&D, acquisitions, and third-party integration. Instead, the LLM emphasizes product integration and technological expansion without capturing this strategic pivot in business focus and investment approach. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model synthesizes Qualcomm’s AI evolution across time and domains correctly but fails to connect the shift in business strategy (from product-centric to investment/ecosystem-centric), which is central to the question. This represents a gap in qualitative reasoning. (4) The answer is contextually relevant and well-structured, providing accurate technical details and industry applications, but lacks the strategic nuance about investment and ecosystem development that defines the evolution. Hence, correctness and qualitative accuracy are reduced accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 427,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Dolce & Gabbana's presence in SPG-operated properties expanded between 2022 and 2023, appearing in additional premium outlet locations such as Las Vegas Outlets North in Nevada (2023) and previously in locations like Gotemba Premium Outlets in Japan and Punta Norte Premium Outlets in Mexico (2022). This expansion indicates that SPG is enhancing its brand positioning strategy by attracting high-end luxury tenants to its premium outlet locations, reinforcing their appeal as destinations for upscale shopping experiences.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Dolce & Gabbana's presence expanded between 2022 and 2023. The ground truth shows a contraction — from multiple locations in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) to only one location in the U.S. (Las Vegas Outlets North) in 2023. The LLM incorrectly claims the brand was present in Punta Norte Premium Outlets in Mexico in 2022, which is not supported by the ground truth. (2) Quantitative accuracy is low: the LLM fabricates a location (Punta Norte) and misrepresents the geographic trend (expansion vs. contraction). The mention of Las Vegas Outlets North in 2023 is correct, but the inference of expansion is not. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in tenant presence across years and geographies to infer strategic intent. The LLM fails this by misrepresenting the direction of change (expansion vs. strategic consolidation), leading to an incorrect conclusion about SPG’s brand positioning strategy. The ground truth indicates a shift toward exclusivity in a key U.S. market, while the LLM suggests broad upscale expansion, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the general topic of brand positioning and luxury tenants, but the factual foundation is wrong, undermining the validity of the interpretation. The conclusion is therefore misleading despite using relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 405,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region decreased from $49 million in 2023 to $46 million in 2024. This slight decline suggests a reduced emphasis on exploration in the region, potentially indicating a strategic shift toward optimizing existing assets or focusing on other high-potential areas. However, the continued allocation of funds to exploration in the region implies that COP still views it as a relevant, though less prioritized, part of its global operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that COP's exploration expenditures in the Asia Pacific/Middle East region were $49 million in 2023 and $0 in 2024, indicating a complete halt. However, the LLM incorrectly reports $46 million in 2024, which is not supported by the data. This error fundamentally undermines the answer's validity. (2) The quantitative accuracy is severely compromised: the $46 million figure is wrong, and the implied $3 million decrease misrepresents a total drop to zero. No calculation is needed beyond recognizing $0 vs $46 million, and the model fails this basic comparison. (3) The reasoning is flawed due to incorrect data input. The conclusion of a 'slight decline' and 'continued allocation' contradicts the ground truth of a complete withdrawal. The multi-hop synthesis fails because the model did not correctly identify the 2024 value, leading to an incorrect strategic interpretation. While the general structure of comparing two years and inferring strategy is appropriate, the faulty data leads to invalid reasoning. (4) Contextual relevance is moderate—the answer addresses the right region, company, and type of activity, and attempts to infer strategic intent, which aligns with the question. However, due to the major factual error, the qualitative and correctness scores are very low. A correct answer would have noted the full cessation and interpreted it as a strategic exit or pause, not a minor reallocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 419,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort has remained consistent at a 30% ownership interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion in debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion in debt outstanding, including a $3.1 billion term loan, as of December 31, 2023. Comcast consolidates Universal Beijing Resort due to its ability to direct activities impacting its economic performance, and its maximum risk of financial loss is limited to its 30% stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that Comcast's 30% ownership interest was established in 2022, while the original answer clarifies that no specific financial stake was disclosed in 2022—Comcast only mentioned the resort's opening and related expense impacts. The 30% stake was first explicitly stated in 2024, not retroactively in 2022. Additionally, the LLM introduces term loan details ($3.0 billion and $3.1 billion) that are not present in the original answer and cannot be verified against the ground truth. While the debt figures of $3.4 billion (2024) and $3.5 billion (2023) are correct, the breakdown into term loans is extraneous and unsupported. (2) The quantitative accuracy is partially correct: the debt amounts and ownership percentage are accurate for 2024, but the attribution of the 30% stake to 2022 is factually wrong. The original answer notes that asset and liability figures were reported in 2024 ($7.3B assets, $7.0B liabilities) and 2023 ($7.8B, $7.2B), but the LLM omits these entirely, reducing completeness. (3) The reasoning shows partial multi-hop synthesis—correctly identifying the evolution of debt and ownership—but fails to accurately represent the timeline of disclosure. The claim that Comcast consolidates the resort due to its ability to direct economic performance is plausible but not confirmed in the original answer, introducing unverified qualitative judgment. (4) Contextual relevance is high as the answer addresses financial stake and debt evolution directly. However, due to significant factual errors in timing and unsupported details, the correctness score is reduced to 6, with quantitative accuracy at 5 due to incorrect temporal attribution and invented loan breakdowns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 493,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $29 million to $13 million, reflecting a reduction in derivative assets and liabilities. The 2023 balance sheet shows derivative assets of $1 and derivative liabilities of $147, resulting in a net liability of $146, compared to a net liability of $168 in 2022. This decline suggests a reduction in exposure or more effective management of derivative instruments, potentially due to settlements or a decrease in market volatility. The company's continued use of Level 2 fair value measurements also indicates reliance on observable market data, supporting disciplined risk management practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. While it correctly states the 2022 net derivatives balance of $29 million and the 2023 decrease to $13 million, it introduces incorrect derivative asset and liability figures: claiming derivative assets of $1 and liabilities of $147 million in 2023 (resulting in a net liability of $146 million), which contradicts the ground truth net balance of $13 million. This suggests a fundamental error in data retrieval or synthesis. Similarly, the claim of a $168 million net liability in 2022 does not align with the ground truth net balance of $29 million. (2) The settlements data—$32 million in 2022 and $68 million in 2023—is completely omitted in the LLM answer, which is a major omission since settlement activity is a core part of the question. The absence of these figures undermines the answer's completeness and quantitative accuracy. (3) The reasoning about reduced exposure and improved management is partially aligned with the ground truth interpretation, but it is based on incorrect financial figures and misses the key insight that higher settlements coincided with a declining net balance—indicating active management or unwinding of positions. The mention of Level 2 fair value measurements, while potentially true, is not supported by the ground truth and adds unsupported detail. (4) The contextual relevance is moderate because the answer addresses derivative balance trends and risk management implications, but the incorrect numbers and missing settlement data severely limit factual correctness. The qualitative reasoning is plausible but built on faulty premises. Correctness score is low due to major quantitative errors and missing multi-hop data points essential to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 486,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units remained consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. However, SPG continued to refine its valuation modeling for LTIP Units in 2023, using a Monte Carlo model to estimate the grant-date fair values of market-based awards, with resulting fixed expenses recorded regardless of whether market conditions were achieved. The LTIP Units were still classified as participating securities under the two-class method of computing earnings per share.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor inaccuracy in framing SPG's disclosure evolution. (1) Quantitatively, all facts are accurate: the use of the Monte Carlo model in 2023 for grant-date fair value estimation, the classification of LTIP units as participating securities under the two-class method, and the absence of material dilutive effect in both years are correctly stated. (2) The answer correctly identifies the entities (SPG, LTIP Units), years (2022 to 2023), and financial concepts (dilutive effect, valuation modeling, earnings per share treatment). (3) However, the LLM states that treatment and disclosure 'remained consistent' regarding dilutive effect, which understates the evolution. The ground truth emphasizes a shift from minimal disclosure in 2022 (only noting no material dilution) to more granular, valuation-focused disclosures in 2023, including methodology (Monte Carlo). This represents a qualitative enhancement in disclosure, not just a refinement. The LLM downplays this evolution by focusing on consistency, missing the nuance of increased transparency and methodological detail. (4) Despite this, the core facts and multi-hop synthesis—linking changes in disclosure depth, valuation technique, and accounting treatment—are sound. The answer is contextually relevant and factually precise, warranting a high score but not perfect due to the softened characterization of the disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 406,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's financial commitment to Atairos Group, Inc. remained consistent in terms of capital funding and management fee commitments. As outlined in the 2024 10-K, Comcast's maximum aggregate commitment to fund Atairos was capped at $4.5 billion, with an annual capital call limit of $400 million plus previously distributed amounts. Additionally, Comcast committed to funding $40 million annually for a management fee. These terms were established in the November 2020 agreement and remained unchanged during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the $4.5 billion capital commitment and $40 million annual management fee in 2024, it incorrectly claims these terms were unchanged from 2022. The ground truth states that in 2022, Comcast's capital commitment was $5 billion, which was reduced to $4.5 billion by 2024—indicating a change. The LLM also fails to mention that Comcast was the sole third-party investor in 2022, a key detail about its evolving involvement. (2) Quantitatively, the $4.5 billion and $40 million figures are accurate for 2024, but the $400 million annual capital call limit is not mentioned in the ground truth and appears to be extraneous or misattributed. The absence of the $5 billion 2022 figure is a major omission. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2022 and 2024, requiring comparison across years. The LLM incorrectly asserts no change, contradicting the ground truth's clear indication of a recalibration in commitment. (4) Contextual relevance is moderate—the answer discusses the right entities and time frame and includes relevant financial terms, but the core conclusion (no change) is factually wrong, severely undermining correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 362,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This slight decline, despite positive revisions and extensions, indicates a modest reduction in the region's reserve base. The company's operational focus in this area appears to be stabilizing rather than expanding, as the reserves have not grown significantly and are influenced by factors like production and minor revisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that reserves 'increased from 312 BCF to 296 BCF', which is incorrect because 296 is less than 312, indicating a decrease, not an increase. This misstatement undermines the core quantitative claim. The correct evolution is a decrease from 312 to 296 billion cubic feet. (2) While the actual numbers (312 BCF in 2023 and 296 BCF in 2024) are correctly cited, the interpretation of the trend is wrong due to the misuse of 'increased' instead of 'decreased'. This leads to a significant quantitative inaccuracy despite correct raw values. (3) The reasoning about operational focus being 'stabilizing rather than expanding' is plausible and aligns with the modest reduction, so the qualitative inference is partially sound. However, the logic is built on a flawed premise (an increase instead of a decrease), weakening the multi-hop synthesis. (4) Contextually, the answer addresses both parts of the question—reserve evolution and operational focus—and includes relevant context like revisions and production effects, earning high marks for relevance. Overall, the correctness score is low due to the major error in interpreting the direction of change, even though numbers themselves are accurate and the response is contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 374,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast focused on wireless gateway procurement, offering customers integrated devices that combine internet modems with Wi-Fi routers to enhance in-and-out-of-home coverage. By 2024, the company shifted its investment focus toward scalable infrastructure and line extensions to support network upgrades for multigigabit symmetrical speeds, reflecting a strategic move from customer premise equipment to broader network expansion and performance enhancement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the shift in Comcast's strategy from 2022 procurement to 2024 strategic investment in network infrastructure, with accurate emphasis on multigigabit symmetrical speeds as a goal. It correctly identifies wireless gateways as customer premise equipment combining modems and Wi-Fi routers. However, it omits the specific point from the ground truth that by 2024, wireless gateways themselves were a key component of capital expenditures and were actively integrated into network scalability plans—not just that investment shifted to broader infrastructure. This downplays the continued strategic importance of gateways in 2024, implying a full move away from CPE, whereas the original answer emphasizes their active deployment as part of the upgrade. (2) There are no numeric values, dollar amounts, or percentages in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024) and strategy (procurement vs investment), and aligns the evolution with network performance goals. The logic is coherent and reflects a valid interpretation of strategic evolution, though slightly less precise in attributing the role of gateways in 2024. (4) Correctness is high due to accurate core facts and timeline, but docked slightly for incomplete representation of the 2024 strategy. Qualitative accuracy is strong but not perfect for the same reason. Contextual relevance is full—response directly addresses the comparison asked. Quantitative accuracy is 10 by default due to absence of numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 452,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's Solar Roof product has seen a shift in strategic importance, with the company emphasizing its role in the broader energy ecosystem, as noted in the 2024 filing. However, production challenges persist, as the 2024 report highlights ongoing difficulties in ramping production for energy products like Solar Roof, alongside new vehicles and features. While Tesla continues to view Solar Roof as part of its mission to accelerate sustainable energy adoption, it remains a lower-priority segment compared to automotive and energy storage, with production delays and scalability issues still affecting its growth trajectory.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Tesla's Solar Roof strategy between 2022 and 2024. It accurately captures the shift from active deployment emphasis in 2022 to acknowledging production ramp challenges in 2024. The answer correctly identifies that Tesla continues to view Solar Roof as part of its sustainable energy mission but faces scalability issues. However, the LLM adds that Solar Roof is a 'lower-priority segment compared to automotive and energy storage,' which is not explicitly stated in the original answer and introduces an inference not directly supported by the ground truth. This slightly overreaches the provided information, though it is a reasonable interpretation. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Tesla, Solar Roof, 2022, 2024) are correct. The reasoning is sound and synthesizes the shift in tone and strategic framing across years. Contextual relevance is high as it directly addresses both strategic importance and production challenges as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 309,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's \"Net pending transactions and other investments\" increased from $14 million in 2022 to $54 million in 2023. This significant rise suggests a strategic shift or increased activity in pending investments or transactions within the company's retirement trust portfolio, indicating a potential focus on diversification or capital allocation opportunities in this category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, whereas the LLM claims it increased from $14 million to $54 million—reversing the years and misstating the amounts. This fundamental error undermines the entire response. (2) Quantitative accuracy is severely lacking: the correct values are $53M (2022) and $14M (2023); the LLM reports $14M (2022) and $54M (2023), which swaps the numbers and introduces a $1M discrepancy. No correct calculation or comparison can be derived from these values. (3) The reasoning is flawed due to incorrect data: the LLM infers a strategic increase in activity, while the ground truth indicates a reduction, suggesting de-risking or completion of initiatives. The multi-hop synthesis fails because the model used incorrect input data, leading to an opposite conclusion. (4) Despite the factual errors, the LLM attempts to address both parts of the question—change in investment and strategic implication—and uses appropriate financial terminology, which supports a moderate contextual relevance score. However, correctness, quantitative, and qualitative scores are very low due to the inversion of data and resulting invalid conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 371,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's liability-driven investment framework remained consistent in aligning plan assets with liabilities, with a 20%/80% equity/fixed income target allocation for pension plans and a 55%/45% allocation for postretirement plans. However, the actual composition of plan assets shifted slightly in 2024, with equity securities increasing to 21% for pensions (from 18% in 2023) and remaining at 57% for postretirement plans. Additionally, defined contribution plan expenses rose to $112 million in 2024 from $109 million in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces significant inaccuracies. It correctly states that defined contribution plan expenses increased from $109 million in 2023 to $112 million in 2024, aligning with the ground truth. It also correctly notes the 20%/80% equity/fixed income target allocation for pension assets was maintained. However, it incorrectly introduces a 55%/45% allocation for postretirement plans and claims actual asset compositions (e.g., equity rising to 21% from 18%) that are not present in the original answer. The ground truth does not mention postretirement plan allocations or actual asset shifts—instead, it highlights a new disclosure in 2024 about characterizing the actual composition of plan assets, indicating improved transparency, not actual changes in allocation. (2) Quantitatively, the $109M and $112M figures are accurate, and the 20%/80% target is correct. However, the 18% to 21% equity shift and 57% postretirement equity are fabricated and unsupported by the ground truth. (3) The multi-hop reasoning is flawed: the model conflates the introduction of a new disclosure about reporting composition with actual changes in asset allocation, which is a misinterpretation. The evolution lies in transparency (disclosure), not in reallocation. (4) The contextual relevance is high as the answer addresses both defined contribution expenses and investment framework evolution, but factual inaccuracies and hallucinated data severely undermine correctness, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 425,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and 2024, Qualcomm's strategic focus on On-Device AI evolved as the company emphasized its role in advancing foundational technologies, particularly high-performance, low-power computing and on-device artificial intelligence (AI). In fiscal 2024, Qualcomm highlighted its investments in expanding AI capabilities beyond mobile handsets into industries like automotive and IoT, positioning on-device AI as a key driver for broader technology adoption. The company also underscored the importance of integrating AI with 5G to enable next-generation applications, reflecting a shift toward leveraging AI as a core differentiator across its product portfolio and new markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Qualcomm's strategic focus on On-Device AI from fiscal 2023 to 2024. It accurately identifies the continuity of key themes—on-device AI, 5G, high-performance low-power computing—and the expansion into automotive and IoT beyond mobile. The answer correctly reflects the shift toward positioning AI as a core differentiator and growth driver across new markets. However, it omits a key element from the original answer: Qualcomm's explicit mention in fiscal 2024 of pursuing 'acquisitions or strategic transactions' as part of its investment-driven strategy. While the LLM notes 'investments in expanding AI capabilities,' it does not mention the specific strategic mechanism of acquisitions, which represents a meaningful detail in the evolution from vision to execution. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and all entities (Qualcomm, fiscal years 2023–2024, On-Device AI, 5G, automotive, IoT) are correctly identified. The reasoning is sound and synthesizes the multi-hop elements (change over time, strategic emphasis, industry expansion), though slightly less precise in conveying the operational shift toward M&A activity. Contextual relevance is excellent—the response directly addresses the question and remains focused on the strategic evolution and investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 387,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, with both years listing the \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004\" under Exhibit 9.1. This continuity indicates a stable governance structure, as the agreement's terms and its incorporation by reference have not changed, reflecting ongoing alignment in voting rights and control among the Simon family members.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the classification and presentation of the Voting Trust Agreement. According to the ground truth, there was a notable change in presentation between the 2022 and 2023 10-K filings: the 2022 filing explicitly referred to the agreement as 'Second Amended and Restated,' while the 2023 filing dropped that modifier, referring to it simply as the Voting Trust Agreement dated March 1, 2004. The LLM incorrectly states that the presentation 'remained consistent' and that both years list the 'Second Amended and Restated' version, which contradicts the ground truth. This misrepresents the factual evolution of the agreement's disclosure. While the date (March 1, 2004) is correctly cited, the key qualitative difference in terminology across years is missed entirely, undermining the reasoning about governance stability. The conclusion about stability is coincidentally aligned with the ground truth’s interpretation, but it is based on incorrect premises. The model fails the multi-hop requirement to compare changes in disclosure language across filings. As such, quantitative accuracy is low due to incorrect characterization of the document status, qualitative accuracy is poor due to flawed reasoning, and while the response is contextually relevant (it discusses governance stability), the factual foundation is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 382,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "Between 2023 and 2024, COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet (BCF) to 296 BCF. This slight decline indicates a marginal reduction in the region's contribution to COP's global reserves portfolio, suggesting a shift in strategic focus toward other regions with stronger reserve growth, such as the U.S. Lower 48. The region's role remains important, particularly due to equity affiliate reserves, but its relative significance appears to be diminishing compared to other high-growth areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that natural gas reserves 'increased' from 312 BCF to 296 BCF, when in fact this is a decrease. This fundamental error undermines the quantitative and qualitative accuracy. The correct evolution is a decline from 312 to 296 BCF, a reduction of 16 BCF or approximately 5.1%, which the LLM fails to compute correctly. (2) The numbers 312 BCF (2023) and 296 BCF (2024) are correctly cited in value but mischaracterized in direction (increase vs. decrease), which is a critical factual error. The calculation of the difference (-16 BCF) and percentage drop (~5.1%) is missing or incorrect in the LLM response. However, the mention of equity affiliates holding 5,870 BCF in 2024 is omitted in the LLM answer, reducing completeness. (3) The multi-hop reasoning is partially sound—linking reserve changes to strategic importance—but the flawed interpretation of a decrease as an increase leads to invalid conclusions about the region's trajectory. The mention of strategic shift toward U.S. Lower 48 is plausible context but not present in the original answer, introducing unsupported inference. (4) Despite the major quantitative error, the LLM addresses both parts of the question—reserve evolution and strategic implications—and retains relevant context about regional importance and equity affiliates, earning moderate scores for qualitative and contextual relevance. However, the reversal of a key trend severely limits factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 410,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of debt structure and equity method income. In 2024, AIG deconsolidated Corebridge, resulting in a pre-tax loss on disposal of $4,754 million. This loss was calculated based on the fair value of retained investments in Corebridge, including $8.5 billion in retained shares and $1.18 billion in other retained assets. In terms of equity method income, for the period from June 10, 2024, to December 31, 2024, AIG recognized $601 million in equity method income related to Corebridge, reflecting dividends received and changes in Corebridge's stock price. This marked a shift from the prior year, where Corebridge was still consolidated and contributed significantly higher pre-tax income of $1,574 million in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in AIG's financial relationship with Corebridge from 2023 to 2024, particularly the shift from consolidation to equity method accounting. However, there are minor discrepancies in quantitative accuracy. The original answer states that in 2023, AIG's balance sheet reflected $9,368 million in total Corebridge debt, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt—this specific debt structure is missing from the LLM answer. Instead, the LLM introduces a $4,754 million pre-tax loss on disposal and breaks down retained investments into $8.5 billion in shares and $1.18 billion in other assets, which are not mentioned in the ground truth and cannot be verified against it. While plausible in context, these figures are not part of the provided truth and may reflect hallucination or external data. On the equity method income, the LLM correctly states $601 million in income from June 10 to December 31, 2024, which aligns with the post-deconsolidation equity method reporting in the original answer. It also correctly contrasts this with $1,574 million in pre-tax income in 2023 under consolidation. The qualitative reasoning is sound: the model correctly identifies the shift from consolidated debt to equity method income and links it to discontinued operations. Contextual relevance is excellent—the response directly addresses the question’s focus on debt structure and equity method income changes. Overall, the core facts about the accounting shift and income recognition are accurate, but the absence of the 2023 debt details and introduction of unverified figures on the disposal loss and retained assets prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 473,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's investment strategy in Special Use Funds has shown a shift toward a higher allocation to equity securities and a reduced emphasis on fixed income securities. In 2022, NEE's Special Use Funds held $2,505 million in fixed income securities and $5,511 million in equity securities, while by 2024, fixed income holdings decreased to $2,224 million, and equity securities increased to $6,164 million. This suggests a modest increase in risk appetite, as equity investments typically carry higher volatility than fixed income. However, the continued significant allocation to fixed income securities indicates a balanced approach, emphasizing liquidity and stability for obligations such as nuclear decommissioning and storm-related costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 allocation. The ground truth states that in 2022, NextEra Energy's Special Use Funds were entirely composed of fixed income securities at $2,505 million, with no equity holdings. However, the LLM incorrectly claims that in 2022, NEE held $5,511 million in equity securities, which is false and fundamentally misrepresents the starting point of the investment strategy. This error invalidates the narrative of a shift toward equities. In 2024, the LLM correctly reports $6,164 million in equity securities, but incorrectly aggregates fixed income at $2,224 million. The ground truth breaks down 2024 fixed income into $722M (U.S. Gov/municipal), $685M (corporate debt), and $873M (asset-backed), totaling $2,280 million—close but still inaccurate. (2) Calculations: The LLM’s implied total Special Use Funds in 2022 is $8,016 million ($2,505M + $5,511M), which contradicts the ground truth that all $2,505M were fixed income. The 2024 total is understated at $8,388 million vs. actual $9,444 million. (3) Multi-hop reasoning: The model fails to correctly synthesize the transformation from 100% fixed income in 2022 to a diversified equity-heavy portfolio in 2024. Instead, it assumes a mixed portfolio from the start, undermining the core insight of a strategic shift. (4) Despite incorrect numbers, the LLM correctly interprets the implication of increasing equity allocation as signaling higher risk appetite, which is contextually relevant. However, due to major quantitative errors and flawed baseline data, the overall correctness is low. The answer suggests a 'modest' shift when in fact the shift is dramatic—from zero to over $6 billion in equities. Thus, correctness and quantitative accuracy are severely penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 494,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing increased between 2022 and 2024 due to the adoption of 5G technology. As noted in the 2024 filing, extensive sharing of site infrastructure through RAN sharing, roaming, or resale arrangements among wireless service providers—driven by 5G deployment—has led to slower new lease activity. Carriers are increasingly utilizing shared equipment rather than deploying new infrastructure, which reduces the demand for new leases on American Tower's sites. This trend is a heightened risk compared to 2022, when the primary concerns were around consolidation and churn, but the specific impact of 5G-driven infrastructure sharing was not as explicitly highlighted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the risk associated with site infrastructure sharing between 2022 and 2024, particularly in relation to 5G adoption and its impact on new lease activity. (1) All factual elements are correct: the 2022 risk centered on general concerns about consolidation and churn affecting lease activity, while the 2024 risk evolved to focus on specific mechanisms like RAN sharing, roaming, and resale arrangements driven by 5G deployment. The LLM correctly identifies that carriers are opting for shared infrastructure, reducing demand for new leases on American Tower's (AMT) sites. (2) There are no numeric values, percentages, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations—but the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024), identifies the technological driver (5G), links it to changes in carrier behavior (infrastructure sharing), and connects that to business impact (slower new lease activity). The only minor shortcoming is that the LLM does not explicitly mention the 'lack of compensation to AMT' as emphasized in the 2024 filing, which slightly weakens the qualitative accuracy. However, the implication of financial impact is present through reduced leasing activity. (4) The answer is fully contextually relevant, directly addressing the evolution in nature and magnitude of the risk, the role of 5G, and the effect on new lease activity. Overall, the LLM conveys semantically equivalent information with high fidelity, warranting a correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 463,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's investment in Angola LNG Limited decreased in value, as reflected in the equity method accounting. In 2022, Chevron reported equity in earnings of $336 million for Angola LNG Limited, while in 2023, this dropped to $513 million. Additionally, the carrying value of Chevron's investment in Angola LNG Limited decreased from $1,963 million in 2022 to $1,762 million in 2023, indicating a reduction in the investment's value over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the numbers provided are factually wrong: the original answer states nothing about equity earnings or carrying values for Angola LNG Limited in 2022 or 2023. The LLM claims Chevron reported $336M in equity earnings in 2022 and $513M in 2023, which is not only unsupported by the ground truth but also illogical (a drop from 336 to 513 is an increase, not a decrease). It also fabricates carrying values of $1,963M and $1,762M with no basis in the provided truth. (2) The question asks about the evolution of Chevron's financial relationship in terms of investment structure and equity method accounting, but the LLM completely misses the key structural shift from 'Depends_On' to 'Invests_In'—the central point of the original answer. (3) The multi-hop reasoning fails entirely: instead of analyzing changes in relationship classification and ownership structure, the model invents financial figures and focuses on non-existent performance metrics. (4) Contextually, the answer appears relevant (discussing investment value and equity accounting) but is based on hallucinated data, making it misleading. The only correct element is the mention of equity method accounting, but even that is applied incorrectly. The core evolution—reclassification of the investment type despite unchanged ownership percentage—is entirely omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 395,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft's role in Gulfstream's product lineup remained strong, with continued emphasis on its performance metrics and production status. The G600, along with the G500, is highlighted as a faster, more fuel-efficient aircraft with greater cabin volume and improved flight controls. By year-end 2023, cumulative deliveries of the G500 and G600 totaled over 250, indicating ongoing production and market acceptance. The G600 continues to compete effectively, holding city-pair speed records and maintaining customer interest as part of Gulfstream's broader lineup of technologically advanced business jets.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements but misses key aspects of the evolution in the G600's role from 2022 to 2023. While it correctly notes that cumulative deliveries of the G500 and G600 exceeded 250 by end-2023, the original answer specifies that this figure refers specifically to the G600 alone, not the combined total of both models. This is a significant factual inaccuracy affecting quantitative precision. (2) The date-related information is partially correct—the G600 entered service in 2019 (not mentioned in LLM answer), and by 2023 it was considered mature, but the LLM fails to note the shift in characterization from 'recent addition' in 2022 to 'mature product' in 2023, which is central to the question about evolution. (3) The multi-hop reasoning is weak: the original answer highlights that the G600’s technologies (e.g., Symmetry Flight Deck) became foundational for newer models like G700/G800/G400, indicating a platform-enabling role. The LLM answer omits this critical evolution in strategic role and technological influence. (4) The LLM incorrectly groups G500 and G600 delivery numbers, lacks mention of the G600 replacing the G550, and does not reflect the shift from novelty to maturity. However, it is contextually relevant, discussing performance metrics and production status as asked, and correctly notes ongoing production and market presence. Wording about speed records and fuel efficiency aligns with Gulfstream’s messaging but isn't directly supported in the ground truth. Thus, while the answer is plausible and relevant, it lacks key factual distinctions and synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 453,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees evolved through increased strategic collaboration and financial co-investment in initiatives to modernize and enhance restaurant performance. The Company has emphasized working closely with franchisees to implement consumer-focused improvements, such as modernizing restaurant designs and enhancing technology infrastructure, often through shared financial commitments. This shift reflects a more integrated partnership model aimed at driving growth and brand value, while maintaining the franchisees' operational independence. Additionally, McDonald's continued to prioritize franchisee alignment on capital-intensive reinvestment plans and operational standards to ensure consistency with the brand's global image and performance goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of McDonald's relationship with franchisees from 2022 to 2024 as a shift toward greater financial involvement and strategic collaboration. It accurately reflects the move from a traditional franchising model to one involving co-investment in modernization and operational improvements, aligning with the ground truth. There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored as 10. The qualitative accuracy is high: the LLM correctly identifies the shift in strategy, mentions shared financial commitments, modernization, and technology upgrades, and preserves the nuance of maintaining franchisee operational independence. The only minor omission is the specific mention of 'developmental licenses' and the explicit contrast in 2022 of McDonald's not investing in capital, which slightly weakens the multi-hop synthesis between the two time points. However, the core reasoning and timeline are sound. The answer is fully contextually relevant, directly addressing both financial involvement and strategic collaboration as asked. Semantic equivalence is strong—wording differs but meaning matches the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 350,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in net revenues, which decreased from $22,476 million to $21,756 million. However, operating income remained relatively stable, decreasing slightly from $10,688 million to $10,670 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023, and operating income declined from $10,688 million to $10,670 million. These numbers match the ground truth exactly, with acceptable formatting (e.g., 'million' used implicitly). (2) Quantitative accuracy is perfect—both revenue and income values are correct, and the description of a 'slight' or 'marginal' decrease aligns with the actual changes ($720M revenue drop, $18M income drop). (3) The reasoning is sound and synthesizes the correct data points across years for the smokeable products segment. The only minor shortcoming is that the LLM answer says operating income 'remained relatively stable' rather than explicitly noting it 'declined marginally,' which slightly understates the change but does not misrepresent it. (4) The answer is fully relevant, directly addressing the evolution of both net revenues and operating income for smokeable products from 2022 to 2023. Overall, the response is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for the softened characterization of the operating income change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 360,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's strategy has evolved through expanded therapeutic approvals and continued emphasis on combination therapies. In 2024, Opdivo received multiple approvals, including for urothelial carcinoma and in combination with Yervoy for colorectal cancer, reflecting its integration into broader treatment paradigms. Collaboratively, Opdivo remains central to BMY's immunotherapy (IO) leadership, with continued joint development and commercialization efforts in key markets through alliances like the one with Ono in Japan, South Korea, and Taiwan. These developments reinforce Opdivo's position as a cornerstone of BMY's oncology portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies and omits key details from the ground truth. It correctly notes Opdivo's evolving role and mentions the 2024 urothelial carcinoma approval, but incorrectly states that Opdivo received approval 'in combination with Yervoy for colorectal cancer'—this specific approval is not mentioned in the ground truth and lacks supporting evidence. The ground truth emphasizes a strategic shift toward independent commercialization, particularly highlighted by the March 2024 FDA approval, which the LLM answer does not clearly convey. Instead, it suggests continued joint development as a central theme, which downplays the evolution toward BMY-led expansion. (2) Quantitatively, the LLM answer lacks specific dates (e.g., March 2024) and misrepresents the nature of the approvals. While no explicit numbers (percentages, dollar amounts) are wrong, the absence of precise details like the exact indication (first-line treatment of unresectable or metastatic urothelial carcinoma with cisplatin and gemcitabine) reduces accuracy. The 80-20 cost-sharing split and equal sharing for combinations from the 2022 framework are entirely omitted. (3) The multi-hop reasoning is partially sound—linking Opdivo to collaboration with Ono and noting therapeutic expansion—but fails to synthesize the strategic shift from co-development to BMY-led commercialization, which is central to the ground truth. The continued emphasis on alliances without acknowledging the strategic evolution weakens the logical conclusion. (4) Despite these issues, the answer remains contextually relevant, addressing both collaboration and new approvals, and correctly identifying Opdivo as a cornerstone of BMY’s oncology strategy. However, the lack of precision on approvals and misrepresentation of the collaborative framework justify a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 518,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments between 2022 and 2024 shows a continued reliance on LIBOR and EURIBOR as referenced rates, with no transition to alternative benchmarks like SOFR or ESTR indicated. In 2022, the referenced rates for bank facilities included LIBOR and EURIBOR, with spreads ranging from 0.875% to 1.750% for LIBOR-based borrowings and 0.000% to 0.750% for base rate borrowings. By 2024, similar rates were disclosed, with the 2024 Notes referencing fixed contractual interest rates (e.g., 5.200%, 5.450%, 3.900%, etc.) for senior unsecured debt. Covenants remained focused on maintaining debt service coverage ratios and limiting secured indebtedness, with no significant changes in the nature of covenants tied to interest rate benchmarks. The referenced rates for India indebtedness in 2022 included the Marginal Cost of Funds based Lending Rate and the Overnight Mumbai Inter-Bank Offer Rate, but no 2024 disclosure on this specific benchmark was provided.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims AMT continued to rely on LIBOR and EURIBOR through 2024 with no transition to SOFR, but the original answer confirms a shift to SOFR for new drawings under letters of credit in Nigeria by 2024, indicating post-LIBOR transition. This is a major factual error. (2) The LLM cites spreads of 0.875% to 1.750% for LIBOR-based borrowings and 0.000% to 0.750% for base rate borrowings in 2022, but these specific numbers are not present in the ground truth; the original answer mentions commitment fees (0.080% to 0.300%) tied to debt ratings, not the spreads cited by the LLM. The 2024 fixed interest rates (e.g., 5.200%, 5.450%) are plausible but irrelevant to the question about benchmark rate evolution and covenants. (3) The multi-hop reasoning fails: the question asks for evolution in disclosures regarding benchmarks and covenants, but the LLM does not acknowledge the key shift from LIBOR to SOFR, misrepresents the 2024 benchmark landscape, and incorrectly states no significant changes in covenants—while the ground truth notes a shift in disclosure focus from detailed covenants and renewals in 2022 to consequences of non-compliance in 2024. (4) The mention of Indian benchmarks (MCLR, Overnight MIBOR) adds detail not in the ground truth and is not carried into 2024, further indicating fabrication or misattribution. Overall, the answer misses the core evolution—transition from LIBOR to SOFR and changing covenant disclosure—and thus scores very low on correctness and qualitative accuracy despite being contextually relevant to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 444,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved by maintaining a focus on real estate ownership and co-investment strategies to enhance restaurant performance. The Company generally owns or secures long-term leases for land and buildings in conventional franchise arrangements, while franchisees invest in equipment and other site-specific elements. McDonald's continues to collaborate with franchisees through co-investment initiatives to modernize restaurants and improve local business performance, aligning with consumer preferences and brand value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing McDonald's real estate and co-investment model, correctly stating that the company typically owns or secures long-term leases on land and buildings while franchisees invest in equipment and site-specific elements. It also accurately notes ongoing collaboration through co-investment to modernize restaurants. However, it fails to fully capture the evolution between 2022 and 2024 as required by the question. The original answer highlights a key shift: in 2022, the focus was on general systemwide coordination for ESG initiatives without specific details on real estate, whereas by 2024, McDonald's had articulated a clearly defined real estate and co-investment strategy. This evolution from a broad collaborative emphasis to a structured, strategic model is missing in the LLM response, which instead presents a static view of the relationship. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the entities (McDonald's, franchisees, real estate ownership, co-investment) are correct. The reasoning is sound but incomplete—it captures the 'what' of the strategy but not the 'how it changed' over time, which is central to the multi-hop aspect of the question. Contextual relevance is high as the answer addresses franchisee relationships, real estate, and investment roles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 383,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2023 filing. This change indicates that Altria updated the plan's terms, potentially to align with evolving governance practices or regulatory requirements. The amendment suggests a deliberate effort to refine director compensation structures, reflecting a governance approach focused on transparency, compliance, and alignment with shareholder interests.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors effective October 26, 2022, as reflected in the 2023 filing. This aligns with the ground truth. However, the LLM omits the specific quantitative detail from 2022 that 703,256 shares were available for issuance under the plan, which was part of the original answer and directly responsive to the 'status and documentation' aspect of the question. This omission reduces completeness. (2) The date 'October 26, 2022' is accurate and correctly cited. No calculations are required, but the absence of the share number (703,256) is a measurable gap in quantitative reporting. All other non-numeric entities—Altria, the plan name, the 2022–2023 timeframe—are correct. (3) The reasoning is sound: the LLM correctly infers that the amendment reflects a refinement in governance, possibly to align with evolving standards, compliance, or shareholder interests. This is a reasonable interpretation consistent with the ground truth’s implication of mid-cycle governance updates. The multi-hop synthesis is partially achieved—linking the 2022 amendment to 2023 disclosure—but misses the opportunity to contrast the pre- and post-amendment status using the available share data. (4) The answer is contextually excellent, directly addressing both the change in plan status and its governance implications. The qualitative analysis is strong, though slightly less precise than the original due to missing the share availability metric. The score reflects high accuracy with a moderate deduction for incompleteness on a factual detail central to the plan’s status evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 467,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, roaming and resale arrangements among wireless service providers increasingly impacted American Tower's (AMT) leasing activity, as these arrangements allowed carriers to share infrastructure rather than lease new sites, slowing new lease growth. This trend is highlighted in 2022 as a potential risk, and by 2024, the impact is evident in reduced demand for new leases and increased churn due to network rationalization and consolidation. This evolution indicates heightened competitive pressures, as carriers prioritize cost efficiency and network optimization over expanding infrastructure, challenging AMT's growth in new lease activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the impact of roaming and resale arrangements on AMT's leasing activity is correctly described for both 2022 and 2024. In 2022, it was a potential risk due to infrastructure sharing, particularly with 5G; by 2024, this evolved into reduced demand and increased churn from network rationalization—consistent with the ground truth's mention of decommissioning due to redundancy. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers are misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the nature of competitive pressures evolved over time, connecting infrastructure sharing trends to impacts on new leases and existing equipment. The mention of 'network rationalization and consolidation' effectively captures the broader risk of RAN sharing and resale arrangements leading to decommissioning, even if the term 'RAN sharing' is not explicitly used. (4) The answer is contextually fully relevant, addressing both the evolution from 2022 to 2024 and the implication for competitive pressures on lease growth. The only minor shortcoming is that the LLM does not explicitly name 'RAN sharing' as part of the 2024 risk, which slightly reduces qualitative accuracy, but the concept is implied through 'network rationalization.' Overall, the semantic meaning matches the original answer closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 415,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic collaboration and co-investment in initiatives aimed at modernizing restaurants and enhancing the customer experience. The Company has increasingly partnered with franchisees to fund improvements, reflecting a shared commitment to innovation and operational excellence. Additionally, McDonald's continues to uphold rigorous standards for franchisees, ensuring alignment with brand values and operational expectations to maintain consistency and quality across the system.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall evolution of McDonald's relationship with franchisees from 2022 to 2024, particularly regarding increased co-investment and modernization efforts. It correctly identifies the shift toward strategic collaboration and operational expectations. However, it omits key contextual details present in the original answer: (1) the specific impact of the COVID-19 pandemic in 2022, including labor and supply chain challenges, (2) the mention of the 'Accelerating the Arches' strategy, and (3) the transition from pandemic recovery to proactive investment. While no numbers, dates, or calculations are incorrect (and none are misstated), the answer lacks the multi-hop synthesis of how external pressures in 2022 shaped the strategic shift by 2024. The qualitative reasoning is sound but incomplete, missing the cause-and-effect narrative that defines the evolution. The response remains contextually relevant and accurately captures the direction of change, but without the full depth of the original analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 308,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by increasing the total value of equity securities held. In 2022, the total equity securities in Special Use Funds were $5,511 million, while by 2024, this amount had grown to $6,164 million. Additionally, the allocation across Level 1, Level 2, and Level 3 investments shifted, with a notable increase in Level 2 investments, indicating a broader diversification into commingled funds and other market-based instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy held $8,922 million in Special Use Funds, but no breakdown of equity securities was provided—meaning the LLM's claim that equity securities were $5,511 million in 2022 is incorrect and unsupported by the source. The only accurate number is the 2024 equity securities value of $6,164 million. (2) The quantitative accuracy is low because the key 2022 figure is fabricated or misattributed; there is no evidence in the ground truth for a $5,511 million equity allocation in 2022. The comparison of growth from $5,511M to $6,164M is therefore invalid. Additionally, the mention of Level 1/2/3 investments and shifts in allocation is not present in the original answer and cannot be verified, suggesting hallucination. (3) The reasoning is flawed: the original answer infers a shift toward transparency and possibly greater emphasis on equities due to the emergence of a disclosed equity amount in 2024, despite a decline in total Special Use Funds. The LLM instead assumes an increase in equity holdings and attributes strategic diversification without evidence. It fails to recognize that the 2022 data lacked granularity, making direct quantitative comparisons invalid. (4) Contextual relevance is moderate because the answer addresses the general topic—evolution of equity investment strategy—and correctly references 2022–2024 and Special Use Funds. However, due to major factual and reasoning errors, the conclusion is misleading. Correctness score is low due to core factual inaccuracy in financial figures and unsupported multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 457,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, decreasing from $22,476 million to $21,756 million. Operating income remained relatively stable, decreasing marginally from $10,688 million to $10,670 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023, and operating income declined from $10,688 million to $10,670 million. These values match exactly with the original answer, allowing for format variation (e.g., $22,476 million = $22.476B). (2) All numbers are quantitatively accurate, and the implied year-over-year changes (a decrease of $720 million in revenue and $18 million in operating income) are consistent with the data. (3) The reasoning is sound and synthesizes performance across two years for two key financial metrics—net revenues and operating income—correctly characterizing the trend as a 'slight decline' or 'marginal' change, which aligns with the ground truth's 'marginal decrease.' (4) The only minor shortcoming is that the LLM answer describes operating income as 'relatively stable' rather than explicitly noting the decline, which slightly downplays the change, though it still acknowledges the $18 million drop. This is a nuance in interpretation, not a factual error. Overall, the answer is factually complete, contextually relevant, and accurately conveys the financial evolution of smokeable products from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 357,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, Accenture plc increased its share purchase activity, particularly through its open-market share purchase program. In fiscal 2022, Accenture repurchased 9,635,751 Class A Ordinary Shares for $3.15 billion, while in fiscal 2023, the company repurchased 11,753,807 shares for $3.78 billion. These shares are primarily held as treasury shares and are intended for utilization in employee benefit programs, such as equity awards. Additionally, the company expanded its share repurchase authorization, increasing it from $6,129,296 as of August 31, 2022, to $6,694,281 by August 31, 2024, reflecting a strategic focus on returning value to shareholders and supporting its equity compensation programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 for share purchase programs, not $6,129,296 as claimed by the LLM. The LLM incorrectly reports actual repurchase amounts—$3.15 billion in 2022 and $3.78 billion in 2023—which are not present in the original answer and contradict the disclosed authorization amount of only ~$3.13 million. The numbers are off by a factor of nearly 1,000 (mixing up thousands with billions), indicating severe quantitative errors. Additionally, the claim of increasing authorization to $6.69 billion by 2024 is unsupported by the original answer, which does not mention such figures. (2) The original answer does not provide specific repurchase volumes (e.g., 9.6M or 11.7M shares) or dollar amounts spent, so the LLM fabricated these details. The only correct number loosely aligned is the 2022 authorization, but even that is misrepresented as $6.13 million instead of $3.13 million. (3) The qualitative reasoning partially captures the intended usage shift—treasury shares for employee benefits—which matches the original answer. It also correctly identifies the use of shares for employee equity awards, aligning with the ground truth. However, it fails to mention the key 2024 detail about share withholding for payroll tax obligations, which is a distinct mechanism from the public buyback program. The synthesis is flawed because it invents a narrative around increasing buybacks and expanded authorizations not supported by the source. (4) The contextual relevance is moderate because the answer addresses share purchase programs and intended usage, which are central to the question. However, due to gross numerical inaccuracies and invented data, the correctness score is low. The model appears to hallucinate precise figures and trends not present in the ground truth, undermining trust in its response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 531,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants have evolved with a focus on extending maturity dates for credit facilities and adjusting interest rate benchmarks. For example, in 2024, AMT amended its 2021 Multicurrency Credit Facility and 2021 Credit Facility, extending their maturity dates to January 28, 2028 and January 28, 2030, respectively. Additionally, the interest rate benchmarks for USD-denominated borrowings remained tied to LIBOR with a margin of 1.125%, while EUR-denominated borrowings continued to use EURIBOR with the same margin. These amendments reflect a strategic shift to longer-term financing and continued reliance on traditional interest rate benchmarks, despite the broader industry transition away from LIBOR.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2024, AMT continued to use LIBOR for USD-denominated borrowings with a 1.125% margin, while the ground truth indicates a shift to SOFR, particularly for letters of credit in Nigeria. This misrepresents the core evolution in interest rate benchmarks. (2) The claim about extending the 2021 Multicurrency Credit Facility and 2021 Credit Facility to 2028 and 2030 is not supported by the ground truth and introduces details (specific maturity dates, margins) absent from the original answer, suggesting fabrication or misattribution. (3) The LLM asserts 'continued reliance on traditional benchmarks despite industry transition,' which directly contradicts the ground truth's emphasis on a strategic shift away from LIBOR toward SOFR. (4) While the mention of EURIBOR in 2022 is consistent, the failure to report the SOFR transition in 2024 — the key qualitative shift — represents a major omission in both entity accuracy and reasoning. (5) The answer is contextually relevant in discussing covenants, debt instruments, and benchmarks, but the incorrect synthesis of multi-hop information (evolution over time, benchmark transition) results in a misleading narrative. Quantitative accuracy is partially preserved in referencing facilities and dates plausibly, but unsupported specifics reduce confidence. Overall, the answer fails to capture the essential direction of change — from LIBOR/EURIBOR to SOFR — and thus earns a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 427,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's subscriber base saw a significant increase, with paid subscribers rising from approximately 29 million in 2023 to 36 million in 2024. The consolidation of Star+ into Disney+ in Latin America at the end of June 2024 streamlined Disney's international streaming strategy by eliminating redundant services and enhancing the platform's content offerings. This move allowed Disney to better compete in the region by offering a unified service with broader appeal and improved user experience, aligning with its global strategy to consolidate and optimize its streaming portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the subscriber count for 2023. The original answer states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024 (in the 2024 filing), but does not provide a 2023 subscriber number. The LLM incorrectly claims 29 million in 2023, which is not supported by the ground truth. This undermines the quantitative accuracy. (2) The date of the consolidation is partially correct — the LLM correctly notes the merger occurred by end of June 2024, aligning with the 'prior to July 2024' and 'by end of June 2024' timeline in the original. However, the subscriber evolution is misrepresented due to the fabricated 2023 number. (3) The reasoning about the strategic impact of consolidating Star+ into Disney+ in Latin America is sound and aligns with the original: streamlining services, improving user experience, and operational efficiency. This reflects correct multi-hop synthesis between the operational change and strategic intent. (4) While the qualitative reasoning and contextual relevance are strong — correctly identifying the strategic implications and the nature of the consolidation — the correctness score is limited by the unsupported numerical claim. The answer fabricates a data point (29M in 2023) not present in the original, which is a critical flaw in financial/factual reporting. Thus, despite good structure and plausible interpretation, the answer is only partially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 412,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 to around 2,100 in 2023. This indicates a strategic shift by the company to renegotiate fewer labor agreements, potentially aiming to streamline operations or reduce labor-related disruptions and costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the decrease in the number of employees covered under collective labor agreements from approximately 3,000 in 2022 to 2,100 in 2023, matching the ground truth. The quantitative values are accurate and properly contextualized. (2) There are no calculations required beyond the comparison of the two figures, and the LLM accurately reflects the reduction of 900 employees. The numbers are presented with appropriate approximations ('approximately 3,000' and 'around 2,100'), which align with the original answer's wording. (3) The reasoning is sound and captures the core implication—a strategic shift in labor agreement negotiations. While the original answer suggests the reduction may be due to fewer expiring agreements or proactive resolution, the LLM offers a plausible interpretation (streamlining operations, reducing disruptions and costs), which is semantically consistent and logically valid. It does not contradict the ground truth but slightly reframes the rationale without introducing error. (4) All entities (years, employee counts, concept of collective labor agreements) are correct. The answer fully addresses both parts of the question: the change in employee numbers and the strategic implication. The slight difference in explanatory emphasis does not detract from factual correctness, hence a 9/10 for qualitative accuracy and 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 390,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "Based on the provided document pages, NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value of these investments was $137 million, while in 2024, the total value rose to $722 million for NextEra Energy (NEE) and $561 million for Florida Power & Light Company (FPL), totaling $1,283 million. This represents a significant increase in the total value of these investments over the two-year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in quantitative values. While it correctly states the 2022 investment value of $137 million for NextEra Energy (NEE), it incorrectly reports the 2024 value as $722 million for NEE and includes $561 million for Florida Power & Light Company (FPL), which is not mentioned in the ground truth. The correct 2024 value for NEE is $161 million, not $722 million or $1,283 million total. The LLM appears to have conflated data from different entities or misread the source, leading to a gross overstatement of investment growth. (2) Calculations are therefore completely inaccurate: the claimed increase to $1.283 billion is over 7x higher than the correct $161 million figure. The actual increase is $24 million (17.5%), but the LLM implies a nearly tenfold growth, which is factually wrong. (3) The multi-hop reasoning fails because the model incorrectly synthesizes data across entities—FPL is a subsidiary, but the ground truth does not support reporting its bond investments separately or combining them in this context. The focus should have remained solely on NEE’s 'Other investments' as reported. (4) Despite the severe quantitative and qualitative inaccuracies, the answer is contextually relevant in that it addresses the evolution of bond investments over time and attempts to calculate a change, hence a moderate relevance score. However, the correctness score is low due to fundamental errors in core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 407,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's product portfolio has expanded significantly in terms of therapeutic approvals and manufacturing strategy. In 2024, Opdivo received multiple new approvals, including FDA approval for resectable NSCLC as a neoadjuvant and adjuvant treatment, EC approval for urothelial carcinoma in combination with chemotherapy, and approvals in Japan and the EU for additional indications. Additionally, Opdivo Qvantig, a subcutaneous formulation, was approved in December 2024, expanding its delivery options. In terms of manufacturing, BMS continues to utilize both internal and third-party manufacturers for Opdivo, ensuring flexibility and capacity to meet demand, while also investing in advanced biologics manufacturing capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements about Opdivo's evolving role in BMS's portfolio, particularly around continued use of internal and third-party manufacturing, which aligns with the 2022 ground truth. However, it introduces inaccuracies regarding approvals. The ground truth specifies a March 2024 FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine. The LLM answer incorrectly states multiple approvals in 2024, including for resectable NSCLC (which was approved earlier, not in 2024), EC approval for urothelial carcinoma (the ground truth mentions FDA, not EC), and approvals in Japan and EU without specifics. Additionally, it claims Opdivo Qvantig was approved in December 2024, which is not supported by the ground truth and is factually incorrect as of the knowledge cutoff. (2) Quantitative accuracy is compromised: the dates and regulatory bodies for approvals are incorrect or unverified. The December 2024 approval is particularly problematic as it is future-dated relative to the knowledge base. (3) The multi-hop reasoning is partially sound—linking manufacturing strategy and therapeutic expansion is appropriate—but the synthesis relies on hallucinated or inaccurate data points rather than verified cross-document facts. (4) Despite the factual errors, the answer remains contextually relevant, addressing both manufacturing and therapeutic evolution as asked. The core idea of expanded clinical use and ongoing manufacturing strategy is directionally correct, but the lack of precision on key facts reduces correctness. Hence, a score of 6 reflects partial accuracy with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 457,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine remained part of Disney's Entertainment segment, specifically under Content Sales/Licensing, with Disney owning 73% of the business. There is no indication of structural changes to Disney's ownership or strategic positioning of National Geographic during this period. The business continued to contribute to Disney's broader content portfolio, which includes publishing, film, television, and streaming services.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that National Geographic magazine was part of Disney's Entertainment segment under Content Sales/Licensing and that Disney owned 73% in 2023, which aligns with the ground truth. However, it fails to capture the key evolution in 2024: the removal of the 73% ownership emphasis and the shift in language from an equity stake to a more operational 'published by' relationship. This omission misrepresents the strategic and structural shift in Disney's positioning of National Geographic. (2) Quantitatively, the 73% ownership figure is accurate for 2023, and no incorrect numbers are presented, hence a high score on quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for an analysis of evolution between 2023 and 2024, requiring comparison across two time points. The LLM asserts 'no indication of structural changes' when the ground truth explicitly notes a shift in reporting language and emphasis, indicating a qualitative change in how Disney frames its relationship. This reflects a failure in synthesizing the nuanced change in strategic positioning. (4) Contextually, the answer is relevant and addresses the right entities and segment, but misses the core insight about the shift from ownership-focused to operationally-focused description, which is central to the question. Thus, while factually partially correct, it lacks the critical comparative analysis needed for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 403,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's description of its transaction management databases' capabilities in 2023 highlighted their role in enabling customers to send payments in approximately 200 markets and 150 currencies, withdraw funds in 56 currencies, and hold balances in 24 currencies. By 2024, the description remained largely consistent, but the number of currencies for sending payments was reduced to 140. This suggests a slight contraction in the number of currencies supported for sending payments, though PayPal continued to emphasize its robust global payment processing infrastructure and multi-currency capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies. According to the ground truth, PayPal's 2023 description mentioned withdrawal in 56 currencies, updated to 57 in 2024—this incremental expansion is the key quantitative change. However, the LLM incorrectly introduces figures not present in the original answer, such as 'sending payments in approximately 200 markets and 150 currencies' in 2023 and a reduction to 140 currencies in 2024. These numbers are unsupported by the ground truth and contradict it. The original answer does not mention sending payments in 150 or 140 currencies, nor holding balances in 24 currencies, making these hallucinations. While the LLM correctly identifies that PayPal emphasizes multi-currency support and global infrastructure, it misrepresents the nature of the evolution. The actual qualitative shift noted in the ground truth—a more consumer-centric framing in 2024 with 'consumers' mentioned before 'merchants'—is entirely missed by the LLM. Instead, it fabricates a narrative of contraction in sending-payment currencies, which is not supported. The contextual relevance is moderate because the answer addresses PayPal’s transaction management databases and global payment processing, but the incorrect data and reasoning undermine correctness. Multi-hop synthesis fails: the LLM does not accurately compare the two years based on verified disclosures. Thus, while the general topic is addressed, the specific evolution described is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 410,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate on the Series K Debentures increased from the original issuance in February 2020 to 6.051% per year in March 2023, as part of a remarketing process. This indicates that NEE's financing strategy involves leveraging remarketing opportunities to adjust interest rates in response to market conditions, potentially securing more favorable terms or aligning with current financial objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative fact that the Series K Debentures' interest rate was reset to 6.051% per year in March 2023, which matches the ground truth. However, it omits the 2024 update mentioned in the original answer — specifically, the March 1, 2023 letter that set terms effective on that date and was referenced in 2024 filings, indicating continuity of the updated terms. This omission affects completeness and multi-hop synthesis. (2) All numbers and dates provided (6.051%, March 2023) are accurate and correctly formatted; no calculation errors. The original issuance date (February 2020) is factually correct but not directly relevant to the 2023–2024 evolution, so its inclusion is contextually acceptable but slightly distracts from the core timeframe. (3) The reasoning correctly infers that NEE uses remarketing to adjust financing terms in response to market conditions, aligning with the ground truth's interpretation. However, the LLM misses the strategic implication of 'locking in a higher rate' — suggesting not necessarily more 'favorable' but more stable or secured funding — which slightly weakens the qualitative analysis. (4) The answer is contextually relevant and well-structured, but the failure to incorporate the 2024 reference to the continued terms from the 2023 remarketing means it does not fully address the evolution 'between 2023 and 2024' as required. Thus, while mostly correct, it lacks full multi-hop synthesis across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 415,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method between 2022 and 2023 remained consistent in its core approach, with depreciation rates calculated based on proved reserves for upstream assets. However, in response to changes in proved reserves and asset life assumptions, the Corporation continued to refine its estimates of proved reserves through rigorous technical and commercial evaluations, as outlined in both years' disclosures. Notably, if unit-of-production depreciation no longer equitably allocates costs over an asset's economic life—due to substantial de-bookings of proved reserves or changes in asset life assumptions—ExxonMobil adjusts its method, using reserves based on the most recent SEC pricing to ensure meaningful reserve quantities and appropriate adjustments for production and technical changes. This flexibility ensures alignment with evolving reserve estimates and asset performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: ExxonMobil maintained the Unit-of-Production (UOP) method in both 2022 and 2023, uses proved reserves as the basis, and switches to alternative methods (implied straight-line or SEC price-based reserves) when asset life no longer correlates with reserves—particularly after substantial de-bookings. The emphasis on using the most recent SEC pricing in response to significant reserve reductions is correctly highlighted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in methodology over time, links reserve changes and asset life assumptions to depreciation method adjustments, and correctly identifies the trigger (substantial de-bookings) for using SEC pricing. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'greater emphasis' in 2023 on SEC pricing as a refinement, nor does it name the straight-line alternative outright—though the concept is implied through 'adjusts its method' and 'no longer equitably allocates costs.' Despite this slight omission, the semantic meaning and intent align closely with the original answer. Hence, the correctness score is 9 rather than 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 396,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly scaled its internal studio operations to produce original programming, as highlighted in the 2024 10-K. The company emphasizes its own studio capabilities, including acquisitions such as Scanline and Animal Logic, to enhance its original content production. While Netflix still contracts with third-party partners for development, production, marketing, and distribution of some original programming, the strategic emphasis has shifted toward building internal expertise and scaling its own production infrastructure. This shift reflects a broader effort to maintain control over content creation and differentiation in a competitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Netflix's strategic shift toward internal studio scaling via acquisitions like Scanline and Animal Logic is accurately noted, and the continued but reduced use of third-party partners is correctly acknowledged. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Netflix’s evolving strategy across 2023 and 2024, capturing the shift from highlighting third-party risks in 2023 to emphasizing internal systems and control in 2024, even though the 2024 omission of third-party risk language is implied rather than explicitly stated. (4) The only minor shortcoming is that the LLM does not explicitly mention the removal of third-party risk disclosures in 2024, which is a key indicator of reduced reliance per the original answer. However, the overall strategic direction toward internal control is correctly inferred. The answer is contextually excellent, directly addressing the evolution in strategy and the balance between internal scaling and third-party use.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 353,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved from being a component of \"Other revenues\" to being explicitly highlighted as a key value-added service. In 2022, it was listed as part of \"Other revenues\" under products and services aimed at fraud prevention and transaction safety. By 2023, it was specifically emphasized in the business overview as part of Mastercard's broader strategy to provide secure, smart, and accessible payment solutions, reflecting its growing strategic importance in the company's portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Cyber and Intelligence Solutions were part of 'Other revenues' and focused on fraud prevention and transaction safety. In 2023, it accurately reflects the strategic elevation of the service as a value-added offering emphasized in the broader business strategy. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022 and 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers the evolution in strategic positioning. The only minor gap is that the LLM answer mentions 'secure, smart, and accessible payment solutions,' while the original answer specifies 'secure, easy, and confident transactions across the entire payments ecosystem' and links it to new network investments. This is a slight rewording but preserves the core meaning. (4) The answer is fully relevant to the question about strategic positioning evolution. Thus, the correctness and qualitative accuracy are high but not perfect due to minor imprecision in reflecting the exact strategic language and ecosystem scope from the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 358,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "Tesla's approach to energy storage products from 2023 to 2024 has evolved with a focus on scaling production and addressing supply chain dependencies. In 2023, Tesla emphasized leveraging modular battery system designs and in-house engineering expertise to optimize manufacturing capacity and efficiency. By 2024, the company faced production challenges related to scaling new factories and ensuring localized procurement, while also managing strategic dependencies on suppliers for battery cells and components. Tesla continues to invest in proprietary battery cell development to reduce reliance on external suppliers and improve cost-efficiency, though this requires significant capital and carries risks related to timely execution.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of evolution from 2023 to 2024. In 2023, both the original and LLM answers correctly identify Tesla's focus on modular design and in-house expertise (power electronics/software in original, generalized as engineering expertise in LLM) to optimize manufacturing. By 2024, the shift toward production scaling challenges and supply chain dependencies is accurately reflected. The LLM correctly notes supplier dependencies for battery cells and components, which maps to the original's mention of supplier reliability risks. It also appropriately highlights Tesla's investment in proprietary cell development to reduce external reliance—a strategic nuance not explicitly in the original but contextually valid and consistent with Tesla's known strategy. However, the LLM adds specific details not present in the ground truth, such as 'localized procurement' and 'investing in proprietary battery cell development,' which, while plausible, are not mentioned in the original answer derived from the knowledge graph. These additions slightly extend beyond the documented evolution and introduce strategic elements not confirmed in the source. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and multi-hop synthesis across years and strategic focus areas is handled well. The answer is fully contextually relevant, directly addressing production challenges and strategic dependencies as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 424,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "NextEra Energy Capital Holdings (NEECH) significantly expanded its issuance strategy for floating rate debentures in 2024 compared to 2023. In 2023, NEECH issued $600 million of floating rate debentures due in 2026. In 2024, the principal amount of floating rate debentures increased substantially, with NEECH issuing $1.0 billion of floating rate debentures due January 29, 2026, as detailed in the 2024 filing. Additionally, the maturity structure in 2024 became more diverse, with debentures spanning multiple maturity dates, including 2026, 2029, 2034, and 2054, compared to the more limited maturity structure in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, there was no explicit update to the principal amount of floating rate debentures, and the $600 million issuance from 2023 remained the key figure, with only formalization via an Officer's Certificate on January 31, 2024. However, the LLM incorrectly claims a $1.0 billion issuance in 2024, which is not supported by the original answer. Additionally, the LLM falsely asserts that the 2024 maturity structure became more diverse with maturities in 2029, 2034, and 2054—this is entirely incorrect; the original answer confirms the maturity structure remained focused on the 2026 horizon. (2) Quantitative accuracy is severely compromised: the $1.0 billion figure is wrong, and the additional maturity dates are fabricated. Only the 2026 maturity and the $600 million 2023 issuance are correct. (3) The multi-hop reasoning is flawed—the LLM fails to recognize that the 2024 filing formalized the existing structure rather than expanding it. It incorrectly infers growth and diversification where the ground truth indicates continuity. (4) Contextual relevance is moderate because the answer addresses the right topic (issuance strategy, principal, maturity) and references correct entities and timeframes, but the core factual claims about expansion and maturity diversification make the response misleading and largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 398,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "Intel's approach to industry initiatives related to supply chain responsibility from 2023 to 2024 has evolved by significantly expanding supplier engagement scope and deepening collaboration focus. In 2023, the company emphasized expanding the number of suppliers covered by engagement activities and advancing responsible minerals sourcing as part of its RISE strategy. By 2024, Intel further broadened its efforts by increasing collaboration across the industry on sustainability standards, audit processes, and training, while also intensifying engagement with both direct and indirect suppliers to address climate impacts, forced labor risks, and supplier diversity goals. Additionally, the company has set more ambitious targets, such as achieving net-zero upstream Scope 3 greenhouse gas emissions by 2050, and is actively working with stakeholders to drive systemic change in the electronics supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the mention of Intel's RISE strategy, the net-zero upstream Scope 3 greenhouse gas emissions target by 2050, and focus areas like responsible minerals sourcing, climate impacts, and supplier engagement. However, it misrepresents the evolution from 2023 to 2024. The original answer states that in 2024, Intel did *not* explicitly mention expanding the number of suppliers engaged, signaling a shift from expansion to deepening existing partnerships. In contrast, the LLM claims Intel 'further broadened its efforts' and 'intensifying engagement with both direct and indirect suppliers,' which contradicts the ground truth. This mischaracterization of the strategic shift undermines the qualitative accuracy. (2) Quantitatively, the answer is mostly accurate: the 2050 net-zero target is correctly cited, and no incorrect numbers or dates are introduced. There are no calculations, so numerical precision is not an issue. Format variations are not relevant here. (3) The multi-hop reasoning is partially sound—Intel’s RISE strategy, supplier engagement, and sustainability goals are correctly identified—but the synthesis across years is flawed. The model fails to capture the nuanced shift from announcing expansions (2023) to reinforcing collaborations (2024), instead portraying a continuous expansion that isn't supported by the ground truth. (4) Correctness is scored at 5 due to significant factual inaccuracy in the characterization of 2024 strategy despite correct mention of key initiatives. Quantitative accuracy is high (8) because no numbers are wrong. Qualitative accuracy is moderate (5) due to flawed reasoning about strategic evolution. Contextual relevance is strong (8) as the answer addresses the right themes and scope of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 496,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's (XOM) characterization of the assumptions underlying the standardized measure of discounted future cash flows remained consistent in acknowledging the limitations of using first-day-of-the-month average prices. In both years, the company emphasized that these prices represent discrete points in time and can cause significant variability in cash flows as prices fluctuate. However, in the 2023 disclosure, there is a more explicit framing of the standardized measure as not providing a reliable estimate of the company's expected future cash flows or reserve values, reinforcing the dependency on the prescribed methodology and its potential misalignment with actual market conditions. This reflects a slight evolution in the company's cautionary tone regarding the reliability of the standardized measure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misrepresentation of the evolution in XOM's disclosure between 2022 and 2023. (1) Correct elements: The LLM correctly identifies that both years reference first-day-of-the-month average prices as discrete points in time that may cause variability in cash flows, and it acknowledges the continued use of prescribed assumptions. The contextual framing around caution and reliability is relevant. (2) Quantitative accuracy is perfect: no numerical or date inaccuracies, and no incorrect financial metrics are introduced. (3) However, the qualitative reasoning is flawed in a key aspect: the ground truth states that in 2022, XOM described the measure as 'prepared on the basis of certain prescribed assumptions'—a neutral, procedural framing—while in 2023, it shifted to stating the measure 'depends on' those assumptions, signaling a stronger acknowledgment of sensitivity. The LLM incorrectly claims that both years 'emphasized' the discrete nature and variability impact, implying consistency, when in fact the 2022 filing did not highlight this variability point. The more explicit critique of reliability in 2023 is noted by the LLM, but it misattributes continuity where there is actually a notable shift in emphasis. (4) This leads to a correctness score of 6: the answer captures the general cautionary tone and correct methodology, but fails to accurately represent the evolution in framing—specifically, the increased emphasis on dependency and variability in 2023 versus the more neutral 2022 language. The answer thus misses the core of the multi-hop comparison: the change in rhetorical stance despite unchanged methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 460,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions have evolved to offer more seamless and secure digital experiences, with a stronger focus on integrating with open banking capabilities. In 2023, Mastercard expanded its open banking platform to provide connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, enhancing its reach across financial institutions. Additionally, Mastercard launched new solutions such as Mastercard Receivables Manager, which automates reconciliation for virtual card payments, and expanded its ACH payment solution using open banking capabilities to enable secure consumer bill payments. These developments reflect a strategic push to leverage open banking for broader financial inclusion and improved transaction efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of MA's digital identity solutions between 2022 and 2023, with accurate details on the expansion of open banking connectivity to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe in 2023. These quantitative figures match the ground truth exactly. (2) The mention of launching an ACH payment solution using open banking infrastructure is consistent with the original answer, though the LLM adds 'Mastercard Receivables Manager'—a detail not present in the ground truth. While this may reflect real-world developments, it introduces a solution not tied to digital identity or open banking in the provided context, slightly deviating from the focus. (3) The multi-hop reasoning is largely sound: the answer synthesizes information across years and geographies, correctly linking expanded connectivity to broader reach and integration with financial services. However, it omits the 2022 foundational aspects of consumer protection, consent management, and identity verification across people, devices, and transactions, which were central to the original answer. This results in a partial loss of completeness regarding the 2022 baseline. (4) Despite the omission and the addition of a peripheral product, the core facts about open banking integration and institutional reach are accurate and relevant. The answer stays focused on the question’s intent, earning high marks for contextual relevance and quantitative precision, with a minor deduction in qualitative accuracy due to incomplete synthesis of the 2022 foundation and introduction of an extraneous solution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 453,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved with a stronger focus on addressing production challenges and strategic dependencies. In 2023, the company highlighted the Solar Roof's design improvements and integration with Powerwall but did not detail specific production hurdles. By 2024, Tesla acknowledged broader production risks across its product lines, including Solar Roof, citing potential delays due to supplier issues, automation challenges, and the need for localized manufacturing. Additionally, the 2024 filing emphasized Tesla's growing reliance on in-house capabilities and strategic supplier relationships to manage costs and ensure scalability, reflecting a more proactive stance on mitigating production bottlenecks and supply chain dependencies.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla and the relevant time frame (2023–2024), and accurately reflects that in 2023, Tesla emphasized design and integration with Powerwall. It also correctly notes that by 2024, production challenges were acknowledged. However, the original answer does not mention 'supplier issues', 'automation challenges', or 'localized manufacturing' as specific causes—these details are fabricated or over-specified. The ground truth states only that Tesla acknowledged delays 'similar to those experienced with other products', without detailing root causes. Additionally, while the LLM correctly infers strategic dependencies, it misrepresents the nature of the 2024 filing’s emphasis: the original highlights that Tesla's success 'depends in large part' on mass-market vehicle production, implying a potential deprioritization of Solar Roof, which the LLM omits entirely. Instead, the LLM introduces a narrative about in-house capabilities and supplier relationships not present in the original. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model connects 2023 positioning to 2024 challenges, but fails to correctly synthesize the key strategic shift regarding vehicle production prioritization, which is central to the original answer. This omission significantly weakens the qualitative accuracy. (4) The correctness score is 6 due to accurate framing and correct entities/years but significant addition of unsupported details and omission of the critical strategic dependency on vehicle production. Contextual relevance is high because the response stays on topic and addresses production and strategy evolution, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 492,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024 with the addition of new agreements dated June 1, 2024, and October 1, 2024, as detailed in the 2024 filing. These agreements, like the prior ones from September 1, 2022, involve NextEra Energy, Inc., Deutsche Bank Trust Company Americas, and The Bank of New York Mellon. No new Pledge Agreements were disclosed in the 2023 filing beyond the September 1, 2022 agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All dates—September 1, 2022, June 1, 2024, and October 1, 2024—are accurately reported. The counterparties, Deutsche Bank Trust Company Americas and The Bank of New York Mellon, are correctly identified. (2) Quantitative accuracy is perfect: all dates and agreement counts match the original answer. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that while the 2023 filing references a 2022 agreement, no new agreements were disclosed in that year, and two new ones were introduced in 2024. This reflects proper multi-hop synthesis across filings. (4) The only minor shortcoming is that the LLM does not explicitly state that the evolution reflects an 'expansion in structure and timing' as noted in the original answer, slightly reducing qualitative depth. However, the factual content and implications are equivalent. Wording differs but meaning is preserved. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 304,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel enhanced its strategic positioning in Edge AI by expanding its software platform offerings and strengthening ecosystem partnerships. Intel introduced an edge-native software platform with modular building blocks, enabling developers to build, deploy, and manage distributed edge infrastructure and AI applications across multiple verticals. Additionally, Intel collaborated with ecosystem partners like Ericsson, Nokia, Cisco, Dell Technologies, HPE, Lenovo, Amazon, Google, and Microsoft to drive the software-defined transformation of network and edge infrastructure and accelerate AI-driven automation. These efforts reflect Intel's focus on providing a seamless cloud-like experience at the edge while leveraging its broad silicon portfolio and industry expertise.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel's Edge AI strategy from 2023 to 2024 with accurate qualitative details. It correctly identifies Intel's 2023 focus on an edge-native software platform with modular building blocks for distributed edge infrastructure and AI, targeting multiple verticals. The mention of ecosystem partnerships with Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google, and Microsoft aligns with the ground truth and reflects Intel's collaborative push. However, the LLM omits the specific 2024 NEX initiative, which is a key strategic evolution in Intel's shift toward cloud-native software on programmable hardware and general-purpose compute at the edge. While the answer describes the outcome (software-defined transformation, cloud-like experience), it misses the NEX branding and the explicit pivot from fixed-function hardware to programmable systems, which is a critical detail in the original answer. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning is sound, though slightly incomplete in synthesizing the full multi-hop progression (2023 platform → 2024 NEX-driven transformation). The answer remains contextually relevant and semantically close to the ground truth, warranting a high score but not full marks due to the missing NEX initiative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 384,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting a value of $1,250 million for these notes. This indicates that there were no issuances, repayments, or modifications to the 1.75% senior notes due August 2030 during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the value of the 1.75% senior notes due August 2030 remained unchanged at $1,250 million between 2023 and 2024, which matches the ground truth. All numeric values (percentage, maturity date, dollar amount, years) are accurate. (2) Quantitative accuracy is perfect: $1,250 million in both years, correct interest rate (1.75%), and correct due date (August 2030) are all correctly reported. (3) The reasoning is sound for the specific focus on the 1.75% notes. However, the LLM omits mention of other senior notes due in 2030 (e.g., the 3.75% notes due April 2030), which were included in the original answer to provide broader context on the composition of long-term debt. While the question emphasizes the 1.75% notes, it asks about the 'composition and value' of long-term debt related to senior notes due in 2030, implying a slightly broader scope. This partial omission reduces completeness slightly but does not affect the core accuracy. (4) The answer is highly relevant, correctly focused on the key debt instrument, and conveys the essential truth. The minor lack of broader compositional context prevents a perfect 10, but the response is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 343,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan became a more central element of its pricing strategy and membership growth objectives. Introduced in 2023 as a lower-priced option, the plan was positioned to attract a broader audience while maintaining revenue per user. By 2024, the plan was explicitly highlighted as part of Netflix's strategy to offer a range of pricing plans to meet diverse consumer needs, with a focus on driving membership growth and enhancing affordability. The company also emphasized the role of this plan in its broader efforts to manage growth and operating margins, particularly in markets where price sensitivity is a key factor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to broaden its audience and address price sensitivity, and by 2024 it became a core part of the pricing strategy aimed at diverse consumer needs and sustained membership growth. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (2) The answer is complete, addressing both the 2023 introduction and the 2024 strategic evolution of the plan, including its role in pricing strategy and membership growth. (3) Multi-hop reasoning is sound: the model correctly synthesizes the plan’s evolution from an experimental offering to a strategic, integrated component, reflecting long-term planning and market adaptation. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'maintaining revenue per user', 'managing operating margins'), these are reasonable inferences consistent with Netflix’s public strategy and do not contradict the ground truth. The only minor gap is that the LLM does not explicitly mention 'competitive pressures' or 'value perception' from the original, but it captures the functional intent (affordability, price sensitivity). Thus, the answer is fully contextually relevant and qualitatively very strong, warranting a 9/10 in correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 413,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Tesla's approach to the Tesla Semi evolved from early production in 2023 to pilot production in 2024, indicating progress toward scaling manufacturing. In 2023, the Tesla Semi was in early production and delivery phases, while by 2024, it had advanced to pilot production at the Nevada Gigafactory. This shift reflects Tesla's strategic focus on ramping production for commercial vehicles and integrating them into its broader product roadmap, alongside efforts to enhance manufacturing efficiency and expand its energy and vehicle offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Tesla began early production and deliveries in 2023 and advanced to pilot production at the Nevada facility in 2024. These details match the original answer exactly. (2) There are no numeric values requiring calculation, but the years (2023 and 2024) and production phases ('early production' and 'pilot production') are correctly cited. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution in production status across two years and infers strategic progression toward scaling and integration into Tesla's broader roadmap. The mention of 'Nevada Gigafactory' adds specificity consistent with known Tesla facilities. (4) The only minor difference is that the LLM slightly expands on strategy by mentioning 'enhance manufacturing efficiency and expand its energy and vehicle offerings,' which is plausible but not explicitly stated in the ground truth. This does not introduce inaccuracy but adds interpretive context. Overall, the answer is factually correct, complete, and semantically equivalent to the original, warranting a high correctness score with a small deduction for slight over-enrichment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 344,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggests a deliberate focus on ensuring leadership continuity and reinforcing the company's commitment to retaining key executive talent. By extending and formalizing these agreements for multiple executives, including roles such as Chief Nuclear Officer, Chief Financial Officer, and Human Resources leadership, NextEra Energy emphasizes the strategic importance of maintaining a stable and experienced leadership team to drive long-term growth and operational success. This approach reflects confidence in its leadership and aligns with the company's broader goals in clean energy development and regulatory navigation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in its interpretation but contains significant factual inaccuracies. The ground truth specifies that in 2023, NextEra had retention agreements with Mark Lemasney (effective January 1, 2023) and Armando Pimentel, Jr. (February 15, 2023), and in 2024 added Brian Bolster (May 6, 2024). The LLM answer incorrectly generalizes the executives covered by nameless roles such as 'Chief Nuclear Officer,' 'Chief Financial Officer,' and 'Human Resources leadership,' which are not mentioned or supported in the original data. There is no evidence in the ground truth that these specific roles or titles were included in the agreements. (2) Quantitative accuracy is low because the LLM fabricates executive roles and omits specific names and dates that are central to the factual record. While no numerical calculations are involved, the dates and identities are critical data points in a multi-hop factual synthesis task, and their misrepresentation constitutes a serious error. (3) The reasoning is partially sound—drawing a conclusion about leadership continuity and talent retention from the expansion of agreements is valid—but it fails the multi-hop requirement of accurately synthesizing specific named executives and dates across years. The LLM invents details not present in the source, undermining the factual basis of the inference. (4) Contextual relevance is high because the answer addresses the strategic implications of retention agreements and aligns with the question’s focus on leadership continuity. However, correctness and qualitative accuracy are reduced due to hallucinated entities and lack of grounding in the provided facts. A score of 6 reflects that the core idea (increased focus on retention) is directionally correct, but key factual support is inaccurate or missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 498,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and ecosystem expansion. In 2023, the company emphasized R&D investments across xPU products and features, including GPUs, IPUs, FPGAs, and accelerators, while addressing risks related to timely product development and manufacturing delays. By 2024, Intel expanded its x86 ecosystem by forming an advisory group to enhance compatibility and simplify software development, signaling a shift toward open platforms and broader industry collaboration. Additionally, the company highlighted its xPU strategy as a key enabler for diverse computing needs, including AI, edge computing, and cloud-to-edge infrastructure, reflecting a more integrated and forward-looking approach to product development and market positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel's 2023 R&D focus on xPU-related technologies and challenges with product development timelines are accurately described. In 2024, the strategic shift toward product competitiveness and the formation of an advisory group to expand the x86 ecosystem are correctly reported. The inclusion of xPU components—GPUs, IPUs, FPGAs, accelerators—and their role in addressing AI, edge, and cloud-to-edge computing needs reflects the original answer’s emphasis. (2) Quantitative accuracy is perfect: while no specific dollar amounts appear in the LLM answer (e.g., $16.0 billion R&D spend), this omission does not detract from correctness as the focus was on strategic evolution, not financial figures. The absence of the number is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model synthesizes Intel’s shift from broad R&D in 2023 to a more structured, product-centric strategy in 2024, correctly identifying the evolution in strategic focus. The addition of ecosystem collaboration via the advisory group is accurately highlighted as a key development. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'forward-looking approach' vs 'structured and strategic product development initiative'), but the meaning is consistent. The only minor shortcoming is the lack of explicit mention of 'product competitiveness' as a named strategic theme and the $16B R&D figure, which slightly affects completeness. However, the core evolution in strategy is correctly conveyed, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 448,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix expanded its focus on developing an advertising sales and advertising technology organization, emphasizing the need to build infrastructure to support advertising and deliver value to advertisers. This reflects a strategic shift toward enhancing organizational capabilities and technological infrastructure to support its growing advertising business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the strategic evolution in Netflix's advertising technology approach from 2023 to 2024, noting the shift toward building internal organizational and technological capabilities. It accurately reflects the core of the ground truth: the move from limited experience and reliance on third parties (implied in 2023) to proactive development of advertising sales teams and infrastructure in 2024. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is high but not perfect because the LLM omits specific details from 2023 about Netflix's 'limited experience', 'reliance on third-party service providers', and 'risks related to infrastructure development'—key context that highlights the contrast with 2024. While the answer conveys the directional shift, it does not fully synthesize the multi-hop contrast between the two years as explicitly as the original. Contextual relevance is strong—the response directly addresses organizational development and infrastructure investment as asked. Minor omission of 2023 risk factors and dependencies prevents a perfect score, but the essential evolution is correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 347,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging programs remained a component of deferred revenue related to automotive sales, with no major structural changes indicated. In both years, deferred revenue for free Supercharging, along with other features like FSD and internet connectivity, was recognized over the performance period, generally the expected ownership life of the vehicle. In 2024, deferred revenue increased slightly to $3,599 million from $3,536 million in 2023, and revenue recognized from these programs rose to $1,188 million in 2024 from $595 million in 2023, reflecting higher vehicle deliveries and ongoing usage of the service. The program structure continued to involve recognizing revenue over time on a straight-line basis for unlimited free Supercharging, while limited incentives were based on actual usage or expiration.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Tesla's revenue recognition evolution. The Original Answer states that in 2023, free Supercharging was bundled into Automotive Sales Revenue and recognized over time, but in 2024 Tesla began deferring revenue for features like free Supercharging and treating them as liabilities to be amortized—indicating a structural shift. The LLM incorrectly claims there was 'no major structural changes,' which directly contradicts the ground truth. This misrepresents the core evolution in program structure and revenue recognition. (2) The LLM introduces specific dollar figures—$3,599 million deferred revenue in 2024 vs $3,536 million in 2023, and recognized revenue of $1,188M vs $595M—that are not present in the Original Answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for a comparison of program evolution between 2023 and 2024 in terms of structure and revenue recognition. The LLM fails to identify the key shift from bundling to deferral and amortization, instead asserting continuity. It also incorrectly implies that the accounting treatment was the same in both years, missing the transition to a more segmented monetization approach. (4) While the LLM addresses the general topic of deferred revenue and mentions relevant features (FSD, connectivity), its failure to capture the fundamental change in accounting policy results in a low correctness score. The contextual relevance is moderate because it discusses related concepts, but the qualitative and quantitative inaccuracies are severe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 473,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024 in terms of coupon structure and maturity dates. In 2023, the Series O Debentures had a fixed coupon rate of 4.45% with a maturity date of May 1, 2079. By 2024, the Series O Debentures transitioned to a floating rate structure with a maturity date of November 1, 2029. This shift suggests a strategic move towards greater flexibility in managing interest rate risk and aligning with market conditions, potentially optimizing financing costs in a dynamic interest rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2023 Series O Debentures had no explicitly disclosed coupon rate, not a fixed 4.45% as claimed. The 2024 issuance had a fixed coupon of 5.55%, not a floating rate as stated. The maturity dates are partially correct—May 1, 2079 for 2023 is accurate, and November 1, 2029 for 2024 matches—but the associated terms (coupon structures) are wrong. (2) Quantitative accuracy is severely compromised: the 4.45% rate and floating rate structure are unsupported by the ground truth; the correct 5.55% fixed rate in 2024 is omitted. These are not minor discrepancies but core factual errors affecting interpretation. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two years’ debenture terms and infer strategic intent. However, because the underlying data is incorrect, the conclusion about 'floating rate' and 'flexibility in managing interest rate risk' is based on false premises. The actual shift—from no disclosed coupon (possibly fixed/deferred) to a short-term, fixed 5.55% instrument—suggests a move toward transparency and shorter duration, not floating-rate flexibility. (4) Correctness is low (3/10) due to major factual errors in coupon structures and rates. Quantitative accuracy is poor (2/10) due to incorrect percentages and mischaracterization of rate type. Qualitative accuracy is moderate (4/10) because the model recognizes a strategic shift but misattributes the rationale. Contextual relevance is high (7/10) as the response addresses the question’s structure and intent, just with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 452,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil's impairment assessment framework has incorporated OPEC investment activities and production policies as factors influencing long-term oil supply dynamics in both 2022 and 2023. In 2022, the Corporation emphasized that OPEC's actions, alongside declining production from mature fields, impact global oil supply, which is balanced against demand driven by economic activity and alternative energy adoption. By 2023, this consideration remained consistent, with the Corporation reaffirming that long-term oil prices are driven by supply and demand fundamentals, including OPEC's role in shaping supply. However, no specific changes in the treatment or weight of OPEC-related factors were identified in the provided pages for 2023 compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in ExxonMobil's impairment assessment framework from 2022 to 2023, which is the central focus of the question. (1) What was correct: The LLM accurately states that in 2022, ExxonMobil considered OPEC's investment activities and production policies as influencing global oil supply, and that supply-demand fundamentals remained relevant in 2023. Entity accuracy (ExxonMobil, OPEC, years 2022 and 2023) and contextual relevance are strong. (2) Quantitative accuracy: There are no numerical figures in this question, so this dimension is not applicable; however, the absence of incorrect numbers or dates supports a full score. (3) Multi-hop reasoning assessment: The model fails in synthesizing the key shift described in the ground truth — that in 2023, OPEC's role was no longer discussed in isolation but embedded within a broader framework including greenhouse gas costs and net-zero targets. The LLM incorrectly claims 'no specific changes' were identified, contradicting the ground truth which documents a clear shift in framing and integration. (4) Justification for scores: Correctness is scored at 5 because core facts about OPEC’s influence are present, but the critical evolution in the assessment framework is omitted. Qualitative accuracy is low due to flawed reasoning and failure to capture the nuanced shift in how OPEC factors into long-term asset valuation. Contextual relevance is high because the response stays on topic and addresses the general theme of OPEC's role in impairment assessments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 430,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan is discussed more prominently and with greater strategic emphasis in the 2024 filing compared to the 2023 filing. In the 2024 10-K, the plan is explicitly mentioned as part of Netflix's core strategy to offer a range of pricing plans to meet diverse consumer needs, indicating a more integrated and emphasized role in their business model. In contrast, the 2023 filing references the ad-supported plan less prominently, focusing more on broader financial and operational risks without the same level of strategic detail.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures the evolution in Netflix's approach to its ad-supported subscription plan from 2023 to 2024: in 2023, the plan was mentioned in the context of risk and uncertainty, while in 2024, it was integrated into the core pricing strategy. The LLM correctly identifies the shift in emphasis and strategic positioning without introducing any factual errors. All entities (Netflix, 2023, 2024, ad-supported plan) are accurate, and the reasoning reflects proper multi-hop synthesis across the two filings. The only minor limitation is that the LLM does not explicitly mention 'lack of operating history' or 'discrepancies between forecasts and actual results' from the 2023 filing, which slightly reduces completeness in qualitative detail—hence a 9 instead of 10 on qualitative accuracy. However, the core meaning and strategic shift are correctly conveyed, and there are no issues with quantitative accuracy (no numbers involved, but years and references are correct). The response is fully contextually relevant and directly addresses the question about level of detail and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 332,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers between 2022 and 2024 has evolved with a continued strategic focus on fulfillment efficiency and cost management. In 2024, shipping costs increased due to higher sales volumes and investments in the fulfillment network, but the company offset these costs through network efficiencies, lower transportation expenses, and optimization efforts. Compared to 2022, where rising carrier rates, labor costs, and supply chain constraints drove up fulfillment expenses, Amazon has increasingly prioritized long-term efficiency gains, such as renegotiating supplier terms, leveraging automation, and scaling operations to reduce per-unit costs. This reflects a shift toward balancing customer-centric shipping offers with operational cost control to sustain growth and profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Amazon's shipping strategy from 2022 to 2024, noting increased shipping costs due to sales growth and network investments, and the offsetting role of efficiency gains. It accurately reflects the shift from external cost drivers (carrier rates, supply chain constraints) in 2022 to internal, operations-focused efficiency efforts by 2024. However, the original answer specifies a concrete shipping cost figure for 2021 ($76.7 billion) and notes expectations for continued growth into 2022, which the LLM omits. While the LLM references rising costs in 2022, it does not mention this key data point, representing a minor factual omission. (2) No incorrect numbers are stated—the LLM avoids making up figures and does not contradict the ground truth numerically. It refrains from citing the $76.7B figure but doesn’t invent or misstate any dollar amounts, so quantitative accuracy is high. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022 vs 2024), identifies shifting cost drivers, and correctly infers a strategic pivot toward fulfillment efficiency. It adds contextual details like automation and supplier renegotiation, which are consistent with the original’s mention of supplier negotiations and operational efficiencies. (4) The answer is highly relevant and conveys the core strategic evolution. The omission of the specific $76.7B figure prevents a perfect score, but the overall meaning and direction of the strategy shift are accurately communicated. Thus, correctness is rated 8 due to this partial omission, though qualitative and contextual accuracy remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 459,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy adjusted the asset allocation for its Master Retirement Trust to reflect a shift in investment strategy. For the RCBP assets, the target allocation changed from 35% liability hedging and 65% return-seeking assets in 2023 to 35% liability hedging and 65% return-seeking assets in 2024, while for the DELPP assets, the target allocation remained at 80% liability hedging and 20% return-seeking assets. In terms of disclosure practices, Duke Energy provided detailed fair value measurements for the trust's assets, categorizing them into Level 1, Level 2, Level 3, and Not Categorized, with specific allocations for equity securities, corporate debt, short-term investment funds, and other categories. These disclosures were consistent between 2023 and 2024, with minor changes in the fair value amounts and categorizations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the evolution of Duke Energy's Master Retirement Trust reporting between 2023 and 2024. (1) Quantitatively, the LLM incorrectly states that the target allocation for RCBP assets remained unchanged from 2023 to 2024 (35% liability hedging, 65% return-seeking), implying no change, which contradicts the expectation of identifying reporting evolution, not static allocations. More critically, the ground truth does not mention RCBP or DELPP asset allocations at all—these specific plan names and their allocations are hallucinated. (2) The LLM claims consistent Level 1–Level 3 disclosures in both years, but the ground truth states that Level 3 fair value disclosures and a reconciliation of beginning and ending balances were introduced in 2024 and were not present in 2023—this key advancement in transparency is misrepresented. (3) The ground truth highlights new subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%) in 2024, which the LLM completely omits. (4) Instead, the LLM invents detailed fair value categorizations and asset breakdowns not supported by the original answer. While the response is framed around asset allocation and disclosure practices (hence partial contextual relevance), it fails on core facts, introduces incorrect entities (RCBP, DELPP), and misrepresents the nature of reporting changes. The reasoning is unsound due to reliance on fabricated data rather than accurate multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 423,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's financial relationship with Google Network Partners has evolved in terms of cost structure and payment obligations. In 2024, the cost of revenues, including TAC (traffic acquisition costs), increased by $13.0 billion compared to 2023, with TAC rising by $4.0 billion. The TAC rate decreased slightly from 21.4% to 20.7% due to a revenue mix shift from Google Network properties to Google Search & other properties. However, the TAC rate on Google Search & other revenues increased, primarily due to higher TAC related to mobile searches. Additionally, other cost of revenues increased due to higher content acquisition costs, depreciation, and technical infrastructure expenses. These changes indicate a growing financial commitment to Google Network Partners, driven by increased revenues and operational investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, TAC was part of cost of revenues with a higher percentage for Network partners, and by 2024, payments to these partners were highlighted as a primary use of operating cash outflows—indicating a shift in financial structure. However, the LLM introduces specific dollar figures ($13.0B increase in cost of revenues, $4.0B TAC increase) and a TAC rate drop from 21.4% to 20.7% between 2023 and 2024, which are not present in the ground truth and cannot be verified from the provided context. There is no mention of 2023 data in the original answer, making the year-over-year comparison unsupported. (2) The quantitative claims—such as the $4.0B TAC increase and precise TAC rates—are entirely absent from the ground truth and thus factually incorrect in this context. The original answer does not provide any numerical data for 2024 beyond the qualitative shift to operating cash outflows. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers trends between 2023 and 2024 when the original answer only compares 2022 and 2024 without intermediate years. It also mischaracterizes the evolution as a continuation of cost-of-revenue accounting rather than a structural shift toward operational cash flow obligations. The core insight of the original—that the nature of the financial relationship changed from cost-of-revenue to a direct cash flow obligation—is entirely missing. (4) While the LLM discusses TAC and Google Network Partners, which are contextually relevant, it fabricates numerical details and misses the key conceptual shift described in the ground truth. Hence, despite addressing the general topic, the answer fails on correctness and reasoning, warranting low scores in quantitative and qualitative accuracy. The contextual relevance is moderate because it discusses the right entities and general theme, but with incorrect details and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 534,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of offsetting swap positions and non-designated derivative instruments on UPS's consolidated income shifted significantly. In 2022, fair value changes and settlements of these instruments resulted in a total loss of $69 million, primarily driven by foreign currency exchange contracts. In contrast, 2023 saw a much smaller loss of $7 million, also attributed to foreign currency exchange contracts, indicating a notable reduction in the negative impact on consolidated income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that UPS provided figures for 2021 ($163M net gain) and 2020 ($124M net gain), but did not report a quantified financial impact for 2022 or 2023 in the excerpt. In contrast, the LLM claims specific losses of $69M in 2022 and $7M in 2023, which are not supported by the original answer. These numbers are entirely fabricated or misattributed, making the quantitative claims false. (2) There are no verifiable calculations in the ground truth for 2022 or 2023, so the LLM’s precise figures cannot be accurate. The original answer emphasizes a lack of quantification for 2023 and a shift in disclosure focus, not actual loss amounts. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers year-over-year changes from data not present in the ground truth. It fails to recognize that the absence of 2022 and 2023 figures in the original context (except as newly included in disclosures) means no such comparison can be made. The model invents a narrative of 'reduction in negative impact' that is unsupported. (4) While the LLM correctly identifies the types of derivatives (foreign currency exchange contracts) and the general accounting treatment (fair value changes affecting earnings), it misrepresents the core financial impact due to incorrect numbers and false trends. The contextual relevance is moderate because it addresses derivative impacts on income, but the factual inaccuracies severely undermine correctness. Thus, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher due to correct terminology and entity identification (UPS, derivative types), but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 479,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures, compared to 2023, indicates a shift in the company's director compensation strategy toward emphasizing deferred compensation mechanisms. This suggests a potential focus on aligning director incentives with long-term value creation and enhancing retention by offering more flexible, long-term compensation structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 and infers a strategic shift in director compensation toward deferred compensation. The core interpretation—that this reflects a move toward long-term incentives and retention via flexible structures—is consistent with the ground truth. However, the LLM omits specific evidentiary details from the filings that ground the conclusion: in 2023, the plan was only referenced in exhibit lists (e.g., Exhibit 10.12) without descriptive detail, whereas in 2024, it includes a substantive explanation of deferral mechanics, phantom investments, and balance adjustments. These omissions reduce completeness and weaken the multi-hop synthesis. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The reasoning is logically sound and directionally accurate—linking increased disclosure to strategic emphasis on long-term alignment and flexibility—but lacks the document-level evidence (exhibit references vs. descriptive text) that forms the basis of the ground truth’s multi-hop inference. This limits qualitative accuracy despite correct high-level interpretation. (4) The answer is highly relevant to the question and captures the strategic implication well, warranting a high contextual relevance score. Overall, the answer is factually plausible and semantically aligned in intent but lacks the granular, evidence-based synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 443,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by focusing on enhancing digital capabilities, expanding premium offerings for younger demographics, and strengthening its commercial and small business solutions. In response to competitive pressures and changing customer behaviors, the company has invested in technological advancements, such as improving the Amex app and integrating AI and machine learning, to better meet customer needs and improve digital engagement. Additionally, American Express has emphasized strategic partnerships and initiatives like its dining platform and Shop Small campaigns to differentiate its offerings and drive customer loyalty.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. It accurately identifies key elements such as response to competitive pressures, changing customer behaviors, investments in digital capabilities (Amex app, AI), targeting younger demographics, strategic partnerships, and initiatives like the dining platform and Shop Small. However, it omits specific details present in the ground truth, such as the explicit mention of Millennial and Gen-Z targeting by name, the shift from a reactive to proactive stance, and specific platform names like Tock and Rooam. It also does not mention global merchant coverage growth or the challenge of rising Card Member rewards costs in 2022. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers were misstated), and the reasoning is sound, showing appropriate multi-hop synthesis across time and strategic themes. The answer is highly relevant to the question and conveys the overall strategic shift, but lacks some specificity that would make it fully equivalent to the original answer. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 357,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil's long-term debt financing approach between 2022 and 2024 shows a shift in the composition of its long-term notes, as evidenced by the specific notes listed in the 10-K filings. In 2022, the company's long-term debt included 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039. By 2024, the composition remained similar, with the same set of notes listed, but no new series introduced during this period. This suggests a relatively stable approach to long-term debt financing, with no significant changes in the maturity or interest rate structure of its long-term notes between 2022 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the debt instruments listed in 2022, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, which matches the ground truth. However, it incorrectly states that the same set of notes was listed in 2024, directly contradicting the ground truth, which explicitly notes that the 0.142% Notes due 2024 were no longer disclosed in 2024, indicating maturity or repayment. This is a critical factual error. (2) Quantitatively, all percentages and maturity years mentioned are accurate as per the 2022 data, and no incorrect numbers are introduced. The error lies not in the values themselves but in their application to 2024. (3) The multi-hop reasoning fails because the LLM does not recognize the absence of the 2024 notes in the 2024 filing as a meaningful change. Instead, it concludes there was 'no significant change,' while the ground truth emphasizes a strategic shift toward longer-term debt by retiring near-term obligations. The model misses the evolution in capital structure strategy. (4) While the answer is contextually relevant and addresses the question about debt composition, the core conclusion is factually incorrect due to misrepresenting the 2024 debt composition. Hence, correctness and qualitative accuracy are significantly penalized despite numerical fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 383,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has increasingly emphasized innovation and differentiation in its corporate card solutions. In 2022, the company highlighted evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, this strategic emphasis expanded to include designing innovative products and features such as financing, banking, and payment solutions tailored for business customers, reflecting a stronger focus on digital transformation and meeting the evolving needs of commercial clients.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies American Express's strategic emphasis in 2022 on evolving card value propositions and differentiating corporate card and accounts payable solutions, which matches the ground truth. It also accurately reflects a continued strategic focus in 2024, noting innovation and tailored solutions for business customers. However, the LLM answer diverges from the ground truth by emphasizing 'financing, banking, and payment solutions' and 'digital transformation'—elements not mentioned in the original answer. The ground truth specifies a shift toward an integrated global network, increased merchant acceptance, and enhanced fraud protection and marketing insights by 2024, which the LLM answer omits. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are incorrect. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across 2022 and 2024, but fails to accurately represent the nature of the strategic evolution—shifting from internal product development to an externally focused ecosystem strategy. Instead, it introduces unverified elements like 'digital transformation' and 'innovative products' not present in the source. (4) The correctness score is 7 because the core facts about 2022 are accurate and the general direction of strategic evolution is acknowledged, but key differentiating aspects of the 2024 strategy are misrepresented or missing. Qualitative accuracy is 7 due to partial reasoning fidelity; contextual relevance is high at 9 because the response stays focused on the question and timeframe, despite inaccuracies in the strategic details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 479,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has shown significant evolution between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis. In 2024, AWS continued to be a major driver of cash flow, with operating activities generating $115.9 billion in cash, a notable increase from $84.9 billion in 2023. This growth reflects AWS's strong performance and its increasing contribution to Amazon's overall financial health. Strategically, AWS remains a central focus for Amazon, with continued investment in technology and infrastructure, including advancements in cloud computing, artificial intelligence, and machine learning, as highlighted in the 2024 filing. These investments underscore AWS's role as a key growth engine for Amazon's long-term innovation and market leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key financial figures: $115.9 billion in operating cash flow for 2024 and $84.9 billion for 2023, matching the ground truth exactly. These numbers are critical and accurately presented, with no calculation or formatting errors. (2) The quantitative accuracy is perfect—both cash flow values are correct and properly attributed to the right years. The comparison (increase from 2023 to 2024) is also logically sound. (3) The multi-hop reasoning is mostly sound: the model correctly infers AWS's growing strategic and financial role. However, it omits a key qualitative shift highlighted in the ground truth—the evolution of AWS from being framed in 2022 as a business facing competitive risks to becoming a core financial pillar by 2024. While the LLM mentions AWS's strategic importance in 2024, it does not contrast this with the 2022 risk-focused narrative, which is central to the question about 'evolution' over time. (4) Despite this omission, the answer captures the core financial progression and strategic emphasis in 2024, making it highly accurate overall. The contextual relevance is strong as it directly addresses cash flow and strategy. The qualitative accuracy is slightly reduced due to the missing 2022 contrast, but the rest of the reasoning is solid. Hence, a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 377,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used in evaluating the historical consistency of regulatory asset balances expanded. In 2023, the analyses primarily involved assessing changes in regulatory orders, asset balances, and comparing recorded balances to expectations based on commission-approved amortization and incurred costs. By 2024, the trend analyses were complemented by a more detailed evaluation that included a broader review of regulatory developments, an independently developed expectation of balances, and a deeper examination of specific regulatory matters such as coal ash retirements and storm costs. This evolution reflects a more comprehensive and nuanced approach to verifying the consistency and recoverability of regulatory assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces details not present in the ground truth, leading to significant qualitative inaccuracies. (1) Correct elements: The answer correctly identifies an evolution in trend analyses between 2023 and 2024 and notes a broader, more detailed approach in 2024, which aligns with the ground truth's indication of expanded audit procedures. The years (2023 and 2024) are accurate. (2) Quantitative accuracy is high: no specific numbers are involved, and the temporal references are correct. (3) Multi-hop reasoning is partially sound but flawed—while the ground truth specifies a new focus on 'asset retirement obligations related to coal ash' within regulatory recoverability, the LLM generalizes this to 'coal ash retirements and storm costs' and adds unverified elements like 'independently developed expectation of balances' and 'assessment of regulatory orders,' which are not mentioned in the original. This over-expansion misrepresents the scope of change. (4) The core idea of increased focus and specialization in 2024 is consistent, but the specific shift toward coal ash AROs (asset retirement obligations) is diluted by adding 'storm costs' and other audit enhancements not in the original. Thus, while contextually relevant and factually plausible, the answer does not accurately reflect the precise evolution described in the ground truth, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 394,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to respond to cost and pricing pressures. In 2022, the company mentioned adjusting its merchandising and pricing strategies in response to higher inflation, including increasing the penetration of private-label items to maintain competitive pricing and preserve member value. By 2023, this strategy continued as a key component of Costco's approach to manage cost increases and maintain gross margin stability, with a focus on leveraging private-label items to offer quality goods at competitive prices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco increased the penetration of private-label items in response to cost and pricing pressures in both 2022 and 2023, which aligns with the ground truth. It accurately reflects that this strategy was part of broader efforts to maintain competitive pricing, preserve member value, and manage gross margins. However, the LLM slightly misrepresents the evolution by stating that increasing private-label penetration was a noted strategy in 2022, whereas the original answer specifies that 2022 was more focused on reactive measures (absorbing costs, bulk buying, selective price passing), with private-label emphasis becoming more strategic and sustained in 2023. The LLM implies continuity of the private-label focus in 2022 that the ground truth does not fully support. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present, hence a score of 10. (3) The multi-hop reasoning is mostly sound: the model connects cost pressures to strategic responses across two years and correctly identifies private-label expansion as a key lever. However, it misses the nuanced shift from reactive (2022) to strategic (2023) emphasis on private labels, which is central to the original answer’s conclusion about strategic evolution. (4) The answer is highly contextually relevant, directly addressing the question about strategic evolution. The qualitative accuracy is slightly reduced due to the conflation of the timing and emphasis of the private-label strategy. Overall, the answer is factually consistent in broad strokes but lacks precision in depicting the strategic shift between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 473,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly shifted between 2023 and 2024 based on Pfizer's remaining performance obligations. In 2023, Paxlovid contributed $1,279 million in revenue, with a non-cash revenue reversal of $3.5 billion due to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid's revenue increased to $5,716 million, reflecting its transition to commercial markets and a favorable adjustment of $771 million after fewer treatment courses were returned than initially estimated. Additionally, remaining performance obligations for Paxlovid totaled $1 billion as of December 31, 2024, with expected deliveries from 2025 through 2028.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2023, but the LLM incorrectly asserts revenue figures ($1,279 million) and a $3.5 billion non-cash reversal for that year—details not mentioned in the original answer and unverified by the provided context. While the $1 billion RPO as of December 31, 2024, is correctly reported, the LLM adds unverified details such as revenue increasing to $5,716 million in 2024 and a $771 million favorable adjustment, which are not present in the ground truth. Additionally, the mention of deliveries expected from 2025 through 2028 introduces new timeframes not referenced in the original answer. (2) Quantitative accuracy is low: none of the revenue numbers or adjustments ($1,279M, $3.5B reversal, $5,716M, $771M) can be verified against the ground truth, which does not provide any revenue figures for Paxlovid in either year. Only the $1 billion RPO in 2024 matches. (3) The multi-hop reasoning is flawed—the question asks specifically about the evolution of financial outlook based on remaining performance obligations, but the LLM diverts into revenue trends and inventory adjustments not present in the original answer, failing to focus on RPO disclosure (or lack thereof) in 2023 versus explicit $1B in 2024. (4) Contextual relevance is moderate because the answer discusses Paxlovid, Pfizer, and RPOs, but it introduces extensive extraneous financial data not in the ground truth, undermining factual correctness. The core point about increased contractual certainty due to disclosed RPOs in 2024 is partially captured, but drowned in inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 473,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express's use and assumptions around the Reasonable and Supportable (R&S) Period for estimating credit loss reserves have shown a more refined and data-driven approach. In 2022, the R&S Period was based on historical loss experience and incorporated current and future economic conditions, with qualitative reserves used to address model limitations and emerging trends. By 2024, the company continued to use statistically-based models but emphasized the importance of testing the accuracy and completeness of inputs, as well as the reasonableness of assumptions, including the R&S Period and loss rates beyond it. This evolution indicates a stronger focus on model validation and risk management, reflecting a more proactive and transparent approach to financial risk management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that American Express used the Reasonable and Supportable (R&S) Period in both 2022 and 2024 as part of credit loss estimation, and accurately describes the general methodology involving historical loss experience and economic conditions. There are no numeric inaccuracies—while the original answer references $3.3 billion in reserves as of December 31, 2021 (relevant context for 2022 reporting), the LLM answer does not contradict this and avoids making false claims about reserve levels. (2) Quantitative accuracy is high: no incorrect numbers are introduced, and the absence of specific dollar figures does not detract from correctness since the question does not explicitly ask for them. (3) However, the LLM answer misses the key evolution highlighted in the ground truth: in 2022, the R&S Period was presented as a newly emphasized or explicitly explained concept, while by 2024 it had become an embedded, standard part of the framework. Instead, the LLM focuses on increased model validation and input testing, which, while plausible, is not supported by the original answer and shifts the emphasis from conceptual integration to methodological rigor. This represents a deviation in qualitative reasoning. (4) The answer remains contextually relevant and captures the broad direction of maturing risk practices, but fails to accurately reflect the specific nature of the evolution—i.e., from introducing the R&S Period to treating it as a foundational element. Thus, while factually consistent and well-reasoned, it does not fully align with the ground truth’s emphasis, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 462,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon's approach to debt financing evolved between 2022 and 2024, with the 0.800% Note due 2025 being issued as part of a broader strategy to manage capital structure and access capital at favorable rates. In 2020, Amazon issued the 0.800% Note due 2025, as noted in the 2024 filing. By 2022, Amazon issued higher-yielding notes, such as the 4.600% Note due 2025, indicating a shift toward issuing debt with higher coupon rates likely in response to rising interest rates. This suggests a diversification of debt maturities and rates to balance cost and risk, with the 0.800% Note representing a lower-cost component of Amazon's debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.800% Note due 2025 and the 4.600% Note due 2025 as part of Amazon's debt structure, which aligns with the ground truth. However, it incorrectly states that the 4.600% Note due 2025 was issued in 2022, while the original answer does not specify an issuance date for that note—only that it was introduced by 2024. This misattribution of timing is a factual error affecting quantitative accuracy. Additionally, the LLM claims the 0.800% Note was issued in 2020 'as noted in the 2024 filing,' which is consistent with the Officers' Certificate date in the ground truth, but the phrasing may imply the 2024 filing reported the issuance, which could be misleading. (2) The percentages (0.800% and 4.600%) and maturity year (2025) are accurate. The error lies in the implied timeline—specifically, asserting issuance in 2022 without evidence in the ground truth. No calculations are involved, so numerical precision is otherwise acceptable. (3) The multi-hop reasoning is generally sound: the model synthesizes information about Amazon's debt instruments across years and infers a strategic shift toward diversification in rates and maturities, which matches the ground truth's conclusion. However, the incorrect assignment of the 4.600% Note issuance to 2022 weakens the logical chain. The ground truth only confirms the note's presence in 2024 filings, not its issuance date. (4) Despite the timing inaccuracy, the core message about evolving debt strategy—using a broader range of interest rates to manage risk—is semantically equivalent and well-reasoned. The answer is highly relevant and captures the strategic intent, warranting strong scores in qualitative accuracy and contextual relevance, but the factual error in timing prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 493,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated June 1, 1978, was disclosed in both the 2022 and 2024 SEC filings under Duke Energy Progress' historical list of indentures. However, in the 2024 filing, there is no new activity or amendment related to this indenture, indicating that it has remained unchanged and is likely no longer active or material to Duke Energy's current operations. This suggests that the indenture has reached a status of historical record without ongoing relevance.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the date of the Twenty-third Supplemental Indenture (June 1, 1978), which matches the ground truth. However, it incorrectly states that the indenture was disclosed in both the 2022 and 2024 filings. According to the ground truth, while the 2022 filing explicitly references the Twenty-third Supplemental Indenture (via Exhibit 2(c), File No. 2-61611), the 2024 filing contains no mention of it—this is a critical factual error. Instead, the 2024 filing highlights newer indentures like the Forty-ninth Supplemental Indenture (March 14, 2024), indicating a shift in focus. The LLM’s claim that it was 'disclosed in both' filings is therefore false. (2) Quantitatively, the only key date is 1978, which is accurate. No calculations are involved, so numerical accuracy is high. (3) The multi-hop reasoning fails because the model does not correctly synthesize the change in disclosure practice between 2022 and 2024. It misses the absence of the indenture in the 2024 filing, which is central to the correct conclusion about its diminished relevance. The reasoning that it is 'no longer active or material' may be plausible, but it is based on incorrect premises. (4) The contextual relevance is moderate—the answer addresses the right topic and draws a reasonable conclusion about relevance, but due to the factual inaccuracy about the 2024 disclosure, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 405,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the repurchase activity for Class C Capital Stock decreased in terms of shares repurchased but remained relatively stable in total value. In 2022, 450 million shares were repurchased for $52.87 billion, in 2023, 306 million shares were repurchased for $50.19 billion, and in 2024, 306 million shares were repurchased for $50.19 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Alphabet repurchased $59.3 billion in 2022, $62.2 billion in 2023, and $62.0 billion in 2024 across Class A and Class C shares. However, the LLM claims $52.87 billion in 2022, $50.19 billion in 2023, and $50.19 billion in 2024—these values are incorrect and show a decreasing trend, contradicting the actual increasing trend. Additionally, the LLM introduces specific share counts (450 million, 306 million) not present in the original answer and not supported by the ground truth provided. (2) The dollar amounts are quantitatively wrong: $52.87B vs $59.3B (2022), $50.19B vs $62.2B (2023), $50.19B vs $62.0B (2024)—errors exceed 10% and change the interpretation. No calculations are shown, but the totals themselves are incorrect. (3) The reasoning is flawed: the LLM concludes that repurchase value remained stable while shares decreased, but the ground truth shows an increase from 2022 to 2023 and slight decrease in 2024—this trend is misrepresented. Furthermore, the original answer does not break down repurchases by share count or separate Class C from Class A, so the LLM introduces unsupported granular detail. (4) The contextual relevance is moderate—it addresses repurchase activity over 2022–2024 and attempts to provide annual values—but the factual foundation is incorrect, undermining the response. The mention of Class C specifically is misleading since the ground truth combines Class A and C. Thus, while the structure matches the question’s intent, the content is largely inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 440,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan is referenced in both the 2022 and 2024 SEC filings, but no specific changes in the treatment or documentation of the plan itself are detailed in the provided pages. However, the 2024 filing includes an updated description of compensation payable to non-management directors effective January 1, 2025 (page 171), which may indirectly relate to deferral plan administration. No substantive amendments to the Salary/Bonus Deferral Plan are explicitly outlined in the 2024 filing compared to the 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in substance. The ground truth indicates specific changes in the documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 filings, including the reintroduction of the plan via new exhibit numbers (Exhibit 10.13 and 10.14) and the addition of Exhibit 10.16 incorporating 1997 amendments. The LLM incorrectly claims no specific changes are detailed and fails to identify these key exhibit-level updates. (2) There are no numeric values in the question or answer requiring calculation, but the LLM omits critical dates (1988 plan, 1994 amendment, 1997 amendments) that are central to the factual record. These omissions constitute significant factual inaccuracies. (3) The multi-hop reasoning is flawed: the model fails to synthesize information across filings and exhibits, missing that the reintroduction and expansion of exhibits in 2024 represent a clear change in documentation practice. Instead, it defaults to a 'no change' conclusion despite evidence to the contrary. (4) The contextual relevance is moderate because the answer addresses the general topic (deferral plan in both filings) and notes a tangential update about director compensation, but this does not compensate for the failure to report the actual documentation changes. The answer misses the core factual developments entirely, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 396,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps has significantly decreased between 2022 and 2024 in terms of liability magnitude. As of October 2, 2022, the liability related to interest rate swaps was $34.0 million, primarily classified under other long-term liabilities. By September 29, 2024, this liability had reduced to $19.2 million, still classified under other long-term liabilities. Additionally, the cumulative fair value hedging adjustment included in the carrying amount of long-term debt shifted from a negative $52.3 million in 2022 to a negative $17.8 million in 2024, indicating a reduction in the impact of these swaps on the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the interest rate swap liability amounts for 2022 ($34.0 million) and 2024 ($19.2 million), both accurately reported and properly classified under 'other long-term liabilities', which matches the ground truth. However, the LLM omits the 2023 liability of $41.4 million mentioned in the original answer, which is a key part of the multi-year evolution and context for the 2024 reduction. This omission affects completeness and reasoning, as the decrease from 2023 to 2024 is a critical point in the trend. (2) The additional figures about the cumulative fair value hedging adjustment (-$52.3M in 2022 to -$17.8M in 2024) are factually accurate but not present in the original answer, suggesting the LLM introduced correct but extraneous data. While not incorrect, this distracts from the core focus on balance sheet classification and liability magnitude of the swaps themselves. (3) The multi-hop reasoning is partially sound—liabilities are correctly compared across years and classified, but the failure to incorporate 2023 data weakens the synthesis of the full trend from 2022 to 2024. The conclusion of 'significant decrease' is reasonable but lacks the nuance of the prior-year liability increase (2023) before the 2024 drop. (4) Scores reflect high quantitative accuracy and full contextual relevance, with a moderate deduction in qualitative accuracy due to incomplete entity synthesis across all years. Correctness is rated 7 because core facts are right but key contextual data from 2023 is missing, affecting the completeness of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 441,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, the Directors' Savings Plan at Duke Energy has remained a nonqualified, unfunded deferral mechanism allowing outside directors to defer all or part of their annual compensation, typically in the form of retainers. The plan credits deferred amounts to an unfunded account adjusted for phantom investment performance, including the Duke Energy Common Stock Fund. The lack of material changes to the plan's structure suggests Duke Energy maintains a consistent governance approach, emphasizing flexibility for directors while aligning their interests with long-term stock performance. This reflects a stable and transparent compensation governance framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the Directors' Savings Plan as a nonqualified, unfunded deferral mechanism tied to phantom investment performance, including the Duke Energy Common Stock Fund, which aligns with the ground truth. There are no numeric values, dates, or financial figures in either answer that conflict—both correctly describe the plan’s structure—so quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the evolution of the plan and Duke Energy’s governance approach. However, the qualitative accuracy is slightly lower because the LLM misses a key nuance in the evolution: the ground truth emphasizes that 2022 marked the formal introduction and documentation of the plan (with a specific amendment date), indicating active policy development, while 2024 reflects operational transparency in how deferrals are invested. The LLM instead states there is a 'lack of material changes' and emphasizes 'consistency,' which downplays the significance of the 2022 formalization as an evolution. This mischaracterizes the progression from policy establishment to operational detail, weakening the multi-hop reasoning about governance trajectory. While the conclusion about alignment with shareholder interests is reasonable, it omits the implication that increased transparency in 2024 may reflect a strategic shift in governance communication. Thus, the answer is largely correct but lacks depth in capturing the true evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 420,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has continued to strengthen its positioning as a high-quality, cost-effective alternative to national brands. The brand is emphasized as a key differentiator in merchandise offerings, contributing to higher margins and lower costs for members. Costco remains committed to expanding the sales penetration of Kirkland Signature items, reflecting its strategic importance. The associated risk profile remains relatively low, as the brand aligns with Costco’s core value proposition of offering quality products at competitive prices, which supports member satisfaction and loyalty. However, the brand's success depends on maintaining product quality and member trust, which could be impacted by supply chain disruptions or quality issues.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the continued strategic importance of the Kirkland Signature brand in both 2022 and 2023, noting its role in driving higher margins, cost efficiency, and member value. It accurately reflects Costco's commitment to expanding sales penetration of the brand. However, it fails to capture a key evolution in the risk profile between the two years. While the ground truth shows that the 2023 filing introduced a more explicit and expanded risk focus—linking supply chain disruptions, foreign exchange fluctuations, and catastrophic events directly to potential impacts on Kirkland Signature—the LLM downplays this shift by stating the risk profile 'remains relatively low.' This misrepresents the nuanced change in tone and emphasis from growth-oriented in 2022 to risk-aware in 2023. There are no numerical inaccuracies (quantitative accuracy is high), and the entities (Costco, Kirkland Signature, years 2022–2023) are correct. The reasoning is partially sound but misses the multi-hop insight that increased reliance on the brand amplifies exposure to operational and financial volatility, which is central to the question. Thus, while contextually relevant and factually consistent in parts, the answer lacks critical qualitative depth regarding the evolving risk disclosure, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 374,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 billion cubic feet (BCF) at the end of 2022 to 296 BCF at the end of 2024. The key changes in 2024 included revisions (10 BCF decrease), production (25 BCF decrease), and sales (no significant impact). Notably, there were no significant additions from extensions and discoveries or purchases in 2024, indicating a decline in reserve volumes primarily due to production and revisions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that reserves 'increased' from 326 BCF in 2022 to 296 BCF in 2024, when in fact this is a decrease. This fundamental misrepresentation severely undermines the answer's correctness. (2) While the numeric values of 326 BCF (2022) and 296 BCF (2024) are accurate, the interpretation of the trend is incorrect. The LLM also introduces specific figures for revisions (10 BCF decrease) and production (25 BCF decrease), which are not present in the original answer and cannot be verified from the provided ground truth. These additions appear to be fabricated or inferred without support. (3) The multi-hop reasoning is partially sound in that it attempts to explain changes in reserves using standard categories (revisions, production, discoveries), but it fails to accurately reflect the original conclusion that there were minimal additions and no significant sales or discoveries. The unsupported quantification of revisions and production undermines the reasoning. (4) Despite the incorrect trend statement and unsupported numbers, the answer does correctly identify the lack of significant additions from extensions, discoveries, or purchases in 2024, which aligns with the original. Contextually, it addresses the right region, company, and time frame, and uses appropriate terminology, hence the moderate contextual relevance score. However, the core quantitative and qualitative inaccuracies result in a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 423,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has evolved in terms of fleet ownership and modernization focus. As of May 31, 2022, FedEx Express owned 114 Boeing 767F aircraft with none leased. By 2024, the company emphasized modernization through the purchase of more fuel-efficient aircraft, including the Boeing 767F, as part of its aircraft modernization programs. These programs aim to replace older aircraft and achieve long-term operating savings, indicating a continued strategic focus on the Boeing 767F as part of its modernized fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that FedEx owned 114 Boeing 767F aircraft as of 2022 with no leases, matching the ground truth. It accurately reflects the continued strategic focus on the 767F in 2024 for modernization, fuel efficiency, and long-term savings. The only minor omission is that the original answer notes the lack of updated ownership figures in 2024 and emphasizes the limited flexibility to delay purchases due to significant costs—details not explicitly mentioned in the LLM response. However, the core facts, entities, and reasoning are preserved. (2) Quantitative accuracy is perfect: the number 114 is correct, and the year 2022 is accurately cited. No incorrect calculations or fabricated numbers. (3) The multi-hop reasoning is sound—linking 2022 ownership data to 2024 modernization strategy across time and strategic context. The LLM correctly infers continuity in strategic importance despite lack of updated ownership data. (4) Scores reflect near-perfect factual alignment, with a small deduction in qualitative accuracy due to the omitted nuance about procurement inflexibility and absence of 2024 ownership data, but overall semantic equivalence is strong and context fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 345,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' inventory value for roasted coffee increased from $310.3 million (as of October 2, 2022) to $310.3 million (as of September 29, 2024), indicating no change in the value of roasted coffee inventory during this period. However, the company expanded its production infrastructure, with key roasting facilities in locations such as York, PA; Minden, NV; Kunshan, China; and Kent, WA, totaling over 3.9 million square feet dedicated to roasting, warehousing, and distribution. This expansion suggests a strategic investment in roasting and logistics infrastructure to support global operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 roasted coffee inventory value of $310.3 million and accurately lists the key roasting facilities (York, PA; Minden, NV; Kunshan, China; Kent, WA), which aligns with the ground truth. However, it incorrectly states that the inventory value remained unchanged at $310.3 million in 2024, citing September 29, 2024 — a date in the future relative to available public filings as of 2024. No 2024 10-K would have been published by that date, and the ground truth does not provide a 2024 inventory value for roasted coffee, only noting infrastructure expansion. Thus, the claim of identical inventory value is unsupported and factually suspect. (2) The quantitative accuracy is partially flawed: while the 2022 number is correct, the 2024 figure is either fabricated or based on incorrect assumptions. The addition of 'over 3.9 million square feet' is not present in the ground truth and introduces unverified data, reducing quantitative reliability. (3) The reasoning is sound in connecting infrastructure expansion to increased involvement in roasting, correctly synthesizing location data across facilities to infer strategic investment. This reflects good qualitative understanding and multi-hop reasoning. (4) Contextual relevance is perfect — the answer directly addresses both inventory value and production infrastructure evolution. Despite the numerical inaccuracies, the core narrative of shifting toward active production aligns with the ground truth. The score is reduced primarily due to unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 434,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024, as both years reference the same debt instrument incorporated by reference to Exhibit 4.4 to PepsiCo's Current Report on Form 8-K filed on April 30, 2015. There is no indication of changes in terms, issuance, or usage of this specific note during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. While it correctly identifies that the 2.750% Senior Notes due 2025 were originally established via Exhibit 4.4 to the 2015 Form 8-K, it fails to capture the evolution between 2023 and 2024 as described in the ground truth. Instead of showing evolution, the LLM asserts there was 'no indication of changes,' which contradicts the ground truth that PepsiCo extended its use of the 2.750% rate to a new 2030 note, signaling strategic evolution. (2) Quantitatively, the LLM correctly references the 2.750% interest rate and the 2025 maturity, and the 2015 filing date is accurate contextually (though not the focus of the question), so numerical elements are not wrong per se, but they are misapplied to support an incorrect conclusion. (3) The multi-hop reasoning is flawed: the question asks about evolution in utilization between 2023 and 2024, requiring synthesis of how the instrument was used in each year. The LLM fails to mention the 2023 Board Resolutions authorization or the 2024 introduction of the 2.750% Senior Notes due 2030, which is the key evolution. Thus, the model misses the critical inference that PepsiCo reused the same coupon rate for a longer-term instrument, indicating strategic continuity and extension. (4) The answer is contextually relevant in discussing the notes and referencing filings, but it draws an incorrect conclusion due to lack of proper synthesis across years and documents, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 426,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased significantly from 2022 to 2024. In 2022, FedEx had planned to receive 8 B777F aircraft across 2023, 2024, and beyond, but by 2024, only 2 B777F aircraft were scheduled for delivery in 2025, with none beyond that. This reduction indicates a diminished strategic role for the B777F in FedEx's fleet planning, suggesting a potential shift in focus toward other aircraft types or operational strategies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025 — not 8 across multiple years as stated by the LLM. The LLM incorrectly claims '8 B777F aircraft across 2023, 2024, and beyond' which is not supported by the original data. The only correct quantitative point is that by 2024, only 2 aircraft were planned for 2025 with none beyond, aligning with the phase-out indication. (2) The numbers related to timing and fleet size are incorrect: the original answer specifies exact planned operations for 2024 (4 aircraft) and 2025 (2), while the LLM misrepresents both the total number and the rollout timeline. There is no mention in the ground truth of 8 aircraft or deliveries spanning 2023–beyond. (3) The reasoning about strategic shift is sound and aligns with the original conclusion — the reduction from 4 to 2 then to zero indicates a phase-out, and the LLM correctly infers a diminished strategic role and possible shift in fleet strategy. This shows adequate multi-hop synthesis in terms of interpreting implications, though based on flawed input. (4) While the qualitative reasoning and contextual relevance are strong — correctly identifying the trend and its strategic meaning — the correctness score is limited by major factual errors in fleet numbers and timing. The answer conveys a similar overall narrative but with incorrect foundational data, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 417,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolved as follows: in 2022, the net gains in AOCI were $55.3 million, increasing to $39.6 million in 2023, and further rising to $11.5 million in 2024. This decline in gains over time indicates a reduction in the positive impact of foreign currency fluctuations on the company's comprehensive income. The trend suggests that Starbucks' exposure to foreign currency fluctuations has either decreased or has become less favorable, potentially due to changes in hedging effectiveness, shifts in currency markets, or adjustments in the company's international operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million (not net gains in AOCI of $55.3 million). The LLM incorrectly states that net gains in AOCI were $55.3 million in 2022, $39.6 million in 2023, and $11.5 million in 2024. Only the 2024 figure ($11.5 million) matches the ground truth, but it is misrepresented as part of a declining trend rather than a shift from a liability to a gain. There is no mention of the $0.3 million liability in 2022 in the LLM answer, which is a key fact. (2) The quantitative inaccuracies are severe: the 2022 and 2023 figures are entirely fabricated or misattributed. The correct evolution is from a $0.3M liability in 2022 to an $11.5M unrealized gain in 2024 — not a decline in AOCI gains over three years. The LLM invents a time series that does not exist in the ground truth. (3) The multi-hop reasoning is flawed. The question requires synthesizing balance sheet liabilities (derivative liabilities) with changes in AOCI over time. The LLM fails to make this connection, instead fabricating AOCI values for 2022 and 2023 and missing the shift from liability to gain. The conclusion about reduced exposure contradicts the ground truth, which suggests increased exposure or hedging activity due to the significant unrealized gain in 2024. (4) Correctness is scored 2/10 due to one correct number (2024 gain) but major errors in others and incorrect interpretation. Quantitative accuracy is 2/10 because only one number is correct and two are wrong. Qualitative accuracy is 3/10 because the reasoning structure is logical but based on false premises. Contextual relevance is 6/10 because the answer addresses the general topic and timeframe but misrepresents the core data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 501,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent between 2023 and 2024, as both years reference the same debt instrument under broader debt disclosures. In 2023, the 2.625% Senior Notes due 2026 are listed in the 10-K as part of the company's long-term debt instruments (PEP_10k_2023.pdf, page 108). In 2024, the same notes are included in the list of authorized senior notes under Board of Directors Resolutions (PEP_10k_2024.pdf, page 130), indicating ongoing recognition within PepsiCo's comprehensive debt structure without notable changes in terms or engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in identifying that the 2.625% Senior Notes due 2026 were disclosed in both 2023 and 2024 filings, and correctly references their inclusion in the respective 10-Ks (PEP_10k_2023.pdf, page 108 and PEP_10k_2024.pdf, page 130). All entities (PepsiCo, 2.625% Senior Notes due 2026, years 2023 and 2024) are correct, and there are no errors in quantitative details such as interest rate or maturity year. However, the LLM fails to capture a key aspect of the evolution highlighted in the ground truth: the expansion of PepsiCo’s debt portfolio in 2024 to include new senior notes like the 3.000% due 2027 and 2.625% due 2029. This omission significantly weakens the qualitative analysis, as the broader context of an active and diversified capital markets strategy is missing. The LLM concludes there was 'no notable changes in terms or engagement,' which underrepresents the strategic evolution indicated by the introduction of new debt instruments. While the answer is contextually relevant and factually sound on the specific note, it lacks the multi-hop synthesis needed to compare the scope of disclosures across years and infer strategic intent. Thus, while quantitatively accurate, the qualitative reasoning is incomplete, leading to a partially correct assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 362,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles has increased from 2022 to 2024, particularly in key strategic areas such as AI, cloud, and cybersecurity. The company has made significant investments in engineering and product development, including the acquisition of Splunk in fiscal 2024, to address evolving customer needs and technological transitions. These investments reflect a growing emphasis on overcoming complex technical challenges to maintain leadership in core networking and to expand into emerging markets. However, the complexity of these initiatives introduces risks related to timely product development, market acceptance, and potential delays, which could impact Cisco's competitive position and financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the evolution of Cisco's exposure to technical hurdles from 2022 to 2024. It correctly identifies the increasing complexity and strategic importance of overcoming technical challenges, particularly in AI, cloud, and cybersecurity—consistent with the 2024 focus on AI, security, observability, and cloud. The mention of the Splunk acquisition in fiscal 2024 is factually accurate and relevant, reflecting Cisco's strategic investment to address technical and market transitions. However, the LLM answer does not fully capture the qualitative shift emphasized in the original answer: from internal execution risks (product planning, timing, resource allocation) in 2022 to broader strategic dependencies in 2024 involving reputational damage, legal liability, and customer retention. While the risks of delays and competitive impact are noted, the expanded consequences in 2024 are under-articulated. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Cisco, Splunk, fiscal 2024) are correct. The reasoning is sound and contextually relevant, synthesizing strategic investments with evolving technical challenges, but the multi-hop synthesis slightly misses the depth of the risk evolution. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 400,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided document pages, Google Ad Manager's role in driving Google Network revenues remained significant in both 2022 and 2023. In 2022, Google Network revenues were highlighted as being driven by strength in AdMob, Google Ad Manager, and AdSense. In 2023, while specific revenue figures for Google Ad Manager were not directly mentioned, the continued listing of Google Ad Manager as a primary advertising platform used by customers suggests it maintained its role in contributing to Google Network revenues. Thus, there is no indication of a significant change in its role between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that Google Ad Manager was a driver of Google Network revenues in 2022, alongside AdMob and AdSense, which aligns with the ground truth. It also correctly notes that Google Ad Manager remained a listed advertising platform in 2023. However, the key qualitative shift identified in the original answer — that Google Ad Manager went from being a specifically cited growth driver in 2022 to being part of a broader suite of tools without explicit attribution to revenue growth in 2023 — is missed entirely. The LLM incorrectly concludes there was 'no indication of a significant change in its role,' which contradicts the ground truth that highlights a clear shift in emphasis and positioning. This represents a failure in multi-hop reasoning: the model did not synthesize the change in narrative tone and strategic emphasis across the two years. While all entities (Google Ad Manager, AdMob, AdSense, Google Network) and years are correctly identified, and no numeric inaccuracies are present (the $8.6 billion figure isn't mentioned but isn't contradicted), the absence of this critical comparative insight severely undermines the answer's correctness. The answer is contextually relevant and factually consistent with parts of the data, but lacks the deeper analytical synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 374,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other decreased significantly from 2022 to 2024. In 2022, the liabilities were $0.3 million (under accrued liabilities) and $- (no amount under other long-term liabilities), while in 2024, they were $4.7 million (accrued liabilities) and $4.1 million (other long-term liabilities). The magnitude of the change was an increase of $8.5 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that derivative liabilities 'decreased significantly' when in fact they increased from $0.3 million in 2022 to $4.7 million in 2024, according to the ground truth. This mischaracterization of the trend severely undermines the answer's correctness. (2) The quantitative inaccuracies are substantial. The LLM claims that in 2024, liabilities were $4.7 million (accrued) and $4.1 million (other long-term), totaling $8.8 million, and calculates a change of $8.5 million. However, the ground truth only reports $4.7 million in 2024 under accrued liabilities, with no mention of $4.1 million in other long-term liabilities. The magnitude of change should be $4.7M - $0.3M = $4.4 million, not $8.5 million. The LLM introduces data not present in the original answer. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution of the liability over time and invents a breakdown across liability categories (accrued and long-term) that is not supported by the ground truth. The original answer specifies the amount is under 'accrued liabilities' in both years, but the LLM incorrectly splits 2024 into two categories. (4) Contextual relevance is moderate because the answer addresses the right company, metric, and time frame, but the incorrect numbers, invented data, and reversed trend severely limit its usefulness. The answer is on-topic but factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 408,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "In 2023, PepsiCo issued the 4.600% Senior Notes due 2045, as noted in the 2023 10-K on page 109. By 2024, these notes are still listed among the company's issued debt instruments, as shown on page 110 of the 2024 10-K. This continuity indicates that PepsiCo has maintained this long-term debt issuance as part of its strategy to diversify and extend its debt maturity profile, ensuring stable financing over an extended period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 4.600% Senior Notes due 2045 were part of PepsiCo's debt structure in both 2023 and 2024, and accurately references the correct pages in the respective 10-K filings (page 109 in 2023 and page 110 in 2024). The percentage (4.600%), maturity year (2045), and continuity of the notes are factually correct. (2) Quantitative accuracy is perfect: all numbers (interest rate, years) match the ground truth exactly, with no calculation errors. (3) However, the LLM answer falls short in qualitative accuracy because it fails to capture the full multi-hop reasoning present in the original answer. Specifically, it does not mention that in 2024, the 4.600% notes were referenced alongside newly introduced instruments like the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This omission weakens the analysis of PepsiCo’s strategy toward a more diversified debt portfolio. The LLM correctly infers a strategy of diversification and maturity extension but misses the key evidence of new debt instruments that support this conclusion in the ground truth. (4) The answer remains contextually relevant and logically sound, offering a reasonable interpretation of the company's long-term financing strategy, but lacks the completeness needed for a top score. Thus, correctness is scored 7 due to missing key comparative details about the evolution of the debt structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 395,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "Between 2022 and 2024, COP's natural gas position in the Asia Pacific/Middle East region showed a decline in proved reserves, from 326 BCF at the end of 2022 to 296 BCF at the end of 2024. This reduction, despite some extensions and discoveries, indicates a strategic shift or operational challenges in the region. The company appears to have reduced its focus on natural gas development in Asia Pacific/Middle East, as evidenced by minimal additions to reserves and a net decrease after accounting for production and revisions. This suggests a reallocation of resources or a strategic pivot toward other regions or energy sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the natural gas reserves for COP in the Asia Pacific/Middle East region as 326 BCF in 2022 and 296 BCF in 2024, matching the ground truth exactly. These figures are accurately represented with correct units (BCF), and the slight decrease is correctly noted. (2) The quantitative accuracy is perfect—both numbers are correct, and the implied difference of 30 BCF reduction is accurate even though not explicitly calculated. Format (BCF vs billion cubic feet) is consistent and acceptable. (3) The reasoning is sound and adds value: the LLM correctly infers a strategic shift or operational challenges, aligning with the ground truth’s suggestion of a potential strategic focus change. It enhances the original answer by mentioning 'extensions and discoveries' and 'net decrease after accounting for production and revisions,' which are reasonable inferences from reserve trends, even if not in the ground truth. This shows strong multi-hop reasoning. (4) The answer is fully contextually relevant, addressing both parts of the question: evolution of natural gas position (quantitative change) and strategic implications. The only reason for not scoring 10 is that the original answer does not mention 'extensions and discoveries' or 'revisions,' so the LLM introduces plausible but unverified details—minor overinterpretation without contradicting facts. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with slight elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 422,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy remained a consistent contributor, as reflected in the continued emphasis on platforms like Google Play for app and in-app purchase sales in both the 2022 and 2023 filings. While specific revenue figures for Google Play are not provided, the filings highlight that Google Services increasingly generates revenue from non-advertising sources, including platforms such as Google Play, alongside hardware and YouTube subscriptions. The TAC (traffic acquisition costs) related to Google Play and other distribution partners increased in 2023 due to higher revenues subject to TAC, indicating that Google Play's growth contributed to the broader non-advertising strategy. However, the TAC rate slightly decreased, suggesting potential optimization in cost efficiency. Overall, Google Play continued to play a stable and growing role in diversifying Google's revenue beyond advertising.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses the key evolution in how Google Play's revenue sources were described in the filings from 2022 to 2023. The ground truth highlights a narrowing of focus—from 'sales of apps and in-app purchases and digital content' in 2022 to a more focused 'apps and in-app purchases' in 2023—and a reclassification under the broader 'platforms' category. This strategic shift in narrative is not captured in the LLM response, which instead emphasizes stability and growth without acknowledging the change in emphasis. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable; the LLM does not introduce any incorrect figures, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesis of how the *description* and *strategic framing* of Google Play’s revenue evolved across two years in the filings. The LLM fails to identify the shift in language and categorization, instead inferring continuity and growth based on TAC trends, which, while contextually relevant, does not directly address the evolution in revenue source description. (4) Contextual relevance is high because the LLM discusses Google Play’s role in non-advertising revenue and references platforms, TAC, and related trends. However, it substitutes analysis of strategic narrative evolution with operational performance indicators (TAC changes), missing the core qualitative shift the question targets. Thus, while factually plausible, it does not align with the ground truth derived from the actual filing language changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 444,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The projected utilization of the Cessna SkyCourier 408 declined from 49 units scheduled for delivery by 2022 (as of May 31, 2022) to 31 units expected by 2025 (as of May 31, 2024). This reduction indicates a decreased strategic reliance on the Cessna SkyCourier 408 by FedEx, as the company shifted its focus to other aircraft models like the ATR 72-600F and B767F for future fleet expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected aircraft from 49 to 31, aligning with the ground truth. However, it misrepresents the timeframes: the original answer states the 2022 projection was for '2023 to thereafter' and the 2024 projection covers '2025 through 2029', but the LLM incorrectly frames the 49 units as 'scheduled for delivery by 2022', which contradicts the source (the projection was made in 2022 for future years). Similarly, stating 31 units are 'expected by 2025' misrepresents the 2024 report's projection spanning 2025–2029. (2) Quantitatively, the numbers 49 and 31 are accurate and correctly compared, earning high marks for numerical precision. (3) The qualitative reasoning is flawed: while the ground truth notes a shift from 'Increases' to 'Depends_On' in strategic relationship—indicating moderated but still significant reliance—the LLM concludes a 'decreased strategic reliance' and introduces unrelated aircraft models (ATR 72-600F, B767F) not mentioned in the original answer, reflecting unsupported inference. This fails the multi-hop synthesis by missing the nuanced strategic interpretation provided in the ground truth. (4) Contextually, the answer addresses the evolution of utilization and strategic reliance, so relevance is high, but the reasoning and entity synthesis reduce overall correctness. The conclusion diverges significantly in tone and implication from the original, which sees continued significance despite lower numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 414,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved in terms of segmentation and the types of casualty lines analyzed. In 2023, AIG has further refined its segmentation, particularly in U.S. Excess Casualty, where it segments between automobile-related claims and non-automobile claims due to the shorter-tail nature of the former. Additionally, non-automobile claims are further segmented for latent exposures such as construction defects and mass torts, which have unique loss emergence patterns. For U.S. Workers' Compensation, AIG continues to use a combination of loss development, frequency/severity, and expected loss ratio methods, with segmentation by state, industry subset, and deductible size. The expected loss ratio methods are applied to at least the three latest accident years due to the low credibility of reported losses, and adjustments are made for recent events like the impact of the COVID-19 pandemic on claims frequency, severity, and reporting patterns.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but misrepresents the core evolution of AIG's use of expected loss ratio methods between 2022 and 2023. (1) Correctly identifies segmentation by automobile vs. non-automobile claims and latent exposures like construction defects and mass torts, which aligns with the 2022 practices. It also correctly notes segmentation by state, industry, and deductible size in Workers' Compensation, which matches part of the 2023 approach. However, it incorrectly states that in 2023 AIG continued refining segmentation in U.S. Excess Casualty, when in fact the focus shifted *from* U.S. Excess Casualty *to* U.S. Workers' Compensation. This is a critical factual error in entity and temporal alignment. (2) Quantitatively, the mention of 'at least the three latest accident years' is consistent with the original answer’s reference to 'three latest accident years' in 2022, though the LLM incorrectly applies this to 2023 in the context of Workers' Compensation without confirmation in the ground truth. No explicit numbers are wrong, so quantitative accuracy is relatively high. (3) The multi-hop reasoning is flawed: the model fails to capture the strategic shift in focus between casualty lines (from Excess Casualty to Workers' Comp), instead implying continuity in Excess Casualty segmentation into 2023. It also introduces unverified details such as 'impact of the COVID-19 pandemic on claims frequency, severity, and reporting patterns,' which are not present in the original answer and constitute unsupported additions. (4) Contextual relevance is strong because the answer addresses segmentation, casualty lines, and method application, but the misattribution of focus undermines the qualitative accuracy. Overall, the answer is partially correct with significant factual and reasoning deficiencies, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 504,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the Consumer Direct Acceleration strategy. In fiscal 2022, unisex products were reclassified under Men's, and the Jordan Brand was separately reported, with unallocated products categorized under \"Others.\" By fiscal 2024, this structure remained consistent, with \"Others\" continuing to include products not allocated to Men's, Women's, Kids', or Jordan Brand. However, the 2024 reporting showed a smaller negative contribution from \"Others\" compared to 2022, indicating a more refined alignment with the consumer-focused Men's, Women's, and Kids' categories.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the structure of Nike's consumer construct in both fiscal years 2022 and 2024, noting that unallocated products were categorized under 'Others' and that Men's, Women's, Kids', and Jordan Brand were distinct categories. It accurately states that in 2022, unisex products were classified within Men's. However, the LLM introduces a claim not present in the ground truth: that the 'structure remained consistent' into 2024 with respect to unisex product classification. The original answer highlights that by 2024, there was *no specific mention* of unisex products being classified under Men's, suggesting a potential shift—this nuance is missed by the LLM, which instead assumes continuity. Additionally, the LLM adds a qualitative interpretation about 'a smaller negative contribution from Others' in 2024 compared to 2022, which is not supported by the ground truth and introduces financial performance data not present in the original answer. While the entities (Men's, Women's, Kids', Jordan Brand, Others) and years are correct, and no explicit numbers are wrong (so quantitative accuracy is high), the reasoning misrepresents the evolution by failing to acknowledge the ambiguity or potential change in unisex product classification. This constitutes a significant qualitative error in multi-hop synthesis, as the model should have noted the absence of information in 2024 as a meaningful change rather than assuming consistency. Contextual relevance is high as the answer stays focused on the classification evolution within Nike's consumer construct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 434,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 3.500% Senior Notes due 2025 remained consistent, as evidenced by the continued inclusion of these notes in the company's debt instruments filings. In 2023, the notes were referenced in filings from July 17, 2015, and in 2024, they were again listed in filings from February 28, 2013, indicating no material changes in terms or structure. This continuity suggests that PepsiCo is maintaining its existing debt obligations without early redemption or refinancing, reflecting a stable and disciplined debt management strategy focused on long-term financial planning and obligation fulfillment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained the 3.500% Senior Notes due 2025 in both 2023 and 2024, which aligns with the ground truth. However, it introduces factually incorrect filing dates—July 17, 2015, and February 28, 2013—which are not mentioned in the original answer and appear to be fabricated or misattributed. These dates undermine quantitative and factual accuracy. (2) There are no numerical calculations in this response, but the use of incorrect dates constitutes a quantitative inaccuracy because dates are critical data points in financial filings. The percentages (3.500%) and note maturities (2025) are correct. (3) The multi-hop reasoning is flawed: while the LLM correctly notes continuity in the presence of the 2025 notes, it fails to capture the key strategic evolution highlighted in the ground truth—the introduction of new long-term debt instruments like the 3.500% Senior Notes due 2040 and 3.550% due 2034. This omission means the LLM misses the core insight about PepsiCo’s shift toward diversifying its debt maturity structure. Instead, it concludes only that the strategy is 'stable and disciplined,' which is partially valid but incomplete and less insightful. (4) The contextual relevance is moderate because the answer addresses the evolution of the specific notes and debt management, but it lacks the broader strategic interpretation supported by the addition of new long-term debt. Thus, while semantically plausible, it does not fully reflect the multi-hop synthesis required to compare debt portfolios across years and infer strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 442,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP's financial disclosures for the Lower 48 region showed notable changes in capital expenditures and future cash inflow revisions. In 2022, capital expenditures for the Lower 48 were $3,129 million, increasing to $29,952 million in 2024, reflecting significant investment in development and acquisitions. Future cash inflows for the Lower 48 rose from $195,605 million in 2022 to $164,264 million in 2024, indicating revised expectations, likely influenced by market conditions and operational adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, COP reported capital expenditures of $3,129 million for the Lower 48 region. However, the LLM incorrectly states that capex increased to $29,952 million in 2024, which is not supported by the original answer—no new capital expenditure figure was provided for 2024. This is a critical error. Additionally, the LLM fabricates future cash inflow numbers: $195,605 million in 2022 and $164,264 million in 2024, neither of which appear in the ground truth. The original answer mentions revisions to reflect additional future cash inflows and production costs but does not provide specific figures. (2) Quantitative accuracy is extremely low: both capex and future cash inflow numbers are entirely incorrect or hallucinated. There is no indication in the ground truth that capex increased to nearly $30 billion or that specific cash inflow values were disclosed in those years. (3) The multi-hop reasoning is flawed. The original answer indicates a shift from active investment (2022) to revised financial projections (2024), implying a qualitative change in disclosure focus. The LLM instead interprets this as a quantitative increase in capex and a decrease in future cash inflows, drawing incorrect conclusions about investment growth and market influences. It fails to recognize the absence of a 2024 capex figure and misrepresents the nature of the disclosures. (4) Contextual relevance is moderate—the response addresses the Lower 48 region, capital expenditures, and future cash inflows as asked, and attempts to compare 2022 and 2024. However, due to severe factual and quantitative errors, the answer misleads rather than informs. Correctness and quantitative accuracy are severely penalized; qualitative accuracy is low due to flawed reasoning, though some relevant concepts are mentioned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 513,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group evolved as follows: \n\nIn 2023, the Fourth Amended and Restated Shareholders Agreement with Atairos Group was amended on June 2, 2023 (Exhibit 10.28 in 2023 filing). By 2024, the capital obligations under the Atairos agreement remained capped at a total commitment of up to $4.5 billion, with annual capital calls limited to $400 million plus previously distributed amounts. Comcast also committed to fund $40 million annually for a management fee. Governance structures continued to centralize control with management companies led by Comcast's former CFO, who holds all voting rights, while Comcast retained economic interests with the right to 86% of residual returns and obligation to absorb 99% of losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the $4.5 billion total capital commitment, $400 million annual capital call limit, $40 million annual management fee, 99% loss absorption by Comcast, 86% residual returns, and governance control retained by management companies led by Comcast’s former CFO with all voting rights. The June 2023 amendment date (June 2) is correctly specified, even adding a detail (Exhibit 10.28) not in the original answer but consistent with filing conventions. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and limits match the ground truth. The reduction from $5 billion to $4.5 billion is implied by stating the 2024 cap, though not explicitly mentioned as a reduction—this is a minor omission but not incorrect. (3) Multi-hop reasoning is sound: the answer synthesizes changes in financial commitments and governance across 2023 and 2024, correctly identifying the shift to a more formalized equity method framework (implied by updated terms). (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 structure operates under 'equity method accounting'—a qualitative nuance—but conveys the economic substance. Otherwise, the answer is complete, factually precise, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 370,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with planned deliveries dropping from 49 aircraft by 2027 in 2022 to just 31 by 2025 in 2023. This reduction suggests a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F and Boeing models, which retained more consistent delivery commitments. The shift may indicate a reallocation of focus toward larger or more efficient aircraft better suited to FedEx's evolving operational needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected Cessna SkyCourier 408 aircraft from 49 to 31, which matches the ground truth. However, it incorrectly states the 2023 projection end year as 2025 instead of 2029, a significant factual error in timeline. The original answer specifies 'through 2027' (2022 filing) and 'through 2029' (2023 filing), so the LLM misrepresents the forward-looking period. (2) The numbers 49 and 31 are accurate, but the end dates are not. This affects quantitative accuracy because the time horizon is part of the projection context and impacts interpretation of fleet planning. (3) The reasoning about strategic role is sound—correctly inferring diminished importance and comparing to other aircraft types like Boeing models (B767F/B777F, though LLM mentions ATR 72-600F not in original). The synthesis across filings and strategic interpretation is logical and aligns with the ground truth. (4) Scores reflect mostly correct facts with a key error in date range, minor entity shift (ATR vs Boeing focus), but strong qualitative reasoning and relevance to the strategic question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 321,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike's approach to the Air Max product line shows increased emphasis on technological innovation, as evidenced by the mention of Air Manufacturing Innovation, a wholly-owned subsidiary responsible for Air-Sole and cushioning components in 2024, which was not explicitly detailed in 2022. However, there is no significant change in revenue transparency for the Air Max line, as neither document provides specific revenue figures for individual product lines like Air Max; both years report revenues by product category (footwear, apparel, equipment) and distribution channel rather than by specific technologies or sub-brands.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, there are no numeric inaccuracies—both the original and LLM answers confirm no specific revenue figures were disclosed for Air Max in either 2022 or 2024, which is accurately reflected. (2) The LLM correctly identifies that revenue transparency did not improve, as Nike continued to report revenues by broad categories (footwear, apparel) rather than by sub-brands or technologies like Air Max. (3) On innovation emphasis, the LLM introduces a specific detail—'Air Manufacturing Innovation,' a wholly-owned subsidiary highlighted in 2024—as evidence of increased technological focus, which supports the ground truth's claim of Air Max being positioned as a key innovation driver. While the original answer does not mention this subsidiary, the LLM’s use of it as evidence for heightened innovation emphasis is consistent with and enriches the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly note the shift from Air Max being 'listed among technologies' in 2022 to being a 'central example of innovation' in 2024, which is a key nuance in the original answer. However, the core reasoning about increased innovation focus and unchanged revenue transparency is sound and factually accurate. Thus, the answer earns high marks for correctness and relevance, with a slight deduction in qualitative accuracy for missing the rhetorical shift in how Air Max was presented in disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 412,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast increased its capital expenditures for Epic Universe from 2023 to 2024, with 2024 expenditures specifically tied to the development of the theme park in Orlando. While specific investment amounts for 2023 and 2024 are not provided, the 2024 report indicates that capital expenditures for the Theme Parks segment increased due to Epic Universe development. The company also emphasized continued investment in new attractions at Universal theme parks, including Epic Universe, as a priority in 2025.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses key quantitative details from the ground truth. It incorrectly states that 'specific investment amounts for 2023 and 2024 are not provided,' which is inaccurate because the original answer clearly specifies that $8.2 billion was allocated to Connectivity & Platforms in 2023, which included Epic Universe infrastructure. This figure is critical and was omitted. Additionally, the LLM implies no specific numbers were disclosed in either year, while the ground truth confirms the 2023 amount and explains that only 2024's breakdown (not total) was unspecified. (2) The quantitative accuracy is low because the model fails to report the $8.2 billion figure for 2023, a central data point. It also does not clarify that while Epic Universe-specific figures were not broken out in 2024, broader Theme Parks capex increases were attributed to it. There are no calculation errors per se, but the absence of a key number undermines factual completeness. (3) The reasoning is partially sound: the model correctly identifies the ongoing investment in Epic Universe and the emphasis on new attractions as part of a multi-year strategy, including a forward look to 2025. However, it fails to capture the evolution in focus—from infrastructure-heavy spending in 2023 to a broader guest experience and capacity expansion in 2024—thus missing the nuanced strategic shift. (4) Contextual relevance is high because the answer stays focused on the question about capex strategy evolution and thematic park priorities. Despite missing key data, it correctly identifies the continuity of investment and strategic importance of Epic Universe. Overall, the answer is directionally correct but lacks precision and key details required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 491,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft increased in terms of planned fleet additions. In 2022, FedEx had committed to purchasing 24 ATR 72-600F aircraft across 2023 to 2026, with 11 planned for 2023. By 2023, the commitment was adjusted to 10 ATR 72-600F aircraft in total, with all planned deliveries scheduled for 2025 and 2026. This shift indicates a postponement of deliveries rather than a reduction in overall planned acquisitions, reflecting evolving strategic or operational priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections changed to 7 for 2025 and 3 for 2026. The LLM incorrectly states that in 2022, FedEx committed to purchasing 24 ATR 72-600F aircraft across 2023–2026, which is not supported by the ground truth. The ground truth does not mention a 24-aircraft purchase commitment or a total of 10 aircraft planned by 2023. Instead, it reflects fleet operation projections, not purchase commitments. (2) The numbers are fundamentally wrong: the LLM invents a 24-aircraft purchase and a revised 10-aircraft plan, neither of which appear in the original answer. The correct trend is a reduction in projected utilization over time (from 11 → 1 between 2023 and 2026 in the 2022 projection, then further reduced to 7 in 2025 and 3 in 2026 in the 2023 projection). (3) The multi-hop reasoning is flawed: the LLM misinterprets fleet operation projections as purchase commitments and incorrectly frames the change as a 'postponement' rather than a reduction in planned usage. It fails to capture the downward trend in projected fleet size over time, which is the key insight in the ground truth. (4) The contextual relevance is moderate because the answer discusses the right aircraft and time periods, but the core facts and conclusion are incorrect, leading to a low correctness score. The qualitative and quantitative accuracy are low due to fabricated numbers and mischaracterized trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 440,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves became more detailed and transparent, with a clearer explanation of how reserves are calculated based on historical rates, specific identification of outstanding returns, and estimated future returns. In fiscal 2022, the sales-related reserve was $1,015 million, while in fiscal 2024, the methodology emphasized variable consideration and the timing of revenue recognition based on when control is transferred to the customer. This evolution indicates a refinement in Nike's revenue recognition methodology, aligning more closely with ASC 606 standards by improving the accuracy of variable consideration estimates and enhancing transparency in financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that Nike's estimated cost of inventory for expected product returns in fiscal 2022 was $269 million, recorded in Prepaid expenses and other current assets. However, the LLM incorrectly claims the 'sales-related reserve' was $1,015 million in fiscal 2022, which is not supported by the original answer and misrepresents both the amount and the nature of the reserve. Additionally, the LLM states that in fiscal 2024, Nike emphasized variable consideration and control transfer timing, but the original answer does not mention $1,015 million or this specific phrasing about control transfer—instead, it highlights a shift to estimating 'most likely amount' for variable consideration. (2) The calculation and number verification fails: $1,015 million is materially different from $269 million, and no such figure appears in the ground truth. The LLM invents a number not present in the source, which severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that Nike’s methodology evolved toward a more refined, ASC 606-aligned approach involving variable consideration. This aligns with the ground truth's mention of a shift toward probabilistic estimation under the revenue recognition framework. However, the reasoning is based on incorrect data, weakening its validity. (4) Contextual relevance is moderate: the answer addresses the evolution in estimation approach and links it to revenue recognition methodology, which is relevant. However, due to the incorrect dollar amount and mischaracterization of the reserve (e.g., 'sales-related reserve' vs. 'inventory cost for returns'), the qualitative accuracy is reduced. The core insight about alignment with ASC 606 is correct but not enough to offset major factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 518,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "Between 2022 and 2023, the planned fleet composition of the Cessna SkyCourier 408 for 2025 and beyond decreased from 12 units in 2022 to 17 units in 2023, indicating a reduced strategic reliance on this aircraft model for future operations. The overall planned orders for the Cessna SkyCourier 408 dropped from 49 units in 2022 to 31 units in 2023, suggesting a shift in focus toward other aircraft models like the ATR 72-600F and B767F. This change reflects a strategic adjustment in fleet planning, likely driven by operational needs, cost considerations, or evolving market demands.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the planned fleet composition decreased from 12 to 17 units, which is contradictory—'decreased' is used when the number actually increased. The correct change is an increase from 12 to 17 for 2025, then a reduction to 14 for 2026. The LLM fails to mention the 2026 figure entirely. Additionally, the claim that 'overall planned orders dropped from 49 to 31' is not supported by the ground truth and introduces fabricated data. (2) Quantitative accuracy is poor: while the 12 (2022) and 17 (2025) figures are correctly mentioned, the direction of change is mischaracterized as a decrease. The 2026 number (14) is omitted, and the made-up totals of 49 and 31 units have no basis in the original answer. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers reduced strategic reliance despite an increase in planned units for 2025, which contradicts the ground truth's conclusion of short-term increased reliance. The mention of ATR 72-600F and B767F is extraneous and unsupported by the provided information. (4) Contextual relevance is moderate—the answer addresses fleet composition changes and strategic reliance, but due to factual errors and incorrect synthesis, the conclusion is invalid. The structure follows the question, but the content is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 383,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing the number of markets where it operates or implements real-time payments infrastructure, growing from 13 markets as of December 31, 2023, to not explicitly stated but implied to have further expanded in 2024. Additionally, the infrastructure now supports enhanced security features, including fraud scoring, tokenization services, and a multi-layered approach to protect the global payments ecosystem, ensuring secure and seamless transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard operated or was implementing real-time payments infrastructure in 13 markets as of 2023, which matches the ground truth. However, it notes that the 2024 market count is 'not explicitly stated but implied to have further expanded,' which is accurate in that the original answer confirms expansion without specifying a new number. This cautious phrasing is appropriate and does not introduce false precision. (2) All numeric references (13 markets in 2023) are correct, and no incorrect calculations are made. The LLM avoids fabricating a specific number for 2024, which aligns with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information about operational scale (market expansion) and security enhancements (fraud scoring, tokenization, multi-layered security) across years, correctly inferring a progression from 2023 to 2024. It captures the strategic evolution even without exact 2024 figures. (4) The answer is contextually fully relevant, addressing both operational scale and security capabilities as asked. Minor deduction in correctness and qualitative accuracy due to slightly less detailed elaboration on the nature of 2024 enhancements (e.g., ACH integration, intelligent routing, value-added services) compared to the original, but core facts and synthesis remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 383,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options had a notable impact on its financial liabilities and hedging strategy. In 2022, these instruments resulted in a net gain reclassification of $19 million before tax, primarily affecting revenues, cost of sales, and other expenses. By 2024, the net gain reclassified increased to $270 million before tax, with significant gains in cost of sales ($294 million) and revenues ($24 million). Additionally, the total derivative liabilities related to foreign exchange forwards and options rose from $145 million in 2023 to $146 million in 2024, indicating a slight increase in liabilities but a more pronounced positive impact on financial results through effective hedging. Nike's hedging strategy remained focused on mitigating foreign currency risks, with a central program managing exposures across geographic segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million *after tax*, but the LLM incorrectly reports a $19 million gain *before tax*. The 2024 data in the original answer does not mention any reclassification gains; instead, it highlights an increase in liabilities to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities. However, the LLM claims a $270 million before-tax gain reclassified in 2024 and breaks it down into $294 million in cost of sales and $24 million in revenues—none of which appears in the ground truth. Additionally, the LLM introduces a $145 million liability figure for 2023 and $146 million in 2024, which are not present in the original answer. (2) The quantitative inaccuracies are severe: all key numbers (gains, tax treatment, liability amounts, years) are either fabricated or misstated. The original answer does not provide any before-tax reclassification gains for 2022 or 2024, nor does it mention 2023 liabilities. The only liability figures given are $110 million and $5 million in 2024, totaling $115 million—still far from the $146 million claimed. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution from financial impact (gain) in 2022 to liability reporting in 2024. Instead, it invents a narrative around increasing gains and rising derivative liabilities over three years, which is unsupported by the ground truth. The core evolution described in the original—increased liabilities indicating a shift in management or reporting—is missed entirely. (4) Despite the factual errors, the LLM stays contextually relevant by addressing Nike’s hedging strategy, foreign exchange instruments, and their financial impact. It correctly identifies the purpose of hedging (mitigating currency risk) and mentions geographic exposure management, which aligns with typical corporate hedging programs. However, the severe numerical and factual discrepancies drastically reduce correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 576,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In 2022, Puffs was classified under the \"Family Care\" sub-category within the Baby, Feminine & Family Care segment. By 2023, Puffs remained within the same segment but was reclassified under the broader \"Family Care\" category without specifying sub-categories, indicating a simplification or restructuring of how the category was presented.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that in 2022, Puffs was classified under the 'Family Care' sub-category and remained in the same segment in 2023, which matches the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022 and 2023) are correct. (3) The reasoning is sound: the model correctly infers a shift in reporting structure—specifically, a move from a more detailed sub-category listing (including 'Tissues') to a broader, less granular presentation—indicating simplification or restructuring, which is consistent with the original answer's interpretation. (4) The only minor difference is in wording: the original mentions that 'Tissues' was replaced with a more general listing, while the LLM says 'without specifying sub-categories,' which is semantically equivalent but slightly less precise in describing the change in disclosure. However, this does not affect factual correctness. All parts of the question are addressed, entities are accurate, and the synthesis across years is valid. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 365,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Tampax remained within the Baby, Feminine & Family Care segment in both 2022 and 2023, positioned under the Feminine Care sub-category. In both years, it was listed as one of the major brands within this segment, alongside Always and Always Discreet. There is no indication of a change in its categorization or associated product lines between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no change in Tampax's categorization between 2022 and 2023. The ground truth states that in 2022, Tampax was under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, but by 2023, it was repositioned under a more specific 'Menstrual Care' sub-category, reflecting a strategic refinement. The LLM incorrectly asserts that the categorization remained unchanged and that Tampax stayed under 'Feminine Care' in both years. This misrepresents the evolution in P&G's product portfolio structure. While the broader segment ('Baby, Feminine & Family Care') is correctly identified and no numeric inaccuracies are present (hence full quantitative accuracy), the qualitative analysis fails on entity accuracy (wrong sub-category for 2023) and reasoning (missed multi-hop insight about repositioning). The answer is contextually relevant—addressing the right segment and timeframe—but fundamentally wrong on the key point of categorization change. Thus, the correctness score is low due to a critical factual error in the synthesis of portfolio evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 318,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's strategy for Oracle Engineered Systems shifted toward a reduced emphasis on nonstrategic hardware offerings, leading to lower sales volumes and a decline in hardware revenue contribution. In fiscal 2022, hardware revenues decreased by 5%, and Oracle continued to focus on cloud-based infrastructure technologies. For fiscal 2023, Oracle reiterated its commitment to investing in research and development to improve existing hardware products and develop new ones, but the hardware business remained a smaller portion of total revenues (6% in fiscal 2023). This reflects a strategic pivot toward higher-margin cloud offerings while maintaining selective investment in hardware innovation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that Oracle maintained R&D investment in hardware for fiscal 2023 and that hardware represented 6% of total revenue in that year, which aligns with the ground truth. However, it introduces a claim not present in the original answer—that hardware revenues decreased by 5% in fiscal 2022 and that Oracle shifted toward reducing nonstrategic hardware offerings—information absent from the ground truth and potentially misleading. The original answer does not mention any revenue decline or strategic de-emphasis, only a change in disclosure and continued R&D investment. (2) The 6% revenue figure in fiscal 2023 is accurately reported, and fiscal years are correctly referenced. However, the 5% revenue decrease in fiscal 2022 is not supported by the ground truth, making this a significant quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—linking R&D plans in 2023 and revenue contribution—but incorrectly infers a strategic retreat from hardware, which contradicts the original answer’s emphasis on continued investment and clearer strategic positioning. The model fails to accurately synthesize the evolution as one of improved clarity and forward-looking investment rather than contraction. (4) The contextual relevance is high because the answer addresses revenue contribution and R&D investment as asked. However, the correctness score is limited by unsupported claims and misrepresentation of strategic direction, despite including key correct elements like the 6% figure and R&D focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 442,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans saw a notable increase in private fund investments. In 2022, the total fair value of private funds was $90 million, classified with $54 million in Level 2 and $36 million in Level 3. By 2023, this increased to $115 million, with $41 million in Level 2 and $74 million in Level 3. This shift reflects a greater allocation to Level 3 investments, indicating an increase in less observable valuation inputs for private funds within the Non-U.S. pension plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Honeywell reported $1,105 million in private fund investments for its U.S. pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $90 million in Non-U.S. plans for 2022 with a split of $54M Level 2 and $36M Level 3—none of which appears in the ground truth. The 2023 data is partially correct: $115M total in Non-U.S. plans with $41M Level 2 and $74M Level 3 matches the original answer. (2) Quantitative accuracy fails on the 2022 figures—$90M vs. $1,105M is a major discrepancy, and misattribution to Non-U.S. plans compounds the error. The 2023 numbers are accurate. (3) The reasoning is flawed because the LLM misidentifies the geography of the 2022 investment (Non-U.S. vs. U.S.), preventing correct multi-hop synthesis. It incorrectly frames the trend as an 'increase' in Non-U.S. investments when the original answer highlights a significant decrease overall and a shift from U.S. to Non-U.S. plans. (4) Contextual relevance is moderate because the answer discusses the right topic (private fund allocation across fair value levels) and correctly interprets the increased proportion of Level 3 in 2023 for Non-U.S. plans, but the foundational data errors severely undermine correctness. The core narrative of the answer contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 391,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which had a principal amount of $1,000 million and a maturity date of April 2024, were fully repaid in April 2024. This repayment marked the conclusion of this debt obligation. No further actions were taken regarding the 2014 USD Notes in 2024, as they were no longer outstanding after their maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2014 USD Notes had a $1 billion principal (stated as $1,000 million), matured in April 2024, and were fully repaid at maturity. This aligns with the ground truth, which specifies that $1 billion of principal matured and was paid in full in April 2024. The classification of the notes as short-term debt in 2023 is omitted, but the core evolution—transition from near-term liability to settled debt—is accurately conveyed. (2) Quantitatively, all figures are correct: $1,000 million = $1 billion, and the April 2024 maturity date matches exactly. No calculations are required, but the repayment amount and timing are precise. (3) The reasoning is sound: the LLM correctly infers that repayment at maturity concludes the obligation and that no further actions were needed in 2024. It synthesizes the status change across years, though it does not explicitly reference the 2023 classification as short-term debt, which is a minor omission in completeness. (4) The answer is contextually fully relevant, directly addressing the evolution and actions taken. The only reason for not scoring a 10 is the lack of explicit mention of the 2023 short-term debt classification, which is part of the full evolution but does not undermine the factual correctness of the core events in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 373,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Between 2022 and 2024, the documentation of Lowe's Officer Indemnification Agreements remained consistent in form, as both years reference the same agreement structure under similar exhibit numbers (e.g., 10.31 in 2022 and 10.23 in 2024). However, the 2024 filing includes updated references to broader governance policies, such as the Senior Officer Compensation Recovery (Clawback) Policy (Exhibit 97.2), indicating a more robust framework for executive accountability and risk management. This evolution suggests that Lowe's is enhancing its governance continuity by aligning indemnification practices with additional safeguards to mitigate executive risk and ensure compliance with evolving regulatory expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The ground truth states that the Officer Indemnification Agreement was unchanged and refiled without amendment in both 2022 and 2024, using the same exhibit number (10.43) originally filed on April 2, 2019. However, the LLM claims different exhibit numbers (10.31 in 2022 and 10.23 in 2024), which contradicts the original data. Additionally, the LLM asserts that the 2024 filing includes updated references to a 'Senior Officer Compensation Recovery (Clawback) Policy' under Exhibit 97.2 as part of the indemnification agreement evolution—this is unsupported by the ground truth, which makes no mention of such integration or policy linkage. (2) Quantitative inaccuracies include the incorrect exhibit numbers and the implied timeline of changes between 2022 and 2024. There are no correct numerical or date-based facts in the LLM response that align with the ground truth beyond the correct years (2022–2024), which are part of the question prompt. The filing date (April 2, 2019) and consistent exhibit number (10.43) are missing or misrepresented. (3) The multi-hop reasoning is flawed: the model incorrectly infers an evolution in documentation and governance based on non-existent changes. It fails to recognize that the continuity of the same unamended exhibit across filings is the key insight, instead fabricating a narrative of enhancement. There is no evidence in the ground truth that clawback policies were integrated into or referenced by the indemnification agreements. (4) The contextual relevance is moderate because the answer addresses executive risk management and governance continuity as asked, but the conclusions are based on false premises. Due to major factual and reasoning errors, the correctness score is low at 3, with similarly low scores for quantitative (2) and qualitative accuracy (3). Contextual relevance is scored 6 because the topic and intent align with the question, despite incorrect content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 539,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the information provided in the 2022 and 2023 10-K filings, Always Discreet's market share in the adult incontinence category increased from \"about 15% market share in the markets in which we compete\" in 2022 to \"over 10% market share in the key markets in which we compete\" in 2023. The positioning of Always Discreet remained consistent as a key brand in the adult incontinence sub-category under the Baby, Feminine & Family Care segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors. (1) Quantitative inaccuracy: The 2022 filing states 'over 10%' market share, not 'about 15%', and the 2023 filing does not provide any specific market share figure—certainly not 'over 10%' as a new or increased number. The LLM incorrectly implies both years have explicit market share disclosures and falsely claims an increase, when in fact the 2023 filing omits the metric entirely. (2) Completeness: The answer fails to note the key change—that P&G stopped disclosing a specific market share in 2023, which is central to the ground truth. Instead, it invents a comparison that does not exist. (3) Entity and reasoning errors: While the brand and segment (Baby, Feminine & Family Care) are correctly identified, the reasoning is flawed—the absence of a number in 2023 does not equate to 'over 10%' being newly reported. The model misinterprets the lack of data as a continuation or increase, when the actual shift is a removal of quantitative disclosure. (4) Semantic mismatch: The conclusion that market share increased is factually wrong and contradicts the ground truth, which notes a shift in communication strategy, not a numerical change. The contextual relevance is moderate because it addresses the right brand and category, but the core factual claims are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 368,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Oracle's strategic positioning of Engineered Systems between 2022 and 2023 has evolved to reinforce their role in supporting Oracle's cloud transformation narrative. Engineered Systems, such as Oracle Exadata, remain central to Oracle's infrastructure offerings, serving as pre-integrated platforms that optimize performance for Oracle Database and other cloud-based and on-premise environments. These systems are increasingly marketed through flexible deployment options, including as cloud offerings in Oracle Cloud Infrastructure (OCI) and hybrid models, aligning with Oracle's broader push toward cloud adoption. This evolution underscores Oracle's strategy to leverage Engineered Systems as a bridge for customers migrating from on-premise to cloud environments, thereby enhancing Oracle's cloud ecosystem and long-term growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Oracle's Engineered Systems as part of its cloud transformation narrative and their role in hybrid and cloud deployments, which aligns with the ground truth. It accurately describes Engineered Systems (e.g., Exadata) as pre-integrated platforms supporting both on-premise and cloud environments and emphasizes their strategic use in customer migration to the cloud. However, it omits key quantitative and structural details from the original answer. Specifically, it fails to mention that hardware revenues—including Engineered Systems—represented 6% of total revenues in fiscal 2023 and 2024, a critical data point for assessing the business impact. It also does not reference the 2023 strategic shift to group Engineered Systems under a broader hardware business category (including servers, storage, and operating systems) with combined performance obligations, which is a significant change in reporting and positioning. Additionally, the R&D investment note in the original answer is missing. (2) There are no numerical inaccuracies because the LLM avoids citing specific numbers, so no incorrect figures are presented—this results in full credit for quantitative accuracy by default, though the lack of numbers limits completeness. (3) The multi-hop reasoning is partially sound: the model connects Engineered Systems to Oracle’s cloud strategy across years and infers their bridging role in hybrid deployments. However, it fails to synthesize the full scope of the 2023 repositioning involving financial reporting changes and revenue context, indicating a gap in deeper strategic implications. (4) The correctness score is 7 because the core qualitative direction is accurate and contextually relevant, but important factual and strategic details from the ground truth are missing, reducing completeness and depth. Qualitative accuracy is 7 due to correct entities and general logic but incomplete synthesis. Contextual relevance is high as the response directly addresses the question’s focus on strategic evolution and cloud alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 566,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan became more explicit. In the 2023 filing, it was stated that the 2020 Stock Plan is the \"successor to the 2011 Stock Plan\" and that shares available under the 2011 Stock Plan at adoption were carried forward to the 2020 Stock Plan. In contrast, the 2022 filing only mentioned that the 2020 Stock Plan was adopted subject to stockholder approval and did not explicitly describe it as the successor to the 2011 Stock Plan.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and content. (1) The original answer states that the 2022 10-K included a specific disclosure about 5,530,106 shares being carried forward from the 2011 Stock Plan to the 2020 Stock Plan, but this detail was omitted in the 2023 10-K. In contrast, the LLM claims the opposite: that the 2023 filing added more explicit language calling the 2020 Plan the 'successor' and referencing carry-forward, while the 2022 filing lacked it. This reverses the actual evolution. (2) There is a complete mismatch in quantitative accuracy—the key number 5,530,106 is missing from the LLM response, and no numeric detail about shares is provided, despite being central to the ground truth. (3) The multi-hop reasoning is flawed: the question asks how the relationship disclosure evolved between two years, requiring accurate comparison across filings. The LLM incorrectly characterizes the 2022 disclosure as lacking successor language and the 2023 as adding it, when in fact the 2023 filing removed specific linkage details. (4) Contextual relevance is low but not zero—the response addresses the 2020 and 2011 Stock Plans and attempts a year-over-year comparison, so it stays on topic—but the factual inversion renders it highly misleading. Due to total factual inaccuracy and reversed logic, the correctness score is near minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 379,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Between 2022 and 2023, Honeywell slightly reduced its allocation to private funds within its U.S. pension plans, with the value of private funds dropping from $1,258 million in 2022 to $1,265 million in 2023. However, the overall shift is minimal, and the company continues to maintain a consistent allocation strategy within its target ranges (10%-20% for other investments, which include private equity). This suggests that Honeywell's capital deployment priorities remain focused on maintaining a diversified portfolio aligned with long-term investment objectives, emphasizing stability and risk-adjusted returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers and direction of change. It incorrectly states that Honeywell 'slightly reduced' its allocation from $1,258 million in 2022 to $1,265 million in 2023, when in fact the correct figures are $1,244 million in 2022 and $1,265 million in 2023, representing a slight increase (not decrease), and the starting value is wrong. The $1,258 million figure does not appear in the ground truth and is inaccurate. (2) The calculation is flawed: the LLM implies a decrease despite citing a higher number in 2023, which contradicts basic arithmetic. The correct increase is approximately 1.7% ((1,265 - 1,244)/1,244 ≈ 0.0169), but the model fails to compute or report this correctly. (3) The qualitative reasoning about strategic stability and diversification is partially sound and aligns with the original answer’s interpretation, and the mention of target allocation ranges (10%-20%) adds relevant context, though this detail was not in the ground truth and cannot be verified. However, the multi-hop synthesis is compromised due to incorrect base data. (4) The contextual relevance is fair because the answer addresses the question's intent regarding strategy evolution and capital priorities, but the factual foundation is unsound, severely undermining the conclusion. Thus, correctness is low due to major quantitative inaccuracies, despite some relevant qualitative themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 402,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock emerged as a new class following the Class B-1 Common Stock exchange offer in May 2024. In 2023, no shares of Class B-2 were outstanding. In 2024, 49 million shares of Class B-2 were outstanding, issued in exchange for 241 million shares of Class B-1 Common Stock. Class B-2 shares are subject to conversion rate adjustments with double the impact compared to Class B-1 shares and are governed by the same transfer restrictions and litigation-related conditions as other Class B stocks.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Class B-2 Common Stock between 2023 and 2024. (1) Quantitatively, the claim that '49 million shares of Class B-2 were outstanding in 2024' and that they were 'issued in exchange for 241 million shares of Class B-1' is unsupported by the ground truth, which states no such issuance occurred and that the 2024 filing did not report any outstanding shares or updates on Class B-2. The numbers (49M, 241M) are entirely fabricated. (2) The timeline is incorrect: the LLM claims Class B-2 emerged in May 2024, but the ground truth indicates it existed in 2023 in relation to conversion adjustments and litigation escrow, not as a result of a 2024 exchange offer. (3) Qualitatively, the LLM incorrectly implies Class B-2 became active in 2024, while the ground truth shows it was referenced only historically in 2024, with no new disclosures—suggesting reduced relevance or discontinuation, not activation. (4) The LLM invents details about 'double the impact' conversion rates and transfer restrictions not present in the original answer. (5) Contextually, the answer addresses the question's topic and attempts to compare years and stock classes, so it maintains moderate relevance despite factual failures. Overall, the answer fails on correctness due to invented data and reversed reasoning about the stock's status trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 390,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program increased significantly between 2022 and 2024, with deferred revenue rising from $89 million in 2022 to $19 million in 2024. This indicates a shift in the program's structure, likely due to the introduction of the Target Circle 360 membership, which may have altered how rewards and associated liabilities are recognized. The change suggests the program has evolved to offer more premium features or a tiered structure, affecting the timing and recognition of related revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2024 deferred revenue amount. The ground truth states that deferred revenue was $117 million as of February 3, 2024, but the LLM incorrectly states it was $19 million in 2024. The $19 million figure actually corresponds to February 1, 2025, not 2024. This misrepresentation completely inverts the trend: the correct data shows an increase from $89M (2022) to $117M (2024), not a decrease to $19M. (2) The calculation and comparison of financial obligations are therefore fundamentally flawed. The LLM suggests a decline between 2022 and 2024, when in fact there was a significant increase. The drop to $19M occurred only in 2025, which the LLM misattributes to 2024. (3) The reasoning about the Target Circle 360 membership and structural changes is speculative and not supported by the original answer, which does not mention this program tier. While the idea of program evolution is thematically relevant, the logic is based on incorrect data and introduces unverified explanations. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of financial obligations in Target Circle) and attempts to interpret the trend, but the incorrect numbers and timeline severely undermine the validity. The qualitative reasoning would be stronger if based on accurate data. Due to the severe quantitative inaccuracy that distorts the core finding, the overall correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 414,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million as of December 31, 2022, to $996 million as of December 31, 2023. This slight increase in fair value suggests that investor perception of Netflix's creditworthiness remained stable or improved slightly, or that broader market conditions for debt instruments improved during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the fair value 'decreased from $980 million ... to $996 million', which is incorrect because $996 million is higher than $980 million, meaning the value increased, not decreased. The original answer correctly notes the increase from $980M to $996M but mischaracterizes it as a 'decrease'—however, the LLM repeats this contradiction by using the word 'decreased' while citing numbers that show an increase. This fundamental inconsistency undermines the quantitative accuracy. (2) The numeric values themselves—$980 million on December 31, 2022, and $996 million on December 31, 2023—are factually correct and match the ground truth. Dates and entity (Netflix's 4.375% Senior Notes) are accurate. However, the directional description (decrease vs. increase) is wrong, leading to a major error in interpretation. (3) The reasoning is partially sound: the LLM correctly infers that a rise in fair value toward par suggests stable or improved credit perception. This aligns with financial logic and the original answer’s conclusion. However, because the LLM incorrectly frames an increase as a decrease, the multi-hop synthesis fails on coherence despite having correct component data. (4) The contextual relevance is high—the response addresses both parts of the question (change in fair value and its implication) and discusses investor perception and market conditions appropriately. However, the core contradiction between numbers and narrative severely limits correctness. A score of 4 reflects that some facts are right but the central claim is factually inverted, leading to significant misunderstanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 460,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock remained largely unchanged in terms of share issuance, with 10 shares issued and outstanding in both years. Class C Common Stock is part of Visa’s complex capital structure, which includes Class A, B-1, and B-2 common stock, and is not publicly traded. Notably, in May 2024, Visa conducted a class B-1 common stock exchange offer, issuing shares of Class C common stock as part of the exchange, indicating some activity in the broader equity structure involving Class C shares. However, no direct issuance of new Class C shares occurred, and there were no material changes in its equity classification during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the number of Class C shares issued and outstanding was 10 in both 2023 and 2024, which contradicts the ground truth stating that approximately 48 million Class C shares were issued in 2023 as part of an exchange offer. The LLM incorrectly states there was 'no direct issuance of new Class C shares,' when in fact 48 million were newly issued in 2023. Additionally, the LLM incorrectly places the exchange offer in May 2024, while the ground truth specifies it occurred in 2023. The only correct quantitative point is that by 2024, only 10 Class C shares remained outstanding. (2) The key numbers — 241 million Class B-1 shares tendered, ~48 million Class C shares issued in 2023 — are entirely missing or wrong in the LLM response. The date of the exchange (2023 vs. May 2024) is factually incorrect. These are critical quantitative and temporal errors. (3) The multi-hop reasoning is flawed: the model fails to correctly link the 2023 exchange offer to the issuance of Class C shares and misattributes the timing and impact of the restructuring. It also fails to explain the dramatic reduction from ~48 million issued in 2023 to only 10 outstanding in 2024, which is central to understanding the equity evolution. (4) While the LLM correctly identifies the existence of Class C stock and its non-traded status, and touches on the broader capital structure, the core facts about issuance and timing are wrong, leading to a low correctness and quantitative accuracy score. Contextual relevance is higher because it attempts to address the equity structure and exchange activity, albeit inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 460,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing has evolved from being a subset of the Building Products division in 2022 to being explicitly highlighted as part of its expanded service offerings by 2024. In 2022, Rough Plumbing was categorized under Building Products, which included categories like Building Materials, Electrical, Lumber, Millwork, and Rough Plumbing. By 2024, Rough Plumbing was specifically mentioned as one of the categories where Lowe's offers extended protection plans and repair services, indicating a strategic emphasis on enhancing customer service and value in this segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Rough Plumbing was classified under 'Building Products' and lists it alongside related categories, which matches the original answer's assertion. (2) It accurately reflects the evolution by 2024, noting that Rough Plumbing became part of expanded service offerings, including extended protection plans and repair services—consistent with the shift toward a service-oriented model. (3) The answer captures the strategic emphasis on service and customer value, which is semantically equivalent to the original answer’s point about integration into installation and protection plans. (4) The only minor omission is the specific mention of 'installation services'—the LLM mentions 'repair services' and 'protection plans' but does not explicitly state 'installation', which was a key component in the ground truth. Additionally, the LLM does not include the quantitative detail that installed sales accounted for approximately 5% of total sales in 2024, which is a small but relevant contextual metric. However, since the question did not explicitly ask for financial impact metrics, this omission does not severely detract from correctness. All entities (Lowe's, Rough Plumbing), years (2022, 2024), and classifications are correct. No numerical inaccuracies are present—the absence of the 5% figure is a completeness gap but not a quantitative error. Multi-hop reasoning is sound: the model correctly synthesizes a shift in business classification and service offerings over time. Overall, the answer is factually correct, contextually relevant, and conveys the core evolution accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 461,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "Between 2023 and 2024, the introduction and status of Class B-2 common stock evolved through an exchange offer initiated by Visa. In January 2024, Visa amended its certificate of incorporation to authorize the exchange of Class B-1 common stock for Class B-2 and Class C common stock. On May 6, 2024, Visa accepted 241 million shares of Class B-1 common stock in the exchange offer, issuing 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock in return. The introduction of Class B-2 common stock reflects a structural adjustment to Visa's capital framework, allowing for more flexibility in managing transfer restrictions and conversion rates tied to litigation settlements. This evolution indicates that Class B-2 common stock plays a role in facilitating the resolution of litigation-related obligations while maintaining alignment with the broader capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims that 120 million shares were issued on May 6, 2024, as part of an exchange offer—information not present in the ground truth. Additionally, the ground truth indicates that by 2024, no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, implying they were either retired or restructured, which contradicts the LLM's claim of newly issuing 120 million shares. (2) Quantitative accuracy is poor: the LLM invents specific dates (January 2024, May 6, 2024), share counts (241 million Class B-1 exchanged, 120 million Class B-2 issued, 48 million Class C issued), and corporate actions (amendment to certificate of incorporation) that are not supported by the original answer. These numbers do not align with the ground truth’s 77 million shares in 2023 and zero prior to an exchange in 2024. (3) The multi-hop reasoning is flawed. The LLM fabricates a narrative around Visa (not named in the question or original answer) and an exchange mechanism involving Class C stock and litigation settlements, which are absent from the ground truth. There is no evidence in the original answer that Class B-2 was used for litigation resolution or conversion flexibility. Instead, the correct inference should focus on the introduction and subsequent absence of Class B-2 shares suggesting a strategic restructuring. (4) Contextual relevance is moderate because the LLM addresses the evolution of Class B-2 stock and its role in capital structure, but the details are factually incorrect and based on fabricated events. The core idea of structural adjustment is plausible, but it is unsupported by the actual data provided. Thus, while the general theme is relevant, the specifics fail to match the ground truth, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 528,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased from $117 million in 2024 to $19 million in 2025. This significant reduction suggests that more deferred revenue from the program was recognized during the period, potentially indicating increased program engagement and usage by members.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude. The original answer states that no specific liability was disclosed in 2022, and $117 million was reported in 2024—indicating growth. The LLM incorrectly claims a decrease from $117 million in 2024 to $19 million in 2025, which is not supported by the ground truth and introduces a future year (2025) not mentioned in the question or original answer. (2) Quantitative inaccuracies are severe: the $19 million figure is fabricated, and the 2025 date is erroneous. The original answer does not provide any liability figure for 2022, so any numerical comparison between 2022 and 2024 cannot be based on a decrease. (3) The multi-hop reasoning is flawed—the LLM fails to recognize that the introduction of a $117 million deferred revenue figure in 2024 (with no prior figure) implies growth, not a reduction. Instead, it invents a non-existent trend. (4) The contextual relevance is low because the answer addresses a different timeframe and trend, but it does attempt to interpret financial liability in relation to program engagement, which is thematically relevant. However, the factual foundation is entirely incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 351,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "Between 2023 and 2024, NVDA's exposure to and concern about pollution limits and related regulations have increased, particularly due to evolving climate-related laws and their potential impact on operations and customer data center expansion. In 2023, the company highlighted the potential for new or proposed regulations related to carbon taxes, pollution limits, and sustainability-related governance to increase direct and indirect costs, including compliance expenses and changes to manufacturing processes. By 2024, the company expanded on these concerns, noting that such regulations could lead to higher capital expenditures, compliance costs, and operational changes. Additionally, NVDA expressed concern that data centers, which rely on clean water and predictable energy, could face limitations due to power or water shortages or regulatory constraints, potentially impairing their ability to expand and consume NVDA's products. This indicates a growing awareness of regulatory and environmental challenges impacting both NVDA's operations and its customers' data center growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2023, NVDA noted that pollution limits and climate regulations could increase costs (compliance, energy, capital expenditures) and require changes to manufacturing and supply chain operations. In 2024, the concern expanded to include land and permitting constraints affecting customer data center expansion. The LLM correctly captures this evolution, noting increased capital costs and operational changes, and importantly, highlights how regulatory constraints could impair data center expansion—directly linking it to demand for NVDA's products. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a strict sense, but all references to years (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes NVDA's evolving risk disclosures across two years and connects regulatory impacts on customers (data centers) to potential demand-side effects for NVDA—this is a key insight from the ground truth. (4) The only minor shortcoming is that the LLM mentions 'clean water' and 'water shortages' as concerns, which are not explicitly mentioned in the original answer; the original focuses on land and permitting constraints due to pollution limits. While water could be a component of pollution regulation, this addition slightly extends beyond the provided truth. Otherwise, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 426,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolved as follows: In November 2023, four Guaranteed Senior Notes totaling approximately $500 were issued at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In July 2024, $77 of these Guaranteed Senior Notes were repaid. No further issuance or repayment of these notes is noted for the remainder of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: four Guaranteed Senior Notes totaling approximately $500 were issued in 2023 at fixed interest rates from 1.400% to 2.120%, valued using Level 3 inputs; $77 was repaid in 2024. The LLM adds specific months (November 2023, July 2024), which are not contradicted by the original answer and may reflect additional precision. (2) Quantitative accuracy is perfect: dollar amounts ($500 issuance, $77 repayment) match exactly; no calculation errors. (3) The multi-hop reasoning is sound—correctly linking the Japanese subsidiary to the issuance and repayment, and maintaining focus on Guaranteed Senior Notes. However, the LLM omits the comparative fair value of total long-term debt at the end of 2023 ($5,738) and 2024 ($5,412), which is part of the valuation evolution and mentioned in the original answer. This is a minor omission affecting completeness but not the core correctness. (4) Entity identification (Costco's Japanese subsidiary, Guaranteed Senior Notes, Level 3 inputs) is accurate. The answer is fully relevant and well-structured. The omission of the overall fair value trend prevents a perfect 10, but all presented information is factually correct and semantically aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 364,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix's investment in streaming service improvements and associated risk exposure evolved with a stronger emphasis on cybersecurity and personnel expertise. In 2022, the company highlighted increased technology and development expenses, driven by headcount growth to support production and streaming service improvements. By 2024, Netflix disclosed a more robust enterprise-wide cybersecurity program, including a dedicated Vice President of Security and Privacy Engineering with over 30 years of experience, regular risk assessments, and advanced security tools like bug bounty programs and third-party risk management. This reflects a strategic shift toward proactive risk mitigation and enhanced oversight of cybersecurity threats.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution from personnel-driven investment in 2022 to cybersecurity focus in 2024, aligning with the ground truth's narrative of shifting from growth-oriented spending to risk-aware posture. However, it omits the specific $384 million increase in personnel costs disclosed in 2022, which is a key quantitative fact from the original answer. Instead, it vaguely references 'increased technology and development expenses' without citing the dollar amount, leading to a partial factual omission. (2) No incorrect numbers are stated, but the absence of the $384M figure reduces quantitative accuracy. The mention of a 'dedicated Vice President of Security and Privacy Engineering with over 30 years of experience' is plausible but not present in the ground truth, introducing a detail not supported by the original data—this does not contradict but adds unverified specificity. (3) The multi-hop reasoning is sound: the model correctly synthesizes a shift in focus across years and connects personnel growth (2022) with cybersecurity maturation (2024). It accurately reflects the strategic evolution even without the exact financial figure. (4) The answer remains contextually relevant and captures the qualitative shift well, hence high scores in qualitative accuracy and relevance. The correctness score is 7 because core facts are correct but a major quantitative detail is missing, and a minor unsupported detail is added.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 408,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its restricted stock unit (RSU) agreements, as evidenced by the inclusion of the \"2024 Form of Restricted Stock Unit Agreement\" in the 2024 filing (page 19), which was not present in the 2023 filing. This evolution suggests a refinement in the lifecycle management of these equity instruments, potentially aligning with updated executive compensation strategies, such as revised vesting terms, performance conditions, or governance enhancements. The continued use of RSUs as part of employee equity grants indicates a sustained focus on long-term incentive alignment with shareholder value, while the new agreement likely reflects adjustments to regulatory or internal compensation policies.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the introduction of the '2024 Form of Restricted Stock Unit Agreement' in the 2024 filing and notes its absence in the 2023 filing, which aligns with the ground truth. It also correctly infers that this reflects an evolution in lifecycle management and executive compensation strategy, showing contextual understanding. However, the answer misses key multi-hop details that are central to the question: (1) it fails to note that in the 2023 filing, the '2024 Form' was explicitly marked as 'Filed herewith,' signaling its new adoption, and (2) it does not mention that in the 2024 filing, the '2024 Form' became 'Previously filed' while the '2025 Form' was newly introduced as 'Filed herewith.' These omissions significantly weaken the qualitative accuracy, as they represent the core of the annual iterative process described in the ground truth. The LLM instead vaguely attributes changes to 'refinement' and 'potentially revised vesting terms' without evidence from the filings, introducing speculation. While the entities (company, form names, years) are mostly accurate and the reasoning direction is logical, the failure to synthesize the specific filing status changes ('Filed herewith' vs 'Previously filed') across years—critical to the lifecycle management narrative—results in a partially correct answer. Quantitative accuracy is high because no incorrect numbers or dates are presented (the mention of page 19 is not contradicted in the ground truth). Contextual relevance is strong as the response stays focused on RSU evolution and executive compensation. However, the lack of precise document status tracking across filings limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 459,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes due April 2029 had a carrying amount of $743 million as of January 28, 2024, and remained at $744 million as of February 2, 2025. The maturity timeline remained unchanged, with the notes maturing in April 2029. No repayments or significant changes in structure were noted during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly states the carrying amount as $743 million as of January 28, 2024, which matches the ground truth. However, it incorrectly claims the carrying amount was $744 million as of February 2, 2025 — this date is outside the 2023–2024 scope of the question and not supported by the original answer. The original does not provide any data for 2025, so this is an unsupported addition. (2) The maturity date is correctly cited as April 2029, consistent with the ground truth. However, the LLM omits key details about the issuance in November 2023, the principal amount of $750 million, the initial discount of $3.4 million, and the first interest payment date (April 15, 2024). These omissions affect completeness and understanding of the note’s evolution. The carrying amount decrease is mentioned in the original as due to discount amortization, but the LLM fails to explain the change from $750M principal to $743M carrying amount. (3) The multi-hop reasoning is partially sound — the model correctly identifies that the notes remained outstanding and unchanged in maturity, but it fabricates a future carrying amount and misses the synthesis of issuance details with subsequent valuation. (4) The contextual relevance is high because the answer addresses the evolution of the notes’ status and structure, but the quantitative accuracy is reduced due to the incorrect future value and missing original terms. The qualitative accuracy is moderate due to correct identification of the maturity and current carrying amount, but lacks depth in explaining the financial structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 461,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes totaling approximately $500 in 2023 and the repayment of $77 in 2024, matching the ground truth. It adds specific months (November 2023 and July 2024) and maturities extending to 2043, which are not contradicted by the original answer and provide additional precision. All numeric values—$500 issuance, $77 repayment, interest rates from 1.400% to 2.120%—are accurate and match the ground truth. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and timeframes are correct. Format variations (e.g., '$500' vs '$500 million') are acceptable and semantically equivalent in context. (3) The multi-hop reasoning is sound: the model correctly synthesizes issuance in 2023 and repayment in 2024 by the Japanese subsidiary, linking two events across years and financial actions. The addition of maturity dates (2043) and specific months improves detail without introducing error. (4) The only minor limitation is that the LLM omits the mention that proceeds were referenced in the 2024 filing as a source of financing activity, a small contextual detail about continued financial engagement. However, this does not affect the core factual accuracy. Scores reflect high correctness with near-complete qualitative and quantitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 375,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk associated with competitors developing after-market parts for DHR's products remained consistent from 2022 to 2023, as both years' filings explicitly mention this risk as a potential factor that could detract from the company's sales. In 2022 (page 23) and 2023 (page 20), DHR notes that competitors may develop after-market services and parts, which could reduce demand for their products. However, there is no indication of a significant evolution or increased impact on the company's business or financial statements in 2023 compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative evolution in how DHR framed the risk of competitors developing after-market parts from 2022 to 2023. Quantitatively, the answer is accurate: it correctly identifies that both the 2022 and 2023 filings mention the risk of after-market parts and services impacting sales, and it accurately references the relevant pages (23 in 2022, 20 in 2023). There are no numerical inaccuracies, hence a perfect score on quantitative accuracy. However, the qualitative analysis is flawed. The original answer highlights a meaningful shift in framing: in 2022, the risk was presented as a direct threat to sales and competitive position due to commoditization and private-label competition. In 2023, the risk was contextualized more broadly within systemic healthcare cost pressures and was described as 'Impacted By' rather than a primary threat, suggesting a de-emphasis or strategic recalibration. The LLM answer incorrectly concludes there was 'no significant evolution,' which contradicts the ground truth. This reflects a failure in multi-hop reasoning and synthesis—while the surface-level facts are present, the model did not interpret or convey the nuanced shift in risk characterization. Contextual relevance is moderate: the answer addresses the question directly and includes relevant excerpts, but fails to capture the deeper analytical point about evolving risk perception, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 403,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved with a broader pricing range, expanding from $2 to $27 per month in 2022 to $1 to $32 per month in 2024, including lower-priced ad-supported plans. The average monthly revenue per paying membership increased from $11.67 in 2022 to $11.63 in 2023 and further to $17.20 in the U.S. and Canada by 2024. These changes were intended to address challenges such as retaining members in a competitive market, mitigating the impact of macroeconomic conditions like inflation, and adapting to evolving consumer preferences, including the introduction of new features like games and live programming.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in numerical data. For example, it claims Netflix's pricing expanded from $2 to $27 in 2022 and $1 to $32 in 2024, which is not supported by the ground truth and is implausible (pricing dropping to $1 contradicts Netflix's strategy). The average monthly revenue per membership is misstated: the ground truth reports a 7% increase in 2022 (from prior year), but the LLM claims $11.67 in 2022 and $17.20 in 2024 for U.S. and Canada—this specific regional figure and trajectory are unsupported. The $17.20 figure appears fabricated or misattributed. (2) The ground truth does not mention games or live programming as part of the 2022–2024 plan changes, nor does it provide global or regional ARPU values as cited. The LLM invents specific dollar ranges and figures not present in the source. (3) While the LLM correctly identifies the introduction of an ad-supported tier and links pricing changes to competition and macroeconomic pressures—aligning with the ground truth's mention of competition, pricing sensitivity, and retention—it fails to mention the enforcement of terms of use to limit password sharing, a key 2024 change. It also omits the 50% drop in paid net additions and the 19% revenue growth context from 2022, which are critical to the multi-hop reasoning. (4) The answer is partially relevant and captures the general strategic direction (ad-tier, pricing sensitivity), but the severe quantitative inaccuracies and invented metrics undermine factual reliability. The qualitative reasoning is plausible but not fully grounded in the provided truth. Hence, correctness is scored low due to false numbers, despite some correct thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 473,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased financial recognition risk due to performance uncertainties. In 2023, the company emphasized that the net present value of expected in-orbit incentive fees is recognized as revenue during the construction period, but if satellites fail to meet performance criteria, customers may withhold payments and Boeing could face refund obligations and significant charges. This reflects heightened risk exposure compared to 2022, where such payments were mentioned in the context of development programs but without explicit financial recognition details. The 2023 disclosure highlights the long-term performance risks and potential adverse financial impacts more explicitly.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Boeing's approach to in-orbit incentive payments from 2022 to 2023, emphasizing increased risk exposure and changes in financial recognition. It accurately notes that in 2023, Boeing recognized the net present value of in-orbit incentive fees as revenue during construction, creating financial risk if performance criteria are not met. This aligns with the ground truth. However, the LLM omits the specific $1,585 million in additional losses recorded in 2023 on Boeing’s five major fixed-price development programs—a key quantitative detail in the original answer. While the qualitative shift from general risk mention in 2022 to explicit financial recognition in 2023 is correctly conveyed, the absence of this figure reduces quantitative accuracy. (2) No incorrect numbers are stated, but the failure to include the $1,585 million loss—a central data point in the ground truth—means the answer is incomplete on quantification. The years (2022 and 2023) and entities (Boeing, in-orbit incentive payments, fixed-price development programs) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years, identifying a shift in disclosure depth and financial treatment. It correctly infers that earlier mentions of risk evolved into more concrete financial recognition practices with real losses incurred. The connection between revenue recognition timing and performance risk is logically and accurately explained. (4) The correctness score is 8 because the core reasoning and qualitative accuracy are strong, but the missing $1,585 million figure prevents a higher score. Quantitative accuracy is 7 due to the omission of a major financial figure. Qualitative accuracy is 9 due to precise description of risk evolution and revenue recognition. Contextual relevance is 10 as the response directly addresses the question’s focus on risk exposure and financial recognition changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 534,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the disclosure and accessibility of the Directors' Code of Conduct remained consistent, with both years stating that the code is available on the company's website. In 2024, the Directors' Code of Conduct was explicitly mentioned as being posted at https://www.bnymellon.com, and the company committed to disclosing amendments or waivers on its website. The 2023 document similarly referenced the availability of the Directors' Code of Conduct on the company's website, with a comparable commitment to disclose updates. Thus, there was no significant evolution in the method or accessibility of disclosure during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The original answer states that there was a clear evolution in disclosure approach from 2023 to 2024: in 2023, the Directors' Code of Conduct was explicitly posted with a direct URL and a commitment to disclose amendments; in 2024, it was only referenced generally as part of a broader list of governance materials without repeating the URL. The LLM incorrectly claims there was 'no significant evolution,' which contradicts the ground truth. Additionally, the LLM falsely states that in 2024 the code was 'explicitly mentioned as being posted at https://www.bnymellon.com,' which is inaccurate—the 2024 filing did not include the direct URL. (2) Quantitatively, there are no numerical values to assess, but the dates (2023 and 2024) are correctly referenced, and the domain name is accurate, though the specific PDF path is omitted in the LLM answer. (3) The multi-hop reasoning is flawed: the model failed to recognize the shift from explicit, detailed disclosure in 2023 to a more implicit, consolidated reference in 2024. This requires synthesizing the change in disclosure style across years, which the LLM did not do. Instead, it assumed consistency without acknowledging the reduced specificity in 2024. (4) The contextual relevance is moderate because the answer addresses the right topic and timeframe, but the qualitative inaccuracy in describing the nature of the disclosure change severely undermines the correctness. The answer misrepresents the evolution, leading to a low correctness score despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 442,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from being a foundational L4 autonomous driving solution for commercial deployment to a more scalable and integrated platform targeting both Robotaxi services and future consumer AVs. In 2022, Mobileye focused on securing commercial partnerships for fleet deployment, such as with Udelv and Transdev, and announced plans for Robotaxi services in Germany and Tel Aviv. By 2023, the strategy expanded to include a Vehicle-as-a-Service model and integration with Moovit’s mobility platform, emphasizing global scalability and deployment across public transit, goods delivery, and consumer mobility. Additionally, advancements in hardware, such as the EyeQ6 and EyeQ Ultra SoCs, and sensor technologies like imaging radar, were introduced to support cost-effective and efficient AV solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mobileye Drive™’s deployment strategy from 2022 to 2023 with accurate key partnerships (Udelv, Transdev), mentions of L4 autonomy, and the strategic shift toward mobility-as-a-service and fleet deployment. It accurately notes the integration with Moovit and the focus on public transit and delivery. However, it adds information not present in the ground truth, such as Robotaxi services in Germany and Tel Aviv, and the mention of EyeQ6 and EyeQ Ultra SoCs and imaging radar advancements, which are not referenced in the original answer and thus introduce unsupported technical details. Also, while the original answer highlights the first consumer L4 design win with Geely in 2022, this is omitted in the LLM response, representing a minor factual omission. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; all references to 2022 and 2023 are correct. (3) The multi-hop reasoning is largely sound—the model correctly infers a strategic evolution from commercial partnerships to broader ecosystem integration. However, the addition of unverified details (e.g., specific SoCs, Robotaxi launches) and omission of the Geely design win slightly weaken the qualitative accuracy. (4) The contextual relevance is high as the answer directly addresses the strategic evolution of Mobileye Drive™. The correctness score is 8 due to accurate core facts and good synthesis, but docked for minor omissions and unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 435,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure and distribution rate of the Tower Preferred Interests evolved significantly. Initially, in 2022, the Tower Preferred Interests consisted of two series: Tower Class A-1 ($1,500) with a 5.0% initial distribution rate and Tower Class A-2 ($4,500) with a 4.75% initial distribution rate. By 2024, these were restructured into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) with a 5.90% preferred distribution rate. Additionally, a portion of these interests transitioned to Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which pay a distribution rate of SOFR plus 250 basis points. This restructuring introduced a mix of fixed and floating rate distributions, with the floating rate component potentially reaching $525 by 2028 if not called earlier.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Tower Preferred Interests from 2022 to 2024. It correctly identifies the two initial series in 2022: Class A-1 ($1,500 at 5.0%) and Class A-2 ($4,500 at 4.75%), matching the ground truth. It accurately describes the 2024 restructuring into Fixed Rate Class A Limited Membership Interests with a 5.90% distribution rate and the introduction of Floating Rate Class A Limited Membership Interests paying SOFR + 250 bps. The only minor discrepancy is the mention of '$525 by 2028' in the floating rate transition, which is not present in the original answer and introduces a specific dollar projection not supported by the ground truth. This detail was not part of the provided knowledge and appears to be an unsupported extrapolation, slightly reducing quantitative and qualitative accuracy. However, the core structural and rate changes are correctly synthesized across time periods and entity types, demonstrating sound multi-hop reasoning. The answer is contextually fully relevant, addressing both structural and rate evolution as asked. Wording differences are acceptable and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 335,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The Balanced Index Fund, which comprises approximately 60% equities and 40% debt securities, is the primary investment for OPB plan assets. From 2022 to 2023, the unrealized gains/(losses) for Level 3 assets related to the fund showed improvement. In 2022, the net unrealized losses were significant at ($90), driven by losses in corporate fixed income securities ($19), mortgage-backed and asset-backed securities ($11), and municipal bonds ($14). By 2023, the net unrealized losses narrowed to ($14), with gains in corporate fixed income ($5), mortgage-backed and asset-backed securities ($7), and other fixed income ($3), indicating a more favorable performance in 2023 compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, in 2022, the unrealized losses were ($16) million for corporate fixed income and ($11) million for mortgage-backed and asset-backed securities. In 2023, these turned into gains of $2 million and $6 million respectively. However, the LLM states incorrect values: $19M loss (vs $16M), includes $14M loss in municipal bonds (not mentioned in ground truth), and reports $5M gain in corporate and $7M in MBS/ABS (vs $2M and $6M). The net losses of ($90) in 2022 and ($14) in 2023 are not supported by the original data and appear to be fabricated aggregations. (2) Calculations are incorrect: the LLM implies a net change from ($90) to ($14), suggesting an $76 improvement, which is not aligned with the actual shift from a total loss of ($27)M to a gain of $8M—an improvement of $35M. The original data does not support inclusion of municipal bonds or 'other fixed income' categories. (3) The qualitative reasoning is partially sound—there is recognition of a performance improvement and correct mention of the Balanced Index Fund’s 60/40 allocation. However, the LLM fails to mention the key evolution in valuation methodology in 2023 (adoption of Level 1 market approach), which is a critical part of the investment approach evolution. (4) Contextual relevance is moderate—the answer addresses the general theme of performance evolution and asset allocation, but introduces unsupported entities and numbers, undermining factual reliability. Due to major quantitative errors and missing key qualitative details, the correctness score is low despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 464,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has shifted from a general mention of their potential impact on operations to a more explicit acknowledgment of their influence on strategic priorities. In 2023, the focus was on how accounting developments could affect business outcomes, while in 2024, the language suggests a broader integration of these standards into strategic planning, indicating a growing influence of evolving accounting standards on the company's operational and financial strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in BNY Mellon's forward-looking statements from 2023 to 2024. It accurately identifies the shift from a general mention of accounting developments in 2023 to a more explicit and integrated treatment in 2024, linking this to strategic planning. The answer correctly reflects the increasing influence of accounting standards on operational and financial strategies. However, it omits specific textual details present in the ground truth, such as the exact phrasing changes (e.g., the inclusion of 'regulatory, technology, market, economic or accounting developments' and the mention of 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024), which provide concrete evidence of the deeper integration into strategic decision-making. These omissions reduce completeness and slightly weaken the qualitative accuracy, though the overall reasoning and synthesis remain sound. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the response is fully relevant to the question. Semantic equivalence is mostly achieved, but with some loss of specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 329,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2023, the evolution of risks related to store safety and cybersecurity had a potentially negative impact on the associate experience, as increased shrink and organized retail crime led to operational changes that may have raised costs and reduced margins, while also affecting associate morale and retention. In contrast, 2022's engagement-focused initiatives emphasized associate compensation enhancements, diversity and inclusion efforts, and development programs, which contributed to higher engagement and a more positive associate experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall reasoning and captures the core contrast between 2022's engagement initiatives and 2023's emerging risks. It correctly identifies that 2023 store safety and cybersecurity risks potentially harmed associate morale and retention, which aligns with the ground truth. However, there are some inaccuracies in the details of 2022 initiatives: the original answer specifies engagement surveys, a digital engagement platform, and recognition programs—not compensation enhancements, diversity and inclusion efforts, or development programs, which are not mentioned in the ground truth. While these are plausible HR initiatives, they are not supported by the provided knowledge graph, making this a factual deviation. The answer correctly notes the potential negative impact on associate experience in 2023 due to organized retail crime and cybersecurity threats, and it appropriately contrasts the focus across years. There are no numeric values to verify, so quantitative accuracy is scored as 10. Contextual relevance is high as the response directly addresses the evolution of risks and their impact on associate experience. The qualitative accuracy is reduced due to the incorrect attribution of 2022 initiatives, which affects the fidelity of the multi-hop synthesis. Despite this, the central logic—that positive engagement efforts in 2022 were threatened by 2023's external risks—remains sound and semantically aligned with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 408,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The role of the learning curve in influencing cost and production estimates between 2022 and 2023 has become increasingly critical due to ongoing production challenges, regulatory scrutiny, and supply chain disruptions. In 2023, the learning curve is explicitly highlighted as a key factor affecting program profitability and risk management, particularly for commercial aircraft programs like the 787 and 737 MAX. Delays, rework, and production instability have made achieving anticipated cost reductions more challenging, heightening the risk of lower margins or material charges if cost estimates exceed revenue projections. This underscores a more cautious approach to leveraging the learning curve for cost efficiency, with greater emphasis on rigorous quarterly reassessments of cost and revenue estimates to mitigate risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, so there are no quantitative inaccuracies—this aspect is neutral but does not detract, hence a score of 10. However, the core factual claim in the LLM answer contradicts the ground truth. In 2022, the learning curve was framed as a risk (correctly noted in the LLM answer with reference to 787 challenges), but the key evolution in 2023—where Boeing began integrating the learning curve into cost estimation and planning as a predictable, managed factor—is entirely missing. Instead, the LLM claims that in 2023, the learning curve remains a heightened risk due to production instability and requires cautious reassessment, which misrepresents the shift from risk to planning input. (2) There are no numbers to verify, so quantitative accuracy is not penalized. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct evolution—from risk factor in 2022 to an integrated, predictive component in 2023—and instead portrays a continued or worsening risk posture, which is the opposite of the ground truth. It references relevant programs (787, 737 MAX) and contextual factors (supply chain, rework), but uses them to support an incorrect conclusion. (4) Correctness is scored low (4) because the central claim about the evolution of the learning curve’s role is factually wrong. Qualitative accuracy is also low due to incorrect reasoning and synthesis. Contextual relevance is high because the answer addresses the right topic, timeframe, and programs, and discusses profitability and risk management as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 437,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment and disclosure of the Dividend Reinvestment Plan in the 2024 filing show a more explicit acknowledgment of officer and director participation compared to the 2023 filing. In both years, the disclosure notes that officers and directors participate in the Dividend Reinvestment Plan and may have shares withheld to cover taxes or exercise stock awards. However, the 2024 filing specifically clarifies that these arrangements may be designed to satisfy Rule 10b5-1 affirmative defense conditions or may constitute non-Rule 10b5-1 trading arrangements, as defined in Regulation S-K Item 408(c). This added specificity in 2024 reflects a more detailed alignment with SEC disclosure requirements regarding insider trading practices.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of disclosure between 2023 and 2024. According to the ground truth, the 2023 filing included a detailed description of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements in the context of the Dividend Reinvestment Plan, while the 2024 filing omitted this detail, indicating a simplification. However, the LLM answer incorrectly states that the 2024 filing added specificity by clarifying these trading arrangements, which is the opposite of the truth. This is a critical factual reversal, not just a wording difference. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is very low because the reasoning and synthesis across years are flawed—the model failed to correctly interpret the direction of change in disclosure. Contextual relevance is moderate because the answer addresses the right topic (officer/director participation, tax withholding, trading arrangements) and regulatory context (Rule 10b5-1, Item 408(c)), but with incorrect temporal comparison. The answer appears plausible but misrepresents the actual evolution of disclosure, leading to a correctness score of 2 due to the major factual error in the multi-hop comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 362,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023 by enhancing digital capabilities, tailoring the experience to customer intent and location, and improving in-store features. In fiscal 2021, the focus was on adapting to the pandemic by supporting digital interactions and store resets. By fiscal 2023, the company had expanded its digital investments to include improved website and mobile app functionality, personalized marketing, and enhanced fulfillment options. Specific changes included mobile app-enabled store navigation, self-service lockers, curbside pickup, and electronic shelf labels, all aimed at providing a seamless blend of digital and physical shopping experiences.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several plausible details about The Home Depot's digital and in-store enhancements but fails to include the key quantitative fact from the ground truth: the $2.6 billion capital expenditure in fiscal 2021 specifically for interconnected customer experience. This number is missing entirely, which is a major omission in quantitative accuracy. Additionally, there is no mention of the shift to using 'enhanced merchandising information technology tools' to tailor the experience based on shopping intent and location as highlighted in fiscal 2023. Instead, the LLM lists generic improvements like mobile app navigation, self-service lockers, curbside pickup, and electronic shelf labels—details not present in the original answer and potentially fabricated or inferred beyond the source. (2) The absence of the $2.6 billion figure results in a low quantitative accuracy score. While fiscal years (2021 and 2023) are correctly referenced, no financial figures are provided in the LLM response, making it impossible to verify investment evolution numerically. (3) The qualitative reasoning shows partial understanding of the evolution—shifting from pandemic response to more advanced digital integration—but misrepresents the nature of the 2023 strategy. The original emphasizes data-driven personalization via IT tools tied to intent and location; the LLM focuses on fulfillment and interface features without linking them to underlying data systems or personalization logic. This reflects incomplete multi-hop synthesis. (4) Contextual relevance is high because the answer addresses the general theme of evolving shopping experience and attempts to compare 2021 and 2023. However, due to missing key facts, incorrect emphasis, and potential hallucination of specific features, the overall correctness is only partially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 505,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron primarily revolved around the acquisition and integration of Aldevron, which occurred in August 2021. In 2022, DHR incurred higher capital expenditures, partially driven by the Aldevron acquisition, with total capital spending reaching approximately $1.5 billion. By 2023, while specific capital investment figures for Aldevron were not provided, the company reported transaction-related costs of $27 million for the Abcam Acquisition and $68 million in non-recurring fair value adjustments related to the Abcam and Aldevron acquisitions. These figures indicate continued financial activity tied to Aldevron's integration and related expenditures in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it incorrectly states that the Aldevron acquisition occurred in August 2021, while the ground truth implies integration and major cash outflow occurred in 2023. The $9,561 million net cash consideration paid to Aldevron in 2023 is completely omitted, which is the central financial event in the evolution of the relationship. Instead, the LLM introduces $27M in transaction costs for the Abcam acquisition and $68M in fair value adjustments related to both Abcam and Aldevron—details not present in the ground truth and potentially conflating acquisitions. While the $1.5 billion capital expenditure figure for 2022 is correctly cited, it misattributes the timing and nature of the Aldevron-related spending. (2) Quantitative accuracy is low: the key number ($9,561 million) is missing, and unrelated figures ($27M, $68M) are introduced without support from the original answer. The $1.5B capex is correct, but no other numbers align. (3) Multi-hop reasoning is flawed: the model fails to trace the evolution from pre-acquisition capital investment (2022) to full acquisition and consolidation (2023). It does not recognize the shift from 'investment in capacity' to 'acquisition and integration' as a transformation in financial relationship. Instead, it focuses on unrelated transaction costs and misdates the acquisition. (4) Contextual relevance is moderate—the response addresses capital investment and acquisition-related expenditures as asked, and correctly identifies Aldevron and DHR, but misrepresents the timeline and core financial events, undermining the overall correctness. The qualitative reasoning shows some understanding of integration costs but fails to capture the primary shift in the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 492,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $2,000 (as of September 2020) to $7,250 by December 31, 2024, following the issuance of additional preferred interests in April 2023 (Telco Class A-2 and A-3). The structure evolved to include three classes: Telco Class A-1 (4.25% annual distribution, reset every seven years) and Telco Class A-2 and A-3 (6.85% annual distribution, reset on November 1, 2027, and every seven years thereafter). No changes to the distribution rates or reset schedules were made during this period, as the initial rates and reset terms remained in place.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of preferred interests in 2022 as $2,000 and the post-issuance total in 2024 as $7,250, with an additional $5,250 issued in April 2023—this aligns with the ground truth. The distribution rates (4.25% for Class A-1 and 6.85% for A-2/A-3) and reset schedules (seven years for A-1, first reset November 1, 2027, for A-2/A-3) are accurately reported. However, the LLM incorrectly states that the $2,000 amount was 'as of September 2020'—the ground truth only confirms this value in 2022, not 2020, which introduces a minor factual inaccuracy. (2) All numeric values—$2,000, $5,250, $7,250, 4.25%, 6.85%, and November 1, 2027—are correct and properly contextualized. The sum ($2,000 + $5,250 = $7,250) is accurate. The only issue is the erroneous reference to September 2020, which is not supported by the ground truth and could mislead about the timeline. (3) The multi-hop reasoning is sound: the model correctly synthesizes the structural evolution (addition of two new classes), tracks the total value change, and distinguishes between the distribution and reset terms across classes. It correctly infers that no changes were made to existing terms—only new instruments were added. (4) The answer is highly relevant and mostly accurate, but the incorrect dating of the $2,000 figure prevents a perfect score. Despite this, the core facts about structure, value, rates, and resets are correct, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 414,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG's use of Expected Loss Ratio Methods has evolved in terms of the types of insurance lines and the rationale for their application. In 2022, these methods were primarily used for the latest accident year in program business, with variations by line of business, and for U.S. Personal Insurance, where favorable development was driven by subrogation recoveries and catastrophe events. By 2024, the application of Expected Loss Ratio Methods expanded to include U.S. Workers' Compensation, where they were used alongside loss development and frequency/severity methods. The rationale for their use in 2024 included managing risk-sharing features, such as high deductibles and self-insured retentions, and adapting to changes in claim reporting patterns due to an increased proportion of large deductible business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Expected Loss Ratio Methods to U.S. Workers' Compensation by 2024 and notes its use in combination with other methods, which aligns with the ground truth. However, it introduces incorrect details about 2022 usage, stating the method was used for 'program business' and 'U.S. Personal Insurance' due to subrogation recoveries and catastrophes—this is not supported by the original answer. The ground truth specifies that in 2022, the method was primarily used for the latest accident year in aviation exposures due to high severity, not personal insurance or program business. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years 2022 and 2024 are correctly used, earning full marks here. (3) The multi-hop reasoning is partially sound: the model correctly infers an expansion across time and lines of business, but fails to accurately represent the starting point (2022) and misattributes the rationale. The correct evolution is from high-severity short-tail lines like aviation to long-tail lines like Workers' Compensation, reflecting methodological broadening—but the LLM invents a different starting context. (4) The contextual relevance is high because the answer addresses both time points, insurance lines, and rationale, even if some facts are wrong. The qualitative accuracy is reduced due to factual misstatements about 2022 usage, though the 2024 information is largely correct. Overall, the answer captures part of the evolution but distorts the initial state and reasoning, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 466,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "From 2023 to 2024, Target's approach to its owned brands has shifted toward greater strategic emphasis on innovation, expansion, and differentiation. In 2024, the company launched or expanded several owned brands, including dealworthy—a low-price line of essentials—and Auden, Cat & Jack, Gigglescape, and up&up. Additionally, 11 of Target's owned brands exceeded $1 billion in annual sales, reflecting a focus on scaling successful brands. The company also introduced a steady flow of exclusive products and designer collaborations to enhance its brand portfolio and attract consumers. This evolution underscores Target's commitment to leveraging owned brands as a key differentiator and growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several factual inaccuracies not present in the ground truth. While the general direction of strategic evolution—increased emphasis on owned brands—is consistent, the specific details about brand launches (e.g., dealworthy, Auden, Gigglescape) and the claim that 11 owned brands exceeded $1 billion in sales are not supported by the original answer and cannot be verified from the provided ground truth. These are significant additions that introduce unverified quantitative and qualitative claims. (2) Quantitative accuracy is low because the statement about 11 brands exceeding $1 billion in annual sales is a specific numeric claim absent from the original answer and thus cannot be confirmed. The original answer mentions over 40 distinct brands but does not reference sales figures or billion-dollar brands. This introduces potentially misleading data. (3) The reasoning partially aligns with the multi-hop intent: the model infers a strategic shift toward brand development from 2023 to 2024, which matches the original’s description of moving from strategic emphasis to concrete execution. However, it overreaches by adding unsupported examples and metrics, weakening the logical fidelity. (4) Contextual relevance is high because the response addresses the evolution of Target's owned brand strategy and attempts to describe both strategic emphasis and product portfolio changes. The qualitative accuracy is moderate because while the direction of the strategy is correctly interpreted, the supporting evidence is embellished. Correctness score is 6 due to partially correct strategic narrative but significant fabrication of specific brand names and financial metrics not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 475,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 alongside the new 2.900% Notes due 2030 suggests a strategy to diversify its long-term debt structure by offering varying interest rates to attract a broader range of investors. This indicates that IBM is capitalizing on favorable market conditions for long-term borrowing, potentially securing lower interest costs while also accessing higher-yield investor demand. The move reflects confidence in stable borrowing conditions and a proactive approach to managing its debt portfolio for flexibility and cost efficiency.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two notes (0.875% and 2.900% Notes due 2030) and their coexistence in IBM's capital structure, which matches the ground truth. The entities (IBM, 2030 maturity, interest rates) and years are accurate. (2) Quantitatively, all numbers—0.875%, 2.900%, and the 2030 maturity—are correctly stated, and no calculations are required beyond comparison, which is factually sound. (3) However, the reasoning is flawed in interpreting market conditions: the ground truth suggests that the higher coupon rate in 2024 likely reflects *less favorable* borrowing conditions (rising interest rates), whereas the LLM incorrectly claims IBM is capitalizing on *favorable* conditions and securing *lower interest costs*. This misrepresents the core implication of the rate increase. Additionally, the ground truth emphasizes refinancing risk management and possible targeting of different investor segments, while the LLM overemphasizes investor diversification without acknowledging the shift in macroeconomic environment. (4) The answer is contextually relevant and addresses the debt financing strategy question, but the incorrect interpretation of market conditions and lack of recognition of deteriorating borrowing terms significantly undermines the qualitative accuracy. Hence, correctness is partially compromised despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 383,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "The 4.000% Global Notes due June 1, 2049 (T 49A) were listed on the New York Stock Exchange in both the 2022 and 2024 filings, indicating no new issuance of this specific instrument between those years. However, in 2024, AT&T added new long-term notes, including the 4.300% Global Notes due November 18, 2034 (T 34C), which were not present in the 2022 filing. This suggests the company issued new long-term debt in 2024 to diversify its debt composition and potentially manage its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.000% Global Notes due June 1, 2049 (T 49A) were present in both 2022 and 2024 filings, and that the 4.300% Global Notes due November 18, 2034 (T 34C) were added in 2024 and not present in 2022. All entities—note types, interest rates, maturity dates, ticker symbols—are accurate and match the ground truth. (2) Quantitative elements (interest rates: 4.000%, 4.300%; maturity dates: June 1, 2049; November 18, 2034; security symbols: T 49A, T 34C) are all factually correct with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from the presence/absence of instruments across years that AT&T expanded its debt portfolio by issuing new notes in 2024 while retaining long-dated obligations. The conclusion about diversifying debt composition and managing capital structure is a reasonable qualitative inference, though slightly more interpretive than the original answer. (4) The answer is semantically equivalent to the ground truth, with only minor differences in emphasis—the original highlights the continuity of the 2049 notes and the addition of the 2034 notes as evidence of portfolio expansion, while the LLM adds a plausible strategic rationale. No factual inaccuracies; minor deduction in qualitative accuracy only because the LLM slightly extends beyond the documented facts with strategic interpretation, but this does not compromise correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 403,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing significantly from $258 million in 2023 to $560 million in 2024, primarily due to the amortization of intellectual property and customer relationships from the acquisition. Restructuring costs related to the Heritage AspenTech acquisition were $1 million in 2023 and increased to $8 million in 2024, reflecting ongoing integration and restructuring efforts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, intangibles amortization decreased from $258 million in 2023 to $97 million in 2024, but the LLM incorrectly states it increased to $560 million in 2024. Similarly, restructuring costs rose from $72 million to $228 million in the ground truth, but the LLM claims they were only $1 million and $8 million in 2023 and 2024 respectively—both figures are drastically wrong. (2) All key numbers are incorrect: amortization ($258M → $97M actual vs $258M → $560M claimed), restructuring costs ($72M → $228M actual vs $1M → $8M claimed). These are not minor discrepancies but complete inversions and misstatements of magnitude. (3) While the LLM attempts multi-hop reasoning by discussing trends in amortization and restructuring costs over two years, the underlying data synthesis is fundamentally flawed—there is no evidence it accessed or processed the correct data points. The reasoning about 'ongoing integration efforts' is plausible contextually but unsupported by accurate data. (4) The contextual relevance is moderate because the answer addresses the right topic (financial impact of the Heritage AspenTech acquisition over 2023–2024) and the correct categories (intangibles amortization, restructuring costs), but the severe quantitative errors destroy factual reliability. Correctness and quantitative accuracy scores are very low due to total inversion of trends and orders-of-magnitude errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 418,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved to place greater emphasis on segmentation of business types and the impact of large deductible accounts. The proportion of large deductible business has increased over time, which has slowed the reporting pattern of claims. For guaranteed cost business, expected loss ratio methods are primarily used in the most recent accident year, while for excess of deductible business, these methods are given significant weight in the most recent five accident years. AIG further segments its workers' compensation business by state, industry subset, deductible size, and whether claims are handled internally or by third-party administrators, reflecting a more granular approach to reserving.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the core evolution: increased segmentation by deductible size and claim handling, the growing proportion of large deductible accounts, and their impact on slowing claim reporting patterns. The distinction between guaranteed cost (most recent accident year) and excess of deductible (recent five accident years) in the application of expected loss ratio methods is correctly stated and matches the 2022 data. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes information about business segmentation, claim handling, and temporal changes in reserving methodology. However, the LLM omits a key 2024-specific disclosure mentioned in the ground truth: the limitations in claim count data due to aggregation and reinsurance exclusions, which were explicitly highlighted in 2024 but not in 2022. This is a notable qualitative omission affecting completeness. (4) The answer remains highly contextually relevant, directly addressing the evolution between 2022 and 2024, segmentation, and large deductible impacts. The omission prevents a 9–10 correctness score, but the core facts and reasoning are accurate, warranting an 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 384,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target enhanced its Cyber Fusion Center operations by integrating threat investigation and response more deeply into its enterprise risk management program and increasing collaboration with external organizations. In 2023, the Cyber Fusion Center focused on proactive threat intelligence and incident response, while in 2024, the company emphasized expanding collaboration across industries to share best practices, fight cybercrime, and enhance privacy. Additionally, Target's Chief Information Security Officer actively contributes to the broader cybersecurity community through board and advisory roles, promoting collaboration and talent development.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and relevant but misses key factual developments from the ground truth, particularly around the structured incident response program and third-party assessments in 2024. (1) Correct elements: The answer correctly identifies Target's Cyber Fusion Center operations in 2023 and continued external collaboration in 2024, including cross-industry information sharing. It also appropriately notes leadership engagement in the cybersecurity community, which aligns with Target's broader collaboration efforts. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this criterion is satisfied by default (no incorrect numbers). (3) Multi-hop reasoning: The model attempts to synthesize evolution over time (2023 to 2024) and across internal/external dimensions, but fails to accurately report the specific enhancements in 2024—namely, the coordinated escalation model for Board reporting, structured incident response program, and use of third-party vendors for testing and compliance training. Instead, it generalizes with less specific claims about 'deeper integration' and 'expanded collaboration' without citing these concrete operational changes. (4) The answer is contextually relevant and well-structured but lacks precision in conveying the actual evolution. It substitutes specific programmatic improvements with broader statements about risk management integration and community contributions, which, while plausible, are not supported in the ground truth. This results in a moderate correctness score due to significant omissions in factual detail despite correct framing and no outright errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 453,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024, primarily through the sale of rights. In June 2023, Lilly sold the rights for Baqsimi to Amphastar Pharmaceuticals, receiving $500.0 million in cash in 2023 and an additional $125.0 million in 2024. The $579.0 million in revenue recognized in 2023 was primarily related to the net gain on the sale of rights for Baqsimi. Additionally, Lilly entered into a supply agreement with Amphastar, recognizing net product revenue over time as it manufactured Baqsimi, as the product had no alternative use and Lilly had the right to payment. By 2024, the transaction price included the 2023 and 2024 cash receipts, with potential future milestone payments of up to $450.0 million not yet included in the transaction price.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes mostly correct information but contains significant quantitative inaccuracies. The original answer states that Eli Lilly recognized $579.0 million in revenue in 2023 from the sale of Baqsimi rights, which matches the LLM's mention of $579.0 million. However, the LLM incorrectly breaks this down into $500.0 million in 2023 and $125.0 million in 2024 cash receipts, implying a total of $625.0 million, which contradicts both the reported $579.0 million and the ground truth. There is no mention in the original answer of Amphastar Pharmaceuticals, the $125.0 million 2024 payment, or future milestones of $450.0 million—these details are either fabricated or misattributed. (2) The $579.0 million figure is accurate, but the split and additional payments are not supported by the ground truth. The calculation of total consideration is therefore incorrect. The dates (2023 sale) are generally correct, but specific timing (June 2023) is not in the original and cannot be verified. (3) The reasoning about revenue recognition evolving from direct product revenue to collaborative arrangements is well-articulated and aligns with the original answer’s theme. The mention of a supply agreement and revenue recognition over time due to lack of alternative use and right to payment shows strong qualitative understanding of ASC 606 principles and multi-hop synthesis, even if some entities and numbers are incorrect. (4) The contextual relevance is high because the answer directly addresses the evolution in financial relationship, revenue recognition, and contractual changes. Despite strong reasoning and relevance, the quantitative inaccuracies—especially the unsupported breakdown of payments and introduction of a third party (Amphastar)—reduce the correctness score. The answer captures the core shift in accounting treatment but adds unverified specifics that undermine factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 521,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T's approach to managing its capital structure through preferred interests evolved as follows: In 2023, the company repurchased the remaining 213 million Mobility Preferred Interests for $5,414, funded primarily by the issuance of additional Telco LLC preferred interests. In 2024, AT&T expanded its Tower Holdings preferred interests by restructuring the 2019 Tower preferred interests into Fixed and Floating Rate Class A Limited Membership Interests, with adjusted distribution rates, and continued to manage its Telco LLC preferred interests by issuing additional nonconvertible cumulative preferred interests, increasing the total to $7,250.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in AT&T's capital structure strategy from 2023 to 2024. (1) It correctly identifies the 2023 repurchase of 213 million Mobility Preferred Interests for $5,414 and notes the funding via issuance of Telco LLC preferred interests. It also accurately reflects the 2024 restructuring of Tower Holdings preferred interests and the increase in total Telco LLC preferred interests to $7,250. (2) Quantitatively, the LLM omits some specific details present in the ground truth: it does not mention the $5,250 issuance amount for the 2023 Telco LLC preferred interests, the 6.85% distribution rate, or the breakdown of the $7,250 total (including the original $2,000 Telco Class A-1 and 2023 additions). Additionally, it fails to specify the new distribution terms for the restructured Tower Holdings interests—5.90% base rate and SOFR + 250 bps—though it correctly notes the restructuring into fixed and floating rate classes. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and entities (Mobility, Telco LLC, Tower Holdings) and infers a strategic shift from repurchasing legacy interests to issuing new structured preferred interests. However, the absence of key financial terms and precise funding figures limits full quantitative accuracy. (4) Despite missing some granular details, the LLM conveys the core strategic pivot and timeline accurately, making the response contextually excellent and semantically close to the original. Minor omissions prevent a top score, but the overall correctness is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 439,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024, Emerson's relationship with AspenTech evolved significantly. In 2023, Emerson had already acquired Heritage AspenTech, which contributed to its Software and Control business group. By 2024, Emerson proposed to acquire the remaining shares of AspenTech not already owned by Emerson for $240 per share in cash, implying a fully diluted market capitalization of $15.3 billion. This acquisition would increase Emerson's ownership from approximately 57% to 100%. Financially, the transformation had mixed impacts: the Heritage AspenTech acquisition in 2023 positively influenced gross margin by 0.6 percentage points, while the 2024 proposed acquisition and related restructuring activities led to higher amortization costs and a loss on the Copeland note receivable, which negatively impacted earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Emerson 'acquired Heritage AspenTech' in 2023, while the ground truth indicates that Emerson acquired a 55% stake in 'New AspenTech' (formerly Heritage AspenTech) as part of a transaction involving $6.0 billion in cash—not a full acquisition. The LLM also falsely claims that in 2024, Emerson proposed to acquire the remaining shares for $240 per share, implying a $15.3 billion valuation, which is not supported by the original answer. The ownership stake in 2023 was 55%, not 57% as stated. (2) Quantitative inaccuracies include the gross margin impact: the LLM says AspenTech contributed 0.6 percentage points in 2023, but the correct figure is 3.3 percentage points. For 2024, the LLM does not mention the 1.8 percentage point increase in gross margin due to broader changes including the AspenTech transaction, instead citing negative impacts from amortization and a Copeland note loss—details absent from the ground truth. The $6.0 billion cash figure is omitted entirely. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution from partnership to majority ownership (55%), misrepresents the nature of the transaction, and invents a future acquisition not mentioned in the original. It also confuses financial impacts by introducing unrelated negative factors. (4) Despite these issues, the answer is contextually relevant—it addresses the relationship evolution and financial impacts as asked, and correctly identifies AspenTech as part of Software and Control. However, due to major factual and numerical errors, especially in ownership percentages, transaction details, and margin impacts, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 478,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG's Japan pension plans contributed approximately 50% of total non-U.S. pension obligations in 2024, down from 54% in 2023 and 61% in 2021, indicating a gradual decline in their relative contribution to non-U.S. pension obligations between 2022 and 2024. The weighted average discount rate for these plans increased from 1.09% in 2022 to 1.48% in 2023 and further to 1.81% in 2024, reflecting a steady rise in the discount rate applied to Japan pension obligations during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and time periods. It incorrectly states that Japan's share was 61% in 2021, while the ground truth specifies 61% in 2022. This misalignment affects the temporal evolution claimed between 2022 and 2024. Additionally, the LLM claims the discount rate was 1.09% in 2022, but the ground truth does not provide a discount rate for Japan plans in 2022—only that it increased to 1.81% in 2024 from 1.48% in 2023. Thus, the 1.09% figure for 2022 is unsupported and incorrect. (2) The projected benefit obligation percentages are mostly correct: 54% in 2023 and 50% in 2024 match the ground truth, showing a correct downward trend. However, the reference to 2021 instead of 2022 breaks the required period of analysis (2022–2024). The discount rate increase from 1.48% in 2023 to 1.81% in 2024 is accurate per the original answer, but the addition of a 1.09% rate in 2022 introduces a false data point. (3) The multi-hop reasoning is partially sound—the model correctly infers a declining contribution of Japan plans to non-U.S. obligations and identifies an increasing discount rate trend. However, the unsupported 2022 discount rate undermines the quantitative validity of the trend. (4) Despite these issues, the overall direction of change (declining share, rising discount rate) is correctly interpreted, and the answer remains contextually relevant. The core narrative aligns with the ground truth, but factual errors in key numbers reduce correctness. Hence, scores reflect partial accuracy with significant quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 437,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's framing of the impact of competitive stores on its business became more expansive and detailed. In 2022, the mention of competitive stores was included as one of several factors affecting sales and operating results, without specific emphasis on market conditions. In 2023, the discussion of competition was more prominent, with a dedicated section outlining the breadth of competitors across various sectors and highlighting the intensifying global market environment, including the entry of new and well-funded competitors. This shift reflects a more strategic and comprehensive acknowledgment of external market pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no numbers to misstate, it is scored as 10 by default. The answer addresses the evolution of Amazon's disclosure between 2022 and 2023, but misrepresents the nature and location of the changes. According to the ground truth, the core language about competitive stores remained unchanged between the two filings—the same phrase was retained. The key shift was contextual: in 2023, the mention of competitive stores was embedded within a broader discussion of external economic and geopolitical conditions, reframing competition as part of a larger set of external risks. However, the LLM incorrectly claims that the 2023 filing included a 'dedicated section' on competition and highlighted 'intensifying global market environment' and 'new and well-funded competitors,' which is not supported by the original answer. There is no evidence in the ground truth that competition received more prominence or a separate section in 2023. Instead, the framing shift was subtle and contextual, not structural or expansive. This constitutes a significant qualitative inaccuracy in reasoning and synthesis. While the general direction of the answer (increased emphasis on external pressures) aligns loosely with the truth, it fabricates structural changes in the filing and overstates the extent of the shift, missing the actual nuance of how the identical language was repositioned within a broader risk context. Thus, while contextually relevant and attempting the right comparison, the factual misrepresentation of the filings' content reduces its correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 455,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks between 2023 and 2024 remained consistent in terms of geographic focus, with major U.S. ports—particularly California ports—still being critical points of vulnerability due to their role in receiving a significant portion of imported merchandise. Operationally, the company continued to face risks such as periodic port closures, labor disputes, and congestion, which could disrupt supply chains and increase costs. However, there is no indication of a significant evolution in the nature or impact of these risks during the period, as Target maintained strategies to address disruptions by making alternative arrangements when necessary.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that Target faces port security risks related to major U.S. ports and imported merchandise, but it incorrectly states that the geographic focus remained consistent, specifically still highlighting California ports. According to the ground truth, there was a clear evolution: in 2023, Target explicitly named California ports as a key area, but in 2024, it broadened its risk disclosure to 'major U.S. ports' without specifying California, indicating a shift from a localized to a more generalized concern. This evolution is entirely missed by the LLM, which claims 'no significant evolution,' contradicting the original answer. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the question requires comparing Target’s risk disclosures across two years (2023 vs 2024) to assess evolution in geographic focus and operational impact. The LLM fails to correctly synthesize this change over time. It also misrepresents the operational shift: in 2023, Target referenced past disruptions and alternative arrangements, whereas in 2024, the focus was on potential future impacts like increased costs and supply issues due to global conflicts and labor disputes. The LLM incorrectly suggests continuity in both strategy and risk nature. (4) Correctness and qualitative accuracy are low due to the failure to capture the key evolution in both geographic scope and operational risk framing. Contextual relevance is high because the answer addresses the right topic (port risks, supply chain, labor issues) and company (Target), but the core analytical point—evolution over time—is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 485,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved in terms of acquisition-related amortization and restructuring costs. Amortization of intangibles related to the Heritage AspenTech acquisition increased from $258 million in 2023 to $439 million in 2024, reflecting the higher value and expanded scope of intangible assets recognized post-acquisition. Additionally, restructuring costs attributed to Heritage AspenTech rose from $1 million in 2023 to $8 million in 2024, indicating increased operational adjustments and integration efforts following the acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, amortization related to the Heritage AspenTech acquisition was $258 million in 2023 but was no longer reported in 2024, indicating a decline or cessation of acquisition-related amortization. However, the LLM incorrectly states that it increased to $439 million in 2024, which is factually wrong. Similarly, restructuring costs in the ground truth rose from $72 million in 2023 to $228 million in 2024, but the LLM claims they were only $1 million in 2023 and $8 million in 2024—dramatically underreporting both figures and misrepresenting the trend. (2) Quantitative accuracy is very low: both amortization and restructuring cost figures are incorrect, with no alignment to the ground truth. The LLM invents numbers not present in the source data. (3) The multi-hop reasoning is flawed. While the LLM attempts to interpret the financial evolution as integration efforts, it fails to recognize that the absence of AspenTech-specific amortization in 2024 suggests the transition out of initial acquisition accounting, not an increase. The reasoning is based on false numerical premises. (4) Contextual relevance is moderate because the answer addresses the right topic—acquisition-related amortization and restructuring costs—and attempts to explain Emerson's evolving relationship with AspenTech. However, due to severe factual and numerical errors, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 412,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio (ELR) methods has evolved between 2022 and 2024 by giving more weight to these methods in recent accident years, particularly for lines with low-frequency, high-severity losses such as D&O, E&O, and EPLI. In 2022, ELR methods were emphasized in newer accident years, while loss development methods were used for older, more mature years. By 2024, the application of ELR methods expanded further, especially in newer accident years, with IBNR factors applied to earned premiums to estimate ultimate losses. This shift reflects the need to adapt to changing loss trends, including the impact of recent events like the pandemic and evolving underwriting strategies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AIG's use of Expected Loss Ratio (ELR) methods in 2022, correctly identifying their application in low-frequency, high-severity lines such as D&O, E&O, and EPLI, particularly for recent accident years. It also correctly notes the use of IBNR factors applied to earned premiums by 2024. However, it omits a key evolution highlighted in the ground truth: the expansion of ELR methods into U.S. Workers' Compensation, a long-tail line of business, which represents a significant shift in the method's application across different risk profiles. This omission reduces completeness and weakens the qualitative accuracy, as the broader diversification into new lines of business is a central part of the evolution. While the LLM captures the general trend of increased reliance on ELR methods and adaptation to changing loss trends, it fails to mention the integration with loss development and frequency/severity methods in 2024, which reflects a more nuanced, hybrid reserving approach. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect numbers are cited), and the answer remains contextually relevant throughout. The reasoning is sound but incomplete in synthesizing the full scope of multi-hop information across time, lines of business, and methodological combinations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 377,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with an increase in capitalized video and music content costs, rising from $16.7 billion in 2022 to $17.4 billion in 2023. This growth in capitalized costs was accompanied by a corresponding increase in associated expenses, which rose from $16.6 billion in 2022 to $18.9 billion in 2023. The strategy appears to involve expanding original content production and licensing, with these costs being amortized based on estimated viewing patterns, primarily on an accelerated basis. The film groups are monetized as a unit within each major geography where Amazon offers Prime memberships, indicating a continued focus on bundling content to drive Prime subscriptions and customer engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: capitalized video and music content costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and associated expenses rose from $16.6 billion to $18.9 billion. These figures match the original answer exactly, with no calculation or reporting errors. (2) Quantitative accuracy is perfect—numbers, years, and dollar amounts are all correct and properly contextualized. (3) The reasoning is sound and goes beyond the original answer by adding relevant qualitative context about amortization methods and monetization via Prime membership bundling. While this additional detail is not in the ground truth, it is plausible and does not contradict it. The core multi-hop synthesis—linking increased capitalized costs and expenses to a more aggressive monetization strategy—is correctly inferred and aligns with the original conclusion. (4) The answer is fully contextually relevant, directly addressing the evolution of Amazon's monetization strategy based on changes in content costs and expenses. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes the *implication* of more aggressive monetization efforts, while the LLM slightly shifts focus toward production expansion and amortization mechanics, which, while relevant, are not the central point of the ground truth. However, this does not detract significantly from factual accuracy or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 419,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International (PMI) recorded a significant impairment related to its equity investment in Rothmans, Benson & Hedges (RBH). In 2024, PMI concluded that the estimated fair value of its RBH investment was lower than its carrying value due to developments in the proposed settlement of Canadian tobacco claims, which narrowed the potential allocation of the CAD 32.5 billion settlement among RBH and other parties. As a result, PMI recorded a non-cash impairment charge of $2,316 million (diluted EPS charge of $1.49 per share) in 2024. No similar impairment was disclosed in the 2022 filing, indicating a material decline in the value of PMI’s stake in RBH during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2,316 million impairment charge in 2024 and the reference to the CAD 32.5 billion Canadian tobacco litigation settlement are factually accurate. The mention of a $1.49 diluted EPS charge adds detail not in the original but is consistent with typical reporting and does not contradict it. (2) The answer correctly identifies the shift in PMI's relationship with RBH from no reported impairment in 2022 to a major equity impairment in 2024, capturing the evolution over time. (3) The reasoning is sound: it correctly links the impairment to developments in the Canadian litigation settlement and the reduced expected allocation to RBH, which affected the fair value of PMI’s investment. (4) The only minor gap is that the original answer notes PMI’s earlier trademark and brand licensing relationship with RBH (e.g., reporting HEETS volumes) in 2022, which the LLM omits. While the LLM implies a change by stating no impairment was disclosed in 2022, it doesn’t explicitly acknowledge the nature of the prior relationship (trademark/brand reporting), slightly reducing completeness in the multi-hop synthesis. However, the core financial evolution—no impairment in 2022 to a $2.3B+ impairment in 2024 due to litigation uncertainty—is accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 429,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Based on the disclosures in the 2023 and 2024 10-K filings, LLY's sensitivity of net product revenue to changes in sales return, rebate, and discount liabilities increased between 2023 and 2024. In 2023, a 5% change in these liabilities would have resulted in a revenue change of approximately $615 million. The increase in U.S. rebate liabilities in 2023, driven by higher volume of rebates for managed care, Medicare, chargebacks, and Medicaid programs, contributed to this sensitivity. In 2024, the overall growth in revenue, particularly in the U.S. due to products like Zepbound and Mounjaro, likely amplified the exposure to these liabilities, although specific sensitivity percentages were not provided for 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly states the 2023 sensitivity figure: a 5% change in sales return, rebate, and discount liabilities would result in a $615 million change in revenue, which matches the ground truth. This earns high marks for quantitative accuracy. However, the answer incorrectly implies that sensitivity increased in 2024 due to revenue growth and product performance (e.g., Zepbound and Mounjaro), suggesting a conclusion not supported by the 2024 filing. The ground truth explicitly states that LLY did not provide a 2024 sensitivity figure, making any claim about an 'increase' in sensitivity factually incorrect. The LLM invents a causal inference (amplified exposure) not present in the disclosures, which constitutes a significant qualitative error. While the entities (LLY, 2023, 2024, rebates, discounts) and context (sensitivity of revenue to liabilities) are relevant and mostly accurate, the core reasoning fails on multi-hop synthesis: the model should have concluded that the sensitivity could not be determined for 2024 due to lack of disclosure, not inferred an increase. Thus, despite correct 2023 data and relevant context, the answer's main claim is unsupported, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 343,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2024, Bulk shipments generated 32% of the company's freight revenues, down slightly from 33% in 2022. Revenue from Bulk shipments increased by 12% in 2024 compared to 2022, driven by a 5% increase in carloads and higher pricing. However, coal shipments, a major component of the Bulk group, declined significantly due to reduced demand, partially offset by growth in grain and agricultural products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Bulk shipments contributed 32% of total freight revenues in 2024, but does not provide a 2022 percentage or state that it declined from 33%. The claim of a 12% revenue increase from 2022 to 2024, driven by a 5% increase in carloads and higher pricing, is not supported by the original answer and introduces fabricated data. Additionally, the original answer does not mention any decline in coal shipments or growth in grain and agricultural products as a counterbalance—these details are speculative and not in the ground truth. (2) Quantitatively, the only correct number is the 32% revenue contribution in 2024. All other figures—33% in 2022, 12% revenue growth, 5% carload increase—are incorrect or unsupported. The original answer references average revenue per car of $3,305 in 2021 (from the 2022 filing) and a 6% increase from 2020, but the LLM omits this entirely. (3) The multi-hop reasoning is flawed. The original answer traces the evolution from revenue-per-unit metrics in earlier years to strategic integration and increased revenue share by 2024. The LLM fails to capture this trajectory and instead invents a narrative of slight decline in share and growth driven by volume and pricing, which misrepresents the evolution. (4) Contextual relevance is moderate—the answer addresses Bulk shipments and their revenue role over time, which is relevant—but due to major factual and reasoning errors, the correctness score is low. The LLM introduces unverified trends and omits key disclosed metrics, resulting in a mostly incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 452,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "Between 2023 and 2024, the interest rate for IBM's Notes due 2028 remained at 0.300% (IBM 28B) in both years, indicating no change in the rate during this period. This suggests that IBM maintained its existing low-cost debt instruments as part of a stable and conservative debt strategy, likely aiming to manage interest expenses and preserve financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that IBM's Notes due 2028 had an interest rate of 0.300% (IBM 28B). The ground truth confirms the rate was 1.750% for IBM 28A, not 0.300% or IBM 28B. This misidentifies both the rate and the note series, leading to a major factual error. (2) Quantitatively, the interest rate (0.300% vs 1.750%), the note designation (28B vs 28A), and the absence of any mention of new debt issuances in 2024 (e.g., 2.900% Notes due 2030, 3.150% due 2033) are all incorrect. No calculations were required, but the core numbers are wrong. (3) The reasoning is partially sound in interpreting a stable rate as indicative of a conservative debt strategy, but it fails the multi-hop requirement: it does not acknowledge that while the 2028 note rate was unchanged, IBM issued new higher-rate, longer-term debt in 2024 — a key part of the strategic insight. The model invents a non-existent note (28B) instead of referencing the correct one (28A). (4) Correctness and quantitative accuracy are low due to fundamental factual errors. Qualitative accuracy is slightly higher because the general logic of stable rates suggesting conservative strategy is plausible, though based on false premises. Contextual relevance is moderate as the answer addresses the question structure but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 372,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T repurchased all of its Mobility Preferred Interests in April 2023, eliminating this component from its capital structure. In 2024, the company introduced new preferred instruments, specifically the Tower Holdings and Telco LLC preferred interests. These new instruments included fixed and floating rate structures with specific distribution terms and redemption features, indicating a strategic shift towards more structured and diversified preferred capital instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repurchase of Mobility Preferred Interests in April 2023 and the strategic shift toward new preferred instruments in 2024, including Tower Holdings and Telco LLC. However, it omits key quantitative details present in the ground truth: the $5,340 million redemption value and $373 million annual distributions for the Mobility Preferred Interests, which are significant to the capital structure discussion. These omissions reduce quantitative accuracy. (2) The dates are partially correct—April 2023 is accurate—but the introduction of the new instruments in 2024 is stated generally without specifying any timing or exact amounts. The expansion of Telco LLC to $7,250 million is completely omitted, which is a material figure. (3) The multi-hop reasoning is sound: the model correctly synthesizes a strategic evolution from eliminating one type of preferred interest to introducing others, indicating a pivot in capital structure strategy. The qualitative assessment of a shift toward 'more structured and diversified' instruments aligns well with the ground truth. (4) Contextual relevance is perfect—the answer directly addresses the evolution of AT&T's capital structure strategy regarding preferred interests across 2023 and 2024. While the core facts and reasoning are correct, the lack of specific financial figures prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 398,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites evolved to emphasize a broader and more dynamic array of competitors, reflecting the increasing complexity and intensity of competition. In 2022, the language focused on traditional competitors such as physical and e-commerce retailers, search engines, and advertising services. By 2023, the language expanded to include a more detailed list of competitors across various sectors, including companies providing e-commerce services, fulfillment and logistics, and information technology services, as well as new entrants and business models. This shift in language indicates a recognition of the evolving digital landscape and the emergence of new, well-funded competitors in multiple domains.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key aspects of Amazon's evolving characterization of competitive threats. (1) What was correct: The answer correctly identifies a shift in Amazon's language between 2022 and 2023 regarding competition, and it appropriately frames the evolution as reflecting increased complexity and intensity. The years (2022 and 2023) are accurate, and there are no numeric inaccuracies (quantitative accuracy is high because no incorrect numbers were cited). (2) What was incorrect: The ground truth specifies that in 2022, Amazon mentioned competitive websites as part of a broader list of fluctuating business factors, while in 2023, it specifically highlighted 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. The LLM answer misrepresents this by claiming in 2022 Amazon focused on 'traditional competitors such as physical and e-commerce retailers, search engines, and advertising services'—this level of specificity is not supported by the ground truth. Moreover, the LLM introduces new categories like 'fulfillment and logistics' and 'information technology services' as competitive threats in 2023, which are not mentioned in the original answer. (3) Multi-hop reasoning assessment: The model fails to accurately synthesize the precise shift in language from general operational risk to a more strategic and dynamic competitive challenge centered on digital platforms. Instead, it infers a broader expansion into service domains not referenced in the ground truth, indicating flawed reasoning. (4) Justification for scores: Correctness is scored 5 due to partial factual alignment but significant deviation in the core evidence of language change. Quantitative accuracy is 10 because no numbers are incorrect (none were used). Qualitative accuracy is 5 due to incorrect entity elaboration and reasoning gaps. Contextual relevance is 7 because the answer addresses the general theme of evolving competition but misses the specific linguistic shift emphasized in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 564,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's strategic reliance on KT&G's heat-not-burn products has grown from 2022 to 2024, as evidenced by the inclusion of licensed KT&G heat-not-burn products within PMI's smoke-free portfolio and their contribution to PMI's smoke-free net revenues. In 2024, smoke-free net revenues totaled $14.66 billion, with KT&G's heat-not-burn products explicitly noted as part of PMI's heat-not-burn offerings. This reflects an expansion of PMI's collaboration with KT&G, which began in 2020, to commercialize KT&G's products globally, excluding the U.S. The increased focus on heat-not-burn products aligns with PMI's broader strategy to shift toward smoke-free alternatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of PMI's relationship with KT&G, noting increased strategic reliance and inclusion of KT&G's heat-not-burn products in PMI's portfolio. However, it introduces significant factual inaccuracies that undermine correctness. (1) The $14.66 billion smoke-free net revenues in 2024 is not supported by the ground truth and appears fabricated; the original answer does not provide any financial figures for PMI's smoke-free revenues. This major quantitative error severely impacts accuracy. (2) The claim that the collaboration began in 2020 contradicts the ground truth, which states the agreement started in 2022. (3) The exclusion of the U.S. is not mentioned in the original and may be incorrect. While the LLM correctly identifies the shift from distribution to integration into PMI's portfolio, it fails to mention the exclusive global distribution agreement outside South Korea or the three-year term, which are key elements of the strategic evolution. (4) The reasoning partially reflects multi-hop synthesis—linking KT&G product inclusion to strategic reliance—but relies on unsupported data. Despite these issues, the answer remains contextually relevant and conveys a plausible narrative about deepening partnership. Wording differences are acceptable, but invented numbers and dates constitute serious factual errors, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 388,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in its purpose and administration, as it continued to be used solely to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who became IBM employees following the 2002 acquisition. The scope of the plan did not expand to include senior executives, and its terms and conditions remained substantively identical to those of the 2001 Plan. No significant changes were disclosed in its administration during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that the PWCC Plan was used solely to fund awards for former PwCC employees who joined IBM after the acquisition, and that the plan's terms remained substantively identical to the 2001 Plan—both of which are correct per the original answer. The administration and scope are accurately described as unchanged between 2022 and 2024. The only minor shortcoming is that the LLM does not mention the evolution in language tone from 2022 to 2024 (from 'will continue to be used' to a more definitive 'has been and will continue to be used solely'), which the original answer highlights as indicating a stronger commitment. This nuance in rhetorical emphasis is a qualitative detail that adds depth to the 'evolution' aspect of the question, but its omission does not make the answer factually incorrect—just slightly less complete in capturing subtle shifts in messaging. All entities (PWCC, IBM, 2001 Plan) and timeframes (2022–2024) are correct. No numerical data is involved, so quantitative accuracy is scored as 10 by default. The reasoning is sound, and the answer is highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 335,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "AT&T fully repurchased all outstanding Mobility Preferred Interests by April 2023, eliminating this financial obligation by year-end 2023. This action reflects a strategic shift to simplify its capital structure by removing complex, contingent liabilities and reducing financial risk. The repurchase aligns with broader capital structure management efforts to enhance financial flexibility and focus on core operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, eliminating the obligation, which aligns with the ground truth. However, it omits the specific dollar amount of $5,414 million (including accrued distributions), a quantitatively relevant detail present in the original answer. The timing is partially accurate—'by April 2023' is more specific than the ground truth's 'in 2023', but without corroboration in the source, this precision may be overstated. (2) The ground truth includes a comparative element—contrasting the elimination of Mobility Preferred Interests with the continued existence and restructuring of Tower Holdings and Telco LLC preferred interests in 2024—which the LLM omits. This affects completeness and qualitative depth, as the strategic selectivity in capital structure management is underdeveloped. (3) The reasoning is sound in linking the repurchase to simplification of capital structure and risk reduction, and the conclusion about enhancing financial flexibility is consistent with the original. However, the multi-hop synthesis is incomplete, as the model fails to contrast this instrument's treatment with others, weakening the strategic interpretation. (4) Despite missing specific figures and comparative context, the LLM captures the core factual evolution and strategic implication, warranting a high correctness score. Quantitative accuracy is slightly reduced due to the missing $5,414M figure, but no incorrect numbers are stated. Qualitative accuracy is strong but not complete. Contextual relevance is excellent—the response directly addresses the question's focus on financial obligations and strategic capital management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 468,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained largely consistent, with no significant changes in the nature of its relationship with stock exchange regulations. Both the 2022 and 2024 filings highlight that the value of IBM's debt securities is subject to factors such as interest rates, exchange rates, governmental regulations, and stock exchange rules, which the company has little or no control over. Additionally, in both periods, IBM emphasized that its ability to meet obligations on debt securities depends on its operational performance and broader market conditions, with no assurance of successful risk management. There is no indication of increased regulatory exposure during this timeframe.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that IBM's regulatory exposure remained 'largely consistent' with 'no significant changes' between 2022 and 2024. The ground truth shows a clear evolution in IBM's language: from describing stock exchange regulations as one of several external factors influencing debt securities in 2022, to stating in 2024 that it is 'subject to' these regulations, indicating a stronger, more direct regulatory exposure. This shift reflects a meaningful change in how IBM characterizes its regulatory obligations, which the LLM answer fails to recognize. While the LLM correctly identifies that both years mention external factors like regulations, it misinterprets the qualitative shift in tone and legal implication. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is very low because the model fails to capture the multi-hop nuance of evolving regulatory language and its implications. Contextual relevance is moderate because the answer discusses related concepts but misses the central point of change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 324,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's financial relationship with A&E, particularly in terms of equity income contribution, declined from 2022 to 2024. In 2022, A+E was described as a significant equity investment, with domestic subscribers across its channels and detailed subscriber figures provided. However, by 2024, Disney's equity income from investees, including A+E, decreased by $207 million to $575 million, indicating a notable reduction in A+E's contribution to Disney's financial results during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $207 million decrease in equity income by 2024 is correctly reported, matching the original answer. The mention of equity income decreasing to $575 million adds specificity not in the original but does not contradict it—this figure may come from additional context in the filings and is plausible. (2) The entities are correct: Disney, A&E (referred to as A+E, which is standard), and the time frame (2022 to 2024) is properly addressed. (3) The reasoning is sound: the answer captures the multi-hop element by noting A&E's significance in 2022 and the decline by 2024, synthesizing changes over time in equity income contribution. (4) The only minor shortcoming is that the original answer emphasizes A&E’s status relative to other investees like CTV Specialty Television, which the LLM omits—this is a small completeness gap but does not detract from the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 300,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16,973 million in 2022 to $18,043 million in 2023, indicating a $1,070 million rise. This increase suggests that the company is actively utilizing securitized debt as part of its long-term funding strategy to support its operations and manage liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021, with securitized debt being a significant portion. The LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. (2) The quantitative values are not supported by the ground truth: no mention of $16,973 million in 2022 exists in the original; instead, the only specific figure given for securitized debt is $18.043 billion in 2023. The $1,070 million increase is therefore fabricated. Additionally, the $42.3 billion figure refers to total long-term funding as of December 31, 2021 (not 2022), further misaligning timelines. (3) The multi-hop reasoning fails: the model should have inferred a reduction in securitized debt obligations as part of a strategic shift away from this funding source, but instead infers increased reliance due to a false increase. This reverses the correct strategic interpretation. (4) Contextual relevance is moderate because the answer addresses the right topic (securitized debt and long-term funding strategy), but the incorrect data and reasoning lead to a fundamentally wrong conclusion. Scores reflect major factual and quantitative errors undermining correctness and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 437,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney shifted its approach to scripted programming by consolidating and integrating its international general entertainment channels into its Direct-to-Consumer (DTC) platforms, such as Disney+ and Disney+ Hotstar. This strategic move reflects a broader shift from monetizing content through international linear channels to prioritizing DTC streaming services, which allows for more direct engagement with global audiences and greater control over content distribution. Notably, in June 2024, Disney merged its Latin American Star+ and Disney+ services into a single Disney+ offering, streamlining its international DTC strategy. Additionally, the Star-branded tile on Disney+ now features general entertainment programming, further emphasizing the integration of scripted content into the DTC ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Disney's strategic shift from international linear channels to DTC platforms between 2022 and 2024, and accurately references the integration of Star+ into Disney+ in Latin America in June 2024, which aligns with the broader trend of consolidating general entertainment content into streaming. The use of the Star-branded tile on Disney+ to deliver scripted and general entertainment content is also factually consistent with Disney's strategy. However, the LLM omits key elements from the ground truth: (1) the specific number of ~220 international general entertainment channels in 2022, (2) the joint venture Venu Sports with Fox Corp and Warner Bros. Discovery announced in 2024 as a major DTC move, and (3) the planned fall 2025 launch of a new DTC product combining live ESPN linear streams with ESPN+. While the LLM captures the directional shift toward DTC, it misses these critical multi-hop details that define the scope and partnerships involved in Disney’s strategic evolution. There are no numerical inaccuracies—dates and events mentioned (e.g., June 2024 merger) are correct where stated. The reasoning is sound but incomplete in synthesis, particularly regarding third-party collaborations and future-facing initiatives. The answer remains contextually relevant and conveys a plausible narrative, but lacks full completeness on the strategic breadth outlined in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 394,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to its energy storage products, particularly concerning accounts receivable and production scaling. In 2022, accounts receivable balances were influenced by government rebates, which could take up to a year to collect, and fluctuations due to contractual payment terms with financing partners. By 2023, while no specific accounts receivable figures were provided, the company continued to emphasize modular design and manufacturing optimization to scale energy storage production. However, production scaling remained dependent on efficient supply chains and localized manufacturing, which could be impacted by bottlenecks, supplier constraints, and global disruptions, as highlighted in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift from financial challenges (accounts receivable tied to government rebates) in 2022 to operational and production scaling dependencies in 2023, which aligns with the ground truth. However, it omits the specific $627 million receivable balance as of December 31, 2021, which is a key quantitative anchor in the original answer. While it references 'up to a year to collect'—consistent with the ground truth's 'up to a year or more'—the absence of the exact figure reduces quantitative accuracy. (2) No incorrect numbers are stated, but the lack of specific data (e.g., the $627M figure) and absence of a clear update for 2023 receivables weakens completeness. The ground truth emphasizes a shift in focus from financial exposure (with concrete data) to operational risks, while the LLM generalizes without citing the disclosed amount. (3) The multi-hop reasoning is sound: the model connects 2022 financial disclosures about receivables to 2023 operational risks like bottlenecks and supplier constraints, correctly identifying Nevada and Texas facilities as part of scaling dependencies (implied via 'localized manufacturing'). However, it does not explicitly name the factories or tie the shift directly to cost and profitability targets, slightly weakening synthesis. (4) Despite missing key numbers, the LLM captures the qualitative evolution in Tesla’s challenges and maintains contextual relevance. Wording differences are acceptable under semantic equivalence, but the omission of the $627M figure prevents a higher score. Thus, correctness is partially impacted by incomplete quantitative support, though core reasoning and entity identification (Tesla, energy storage, government rebates, supply chain) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 484,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to its operations, particularly in relation to bottling partners and fountain retailers. Syrups, including fountain syrups, are sold to bottling partners who either produce finished beverages or sell them directly to fountain retailers for on-the-spot consumption. The 2023 documents emphasize Coca-Cola's continued reliance on this model, with fountain syrup sales included in the North America operating segment. There is no indication of a significant shift in this structure, but the focus on productivity initiatives and supply chain management suggests ongoing efforts to optimize syrup-related operations and partnerships.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses the key evolution in Coca-Cola's syrup business model between 2022 and 2023 as described in the ground truth. (1) What was correct: The answer correctly identifies that syrups are sold to bottling partners and used in fountain retail, and notes the inclusion of fountain syrup sales in the North America segment, which aligns with the operational context. There are no numeric inaccuracies, so quantitative accuracy is high. (2) However, there are no numbers in either the original or LLM answer, so quantitative accuracy is not testable beyond consistency—no issues found. (3) Multi-hop reasoning is weak: the question asks for an evolution between 2022 and 2023, but the LLM fails to capture the shift in accounting and strategic emphasis. In 2022, revenue recognition differed based on bottler consolidation status (deferred for consolidated, immediate for unconsolidated), while in 2023, the framing shifted to syrups as an operationally embedded component, especially via direct sales to fountain retailers or wholesalers. The LLM incorrectly states there is 'no indication of a significant shift,' which contradicts the ground truth. (4) This omission of a strategic and accounting evolution significantly undermines qualitative accuracy. While the answer is contextually relevant and factually plausible, it fails to report the actual change in business model framing, resulting in a moderate correctness score. Contextual relevance is high because it addresses bottling partners, fountain retailers, and operational focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 430,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) decreased from fiscal year 2022 to fiscal year 2024, with the fair value dropping from $84 million in 2024 to $166 million in 2024. However, its proportion relative to the overall fair value hierarchy remained relatively stable, representing 1% in both fiscal years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in quantitative data. According to the ground truth, Disney's investment in Other MBS & ABS increased from $96 million in fiscal year 2022 to $120 million in fiscal year 2024. However, the LLM incorrectly states that the investment decreased and reports contradictory figures: it claims the value dropped 'from $84 million in 2022 to $166 million in 2024', which is both numerically incorrect and logically inconsistent (a drop cannot go from a lower to a higher value). These numbers do not match the ground truth in any format variation. (2) The only correct element is the proportional representation—1% in both years—which aligns with the original answer. However, this does not compensate for the severe inaccuracies in absolute values and trend direction. (3) The reasoning is flawed: the LLM incorrectly infers a decrease in investment despite citing a higher number in the later year, indicating a failure in basic comparative logic. It also fails to correctly synthesize the multi-hop information across fiscal years, misrepresenting both the magnitude and direction of change. (4) Contextually, the answer addresses the right metric (investment in Other MBS & ABS) and time frame (fiscal years 2022–2024), and attempts to discuss both absolute value and proportional trends, so relevance is moderate. However, due to severe quantitative inaccuracies and incorrect directional trend analysis, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 413,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs (ADP) expanded their focus to include more emphasis on next-generation military aircraft capabilities such as air dominance, hypersonics, intelligence, surveillance, reconnaissance, and network-enabled systems. This evolution reflects a strategic shift towards integrating innovative technologies to enhance competitiveness in military aircraft design, development, and production.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Skunk Works' focus areas between 2022 and 2023, noting increased emphasis on next-generation military aircraft capabilities such as air dominance, hypersonics, and ISR. It accurately reflects a strategic shift, aligning with the ground truth's mention of heightened focus on air dominance. However, it omits the specific 2022 focus on both unmanned and manned aerial systems and does not explicitly contrast the 2022 and 2023 priorities as a refinement rather than a complete overhaul. Additionally, the LLM introduces 'network-enabled systems'—not mentioned in the original answer—which is potentially misleading. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; the years 2022 and 2023 are correctly referenced, earning full marks. (3) The multi-hop reasoning is partially sound: the model infers a strategic evolution but fails to fully synthesize the specific continuity and shift in focus areas (e.g., maintaining hypersonics and ISR while elevating air dominance). The omission of the balanced 2022 focus on manned/unmanned systems weakens completeness. (4) The answer is contextually relevant and captures the general direction of evolution, but lacks precision in representing the exact focus areas and their refinement. Thus, correctness and qualitative accuracy are reduced due to omissions and an unsupported addition, though core elements remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 417,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its Powerwall strategy to emphasize integration with residential solar products and grid stability solutions. In 2022, Powerwall was highlighted for cross-selling with retrofit solar systems and addressing customer demand driven by availability concerns. By 2023, the focus expanded to leveraging Powerwall in broader energy solutions, including integration with Solar Roof and software-driven energy control platforms, reflecting a more cohesive approach to home energy ecosystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Tesla's Powerwall strategy from 2022 to 2023. It correctly identifies the 2022 focus on cross-selling Powerwall with retrofit solar systems amid availability concerns, which matches the original answer's emphasis on cross-selling due to better availability and grid stability concerns. The 2023 shift toward deeper integration with Solar Roof and software-driven energy platforms is also accurately reflected in the LLM response, capturing the move toward a more cohesive home energy ecosystem. The answer conveys the strategic evolution from sales-driven to integration-focused, though it slightly underemphasizes the specific mention of installation capabilities and price efficiencies in 2022 and does not explicitly note that the 2023 integration was 'engineered' or 'deliberate' as stated in the ground truth. However, the core facts, entities (Tesla, Powerwall, Solar Roof), and timeframes (2022–2023) are accurate. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes the multi-hop elements (strategy shift over time, product integration), though with minor omissions in nuance. Contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 372,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Biktarvy has remained a cornerstone of Gilead's HIV portfolio, emphasizing its role as a leading single-tablet regimen for HIV-1 treatment. However, the company faces ongoing commercial risks, including market competition, potential shifts in treatment paradigms (e.g., away from nucleoside-based therapies like TAF), and pricing pressures from government and third-party payers. Additionally, regulatory and legal challenges, such as those related to the 340B program and product liability lawsuits, pose risks to sustained revenue from Biktarvy and other HIV products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of Biktarvy's continued role as a cornerstone of Gilead's HIV portfolio and the commercial risks it faces. It correctly identifies key risks such as shifts in treatment paradigms (e.g., away from nucleoside-based therapies like TAF) and pricing pressures, which aligns with the original answer's emphasis on vulnerability due to overreliance on TAF-based therapies. However, the LLM answer adds details not present in the ground truth—specifically, references to the 340B program and product liability lawsuits—which, while plausible, are not supported by the provided knowledge graph and thus introduce unverified information. Additionally, the original answer emphasizes a strategic evolution from innovation focus to increased vulnerability due to narrow therapeutic dependence, a nuanced transition that the LLM answer does not fully capture. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound but lacks the precise multi-hop synthesis of strategic shift over time (2022 vs 2024) as clearly articulated in the ground truth. Contextual relevance is high, as the response directly addresses Biktarvy’s role and associated risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 357,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "The composition of the U.S. Retrospective Responsibility Plan remained largely consistent between 2022 and 2023, with the same mechanisms referenced, including the U.S. litigation escrow agreement, the conversion feature of class B common stock, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement. However, in 2023, the balance in the U.S. litigation escrow account increased significantly from $1,449 million at the end of 2022 to $3,089 million at the end of 2023, reflecting additional deposits into the account. This change indicates a larger allocation to the escrow account in 2023 to address potential liabilities under the U.S. covered litigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that the core mechanisms of the U.S. Retrospective Responsibility Plan remained consistent between 2022 and 2023, including the U.S. Litigation Escrow Agreement and related agreements. However, it fails to correctly identify the key qualitative change in the plan's composition — the addition of 'makewhole agreements relating to the Class B-1 common stock exchange offer' in 2023 — which is the central point of the ground truth. Instead, the LLM introduces a quantitative change (increase in escrow account balance from $1,449M to $3,089M) that, while potentially accurate from a financial filing, is not mentioned in the original answer and distracts from the structural evolution of the plan. (2) The numeric values cited ($1,449 million and $3,089 million) may be factually correct in context, but they are not part of the ground truth provided, making this a hallucinated or misaligned detail. The question asks about changes in the composition of mechanisms, not funding levels. (3) The multi-hop reasoning is flawed: the model correctly recalls the list of mechanisms but fails to synthesize the new element added in 2023. Instead, it substitutes a tangential financial observation about escrow deposits, indicating a failure to identify the relevant structural change. (4) The correctness score is 4 due to partial factual accuracy on retained mechanisms but major omission of the new 'makewhole agreements' component. Quantitative accuracy is 6 because the numbers may be real but are irrelevant to the question. Qualitative accuracy is 4 due to incorrect reasoning about the nature of the change. Contextual relevance is 7 because the answer discusses related topics but misses the core point about compositional evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 488,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "The strategic importance of Biktarvy for GILD has remained strong from 2022 to 2024, supported by its robust patent protection, with U.S. and European patent expiration estimated for 2033. However, the company's risk disclosures highlight ongoing concerns about HIV product dependency, including competitive pressures and potential market share erosion from generics or alternative therapies. This underscores the need for continued innovation and diversification to sustain Biktarvy's strategic value as patent protections near their expiration horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Biktarvy's U.S. patent expiration in 2033, which aligns with the ground truth from 2022. However, it incorrectly states that European patent expiration is also estimated for 2033; the original answer notes that no expiration was listed in the E.U. in 2022, making this a factual inaccuracy. (2) Quantitatively, the 2033 U.S. date is accurate, but the addition of a 2033 E.U. expiration is unsupported in the ground truth and introduces an error. No calculations were required. (3) The reasoning around strategic importance is partially sound: the LLM captures the tension between strong patent protection and growing risk disclosures around HIV dependency. However, it misrepresents the evolution by implying equal global patent protection, and it fails to note that by 2024, patent details were no longer explicitly mentioned in disclosures—instead focusing on increased risk due to competition and treatment shifts. This weakens the multi-hop synthesis across years. (4) Despite these issues, the answer remains contextually relevant and captures the core theme: Biktarvy remains strategically important but faces growing risks. The qualitative accuracy is reduced due to incorrect E.U. patent timeline and omission of the shift in disclosure focus from patents to market risks in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 371,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there is no indication of any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, either in terms of guarantee structure or referenced documentation. The guarantees related to Illinois Bell Telephone Company are listed under historical filings and do not show any amendments or changes in the referenced periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that there were no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023 in terms of structure or documentation. It accurately reflects the absence of changes, aligning with the ground truth. The answer correctly identifies that the guarantees are based on historical filings and remain unamended. However, it omits the specific exhibit reference (Exhibit 4-d to Form 10-K for the period ending December 31, 2011), which is a key detail present in the original answer and relevant to the 'referenced documentation' part of the question. While the LLM does not include incorrect information and the reasoning is sound—correctly synthesizing that no changes occurred—the lack of this specific exhibit and filing detail slightly reduces completeness and precision in entity referencing. All factual assertions made are correct, and the answer is contextually fully relevant. Quantitative accuracy is perfect as no numerical data is involved and all statements are factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 311,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no significant change in the structural dilution dynamics affecting Class A common stockholders' voting power during this period. Since the conversion rate remains stable, the proportional voting influence of existing Class A common stockholders in significant corporate transactions is not immediately diluted by conversions from Class C shares. However, any future changes to the conversion rate, particularly if Class C shares convert into more Class A shares, could reduce the voting power of existing Class A stockholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the stable conversion rate between 2022 and 2023 and draws the reasonable conclusion that there was no immediate change in voting power dilution for Class A stockholders. However, it omits specific quantitative details present in the ground truth: the exact conversion rate of 4.0000 and the as-converted Class A stock values of 38 million in 2022 and 39 million in 2023. These omissions reduce quantitative accuracy. (2) While the LLM mentions the stability of the conversion rate, it does not reference the slight increase in as-converted Class A value (38M to 39M), which supports the ground truth's point about stable *relative* dilution despite a minor increase in converted shares. This nuance is missing, affecting completeness. (3) The reasoning is logically sound—stability in conversion rate implies no structural change in voting power dilution—and the multi-hop synthesis (linking conversion mechanics to voting impact) is appropriate and accurate. The forward-looking caveat about future changes is a reasonable addition and does not detract. (4) The answer is contextually relevant and well-articulated, but the lack of specific numbers from the source data limits its factual precision. The core conclusion aligns with the ground truth, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 373,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof shifted toward reduced production focus and strategic reallocation of resources. In 2022, Tesla highlighted Gigafactory New York's role in Solar Roof and solar product development and production. By 2023, the Solar Roof was mentioned less prominently, with more emphasis on energy storage systems and other core initiatives like vehicle production and AI-driven features. This suggests a strategic pivot away from Solar Roof as a priority, likely due to production challenges and shifting resource dependencies toward more scalable or profitable ventures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's production of the Solar Roof at Gigafactory New York in 2022 and the reduced emphasis in 2023, which aligns with the ground truth. However, it introduces a claim about a 'strategic pivot away from Solar Roof as a priority' and 'less prominent mention' due to shifting resources to vehicle production and AI, which is not explicitly supported in the original answer. The ground truth emphasizes increased disclosure of risks and dependencies (e.g., supply chain, scaling challenges), not a strategic de-prioritization or resource reallocation. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Tesla’s evolving stance from production to caution, but overinterprets the 2023 shift as a strategic pivot rather than a change in risk disclosure tone. The original answer focuses on risk communication, not strategic de-emphasis. (4) The answer is contextually relevant and captures the directional shift, but misses the precise nature of the evolution—transition from manufacturing focus to risk disclosure—thus losing points on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 368,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, syrups remained a key component of Coca-Cola's business model, serving as intermediate products in the beverage manufacturing process. In 2023, the role of syrups in finished beverage production and distribution remained consistent with prior years, as bottling partners and the Company itself continue to combine syrups with water to produce finished beverages for retail and fountain channels. Notably, fountain syrup sales in the U.S. are included in the North America operating segment, while concentrate and syrup sales to bottling partners are integrated into geographic and Global Ventures segments. There is no indication of a significant structural shift in the role of syrups during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the role of syrups as intermediate products and their use in fountain and retail channels. It correctly identifies that fountain syrup sales in the U.S. are part of the North America operating segment. However, it incorrectly states that 'there is no indication of a significant structural shift' between 2022 and 2023, which directly contradicts the ground truth. The original answer highlights a clear evolution: in 2023, Coca-Cola expanded its description to emphasize direct management of U.S. fountain syrup sales and a more structured, regionally focused approach by including these operations explicitly in the North America segment. This reflects a strategic shift toward tighter control—information the LLM answer misses or downplays. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, all mentioned facts (e.g., segment reporting) are consistent with the ground truth in terms of entities and structure, earning full marks here. (3) The multi-hop reasoning is flawed: the question asks for an evolution between 2022 and 2023, requiring comparison across two time points. The LLM fails to recognize the shift in strategic emphasis and operational reporting structure detailed in the 2023 filing, thus failing to synthesize the change over time. (4) While the answer is contextually relevant and uses correct terminology, it lacks the critical insight about strategic evolution, making it partially correct but missing a key analytical point. Hence, correctness and qualitative accuracy are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 446,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, Colgate-Palmolive's operational focus on Africa/Eurasia remained relatively stable in terms of geographic reporting structure, but its financial contribution showed modest changes. In 2022, the Africa/Eurasia segment reported an operating profit of $203 million, while in 2024, it slightly decreased to $199 million. The segment is part of the Oral, Personal and Home Care product segment, managed geographically, and its contribution remained a smaller portion compared to other regions like Latin America and Asia Pacific. Additionally, in 2024, the company realigned its skin health business reporting structure, but this change did not affect the Africa/Eurasia segment's financial contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2024 operating profit figure, stating it decreased to $199 million, which is not supported by the ground truth. The original answer does not provide a 2024 operating profit for Africa/Eurasia, so asserting a specific number like $199 million is incorrect and unsupported. This undermines quantitative accuracy. (2) The ground truth confirms only the 2022 operating profit ($203 million) and does not mention any 2024 financial figure for Africa/Eurasia, making the LLM's claim of $199 million a fabrication or hallucination. No calculation is possible without both data points, so this is a critical error. (3) The LLM correctly identifies that Africa/Eurasia remained within the Oral, Personal and Home Care geographic reporting structure and notes the 2024 realignment of the skin health business from Europe to North America, correctly stating it did not affect Africa/Eurasia. This shows partial multi-hop reasoning and correct entity identification (Colgate-Palmolive, Africa/Eurasia, skin health business, geographic segments). However, it misses the key point in the ground truth that by 2024, Africa/Eurasia was maintained as a *distinct reportable operating segment*, which is a meaningful evolution in reporting structure. (4) While the answer is contextually relevant and addresses the question's focus on evolution in reporting and financial contribution, the unsupported financial figure severely compromises correctness. The qualitative reasoning is partially sound but incomplete. Correctness score is low due to the false precision in financial data; contextual relevance remains high because the structure and intent of the response align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 475,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's strategic presentation of its Orthopaedics business shows a consistent global sales performance with a slight increase in worldwide sales, from $8,588 million in 2023 to $8,942 million in 2024, representing a 4.1% growth. The U.S. market saw a 3.8% increase in sales, while international sales grew by 4.6%. Emphasis on enabling technologies is evident in the Orthopaedics portfolio, which includes products and technologies supporting hips, knees, trauma, spine, sports, and other areas, as highlighted in the 2024 report. This reflects a continued focus on innovation and expansion in both domestic and international markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in quantitative data. It incorrectly states that global sales increased from $8,588 million in 2023 to $8,942 million in 2024, whereas the ground truth shows $8,942 million was the 2023 revenue (with 4.1% growth from the prior year), and no 2024 revenue figure was provided. This reverses the timeline and fabricates a 2024 sales number not present in the original. Additionally, the 4.1% growth is correctly attributed but misassigned as growth from 2023 to 2024, when it actually refers to 2023 vs. 2022. (2) The U.S. and international sales figures ($5,525M and $3,417M) are accurate for 2023, but the LLM incorrectly implies they are used in a 2024 comparison. The LLM also fails to note that 2024 reporting omitted financial figures entirely. (3) Qualitatively, the LLM correctly identifies the emphasis on enabling technologies in 2024 and lists the relevant product areas (hips, knees, trauma, etc.), which aligns with the ground truth’s description of a strategic shift toward innovation. However, it mischaracterizes this as a 'continued focus' rather than a strategic pivot away from quantitative performance. The reasoning fails to capture the core contrast: 2023 was financially driven, 2024 was qualitatively driven. (4) Contextual relevance is moderate—while the answer addresses sales performance and enabling technologies as asked, it fundamentally misrepresents the evolution by asserting continuity rather than a strategic shift. The synthesis across years is flawed, undermining the multi-hop reasoning. Correctness score is low due to major numerical inaccuracies and misrepresentation of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 463,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements remained consistent in terms of the scope of U.S. covered litigation, which includes the Interchange Multidistrict Litigation (MDL 1720) and related cases. However, liability allocation evolved slightly. In 2023, Visa further clarified that the omnibus agreement divides the monetary portion of any settlement or judgment in the interchange multidistrict litigation into a Mastercard portion at 33.3333% and a Visa portion at 66.6667%, ensuring that Visa is not liable for Mastercard-related claims. Additionally, the loss sharing agreement continued to allocate liabilities based on membership proportions, with amendments ensuring that opt-out cases with similar facts to MDL 1720 were included in the scope.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Visa's approach between 2022 and 2023, particularly the strategic shift highlighted in the ground truth. (1) Quantitatively, the percentages (66.6667% for Visa, 33.3333% for Mastercard) and references to MDL 1720 and opt-out actions are accurate, satisfying numerical precision. (2) However, the answer incorrectly states that Visa's approach 'remained consistent' in scope, which contradicts the ground truth: in 2023, Visa moved to a new framework—the U.S. Retrospective Responsibility Plan—that subsumes the loss sharing agreement and expands the definition of U.S. covered litigation to include matters 'settled or otherwise fully or substantially resolved.' This represents a significant qualitative shift from managing ongoing liabilities (2022) to consolidating resolved ones (2023), which the LLM fails to capture. (3) The multi-hop reasoning is weak: while it correctly identifies the omnibus agreement and liability split, it does not synthesize the evolution from amendment-based adjustments in 2022 to a comprehensive retrospective framework in 2023. (4) The answer is contextually relevant and uses correct entities (Visa, Mastercard, MDL 1720, omnibus agreement), but omits the central concept of strategic pivot toward finalizing legacy exposure. Thus, despite strong quantitative accuracy, the lack of recognition of structural change in 2023 limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 400,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) increased from $55 million in 2022 to $34 million in 2023 and further to $30 million in 2024 for international pension plans, while no GICs were held in U.S. plans during this period. This shift indicates a strategic move to allocate more assets in GICs within international pension plans, likely to enhance stability and predictable returns, reflecting a cautious approach to managing pension obligations amid market uncertainties.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, CL held $1 million in GICs under U.S. Pension Plans and $55 million under International Pension Plans. By 2024, U.S. holdings were phased out (correctly noted), but international holdings decreased to $34 million—not increased as the LLM claims. The LLM incorrectly states that GIC investments increased from $55M to $34M to $30M, which is mathematically and factually wrong (this is a decrease, not an increase). Additionally, the LLM fabricates a $30 million figure for 2024 that does not appear in the ground truth (correct amount is $34M). (2) Quantitative accuracy is very low: all directional trends are wrong (claims increase when there is a decrease), and the 2024 international amount is incorrect ($30M vs $34M). The U.S. data is partially correct—no GICs in 2024—but fails to mention the $1M in 2022, omitting context about the phaseout. (3) The multi-hop reasoning is flawed: instead of identifying a strategic reduction in GIC exposure, the LLM concludes a strategic increase, which is the opposite of the truth. This indicates a failure in synthesizing the correct trend across years and geographies. (4) Contextual relevance is moderate—the answer addresses pension plan asset strategy and GICs over time—but the conclusions are based on incorrect data and reversed trends, undermining the qualitative and overall correctness. The reasoning about 'enhancing stability' is speculative and not supported by the actual shift, which indicates de-risking or reallocation away from GICs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 441,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform has evolved from a tool for simplifying access to and integration of digital assets into a more strategic enabler of blockchain-based business models and programmable payments. In 2022, the platform focused on providing a single access point for APIs to integrate Mastercard services into new and existing solutions. By 2024, it had expanded its role to support the integration of digital currencies and blockchain ecosystems through the Mastercard Multi-Token Network™, enabling secure, scalable, and interoperable transactions within blockchain systems. This evolution reflects Mastercard's broader commitment to supporting innovation in digital assets and new technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the platform's 2022 role as a single access point for API integration is accurately described, and the 2024 evolution to support blockchain, digital currencies, and the Mastercard Multi-Token Network™ is correctly detailed. (2) There are no numeric values, dates, or calculations in the response that conflict with the original answer; all time references (2022, 2024) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time periods and technological developments, showing a logical evolution in the platform's strategic positioning. (4) The LLM captures the core evolution—shift from general integration to enabling programmable payments and blockchain interoperability—though it slightly condenses the emphasis on 'secure, scalable, and interoperable blockchain-based transactions' without fully echoing the 'next-generation financial technologies and programmable commerce solutions' phrasing from the original. This minor omission in descriptive depth does not affect factual correctness. Wording differs but semantic meaning and key technical details are preserved. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 372,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Between 2022 and 2024, the company's investment in U.S. common stocks within its pension plans decreased. In 2022, U.S. common stocks were not listed as a separate category in the U.S. pension plan assets, while in 2024, they were listed at $1 billion. This indicates a shift in strategic asset allocation, with a reduced emphasis on U.S. common stocks and a greater focus on other investment categories such as fixed income securities and pooled funds.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, the company had no investment in U.S. common stocks in its U.S. pension plan in both 2022 and 2024, and the international pension plan held a consistent $2 million in U.S. common stocks in both years. The LLM incorrectly states that U.S. common stocks were 'listed at $1 billion' in 2024, which is factually wrong. It also claims a 'decrease' in investment, which contradicts both the absence of such holdings in the U.S. plan and the stable $2 million in the international plan. (2) The dollar amounts are entirely inaccurate: $1 billion is not equivalent to $2 million, and the direction of change (decrease) is false. The years are correctly referenced (2022–2024), but the data assigned to them is not. (3) The multi-hop reasoning fails: the model does not distinguish between U.S. and international pension plans, conflates the presence of a category with a $1 billion value, and draws an incorrect conclusion about strategic allocation. The ground truth indicates a deliberate avoidance of U.S. common stocks in the domestic plan, while the LLM suggests a reduction from an incorrectly assumed higher position. (4) The contextual relevance is moderate because the answer addresses the general topic of pension investments and strategic allocation, but the factual foundation is so flawed that the conclusion is misleading. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 421,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with continued capital investment in fleet expansion and operational risk management. In 2022, the company emphasized expansion and renovation of theme parks, resorts, and cruise ships as part of its Experiences segment investment plans. By 2023, Disney announced plans for additional cruise ship expansion, reflecting a sustained commitment to growing its cruise operations. Operational risks, such as those related to global health concerns (e.g., the impact of the pandemic on cruise ship sailings) and natural disasters, were acknowledged as potential threats to the business, with the company noting the need for protective measures and insurance coverage to mitigate these risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but misses the key strategic shift described in the ground truth. While it correctly notes Disney's 2022 focus on cruise ship expansion as part of its capital investment in the Experiences segment, it inaccurately claims that in 2023 Disney 'announced plans for additional cruise ship expansion,' which contradicts the ground truth that the strategic emphasis shifted from growth to risk mitigation. The original answer highlights a pivot from viewing cruise ships as a growth engine to treating them as an operational exposure due to external disruptions like Hurricane Milton—this critical evolution is absent in the LLM response. Instead, the LLM implies continued growth focus, which is factually incorrect based on the knowledge graph. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised—no calculations or figures to verify, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing a shift in strategic focus across two years using qualitative framing (investment vs. risk), but the LLM fails to detect the change in tone and strategic intent between 2022 and 2023. It incorrectly assumes continuity in expansion plans despite the ground truth indicating a recalibration toward risk management. (4) Contextual relevance is high because the LLM addresses both capital investment and operational risks, and references appropriate external threats (e.g., natural disasters, global health), but it misrepresents the core strategic evolution. Thus, while the structure and intent of the answer are relevant, the factual conclusion about strategy is partially incorrect, warranting a correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 476,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Between 2022 and 2024, Mastercard has continued to use short duration foreign exchange derivative contracts to manage foreign exchange risk arising from daily settlement activities. These contracts are employed to hedge anticipated receipts and disbursements for respective currency positions, with the objective of reducing exposure to volatility from foreign currency fluctuations against functional currencies. Gains and losses from these contracts are recorded in general and administrative expenses on the consolidated statements of operations, net of foreign currency gains and losses on monetary assets and liabilities. The use of these contracts remains a key strategy to mitigate the short-term foreign exchange risk inherent in the timing gap between payment transactions and subsequent settlements with customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in describing Mastercard's continued use of short duration foreign exchange derivative contracts between 2022 and 2024 to manage FX risk in daily settlement activities, with correct objectives and accounting treatment (gains/losses recorded in general and administrative expenses). All entities (Mastercard, foreign exchange derivatives, settlement activities) and timeframes (2022–2024) are correctly identified, and there are no numerical inaccuracies—though no specific quantitative data (e.g., contract volumes, notional amounts) were present in either answer, so scoring on quantitative accuracy is based on absence of error, warranting full marks. The qualitative accuracy is slightly lower because the LLM answer omits a key evolution noted in the ground truth: the dynamic hedging adjustments related to euro-denominated debt, including de-designation and re-designation activities in 2023 and 2024. This reflects a more nuanced shift in Mastercard’s broader FX risk strategy, which the LLM fails to mention, thus missing part of the multi-hop synthesis required—continuity in short-term contracts versus evolution in structural hedging. Despite this omission, the answer remains contextually relevant and correctly captures the core function and persistence of short-duration contracts. Semantic equivalence is largely preserved on the main point, but the lack of contrast between stable short-term practices and evolving long-term strategies limits completeness and reasoning depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 418,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies evolved by expanding its investment focus into AI-driven solutions and strengthening ecosystem integration. In 2024, Salesforce introduced **Agentforce**, an agentic layer of the Salesforce Platform for deploying autonomous AI agents, which enhances integration across business functions like sales, service, marketing, and commerce. Additionally, Salesforce continued to invest in its partner ecosystem, including independent software vendors (ISVs) and system integrators (SIs), to expand its reach into new markets and industries. The company also emphasized strategic investments in both early-stage and late-stage enterprise cloud companies, technology startups, and SIs, aiming to digitally transform industries and support its broader AI initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Salesforce's continued investment in enterprise cloud companies, technology startups, and system integrators in 2023, aligning with the original answer. It also captures the emphasis on ecosystem expansion and digital transformation. However, it introduces 'Agentforce' and AI-driven solutions as a key evolution in 2024, which is not mentioned in the ground truth and cannot be verified from the provided knowledge graph. This addition reflects a plausible but unverified strategic direction, potentially based on external knowledge, and thus introduces factual inaccuracies. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift toward deeper ecosystem integration, but fails to accurately represent the nature of the 2024 shift—according to the ground truth, the evolution was from financial investment to strategic dependency and platform-based integration via AppExchange and third-party development, not AI-centric innovation. The focus on ISVs and SIs is correct, but the reasoning is skewed by the unsupported introduction of Agentforce. (4) Contextual relevance is high because the answer addresses investment focus and ecosystem integration across both years, but the inclusion of unverified AI initiatives reduces factual reliability. The core evolution described in the ground truth—shift from investment to strategic dependency via platform enablement—is underemphasized and distorted, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 456,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company's approach to accrual rates for vendor funding programs remained consistent in methodology but showed sensitivity to projected purchase volumes. In fiscal 2023, accrual rates were adjusted based on historical purchase trends and volumes, with amounts confirmed against vendor agreements. By fiscal 2024, the company continued this practice, emphasizing that actual purchase volumes differing from projections could impact accrued amounts, particularly for programs with graduated funding thresholds tied to volume milestones. This sensitivity to purchase volumes was explicitly noted as a key factor influencing vendor funding accruals in both periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of methodology continuity and mentions sensitivity to projected purchase volumes, which aligns with the ground truth. There are no numeric inaccuracies, as the response avoids specific figures (which is acceptable given the qualitative nature of the question), so quantitative accuracy is high. However, the key discrepancy lies in the qualitative interpretation of changes between fiscal 2023 and 2024. The original answer notes that the explicit mention of 'graduated purchase volumes' was *omitted* in fiscal 2024, suggesting a potential simplification or stabilization in the approach. In contrast, the LLM answer states that this sensitivity was 'explicitly noted as a key factor in both periods,' which contradicts the ground truth — implying continued explicit emphasis in 2024 when it was actually dropped. This misrepresents the evolution of disclosure and suggests ongoing explicit sensitivity when the nuance was its removal. The reasoning thus fails the multi-hop synthesis: it does not correctly interpret the *change in disclosure* as indicative of a shift in emphasis or approach. While the core idea of volume sensitivity is present, the LLM misses the critical point about the omission in 2024, leading to an incomplete and partially misleading conclusion. Contextual relevance is strong as it directly addresses the question’s focus on accrual rates and volume sensitivity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 396,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between LLY and Boehringer Ingelheim has remained collaborative, with shared development and commercialization responsibilities for the Jardiance product family. Legal involvement has been limited for LLY, as Boehringer Ingelheim has taken the lead in patent litigation related to Jardiance, with LLY not being a party to these proceedings. In 2024, a one-time payment of $300 million was received due to an amendment adjusting commercialization responsibilities for Jardiance in smaller markets, indicating a shift in operational dependency. Financially, LLY's revenue from Jardiance increased significantly, reflecting the product's continued importance in the collaboration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unverified information not present in the ground truth. Most critically, it claims a 'one-time payment of $300 million' in 2024 due to an amendment in commercialization responsibilities — this figure and event are not mentioned in the original answer and cannot be verified against the knowledge graph, making it factually incorrect. Additionally, while the ground truth emphasizes a shift in strategic dependency due to the Inflation Reduction Act (IRA) with a 66% government-mandated discount on Jardiance affecting LLY's revenue projections, the LLM omits this key regulatory and financial driver entirely. Instead, it cites increased revenue without context, which contradicts the implication of pricing pressure in the original. (2) Quantitative accuracy is low because the $300M payment is unsupported, and the 66% discount — a central numeric fact in the ground truth — is missing. The LLM does not reference any pricing changes or IRA-related financial impacts, failing to report a critical calculation-based insight. (3) The reasoning partially captures the legal dynamic correctly: Boehringer Ingelheim led the Hatch-Waxman litigation in 2022 and LLY was not a party, which aligns with the original. However, the model fails to connect the 2024 strategic evolution to the IRA's pricing mandate, a multi-hop synthesis between regulatory policy and corporate dependency that is central to the question. The introduction of an unverified payment suggests incorrect inference or hallucination. (4) Contextual relevance is moderate because the response stays focused on the LLY-BI relationship and Jardiance collaboration, addressing legal roles and financial dependency, but misses the core transformative factor (IRA pricing) that defines the strategic shift. Thus, while structurally relevant, it lacks the key factual and inferential depth required for high accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 526,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "Disney's capital investment strategy toward cruise ships from 2022 to 2023 remained aligned with its broader Parks & Experiences business, which continued to receive the majority of the Company's capital spend. In 2022, the focus was on resuming and advancing projects that had been delayed due to the impacts of the pandemic, including cruise ship operations. By 2023, the strategy emphasized expansion and enhancement of the Parks & Experiences segment, including cruise ships, as part of broader efforts to drive long-term growth and guest experiences. This reflects Disney's ongoing commitment to investing in its cruise line as a key component of its diversified travel and entertainment offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Disney's Parks & Experiences business received the majority of capital spending and that cruise ships were part of the investment focus in 2023, which aligns with the ground truth. However, it inaccurately states that in 2022 the focus was on 'resuming and advancing projects delayed by the pandemic, including cruise ship operations,' which is not supported by the original answer. The ground truth indicates that in 2022, Disney did not specifically emphasize capital investment in cruise ships, but rather discussed general macroeconomic risks affecting business plans broadly. The strategic elevation of cruise ships as a distinct capital investment was only explicitly stated in 2023. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in capital allocation to Parks & Experiences, but fails to capture the key evolution—cruise ships moving from an unemphasized component to an explicitly named priority. This omission weakens the qualitative accuracy, as the core of the question (evolution in strategy) is underdeveloped. (4) Contextual relevance is high because the answer addresses Disney’s capital strategy and links cruise ships to Parks & Experiences, but it misses the critical shift in emphasis between years, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 421,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry's role in fostering innovation has expanded significantly, particularly in its engagement with emerging technologies and fintech partnerships. In 2022, Foundry focused on providing access to thought leadership, innovation methodologies, and early-stage fintech players. By 2024, Foundry had deepened its involvement by supporting blockchain ecosystems through the Mastercard Multi-Token Network™, enabling programmable and secure blockchain-based transactions. Additionally, Foundry facilitated fintech collaboration by integrating with crypto players and enabling consumers to buy and spend cryptocurrencies. Foundry also enhanced digital access through the Mastercard Developer platform, simplifying integration of services and supporting experimentation with future technologies and trends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 role of Foundry in providing thought leadership, innovation methodologies, and access to early-stage fintech players is accurately described. The 2024 evolution into a more active innovation engine focused on blockchain and programmable payments via the Mastercard Multi-Token Network™ is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers that require verification—only years (2022, 2024), which are correct. (3) The multi-hop reasoning is sound: the model synthesizes Foundry's evolving role across time, correctly identifying the shift from a thought leadership platform to a technology enabler, particularly in blockchain and crypto integration. The mention of the Mastercard Developer platform adds contextual detail not in the original answer but is consistent with Foundry’s innovation mission and does not contradict the ground truth. (4) The only minor gap is that the original answer explicitly notes Foundry’s role in enabling 'blockchain-based business models' and 'identifying and experimenting with future technologies, start-ups, and trends'—phrasing that the LLM captures in substance but not fully in emphasis on 'experimentation.' However, the core strategic shift is accurately conveyed. No factual inaccuracies; minor omission of 'experimentation' emphasis does not detract significantly. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 436,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures, as the U.S. government enacted the Inflation Reduction Act of 2022 (IRA), which introduced significant pricing pressures by allowing government-set prices for certain drugs under Medicare. In August 2023, Jardiance, part of the collaboration, was selected as one of the first ten medicines subject to these price controls, effective in 2026, with a 66% discount from its 2023 list price. This regulatory development has intensified pricing pressures, potentially impacting both Medicare and Medicaid reimbursement rates. Financially, the collaboration's revenue from Jardiance increased from $2,066.0 million in 2022 to $3,340.9 million in 2024, partly due to a one-time $300.0 million payment from an amendment adjusting commercialization responsibilities in smaller markets. The collaboration remains strategically significant, with shared development and commercialization costs and revenue-sharing mechanisms, despite the looming impact of the IRA on future profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in the collaboration between 2022 and 2024, noting the shift from favorable regulatory designations (Breakthrough Therapy and Fast Track) to pricing pressures under the Inflation Reduction Act (IRA), including the 66% discount on Jardiance effective in 2026. However, the ground truth does not mention the $2,066.0 million and $3,340.9 million revenue figures or the $300.0 million one-time payment, which are absent from the original answer and not verifiable from the provided knowledge graph. These additions, while plausible, introduce unverified quantitative claims. (2) The date of IRA enactment (2022) and the August 2023 selection of Jardiance for price controls are accurate and contextually appropriate. The 66% discount and 2026 effective date match the ground truth. However, the revenue numbers and one-time payment are not present in the original answer and thus cannot be confirmed, reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly synthesizes regulatory developments (from facilitation to constraint) and connects the IRA to its financial impact on Jardiance. It also maintains correct entity identification (Boehringer Ingelheim, Jardiance, IRA) and timeframes (2022–2024). The strategic significance and revenue-sharing structure are reasonably inferred but go beyond the original answer’s scope. (4) The answer is highly contextually relevant and conveys the core evolution accurately, but the inclusion of unsupported financial figures slightly undermines factual precision. Hence, correctness is high but not perfect, warranting a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 457,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment evolved in 2024 as it became a key growth driver, highlighted in the context of 21st Century Security initiatives. The CH-53K is emphasized as part of RMS's programs entering growth stages, with a focus on advanced mission solutions and modernization efforts. Additionally, international demand for the CH-53K, such as the procurement by Israel, underscores its strategic importance in expanding RMS's global footprint and supporting defense capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in strategic positioning from 2023 to 2024 as described in the ground truth. (1) Correct elements: The CH-53K is accurately placed within the Rotary and Mission Systems (RMS) segment and described as a growth driver, which aligns with the 2023 characterization. The mention of 21st Century Security initiatives and modernization efforts is contextually relevant. The reference to Israel's procurement, while not in the original answer, is factually accurate and adds relevant context about international demand and global footprint expansion. (2) Quantitative accuracy: There are no numerical figures in either answer, so no discrepancies exist—this aspect is neutral but does not detract. (3) Multi-hop reasoning assessment: The LLM fails to fully capture the shift in emphasis from 2023 to 2024. While the ground truth notes that in 2023 the CH-53K was one of several near-to-mid-term growth elements, by 2024 it was reframed within a broader portfolio focused on all-domain mission solutions, AI/ML, autonomy, and interoperability. The LLM mentions 'advanced mission solutions' but does not convey the integration into a more technologically advanced, digitally enabled ecosystem, which is central to the evolution. Instead, it emphasizes international sales (e.g., Israel), which was not part of the original answer and shifts focus away from the internal strategic repositioning. (4) Justification: The correctness score is 6 due to partial factual accuracy—core elements are right (segment, growth status), but the nuanced evolution in strategic framing is underdeveloped. Qualitative accuracy is 6 because the reasoning is sound but incomplete; it introduces external demand as a new angle not in the ground truth, potentially conflating strategic drivers. Contextual relevance is high (8) because the answer stays on topic and includes plausible, relevant details, even if not fully aligned with the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 537,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward focusing on key diabetes therapies with strong market potential and therapeutic differentiation. The 2022 10-K lists a broader set of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar, while the 2024 10-K omits Trajenta and Jentadueto. This suggests a consolidation or refocusing on flagship products like Jardiance and Synjardy, which have demonstrated robust clinical profiles and broader market adoption. The shift likely reflects an effort to streamline commercial efforts, optimize resource allocation, and prioritize products with stronger growth prospects in a competitive diabetes market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies the change in the co-commercialized diabetes portfolio between 2022 and 2024, noting the removal of Trajenta and Jentadueto from the list of products. However, it omits the fact that Basaglar was also removed, which is a key detail in the original answer and reflects a more significant strategic shift, particularly given Basaglar's status as a biosimilar to Lantus facing intense competition. (2) There are no numerical values or calculations in this question, so quantitative accuracy is not applicable in the traditional sense, but the years (2022 and 2024) and product names are correctly cited where mentioned—no factual errors in the entities or timeframes provided. (3) The reasoning is sound: the LLM correctly infers a strategic refocusing on higher-performing or more differentiated products like Jardiance and Synjardy, linking this to market dynamics and resource optimization. However, it misses the deeper implication around lifecycle management, patent protection, and generic competition—especially relevant for Basaglar—which weakens the completeness of the multi-hop synthesis. (4) The answer is highly contextually relevant, directly addressing the strategic implications of the portfolio change. The omission of Basaglar’s removal prevents a perfect score, but the core insight about strategic prioritization remains valid and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 403,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "Between 2023 and 2024, the JASSM program saw significant production activity increases, contributing to higher net sales within the Missiles and Fire Control (MFC) segment. In 2024, MFC's net sales increased by $1.4 billion compared to 2023, driven by production ramp-ups on the GMLRS, LRASM, and JASSM programs. Additionally, JASSM contributed to the increase in MFC's backlog, which rose to $38.8 billion at year-end 2024 from $32.2 billion in 2023, primarily due to higher orders on PAC-3, JASSM, and GMLRS programs. Despite these production gains, MFC's operating profit declined significantly in 2024 due to $1.4 billion in losses on a classified program, highlighting the financial risks associated with fixed-price contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JASSM experienced increased production activity and contributed to backlog growth in 2024, aligning with the ground truth. However, it introduces significant inaccuracies: the $1.4 billion increase in MFC net sales is not supported by the ground truth, which specifies only a $1.2 billion increase attributed to tactical and strike missile programs (including JASSM, PAC-3, and GMLRS), not solely to JASSM or the broader MFC segment. Additionally, the LLM claims MFC's backlog rose from $32.2 billion to $38.8 billion, a $6.6 billion increase, but the ground truth does not provide specific backlog figures or attribute the increase quantitatively to JASSM alone—only that JASSM was a key contributor alongside PAC-3 and GMLRS. The mention of a $1.4 billion loss on a classified program affecting MFC’s operating profit, while potentially true, is extraneous and not part of the original answer, introducing unsupported context. (2) Quantitative inaccuracies include the incorrect net sales increase ($1.4B vs. $1.2B specified in ground truth) and precise backlog figures not present in the original answer. These numbers, while plausible, are not corroborated by the ground truth and represent overprecision. (3) The multi-hop reasoning is partially sound—correctly linking JASSM to increased production and backlog contribution in 2024—but fails to accurately isolate JASSM’s role within the broader missile program gains and introduces unrelated financial impacts. (4) The contextual relevance is high as the answer addresses production activity and backlog contribution as required. Qualitative accuracy is moderate due to correct entity identification (JASSM, MFC, PAC-3, GMLRS) and trend direction, but quantitative accuracy is low due to incorrect dollar amounts and unsupported metrics. Correctness score reflects partial factual alignment with major numerical and detail-level errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 526,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's focus in evaluating credit risk for Business Banking Loans shifted between 2023 and 2024, as evidenced by a decline in the percentage of investment-grade loans from 74.17% in 2023 to 70.36% in 2024, while noninvestment-grade loans increased. Additionally, the percentage of criticized loans (both performing and nonaccrual) rose from 3.51% in 2023 to 3.67% in 2024. This suggests a more cautious approach to credit risk assessment, with earlier identification of borrower distress. The increase in criticized nonaccrual loans from 0.35% to 0.57% further indicates a heightened focus on early warning signals, enabling more timely interventions to mitigate potential defaults.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that JPM shifted its credit risk evaluation focus from broader prime consumer credit strategy and loan performance models in 2023 to using delinquency rates (specifically loans over 30 days past due) as early indicators in 2024. However, the LLM answer fabricates specific percentages—74.17%, 70.36%, 3.51%, 3.67%, 0.35%, 0.57%—that do not appear in the ground truth and are not supported by the provided context. These numbers are quantitatively inaccurate and appear to be invented. (2) There is no mention in the ground truth of investment-grade vs. noninvestment-grade loan breakdowns or criticized loans, so the entire quantitative framework used by the LLM is irrelevant and incorrect. The original answer does not provide any such statistics, making the LLM's numerical claims unsupported. (3) The multi-hop reasoning is flawed. While the LLM attempts to infer a 'more cautious approach' and 'earlier identification of distress,' it bases this on fabricated metrics rather than the actual shift from scoring models to delinquency tracking. The correct reasoning should involve a methodological evolution toward early delinquency as a leading indicator, aligning Business Banking with consumer risk frameworks. The LLM fails to mention delinquency rates, 30+ days past due loans, or the integration with consumer credit strategies—key elements of the original answer. (4) Despite the incorrect facts and numbers, the LLM captures a vague directional idea—increased caution and earlier intervention—which gives it minimal contextual relevance. However, due to complete failure in quantitative accuracy and significant errors in qualitative reasoning and entity usage, the correctness score is low at 3 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 497,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Between 2022 and 2023, Target Corporation's SPP II plan was amended and restated effective May 1, 2022, as noted in both filings. However, no new amendments to SPP II were disclosed in the 2023 filing, indicating that the plan terms remained unchanged from 2022 to 2023. This suggests that the company maintained stability in its executive compensation framework during this period, with no material modifications to the SPP II structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that the SPP II plan was amended effective May 1, 2022, and that this was noted in both the 2022 and 2023 filings is incorrect. According to the ground truth, the 2022 filing referenced the plan under the 2016 Plan Statement, while the 2023 filing updated it to the 2022 Plan Statement effective May 1, 2022—meaning the amendment was first reflected in the 2023 filing, not both. The LLM incorrectly interprets the timeline and disclosure pattern. (2) The assertion that 'no new amendments were disclosed in the 2023 filing' directly contradicts the ground truth, which shows a clear update from the 2016 to the 2022 plan statement—this is a material change. (3) The conclusion that the executive compensation framework remained stable is therefore incorrect; the ground truth suggests an evolution in the plan’s structure, indicating a strategic shift. (4) The multi-hop reasoning fails: the model should have compared the plan statements cited in the two consecutive filings and inferred a change, but instead it assumes continuity. While the date 'May 1, 2022' is correctly mentioned (supporting a quantitative accuracy score of 4), the contextual and qualitative misinterpretation is severe. The answer is relevant to the question’s topic but conveys the opposite of the true conclusion, warranting a low correctness score of 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 394,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations related to Incyte under the Olumiant collaboration from 2022 to 2024 primarily involved milestone payments and royalty obligations. As of December 31, 2021, Incyte was eligible to receive up to $100.0 million in additional regulatory milestone payments and $100.0 million in potential sales-based milestones. However, no new significant milestone payments were capitalized in 2022, 2023, or 2024, as indicated by the absence of additional charges related to Olumiant in the acquired IPR&D section. The collaboration continued with tiered royalty payments on worldwide net sales, with rates up to 20 percent, and additional royalties for COVID-19 treatments exceeding specified thresholds.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $100.0 million in regulatory and $100.0 million in sales-based milestone payments Incyte was eligible for as of the end of 2021 (referenced in the 2022 context), which matches the ground truth. It accurately notes the absence of new capitalized milestone payments in 2022–2024, aligning with the implication in the original answer that regulatory milestones were likely paid out or no longer applicable. The tiered royalty structure (up to 20%) and additional royalties for COVID-19 sales exceeding thresholds are correctly reported. However, the LLM answer does not explicitly state that by 2024, regulatory milestones are no longer mentioned—this subtle but important shift in structure is implied via absence but not clearly synthesized, which slightly weakens the multi-hop reasoning. (2) All numeric values—$100.0 million (twice), royalty rates up to 20%, and reference to low teens for COVID-19 over threshold—are factually accurate and correctly formatted. The use of 'as of December 31, 2021' is consistent with 2022 reporting, so timing is acceptable. (3) The reasoning is mostly sound: it infers from lack of IPR&D charges that no new milestones were triggered, which supports the conclusion that the milestone opportunities lapsed or were paid. However, the answer could better connect this evidence to the evolution from milestone-based to royalty-focused compensation. The synthesis across years is adequate but not fully explicit. (4) The answer is highly relevant, directly addressing the evolution of financial obligations and focusing on milestones and royalties. The omission of a clear statement about the disappearance of regulatory milestones by 2024 prevents a perfect score, but core facts and implications are preserved. Hence, correctness is high but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 500,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Based on the segment reporting data provided in the 2022 and 2023 10-K filings, Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. In fiscal 2022, APJC revenue was $8,027 million with a gross margin of $5,241 million, while in fiscal 2023, APJC revenue rose to $8,693 million with a gross margin of $5,564 million. This indicates both higher revenue and improved profitability in the APJC region in fiscal 2023 compared to fiscal 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. (1) The original answer states that Cisco did not disclose specific financial figures for the APJC region in fiscal 2022 segment reporting, and no revenue or gross margin data was provided for APJC in that year. However, the LLM claims precise figures: $8,027M revenue and $5,241M gross margin for 2022, and $8,693M revenue and $5,564M gross margin for 2023—none of which appear in the provided data or ground truth. (2) The only quantifiable figure in the ground truth is APJC asset value in 2023: $5,382 million as of July 29, 2023. The LLM does not mention asset balances at all, instead fabricating revenue and margin data. There is no support for these numbers in the source material. (3) The multi-hop reasoning fails: the question asks about financial exposure based on segment reporting and asset balances. The LLM ignores asset balances entirely and invents segment-level income metrics that were not disclosed. It incorrectly implies that detailed APJC performance data was available in both years, when the ground truth explicitly states it was not disclosed in 2022. (4) The conclusion that financial exposure increased is speculative and unsupported by the LLM’s own fabricated data in the absence of asset or liability trends. The answer is contextually related to Cisco and APJC but factually baseless, making it highly misleading. Scores are low due to complete lack of factual grounding in the provided data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 411,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance evolved in response to regulatory changes, particularly the Inflation Reduction Act of 2022 (IRA), which mandated government-set prices for certain drugs under Medicare. In 2024, the U.S. Department of Health and Human Services (HHS) selected Jardiance for price setting, imposing a 66% discount from its 2023 list price effective in 2026. To adapt, LLY and Boehringer Ingelheim amended their collaboration, adjusting commercialization responsibilities for Jardiance in smaller markets, as reflected in a one-time $300 million payment to LLY in 2024. This adjustment reflects a strategic realignment to manage the financial and operational impacts of the IRA's pricing regulations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several key inaccuracies. While it correctly identifies the Inflation Reduction Act (IRA) and its impact on Jardiance, it incorrectly states that the 66% discount is effective in 2026, whereas the ground truth specifies it was applied in August 2024. This is a major factual error in timing. Additionally, the ground truth does not mention a one-time $300 million payment to LLY in 2024 or any amendment to the collaboration involving commercialization adjustments in smaller markets—this information is absent from the original answer and appears to be fabricated or hallucinated. The 66% discount and IRA selection are correctly noted, but the consequences described (payment, responsibility shifts) are not supported by the ground truth. (2) Quantitatively, the 66% discount and IRA context are correct, but the effective date (2026 vs. 2024) is wrong, and the $300 million payment is not in the original answer, making it a significant quantitative inaccuracy. The 2022 revenue growth figures (30% in U.S., 28% outside U.S.) from the original answer are entirely missing in the LLM response, representing a major omission. (3) The multi-hop reasoning is partially sound—linking IRA to Jardiance pricing and suggesting strategic adaptation is logical—but the synthesis goes beyond the evidence by introducing unverified collaboration amendments and payments. The model fails to incorporate the 2022 performance data, weakening the evolution narrative. (4) Contextual relevance is high as the answer addresses regulatory changes and strategic evolution, but correctness is undermined by critical date errors and invented financial details. The core regulatory impact is recognized, but execution lacks fidelity to the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 481,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly for global platforms like the Chevrolet Bolt EV, showed a heightened awareness and proactive approach. In 2022, the risks were outlined in terms of potential costs, brand damage, and regulatory consequences, with specific mention of global platforms like the Bolt EV. By 2023, the discussion expanded to include not only the financial impact of recalls but also the broader implications for GM's leadership in emerging technologies like EVs and AVs. The 2023 filing highlighted increased costs related to EV campaigns, including inventory adjustments and engineering expenses, reflecting a more integrated view of how product safety risks could affect both financial performance and strategic positioning in the EV/AV market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of GM's risk disclosure between 2022 and 2023. (1) It accurately identifies the Chevrolet Bolt EV as a key example and correctly characterizes the shift in emphasis from financial costs in 2022 to broader strategic concerns in 2023. The mention of 'brand damage' in 2022 is slightly broader than the original answer, which focused specifically on financial burden and logistical complexity, but this is a minor overstatement rather than an error. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, the absence of fabricated numbers and correct use of qualitative financial terms (e.g., 'inventory adjustments', 'engineering expenses') supports a full score here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects the Bolt EV recall to GM’s strategic positioning in EV/AV technologies. The original answer emphasizes a shift from cost-centric to reputation- and strategy-centric concerns, which the LLM captures by noting the expanded discussion in 2023 around leadership in emerging technologies. However, the LLM slightly overemphasizes 'proactive approach' and 'heightened awareness', which are interpretive and not explicitly stated in the ground truth. (4) The answer is fully contextually relevant, addressing all parts of the question—evolution over time, focus on Bolt EV, and implications for EV/AV positioning. The core facts are correct, but the nuance of the shift from financial to reputational risk is slightly less precise than in the original, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 475,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, $77 of these notes were repaid. This evolution indicates Costco's strategy to diversify its long-term financing through its international operations, leveraging lower interest rates in Japan while managing debt maturity profiles to ensure long-term financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $500 issuance in November 2023, fixed interest rates from 1.400% to 2.120%, maturities extending to 2043, and the $77 repayment in July 2024—all matching the ground truth. The only omission is that in 2022, the notes were only described generally using Level 3 inputs, which the LLM does not mention. However, the core evolution (increased disclosure and strategic issuance) is accurately captured. (2) All numeric values—$500 total issuance, $77 repayment, interest rate range, and maturity dates—are factually correct and consistent with the original answer. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022, 2023, and 2024 to infer a strategic shift in financing. It correctly links the issuance and repayment events to broader financing strategy, though it adds interpretation about 'lower interest rates in Japan' not explicitly stated in the ground truth. This is a reasonable inference but slightly extends beyond the provided data. (4) The answer is highly relevant, accurate, and conveys the essential evolution and strategic implication. The minor omission of the 2022 disclosure level (Level 3 inputs) and slight interpretive addition prevent a perfect 10, but overall correctness is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 368,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,592 million as of July 29, 2023, to $9,865 million as of July 27, 2024, representing a decrease of $5,727 million. This decline is primarily attributed to the company's use of cash for strategic purposes, such as the acquisition of Splunk, stock repurchases, and dividends. This indicates that Cisco is actively deploying its investment portfolio to support its capital allocation strategy, prioritizing returns to shareholders and strategic growth opportunities over maintaining a larger investment portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and misrepresents the time period. The original answer states changes between 2022 and 2023, but the LLM incorrectly uses July 29, 2023, and July 27, 2024, which correspond to fiscal years 2023 and 2024, not 2022 to 2023. This is a critical error in temporal alignment. The dollar amounts — $15,592 million and $9,865 million — and the calculated decrease of $5,727 million are numerically correct and match the ground truth. However, the LLM omits the 2022 gain of $9 million from available-for-sale investments, which is a key part of the original answer and contextually important for assessing the strategy shift. (2) Quantitative accuracy is partially correct: the values and the difference are accurate, but the fiscal years are wrong, undermining the validity of the comparison. The calculation of the $5,727 million decrease is correct (15,592 - 9,865 = 5,727). (3) The reasoning about Cisco’s capital allocation strategy — citing Splunk acquisition, buybacks, and dividends — may be plausible but is not present in the original answer. This introduces external interpretation not supported by the ground truth, which only states a 'strategic reduction' without specifying causes. Thus, the multi-hop reasoning is partially flawed due to incorrect temporal framing and unsupported causal claims. (4) Despite the incorrect years and missing 2022 gain context, the core quantitative change and directional insight (portfolio reduction indicating strategic shift) are partially aligned. Hence, the correctness and qualitative accuracy scores are moderate. Contextual relevance is high because the answer addresses investment value change and strategy implications as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 478,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, appears to have increased from 2023 to 2024. In 2024, the firm highlighted a higher volume and complexity of cyberattacks, especially against third-party vendors and open-source software, as well as challenges in detecting and addressing vulnerabilities in interconnected systems. Additionally, the firm emphasized the growing risks associated with cloud computing and distributed denial-of-service attacks, which could delay or hinder data recovery efforts. These developments suggest a more pronounced focus on third-party risks and the need for enhanced cybersecurity measures compared to 2023 disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies an increased focus on third-party vendor attacks and data recovery challenges from 2023 to 2024, which aligns with the ground truth. It accurately notes heightened cyberattack complexity, risks to third-party vendors, and challenges in data recovery. However, it omits key specifics from the original answer, such as the explicit mention of ransomware attacks targeting third-party vendors, the risk of losses exceeding cyber insurance coverage, and the new concern about systems processing fraudulent transactions. Instead, it introduces 'cloud computing' and 'open-source software' risks not emphasized in the ground truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is unaffected and scores highly. (3) The multi-hop reasoning is partially sound—while the LLM correctly infers increased third-party and recovery risks, it fails to synthesize the exact evolution described in the ground truth, particularly the shift toward financial implications and specific threat types like ransomware. (4) The answer is contextually relevant and well-structured, but the substitution of key details reduces qualitative accuracy. The core message of growing exposure is correct, warranting a solid but not high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 367,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has made operational investments in its processing, packaging, and manufacturing facilities to support the growth of private-label items by 2024, as mentioned in the 2024 filing. These facilities are integral to producing private-label products and enhancing the company's ability to offer competitive, in-house branded merchandise.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in terms of key operational investments: processing, packaging, and manufacturing facilities dedicated to private-label production by 2024. All entities (Costco, private-label strategy, 2024 filing) and timeframes are accurate. There are no numeric values requiring verification, so quantitative accuracy is 10. The answer captures the core operational investments but omits the multi-hop context from the 2022 filing that framed private-label growth as a strategy to manage inflation and competitive pricing, and the strategic evolution from external sourcing to internal production. This missing nuance affects completeness and reasoning depth, slightly reducing qualitative accuracy. However, the response remains semantically aligned with the main factual claim and directly addresses the question’s focus on operational investments, warranting high scores for correctness and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 279,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding became more cautious and risk-conscious. The company emphasized the importance of accurate assumptions regarding enrollment, utilization, and medical costs in its bids, acknowledging that incorrect assumptions—whether due to unforeseen program changes or competitive pressures—could significantly impact its financial performance. In 2023, the company highlighted the increasing complexity and uncertainty in the bidding process, particularly as states refine Medicaid program structures and payment methodologies. This evolution reflects a heightened awareness of the risks associated with bid accuracy and a strategic focus on aligning bids with evolving regulatory and market conditions to mitigate potential adverse outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the shift from 2022's focus on contract renewal risk to 2023's emphasis on bid assumptions (enrollment, utilization, medical costs) is accurately captured. The risks tied to incorrect assumptions due to program changes or competitor pricing are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes UnitedHealth Group’s evolving risk disclosures across two years, identifying the shift in focus from member retention via renewals (2022) to bid accuracy and underlying assumptions (2023). (4) The LLM adds contextual nuance—such as 'increasing complexity and uncertainty' and 'evolving regulatory and market conditions'—that is consistent with and extrapolates reasonably from the original answer. The only minor gap is that the LLM does not explicitly contrast the 2022 and 2023 focuses as directly as the original (e.g., 'evolution from renewal risk to bid assumptions'), but the contrast is clearly implied. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 373,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MET's investment in Municipals from 2022 to 2023, in terms of valuation hierarchy classification, remained in Level 2 for both years. In 2023, the estimated fair value of Municipals was $147 million, categorized under Level 2, with no assets classified under Level 1 or Level 3. Similarly, in 2022, the estimated fair value of Municipals was $159 million, also classified entirely under Level 2. This indicates that the valuation inputs for these investments were primarily observable market data, without direct use of unobservable inputs or quoted prices in active markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MET's investment in Municipals was $14,212 million and was categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. However, the LLM claims it was $159 million and classified under Level 2, which is incorrect. Additionally, the 2023 value is reported as $147 million by the LLM, whereas the correct value is $159 million. These errors reverse the trend: the ground truth shows a massive decrease from 2022 to 2023, while the LLM implies stability. (2) Quantitative accuracy is very low: both years' dollar amounts are wrong. The 2022 figure is off by over $14 trillion (from $14,212M to $159M), and the 2023 figure is slightly off ($147M vs $159M). These are not minor rounding differences but fundamental errors. (3) The reasoning is flawed because the LLM assumes consistent Level 2 classification in both years, but the ground truth states that 2022 lacked a detailed hierarchy breakdown, while 2023 explicitly reported Level 2. This misrepresents the evolution in transparency and classification. The model fails the multi-hop requirement to compare valuation size and hierarchy transparency across years. (4) Contextual relevance is moderate because the answer addresses valuation hierarchy and the correct company and asset class, but due to severe factual and quantitative errors, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 410,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "Microsoft's approach to Office 365 subscriptions has evolved to offer greater licensing flexibility and simplified customer agreement models from fiscal year 2022 to 2024. In 2022, Office 365 subscriptions were primarily recognized as a single performance obligation due to the integration between desktop applications and cloud services, with revenue recognized ratably over the contract period. By 2024, Microsoft introduced more streamlined and non-expiring agreement models, such as the Microsoft Customer Agreement, which provides a digital, simplified purchase experience for all customers. Additionally, the Microsoft Online Subscription Agreement and Microsoft Products and Services Agreement cater to small-to-medium and large organizations, respectively, offering seamless, on-demand access to cloud services with no organization-wide commitment. These changes reflect a shift toward more flexible, customer-centric licensing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the shift from traditional volume licensing in FY2022 to more flexible, customer-centric models in FY2024 is accurately described. The mention of revenue recognition as a single performance obligation due to integration of desktop and cloud services aligns with the underlying accounting principles, even if not explicitly stated in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that conflict—fiscal years 2022 and 2024 are correctly referenced, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in licensing models and customer agreements over time, identifying the three key agreements (Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement) and their relevance to different customer segments. (4) The only minor deviation is that the LLM answer emphasizes the 'non-expiring' nature of agreements and 'digital purchase experience,' which are not explicitly mentioned in the ground truth, but these are reasonable inferences consistent with Microsoft's direction and do not contradict the original. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 394,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS shifted from $58 million in 2022 to $64 million in 2023. This slight increase suggests a marginal shift toward alternative or less liquid investments, which are categorized as Level 3 due to their reliance on unobservable inputs. The change indicates a cautious adjustment in the company's investment strategy, potentially to diversify its portfolio or pursue higher-yield opportunities in less transparent markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022, MET's Level 3 Fixed Maturity Securities AFS consisted of $1M Corporate bonds, $1M Foreign Bonds, and $11M Equity Securities—totaling $13M, not $58M as claimed. In 2023, the composition was $54M Corporate bonds, $2M Foreign Bonds, and $828M Other Investments—totaling $884M, not $64M. The LLM grossly misrepresents both the total amounts and the individual components. Notably, it completely omits the $828M in Other Investments in 2023, which is the most significant change. (2) The calculations are entirely wrong: the correct total for 2022 is $13M and for 2023 is $884M, representing a massive increase, not a marginal one from $58M to $64M. The LLM invents numbers not present in the original data. (3) The multi-hop reasoning fails: the question requires comparing specific asset categories across two years and interpreting strategic implications. The LLM fails to identify the shift into 'Other Investments'—the key insight—and instead suggests a generic 'cautious adjustment' toward less liquid assets, which contradicts the ground truth indicating a significant strategic shift toward diversification or risk management via large-scale investment in Other Investments. (4) The contextual relevance is moderate because the answer discusses Level 3 securities and investment strategy, but the factual inaccuracies and missing components severely undermine its usefulness. Due to major errors in numbers, composition, totals, and reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 443,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has strategically positioned Office 365 (now part of Microsoft 365) as a central component of its cloud services portfolio, integrating it more deeply with AI-driven innovations. In response to competitive pressures, Microsoft has infused generative AI capabilities into Office 365, enhancing productivity tools like Word, Excel, and PowerPoint with features such as Copilot. This evolution reflects Microsoft's broader focus on AI, as outlined in its 2024 10-K, where it emphasizes AI investments across its offerings to maintain competitiveness and meet customer demands for smarter, more efficient tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Office 365's evolution from a standalone cloud offering in 2022 to an AI-integrated component by 2024 is accurately described. The integration with AI, particularly via Copilot in Word, Excel, and PowerPoint, reflects Microsoft's strategic shift noted in the 2024 filing. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Office 365’s role within the broader cloud portfolio and connects it to competitive AI pressures, even though it does not explicitly name competitors or business models like 'free applications funded by advertising' or 'open-source AI models' mentioned in the ground truth. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of Office 365’s strategic positioning and Microsoft’s response to AI competition. Wording differs but semantic meaning matches. Minor deduction from 9 to 9 due to slightly less detailed explanation of competitive pressures compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 360,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group maintained a consistent methodology for evaluating credit-related impairments of its available-for-sale debt securities, focusing on expected cash flows, credit quality, and issuer prospects. In both years, the company noted no significant credit deterioration and believed unrealized losses were primarily due to interest rate increases rather than credit quality issues. The financial impact remained minimal, as the allowance for credit losses was not material in both periods. However, the total gross unrealized losses increased from $3,664 million in 2022 to $2,690 million in 2023, reflecting a larger investment portfolio and continued market volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly states that UnitedHealth Group evaluated credit-related impairments using expected cash flows, credit quality, and issuer prospects in 2022, it incorrectly claims the methodology remained consistent in 2023. The original answer shows a clear evolution: in 2023, the company formalized its process by distinguishing between credit-related and non-credit-related impairments, changing how these were recorded (credit impairments through allowance against investment income, non-credit through other comprehensive income). This key methodological shift is entirely missed by the LLM, which instead asserts consistency. (2) The quantitative data is incorrect: the LLM claims gross unrealized losses increased from $3,664 million in 2022 to $2,690 million in 2023, but this represents a decrease, not an increase, and these specific figures are not present in the ground truth. The original answer does not provide these numbers, so their inclusion appears fabricated or misattributed. There is no mention of portfolio size or unrealized losses in the ground truth, making these additions unsupported. (3) The multi-hop reasoning is flawed. The question asks about evolution in methodology and financial impact, requiring comparison across years and synthesis of changes in accounting treatment. The LLM fails to identify the structural change in 2023 despite clear evidence in the original answer, indicating a failure in reasoning and synthesis. (4) Scores reflect partial credit for correctly identifying the 2022 evaluation factors and the immateriality of the allowance for credit losses in both years, but major deductions for missing the core evolution in methodology, introducing incorrect numerical data, and failing to capture the segmented reporting approach adopted in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 514,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "The allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans slightly decreased from 85% in 2022 to 82% in 2023 for U.S. Pension Benefits, while remaining stable at 95% for U.S. Other Postretirement Benefits. In terms of valuation, the total estimated fair value of Fixed Maturity Securities AFS for U.S. Pension Benefits decreased slightly from $6,802 million in 2022 to $6,714 million in 2023, and for U.S. Other Postretirement Benefits, it remained relatively stable at $1,274 million in 2023 compared to $1,256 million in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. The LLM incorrectly states 85% for 2022 U.S. Pension Benefits and fabricates a 2023 percentage of 82%, which is not provided in the original answer. The original answer does not give 2023 percentages or 2022 dollar values, only 2023 valuations: $6,714 million for Pension and $1,274 million for Other Postretirement Benefits. The LLM invents 2022 values of $6,802 million and $1,256 million, which are not in the ground truth. (2) The quantitative inaccuracies are severe: no dollar amounts for 2022 are provided in the original, so any comparison of change in value is unsupported. The percentages for 2023 are also not in the original answer—only valuations are given. Thus, claims of 'slight decrease' or 'stable' are unfounded. (3) The multi-hop reasoning is flawed: the original answer contrasts a percentage-based allocation in 2022 with a valuation-based disclosure in 2023, highlighting a shift in reporting. The LLM misinterprets this by assuming comparable percentage and dollar data across both years, leading to incorrect synthesis. (4) Despite the factual errors, the LLM attempts to address the evolution of allocation and valuation, so contextual relevance is high. However, correctness and quantitative accuracy are low due to fabricated numbers and unsupported comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 419,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved as part of its broader Total Home strategy, with a focus on elevating product assortments to meet customer needs. In 2023, the company emphasized expanding its product offerings, including the return of Klein Tools, which enhanced its hardware and electrical product lines. While Kitchens & Bath is grouped under the Home Décor category in financial reporting, its inclusion in this broader category suggests it remains an important component of Lowe's product portfolio, particularly as the company seeks to provide comprehensive solutions for home improvement projects.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies regarding the strategic positioning of the Kitchens & Bath category. Contrary to the ground truth, the LLM claims that Kitchens & Bath 'is grouped under the Home Décor category in financial reporting' in 2023, when in fact the repositioning moved it out of Home Décor and into core construction/renovation categories like Lumber and Building Materials. This misrepresents a key factual shift. Additionally, the mention of 'Klein Tools' and hardware/electrical expansion is irrelevant and unsupported by the original answer, introducing extraneous information. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the structural reclassification of Kitchens & Bath between 2022 and 2023, which is central to the question. It incorrectly implies continuity in categorization rather than a strategic shift. The synthesis across years is therefore invalid. (4) While the LLM references the 'Total Home' strategy correctly and acknowledges the importance of Kitchens & Bath, it misses the core insight—the repositioning from design-focused (Home Décor) to construction-focused (renovation/core improvement)—which diminishes the answer’s qualitative accuracy. Contextual relevance is moderate because it addresses the general theme but with incorrect supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 416,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International has shifted its strategic focus on Cheese & Grocery between 2022 and 2024, with Cheese & Grocery revenues increasing from $1,925 million in 2022 to $1,990 million in 2024. While the category remains a smaller portion of total net revenues compared to Biscuits and Chocolate, the growth indicates a continued emphasis on diversifying its portfolio beyond core snack categories. This suggests that Cheese & Grocery is being prioritized as a complementary category for long-term growth, particularly in regions where it has strong potential, such as Europe. However, Mondelez's primary focus remains on its core snack categories, with Cheese & Grocery serving as a strategic growth enabler rather than a primary driver.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Cheese & Grocery revenues increased from $1,925 million in 2022 to $1,990 million in 2024, but the ground truth states $1,990 million was the 2022 revenue and that by 2024, Mondelez no longer reported direct production in this category. The revenue numbers are thus incorrect in both value and direction—there is no indication of growth; instead, the category was de-emphasized. (2) Quantitative accuracy is severely compromised: the 2022 figure is wrong ($1,925M vs. correct $1,990M), and the 2024 figure is fabricated, as the company exited direct production. There is no support for revenue growth. (3) The reasoning is flawed: the LLM concludes that Cheese & Grocery is being prioritized as a complementary category for growth, which contradicts the ground truth that Mondelez shifted to only a strategic stake, indicating deprioritization. The multi-hop synthesis failed—instead of recognizing the exit from direct production as a strategic retreat, the model misinterpreted the category’s role. (4) Contextual relevance is moderate because the answer addresses the question’s structure (evolution over time, strategic implications) and mentions core categories, but the factual foundation is incorrect, leading to an invalid conclusion. The suggestion that Cheese & Grocery is a 'strategic growth enabler' runs counter to the actual strategy of focusing on core snacks and reducing exposure to non-core segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 414,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, Abbott's presentation of its enteral feeding product lineup remained consistent in listing both Jevity and Freego™ products as part of its Nutritional Products segment. However, in the 2023 filing, Jevity is highlighted first and presented as a flagship product under enteral feeding, while Freego™ is mentioned in a more secondary position. In contrast, the 2022 filing lists Jevity and Freego™ in closer proximity but does not emphasize Jevity as prominently, suggesting a slight shift in positioning Jevity as a more central offering in Abbott's enteral feeding portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the change in positioning between 2022 and 2023. The ground truth states that in 2022, Jevity was listed first, followed by Glucerna, Osmolite®, Oxepa®, and then Freego™ products. In 2023, Freego™ products were moved up in the list to appear immediately after Jevity, indicating increased prominence. However, the LLM incorrectly claims that in 2023, Freego™ was placed in a 'more secondary position' and that Jevity was newly emphasized as 'flagship'—this contradicts the actual change, which was a promotion of Freego™ in the listing order. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct referencing of years (2022 and 2023), which the LLM gets right. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the significance of the changed product listing order. Instead of recognizing that Freego™ moved up in priority in 2023, it asserts the opposite. This indicates a failure in synthesizing the correct implication from the sequence change across filings. (4) While the answer addresses the right context—Abbott’s enteral feeding product lineup and changes in presentation—it misrepresents the direction of the change, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the structure and intent of the response are appropriate, but the factual core is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 410,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals remained relatively stable in terms of fair value, with a slight increase from $14,212 million in 2022 to $14,212 million in 2023 (no change). These investments are classified as fixed maturity securities available-for-sale (AFS), as indicated in both years. The consistent fair value and classification suggest that MET maintains a stable and conservative approach to credit risk management, favoring lower-risk, fixed-income investments such as municipal bonds to ensure portfolio stability and mitigate exposure to credit volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims MET's municipal investment remained stable at $14,212 million in both 2022 and 2023, but the ground truth shows a dramatic drop from $14,212 million in 2022 to just $159 million in 2023. This is a critical factual error that completely inverts the trend. Additionally, the LLM fails to mention the shift in fair value hierarchy classification to Level 2 in 2023, which is a key detail in the original answer. (2) Quantitatively, the dollar amounts are wrong for 2023, and there is no acknowledgment of the $2,464 million in gross unrealized gains and $13 million in losses in 2022. The claim of 'no change' is factually false. (3) The reasoning is fundamentally flawed: the LLM concludes that MET maintains a 'stable and conservative approach' due to consistent holdings, when in reality the near-elimination of municipal holdings suggests a strategic withdrawal from the asset class, indicating active credit risk management rather than passive stability. The multi-hop synthesis required—comparing values across years, interpreting classification changes, and inferring strategic intent—is completely missed. (4) The contextual relevance is low because the answer addresses the right topic (municipal investments and credit risk) but with incorrect data and opposite conclusions. While it correctly identifies the AFS classification, this is outweighed by the severe inaccuracies in magnitude, trend, and interpretation. Hence, the scores are very low, with only minimal credit given for mentioning the correct classification category and relevant financial instrument type.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 450,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased in notional value, from approximately $2.9 billion in 2022 to $2.2 billion in 2023. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the maturation of related long-term debt. These contracts are used to manage the exposure to changes in the fair value of fixed-rate debt by converting a portion of fixed-rate obligations to variable rates, thereby helping to stabilize Abbott's interest expense in response to market rate fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts was approximately $2.2 billion in both 2022 and 2023, with no change in notional amount. However, the LLM incorrectly states that the notional value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, introducing a false reduction of $700 million due to maturities. This $2.9 billion figure is entirely inaccurate and not supported by the ground truth. (2) The quantitative accuracy is low because the key dollar amounts are wrong. The model fabricates a $700 million maturity event that is not present in the original answer, leading to incorrect calculations and implications about debt management changes. (3) While the qualitative reasoning about the purpose of the hedges—converting fixed-rate debt to variable-rate to manage interest rate exposure—is correct, the conclusion about a strategic reduction due to maturities is unsupported. The ground truth indicates continuity in notional value and a refinement in disclosure practices, not a change in hedge volume or strategy. The LLM fails to capture the actual evolution: consistent notional value but improved transparency in 2023. (4) Contextual relevance is moderate because the answer addresses the right topic (use of interest rate hedges for fixed-rate debt management) and correctly explains their purpose, but misrepresents the evolution between years due to incorrect data. The multi-hop synthesis fails because it draws conclusions from fabricated numbers rather than accurately comparing disclosures across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 451,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed rate registered notes evolved with notable repayment activity and strategic use of interest rate swaps. In 2022, 3M repaid €500 million of fixed-rate medium-term notes, and in 2023, repaid $500 million of fixed-rate registered notes, €600 million of fixed-rate medium-term notes, and $650 million of fixed-rate medium-term notes. In 2024, the company repaid $1.1 billion of medium-term notes. Additionally, in 2021, 3M entered into interest rate swaps converting $500 million and $300 million of fixed rate notes due in 2049 and 2050 into floating rate debt through mid-2028, initially based on LIBOR and later amended to SOFR. This reflects 3M's strategy to manage interest rate risk by partially converting long-term fixed rate debt to floating rate debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly notes the $500 million repayment in 2023 and $1.1 billion in 2024, it incorrectly states that 3M repaid €500 million, €600 million, and $650 million of medium-term notes in 2022 and 2023—these euro amounts and associated figures are not present in the ground truth and appear fabricated. The original answer only mentions $500 million in fixed-rate registered notes repaid in 2023 and $1.1 billion in medium-term notes in 2024, with no euro-denominated repayments. (2) The interest rate swap details are partially correct: the LLM correctly identifies that swaps were initiated in 2021 to convert portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, and correctly references the transition from LIBOR to SOFR. However, the original answer does not specify the amounts swapped as $500 million and $300 million—the LLM adds these figures without support, which undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward managing interest rate exposure via swaps and reduced fixed-rate debt, aligning with the original answer’s conclusion. However, it misrepresents the issuance history—while the original answer notes $3.25 billion issued in 2019 (not during 2022–2024), the LLM omits this context and instead invents repayment activity during the period, failing to accurately reflect the evolution of issuance. (4) Contextual relevance is high—the answer addresses repayment activity and interest rate strategies as asked, and the overall structure and intent match the question. However, due to major numerical inaccuracies and unsupported specifics, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning direction is valid but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 526,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, securities issuances by Schwab remained a component of its capital structure, primarily serving as a source of funding for corporate purposes and to support regulatory and operational needs. However, the role of securities issuances became less prominent compared to other funding sources, such as client-generated cash flows from bank deposits and brokerage accounts. Schwab's capital management strategy continued to emphasize maintaining strong liquidity and regulatory capital ratios, with a focus on returning excess capital to shareholders through dividends and share repurchases rather than relying heavily on external securities issuances. This shift reflects Schwab's stable financial position and its ability to generate internal capital to support its operations and growth objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that securities issuances remained part of Schwab's capital structure and touches on capital management goals like liquidity and shareholder returns. However, it diverges from the ground truth by emphasizing a decline in prominence due to internal capital generation (e.g., client cash flows), which is not mentioned in the original answer. Instead, the ground truth highlights a strategic shift toward a more diversified funding mix including FHLB borrowings, repurchase agreements, and CDs — details entirely missing in the LLM response. (2) There are no specific numbers, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised; the LLM does not fabricate any figures, earning a 10. (3) The multi-hop reasoning is partially sound — the model infers a reduced reliance on securities issuances, which aligns with the idea of integration into a broader framework. However, it fails to correctly identify the key evolution: the expansion of alternative funding sources beyond securities, which is central to the original answer. This omission affects qualitative accuracy. (4) Contextual relevance is high because the answer addresses capital structure evolution, funding sources, and capital management strategy, even if the specifics are misaligned. The core theme is preserved, but key factual components of the evolution are incorrect or missing, justifying a correctness score of 6 — partially correct with significant gaps in synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 421,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, with a $6,126 million liability recorded as of December 31, 2024, compared to a $270 million liability as of the acquisition date in 2020. This increase indicates that fairlife has likely performed well against its financial targets, as the contingent consideration is based on formulas tied to fairlife's operating results and has no ceiling, implying higher potential payments as targets are met or exceeded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Coca-Cola had a $270 million contingent liability in 2022 related to fairlife, with a $100 million payment already made in 2021 for 2020 targets. The LLM incorrectly states that the liability increased to $6,126 million by 2024, which is not supported by the original answer and represents a massive overstatement (over 22x the original amount). There is no mention of a $6,126 million liability in the ground truth. (2) The quantitative inaccuracies are severe: the LLM misstates both the timeline and magnitude of the contingent payments. It references a '2020' liability of $270 million, but the original answer states this $270 million was disclosed in 2022, not at the 2020 acquisition. The LLM also fabricates a $6,126 million figure with no basis in the provided data. (3) The reasoning is flawed: the LLM concludes that the increase indicates strong performance, but this inference is based on false numbers. While the ground truth confirms fairlife met early targets (triggering the $100M payment) and that the remaining obligation was still active in 2024, suggesting continued progress, the LLM invents a narrative around a non-existent escalation in liability. (4) Contextual relevance is moderate—the answer addresses contingent payments and links them to performance, which is relevant—but due to severe factual and numerical errors, the overall correctness score is very low. The answer fails the core requirement of factual fidelity to the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 431,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) between 2022 and 2024 has shown a clear shift toward global market expansion and deeper integration with enterprise IT solutions. In 2022, Oracle focused on transitioning customers from non-strategic hardware products to cloud-based infrastructure, emphasizing cloud services and license support. By 2024, Oracle had further solidified its global positioning by investing in expanding data center capacity and establishing new geographic locations to meet growing demand for OCI. Additionally, Oracle integrated OCI more closely with enterprise IT solutions, offering comprehensive and interoperable deployment models (on-premise, cloud-based, and hybrid) to address diverse customer needs. These efforts reflect Oracle's commitment to positioning OCI as a central pillar of its enterprise IT strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of Oracle's emphasis on OCI from 2022 to 2024, aligning with the ground truth. It accurately reflects the shift from a focus on cloud and license support in 2022 to positioning OCI as a central, integrated component of enterprise IT solutions by 2024. However, the LLM introduces details not present in the original answer, such as 'transitioning customers from non-strategic hardware products' and 'investing in expanding data center capacity and establishing new geographic locations,' which, while plausible, are not mentioned in the ground truth and thus represent unsupported additions. (2) There are no numerical values in the LLM answer, so quantitative accuracy is not violated—no incorrect figures or miscalculations are present. The original answer includes a specific revenue figure ($36.052 billion in 2022, 85% of total revenue), but the LLM omits this data. While omission is not a factual error, it reduces completeness. (3) The multi-hop reasoning is generally sound: the LLM correctly infers a strategic shift over time and synthesizes the growing importance of OCI in Oracle’s enterprise offerings. However, it fails to explicitly reference the key differentiator in the ground truth—OCI’s elevation to a 'core component of Oracle Cloud Services alongside SaaS' and the specific language about 'comprehensive and integrated applications and infrastructure services.' Instead, it paraphrases with 'comprehensive and interoperable deployment models,' which is semantically close but not precise. (4) The contextual relevance is high—the response directly addresses the question about strategic evolution, market positioning, and integration with enterprise IT. The qualitative accuracy is slightly reduced due to the omission of key specifics and the introduction of unverified details. Overall, the answer is factually consistent in direction and logic but lacks full fidelity to the ground truth's specific evidence and phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 544,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "The treatment and risk profile of Pledged Asset Lines (PALs) evolved between 2023 and 2024 with a reduction in credit risk exposure. In 2023, the allowance for credit losses on PALs was $4 million, reflecting a 103% coverage ratio against nonaccrual PALs. By 2024, the allowance for credit losses on PALs increased to $6 million, but no nonaccrual PALs existed, resulting in an infinite coverage ratio. Additionally, all PALs remained fully collateralized by securities with fair values exceeding the loan amounts in both years, indicating continued low credit risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no allowance for credit losses was required in 2024 due to the collateral maintenance practical expedient under ASC 326, yet the LLM claims a $6 million allowance existed in 2024—this directly contradicts the original answer. Additionally, the ground truth indicates a slight decrease in PALs in 2023 and full collateralization with no allowance needed in 2024, whereas the LLM introduces unsupported figures like a $4M allowance in 2023 and $6M in 2024, which are not mentioned in the ground truth. The '103% coverage ratio' and 'infinite coverage ratio' are fabricated metrics with no basis in the provided answer. (2) Quantitative accuracy is very low: none of the dollar amounts ($4M, $6M) or percentages (103%) appear in the ground truth, and the calculations or ratios introduced are speculative and incorrect. The only correct detail is that PALs were fully collateralized in both years, aligning with the original answer. (3) The multi-hop reasoning is flawed—the LLM fails to recognize the key shift in accounting treatment under ASC 326 in 2024 and instead invents a narrative around increasing allowances and coverage ratios, missing the core point that no allowance was required in 2024 due to the practical expedient. It also omits the explanation of improved credit quality in 2023 influencing the allowance. (4) Contextual relevance is moderate because the response addresses credit loss allowance and collateralization as requested, but the incorrect data and reasoning undermine the overall validity. The mention of full collateralization maintains some relevance, but the erroneous emphasis on allowance increases misrepresents the risk profile improvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 483,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved in terms of operational structure and strategic emphasis through the transition of certain APLA businesses to third-party distributors, as noted in Note 18 of the 2024 10-K. This shift reflects a strategic realignment to optimize operations and focus on core markets. Additionally, the region's inclusion as a reportable operating segment highlights its continued importance in Nike's global structure, though the company is streamlining operations in select countries to enhance efficiency and responsiveness to regional dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key evolution in Nike's relationship with the APLA region: the transition from direct operations to third-party distributors in fiscal year 2024, referencing Note 18 of the 2024 10-K, which supports the factual basis. This matches the ground truth's claim of a strategic shift toward outsourcing. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no numbers were misstated. (3) The multi-hop reasoning is sound: the model synthesizes information about operational structure changes (shift to third-party distributors) and infers strategic emphasis (optimization, efficiency), correctly linking these to Nike’s broader restructuring. The mention of APLA as a reportable segment adds contextual depth, though this detail is not in the ground truth; however, it does not contradict it and enhances relevance. (4) The only minor gap is that the LLM omits the specific detail about trade union representation in APLA in FY2023, which the ground truth cites as evidence of localized workforce structure. While this omission slightly reduces completeness, the core operational and strategic evolution is accurately conveyed. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent in substance, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 400,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized Pedialyte as a key growth driver within its U.S. Pediatric Nutritionals business, with sales increasing significantly. In 2021, U.S. Pediatric Nutritionals sales rose 10.3%, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, Abbott continued to expand its product portfolio, leveraging Pedialyte's strong market position to enhance its offerings in the pediatric nutritional segment. This strategic focus on Pedialyte reflected Abbott's commitment to strengthening its presence in the U.S. market through innovation and brand leadership.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative claim—stating that the 10.3% sales growth for U.S. Pediatric Nutritionals occurred in 2021 instead of 2022, which directly contradicts the ground truth. This misattribution of the year undermines the accuracy of the timeline and weakens the multi-year comparison central to the question. All other numerical references (e.g., Pedialyte's role in growth) are consistent in magnitude but tied to the wrong year. (2) The calculation of growth (10.3%) is accurate per the original answer, but its placement in 2021 instead of 2022 is incorrect. No other calculations are attempted, so no additional math errors exist, but the single error is significant due to the time-sensitive nature of the strategic evolution. (3) The reasoning partially captures the strategic emphasis on Pedialyte as a growth driver and its importance alongside Similac and PediaSure. It correctly identifies the continued focus in 2023 and the expansion within the pediatric nutrition segment. However, it misses the key multi-hop insight that in 2023, Pedialyte was formally integrated into the Nutritional Products segment portfolio alongside Ensure and Glucerna—this structural repositioning is a core element of the strategic evolution and is absent in the LLM response. (4) Contextual relevance is high, as the answer addresses Abbott’s strategic focus on Pedialyte and its role in the U.S. pediatric business. The qualitative reasoning is sound but incomplete without the formal portfolio integration detail. The correctness score is 6 due to the mix of correct strategic framing but major factual error in timing and omission of a key structural development in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 470,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's 7.100% notes due 2027 decreased slightly from $141 million in 2022 to $135 million in 2023. This reduction, though minimal, suggests a cautious approach to debt management, potentially involving partial repayments or refinancing strategies to optimize its debt portfolio. Overall, the stability in the balance indicates a strategic effort to maintain manageable debt levels while addressing maturing obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, RTX's aggregate principal balance for the 7.100% notes due 2027 was $6 million in 2022 and increased to $135 million in 2023. The LLM incorrectly states that the balance was $141 million in 2022 and decreased to $135 million in 2023, reversing both the direction and magnitude of change. This fundamental error undermines the entire response. (2) The numbers are not accurate: $141M vs. $6M in 2022 is a massive discrepancy. The calculation of a 'slight decrease' from $141M to $135M is mathematically correct but based on false inputs, making the conclusion invalid. (3) The multi-hop reasoning is flawed because the model failed to correctly retrieve and compare the actual balances across years. Instead of identifying a significant increase suggesting a strategic shift (e.g., increased exposure via issuance or acquisition of debt), it infers a minor reduction implying repayment or refinancing, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the right topic—debt management strategy related to specific notes—and attempts to interpret the trend, but the incorrect data leads to a misleading conclusion. The qualitative reasoning would have been stronger if based on correct figures. Thus, correctness and quantitative accuracy are very low due to incorrect core data, while qualitative accuracy is slightly higher only because the structure and intent of the response align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 430,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike's Converse division experienced a decline in revenue performance, with total revenues decreasing by 14% to $2,082 million from $2,427 million. This decline was driven by reduced sales in North America and Western Europe, with wholesale revenues down 16% and direct-to-consumer revenues down 14%. Strategically, Converse faced challenges in maintaining pricing power, as evidenced by a 3% decrease in average selling price (ASP), partly due to increased promotional activity. Earnings before interest and taxes (EBIT) also dropped by 30%, reflecting lower revenues and margin pressures from foreign currency fluctuations and higher operating costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific financial figures such as a 14% revenue decline from $2,427 million to $2,082 million, a 3% decrease in average selling price (ASP), and a 30% drop in EBIT. However, the ground truth states a 15% currency-neutral revenue decline without providing exact dollar amounts or EBIT changes. The $2,427M to $2,082M calculation implies a 14.2% drop, which is close but not exactly aligned with the 15% cited in the original answer. More critically, these specific dollar figures and EBIT metrics are not present in the ground truth, suggesting the LLM may have hallucinated precise numbers not supported by the source. (2) The quantitative accuracy is compromised because while the percentages are in the ballpark, the exact figures (e.g., $2.082B revenue, 3% ASP drop, 30% EBIT decline) are not verifiable from the original answer and appear fabricated. The original only confirms a 15% currency-neutral decline and mentions pricing pressure but not the magnitude of ASP change. (3) On qualitative reasoning, the LLM correctly identifies the geographic and channel-based drivers (North America, Western Europe, wholesale and DTC declines), which aligns with the ground truth. However, it fails to mention the key strategic evolution in fiscal 2024 — that Converse operates as a stand-alone subsidiary, a critical multi-hop insight from the original answer. This omission significantly weakens the response’s completeness and strategic analysis. (4) The contextual relevance is high because the answer addresses revenue performance and strategic challenges, but the lack of the 2024 strategic positioning update — a core part of the question — downgrades correctness. The answer focuses heavily on financial deterioration but misses the shift in strategic posture, which is central to the evolution between 2023 and 2024. Thus, while partially accurate, it lacks key factual and strategic elements, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 530,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola's financial risk assessment regarding digital evolution has become more pronounced from 2022 to 2024, with a heightened emphasis on its critical role in sales growth and margin improvement. In 2022, the company acknowledged the impact of digital evolution on consumer behavior and shopping preferences but did not explicitly frame it as a financial risk. By 2024, the risk was explicitly outlined, noting that failure to digitalize the Coca-Cola system could directly hinder the company's ability to increase sales and improve margins. Additionally, the 2024 filing highlights the importance of digital initiatives in enhancing customer experiences, operational efficiency, and retail customer tools, underscoring the potential financial consequences of underinvestment or ineffective execution in this area.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the shift in Coca-Cola's risk assessment from 2022 to 2024 is accurately portrayed, with the company moving from viewing digital evolution as a general influence on consumer behavior to explicitly framing it as a financial risk tied to sales growth and margin improvement. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors in dates (2022 and 2024 correctly cited). (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution in tone and strategic importance of digital transformation across two years, noting the increased financial stakes in 2024. The only minor gap is that the LLM states Coca-Cola 'did not explicitly frame' digital evolution as a financial risk in 2022, while the ground truth says it *was* framed as a risk (albeit less strongly, with potential loss in sales and brand relevance). This is a subtle but important distinction—the original answer confirms it *was* a risk factor, just not as tightly linked to financial performance as in 2024. The LLM slightly understates the 2022 risk framing, which prevents a perfect 10. (4) Despite this nuance, the LLM captures the core progression in risk assessment, emphasizes the strategic dependency in 2024, and correctly identifies the financial consequences of inaction. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses sales growth, margin improvement, and risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 435,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services from fiscal year 2022 to 2024 has shown a marked increase in R&D investment and a stronger positioning of cloud offerings relative to on-premise solutions. In fiscal 2022, Oracle invested $7.2 billion in R&D, with a focus on enhancing existing offerings and developing new cloud technologies. By 2024, Oracle continued to prioritize cloud innovation, as evidenced by the 2024 Restructuring Plan, which aimed to improve operational efficiencies to better support cloud-based offerings, including investments in second-generation cloud infrastructure. Oracle has increasingly positioned its cloud services as flexible, cost-effective, and rapidly deployable solutions, emphasizing their interoperability with on-premise and hybrid environments, while continuing to support on-premise deployments as part of its broader strategy to provide customer choice.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $7.2 billion R&D investment in fiscal 2022 is accurately reported, and no specific figure is claimed for 2024, which matches the original answer's note that the 2024 report does not specify R&D investment. (2) The LLM correctly identifies Oracle's continued strategic focus on cloud services, including references to cloud innovation and infrastructure improvements, though it introduces the '2024 Restructuring Plan'—a detail not present in the ground truth. While this may reflect real-world context, it is not supported by the provided knowledge graph and slightly overreaches. (3) The reasoning is sound: the answer captures the evolution from 2022 to 2024, showing a deepening commitment to cloud services and a shift toward cloud-first positioning with customer choice. It correctly notes interoperability and hybrid support, which is consistent with Oracle's messaging. (4) The answer is contextually relevant and addresses both R&D investment and the positioning of cloud vs. on-premise solutions. The only minor gap is the lack of explicit mention that Oracle positioned cloud as a 'key differentiator' in 2022 and the more refined 'choose the best option' messaging in 2024, though the essence of customer choice is conveyed. Overall, the answer is factually accurate with strong qualitative reasoning, warranting a high score but not perfect due to slight overstatement of specifics not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 413,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan is no longer active for future stock awards or deferrals, as stated in both the 2023 and 2024 filings. In 2023, the plan had 4,264,741 shares issuable upon distribution of deferred compensation benefits and 1,993,916 shares remaining available for future issuance. By 2024, the number of shares issuable under the plan had decreased to 3,730,025, with 1,769,581 shares remaining available for future issuance. The decline reflects the continued distribution of deferred benefits, with no new awards or deferrals permitted under the plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The LLM claims that in 2023, 4,264,741 shares were issuable and 1,993,916 remained available for future issuance, and in 2024, 3,730,025 shares were issuable with 1,769,581 available — none of these numbers appear in the ground truth. The original answer states that by 2024, only 391 shares were issuable, indicating near-complete wind-down of the plan. The LLM's numbers are off by orders of magnitude and contradict the closure narrative. (2) COMPLETENESS: While the LLM correctly notes that no future awards or deferrals are allowed, it fails to convey the key evolution — that the plan was not just inactive but effectively concluded, with only minimal remaining obligations. It incorrectly implies that thousands of shares are still available for future issuance, which contradicts the 'no future awards' status. (3) ENTITY & REASONING: The plan name and general concept are correct, but the reasoning is flawed. The LLM suggests ongoing distributions are reducing a large pool, whereas the ground truth indicates the plan was already closed and only minimal residual shares remained. The multi-hop synthesis fails — the model did not infer from the filings that the plan had transitioned to a fully inactive state with only legacy obligations. (4) SEMANTIC EQUIVALENCE: The overall message is not equivalent — the LLM portrays an active wind-down with significant remaining shares, while the truth is the plan had already wound down to near zero. Only the contextual point about no new awards is correct, earning partial relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 448,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure around food safety concerns, particularly in relation to supply chain risks and cost volatility. In 2022, the company highlighted its food safety priorities and the potential impact of food-borne illnesses or contamination on its brand and financial results, but did not explicitly link these risks to supply chain volatility or cost challenges. By 2023, McDonald's provided more detailed insights, noting that food safety concerns in the supply chain are influenced by factors such as climate conditions, international commodity markets, and government regulations, all of which contribute to cost volatility. The 2023 disclosure also emphasized the company's efforts to manage these risks through supplier collaboration and quality management systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, McDonald's framed food safety as a reputational and brand risk affecting financial results; by 2023, the focus expanded to include supply chain volatility and cost pressures. The LLM correctly identifies the shift in disclosure emphasis without introducing false information. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosure across two years, correctly identifying the evolution from reputational concerns to inclusion of supply chain and cost volatility drivers such as climate, commodity markets, and regulations. The mention of supplier collaboration and quality systems adds context not in the original answer but does not contradict it and is plausible within the scope of risk management disclosures. (4) The answer is contextually relevant and fully addresses the question about evolution in disclosure related to food safety, supply chain risks, and cost volatility. The only minor limitation is that the original answer more precisely specifies that food safety issues could directly exacerbate price volatility in beef, chicken, and pork—this level of detail is omitted in the LLM response, but the core conceptual shift is accurately captured. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 444,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024. The effective interest rate also remained consistent at 1.89% for both years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024, and that the effective interest rate remained consistent at 1.89% for both years. These values exactly match the ground truth. (2) All numeric values—$700 million (carrying value) and 1.89% (effective interest rate)—are accurate and correctly attributed to both years. There are no calculation errors or misstatements. (3) The question requires a multi-hop comparison across two fiscal years for a specific debt instrument; the LLM correctly synthesizes that there was no change over time, which aligns with the ground truth reasoning. (4) The answer is factually complete, contextually precise, and semantically equivalent to the original answer, though slightly more concise. No critical information is omitted. All scores are maximized due to full factual alignment, correct entity identification (TMO, 1.750% 7-Year Senior Notes), and accurate temporal comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 298,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023, as noted in the long-term debt schedules for both years. This suggests that RTX did not take action to refinance or retire this specific debt issue during the period, indicating a strategy of maintaining long-term debt maturities to manage cash flow and interest rate risk over an extended horizon.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure remained unchanged at $148 million in both 2022 and 2023. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023. This major quantitative error undermines the entire response. (2) The numbers are not accurate: the 2022 figure is off by over $137 million. The LLM incorrectly asserts no change, when in fact there was a significant increase. Calculations or comparisons based on this error are invalid. (3) The multi-hop reasoning fails because the model did not correctly identify the change in exposure over time. Instead of recognizing an increase suggesting active debt issuance or restructuring, it concludes there was no action, leading to flawed interpretation. The correct reasoning would link the large increase to a strategic decision to extend maturities or issue more long-term debt. (4) While the LLM attempts to address the question’s intent regarding debt management strategy, its conclusions are based on false premises. Contextual relevance is moderate because it discusses long-term debt management, but the incorrect data renders the analysis invalid. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher only because the general concept of long-term debt strategy is addressed, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 390,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees, particularly regarding the collection of rent and royalties, remained stable and showed growth. Revenues from franchised restaurants in 2023 totaled $14,605 million (rents: $9,529 million and royalties: $4,912 million), compared to $13,085 million in 2022 (rents: $8,381 million and royalties: $4,645 million). This reflects an increase in both rent and royalty collections, indicating a recovery and sustained performance post-pandemic. Additionally, the Company did not defer rent and royalty collections in 2023, as it had collected substantially all deferrals from the earlier pandemic period by the end of 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that McDonald's deferred approximately $1 billion in rent and royalties primarily in 2020, and had collected substantially all of it by the end of 2021. However, the LLM incorrectly implies that deferrals occurred in 2022 or were relevant to that year, when in fact the deferrals were from 2020 and fully resolved by 2021. The LLM also introduces specific revenue figures for 2022 and 2023 ($13,085M and $14,605M) that are not present in the original answer and cannot be verified from the provided ground truth. These numbers, while plausible, are fabricated and not supported by the source. (2) The calculation of rent and royalty increases is based on unsupported data; no such figures appear in the original answer, making the quantitative claims invalid. The original answer does not provide any financial totals for 2022 or 2023, only a qualitative description of the normalization of collections. (3) The reasoning is partially sound: the LLM correctly infers that by 2023, McDonald's was no longer offering pandemic-related deferrals and had returned to normal operations, which aligns with the ground truth. It correctly notes that substantially all deferrals were collected by the end of 2021. However, it misplaces the timeline by suggesting the deferral situation was still evolving between 2022 and 2023, when in fact the issue was already resolved. (4) Despite the incorrect numbers, the LLM captures the qualitative shift—normalization of franchisee financial obligations post-pandemic—which makes the answer contextually relevant and directionally accurate in spirit but factually flawed in execution. The core message about resumed collections is correct, but the supporting data is invented, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 501,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. has remained relatively stable from 2022 to 2024, with a slight increase in the difference between fair value and carrying value. In 2022, the Company held a significant influence over Andina, as noted in the refranchising and divestiture activities, and continued to account for its investment under the equity method due to governance rights. The strategic positioning reflects The Coca-Cola Company's long-term interest in maintaining a presence in the Andean region through equity investments, leveraging local bottling partnerships to sustain market access and operational efficiency.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer misses key quantitative facts from the ground truth. Specifically, it fails to mention the $39 million gain in 2022 from the partial sale of Coca-Cola's stake in Embotelladora Andina S.A., which is a critical data point indicating a divestiture. It also omits the 2024 carrying value ($90 million) and fair value ($168 million), which are essential for understanding the evolution of the stake. These omissions severely impact quantitative accuracy. (2) While the LLM correctly identifies Coca-Cola's continued equity method accounting and governance rights, suggesting ongoing influence, it does not acknowledge the strategic refranchising or partial exit implied by the 2022 sale. Instead, it frames the position as 'relatively stable,' which contradicts the ground truth indicating a deliberate reduction in exposure. (3) The multi-hop reasoning is partially sound—linking equity investment to regional market access and operational efficiency is logical—but it fails to synthesize the key shift from 2022 (divestiture) to 2024 (reduced but retained stake). The conclusion of 'long-term interest' downplays the strategic retreat aspect. (4) The answer is contextually relevant and uses appropriate financial terminology, but the absence of specific numbers and mischaracterization of the strategic move (stability vs. partial exit) reduce correctness. The qualitative accuracy is moderate because core entities (Coca-Cola, Embotelladora Andina S.A., equity method) and general strategic rationale are correct, but the reasoning lacks precision on the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 438,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a significant focus on internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle emphasized internal development efforts, leveraging its global workforce to maintain technical control and enhance cloud offerings. By 2024, Oracle had further solidified OCI's role by investing in expanding its infrastructure tools, increasing geographic capacity, and improving migration processes.OCI is now highlighted as a differentiated, secure, and scalable solution, supporting hybrid deployments and multi-cloud architectures, reflecting Oracle's strategic shift toward cloud-based services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle emphasized internal development in 2022, leveraging its global R&D workforce, which matches the original answer. By 2024, the focus evolved to position Oracle Cloud Infrastructure (OCI) as a central, market-facing product—this strategic shift is correctly captured. The LLM accurately reflects the evolution from general cloud development to a structured, integrated offering. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes Oracle's internal development focus in 2022 with the 2024 strategic positioning of OCI as a comprehensive solution, correctly inferring a strategic deepening. The mention of hybrid deployments, multi-cloud support, and migration improvements adds relevant context consistent with OCI's market positioning, even if slightly more detailed than the original. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'differentiated, secure, and scalable' vs. 'comprehensive and integrated'), the core meaning and strategic trajectory match the ground truth. One minor point preventing a perfect 10 is that the original emphasizes the shift from 'general cloud development' to a 'defined, market-ready suite,' which the LLM implies but does not explicitly state. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 438,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO acquired The Binding Site Group in January 2023, adding diagnostic capabilities for blood cancers and immune disorders under the Specialty Diagnostics segment. By 2024, the company continued to integrate this acquisition, as evidenced by the inclusion of The Binding Site Group's results in its consolidated financials and the strategic alignment with its diagnostics portfolio. This evolution indicates TMO's focus on expanding and integrating specialized diagnostic solutions to enhance its offerings and drive growth in high-potential markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies TMO's acquisition of The Binding Site Group in 2023 and its integration into the Specialty Diagnostics segment, with accurate context on the strategic focus in blood cancer and immune disorder diagnostics. However, it omits the specific acquisition cost of $2.70 billion and the key detail about the 19-year weighted-average amortization period for customer relationships, which is a material indicator of integration into intangible assets. The date 'January 2023' is more specific than the ground truth (which only states 2023), and while plausible, cannot be verified from the provided truth and may be an over-precision. (2) The ground truth includes two key quantitative facts: the $2.70 billion purchase price and the 19-year amortization period. The LLM omits both, reducing quantitative accuracy. No incorrect numbers are stated, but the absence of these figures limits completeness. (3) The multi-hop reasoning is sound—linking acquisition to integration and then to strategic focus on diagnostics growth—but misses the deeper financial integration signal (amortization of intangibles), which strengthens the inference about long-term value creation. The LLM infers strategic intent correctly but with less evidentiary support from financial disclosures. (4) Despite missing specific financial figures, the answer captures the core evolution and strategic implication accurately, making it contextually relevant and qualitatively strong. The correctness score is reduced to 8 due to the omission of key quantitative and integration-specific details essential to full multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 450,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the Directors' Code of Conduct at BNY Mellon has remained accessible on the company's website, but the URLs have been updated. In 2022, the Directors' Code of Conduct was posted at **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf**, while in 2024, the link was updated to **https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf**. The scope of application has remained consistent, applying to all directors of BNY Mellon. The company also continues to disclose amendments or waivers of the Directors' Code of Conduct on its website.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 URL is accurately cited, and the 2024 URL is nearly correct—though it uses 'bny.com' instead of the exact 'bny.com' with updated path 'directors-code-of-conduct.pdf' (missing hyphen in 'code-of-conduct' vs 'code-ofconduct' in ground truth). This is a minor formatting discrepancy in the URL string but does not affect accessibility or intent. (2) Quantitative accuracy is perfect: years (2022, 2024), scope (applies to all directors), and website disclosure practices are correctly reported. (3) Reasoning is sound: the model correctly infers consistent scope and updated URLs due to rebranding, even if it doesn't explicitly mention the rebranding from 'BNY Mellon' to 'BNY' as in the original answer. However, this contextual insight is partially missing, slightly weakening qualitative depth. (4) The answer addresses all parts of the question—evolution of disclosure, website links, and scope—making it contextually complete and relevant. The only minor shortcoming is the lack of explicit commentary on the rebranding implication, which slightly reduces qualitative accuracy, but the core facts and synthesis remain correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 349,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis by increasing sales of restaurant businesses to franchisees, particularly in International Operated Markets, and focusing on cost efficiencies through restructuring and operational modernization. Financially, gains on sales of restaurant businesses rose due to more transactions with franchisees, while strategic emphasis shifted toward accelerating growth initiatives, including $250 million in restructuring costs for modernizing internal operations. Additionally, the Company's franchised model continued to drive strong sales and margin growth, with franchised restaurants accounting for 93% of total Systemwide locations in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, such as 'gains on sales of restaurant businesses rose due to more transactions with franchisees', '$250 million in restructuring costs', and 'franchised restaurants accounting for 93% of total Systemwide locations in 2023'. These figures are not mentioned or verifiable from the original answer and appear to be hallucinated or inferred beyond the provided data. The ground truth does not mention any dollar amounts related to restructuring, nor does it provide the 93% franchisee ownership figure. (2) The original answer focuses on the evolution of financial reporting transparency and strategic emphasis—specifically, that in 2022, transactions with franchisees were not material to consolidated financials, while in 2023, franchisees were explicitly recognized as key stakeholders in the business model. The LLM answer shifts focus to operational and financial performance metrics (e.g., cost efficiencies, sales growth, restructuring) that are not supported by the ground truth. (3) While the LLM correctly identifies a strategic shift involving franchisees, it fails to accurately represent the nature of the evolution—namely, the change in disclosure and stakeholder framing in financial reporting. The multi-hop reasoning is partially sound in recognizing a shift in emphasis, but it incorrectly supplements this with unsupported financial data and operational details. (4) The contextual relevance is moderate because the answer addresses the general theme of franchisee relationship evolution, but correctness is low due to significant factual inaccuracies and fabrication of key metrics. The qualitative accuracy is mid-range because the direction of the strategic shift is roughly aligned, but the reasoning is based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 502,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023. This increase was primarily driven by changes in fair value, which were determined using a Monte Carlo simulation and based on updated financial projections for net revenue, gross profit, and EBITDA, along with adjustments for discount and volatility rates. The fair value adjustments were recorded in selling, general, and administrative expenses. Additionally, the contingent consideration liabilities for Clif Bar were classified entirely as long-term liabilities in both 2023 and 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $548 million contingent consideration liability as of December 31, 2023, which matches the ground truth. However, it introduces a figure of $452 million as of December 31, 2022, which is not mentioned in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. The ground truth does not discuss 2022 at all, so this quantitative claim undermines accuracy. (2) The description of the fair value measurement using Monte Carlo simulation, the linkage to financial projections (net revenue, gross profit, EBITDA), and the recording of adjustments in SG&A expenses are consistent with the original answer and factually accurate. However, the LLM fails to address the key evolution between 2023 and 2024—specifically, the absence of contingent consideration disclosures in 2024 and the shift toward purchase price allocation adjustments. This omission is significant because the question explicitly asks about the evolution between 2023 and 2024. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes details about valuation methodology and classification of liabilities in 2023, but it does not complete the required cross-year analysis into 2024. The lack of mention of the 2024 filing’s focus on purchase price allocation adjustments—rather than ongoing fair value measurements—means the answer misses a critical analytical step. (4) While the contextual relevance is high due to accurate terminology and focus on the Clif Bar acquisition, the scores for quantitative and qualitative accuracy are reduced due to the inclusion of unverified data (2022 amount) and failure to address the 2024 status, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 479,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support has evolved from a foundational focus in 2022 to a more integrated and performance-optimized approach by 2024. In 2022, AMD highlighted support for current generation APIs like Vulkan as part of its discrete GPU offerings for desktop and notebook PCs, emphasizing compatibility and immersive gaming experiences. By 2024, the company expanded this support to include advanced features such as ray tracing acceleration and Infinity Cache within its RDNA 3 architecture, reflecting a deeper integration of Vulkan to enhance performance for both gaming and compute workloads. This evolution underscores AMD's commitment to maintaining competitiveness in the discrete GPU market by aligning with industry standards and delivering optimized, next-generation graphics capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AMD supported Vulkan in 2022 with RDNA 2-based GPUs and continued support into 2024 with RDNA 3 architecture (Radeon RX 7000 Series), emphasizing gaming and compute workloads. While the LLM does not explicitly name the Radeon RX 7000 Series, it correctly identifies RDNA 3 as the underlying architecture in 2024, which is semantically close and contextually sufficient. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the years 2022 and 2024 are correctly used and contextualized, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s evolving API support with architectural advancements across two time points, correctly inferring strategic continuity and competitiveness. It adds value by mentioning ray tracing and Infinity Cache, which are accurate features of RDNA 3 and enhance the explanation, even if not in the original answer. (4) The LLM conveys the same core message—AMD maintains Vulkan support while innovating architecturally to stay competitive—demonstrating strong semantic equivalence. The only minor shortcoming is the lack of explicit mention of 'Radeon RX 7000 Series' or 'AI/ML computing' from the ground truth, but the inclusion of 'compute workloads' covers similar ground. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 418,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges significantly impacted its operating profit trends between 2022 and 2023, with the introduction of the Powder Metal Matter charge in 2023 playing a key role. In 2023, operating profit decreased by $1.9 billion compared to 2022, primarily driven by a $2.9 billion charge at Pratt & Whitney related to the Powder Metal Matter. This charge, along with a decrease in the change in FAS/CAS operating adjustment, offset gains in other segments. In contrast, operating profit increased by $0.4 billion in 2022 compared to 2021, largely due to reduced acquisition accounting adjustments and improved segment performance, despite the ongoing integration challenges from the Raytheon Merger.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: the $2.9 billion Powder Metal Matter charge in 2023 and the $1.9 billion decrease in operating profit are accurately reported. The mention of a $0.4 billion increase in 2022 operating profit compared to 2021 is consistent with the trend of improving profitability due to reduced integration charges, though this specific figure is not in the original answer—it is plausible and does not contradict the ground truth. (2) The entity identification is correct: RTX, Pratt & Whitney (as the business unit responsible), and the Powder Metal Matter charge are all accurately named. The time periods (2022 vs. 2023) are correctly used. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer contrasts 2022’s declining integration costs (specifically reduced acquisition accounting adjustments) with the significant new 2023 charge, explaining the reversal in operating profit trend. It correctly identifies the Powder Metal Matter charge as a primary driver of the profit decline. (4) The only minor shortcoming is that the original answer emphasizes the shift in integration-related charges as a trend—from decreasing in 2022 to a major new expense in 2023—and the LLM adds context about FAS/CAS adjustments and segment performance not present in the ground truth. While this additional context is reasonable and likely accurate, it slightly extends beyond the provided truth. However, it does not introduce errors. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 453,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar between 2023 and 2024, in terms of acquisition-related financial activities, is primarily reflected in contingent consideration obligations. As of December 31, 2023, the fair value of the Clif Bar contingent consideration liability was $548 million, and by December 31, 2024, it remained at $548 million, indicating no significant change in the estimated liability during this period. This contingent consideration is tied to Clif Bar achieving certain financial targets in 2025 and 2026, and it is classified as a long-term liability. Additionally, in 2023, there were adjustments related to purchase price allocations for Clif Bar, as noted in the Latin America segment adjustments. However, there is no indication of new acquisitions or major changes in the financial obligations related to Clif Bar in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timing of the Clif Bar acquisition. The original answer states that MDLZ acquired Clif Bar effective August 1, 2022, as reported in the 2023 10-K, meaning the acquisition occurred prior to 2023. However, the LLM implies ongoing acquisition-related activities in 2023–2024, which misrepresents the timeline. Additionally, the LLM claims the contingent consideration liability was $548 million at both year-end 2023 and 2024, but this specific figure is not present in the ground truth and cannot be verified; the original answer only references 'contingent consideration adjustments' without providing dollar amounts. (2) The quantitative accuracy is low because the $548 million figure is not supported by the ground truth and appears to be hallucinated. There is no mention of this number or any specific liability value in the original answer. The claim of 'no significant change' based on identical values is therefore unfounded. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that purchase price allocation adjustments occurred (noted in the 2024 10-K) and that contingent consideration is part of the financial obligations. It also appropriately infers that the lack of new adjustments suggests stabilization post-acquisition. However, it fails to correctly situate the acquisition event in 2022 and misattributes the primary financial activities to 2023–2024. (4) Contextual relevance is high because the response focuses on acquisition-related financial activities like contingent consideration and purchase price allocations, directly addressing the question’s focus. Despite incorrect numbers and timing, it attempts the necessary multi-hop synthesis between years and financial concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 496,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of the ultra-long-range G700, which entered service in March 2024 and features all-new engines for superior high-speed performance and fuel efficiency. Additionally, the G800 and G400, introduced in 2021, reflect Gulfstream's commitment to energy efficiency through their clean-sheet designs and advanced technologies. These developments underscore Gulfstream's ongoing investment in R&D to enhance performance, reduce emissions, and improve fuel efficiency across its aircraft portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the G700's introduction in 2024 with all-new, energy-efficient engines, aligning with the ground truth's emphasis on a shift from R&D to production. However, it incorrectly states that the G800 and G400 were introduced in 2021 and links them to the 2023–2024 evolution, which is factually inaccurate—these models were announced later and do not reflect developments in the specified timeframe. The G400 was not introduced until 2022 at the earliest, and the G800 was unveiled in 2023 but not as part of 2023 engine advancements. (2) The date 'March 2024' for G700 entry into service is plausible but not confirmed in the ground truth, which only notes the 2024 introduction without a specific month—this introduces minor quantitative uncertainty. The core error lies in referencing G800 and G400 as 2021 introductions reflecting 2023–2024 energy efficiency shifts, which misaligns chronologically and contextually. (3) The multi-hop reasoning is partially sound: the model connects Gulfstream’s R&D focus to new engine deployment in the G700, capturing the evolution. However, it fails to contrast the absence of new models in 2023 (a key point in the ground truth) and instead conflates earlier or unrelated models into the narrative, weakening the synthesis. (4) The correctness score is 6 due to accurate mention of the G700’s 2024 introduction and efficient engines, but significant factual errors in aircraft timelines reduce accuracy. Quantitative accuracy is 6 due to plausible but unverified dates and incorrect model years. Qualitative accuracy is 6 because reasoning captures the general trend but misattributes supporting evidence. Contextual relevance is 8 as the response stays on-topic and addresses the evolution theme, despite factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 490,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have seen a decline in revenue contribution, particularly within the Gaming segment, which dropped from $6,805 million in 2022 to $2,595 million in 2024. This reflects a strategic shift away from semi-custom SoC reliance toward growth in the Data Center segment, which more than doubled in revenue to $12,579 million in 2024. AMD's strategic positioning now emphasizes high-growth areas like AI and data center solutions, as evidenced by the Silo AI acquisition, while semi-custom SoC revenue remains tied to third-party product success and has become a smaller portion of overall revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The reported revenue figures for the Gaming segment—$6,805 million in 2022 and $2,595 million in 2024—are not supported by the ground truth and contradict the known trajectory of AMD's semi-custom business, which includes console-related SoCs. These numbers appear fabricated or misattributed. There is no mention in the ground truth of such a decline, nor of the Data Center segment more than doubling to $12,579 million, which is inconsistent with AMD's reported financials for 2024. (2) The calculation of revenue changes and market shifts is therefore invalid due to incorrect base figures. The Silo AI acquisition is factually correct (announced in 2023), but its inclusion as evidence of strategic shift is only partially relevant and not directly tied to semi-custom SoC evolution. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer a strategic pivot from revenue changes, it does so using incorrect data. The ground truth emphasizes a qualitative evolution—from dependency to strategic integration and diversification—rather than a decline in importance. The LLM incorrectly frames semi-custom SoCs as diminishing in strategic value, whereas the original answer describes them as being more centrally integrated into a broader portfolio. (4) Despite these issues, the LLM answer is contextually relevant, addressing revenue structure and strategic positioning, and correctly identifying AI and data centers as growth areas. However, the incorrect numbers and resulting misinterpretation of AMD's strategic direction severely undermine factual correctness, warranting a low quantitative accuracy score and a partial qualitative score for correct framing but flawed execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 492,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization remained unchanged between fiscal years 2023 and 2024, with no Preferred Shares issued or outstanding in either year. This indicates that the company has not utilized preferred shares as a component of its capital structure during this period, focusing instead on other forms of financing such as debt and equity repurchases. This suggests a capital strategy centered on maintaining flexibility through debt management and returning capital to shareholders via share repurchases rather than issuing preferred shares.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that preferred share authorization remained unchanged between 2023 and 2024 and that no Preferred Shares were issued or outstanding in either year, which aligns with the ground truth. However, it omits specific details about the authorized share classes: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value. While the absence of issued shares is correctly noted, the full structure of authorization is not fully detailed, reducing completeness. (2) All numeric values referenced in the LLM answer (i.e., no shares issued or outstanding) are factually correct and consistent with the ground truth. The LLM does not misstate any numbers, so quantitative accuracy is perfect. (3) The reasoning about capital strategy is partially sound—correctly inferring that the lack of preferred share issuance suggests non-utilization in capital structure. However, the LLM adds unsupported strategic interpretation: claiming the company focused on 'debt and equity repurchases' and 'returning capital to shareholders' goes beyond the provided data. The ground truth does not include information about other financing activities, so this inference, while plausible, is not grounded in the evidence. This affects qualitative accuracy due to over-interpretation. (4) The answer is contextually relevant and addresses both parts of the question—evolution of structure and implications for capital strategy—but the strategy interpretation exceeds available evidence. The omission of full authorization details and the addition of unsupported strategic focus prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 452,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has become more specific and integrated with broader concerns. In 2022, reputational risk was mentioned as a general concern linked to adverse events, publicity, or government scrutiny. By 2024, the disclosure explicitly ties reputational harm to impacts from geopolitical events, climate change, and sustainability concerns, indicating a broader recognition of interconnected risks affecting the company's operations and reputation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of BK's risk disclosures from 2022 to 2024. It correctly identifies that in 2022, reputational risk was linked to adverse publicity and government scrutiny, and that by 2024, the framing expanded to include broader concerns such as climate change and sustainability. This matches the original answer's key point about the broadening of reputational risk to include sustainability-related issues. However, the LLM answer introduces 'geopolitical events' as a new element in 2024, which is not mentioned in the ground truth. Conversely, it omits the specific mention of the 'platforms operating model transition' as a new linkage in 2024, which is a key detail in the original answer. These substitutions slightly affect completeness and precision in the multi-hop synthesis, though the overall trend of broadening risk framing is accurately captured. There are no numerical values in the question or answers, so quantitative accuracy is scored based on correct use of years (2022, 2024), which are accurate. The reasoning is sound and contextually relevant, with only minor omissions and an unverified addition affecting full qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 347,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 as follows: In 2023, Amazon invested $1.25 billion in a convertible note from Anthropic, which was classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss). By 2024, the valuation of this investment remained subject to market conditions and was categorized as a Level 3 asset, indicating the use of unobservable inputs. Factors affecting its valuation included the inherent complexity of valuing private companies and the lack of readily available market data, as well as broader economic uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion convertible note investment in 2023, its classification as available-for-sale, reporting at fair value, and inclusion of unrealized gains/losses in accumulated other comprehensive income (loss). It accurately states the investment remained a Level 3 asset in 2024 and correctly notes the valuation challenges due to lack of market data and economic uncertainty. However, it omits the key detail from the original answer that Amazon had an agreement to invest an additional $2.75 billion by Q1 2024, which is a significant part of the investment evolution. (2) All numeric values—$1.25 billion, Level 3 asset classification—are factually correct and match the ground truth. No calculations are required, but the figures are accurately reported. (3) The multi-hop reasoning is largely sound: the model connects Amazon’s investment in Anthropic across two years, tracks the consistent classification, and synthesizes the shift in disclosure focus toward valuation complexity. The only gap is the missing forward-looking $2.75 billion commitment, which weakens completeness slightly. (4) The answer is highly factually accurate, well-structured, and contextually relevant, with only a minor omission affecting completeness. Hence, a 9/10 correctness score is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 372,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the risks related to the protection of MDLZ's intellectual property, including know-how, have evolved to include heightened concerns around artificial intelligence (AI) technologies. In 2023, the risk was primarily focused on the potential failure to obtain or adequately protect intellectual property rights and the impact of legal changes. By 2024, the discussion expanded to emphasize the challenges posed by developments in AI, which could affect the legal protections of intellectual property and increase the complexity of safeguarding proprietary information.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of MDLZ's intellectual property risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically mentioned artificial intelligence (AI) as a concern related to intellectual property protection, while in 2024 it removed that specific reference and instead broadened its risk disclosure to include general legal and regulatory non-compliance, penalties, and reputational damage. The LLM answer incorrectly states the opposite—that AI concerns were introduced or expanded in 2024. This is a critical factual reversal. There are no numeric values in the question or answers, so quantitative accuracy is not applicable in a meaningful way, but since no numbers were misstated, it scores highly. The qualitative accuracy is low because the reasoning is flawed: the model failed to correctly synthesize the multi-hop change over time and misrepresented the direction of evolution in risk disclosure. Contextual relevance is moderate because the answer addresses the general topic of IP risk evolution and mentions relevant concepts like know-how and legal protection, but the central argument is factually inverted. Overall, the answer fails to reflect the actual shift in MDLZ's disclosures and thus conveys the opposite of the truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 368,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024 by introducing a new \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" in the 2024 filing, which was not explicitly referenced in the 2023 filing. Additionally, the 2024 filing includes a more detailed listing of agreements, including specific references to amendments and pre-2015 forms, suggesting a more structured and transparent approach to these agreements in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and misrepresents the evolution of Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024. The ground truth states that in 2023, the agreements were referenced under Exhibit 10.17 with an amendment dated November 28, 2008, and in 2024, the same type of agreements were disclosed under Exhibit 10.18, now referencing Exhibit 10.69 from the 2008 Annual Report—indicating a shift in citation source but continuity in policy. However, the LLM claims a new 'Form of Non-Employee Director RSU Award Agreement (Cash-Settled)' was introduced in 2024, which is not supported by the ground truth. There is no mention of a new form or cash-settled RSUs in the original answer, nor any indication of pre-2015 forms being newly listed. These are fabrications or misinterpretations. The LLM also fails to mention the specific exhibit number changes (10.17 to 10.18) and the pivot to Exhibit 10.69 from the 2008 report, which are central to the correct answer. While the response addresses the general theme of increased transparency or structure, this is speculative and not aligned with the documented exhibit-level evolution. Thus, the quantitative accuracy is very low due to incorrect dates, exhibits, and agreement types. Qualitative accuracy is poor because the reasoning and entity references (e.g., specific exhibits and their relationships) are wrong. Contextual relevance is moderate since the answer attempts to address the evolution of equity award agreements, but the substance is factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 436,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities by increasing the use of merchant-based transactions, particularly through Booking.com. This shift allows BKNG to facilitate payments from travelers directly, expanding its ability to offer secure and flexible payment terms. As a result, BKNG incurs additional expenses related to payment processing, chargebacks, and personnel, which are recorded in \"Personnel\" and \"Sales and other expenses.\" This evolution reflects BKNG's long-term strategy to build a more integrated \"Connected Trip\" offering, enhancing its payment platform and expanding its service scope.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and relevant to the topic. (1) The answer claims BKNG increased 'merchant-based transactions' and incurred new expenses in payment processing and chargebacks, but this is not supported by the original answer or the evolution described between 2022 and 2023. The ground truth emphasizes a shift in accounting treatment and revenue recognition (net basis as agent, timing at service usage), not a structural shift toward merchant models. (2) There are no numeric values in either the original or LLM answer, so quantitative accuracy is neutral—no errors but no numbers to verify, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the LLM misidentifies the core evolution—instead of focusing on revenue recognition principles (agent vs. principal, net revenue timing), it fabricates a narrative around payment integration and 'Connected Trip' strategy not mentioned in the ground truth. (4) Contextual relevance is moderate because the answer discusses BKNG’s relationship with providers and revenue, but it misses the key accounting-driven changes and instead introduces unrelated operational expansions. The original answer centers on disclosure maturity and accounting precision, which the LLM fails to capture, resulting in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 382,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs did not disclose specific changes in the structure of its executive life insurance policy disclosures between the 2023 and 2024 10-K filings. Both filings reference the same policies (e.g., Goldman Sachs & Co. LLC Executive Life Insurance Policy with Metropolitan Life Insurance Company and Pacific Life & Annuity Company) and their incorporation by reference from prior filings, indicating no structural changes were disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is incorrect in asserting that there were no structural changes in the executive life insurance policy disclosures between the 2023 and 2024 10-K filings. The ground truth confirms that while the policies themselves remained substantively the same, there was a clear structural change in the form of exhibit renumbering: Exhibit 10.11 (Metropolitan Life) and 10.12 (Pacific Life) in 2023 became Exhibits 10.12 and 10.13 respectively in 2024. This reorganization of exhibit numbering constitutes a structural update in disclosure format, which the LLM failed to identify. The LLM correctly identified the involved companies and policies, hence partial credit for entity accuracy and contextual relevance. However, it missed the key fact of renumbering, which is central to the question about structural changes in disclosure. The reasoning is flawed because it equates 'no substantive change in policies' with 'no structural change in disclosure,' which is not accurate—the question specifically asks about disclosure structure, not policy content. Therefore, despite correct entity identification, the answer fails on the primary factual and reasoning dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 330,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown, as Broadcom continues to leverage its proprietary FBAR technology to offer industry-leading performance in cellular RF transceiver applications. The manufacturing approach remains focused on internal fabrication to protect IP, with FBAR filters still produced in-house using innovative and proprietary processes. Competitively, Broadcom maintains a strong position in the cellular handset market, with FBAR technology holding a significant market share due to its efficiency in congested RF spectrums.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that FBAR filters remain strategically important and are still fabricated internally using proprietary processes to protect IP, which aligns with the ground truth for both 2022 and 2024. It accurately reflects Broadcom's continued emphasis on in-house manufacturing for competitive advantage. However, it omits a key evolution noted in the original answer: the expansion of the competitive landscape by 2024 to include specific competitors like Qorvo, Qualcomm, and Skyworks, and the implication of increased competitive pressure in wireless communications. This missing context weakens the qualitative accuracy, as the answer does not fully capture the shift in competitive positioning. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the continuity in manufacturing strategy across years, but fails to incorporate the broader competitive environment mentioned in the 2024 data, which is a critical component of the evolution. (4) The answer is contextually relevant and well-articulated, but the absence of the expanded competitor list and increased competitive intensity limits completeness and reasoning depth, justifying a 7 for correctness and qualitative accuracy. Wording differences are acceptable under semantic equivalence, but missing key factual expansions reduces the score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 430,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY significantly advanced the strategic positioning of Krazati, particularly in clinical development and financial valuation. In 2024, Krazati received FDA accelerated approval for use in combination with cetuximab for previously treated KRAS-mutated colorectal cancer and demonstrated positive results in the Phase III KRYSTAL-12 trial for KRAS-mutated NSCLC, showing a statistically significant improvement in progression-free survival. Financially, Krazati became part of BMY's portfolio through the acquisition of Mirati in January 2024 for $4.8 billion, with an additional contingent value right potentially worth up to $1.0 billion tied to the FDA acceptance of an NDA for the PRMT5 Inhibitor. This acquisition reflects BMY's strategic investment in expanding its oncology pipeline and enhancing its competitive position in targeted therapies.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.8 billion acquisition of Mirati by BMY in 2024 and the $1.0 billion contingent value right, which aligns with the ground truth. It also correctly notes FDA approvals and the strategic importance of Krazati in BMY's oncology pipeline. However, it introduces information not present in the ground truth: specifically, the 'FDA accelerated approval for use in combination with cetuximab for KRAS-mutated colorectal cancer' and 'positive results in Phase III KRYSTAL-12 trial for progression-free survival.' While the ground truth confirms FDA approval for advanced KRAS-mutated colorectal cancer, it does not specify the cetuximab combination or the nature of the approval (accelerated). Additionally, the ground truth does not mention KRYSTAL-12 results, only that it was a trial in 2L+ NSCLC. (2) Quantitatively, the $4.8 billion acquisition price and $1.0 billion CVR are accurate. The date of acquisition (January 2024) is plausible and consistent with the 2024 timeframe. No calculation errors. (3) The multi-hop reasoning is partially sound: the model connects the acquisition to Krazati’s valuation and clinical development, but overreaches by adding trial results and approval specifics not in the original data. It correctly infers strategic intent but adds unsupported details. (4) The answer is contextually relevant and addresses both clinical development and financial valuation. However, the addition of unverified trial outcomes and approval details reduces factual accuracy. Core financial and strategic points are correct, warranting a score of 7 for correctness—minor factual overreach but key elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 461,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG has continued to strengthen its relationships with travel service providers by offering platforms, tools, and insights to help them succeed, while also managing financial obligations and incentives through various programs. The Company provides incentive programs such as referral bonuses, rebates, and discounts, with the estimated value of these incentives recognized as a reduction of revenue at the time they are granted. Additionally, BKNG manages deferred merchant bookings, which include amounts payable to travel service providers, reflecting the growth in business volumes during 2023. These practices indicate a strategic focus on fostering mutually beneficial partnerships while maintaining financial accountability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the essential evolution in BKNG's relationship with travel service providers from 2022 to 2023. It accurately identifies key qualitative shifts: the recognition of incentives (referral bonuses, rebates, discounts) as a reduction of revenue, the management of financial obligations via 'deferred merchant bookings,' and the strategic intent to foster partnerships. These points align with the ground truth. However, the LLM omits the explicit contrast between 2022 (competitive stance) and 2023 (dependent, partnership-oriented model), which is central to the multi-hop reasoning required by the question. While it mentions practices in 2023, it does not clearly state the shift from competition to dependence, weakening the comparative analysis over time. No numeric inaccuracies are present—'deferred merchant bookings' and incentive accounting are correctly described—and the entities (BKNG, travel service providers), years (2022–2023), and financial terms are accurate. The reasoning is sound but incomplete in synthesizing the before-and-after relationship dynamic. The answer remains highly relevant and factually consistent with the original, missing only the explicit competitive-to-dependent transition for full fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 355,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "Broadcom's involvement in the development of Custom Touch Controllers from 2022 to 2024 has remained consistent, with the product being offered as part of their Mobile Device Connectivity Solutions. In both 2022 and 2024 filings, Custom Touch Controllers are mentioned as products that process signals from touch screens in mobile devices like handsets and tablets. However, there is no explicit indication of a change in Broadcom's role in the product lifecycle during this period, suggesting that their role has remained stable as a provider of these components.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Broadcom's role remained consistent from 2022 to 2024. The ground truth states a clear evolution from being a supplier in 2022 to an active producer involved in design and creation by 2024. The LLM incorrectly asserts there is 'no explicit indication of a change,' which contradicts the documented strategic shift. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesizing Broadcom's changing role across years, but the LLM fails to detect the shift from component supplier to active developer in custom silicon solutions. Instead, it defaults to surface-level similarity in product description without recognizing the deeper lifecycle involvement. (4) Contextual relevance is moderate—the answer discusses the right product and timeframe but misses the central theme of role evolution. The mention of 'Mobile Device Connectivity Solutions' is contextually relevant but does not compensate for the failure to capture the strategic shift. Overall, the answer is factually misaligned with the ground truth, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 359,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's approach to freight cars from 2023 to 2024 shows a strategic focus on replacement and growth, with capital investments in locomotives and freight cars amounting to $788 million in 2024 compared to $728 million in 2023. The 2025 capital plan emphasizes continued investments in modernizing the locomotive fleet and acquiring freight cars to support replacement needs and growth opportunities, reflecting a consistent strategy of asset renewal and expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses the core shift from leasing to acquiring freight cars, which is central to the original answer. While it correctly notes increased capital investment in freight cars and mentions acquisition for replacement and growth, it fails to highlight the strategic pivot from leasing (dominant in 2023) to buyouts in 2024. Instead, it emphasizes capital expenditures broadly, including locomotives, which dilutes the focus on freight car asset strategy. (2) Quantitatively, the LLM provides $788 million for 2024 and $728 million for 2023 in capital investments, but these figures are not specific to freight cars and are not present in the ground truth. The ground truth specifies lease buyouts of $143 million in 2024 vs. $57 million in 2023 — a key data point entirely missing from the LLM response. These numbers are critical for demonstrating the shift in asset acquisition strategy and their absence constitutes a major factual gap. (3) The multi-hop reasoning is partially sound — the model infers a trend of increased investment and links it to growth and replacement, which aligns with the original answer’s intent. However, it fails to synthesize the specific evolution in freight car strategy: from leasing reliance to ownership via buyouts. This represents a failure in precise entity and metric mapping across years. (4) The contextual relevance is high because the answer discusses Union Pacific, freight cars, and year-over-year changes in strategy. However, the lack of specificity on lease vs. ownership dynamics and incorrect or overly broad financial figures reduces factual accuracy and qualitative reasoning scores. Minor note: mention of a '2025 capital plan' introduces information outside the 2023–2024 scope, adding slight irrelevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 496,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's transition of certain businesses in Asia Pacific & Latin America (APLA) to third-party distributors between FY2022 and FY2023 resulted in a net loss of approximately $550 million in fiscal 2023, primarily driven by the devaluation of local currency and cash equivalents in transferred assets. This loss included $389 million recognized in fiscal 2020, related to anticipated foreign currency translation losses. The transaction also led to the reclassification of accumulated foreign currency translation losses to net income, impacting the Company's financial results. Operationally, this structural change reduced Nike's direct presence in APLA, shifting responsibilities to third-party distributors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claimed net loss of $550 million in FY2023 is not supported by the ground truth, which does not specify any such dollar amount related to the transition. Additionally, the reference to a $389 million loss recognized in fiscal 2020 is factually incorrect and temporally inconsistent—FY2020 predates the FY2022–FY2023 transition period in question and is not mentioned in the original answer. These numbers appear fabricated or misattributed. (2) Quantitative accuracy is severely lacking: no monetary figures were cited in the ground truth, yet the LLM invents precise figures ($550M, $389M) with false temporal and causal attributions. There is no mention of devaluation of cash equivalents or a net loss in the original answer. (3) Qualitatively, the LLM captures the general direction of the structural change—transitioning APLA operations to third-party distributors and reduced direct presence—which aligns with the strategic shift described. It also correctly identifies foreign currency translation impacts as a factor, consistent with the original answer’s mention of non-recurring impairment charges due to anticipated release of cumulative foreign currency translation losses. However, it fails to mention the shift to a 'strategic stake' or the accounting treatment via Note 18 on divestitures, missing key elements of the financial reporting impact. (4) Contextual relevance is moderate: the answer addresses the operational shift and financial implications broadly, but the inclusion of false quantitative data and incorrect timelines undermines its reliability. The reasoning does not accurately reflect the multi-hop synthesis required—linking FY2022 operations, FY2023 transition, strategic stake model, and disclosure in Note 18—resulting in a misleading response despite some correct conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 513,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom's involvement with InP lasers has remained consistent in terms of internal fabrication strategy from 2022 to 2024, as both filings mention their use of internal fabrication facilities for InP lasers in fiber optic communications. However, the 2024 filing emphasizes continued investment in product development and fabrication capabilities to optimize processes for internally manufactured devices, suggesting a strategic focus on enhancing their InP laser technology. This positions Broadcom competitively in the fiber optic communications market by protecting IP and accelerating time-to-market for proprietary products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Broadcom maintained its internal fabrication strategy for InP lasers from 2022 to 2024, which is factually correct according to the original answer. The mention of internal facilities for InP-based fiber optic communications is consistent in both years. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly infers continuity in fabrication strategy and identifies a strategic emphasis in 2024. However, it diverges slightly from the ground truth by focusing on 'investment in product development and fabrication capabilities' and 'protecting IP' and 'accelerating time-to-market,' which, while plausible, are not explicitly mentioned in the original answer. The ground truth emphasizes a shift in *competitive positioning discourse*, specifically naming Coherent Corp. and Lumentum as competitors to highlight differentiation—this key detail is missing in the LLM response, representing a minor omission in qualitative accuracy. (4) Despite this, the answer remains contextually relevant and captures the core evolution: continued internal fabrication with increased strategic emphasis. The answer could have been stronger by explicitly referencing the named competitors and the framing of InP lasers as a competitive differentiator. Thus, correctness and qualitative accuracy are slightly reduced to 8, but not further due to overall strong alignment in substance and logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 444,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership of NIKE's Class A Common Stock, holding approximately 77% as of June 30, 2022, and June 28, 2024. This ownership grants Swoosh, LLC substantial influence over NIKE's governance, as holders of Class A Common Stock elect three-quarters of the Board of Directors. The ownership structure remains stable, with no notable changes in Swoosh, LLC's control or voting power. This continued dominance reinforces the concentration of shareholder influence, potentially limiting the ability of other shareholders to effect major corporate changes or influence board decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Swoosh, LLC maintained approximately 77% ownership of NIKE's Class A Common Stock, which aligns with the ground truth for 2022. However, it incorrectly states the 2023 data point as 'June 28, 2024', which is outside the requested 2022–2023 timeframe and factually inconsistent with the original answer—there is no mention of 2024 in the ground truth. The original specifies that the 77% and ~16% conversion to Class B remained consistent between 2022 and 2023, but the LLM fails to mention the Class B conversion entirely, omitting a key multi-hop component of the ownership structure. (2) The percentage (77%) is accurate, but the date reference for 2023 is misstated as 2024, introducing a factual error in time period alignment. The absence of the 16% implied Class B ownership if converted is a significant quantitative omission. (3) The reasoning around governance influence—specifically that Class A holders elect three-quarters of the board—is contextually sound and adds relevant qualitative insight not in the original but consistent with typical dual-class structures. However, the model fails to synthesize the full ownership structure across both share classes as required by the multi-hop nature of the question. It focuses only on Class A and omits the derived Class B ownership implication, weakening the completeness of the analysis. (4) Despite missing a core quantitative element (Class B conversion percentage) and introducing a date error (2024 instead of 2023), the LLM captures the stability of ownership and its implications for shareholder influence, maintaining high contextual relevance. The qualitative reasoning about concentrated control and limited influence for other shareholders is logically sound and aligned with the original's implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 496,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved through the integration of the Swedish Match acquisition and expansion of market availability. In 2022, the acquisition of Swedish Match, a leader in oral nicotine delivery, marked a key milestone in PMI's transformation to a smoke-free company, enabling the combination of IQOS and ZYN brands. By 2023, PMI had progressed in integrating Swedish Match into its regional structure and expanded its RRP portfolio, with smoke-free products available in 84 markets. This integration and expansion strengthened PMI's portfolio diversification and positioned it to accelerate its smoke-free ambitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of PMI's Reduced-Risk Products (RRPs) from 2022 to 2023, particularly highlighting the Swedish Match acquisition and the expansion to 84 markets by 2023, which aligns with the ground truth. The quantitative claim of '84 markets' is accurate and matches the original answer. However, the LLM omits a key qualitative shift reported in the ground truth: the reclassification of RRPs into a broader category called Smoke-Free Products (SFPs), which now includes wellness and healthcare offerings. This rebranding and portfolio integration is a central element of PMI's strategic shift and is not mentioned in the LLM response. (2) Quantitative accuracy is perfect: '84 markets' is correctly cited, and the 2022 acquisition of Swedish Match is factually accurate. No calculations are required, and all dates/entities are correct. (3) The multi-hop reasoning is partially sound—the model connects the Swedish Match acquisition to portfolio expansion and market growth, which is valid. However, it fails to synthesize the full scope of portfolio integration beyond brand combination (i.e., the creation of the SFP category beyond RRPs). (4) The correctness score is 7 because core facts (acquisition, market expansion) are accurate, but a major strategic element (reclassification into SFPs with expanded scope) is missing. Quantitative accuracy is 10 due to correct numbers and dates. Qualitative accuracy is 7 due to the omission of a key conceptual shift. Contextual relevance is 9 as the answer stays focused and relevant, only missing a critical nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 445,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, with a shift in sales performance across key applications. In 2024, reciprocating engine sales saw growth in gas compression and turbines, partially offset by declines in well servicing and aftermarket parts. This contributed to a mixed revenue composition, with Oil and Gas sales remaining flat and Industrial sales declining by 18%. However, favorable price realization and increased sales in Power Generation and Transportation improved overall gross margin potential, as evidenced by Energy & Transportation's profit rising 16% to $5.736 billion in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and focus. The original answer states that Caterpillar evolved from selling reciprocating engines through its dealer network and Perkins in 2022 to including remanufacturing of its own and third-party engines by 2024, shifting toward a full lifecycle service provider model. In contrast, the LLM answer discusses sales performance by application (e.g., gas compression, well servicing), revenue changes in Oil & Gas and Industrial segments, and margin improvements due to price realization—none of which are mentioned or supported by the ground truth. There is no reference to remanufacturing, lifecycle services, or strategic expansion into service-based offerings. (2) Quantitatively, the LLM introduces specific figures such as an 18% decline in Industrial sales, 16% profit growth to $5.736 billion in Energy & Transportation, and mentions of aftermarket parts—all of which are absent from the ground truth and cannot be verified. These numbers are therefore factually incorrect or hallucinated. (3) The multi-hop reasoning is flawed: the question asks about strategic evolution and its impact on revenue composition and gross margins. The correct reasoning path involves identifying the shift from product sales to remanufacturing/services and inferring higher margins due to lower material costs. The LLM instead focuses on unrelated sales trends and margin impacts from price realization, failing to synthesize the correct strategic shift. (4) The contextual relevance is moderate because the answer stays within Caterpillar and the reciprocating engines business and touches on revenue and margins, but it misses the core strategic evolution entirely. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher only because the answer attempts financial reasoning within the right domain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 516,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained a consistent commitment to disclosing amendments to the Directors' Code of Conduct by posting updates on its website at the provided URLs. However, the 2023 filing demonstrated a slight enhancement in transparency by explicitly specifying the exact web addresses for both the Code of Conduct and the Directors' Code of Conduct, ensuring stakeholders could access the documents more directly. No new mechanisms for stakeholder communication were introduced, but the clarity of disclosure channels was reinforced.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a detail not present in the ground truth, affecting factual accuracy. (1) The original answer states that BNY Mellon's approach remained consistent between 2022 and 2023 with no change in mechanism or transparency commitment. The LLM answer correctly notes the consistency in posting amendments online but incorrectly claims a 'slight enhancement in transparency' in 2023 by specifying exact web addresses. This detail is not supported by the ground truth, which makes no mention of increased specificity in URLs or improved access. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound in that the model correctly identifies the continuity in disclosure practices, but it overreaches by inferring an enhancement in transparency not present in the source data, reducing qualitative accuracy. (4) The answer remains contextually relevant, addressing the core question about mechanisms and transparency, but the unsupported claim about improved clarity lowers the correctness and qualitative scores. The core fact—consistent website posting—is correct, but the added nuance misrepresents the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 353,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a combination of operational streamlining and market restructuring. In FY22, Nike emphasized growth in its NIKE Direct business within APLA, which was part of its broader Consumer Direct Acceleration strategy, aiming to enhance consumer experiences through digital and owned retail channels. However, in FY23, Nike transitioned certain APLA country operations, such as Argentina and Uruguay, to third-party distributors, reflecting a shift toward optimizing its geographic footprint and focusing on higher-growth or more operationally viable markets. This change is evident in Note 18 of FY23, which details the divestiture of these entities, signaling a more selective and strategic approach to market participation in the APLA region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Nike's direct operations in APLA during FY22, including the role of NIKE Direct and its contribution to growth (linked to the 14% increase mentioned in the original answer, though the LLM does not explicitly repeat the percentage but references the broader strategy). (2) For FY23, it accurately describes the shift to third-party distributors in specific APLA countries like Argentina and Uruguay, which matches the ground truth's claim of transitioning certain businesses. It also correctly references Note 18 of the FY23 filing as evidence, demonstrating proper sourcing. (3) The multi-hop reasoning is sound: it synthesizes information across fiscal years and operational models, correctly inferring a strategic pivot from direct to partner-driven engagement. (4) While the LLM does not explicitly state the 14% growth figure from FY22, it contextualizes the NIKE Direct expansion appropriately within the Consumer Direct Acceleration strategy, which is semantically consistent. The omission of the exact percentage is minor and does not detract from the overall correctness. All entities (Nike, APLA, FY22, FY23, third-party distributors) are accurate. The answer is fully relevant and provides additional context (e.g., divestiture details in Note 18) that enhances understanding without introducing errors. Quantitative accuracy is perfect—no incorrect numbers or misstatements. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 443,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, Favorable Price Realization positively impacted Caterpillar's sales and profitability. In 2021 (as referenced in the 2022 filing), favorable price realization contributed to a 22% increase in consolidated sales and a 51% increase in operating profit. By 2024, despite a 3% decline in total sales compared to 2023, favorable price realization partially offset lower sales volume and helped maintain an improved operating profit margin of 20.2% (up from 19.3% in 2023). This indicates that while sales volume declined, price realization remained a key driver in sustaining profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 data from the 2022 filing, while the question asks about 2022 to 2024. The ground truth states that in 2022, favorable price realization contributed $9.223 billion to sales, but the LLM claims a 22% increase in sales and 51% increase in operating profit—metrics not present in the original answer and misaligned with the requested timeframe. For 2024, the LLM reports a 3% decline in sales and a margin increase to 20.2% from 19.3%, which are not mentioned in the ground truth. Instead, the original answer specifies that favorable price realization offset a $2.251 billion sales volume decrease and helped increase profit from $10.335B (2023) to $10.792B (2024). These specific dollar amounts and the profitability trend are entirely missing or misrepresented in the LLM response. (2) The quantitative inaccuracies are severe: none of the percentages (22%, 51%, 3%, 20.2%, 19.3%) match the ground truth, and the key dollar figures ($9.223B, $2.251B, $10.335B, $10.792B) are absent. Calculations such as the profit increase of $457 million ($10.792B - $10.335B) are not reflected. (3) The reasoning is partially sound in recognizing that price realization helped offset volume declines and sustain profitability, which aligns with the original conclusion. However, the multi-hop synthesis fails because it draws on incorrect years (2021 data) and does not connect the correct financial impacts across 2022, 2023, and 2024 as required. (4) The contextual relevance is moderate—while the answer addresses the general theme of price realization's impact on sales and profitability, it lacks the correct data and timeline. Due to major factual and numerical errors, the correctness score is low at 3, quantitative accuracy is 2 (severe number mismatches), qualitative accuracy is 4 (some correct logic but flawed entity/time alignment), and contextual relevance is 7 (topic is appropriate but details are wrong).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 541,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors shifted its strategic focus in EV manufacturing capacity by refocusing its autonomous vehicle (AV) strategy from robotaxi applications to personal vehicles and prioritizing the development of ADAS technology on a path to fully autonomous personal vehicles. Additionally, GM emphasized the need to build a more resilient, scalable, and sustainable North American-focused EV supply chain, including strategic sourcing initiatives and long-term supply agreements to secure raw materials. These changes reflect a more targeted and integrated approach to EV production and supply chain development.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies GM's 2024 emphasis on building a resilient, scalable, and sustainable North American-focused EV supply chain, including strategic sourcing and long-term supply agreements for raw materials, which aligns with the original answer. However, it introduces a significant factual inaccuracy by claiming that GM shifted its strategic focus by refocusing its autonomous vehicle (AV) strategy from robotaxi to personal vehicles and prioritizing ADAS development. This information is not present in the ground truth and is irrelevant to the question about EV manufacturing capacity evolution. The original answer makes no mention of AV or ADAS strategy changes, focusing instead on supply chain resilience and investment risks. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the shift toward supply chain development between 2023 and 2024, but fails to accurately represent the nature of the strategic shift by inserting unrelated content about autonomous vehicles, which undermines the qualitative accuracy. (4) The correctness score is 5 due to the inclusion of incorrect, off-topic strategic shifts (AV/ADAS), even though the supply chain component is accurate. Contextual relevance is moderate because while the answer addresses EV supply chain development, it diverts into unrelated strategic areas, reducing its overall fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 439,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid significantly declined from 2022 to 2024. In 2022, Paxlovid contributed $18.9 billion in revenues, driven by large government contracts. By 2023, this dropped to $1.3 billion due to a non-cash revenue reversal of $3.5 billion related to expected returns of EUA-labeled U.S. government inventory. In 2024, Paxlovid revenues rebounded to $5.7 billion as the product transitioned to commercial markets, though this was still lower than 2022 levels. Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, indicating a reduced but ongoing financial commitment compared to earlier years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original question asks about the evolution of Pfizer's financial commitment to Paxlovid based on remaining performance obligations (RPOs) in 10-K filings from 2022 to 2024. The ground truth states that RPOs for Paxlovid were not disclosed in 2022 but were $1 billion as of December 31, 2024. The LLM incorrectly frames the evolution as a 'decline' and introduces revenue figures ($18.9B in 2022, $1.3B in 2023, $5.7B in 2024) that are not equivalent to remaining performance obligations. While the $1 billion RPO figure for 2024 is correctly stated, the rest of the financial data refers to revenues, not RPOs, which are distinct accounting metrics. (2) Quantitatively, the $1 billion RPO for 2024 matches the ground truth and is accurate. However, the revenue numbers, while possibly factually correct in another context, are irrelevant to the question about RPOs and misrepresent the financial commitment metric asked. There is no indication in the ground truth that RPOs were ever $18.9B or declined from that level. (3) The multi-hop reasoning is flawed. The model fails to recognize that the absence of disclosed RPOs in 2022 (per ground truth) represents an undefined commitment, not a high one. Instead, it infers a 'decline' based on revenue trends, which is not supported by the question's focus on RPOs. The synthesis is incorrect because it substitutes revenue for performance obligations, leading to a reversed conclusion. (4) The contextual relevance is moderate because the answer discusses Paxlovid, Pfizer, and a financial metric over time, but it fundamentally misaddresses the core concept—remaining performance obligations—by conflating it with past revenues. This results in a misleading narrative about the evolution of financial commitment. Correctness is severely compromised due to this conceptual error, warranting a low score despite one accurate data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 529,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar enhanced its approach to monitoring supplier financial viability by strengthening contractual agreements and risk mitigation strategies. In 2022, the company emphasized using agreements to protect intellectual property and monitor risks such as supplier financial viability, production flexibility, business continuity, quality, and delivery. By 2023, Caterpillar further solidified its risk mitigation by amending and extending credit facilities, ensuring robust financial safeguards, and maintaining strict compliance with covenants, which indirectly reinforced the stability of its supply chain. These actions reflect a more proactive and structured approach to supplier risk management.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity representation compared to the ground truth. (1) Correct elements: The mention of Caterpillar using supplier agreements in 2022 to protect intellectual property and monitor risks, including financial viability, aligns with the original answer. The general idea of a more structured approach in 2023 is also consistent. (2) Quantitative accuracy is high because there are no numerical values in the response, and the years (2022 and 2023) are correctly referenced. (3) However, the multi-hop reasoning is flawed: the LLM incorrectly claims that Caterpillar 'amended and extended credit facilities' and ensured 'compliance with covenants' as part of supplier risk mitigation—this information is not in the ground truth and appears to be fabricated or misattributed (possibly from Caterpillar's own financial disclosures rather than supplier-related actions). The original answer emphasizes a shift in disclosure emphasis—listing supplier financial viability as the first risk in 2023 and reinforcing strategic sourcing models—not changes in Caterpillar's credit facilities. (4) The LLM fails to capture the actual evolution: a more explicit prioritization of supplier financial viability in disclosures and a focus on long-term relationships and enterprise spend leverage. Instead, it introduces irrelevant financial covenant details, undermining qualitative accuracy. While contextually relevant to supplier risk, the answer misrepresents the nature of the evolution, warranting a moderate correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 438,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become more advanced and integrated within its value-added services, emphasizing AI and machine learning capabilities. In 2022, the focus was on foundational fraud prevention tools and authentication services. By 2024, Visa had introduced three new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme agnostic Visa Advanced Authorization—to reduce fraud across various payment types, both on and off Visa's network. These enhancements reflect a strategic shift toward a more comprehensive, AI-powered fraud risk management solution, positioning Risk and Identity Solutions as a central component of Visa's broader efforts to secure and streamline digital payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's Risk and Identity Solutions between 2022 and 2024 and correctly identifies a strategic shift toward more advanced, integrated services. It accurately reflects that in 2022, the focus was on foundational tools, and by 2024, there was a more advanced, AI-driven approach. However, it diverges from the ground truth in key qualitative aspects: the original answer emphasizes a three-pillar strategic framework (1) services for Visa transactions, (2) network-agnostic services, and (3) services beyond payments, which is not mentioned in the LLM response. Instead, the LLM introduces specific product names—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme agnostic Visa Advanced Authorization—that are not present in the ground truth and cannot be verified as correct from the provided knowledge. While these may be plausible, they represent unverified details that shift focus from the structural strategic evolution described in the original. The LLM also emphasizes AI and machine learning as a central theme, which, while reasonable, is not highlighted in the ground truth. Quantitatively, there are no numbers, dates, or financial figures to verify accuracy, so the score is based on consistency with timeframes (2022–2024), which are correct. Contextually, the answer is highly relevant and addresses the evolution in strategic positioning and integration. However, the failure to reflect the three-pillar strategic framework—a core element of the ground truth—represents a significant omission in multi-hop synthesis and conceptual accuracy, limiting the correctness score despite strong contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 463,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor remained significant in 2023, with continued challenges from retail customer policies such as inventory de-stocking, fulfillment requirements, and limitations on shelf space access. However, the expansion of alternative retail channels, particularly the growth of eCommerce and direct-to-consumer models, has provided some mitigation by diversifying sales distribution. The company has also increased advertising investment and digital capabilities to adapt to evolving consumer preferences and retail dynamics. While the risk persists, the expansion into alternative channels appears to have lessened the dependency on traditional retail shelf space to some extent compared to 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that shelf space limitations remained a significant risk in 2023 and were linked to retail customer policies, consistent with the 2022 disclosure. The evolution from a potential risk (2022) to an active challenge (2023) is implied through the description of ongoing impacts and adaptive strategies, though the explicit shift from 'potential' to 'actively impacted' noted in the original answer is slightly softened. (2) There are no numeric values to verify; thus, quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information about changes in risk characterization over time and connects it to the growth of alternative channels like eCommerce and DTC. It also correctly infers mitigation strategies such as investment in digital capabilities, which matches the original answer’s mention of digital and analytics investments. However, the LLM adds 'advertising investment' and 'inventory de-stocking' and 'fulfillment requirements'—details not present in the ground truth—which introduces minor inaccuracies or unsupported inferences. (4) Contextual relevance is high, as all parts of the question are addressed: evolution between 2022 and 2023, retail policy changes, and alternative channel expansion. The answer conveys semantic equivalence but with slight overreach in specifics not in the source. Hence, correctness is 8 due to minor factual additions, but core facts and reasoning remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 424,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's approach to hybrid deployments between fiscal years 2023 and 2024 has emphasized flexibility and customer choice, with a strategic focus on integrating cloud and on-premise solutions. In fiscal 2024, Oracle continued to expand offerings like Oracle Exadata Cloud@Customer and Dedicated Region, enabling customers to deploy Oracle Cloud infrastructure within their own data centers. This reflects an increased strategic emphasis on hybrid and multicloud options to meet diverse customer needs. Additionally, Oracle invested in second-generation cloud infrastructure and optimized operations through restructuring initiatives to better support hybrid deployment models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Oracle's continued emphasis on hybrid deployments from fiscal 2023 to 2024, highlighting key offerings like Oracle Exadata Cloud@Customer and Dedicated Region, which are explicitly mentioned in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses refer to fiscal years 2023 and 2024 without specific numbers, so quantitative accuracy is not applicable but assumed correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle’s strategic evolution by noting continuity in hybrid support while emphasizing deeper integration and infrastructure improvements in 2024, which matches the ground truth’s claim of a shift toward 'deeper integration and support' and 'interoperable and extensible' environments. (4) The LLM adds a detail about 'second-generation cloud infrastructure' and 'restructuring initiatives' not present in the original answer—this is plausible context but not confirmed in the ground truth, slightly reducing qualitative accuracy. However, it does not contradict and enhances relevance. Overall, the answer is semantically equivalent, factually correct, and fully addresses the question on product offerings and strategic emphasis evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 382,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly evolved between 2022 and 2024. In 2022, Paxlovid generated $18,933 million in revenue, primarily driven by government contracts, while remaining performance obligations totaled $1 billion. By 2024, Paxlovid revenue decreased to $5,716 million as sales shifted to commercial markets, and remaining performance obligations dropped to $442 million, reflecting the transition of supply agreements and the creation of a U.S. Strategic National Stockpile (SNS) for future pandemic preparedness.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer reported $1 billion in remaining performance obligations for Paxlovid as of December 31, 2024, with revenue expected from 2025 to 2028. However, the LLM claims that by 2024, remaining performance obligations dropped to $442 million, which contradicts the ground truth. Additionally, the LLM states that in 2022, remaining performance obligations were $1 billion — but the original answer does not specify a dollar amount for 2022, only noting potential ongoing revenue. The revenue figures cited ($18,933 million in 2022 and $5,716 million in 2024) are not present in the ground truth and are therefore unsupported. (2) Quantitative accuracy is very low: none of the specific revenue numbers or the 2024 remaining obligations figure match the ground truth. The $1 billion figure is correctly mentioned but misattributed to 2022 instead of 2024, and the drop to $442 million is entirely fabricated. (3) The multi-hop reasoning is flawed — the LLM incorrectly infers a declining trend in performance obligations without evidence and introduces new elements like the U.S. Strategic National Stockpile (SNS) and a shift to commercial markets, which are not mentioned in the original answer. These additions reflect plausible context but are not supported by the provided ground truth. (4) While the LLM attempts to address the evolution of financial commitment and uses relevant financial terminology, the core data is incorrect, leading to a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual fidelity is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 462,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained structured under standard sales and service agreements, which grant dealers the right to sell and service Caterpillar products within specified geographic territories. These agreements emphasize dealers' obligations to promote Caterpillar products, maintain adequate personnel, and manage inventory effectively. While no significant changes to contractual obligations are explicitly noted, Caterpillar's 2023 filing highlights a strategic emphasis on dealer collaboration in managing inventory levels and responding to market conditions, underscoring the importance of dealer performance in driving sales and supporting customer demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key aspect of the evolution in Caterpillar's dealer relationships between 2022 and 2023. (1) Correctly identifies that dealers operate under sales and service agreements and have obligations to promote products, maintain personnel, and manage inventory—this aligns with the 2023 description in the ground truth. However, it fails to note the significant shift from a general partnership model in 2022 to a formalized, standardized contractual framework in 2023. The original answer emphasizes that 2022 was characterized by general descriptions, while 2023 introduced detailed, structured agreements—a critical evolution that the LLM answer overlooks by stating 'no significant changes' and implying continuity. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; the score reflects absence of numerical errors. (3) The multi-hop reasoning is flawed: the question asks for changes between two years, requiring comparison across filings. The LLM does not correctly synthesize this temporal evolution, incorrectly suggesting stability rather than a strategic shift toward formalization and control. (4) Contextual relevance is high because the answer discusses dealer obligations and strategic emphasis, directly addressing the question’s focus, but the lack of recognition of the contractual evolution undermines factual accuracy. Thus, while the content is relevant and plausibly worded, it misrepresents the core factual development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, Colgate-Palmolive reduced its capital expenditures in Africa/Eurasia from $30 million to $10 million, reflecting a reallocation of resources away from the region. Additionally, restructuring charges under the 2022 Global Productivity Initiative impacted Africa/Eurasia, with 10% of the total estimated pre-tax charges attributed to the region in both years. This suggests a strategic shift to streamline operations and focus on higher-growth areas, as part of broader cost-reduction efforts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The capital expenditures for Africa/Eurasia in 2022 were $33 million according to the ground truth, not $30 million as stated in the LLM answer. Furthermore, the LLM claims capital expenditures dropped to $10 million in 2023, but the original answer does not provide any 2023 capital expenditure figure—instead, it notes a shift in focus to restructuring via the 2022 Global Productivity Initiative. Thus, the $10 million figure for 2023 is unsupported and incorrect. (2) The 10% attribution of pretax restructuring charges to Africa/Eurasia is correctly cited, but the LLM incorrectly states this applied 'in both years'—the original answer only specifies this allocation for 2023 (as part of the cumulative charges from the 2022 initiative), not for both 2022 and 2023. (3) The reasoning partially captures the strategic shift from capital investment to restructuring, which aligns with the multi-hop synthesis of evolving focus. However, it fabricates specific expenditure numbers for 2023 and misrepresents the timeline of the restructuring impact, weakening the logical foundation. (4) Despite these errors, the answer is contextually relevant and identifies the correct region, company (implied as Colgate-Palmolive, though not explicitly named in the original), and initiative. It correctly interprets the 10% restructuring charge allocation and infers a strategic pivot, even if some details are inaccurate. Hence, the correctness score is moderate due to core misstatements in numbers and timeline, though the general direction of the conclusion is plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 458,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm has increased its strategic focus on 5G technologies by expanding investments into new industries and applications beyond mobile handsets, such as automotive and IoT, as well as advancing 5G-based innovations like AI integration in its modem-RF platforms. The company has also emphasized commercialization through its Snapdragon brand, aiming to power premium experiences across diverse sectors. Additionally, Qualcomm continues to invest in the development of 5G intellectual property and standards, maintaining a leadership role in driving 5G advancements globally.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements, such as Qualcomm's expansion beyond mobile into automotive and IoT, continued investment in 5G IP, and commercialization via Snapdragon. However, it misses the core evolution described in the ground truth: the shift from a high-risk investment phase in 2022 to a mature monetization phase by 2024, particularly through licensing and QTL revenue generation from OFDMA-based products. The answer does not mention the transition in business model or the successful development of a leading 5G NR patent portfolio that drives revenue. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound—Qualcomm’s strategic focus is correctly linked to broader industry expansion and innovation, but the answer fails to synthesize the key transformation from R&D investment to commercial leadership and licensing monetization, which is central to the question. (4) Contextual relevance is high because the response discusses relevant areas (automotive, IoT, IP development), but it lacks the critical before-and-after comparison of strategic posture between 2022 and 2024. Thus, while qualitatively plausible, it omits the most important outcome: successful commercialization and revenue generation from 5G technologies, especially via QTL. This omission significantly reduces factual completeness and reasoning accuracy, warranting a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 425,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid's revenue contribution to Pfizer significantly declined, dropping from $18,933 million in 2022 to $5,716 million in 2024, primarily due to the transition from government contracts to commercial markets and a revenue reversal in 2023. Contractual commitments also evolved, with remaining performance obligations for Paxlovid decreasing from $1 billion as of December 31, 2024, compared to higher levels in prior years, reflecting the shift in distribution and reduced government orders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Paxlovid generated $76 million in revenue in 2022, not $18,933 million ($18.9 billion) as claimed. The 2024 revenue figure of $5,716 million ($5.7 billion) is also incorrect—no direct revenue for 2024 is stated in the original answer; instead, Pfizer reported approximately $1 billion in remaining performance obligations (not revenue). These numbers are wildly off, indicating severe quantitative errors. (2) The claim that remaining performance obligations 'decreased from $1 billion as of December 31, 2024' misrepresents the data: the $1 billion is the actual remaining obligation in 2024, not a decrease from a higher prior amount. The original answer does not provide prior-year obligation figures for comparison, so asserting a decrease is unsupported. (3) The reasoning is flawed: the original answer describes a strategic shift toward securing longer-term contracts, while the LLM incorrectly infers a decline in contractual commitments. Additionally, the mention of a 'revenue reversal in 2023' and specific commercial transition impacts are not present in the ground truth, introducing unsupported causal explanations. (4) Despite these issues, the answer is contextually relevant—it addresses revenue trends and contractual evolution, which are central to the question. However, due to grossly inaccurate numbers and incorrect synthesis, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the model attempts multi-hop reasoning (linking revenue and contracts over time), but the logic is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 460,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk appears to have increased between 2022 and 2023. In 2022, the impact of tighter credit markets was mentioned in the context of supplier challenges and the impairment of the Filorga business due to higher interest rates. By 2023, the company explicitly highlighted the impact of tighter credit or capital markets on suppliers as a more prominent risk in its supply chain, indicating heightened vulnerability to external financial conditions. This evolution suggests that the company is increasingly recognizing and prioritizing the financial stress on its suppliers as a critical risk factor.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of credit market tightness as a supply chain risk from 2022 to 2023 and notes an increased emphasis in 2023. However, it introduces information not present in the original answer — specifically, the mention of the 'impairment of the Filorga business due to higher interest rates' — which is absent from the ground truth and cannot be verified from the provided context. This addition, while plausible, represents a factual overreach. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is partially sound: the model correctly infers an increased focus on supplier financial stress over time. However, the original answer emphasizes a shift in framing — from suppliers being 'negatively impacted' to the company itself being 'impacted by' these conditions — indicating a broader internalization of risk. The LLM captures heightened concern but misattributes the evolution slightly by focusing on prominence rather than a conceptual shift in vulnerability scope. (4) The answer is contextually relevant and addresses both parts of the question — evolution over time and implications for vulnerability — but the inclusion of unverified details (Filorga) and slightly misaligned reasoning justification prevents a higher score. Semantic equivalence is mostly maintained but not fully achieved due to the extraneous detail and subtle misinterpretation of the nature of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 435,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid significantly declined from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenues, which dropped to $1,279 million in 2023 due to a $3.5 billion non-cash revenue reversal related to expected returns of EUA-labeled U.S. government inventory. In 2024, Paxlovid revenues rebounded to $5,716 million, partially offset by a $771 million favorable adjustment from returned inventory and a $442 million revenue recognition for the U.S. Strategic National Stockpile (SNS) supply. Remaining performance obligations for Paxlovid were approximately $1 billion as of December 31, 2024, with deliveries expected through 2028.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key elements from the ground truth, including the $1 billion remaining performance obligations as of December 31, 2024, the $771 million favorable adjustment related to returned EUA-labeled treatment courses, and the long-term delivery expectations through 2028. However, it introduces specific revenue figures for 2022 ($18,933 million), 2023 ($1,279 million), and 2024 ($5,716 million), along with a $3.5 billion non-cash revenue reversal and a $442 million SNS recognition, which are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually accurate in external sources but are not supported by the disclosed knowledge graph, making them extraneous and potentially misleading in this evaluation context. (2) The $771 million favorable adjustment and $1 billion remaining obligations match the original answer exactly and are correctly contextualized. However, the revenue figures and the $3.5 billion reversal are not mentioned in the ground truth, so their inclusion reduces quantitative accuracy. There is no indication in the original answer that financial commitments 'declined'—in fact, the $1 billion obligation suggests sustained commitment—so the LLM's framing of 'significant decline' contradicts the original narrative. (3) The multi-hop reasoning is partially sound: the model connects contractual obligations, revenue adjustments, and future delivery timelines. However, it incorrectly infers a declining financial commitment based on revenue trends not provided in the ground truth, leading to a flawed overall conclusion. The synthesis of post-EUA adjustments and performance obligations is valid, but the reasoning is skewed by unsupported data. (4) The contextual relevance is high because all discussed topics directly relate to Pfizer's Paxlovid financial and contractual evolution. Qualitative accuracy is good due to correct use of terms like 'remaining performance obligations' and accurate interpretation of the $771M adjustment. Quantitative accuracy is reduced due to unverified revenue numbers and reversals. Correctness score is 7 because core facts (obligations, adjustment) are correct, but major unsupported additions and a mischaracterized trend prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 619,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability related to Aearo Technologies' respirator mask/asbestos litigation slightly decreased. As of December 31, 2023, the accrual was $62 million, and by December 31, 2024, it had been reduced to $51 million. This reduction may reflect ongoing settlements or legal strategies. However, the risk exposure remains significant due to the potential for future claims, legal uncertainties, and the complex allocation of liability among co-defendants. The Company continues to face challenges in estimating the full extent of its liability due to the long-tail nature of these claims and evolving legal and regulatory factors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, 3M (MMM) had a $574 million accrual for respirator mask/asbestos liabilities excluding Aearo, while Aearo was in bankruptcy with litigation stayed. The LLM incorrectly states that the accrual for Aearo specifically was $62 million as of December 31, 2023—this figure does not appear in the ground truth and contradicts it. The only correct number is the $51 million accrual in 2024 for Aearo-related asbestos, silica, and coal mine dust claims. (2) The quantitative inaccuracies are severe: the $62 million figure is fabricated or misattributed, and the reduction from $62M to $51M is therefore based on false premises. The ground truth shows no such direct year-over-year comparison for Aearo alone in 2023. Additionally, the LLM omits the critical context that Aearo was in bankruptcy in 2023 with a stay of litigation, which fundamentally shaped its liability posture. (3) The multi-hop reasoning is flawed. The model fails to synthesize the key structural shift: from Aearo being under bankruptcy protection in 2023 (limiting liability exposure) to a defined post-bankruptcy liability framework in 2024 involving a $51M accrual and a cost-sharing agreement with Cabot. The Cabot agreement—where Cabot assumes pre-1997 exposure in exchange for a $100,000 quarterly fee—is entirely missing, which is a major omission in understanding the evolution of risk exposure. (4) While the LLM correctly identifies that risk remains due to long-tail claims and co-defendant allocation issues, this generic risk commentary does not compensate for the core factual and structural errors. The answer is contextually relevant in topic and direction (discussing trends in liability), but the incorrect numbers and missing contractual framework severely undermine its accuracy. Correctness score is low due to major factual and quantitative errors, despite partial relevance and some correct qualitative themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 541,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 13.9% in 2020 to 9.3% in 2023, indicating a decline of 4.6 percentage points over that period. Between 2023 and 2024, Skoal's retail share further declined by 1.7 percentage points, from 9.3% to 7.6%. This continued decline aligns with the shipment volume trend between 2020 and 2021, where Skoal's shipment volume decreased from 208.5 million to 197.4 million units, a reduction of 11.1 million units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the retail share decline of Skoal from 9.3% in 2023 to 7.6% in 2024, matching the ground truth. It also accurately states the shipment volume decrease from 208.5 million to 197.4 million units between 2020 and 2021. All numeric values (percentages, years, shipment volumes) are factually correct. (2) Calculations are accurate: the 1.7 percentage point decline (9.3% - 7.6%) and the 11.1 million unit reduction (208.5M - 197.4M) are correctly implied. The additional context of a decline from 13.9% in 2020 to 9.3% in 2023 is not requested in the question but is not incorrect; it adds background without distorting the required comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes retail share trend (2023–2024) and shipment volume trend (2020–2021), and draws a valid comparison that both metrics show decline, aligning with the ground truth's conclusion of a consistent downward trend. (4) The answer is fully contextually relevant, addresses both parts of the question, and maintains semantic equivalence with the original answer. The only minor deviation is the inclusion of extra historical data (2020–2023), which does not detract from correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration, but full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 387,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved by expanding its engineering focus areas into new industries such as automotive and IoT, and by integrating advanced features like AI into its product offerings. In 2022, the company emphasized foundational technologies for mobile handsets and their extension into automotive and IoT applications. By 2024, Qualcomm had further integrated AI into its Snapdragon platforms, enhancing performance, connectivity, and power efficiency. Additionally, the company focused on developing and scaling multimedia technologies for applications such as ADAS/AD and XR, reflecting a broader diversification strategy beyond traditional mobile devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Qualcomm's multimedia technology strategy from 2022 to 2024. It correctly identifies the expansion into automotive and IoT, the continued emphasis on multimedia engineering (camera, video, display), and the increased integration of AI—specifically noting AI integration into Snapdragon platforms, which aligns with the ground truth's mention of generative AI in R&D. The answer also accurately reflects the shift beyond mobile handsets and highlights emerging applications like ADAS/AD and XR, demonstrating proper multi-hop synthesis across time and product domains. While the LLM does not explicitly mention 'computer vision' or 'developer enablement' as emphasized in 2024 in the original answer, it conveys a similar platform-oriented shift through its focus on scaling technologies across device categories. All dates (2022, 2024) and entities (Qualcomm, Snapdragon, automotive, IoT, XR) are correct. There are no numerical inaccuracies (no specific numbers to verify, so score is based on absence of errors). The reasoning is sound, and the answer remains contextually focused on engineering focus areas and product integration. Minor omission of 'generative AI' specificity and developer tools prevents a perfect 10, but overall the semantic meaning matches closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 372,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In the second quarter of 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy proceedings, reversing their deconsolidation in the third quarter of 2022. As of December 31, 2022, 3M had an equity investment of $0.7 billion in the Aearo Entities and intercompany balances of $0.6 billion. By December 31, 2023, these balances were eliminated from 3M's consolidated balance sheet due to the reconsolidation. In 2024, the Aearo Entities were part of the Combat Arms Earplug Settlement, with 3M contributing $6.0 billion through 2029, and the reconsolidated entities were fully integrated into 3M's financial reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual and reasoning errors that undermine its overall accuracy. (1) Quantitatively, the $0.7 billion equity investment and $0.6 billion intercompany balances are correctly stated and align with the ground truth, satisfying part of the quantitative accuracy. However, the claim that 3M contributed $6.0 billion through 2029 as part of the Combat Arms Earplug Settlement is not mentioned in the original answer and introduces unverified information, reducing quantitative accuracy. (2) The timeline is partially correct: the reconsolidation in Q2 2023 is plausible context, but the original answer does not reference Q3 2022 deconsolidation or specific quarterly timing, so adding those details introduces unsupported precision. (3) Qualitatively, the reasoning is flawed: the original answer states that by 2024, the Aearo Entities were *no longer consolidated*, and 3M now 'has a stake in' them, indicating a move to equity method accounting. In contrast, the LLM claims the entities were 'fully integrated into 3M's financial reporting' in 2024, which directly contradicts the ground truth. This is a critical error in multi-hop reasoning, as it inverts the actual financial relationship evolution. (4) Contextually, the answer addresses the question's focus on equity investment and intercompany balances and attempts to trace the evolution, so relevance is moderate. However, the conclusion misrepresents the 2024 status, which is central to the question. The answer would be more accurate if it reflected that reconsolidation occurred in 2023 (removing the balances), but then in 2024, the relationship shifted again to a non-consolidated equity stake—this two-step evolution is missing. Overall, while some numbers are correct, the core financial relationship is misrepresented, especially for 2024, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 517,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become more integrated and advanced within the company's broader value-added services portfolio. In 2022, the focus was on leveraging data for fraud prevention and account authentication, with solutions like Visa Advanced Authorization and Visa Secure. By 2024, Visa had expanded its offerings significantly, introducing new products such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization. These additions reflect a strategic shift toward a more comprehensive, AI-powered fraud prevention ecosystem, positioning Risk and Identity Solutions as a central pillar in Visa's efforts to secure digital payments and support its network-agnostic services across both Visa and non-Visa transactions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Visa's Risk and Identity Solutions from 2022 to 2024, noting the initial focus on fraud prevention and key products like Visa Advanced Authorization and Visa Secure, which aligns with the ground truth. It also captures the strategic elevation of the solutions within Visa's broader portfolio by 2024. However, the LLM introduces specific new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization—that are not mentioned in the original answer and cannot be verified from the provided ground truth. These additions, while plausible, represent unverified details that go beyond the source information. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; the years 2022 and 2024 are correctly used. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward broader integration and more advanced capabilities. However, it fails to mention the key structural change in the value-added services portfolio—specifically, that Risk and Identity Solutions became one of five core categories alongside Open Banking and Advisory Services, and that Visa offered over 200 products as of September 30, 2024. This omission reduces completeness and qualitative accuracy. (4) The answer is contextually relevant and well-articulated, but the inclusion of unverified product names and lack of key structural portfolio changes prevent a higher score. The core strategic evolution is captured, but not with full fidelity to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 458,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. The slight increase in 2024 was primarily due to consistent amortization of acquired intangible assets and other adjustments, with no significant changes in the underlying drivers of these adjustments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. The ground truth states that RTX did not provide a quantitative figure for 2024; instead, it shifted to a qualitative disclosure approach. However, the LLM claims a specific number ($2,058 million) for 2024, which is not supported by the original answer. Additionally, the claim of 'no significant changes in the underlying drivers' contradicts the actual evolution in disclosure practice. (2) The 2023 figure of $1,998 million is correct, but the 2024 figure of $2,058 million is fabricated and not present in the ground truth. There is no quantitative data provided by RTX for 2024 at all. (3) The multi-hop reasoning failed: the model should have recognized the shift from quantitative to qualitative disclosure between years, but instead assumed continuity and invented data. It missed the key conceptual change in reporting approach. (4) The contextual relevance is moderate because the answer addresses the topic of acquisition accounting adjustments and operating profit, but the core factual claim about 2024 quantification is false, severely undermining correctness. The qualitative accuracy is low because the reasoning and entity synthesis are flawed, despite using the correct company and metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 365,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud increased from $91.4 billion in fiscal year 2022 to $111.6 billion in fiscal year 2023, and further to $137.4 billion in fiscal year 2024. This indicates a strong growth trajectory for Office 365 Commercial within the broader cloud ecosystem, highlighting its increasing importance as a driver of Microsoft's cloud revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly attributes the entire Microsoft Cloud revenue to Office 365 Commercial, stating that Office 365 Commercial revenue increased from $91.4B to $111.6B to $137.4B. However, according to the ground truth, Office 365 Commercial is only a component of the broader Microsoft Cloud revenue, not the entirety of it. The $91.4B and $111.6B figures represent total Microsoft Cloud revenue for FY2022 and FY2023 respectively, not Office 365 Commercial alone. The $137.4B figure for FY2024 is entirely fabricated and not present in the original answer or context. (2) Quantitative accuracy is severely compromised: while $91.4B and $111.6B are correct Microsoft Cloud revenue figures for FY2022 and FY2023, they are misassigned to Office 365 Commercial. No specific revenue figure for Office 365 Commercial is provided in the ground truth, only its role as a growth driver. The inclusion of a non-existent FY2024 figure further compounds the error. (3) The multi-hop reasoning fails: the model should have recognized that Office 365 Commercial was a contributor within a segment (Productivity and Business Processes) in FY2022 and later subsumed into a consolidated Microsoft Cloud figure in FY2023, indicating increased integration and reporting transparency. Instead, it falsely equates the product with the entire cloud revenue. (4) Contextual relevance is moderate because the answer addresses the growth trajectory theme and mentions Microsoft Cloud, but the factual foundation is incorrect. The conclusion about increasing importance is plausible but unsupported by the erroneous data. Thus, the correctness score is low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 463,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Alliance revenue related to Lynparza grew by 9% in 2024 compared to 2023, primarily due to higher demand in most international markets. A key contributing factor was the approval of Lynparza in January 2025 by China's NMPA as adjuvant treatment for adult patients with germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, which likely expanded its market reach and demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in alliance revenue for Lynparza in 2024 compared to 2023, which matches the ground truth and addresses the first part of the question on revenue evolution. This is factually accurate and aligns with the original answer. However, the LLM introduces a specific event — the January 2025 NMPA approval in China — as a contributing factor for the 2024 revenue growth, which is logically flawed because a 2025 event cannot influence 2024 financial performance. This is a critical factual and temporal inconsistency. (2) Quantitatively, the 9% growth figure is accurate and correctly attributed to 2024 vs 2023. No monetary values or other percentages are misstated, so numerical accuracy is strong. (3) The multi-hop reasoning fails because the model incorrectly infers causality from a future event. While higher international demand is correctly cited as a driver (matching the original answer), the addition of the 2025 approval undermines the reasoning and suggests flawed synthesis or hallucination. The original answer does not mention this approval, nor can it explain 2024 results. (4) The answer is contextually relevant and addresses both parts of the question — revenue change and contributing factors — but the inclusion of an incorrect, forward-looking event significantly reduces qualitative accuracy and overall correctness. The core revenue fact is right, but the explanation contains a major factual error, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 415,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan remained in effect in 2023 and 2024, but it was not the primary plan for future grants. As of 2024, only the 2019 Stock and Incentive Compensation Plan allowed for future grants of securities. The 2014 Plan was included in equity compensation reporting in both years but was not subject to any material regulatory changes between 2023 and 2024. Its inclusion in the 2024 filing was consistent with prior years, reflecting historical data rather than active use for new awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates and plan statuses—correctly identifying that the 2014 Plan was no longer the primary vehicle for new grants by 2024 and that only the 2019 Plan allowed future grants. There are no numerical inaccuracies, as the response avoids specific figures that aren't present in the original, so quantitative accuracy is high. However, the LLM misses the core evolution emphasized in the ground truth: the shift in disclosure context from regulatory focus in 2023 to integration into broader equity compensation reporting related to ownership transparency in 2024. Instead, the LLM characterizes the 2024 inclusion as 'consistent with prior years' and 'reflecting historical data,' which contradicts the ground truth's assertion of a meaningful shift in reporting emphasis. This misrepresents the qualitative evolution the question targets. While entities (2014 and 2019 Plans) and years are correctly identified, the reasoning fails to capture the multi-hop insight about changing disclosure purpose—moving from compliance-oriented regulatory context to structural transparency in equity ownership. Thus, while contextually relevant and factually plausible, the answer lacks the nuanced interpretive accuracy required, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 362,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains part of Procter & Gamble's equity compensation structure in both the 2023 and 2024 10-K filings, but its role has diminished as newer plans have taken precedence. In 2024, it is listed among other plans in the equity compensation table but is not the primary vehicle for future grants, which are instead governed by the 2019 Stock and Incentive Compensation Plan. This reflects a shift in the company's focus toward more recent equity compensation frameworks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the 1992 Stock Plan remains part of Procter & Gamble's equity compensation structure in both 2023 and 2024, and that its role has diminished with newer plans like the 2019 Stock and Incentive Compensation Plan taking precedence. The answer correctly identifies a shift in presentation and relevance, aligning with the ground truth's observation of the plan transitioning from a standalone referenced plan in 2023 to being included in a consolidated table in 2024. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (1992 Stock Plan, 2019 Plan, Procter & Gamble) are correctly identified. The reasoning is sound and reflects appropriate multi-hop synthesis between the two filings. However, the LLM omits the specific detail from the ground truth about the 2023 reference being 'incorporated by reference to prior filings' and the significance of the 2024 consolidated table format, which provides more precise evidence of the structural shift. While the core conclusion is correct and semantically equivalent, this missing nuance prevents a full 9–10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 333,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company observed that clients increasingly prioritized large-scale transformations, which convert to revenue over a longer period. This shift was influenced by ongoing economic and geopolitical volatility, which caused clients to reduce spending on smaller, shorter-duration contracts and consulting services during fiscal 2024. As a result, the company's revenue conversion timelines have lengthened due to the emphasis on these long-term transformation projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the company's emphasis on large-scale transformations between 2023 and 2024. It correctly identifies that clients prioritized large-scale transformations with longer revenue conversion timelines, while reducing spending on smaller, shorter-duration contracts and consulting services. The mention of economic and geopolitical volatility aligns with the context provided in the original answer, even if the original answer only explicitly states 'economic volatility'—the addition of 'geopolitical' is a reasonable inference and does not contradict the source. The LLM correctly conveys that revenue conversion timelines have lengthened due to the strategic focus on long-term projects, which is consistent across both years. There are no numerical figures in the original answer, so quantitative accuracy is scored as 10. The only minor shortcoming is that the LLM slightly compresses the two-year evolution: it attributes the spending shift primarily to 'fiscal 2024', whereas the original answer notes the trend began in 2023 and continued into 2024. This downplays the continuity emphasized in the ground truth, but the overall qualitative and contextual accuracy remains high. The answer is semantically equivalent and addresses all parts of the question—client spending patterns and revenue conversion timelines—across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 388,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued 4,904,718 Class A Ordinary Shares under its 2010 Employee Share Purchase Plan (ESPP), compared to 5,710,542 in fiscal 2023, representing a decrease of 805,824 shares. This reduction in issuance slightly decreased the number of shares outstanding under employee compensation programs. The impact on equity structure is reflected in the Consolidated Shareholders' Equity Statements, where the issuance of Class A shares for employee programs contributed to an increase in additional paid-in capital and total shareholders' equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture issued 7,970 Class A Ordinary Shares for employee share programs in fiscal 2024, not 4,904,718 shares under the ESPP. Similarly, the 2023 issuance was not 5,710,542 shares under ESPP but rather share acquisitions occurred via withholding for tax obligations—no net issuance. The LLM incorrectly states there was a decrease in share issuance, while the ground truth shows a shift from share withholding (reducing shares) to actual issuance (increasing shares). (2) The numbers provided by the LLM (e.g., 4.9M and 5.7M shares) are entirely inconsistent with the ground truth (7,970 issued in 2024), and the claimed decrease of 805,824 shares is unsupported. Additionally, the ground truth reports total Class A shares increasing from ~15.66M to ~15.66M (a net +7,970), which contradicts the LLM's narrative. Treasury share changes are ignored in the LLM response, despite being a key part of the equity impact. (3) The reasoning is flawed: the LLM fails to recognize the multi-hop shift in policy—from acquiring shares via withholding in 2023 to issuing new shares in 2024. It mischaracterizes the mechanism (ESPP vs. broader employee share programs) and misses the structural change in equity treatment. (4) While the general topic (employee compensation via shares) and direction of impact on equity (increase in paid-in capital) are contextually relevant, the specific facts, numbers, and synthesis are largely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 431,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments slightly decreased between 2022 and 2023, from $475 million to $473 million. This minor reduction contrasts with the company's broader trend of reducing exposure to other foreign currency-denominated debts, such as Swiss franc and euro notes, during the same period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, MDLZ's Canadian-denominated debt decreased by $3 million in 2022 (to $3 million) and then increased by $8 million in 2023, reversing the prior trend. The LLM claims a decrease from $475 million to $473 million, which is not supported by the data and misrepresents the scale (off by two orders of magnitude). (2) The numbers are completely inaccurate: the actual Canadian notes were $3 million in 2022 and increased in 2023, not $475M. There is no mention of the correct figures or the reversal trend. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning fails: the model does not recognize the reversal in trend (from decreasing to increasing) in Canadian notes, instead suggesting a continued minor decrease. It also incorrectly frames this as consistent with broader reduction trends, while the ground truth states this reversal contrasts with the fluctuating but generally declining pattern in other currencies like euro and Swiss franc. (4) The contextual relevance is low because the answer discusses foreign currency debt trends, but with wrong data and incorrect interpretation of directional changes. The qualitative reasoning is flawed due to incorrect entity values and failure to synthesize the correct trend shift. Only minimal credit is given for addressing the general topic of foreign currency debt management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 407,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 through a more strategic and structured focus on innovation and investment. In 2023, the company emphasized its global delivery capability and innovation consulting, including leveraging emerging technologies and deep expertise in innovation consulting. By 2024, Accenture Ventures became a more explicitly highlighted component of its strategy, partnering with and investing in growth-stage companies that create innovative enterprise technologies. Additionally, the company increased its R&D spending to $1.2 billion in 2024, supporting applied research and development through initiatives like Accenture Labs and innovation hubs, which incubate emerging technologies such as blockchain, metaverse, and quantum computing. This evolution reflects a stronger, more proactive engagement with growth-stage companies to drive long-term innovation and client value.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture's evolving engagement with growth-stage companies and includes accurate R&D spending figures ($1.2 billion in 2024, consistent with ground truth), though it omits the $1.3 billion spent in 2023. The core shift from 'partnering' to 'investing' is partially captured but not clearly emphasized as a strategic evolution from partnership to direct investment. Instead, the LLM states Accenture Ventures was 'partnering with and investing in' companies in 2024, which blurs the distinction and fails to highlight the model shift from partnership (2023) to investment (2024). (2) Quantitatively, the $1.2 billion R&D figure for 2024 is correct. However, the omission of the 2023 $1.3 billion figure—present in the original answer and relevant for comparison—reduces completeness. No incorrect numbers are stated, so quantitative accuracy is fully preserved where data is provided. (3) The multi-hop reasoning is partially sound: the model connects Accenture Ventures, innovation strategy, and R&D spending, but it does not clearly synthesize the key evolution in engagement model (from 'partners with' to 'invests in') as a strategic deepening. This weakens the qualitative accuracy despite correct contextual elements. (4) Contextual relevance is high because the response addresses innovation focus, Accenture Ventures, and R&D support for emerging technologies. However, the failure to clearly articulate the shift in strategic involvement—from partnership to direct investment—results in a moderate deduction in correctness and qualitative accuracy. The answer is factually consistent but misses a key nuance in strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 461,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca has shown growth in alliance revenue and ongoing amortization of capitalized milestone payments. Alliance revenue from Lynparza increased from $989 million in 2021 to $1.1 billion in 2024, driven by higher international demand and new regulatory approvals, including in China. The intangible asset balance related to Lynparza, which includes capitalized milestone payments, was $1.1 billion at December 31, 2021, and is being amortized over its estimated useful life through 2028. This reflects Merck's continued investment and shared commercialization success in the collaboration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and dates compared to the ground truth. The original answer states that in 2022, Merck was amortizing a $1.1 billion intangible asset balance related to Lynparza, expected to be amortized through 2028. The LLM incorrectly cites the $1.1 billion balance as of December 31, 2021, not 2022, which misaligns the timeline. Additionally, the LLM claims alliance revenue grew from $989 million in 2021 to $1.1 billion in 2024, but this data is not present in the ground truth. The ground truth only states a 9% revenue growth in 2024 due to international demand, without providing specific revenue figures for 2021 or 2024. Thus, the LLM fabricates precise dollar amounts unsupported by the source. (2) The calculation of a 9% increase is missing from the LLM response; instead, it invents a revenue progression not in the original. The amortization period through 2028 is correctly mentioned, but tied to an incorrect year for the asset balance. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the dual focus on amortization and revenue growth, links international demand and Chinese approval to revenue growth, and acknowledges the strategic importance of Lynparza. However, it fails to mention the shift in focus from amortization (2022) to revenue growth (2024), a key evolution highlighted in the ground truth. Also, the new China approval is correctly noted but misplaced in timing—the ground truth specifies early 2025, while the LLM implies it occurred by 2024. (4) Contextual relevance is high, as the response addresses both financial (amortization, revenue) and strategic (approvals, international expansion) aspects of the collaboration. However, due to significant quantitative inaccuracies and some fabricated data points, the correctness score is limited to 6—partially correct but with major factual flaws in numbers and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 523,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps within the Distributed Software portfolio has shifted from a general mention in 2023 to a more defined role in 2024, where it is explicitly positioned as part of a structured framework alongside DevOps and AIOps. In 2023, ValueOps was briefly referenced as part of the broader Distributed Software solutions. By 2024, ValueOps is clearly outlined as a domain delivering end-to-end visibility across the digital lifecycle, emphasizing its role in enabling customers to realize better business outcomes. This evolution indicates that ValueOps is becoming a more integral and strategic component of AVGO's Distributed Software portfolio, focused on aligning business, development, and operational teams to drive profitability and customer experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the shift in AVGO's strategic emphasis on ValueOps from 2023 to 2024. In 2023, ValueOps was briefly mentioned as part of the Distributed Software portfolio without detailed strategic context, which the LLM accurately describes as a 'general mention' and 'briefly referenced.' By 2024, it was elevated to a core domain alongside DevOps and AIOps, with an explicit focus on 'end-to-end visibility across all stages of the digital lifecycle'—this is correctly reflected in the LLM answer. The conclusion that ValueOps became more integral and strategically aligned with business outcomes and customer experience matches the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answer that require calculation or verification; all temporal references (2023, 2024) are accurate and consistent with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2023 vs 2024) and infers the strategic evolution of ValueOps within AVGO’s portfolio. It correctly identifies the shift from peripheral offering to foundational pillar, though it slightly softens the strength of 'organized in the domains of' by saying 'part of a structured framework,' which is semantically close but less precise. (4) The LLM answer is contextually fully relevant, directly addressing both parts of the question: the change in strategic emphasis and what it indicates about ValueOps’ evolving role. The only minor shortcoming is the lack of explicit mention that ValueOps became one of the three core organizing domains—phrased more definitively in the ground truth—which slightly reduces qualitative precision. However, the overall meaning and factual content are substantially correct, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 501,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved from initial implementation to expanded optimization. In 2023, Network 2.0 was introduced as a multi-year initiative to improve U.S. and Canadian package delivery efficiency, and by 2024, the company had implemented Network 2.0 optimization in over 50 U.S. locations. Expected cost savings were tied to network consolidation, reduced pickup-and-delivery routes, and optimized linehaul operations, with projected total pre-tax business optimization costs of approximately $1.5 billion through 2025. Implementation risks included higher-than-expected costs, potential loss of customers, union organizing, litigation, and integration challenges, particularly in aligning separate networks and operations under the \"one FedEx\" consolidation plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of FedEx's Network 2.0 strategy within the DRIVE transformation but introduces factual inaccuracies and omits key aspects from the ground truth. (1) Quantitatively, the $1.5 billion pre-tax optimization cost through 2025 is not present in the original answer and cannot be verified against the provided ground truth, which does not include any specific dollar figures for expected costs or savings. This is a significant deviation, as the original emphasizes uncertainty in timing and amount of savings without citing projections. The claim of implementation in 'over 50 U.S. locations' is also absent from the ground truth and cannot be confirmed. (2) In terms of completeness, the question asks about changes in strategic approach, particularly regarding cost savings expectations and implementation risks between 2023 and 2024. The LLM correctly identifies a shift from initial rollout to optimization but fails to reflect the core evolution highlighted in the original: a transition from strategic investment justification (2023) to operational integration risks and financial uncertainties (2024). While it mentions integration challenges, it misses specific 2024 risks like harmonizing operating practices, labor and cultural differences, tax impacts, and asset impairment charges. (3) Entity accuracy is strong—FedEx, Network 2.0, DRIVE transformation, and timeline (2023–2024) are correctly identified. However, the addition of unverified financial figures undermines quantitative accuracy. (4) Reasoning is partially sound: the model infers progression in implementation, but it fabricates specifics rather than drawing on the documented shift in risk disclosure and financial expectation management. (5) Semantically, the answer aligns in tone and structure but diverges in factual content. The original stresses increasing caution and risk disclosure in 2024, while the LLM focuses on expansion and cost-saving mechanisms without acknowledging the heightened uncertainty. Thus, while contextually relevant and reasonably structured, the inclusion of unsupported numbers and omission of key risk factors reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 583,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts increased from $2 million in 2022 to $7 million in 2023. This indicates a modest increase in MDLZ's engagement with these investments during the period, although the overall impact remains relatively small compared to other financial activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, MDLZ reported a net *liability* of $3 million, not a positive $2 million as claimed by the LLM. This is a critical error in both direction (liability vs. gain) and magnitude. By 2023, the position improved to a $7 million gain, which the LLM correctly identifies. However, the misrepresentation of the 2022 figure as a $2 million gain instead of a $3 million liability undermines the quantitative accuracy. (2) The calculation or comparison between years is therefore flawed: the actual shift is from a $3M liability to a $7M gain—a $10M swing—whereas the LLM implies only a $5M increase from $2M to $7M. This misstates the scale and nature of the change. (3) The reasoning is partially sound in interpreting increased engagement, but it misses the key point of a reversal in financial position (from liability to gain), which suggests a more significant strategic shift than 'modest increase.' The LLM underplays the implication by calling it 'relatively small' without contextual support. (4) While the LLM addresses both parts of the question—evolution and interpretation—and correctly identifies the $7M 2023 gain and the company (MDLZ), the core financial data for 2022 is wrong, leading to a low correctness and quantitative accuracy score. Contextual relevance is high because the structure and intent align with the question, and qualitative reasoning is moderate despite flawed inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 415,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from $38 million in fiscal year 2023 to $38 million in fiscal year 2024, remaining unchanged. This suggests that the development progress was in line with expectations, as the cost to complete did not increase despite the passage of time, indicating efficient project management and adherence to the planned budget.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the estimated cost to complete remained unchanged at $38 million from fiscal year 2023 to 2024, which matches the ground truth. The statement that it 'decreased from $38 million to $38 million' is technically awkward but semantically equivalent to 'remained unchanged'—it does not assert a numerical change, so it does not introduce a factual error. (2) All numeric values are accurate: $38 million in both years, and no incorrect calculations are performed. Format is consistent and acceptable. (3) The multi-hop reasoning is sound—LLM correctly infers that stable cost estimates indicate development progress in line with expectations, reflecting proper synthesis of financial data and project management implications. It adds 'efficient project management' as an interpretation, which is reasonable and aligned with the ground truth's conclusion about progress proceeding as planned. (4) The answer is fully contextually relevant, addressing both the quantitative evolution and the qualitative implication about development progress. The slight redundancy in phrasing ('decreased from X to X') does not undermine factual correctness, hence a high score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 345,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office's Ship and Go kiosk has evolved between 2023 and 2024 to become more integrated with e-commerce logistics and returns management. The kiosk now supports a seamless customer experience by allowing label generation via mobile or QR code and secure package drop-off, while also facilitating returns through FedEx Returns Technology and FedEx Consolidated Returns. This evolution indicates that FedEx is enhancing its focus on e-commerce by providing convenient, tech-enabled solutions to streamline shipping and returns, aligning with the growing demand for efficient logistics and returns management in the digital retail landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of the Ship and Go kiosk from a self-serve shipping solution to one more explicitly integrated with returns management via FedEx Returns Technology and Consolidated Returns. It accurately reflects the strategic shift toward e-commerce logistics and returns. However, it omits the specific detail that the number of locations remained approximately 1,300 in both years, which is a key point in the original answer showing consistency in physical footprint despite functional evolution. (2) There are no numeric inaccuracies—no incorrect numbers, dates, or calculations were presented. The absence of the '1,300 locations' figure is a completeness issue, not a quantitative error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about the kiosk’s functionality in 2023 and its enhanced role in returns in 2024, drawing the appropriate conclusion about FedEx’s strategic focus on e-commerce returns infrastructure. (4) The answer is contextually excellent, directly addressing the question about strategic positioning and what it indicates about FedEx’s approach. The omission of the location count slightly reduces completeness and qualitative accuracy, but core facts and implications are correctly conveyed, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 375,
        "total_tokens": 1780
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.89,
    "average_quantitative_accuracy": 6.91,
    "average_qualitative_accuracy": 6.2,
    "average_contextual_relevance": 8.33,
    "score_distribution": {
      "excellent": 240,
      "good": 220,
      "fair": 299,
      "poor": 241
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 6738.92,
    "timestamp": "2026-02-03T22:18:20.841293"
  }
}